Molecule ChEMBL ID,Molecule Name,Molecule Max Phase,Molecular Weight,#RO5 Violations,AlogP,Compound Key,Smiles,Standard Type,Standard Relation,Standard Value,Standard Units,pChEMBL Value,Data Validity Comment,Comment,Uo Units,Ligand Efficiency BEI,Ligand Efficiency LE,Ligand Efficiency LLE,Ligand Efficiency SEI,Potential Duplicate,Assay ChEMBL ID,Assay Description,Assay Type,BAO Format ID,BAO Label,Assay Organism,Assay Tissue ChEMBL ID,Assay Tissue Name,Assay Cell Type,Assay Subcellular Fraction,Assay Parameters,Assay Variant Accession,Assay Variant Mutation,Target ChEMBL ID,Target Name,Target Organism,Target Type,Document ChEMBL ID,Source ID,Source Description,Document Journal,Document Year,Cell ChEMBL ID,Properties
CHEMBL3660048,,None,377.42,0,3.41,BDBM104169,FC1CCNCCC1Oc1cccc2ccc(-c3nnc4ccccn34)nc12,IC50,'=',1174,nM,5.93,,222584,UO_0000065,15.71,0.29,2.52,9.22,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3660053,,None,375.43,0,2.44,BDBM104179,OC[C@@H]1CC(Oc2cccc3ccc(-c4nnc5ccccn45)nc23)CCN1,IC50,'=',427,nM,6.37,,222592,UO_0000065,16.97,0.31,3.93,7.53,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3660047,,None,353.39,0,3.92,BDBM104168,c1cc(OCc2ccncc2)c2nc(-c3nnc4ccccn34)ccc2c1,IC50,'=',1734,nM,5.76,,222582,UO_0000065,16.3,0.29,1.84,8.84,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3889660,,None,396.49,1,5.52,BDBM238487,CCC1CNC(=O)c2cc(-c3cccc4cc(C)c(Nc5ccccc5)nc34)[nH]c21,IC50,'=',0.9,nM,9.05,,416225,UO_0000065,22.81,0.41,3.53,12.96,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3981344,,None,372.36,0,4.06,BDBM224864,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(-c5cccc(F)c5)n4)c3c2)o1,IC50,'=',10.73,nM,7.97,,393142,UO_0000065,21.4,0.39,3.91,7.48,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1078178,MOMELOTINIB,3,414.47,0,2.98,Momelotinib,N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3919294,,None,365.44,0,3.13,BDBM238616,COc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC(C)(C)C,IC50,'=',5,nM,8.3,,416723,UO_0000065,22.72,0.42,5.17,9.03,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3972296,,None,335.41,0,3.12,BDBM238710,CC(C)(C)Nc1ncc2cccc(-c3cc4c([nH]3)CCNC4=O)c2n1,IC50,'=',3.62,nM,8.44,,416819,UO_0000065,25.17,0.46,5.32,10.21,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3933719,,None,381.87,0,4.36,BDBM238770,Cc1nc2cccc(-c3[nH]c4c(c3Cl)C(=O)N[C@@H]4C)c2nc1NC1(C)CC1,IC50,'=',0.599,nM,9.22,,416879,UO_0000065,24.15,0.47,4.86,11.15,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3889660,,None,396.49,1,5.52,BDBM238487,CCC1CNC(=O)c2cc(-c3cccc4cc(C)c(Nc5ccccc5)nc34)[nH]c21,IC50,'=',16.1,nM,7.79,,416226,UO_0000065,19.66,0.35,2.27,11.16,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3920246,,None,361.45,0,2.68,BDBM238493,O=C1NCCc2[nH]c(-c3cccc4ccc(N[C@H]5CCCNC5)nc34)cc21,IC50,'=',12,nM,7.92,,416231,UO_0000065,21.91,0.4,5.24,9.68,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3939032,,None,406.85,1,5.05,BDBM238381,O=C1NCCc2[nH]c(-c3cccc4ccc(Nc5c(F)cccc5Cl)nc34)cc21,IC50,'=',5.2,nM,8.28,,416159,UO_0000065,20.36,0.39,3.23,11.87,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3910677,,None,405.49,0,2.61,BDBM225061,CN1CCN(c2cccc(-c3c[nH]c4ccc(-c5nnc(N)s5)cc34)n2)CC1=O,IC50,'=',52.68,nM,7.28,,393054,UO_0000065,17.95,0.34,4.67,7,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3912927,,None,361.35,0,4.35,BDBM224923,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(C(F)(F)F)n4)c3c2)s1,IC50,'=',134.76,nM,6.87,,393205,UO_0000065,19.01,0.38,2.52,8.54,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL576982,QUIZARTINIB,3,560.68,2,5.86,AC220,CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1,Kd,'>',10000,nM,,,,UO_0000065,,,,,1,CHEMBL1244923,Binding affinity to PIM2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240346,1,Scientific Literature,Blood,2009,None,
CHEMBL1240960,,None,252.25,0,3.75,3c,O=Cc1c[nH]c2c1ccc1c3cccc(F)c3[nH]c12,Activity,'=',67,%,,,,UO_0000187,,,,,0,CHEMBL1248947,Inhibition of human GST fused Pim2 expressed in Escherichia coli assessed as residual activity at 1 uM after 30 mins,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240519,1,Scientific Literature,Bioorg Med Chem,2010,None,
CHEMBL3926288,,None,394.44,1,5.3,BDBM225071,c1ccc(Nc2nnc(-c3ccc4[nH]cc(-c5cncc(C6CC6)n5)c4c3)o2)cc1,IC50,'=',214.68,nM,6.67,,393064,UO_0000065,16.91,0.3,1.37,7.21,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3964497,,None,536.59,2,5.05,BDBM225086,COc1nc(-c2cn(S(=O)(=O)c3ccc(C)cc3)c3ccc(-c4nnc(NC(C)(C)C)o4)cc23)ncc1F,IC50,'=',28.68,nM,7.54,,393079,UO_0000065,14.06,0.27,2.49,6.03,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4564337,,None,358.2,0,4.59,3,COc1cc2c(-c3cnc(-c4ccc[nH]4)o3)c[nH]c2cc1Br,Activity,'=',54,%,,,,UO_0000187,,,,,0,CHEMBL4338233,Binding affinity to wild-type human partial length PIM2 (M1 to E291 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by active-site directed competition binding assay based Kinomescan method,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4334516,1,Scientific Literature,J Med Chem,2019,None,
CHEMBL3956489,,None,435.48,0,4.13,22g,C[C@H]1[C@@H](N)CCCN1c1ccncc1Nc1ncc2ccc(-c3c(F)cccc3F)nn12,IC50,'=',5.4,nM,8.27,,,UO_0000065,18.99,0.35,4.14,9.8,0,CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3864151,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL3920197,,None,422.44,0,3.77,22c,O[C@H]1CCCN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1,IC50,'=',30,nM,7.52,,,UO_0000065,17.81,0.33,3.75,9.57,0,CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3864151,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL3974585,,None,433.41,0,4.49,BDBM191126,NCC[C@H]1CNC(=O)c2cc(-c3cccc(OC(F)(F)F)c3)c(-c3cccc(F)c3)n21,IC50,'=',12,nM,7.92,,341797,UO_0000065,18.28,0.35,3.43,11.43,0,CHEMBL3887520,Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3914639,,None,416.49,0,2.52,BDBM248955,COc1ccc(-n2ncc3cnc(-c4cncc(C)n4)cc32)nc1N1CCC[C@H](N)C1,Ki,'=',0.134,nM,9.87,,434162,UO_0000065,23.7,0.43,7.35,9.15,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3942186,,None,435.48,0,3.99,BDBM192574,C[C@@H]1C[C@H](N)CN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1,IC50,'=',7.8,nM,8.11,,344638,UO_0000065,18.62,0.35,4.12,9.61,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3921064,,None,420.47,0,4.35,BDBM192600,N[C@H]1CCCN(c2ccccc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1,IC50,'=',6.5,nM,8.19,,344670,UO_0000065,19.47,0.36,3.84,11.45,1,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4115235,,None,418.48,0,3.39,BDBM192637,C[C@@H]1[C@@H](N)CCCN1c1ccncc1Nc1ncc2ccc(-c3ncccc3F)nn12,IC50,'=',1.8,nM,8.74,,344673,UO_0000065,20.9,0.39,5.35,8.99,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3940201,,None,418.45,0,4.71,BDBM192638,N[C@@H]1C=C(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)CCC1,IC50,'=',9.4,nM,8.03,,344678,UO_0000065,19.18,0.35,3.32,9.89,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL493937,,None,338.41,0,2.38,1,CN1CCCN(c2cncc(-c3cccc(/C=C/C(=O)O)c3)n2)CC1,IC50,'=',21,nM,7.68,,,UO_0000065,22.69,0.42,5.3,11.04,0,CHEMBL960093,Inhibition of GST-tagged Pim2 preincubated for 30 mins before addition of ATP measured after 30 mins by scintillation counting-reversal assay in presence of 3 uM [gamma33P]ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153342,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL3905239,,None,404.45,0,3,21h,N[C@H]1CCCN(c2ccncc2Nc2ncc3ccc(-c4cccnc4F)nn23)C1,IC50,'=',12,nM,7.92,,,UO_0000065,19.58,0.36,4.92,8.14,0,CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3864151,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL3973432,,None,439.45,0,3.69,22l,N[C@@H]1CN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)CC[C@H]1F,IC50,'=',49,nM,7.31,,,UO_0000065,16.63,0.31,3.62,8.66,0,CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3864151,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL3900646,,None,435.48,0,4.13,22q,C[C@H]1CC[C@H](N)CN1c1ccncc1Nc1ncc2ccc(-c3c(F)cccc3F)nn12,IC50,'=',1,nM,9,,,UO_0000065,20.67,0.38,4.87,10.67,0,CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3864151,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL3937423,,None,386.46,0,2.86,21f,N[C@H]1CCCN(c2ccncc2Nc2ncc3ccc(-c4ccccn4)nn23)C1,IC50,'=',6.4,nM,8.19,,,UO_0000065,21.2,0.39,5.33,8.42,0,CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3864151,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL3904539,,None,435.47,0,0.9,30c,N[C@@H]1CN(c2ccncc2Nc2ncc3ccc(-c4ncccc4F)nn23)C[C@H](N)[C@H]1O,IC50,'=',1.3,nM,8.89,,,UO_0000065,20.41,0.38,7.99,6.19,0,CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3864151,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL3904472,,None,421.46,0,3.74,8c,N[C@H]1CCCN(c2cnccc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1,IC50,'>',1000,nM,,,,UO_0000065,,,,,0,CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3864151,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL2376158,,None,450.41,0,1.65,9,C[C@@H](NC(=O)c1c[nH]c2ncc(-c3ncn4cc(F)cc(F)c34)nc12)C(=O)N1CC(C#N)C1,Inhibition,'=',-9,%,,,,UO_0000187,,,,,0,CHEMBL2378211,Inhibition of PIM2 (unknown origin) at 10 uM relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2375236,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL2377706,,None,214.27,0,2.58,24,CCCc1c[nH]c2c(N)cc3cn[nH]c3c12,Inhibition,'=',93,%,,,,UO_0000187,,,,,0,CHEMBL2378599,Inhibition of human full length Pim-2 using RSRHSSYPAGT as substrate assessed as residual activity at 10 uM after 30 mins in presence of [gamma-33P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2375344,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL583273,,None,335.43,0,3.87,14a,CN(C)Cc1nc2c(sc3ccc(-c4ccccc4)cc32)c(=O)[nH]1,Ki,'=',8,nM,8.1,,,UO_0000065,24.14,0.46,4.23,16.53,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL2377720,,None,244.37,None,None,19,C[Si](C)(C)c1cc2c([nH]1)c(N)cc1cn[nH]c12,Inhibition,'=',111,%,,,,UO_0000187,,,,,0,CHEMBL2378599,Inhibition of human full length Pim-2 using RSRHSSYPAGT as substrate assessed as residual activity at 10 uM after 30 mins in presence of [gamma-33P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2375344,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL2377723,,None,186.22,0,1.93,22,Cc1c[nH]c2c(N)cc3cn[nH]c3c12,Inhibition,'=',88,%,,,,UO_0000187,,,,,0,CHEMBL2378599,Inhibition of human full length Pim-2 using RSRHSSYPAGT as substrate assessed as residual activity at 10 uM after 30 mins in presence of [gamma-33P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2375344,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL576734,,None,422.6,0,4.21,13c,CN(C)Cc1nc2c(sc3ccc(C#CCCCCN4CCCCC4)cc32)c(=O)[nH]1,Ki,'=',23,nM,7.64,,,UO_0000065,18.07,0.35,3.43,14.62,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL274863,,None,382.44,0,2.45,SB-216385,Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1,Inhibition,'=',0.76,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL2377708,,None,248.29,0,3.29,26,Nc1cc2cn[nH]c2c2c(-c3ccccc3)c[nH]c12,Inhibition,'=',103,%,,,,UO_0000187,,,,,0,CHEMBL2378598,Inhibition of human full length Pim-2 using RSRHSSYPAGT as substrate assessed as residual activity at 1 uM after 30 mins in presence of [gamma-33P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2375344,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL2377705,,None,258.28,0,2.11,23,CCOC(=O)c1[nH]c2c(N)cc3cn[nH]c3c2c1C,Inhibition,'=',102,%,,,,UO_0000187,,,,,0,CHEMBL2378598,Inhibition of human full length Pim-2 using RSRHSSYPAGT as substrate assessed as residual activity at 1 uM after 30 mins in presence of [gamma-33P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2375344,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL2377720,,None,244.37,None,None,19,C[Si](C)(C)c1cc2c([nH]1)c(N)cc1cn[nH]c12,Inhibition,'=',93,%,,,,UO_0000187,,,,,0,CHEMBL2378598,Inhibition of human full length Pim-2 using RSRHSSYPAGT as substrate assessed as residual activity at 1 uM after 30 mins in presence of [gamma-33P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2375344,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL3039517,RABUSERTIB,2,436.31,0,2.87,Rabusertib,Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL1946262,,None,348.41,0,3.24,56,O=c1[nH]c2ncc(-c3ccc4[nH]cnc4c3)nc2n1CC1CCCCC1,Activity,'=',101,%,,,,UO_0000187,,,,,0,CHEMBL1948961,Inhibition of Pim2 assessed as activity remaining at 10 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1944561,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL4082422,,None,353.25,0,3.24,11; Tab 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL206834,BAFETINIB,2,576.63,2,5.39,Bafetinib,Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL2035611,,None,311.73,0,3.57,4j,Nc1ccc2oc3c(=O)[nH]c(-c4ccccc4Cl)nc3c2c1,IC50,'=',5000,nM,5.3,,,UO_0000065,17.01,0.33,1.73,6.24,0,CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034948,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL1945557,,None,391.3,0,3.69,18,CCN1CCC2(CC1)NC(=O)c1c(c3ccc(Cl)c(Cl)c3n1C)C2C#N,Delta Tm,'=',3.9,degrees C,,,,UO_0000027,,,,,0,CHEMBL1947284,Binding affinity to PIM2 assessed as change in thermal denaturation at 10 uM by thermal stability shift assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1944596,1,Scientific Literature,J Med Chem,2012,None,
CHEMBL475599,GSK-300014A,None,603.17,2,6.67,GSK300014A,CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1,Inhibition,'=',-0.99,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL365663,GW780159X,None,338.82,0,4.66,GW780159X,Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1,Inhibition,'=',-0.44,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL381948,GW680975X,None,316.34,0,4.34,GW680975X,Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1,Inhibition,'=',0.19,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL160333,,None,349.17,0,3.18,SB-409514,O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1,Inhibition,'=',1.76,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1909393,GW583373A,None,595.55,2,6.43,GW583373A,Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1,Inhibition,'=',0.25,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL513897,GSK-994854A,None,481.6,1,5.35,GSK994854A,CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1,Inhibition,'=',4.08,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL63728,GW644007X,None,326.36,0,2.57,GW644007X,COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O,Inhibition,'=',4.35,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL434729,GW829906X,None,446.44,1,5.92,GW829906X,Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1,Inhibition,'=',-0.26,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL450071,GSK-1392956A,None,592.68,2,3.21,GSK1392956A,COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1,Inhibition,'=',-3.35,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3687470,,None,527.55,1,4.72,BDBM151866,COC(=O)N(C)[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H]1C,IC50,'=',13.56,nM,7.87,,292122,UO_0000065,14.91,0.28,3.15,7.12,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3687489,,None,468.51,0,3.51,BDBM151885,CO[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)ncc2N)C[C@@H]1C,IC50,'=',2.57,nM,8.59,,292141,UO_0000065,18.33,0.35,5.08,6.66,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL186213,GW827105X,None,462.44,1,5.62,GW827105X,COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1,Inhibition,'=',0.24,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL237570,,None,467.59,1,6.02,SB-630812,COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1,Inhibition,'=',0.03,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL103104,GW831090X,None,330.37,0,2.17,GW831090X,NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1,Inhibition,'=',0.62,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL515466,,None,440.59,1,6.35,18,Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1,Activity,,,,,,Not Evaluated,,,,,,0,CHEMBL982757,Binding affinity to human PIM2 at 10 uM relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1151712,1,Scientific Literature,J Med Chem,2008,None,
CHEMBL1794053,GW407323A,None,529.64,1,5.12,GW407323A,Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1,Inhibition,'=',50.09,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL187985,,None,299.34,0,1.68,SB-744941,CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21,Inhibition,'=',-0.33,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL4061456,,None,386.46,0,2.36,16,Cc1cncc(-c2cn3c(-c4cccc(N5CCCNCC5)n4)ncc3cn2)n1,Ki,'=',16,nM,7.8,,,UO_0000065,20.17,0.37,5.44,9.27,0,CHEMBL4052120,Inhibition of PIM2 (unknown origin) using 5FAM-ARKRRRHPSGPPTA as substrate after 90 mins in presence of ATP by caliper microfluidic mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4049450,1,Scientific Literature,J Med Chem,2017,None,
CHEMBL4563802,,None,434.33,0,2.2,25,CN1CC(C#Cc2c(Cl)c3c(Cl)cc(C(N)=O)nc3n2[C@H]2CCCNC2)CC1=O,IC50,'=',17.5,nM,7.76,,,UO_0000065,17.86,0.37,5.56,8.32,0,CHEMBL4373003,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser-112 residue by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4371067,1,Scientific Literature,Bioorg Med Chem Lett,2019,None,
CHEMBL517171,GSK-1713088A,None,568.05,2,5.6,GSK1713088A,CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1,Inhibition,'=',2.68,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL4076913,,None,407.43,0,3.29,19,Cc1cncc(-c2cc3c(cn2)cnn3-c2cccc([C@H]3CNCCC3(F)F)n2)n1,Ki,'=',0.23,nM,9.64,,,UO_0000065,23.66,0.44,6.35,11.84,0,CHEMBL4052120,Inhibition of PIM2 (unknown origin) using 5FAM-ARKRRRHPSGPPTA as substrate after 90 mins in presence of ATP by caliper microfluidic mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4049450,1,Scientific Literature,J Med Chem,2017,None,
CHEMBL232601,GW846105X,None,401.49,0,4.71,GW846105X,N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1,Inhibition,'=',-0.17,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1794066,GSK-619487A,None,525.49,0,1.34,GSK619487A,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F,Inhibition,'=',11.7,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL306865,GW784752X,None,345.37,0,2.67,GW784752X,COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1,Inhibition,'=',0.77,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3691928,,None,592.64,1,4.09,BDBM151950,COc1cc(F)c(-c2nc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@@H](OCCS(C)(=O)=O)[C@@H](C)C3)ccc2F)c(F)c1,IC50,'=',1.86,nM,8.73,,292205,UO_0000065,14.73,0.29,4.64,6.54,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3652023,,None,458.46,1,5.18,BDBM106929,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)ccc(F)c3F)n2)C1,IC50,'=',3,nM,8.52,,225950,UO_0000065,18.59,0.35,3.34,10.54,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3691975,,None,543.55,1,4.39,BDBM151997,COC(=O)N[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(OC)cc3F)n2)C[C@@H]1C,IC50,'=',27.18,nM,7.57,,292252,UO_0000065,13.92,0.26,3.18,5.89,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3651932,,None,438.48,0,4.61,BDBM106836,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2cccc(-c3c(F)cc(O)cc3F)n2)C1,IC50,'=',3,nM,8.52,,225857,UO_0000065,19.44,0.36,3.91,8.43,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3915064,,None,375.44,0,2.74,6,CCn1cc(-c2cc3c(-c4cccc(N5CCOCC5)n4)n[nH]c3cn2)cn1,Ki,'=',4,nM,8.4,,,UO_0000065,22.37,0.41,5.66,9.91,0,CHEMBL4052120,Inhibition of PIM2 (unknown origin) using 5FAM-ARKRRRHPSGPPTA as substrate after 90 mins in presence of ATP by caliper microfluidic mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4049450,1,Scientific Literature,J Med Chem,2017,None,
CHEMBL270544,GW396574X,None,370.43,0,2.53,GW396574X,CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2,Inhibition,'=',0.68,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL206010,GW814408X,None,344.38,0,3.47,GW814408X,COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1,Inhibition,'=',1.1,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL257113,GW734508X,None,333.39,0,3.85,GW734508X,Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1,Inhibition,'=',1.27,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL263796,GW445014X,None,307.18,0,3.92,GW445014X,CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1,Inhibition,'=',-0.92,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1952132,,None,393.37,0,3.43,7l,O[C@H]1CC[C@H](Nc2ccc3nnn(-c4cccc(OC(F)(F)F)c4)c3n2)CC1,IC50,'=',69,nM,7.16,,,UO_0000065,18.2,0.35,3.73,8.42,0,CHEMBL1954567,Inhibition of PIM2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1949661,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL247228,GW770249X,None,431.35,1,5.27,GW770249X,Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12,Inhibition,'=',0.7,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3687519,,None,582.7,1,3.51,BDBM151915,CC(C)NC(=O)c1ccc(F)c(-c2ccc(N)c(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@@H](S(C)(=O)=O)[C@@H](C)C3)n2)c1,IC50,'=',1.61,nM,8.79,,292171,UO_0000065,15.09,0.29,5.28,5.17,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3703174,,None,319.37,0,1.93,BDBM149682,Cn1c2c(c(C(N)=O)c1-c1ccccc1)CCc1cnc(N)nc1-2,IC50,'>',10000,nM,,,288340,UO_0000065,,,,,0,CHEMBL3707582,Kinase Inhibition Assay: The buffer for PIM-2 assay was composed of HEPES 50 mM,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1957497,,None,496.6,0,1.19,19,CS(=O)(=O)N1CCN(Cc2cn3cc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3n2)CC1,Inhibition,'=',50,%,,,,UO_0000187,,,,,0,CHEMBL1959621,Inhibition of PIM2 at 5 to 10 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1955823,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL2442316,,None,357.46,0,4.23,9f,N[C@H]1CC[C@H](Nc2ccn3ncc(-c4ccc5ccccc5c4)c3n2)CC1,IC50,'=',190,nM,6.72,,,UO_0000065,18.8,0.34,2.49,9.85,0,CHEMBL2446212,Inhibition of Pim2 (unknown origin) using STK1 as substrate preincubated for 30 mins followed by substrate and ATP addition after 60 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2440090,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL258940,FALNIDAMOL,1,387.85,0,3.46,K00619a,CN1CCC(Nc2ncc3ncnc(Nc4ccc(F)c(Cl)c4)c3n2)CC1,Thermal melting change,'=',0.1,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL1738758,ONVANSERTIB,2,532.53,1,1.92,7g,CN1CCN(c2ccc(OC(F)(F)F)c(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3CCO)CC4)c2)CC1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1776305,Inhibition of PIM2 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1773059,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL2035635,,None,389.25,0,2.32,6f,CN1C[C@@H]2C[C@H]1CN2Cc1nc2c(oc3ccc(Br)cc32)c(=O)[nH]1,IC50,'=',110,nM,6.96,,,UO_0000065,17.88,0.4,4.64,10.64,0,CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034948,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL2088998,,None,279.3,0,3.17,19,COC(=O)c1cc2c([nH]c3cccc(N)c32)c2[nH]ccc12,IC50,,,,,,Not Determined,,,,,,0,CHEMBL2090488,Inhibition of human Pim2 using RSRHSSYPAGT as substrate,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2086229,1,Scientific Literature,Eur J Med Chem,2012,None,
CHEMBL3660080,,None,391.45,0,3.76,BDBM104207,CN1CCC(F)(COc2cccc3ccc(-c4nnc5ccccn45)nc23)CC1,IC50,'=',73,nM,7.14,,222620,UO_0000065,18.23,0.34,3.38,12.85,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3660023,,None,347.42,0,3.31,BDBM104141,CC(C)(CN)COc1cccc2ccc(-c3nnc4ccccn34)nc12,IC50,'=',49,nM,7.31,,222558,UO_0000065,21.04,0.38,4,9.33,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL596380,,None,193.16,0,1.66,Syk_Inhibitor_III,O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2,Residual Activity,'=',134,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3703188,,None,593.78,2,5.85,BDBM47183,CCc1cccc(CC)c1NC(=O)c1cn(C)c2c1CCCc1cnc(Nc3ccc(N4CCN(C)CC4)cc3OC)nc1-2,IC50,'>',10000,nM,,,198714,UO_0000065,,,,,0,CHEMBL3707582,Kinase Inhibition Assay: The buffer for PIM-2 assay was composed of HEPES 50 mM,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2035622,,None,393.6,0,4.89,5e,O=c1[nH]c(-c2c(F)cccc2Cl)nc2c1oc1ccc(Br)cc12,IC50,'=',1068,nM,5.97,,,UO_0000065,15.17,0.35,1.08,10.14,0,CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034948,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL2035623,,None,410.05,1,5.41,5f,O=c1[nH]c(-c2cccc(Cl)c2Cl)nc2c1oc1ccc(Br)cc12,IC50,'=',598,nM,6.22,,,UO_0000065,15.18,0.37,0.81,10.57,0,CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034948,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL2035632,,None,334.17,0,2.64,6c,O=c1[nH]c(CN2CCC2)nc2c1oc1ccc(Br)cc12,IC50,'=',68,nM,7.17,,,UO_0000065,21.45,0.49,4.53,11.54,0,CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034948,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL2035641,,None,338.41,0,2.29,7c,CN1CCN(Cc2nc3c(oc4ccc(C5CC5)cc43)c(=O)[nH]2)CC1,IC50,'=',840,nM,6.08,,,UO_0000065,17.95,0.33,3.79,9.29,0,CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034948,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL2035617,,None,354.77,1,5.01,4p,O=c1[nH]c(-c2c(F)cccc2Cl)nc2c1oc1ccc(C3CC3)cc12,IC50,'=',3330,nM,5.48,,,UO_0000065,15.44,0.3,0.47,9.3,0,CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034948,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL2035610,,None,364.71,1,5.01,4i,O=c1[nH]c(-c2ccccc2Cl)nc2c1oc1ccc(C(F)(F)F)cc12,IC50,'=',2330,nM,5.63,,,UO_0000065,15.44,0.31,0.62,9.56,0,CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034948,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL4440880,,None,429.53,0,3.18,59,CN1CCOc2c1cnn1c(-c3ccc4cccc(NCC5CCNCC5)c4c3)nnc21,IC50,'=',4870,nM,5.31,,,UO_0000065,12.37,0.23,2.13,6.67,0,CHEMBL4340984,Inhibition of His tagged human recombinant PIM2 using PIM tide (ARKRRRHPSGPPTA) as substrate incubated for 1 hr by fluorescence based assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4340512,1,Scientific Literature,Eur J Med Chem,2019,None,
CHEMBL3103872,,None,345.43,0,2.74,2b,CC(=O)Nc1nc(C(=O)Nc2cnccc2N2CCCCC2)cs1,Ki,'>',12500,nM,,,,UO_0000065,,,,,0,CHEMBL3106178,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3102815,1,Scientific Literature,ACS Med Chem Lett,2013,None,
CHEMBL2030387,,None,363.22,0,1.96,6h,N[C@H]1CCN(Cc2nc3c(oc4ccc(Br)cc43)c(=O)[nH]2)C1,IC50,'=',49,nM,7.31,,,UO_0000065,20.13,0.45,5.35,8.29,0,CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034948,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL3264257,,None,374.45,0,2.64,7f,CN(C)CCNc1cncc(-c2ccc3[nH]cc(-c4ccnc(N)n4)c3c2)n1,IC50,'=',110,nM,6.96,,,UO_0000065,18.58,0.34,4.32,6.41,1,CHEMBL3269287,Inhibition of PIM2 kinase (unknown origin) using 5-FAM-labeled BAD peptide as substrate after 90 mins by fluorescence polarization assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3259764,1,Scientific Literature,Bioorg Med Chem Lett,2014,None,
CHEMBL2035630,,None,453.34,0,4.51,5m,O=c1[nH]c(-c2ccc(NCC3CCNCC3)cc2)nc2c1oc1ccc(Br)cc12,IC50,'=',29,nM,7.54,,,UO_0000065,16.63,0.35,3.03,9.09,0,CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034948,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL2035624,,None,410.05,1,5.41,5g,O=c1[nH]c(-c2ccc(Cl)cc2Cl)nc2c1oc1ccc(Br)cc12,IC50,'=',293,nM,6.53,,,UO_0000065,15.93,0.39,1.12,11.09,0,CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034948,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL3937096,,None,386.46,0,2.38,BDBM248938,Cc1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CCNC(C)C3)n2)n1,Ki,'=',1.79,nM,8.75,,434145,UO_0000065,22.63,0.41,6.37,10.33,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2103875,TRAMETINIB,4,615.4,1,3.94,Trametinib,CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3664625,,None,361.41,0,2.31,BDBM104249,c1cc(OCC2CNCCO2)c2nc(-c3nnc4ccccn34)ccc2c1,IC50,'=',353.7,nM,6.45,,222660,UO_0000065,17.85,0.33,4.14,8.77,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL1969879,,None,303.37,0,0.62,SID103905420,CC1CCN(C(=O)CO)CC1N(C)c1ncnc2[nH]ccc12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1974664,,None,347.38,0,3.57,SID103905525,COc1ccc(C=NNc2ncnc3c2[nH]c2ccccc23)cc1OC,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2000408,,None,438.48,0,4.18,SID103904770,Cc1cn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc2c(C)n1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3187723,BINIMETINIB,4,441.23,0,3.01,Binimetinib,Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL1236107,SGX-523,1,359.42,0,3.22,SGX-523,Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3922191,,None,308.3,0,2.27,BDBM225048,COc1cncc(-c2c[nH]c3ccc(-c4nnc(N)o4)nc23)c1,IC50,'=',569.6,nM,6.24,,393034,UO_0000065,20.25,0.37,3.97,5.4,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL38380,FASUDIL,3,291.38,0,1.22,SID103905390,O=S(=O)(c1cccc2cnccc12)N1CCCNCC1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1336,SORAFENIB,4,464.83,1,5.55,SID103904444,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1995592,,None,367.8,0,2.77,SID103905641,Cc1cc(O)ccc1-n1c2cc(Cl)ccc2c(=O)c2c(N)nc(N)nc21,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1986943,,None,343.82,0,3.39,SID103904189,OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1,Ki,'=',398.11,nM,6.4,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1968380,,None,521.67,1,3.56,SID103904638,CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2377723,,None,186.22,0,1.93,22,Cc1c[nH]c2c(N)cc3cn[nH]c3c12,Inhibition,'=',105,%,,,,UO_0000187,,,,,0,CHEMBL2378598,Inhibition of human full length Pim-2 using RSRHSSYPAGT as substrate assessed as residual activity at 1 uM after 30 mins in presence of [gamma-33P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2375344,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL1989834,,None,210.24,0,2.52,SID103905442,O=c1[nH][nH]c2cccc(-c3ccccc3)c12,Ki,'>',15848.93,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL260417,,None,373.21,0,3.44,SB-725317,O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1,Inhibition,'=',75.22,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL260417,,None,373.21,0,3.44,SB-725317,O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1,Inhibition,'=',45.5,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL475251,R-406,2,470.46,0,3.63,R406,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL3961287,,None,416.45,0,2.51,BDBM249020,COc1ccc(-n2ncc3cnc(-c4cncc(C)n4)cc32)nc1N1CCCNC1=O,Ki,'=',181,nM,6.74,,434224,UO_0000065,16.19,0.3,4.23,6.08,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3660031,,None,363.4,0,3.02,BDBM104149,F[C@@H]1CNCCC1Oc1cccc2ccc(-c3nnc4ccccn34)nc12,IC50,'=',137,nM,6.86,,222566,UO_0000065,18.89,0.35,3.84,10.67,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL2180604,TAK-593,1,445.48,0,3.47,TAK-593,Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3660067,,None,465.56,0,4.35,BDBM104194,OC1(COc2cccc3ccc(-c4nnc5ccccn45)nc23)CCN(Cc2ccccc2)CC1,IC50,'=',10000,nM,5,,222607,UO_0000065,10.74,0.2,0.65,6.6,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3991935,,None,438.31,0,3.3,P-276-00,CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3660064,,None,387.49,0,4.1,BDBM104191,CCC1(COc2cccc3ccc(-c4nnc5ccccn45)nc23)CCNCC1,IC50,'=',126,nM,6.9,,222604,UO_0000065,17.81,0.32,2.8,10.72,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL1969156,,None,210.24,0,1.98,SID103905329,Nc1nccc2cnc(-c3ccccc3)n12,Ki,'>',15848.93,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3660032,,None,375.48,0,3.96,BDBM104150,CCNCC(C)(C)COc1cccc2ccc(-c3nnc4ccccn34)nc12,IC50,'=',323,nM,6.49,,222567,UO_0000065,17.29,0.32,2.53,10.09,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3660037,,None,361.45,0,3.7,BDBM104155,CC[C@@H](CN)C(C)Oc1cccc2ccc(-c3nnc4ccccn34)nc12,IC50,'=',399,nM,6.4,,222572,UO_0000065,17.7,0.32,2.7,8.17,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3660039,,None,389.5,0,4.48,BDBM104157,CCCC(Oc1cccc2ccc(-c3nnc4ccccn34)nc12)[C@@H](CC)CN,IC50,'=',1346,nM,5.87,,222574,UO_0000065,15.07,0.28,1.39,7.5,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL428690,ALVOCIDIB,3,401.85,0,3.3,Alvocidib,CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3910145,,None,362.44,0,1.99,BDBM238428,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@H]1CCNC1,IC50,'=',3,nM,8.52,,416626,UO_0000065,23.52,0.43,6.53,9,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4245242,,None,475.62,1,5.03,35,O=C(Cc1cccc(OCCCC2CCNCC2)c1)Nc1nc(-c2c[nH]c3ncccc23)cs1,Ki,'>',2000,nM,,,,UO_0000065,,,,,0,CHEMBL4235411,Inhibition of Pim2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4229506,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL3949274,,None,386.46,0,2.38,BDBM248965,Cc1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CCNC[C@@H]3C)n2)n1,Ki,'=',0.864,nM,9.06,,434172,UO_0000065,23.45,0.43,6.68,10.71,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL278315,GELDANAMYCIN,2,560.64,1,2.41,geldanamycin,COC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,Tm,'<',2,degrees C,,,,UO_0000027,,,,,0,CHEMBL1004482,Binding affinity to human recombinant PIM2 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140872,1,Scientific Literature,Bioorg Med Chem,2009,None,
CHEMBL453389,,None,360.45,0,4.43,20,COc1cc2c(c(OC)c1)C(=O)O[C@@H](C)CCCC(=O)[C@@H](C)CC/C=C/2,Tm,'<',2,degrees C,,,,UO_0000027,,,,,0,CHEMBL1004482,Binding affinity to human recombinant PIM2 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140872,1,Scientific Literature,Bioorg Med Chem,2009,None,
CHEMBL3901085,,None,376.46,0,2.38,BDBM238426,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1CCNCC1,IC50,'=',2.4,nM,8.62,,416624,UO_0000065,22.9,0.42,6.24,9.1,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3264256,,None,417.52,0,3.77,7e,CCN(CC)CCCOc1cncc(-c2ccc3[nH]cc(-c4ccnc(N)n4)c3c2)n1,IC50,'=',660,nM,6.18,,,UO_0000065,14.8,0.27,2.41,5.84,0,CHEMBL3269287,Inhibition of PIM2 kinase (unknown origin) using 5-FAM-labeled BAD peptide as substrate after 90 mins by fluorescence polarization assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3259764,1,Scientific Literature,Bioorg Med Chem Lett,2014,None,
CHEMBL3919837,,None,405.44,0,2.39,BDBM192612,N[C@H]1CCCN(c2ccncc2Nc2nnc3ccc(-c4ncccc4F)nn23)C1,IC50,'=',30.5,nM,7.52,,344687,UO_0000065,18.54,0.34,5.13,6.82,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3961097,,None,357.36,0,3.41,BDBM238719,Cc1nc2cccc(-c3cc4c([nH]3)[C@H](C)NC4=O)c2nc1NCC(F)F,IC50,'=',4.57,nM,8.34,,416828,UO_0000065,23.34,0.44,4.93,10.08,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3913905,,None,449.56,1,5.08,BDBM238631,Cc1nc2cccc(-c3cc4c([nH]3)CCN(C(=O)OC(C)(C)C)C4=O)c2nc1NC(C)(C)C,IC50,'=',65.2,nM,7.19,,416740,UO_0000065,15.98,0.3,2.11,7.17,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1163565,,None,530.98,1,4.92,5o,CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1,Inhibition,'<',50,%,,,,UO_0000187,,,,,0,CHEMBL1166808,Inhibition of PIM2 at 1 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1165965,1,Scientific Literature,Bioorg Med Chem,2010,None,
CHEMBL2377712,,None,260.25,0,2.49,11,CCOCc1c[nH]c2c([N+](=O)[O-])cc3cn[nH]c3c12,Inhibition,'=',63,%,,,,UO_0000187,,,,,0,CHEMBL2378599,Inhibition of human full length Pim-2 using RSRHSSYPAGT as substrate assessed as residual activity at 10 uM after 30 mins in presence of [gamma-33P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2375344,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL3982591,,None,349.44,0,3.15,BDBM238713,CN(c1ncc2cccc(-c3cc4c([nH]3)CCNC4=O)c2n1)C(C)(C)C,IC50,'=',3.32,nM,8.48,,416822,UO_0000065,24.26,0.45,5.33,11.47,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3932604,,None,398.47,0,3.79,BDBM238659,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC(C)c1ccccn1,IC50,'=',156,nM,6.81,,416768,UO_0000065,17.08,0.31,3.02,7.12,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL494355,,None,338.41,0,2.92,24,N[C@H]1CC[C@@H](Nc2cncc(-c3cccc(/C=C/C(=O)O)c3)n2)CC1,IC50,'=',19,nM,7.72,,,UO_0000065,22.82,0.42,4.8,7.63,0,CHEMBL960121,Inhibition of Pim2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153342,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL1966425,,None,442.52,0,4.81,SID103904648,CN(C)CCCOc1cc2c(c(-c3ccc(Nc4nc5ccccc5o4)cc3)c1)CNC2=O,Ki,'=',199.53,nM,6.7,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1996979,,None,349.34,0,4.76,SID103904196,O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1c(F)cccc1F,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3979034,,None,457.45,0,4.53,BDBM191116,CC(=O)NCC[C@H]1CNC(=O)c2cc(-c3cccc(OC(F)(F)F)c3)c(-c3ccccc3)n21,IC50,'=',174,nM,6.76,,341787,UO_0000065,14.78,0.28,2.23,9.34,0,CHEMBL3887520,Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP,,,,,,,,,,,,,,,,,,,,,,
CHEMBL406821,,None,319.43,0,1.92,H-1152,Cc1cncc2cccc(S(=O)(=O)N3CCCNC[C@@H]3C)c12,Activity,'=',88,%,,,,UO_0000187,,,,,0,CHEMBL1061086,Percentage PIM2 activity remaining in the presence of 1uM inhibitor,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL102714,SB-216763,None,371.22,0,4.05,SB-216763,Cn1cc(C2=C(c3ccc(Cl)cc3Cl)C(=O)NC2=O)c2ccccc21,Activity,'=',81,%,,,,UO_0000187,,,,,0,CHEMBL1063723,Percentage PIM2 activity remaining in the presence of 2uM inhibitor,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL3977709,,None,379.45,0,3.29,BDBM225060,Oc1nnc(-c2ccc3[nH]cc(-c4cccc(N5CCOCC5)n4)c3c2)s1,IC50,'=',253.57,nM,6.6,,393053,UO_0000065,17.38,0.33,3.31,7.57,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1782529,,None,381.23,0,2.62,37,O=C(O)c1cc2cc(Br)cc(C(=O)NCC3CCNCC3)c2o1,IC50,'=',1300,nM,5.89,,,UO_0000065,15.44,0.35,3.27,6.43,0,CHEMBL1786238,Inhibition of human Pim2 using 5-FAM-RSRHSSYPAGT-CONH2 as substrate after 90 mins by off-chip mobility shift method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1781944,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL3691951,,None,583.61,1,4.75,BDBM151973,COC(=O)N[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C4(O)CCC4)cc3F)n2)C[C@@H]1C,IC50,'=',6.07,nM,8.22,,292228,UO_0000065,14.08,0.27,3.47,5.89,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3687457,,None,530.6,1,4.23,BDBM151853,COC(=O)N(C)[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)sc2N)C[C@@H]1C,IC50,'=',15800,nM,4.8,,292109,UO_0000065,9.05,0.18,0.57,3.52,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3987026,,None,445.44,0,4.36,BDBM191109,COc1ccc(-c2c(-c3cccc(OC(F)(F)F)c3)cc3n2[C@@H](CCN)CNC3=O)cc1,IC50,'=',22,nM,7.66,,341780,UO_0000065,17.19,0.33,3.3,9.75,0,CHEMBL3887520,Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1909384,,None,378.82,0,0.26,SB-772077-B,CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl,Inhibition,'=',48.2,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1794068,GSK-326090A,None,558.63,2,6.07,GSK326090A,C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F,Inhibition,'=',1.56,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3703172,,None,243.27,0,0.26,BDBM149680,Cn1cc(C(N)=O)c2c1-c1nc(N)ncc1CC2,IC50,'>',10000,nM,,,288338,UO_0000065,,,,,0,CHEMBL3707582,Kinase Inhibition Assay: The buffer for PIM-2 assay was composed of HEPES 50 mM,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3687490,,None,528.54,1,3.63,BDBM151886,COC(=O)N[C@@H]1[C@H](N)CN(c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C)cc3F)n2)C[C@@H]1C,IC50,'=',0.82,nM,9.09,,292142,UO_0000065,17.19,0.33,5.46,7.42,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3651954,,None,418.52,1,5.07,BDBM106858,Cc1ccc(F)c(-c2cccc(C(=O)Nc3cnccc3[C@@H]3C[C@H](C)C[C@H](N)C3)n2)c1,IC50,'=',8,nM,8.1,,225879,UO_0000065,19.35,0.36,3.03,10.01,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3652027,,None,456.47,0,4.01,BDBM106935,C[C@@H]1C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1O,IC50,'=',88,nM,7.06,,225956,UO_0000065,15.46,0.29,3.05,6.98,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL502835,NINTEDANIB,4,539.64,1,3.62,Nintedanib,COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3691961,,None,614.62,1,3.32,BDBM151983,COC(=O)N[C@@H]1[C@H](N)CN(c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C4(O)CCOCC4)cc3F)n2)C[C@@H]1C,IC50,'=',1.89,nM,8.72,,292238,UO_0000065,14.19,0.27,5.4,5.74,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3898587,,None,367.45,0,4.67,BDBM238485,CC(c1ccccc1)c1ccc2cccc(-c3cc4c([nH]3)CCNC4=O)c2n1,IC50,'=',23.6,nM,7.63,,416292,UO_0000065,20.76,0.37,2.96,13.2,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4128811,,None,315.38,0,4.69,2,CCOc1cncc(-c2ccc3[nH]cc(-c4ccccc4)c3c2)n1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4118246,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL3651921,,None,439.47,0,2.82,BDBM106825,C[C@H]1CN(c2ccncc2NC(=O)c2ccc(F)c(-c3ccccc3F)n2)C[C@@H](N)[C@@H]1O,IC50,'=',2,nM,8.7,,225846,UO_0000065,19.79,0.37,5.88,8.33,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3652021,,None,506.48,1,4.89,BDBM106927,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3cccc(C(F)(F)F)c3F)n2)C[C@@H](N)[C@@H]1O,IC50,'=',131,nM,6.88,,225948,UO_0000065,13.59,0.26,1.99,6.81,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3687456,,None,530.6,1,4.23,BDBM151852,COC(=O)N(C)[C@@H]1[C@H](C)C[C@H](c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)sc2N)C[C@@H]1N,IC50,'=',21.39,nM,7.67,,292108,UO_0000065,14.45,0.28,3.44,5.62,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3687464,,None,469.52,0,3.24,BDBM151860,C[C@H]1CN(c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)sc2N)C[C@@H](N)[C@H]1C#N,IC50,'=',4.68,nM,8.33,,292116,UO_0000065,17.74,0.34,5.09,6.22,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3691981,,None,572.65,1,2.87,BDBM152003,CC(C)NC(=O)c1ccc(F)c(-c2ccc(N)c(C(=O)Nc3cnccc3N3C[C@@H](N)[C@@H](n4ccnn4)[C@@H](C)C3)n2)c1,IC50,'=',5.15,nM,8.29,,292258,UO_0000065,14.47,0.27,5.42,4.88,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4436895,,None,388.2,0,3.79,46,O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1,Activity,'=',80,%,,,,UO_0000187,,,,,0,CHEMBL4365906,Inhibition of wild-type human partial length PIM2 (M1 to E291 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4364269,1,Scientific Literature,Eur J Med Chem,2019,None,
CHEMBL577784,BX-795,None,591.48,1,4.75,BX-795,O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1,Activity,'=',92,%,,,,UO_0000187,,,,,0,CHEMBL1051299,Percentage PIM2 activity remaining in the presence of 0.1uM inhibitor,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL405130,WHI-P131,1,297.31,0,3.1,JANEX-1,COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3924152,,None,374.45,0,2.24,BDBM248904,CCn1cc(-c2cc3c(cn2)cnn3-c2cccc(N3CC[C@H](N)C3)n2)cn1,Ki,'=',11.1,nM,7.96,,434111,UO_0000065,21.24,0.39,5.71,8.77,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4115539,,None,488.47,0,2.02,BDBM249003,COc1ccc(-n2ncc3cnc(-c4cnn(CC(F)(F)F)c4)cc32)nc1N1CCNC[C@@H](O)C1,Ki,'=',2.25,nM,8.65,,434210,UO_0000065,17.7,0.34,6.63,8.15,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3926862,,None,376.46,0,2.38,BDBM238448,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@@H]1CCCNC1,IC50,'=',1.2,nM,8.92,,416646,UO_0000065,23.7,0.44,6.54,9.42,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3900796,,None,442.53,0,2.49,BDBM249009,Cc1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CCCN(C4COC4)CC3)n2)n1,Ki,'=',31.7,nM,7.5,,434215,UO_0000065,16.95,0.31,5.01,8.81,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL583481,,None,378.35,1,6.3,34,O=Cc1c[nH]c2c1ccc1c3cc(-c4ccc(C(F)(F)F)cc4)ccc3[nH]c12,Activity,'=',52,%,,,,UO_0000187,,,,,0,CHEMBL1057614,Inhibition of Pim-2 assessed as residual enzyme activity at 10 uM relative to untreated control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154186,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL568476,,None,386.45,1,6.95,31,O=Cc1c[nH]c2c1ccc1c3cc(-c4ccc(-c5ccccc5)cc4)ccc3[nH]c12,Activity,'=',67,%,,,,UO_0000187,,,,,0,CHEMBL1051392,Inhibition of Pim-2 assessed as residual enzyme activity at 1 uM relative to untreated control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154186,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL568476,,None,386.45,1,6.95,31,O=Cc1c[nH]c2c1ccc1c3cc(-c4ccc(-c5ccccc5)cc4)ccc3[nH]c12,Activity,'=',70,%,,,,UO_0000187,,,,,0,CHEMBL1057614,Inhibition of Pim-2 assessed as residual enzyme activity at 10 uM relative to untreated control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154186,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL576930,,None,310.36,1,5.28,30,O=Cc1c[nH]c2c1ccc1c3cc(-c4ccccc4)ccc3[nH]c12,Activity,'=',68,%,,,,UO_0000187,,,,,0,CHEMBL1051392,Inhibition of Pim-2 assessed as residual enzyme activity at 1 uM relative to untreated control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154186,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL3919198,,None,439.52,1,6.59,BDBM224890,Fc1ccccc1-c1c[nH]c2ccc(-c3nnc(NCc4cccc5[nH]ccc45)s3)cc12,IC50,'=',3021.02,nM,5.52,,393166,UO_0000065,12.56,0.24,-1.07,7.95,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL573476,,None,357.82,0,4.11,6n,O=c1[nH]c(CNc2cccc(O)c2)nc2c1sc1ccc(Cl)cc12,Ki,'=',147,nM,6.83,,,UO_0000065,19.1,0.39,2.72,8.76,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL4475097,,None,437.09,1,5.35,2,COc1cc(Br)cc2[nH]cc(-c3cnc(-c4ccc(Br)[nH]4)o3)c12,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL4338190,Inhibition of PIM2 (unknown origin) by [33P]-ATP filter binding kinase assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4334516,1,Scientific Literature,J Med Chem,2019,None,
CHEMBL575336,,None,285.14,0,4.56,19,Brc1ccc2[nH]c3c(ccc4cc[nH]c43)c2c1,Activity,'=',46,%,,,,UO_0000187,,,,,0,CHEMBL1057614,Inhibition of Pim-2 assessed as residual enzyme activity at 10 uM relative to untreated control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154186,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL428690,ALVOCIDIB,3,401.85,0,3.3,Flavopiridol,CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1,Kd,'=',770,nM,6.11,,,UO_0000065,15.21,0.3,2.81,6.49,1,CHEMBL1061184,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150977,1,Scientific Literature,Nat Biotechnol,2008,None,
CHEMBL559147,Y-27632,None,247.34,0,2.17,Y27632,C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1,Activity,'=',91,%,,,,UO_0000187,,,,,0,CHEMBL1061149,Percentage PIM2 activity remaining in the presence of 10uM inhibitor,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL1909357,GW410563A,None,347.8,0,3.4,GW410563A,COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl,Inhibition,'=',2.78,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3928492,,None,368.44,0,4.57,BDBM238476,Cc1cc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1Nc1ccccc1,IC50,'=',1.2,nM,8.92,,416213,UO_0000065,24.21,0.44,4.35,12.78,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3676260,,None,433.46,0,3.61,BDBM131730,N[C@@H]1CN(c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)CC[C@H]1F,IC50,'=',23,nM,7.64,,263963,UO_0000065,17.62,0.35,4.03,9.08,0,CHEMBL3706072,Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3982185,,None,374.4,0,3.36,BDBM224984,c1cc2[nH]cc(-c3cncc(C4CC4)n3)c2cc1-c1nnc(NC2COC2)o1,IC50,'=',5.842,nM,8.23,,393274,UO_0000065,21.99,0.4,4.87,8.09,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3676291,,None,445.5,0,2.88,BDBM131761,C[C@@H]1CN(c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1O,IC50,'=',125,nM,6.9,,263994,UO_0000065,15.5,0.3,4.02,6.61,0,CHEMBL3706072,Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3676274,,None,449.91,0,3.88,BDBM131744,NC1CN(c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)CCC1Cl,IC50,'=',54,nM,7.27,,263977,UO_0000065,16.15,0.33,3.39,8.64,0,CHEMBL3706072,Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3676309,,None,462.95,1,5.62,BDBM131779,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2csc(-c3c(F)ccc(Cl)c3F)n2)C1,IC50,'=',12,nM,7.92,,264012,UO_0000065,17.11,0.35,2.3,9.79,0,CHEMBL3706072,Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3926620,,None,435.53,0,3.76,BDBM238827,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C5CCOCC5)c(NC(C)(C)C)nc34)[nH]c21,IC50,'=',0.671,nM,9.17,,416936,UO_0000065,21.06,0.39,5.41,9.08,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4557538,,None,372.86,0,3.51,3c; SKLB0533,Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1,Activity,'=',103.5,%,,,,UO_0000187,,,,,0,CHEMBL4314910,Inhibition of recombinant human Pim2 (2 to end residues) assessed as residual activity at 10 uM using RSRHSSYPAGT as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4311992,1,Scientific Literature,Eur J Med Chem,2019,None,
CHEMBL3676305,,None,458.53,0,4.98,BDBM131775,COc1ccc(F)c(-c2nc(C(=O)Nc3cnccc3[C@@H]3C[C@H](C)C[C@H](N)C3)cs2)c1F,IC50,'=',4,nM,8.4,,264008,UO_0000065,18.31,0.36,3.42,9.32,0,CHEMBL3706072,Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3676300,,None,428.51,0,4.97,BDBM131770,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C1,IC50,'=',7,nM,8.15,,264003,UO_0000065,19.03,0.37,3.18,10.08,0,CHEMBL3706072,Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL603469,LESTAURTINIB,3,439.47,0,3.47,CEP-701,C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O,Kd,'=',250,nM,6.6,,,UO_0000065,15.02,0.27,3.13,7.45,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL3907325,,None,363.47,0,3.82,BDBM238645,Cc1nc2cccc(-c3cc4c([nH]3)CCCNC4=O)c2nc1NC(C)(C)C,IC50,'=',8.14,nM,8.09,,416754,UO_0000065,22.26,0.41,4.27,9.78,1,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3691983,,None,577.66,1,3.82,BDBM152006,COC(=O)N[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2nc(-c3cc(C(=O)NC(C)C)ccc3F)ccc2N)C[C@@H]1C,IC50,'=',5.19,nM,8.29,,292261,UO_0000065,14.34,0.27,4.46,4.75,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL275798,,None,415.47,0,4.86,SB-239272,Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1,Inhibition,'=',-3.69,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3932879,,None,383.88,0,4.6,BDBM238771,Cc1nc2cccc(-c3[nH]c4c(c3Cl)C(=O)N[C@@H]4C)c2nc1NC(C)(C)C,IC50,'=',1.43,nM,8.85,,416880,UO_0000065,23.04,0.45,4.24,10.69,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3687463,,None,541.57,2,5.03,BDBM151859,COC(=O)N(C)[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C)cc3F)n2)C[C@@H]1C,IC50,'=',14.32,nM,7.84,,292115,UO_0000065,14.48,0.27,2.81,7.1,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL272026,GW290597X,None,467.51,0,1.12,GW290597X,NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1,Inhibition,'=',0.82,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3906955,,None,418.41,1,5.08,BDBM192625,Cc1noc(C)c1-c1ccncc1Nc1ncc2ccc(-c3c(F)cccc3F)nn12,IC50,'>',5000,nM,,,344703,UO_0000065,,,,,0,CHEMBL3887611,PIM-Mn Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL362155,GW827102X,None,490.45,1,5.39,GW827102X,FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1,Inhibition,'=',0.66,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1909385,GW458787A,None,565.1,2,5.35,GW458787A,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl,Inhibition,'=',0.19,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3976384,,None,394.48,0,1.8,BDBM238437,C=C(c1cc2c([nH]1)CCNC2=O)c1nc(N[C@@H]2CCN(C(C)=O)C2)c(C)nc1C,IC50,'=',34.5,nM,7.46,,416635,UO_0000065,18.92,0.35,5.66,7.24,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3970964,,None,322.33,0,2.66,BDBM224827,CCOc1cnc(-c2c[nH]c3ccc(-c4nnc(N)o4)cc23)cn1,IC50,'=',324.24,nM,6.49,,393109,UO_0000065,20.13,0.37,3.83,5.61,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3952291,,None,387.47,0,4.28,BDBM224967,CNc1nnc(-c2ccc3[nH]cc(-c4cccc(-n5ccnc5C)n4)c3c2)s1,IC50,'=',122.62,nM,6.91,,393257,UO_0000065,17.84,0.34,2.63,8.2,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL513330,GW781673X,None,336.79,0,3.45,GW781673X,Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1,Inhibition,'=',2.14,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL272028,GW300660X,None,453.48,0,0.8,GW300660X,NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1,Inhibition,'=',3.79,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1909393,GW583373A,None,595.55,2,6.43,GW583373A,Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1,Inhibition,'=',0.46,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3651980,,None,464.54,0,4.28,BDBM106884,CCCOc1ccc(F)c(-c2cccc(C(=O)Nc3cnccc3[C@@H]3CC[C@H](O)[C@H](N)C3)n2)c1,IC50,'=',163,nM,6.79,,225905,UO_0000065,14.61,0.27,2.51,6.15,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3926062,,None,323.4,0,3.24,BDBM238739,Cc1nc2cccc(-c3c[nH]c(C(N)=O)c3)c2nc1NC(C)(C)C,IC50,'=',34.8,nM,7.46,,416848,UO_0000065,23.06,0.42,4.22,7.71,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL456252,GSK-2110236A,None,520.62,1,3.45,GSK2110236A,COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2,Inhibition,'=',0.47,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3984944,,None,502.56,1,4.4,BDBM151837,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@@H]1[S@@+](C)[O-],IC50,'=',10.45,nM,7.98,,292093,UO_0000065,15.88,0.31,3.58,7.68,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3741589,,None,366.24,0,4.09,29; A-971432,O=C(O)C1CN(Cc2ccc(OCc3ccc(Cl)c(Cl)c3)cc2)C1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3742689,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3739276,1,Scientific Literature,J Med Chem,2015,None,
CHEMBL3920600,,None,363.42,0,2.67,BDBM238697,Cc1nc2cccc(-c3cc4c([nH]3)[C@@H](CO)NC4=O)c2nc1NC1(C)CC1,IC50,'=',0.53,nM,9.28,,416806,UO_0000065,25.52,0.47,6.61,9.01,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3896761,,None,411.49,0,1.82,BDBM238447,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1CCS(=O)(=O)C1,IC50,'=',20.5,nM,7.69,,416645,UO_0000065,18.68,0.36,5.87,6.58,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3899021,,None,376.46,0,2.38,BDBM238449,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@H]1CCCNC1,IC50,'=',27,nM,7.57,,416647,UO_0000065,20.1,0.37,5.19,7.99,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL352222,,None,394.17,0,3.09,SB-358518,O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1,Inhibition,'=',1.61,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3939819,,None,365.44,0,2.92,BDBM238642,Cc1nc2cccc(-c3cc4c([nH]3)[C@@H](C)NC4=O)c2nc1NC(C)(C)CO,IC50,'=',1.45,nM,8.84,,416751,UO_0000065,24.19,0.45,5.92,8.59,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL272165,GW300657X,None,450.48,0,1.43,GW300657X,NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1,Inhibition,'=',0.12,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3891210,,None,363.42,0,2.16,BDBM238617,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1(CO)CC1,IC50,'=',0.4,nM,9.4,,416724,UO_0000065,25.86,0.48,7.24,9.13,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3664620,,None,403.49,0,3.48,BDBM104240,COC1(COc2cccc3ccc(-c4nnc5ccccn45)nc23)CCCNCC1,IC50,'=',91.5,nM,7.04,,222651,UO_0000065,17.44,0.32,3.56,9.57,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3934242,,None,453.55,0,4.9,BDBM238693,Cc1nc2cccc(-c3cc4c([nH]3)C(COCc3ccccc3)NC4=O)c2nc1NC1(C)CC1,IC50,'=',1.86,nM,8.73,,416802,UO_0000065,19.25,0.35,3.83,9.5,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3666778,,None,623.76,1,3.37,BDBM141341,COc1cc(C(=O)NC2CCN(C)CC2)ccc1Nc1ncc2c(n1)-c1c(c(C(=O)N[C@H](CN)c3ccccc3)nn1C)CCC2,IC50,'=',3761,nM,5.42,,276606,UO_0000065,8.7,0.16,2.05,3.56,0,CHEMBL3707966,Kinase Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates are trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3651938,,None,456.47,0,4.75,BDBM106842,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2nc(-c3c(F)cc(O)cc3F)ccc2F)C1,IC50,'=',2,nM,8.7,,225863,UO_0000065,19.06,0.36,3.95,8.6,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL218088,GW435821X,None,268.32,0,2.67,GW435821X,Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1,Inhibition,'=',0.5,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL361237,GW785804X,None,322.37,0,4.14,GW785804X,Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1,Inhibition,'=',0.17,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL63728,GW644007X,None,326.36,0,2.57,GW644007X,COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O,Inhibition,'=',0.9,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3981514,,None,403.45,0,3.47,BDBM225014,CC(C)Nc1nnc(-c2ccc3[nH]cc(-c4ncc(C(N)=O)c(C5CC5)n4)c3c2)o1,IC50,'=',2.15,nM,8.67,,393304,UO_0000065,21.48,0.39,5.2,6.39,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3944136,,None,353.4,0,3.53,BDBM238636,Cc1nc2ccc(F)c(-c3cc4c([nH]3)CNC4=O)c2nc1NC(C)(C)C,IC50,'=',0.501,nM,9.3,,416745,UO_0000065,26.32,0.49,5.77,11.25,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3970144,,None,368.44,0,4.13,BDBM238398,O=C1NCCc2[nH]c(-c3cccc4ccc(NCc5ccccc5)nc34)cc21,IC50,'=',21.6,nM,7.67,,416173,UO_0000065,20.81,0.37,3.54,10.98,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4455188,,None,511.55,1,3.87,14,Cn1ncc(NC(=O)c2nc(-c3c(F)cccc3F)sc2N)c1N1CCC[C@H](NCC(F)F)CC1,Ki,'=',6,nM,8.22,,,UO_0000065,16.07,0.32,4.35,8.13,0,CHEMBL4317000,Inhibition of recombinant human PIM2 using FAM-pimtide as substrate after 90 mins by Z-LYTE assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4316591,1,Scientific Literature,J Med Chem,2019,None,
CHEMBL3920197,,None,422.44,0,3.77,BDBM192557,O[C@H]1CCCN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1,IC50,'=',30,nM,7.52,,344549,UO_0000065,17.81,0.33,3.75,9.57,1,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3930132,,None,335.37,0,3.65,BDBM225099,CC(C)Oc1cccc(-c2c[nH]c3ccc(-c4nc(N)no4)cc23)n1,IC50,'=',79.74,nM,7.1,,393091,UO_0000065,21.17,0.39,3.45,6.9,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3943561,,None,476.58,0,4.03,BDBM238420,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1CCN(C(=O)OC(C)(C)C)CC1,IC50,'=',34.9,nM,7.46,,416618,UO_0000065,15.65,0.29,3.43,6.64,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3904314,,None,382.45,0,3.52,BDBM224940,COc1cc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)nc(OC(C)C)n1,IC50,'=',30.09,nM,7.52,,393223,UO_0000065,19.67,0.38,4,6.73,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3944661,,None,379.46,0,4.03,BDBM224885,N[C@H]1CCN(c2nnc(-c3ccc4[nH]cc(-c5ccccc5F)c4c3)s2)C1,IC50,'=',244.47,nM,6.61,,393163,UO_0000065,17.42,0.33,2.58,9.33,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1929238,,None,554.54,2,5.23,27,CN(C)CCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O,IC50,'>',30000,nM,,,,UO_0000065,,,,,0,CHEMBL1931535,Inhibition of PIM2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1926590,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL3652020,,None,506.48,1,4.89,BDBM106926,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3cc(C(F)(F)F)ccc3F)n2)C[C@@H](N)[C@@H]1O,IC50,'=',68,nM,7.17,,225947,UO_0000065,14.15,0.27,2.28,7.09,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3660035,,None,375.48,0,4.09,BDBM104153,CCC(Oc1cccc2ccc(-c3nnc4ccccn34)nc12)[C@@H](CC)CN,IC50,'=',318,nM,6.5,,222570,UO_0000065,17.3,0.32,2.41,8.3,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL481510,GW853606X,None,496.31,1,5.55,GW853606X,NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br,Inhibition,'=',-0.68,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL365248,GW810372X,None,402.34,0,3.84,GW810372X,COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1,Inhibition,'=',-0.29,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3983220,,None,340.41,0,1.94,BDBM238608,CSc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2c(=O)n1C,IC50,'=',11.9,nM,7.92,,416715,UO_0000065,23.28,0.45,5.98,9.93,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL188240,,None,274.28,0,1.48,SB-737198,CCOc1nccc2c1nc(-c1nonc1N)n2CC,Inhibition,'=',1.49,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3652009,,None,440.45,0,2.85,BDBM106915,C[C@H]1CN(c2ccncc2NC(=O)c2cccc(-c3c(F)cccc3F)n2)C[C@@H](O)[C@@H]1O,IC50,'=',2,nM,8.7,,225936,UO_0000065,19.75,0.37,5.85,8.82,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3986065,,None,404.47,0,2.3,BDBM238429,CC(=O)N[C@@H]1CC[C@@H]1Nc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2nc1C,IC50,'=',38.3,nM,7.42,,416627,UO_0000065,18.34,0.34,5.12,6.63,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3965003,,None,379.46,0,3.06,BDBM238436,COCC(C)(C)Nc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2nc1C,IC50,'=',5.4,nM,8.27,,416634,UO_0000065,21.79,0.4,5.21,8.99,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3963827,,None,477.46,0,4.89,BDBM191121,CCOc1ccc(-c2c(-c3cccc(OC(F)(F)F)c3)cc3n2[C@@H](CCN)CNC3=O)cc1F,IC50,'=',24,nM,7.62,,341792,UO_0000065,15.96,0.31,2.73,9.71,0,CHEMBL3887520,Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3935023,,None,461.51,1,5.08,BDBM191123,CSc1ccc(-c2c(-c3cccc(OC(F)(F)F)c3)cc3n2[C@@H](CCN)CNC3=O)cc1,IC50,'=',45,nM,7.35,,341794,UO_0000065,15.92,0.31,2.27,10.6,0,CHEMBL3887520,Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4227817,,None,391.41,0,4.14,12c,CC(C)Nc1ccc2cnn(-c3cncc(-c4ccc(C(=O)O)cc4F)n3)c2c1,IC50,'=',22000,nM,4.66,,,UO_0000065,11.9,0.22,0.52,5.01,0,CHEMBL4222695,Inhibition of PIM2 (unknown origin) expressed in human U2OS cells assessed as reduction in BAD substrate phosphorylation by ELISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,U2OS,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4219163,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL248757,,None,471.93,0,4.27,25,N#Cc1ncc2nc1OCCCCOc1cc(NCc3cncs3)c(Cl)cc1NC(=O)N2,Ki,'>',1424,nM,,,,UO_0000065,,,,,0,CHEMBL941804,Inhibition of PIM2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140564,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,
CHEMBL569114,,None,490.56,1,5.67,17,COc1ccc(/C=C/C(=O)Nc2cc(-c3[nH]c(SC)nc3-c3ccc(F)cc3)ccn2)c(OC)c1,Activity,'=',87,%,,,,UO_0000187,,,,,0,CHEMBL1049899,Inhibition of PIM2 assessed as residual activity at 0.1 uM by Cherenkov counting relative to control in presence of 5 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155278,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL160937,,None,314.73,0,2.53,SB-390527,O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1,Inhibition,'=',-0.21,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1909365,GW607049C,None,617.56,2,6.69,GW607049C,COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O,Inhibition,'=',-0.09,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL2443026,,None,578.67,1,4.49,38,CN(C)c1ccc(Oc2cc(O)cc(O)c2-c2cc(C(=O)NC3CCN(C4CCC5(CC4)OCCO5)CC3)no2)cc1,IC50,'>',10,nM,,,,UO_0000065,,,,,0,CHEMBL2443982,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2439976,1,Scientific Literature,Bioorg Med Chem,2013,None,
CHEMBL84558,,None,263.32,0,2.8,16a,CCCOc1ccc(/C=C2\SC(=O)NC2=O)cc1,IC50,'=',20,nM,7.7,,,UO_0000065,29.24,0.58,4.9,13.9,0,CHEMBL957366,Inhibition of human recombinant Pim2 by ATP depletion assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139352,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL3983191,,None,402.46,0,3.99,BDBM225032,CC(C)Nc1nnc(-c2ccc3[nH]cc(-c4cncc(C(=O)NC5CC5)c4)c3c2)o1,IC50,'=',299,nM,6.52,,393319,UO_0000065,16.21,0.3,2.53,6,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3908883,,None,362.39,0,3.69,BDBM225037,CC(C)Nc1nnc(-c2ccc3[nH]cc(NC(=O)c4ccncc4)c3c2)o1,IC50,'=',115,nM,6.94,,393322,UO_0000065,19.15,0.35,3.25,6.38,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3105022,,None,457.46,0,2.96,1b,C[C@H]1CN(c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@@H]1O,Ki,'<',1,nM,,,,UO_0000065,,,,,0,CHEMBL3794688,Inhibition of Pim2 (unknown origin) using BAD peptide preincubated for 15 mins followed by ATP addition measured after 60 to 100 mins by Kinase-Glo reagent based luminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3792348,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL495827,,None,247.32,0,3.13,9a,CC(C)c1ccc(/C=C2\SC(=O)NC2=O)cc1,IC50,'>',100000,nM,,,,UO_0000065,,,,,0,CHEMBL957366,Inhibition of human recombinant Pim2 by ATP depletion assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139352,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL258844,,None,551.65,2,6.32,Akt-I-1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3687510,,None,528.58,2,5.21,BDBM151906,CCOCc1cc(F)c(-c2nc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@@H](OC)[C@@H](C)C3)ccc2F)c(F)c1,IC50,'=',3.3,nM,8.48,,292162,UO_0000065,16.05,0.3,3.27,8.54,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1909362,GW830900A,None,534.09,0,3.22,GW830900A,CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl,Inhibition,'=',0.27,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL296468,BMS-387032,1,380.54,0,3.66,BMS-387032,CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL1822792,MK-2461,2,495.56,0,2.15,MK-2461,CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL4130257,,None,371.49,0,4.57,12,Cc1cccc(-c2c[nH]c3ccc(-c4cncc(NCCN(C)C)n4)cc23)c1,IC50,'=',830,nM,6.08,,,UO_0000065,16.37,0.3,1.51,10.7,0,CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4118246,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL4125999,,None,372.48,0,3.85,16,CN(C)CCNc1cncc(-c2ccc3[nH]cc(-c4cccc(N)c4)c3c2)n1,IC50,'=',820,nM,6.09,,,UO_0000065,16.34,0.3,2.24,7.35,0,CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4118246,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL1785002,,None,472.52,0,3.89,SB-264865,NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1,Inhibition,'=',0.18,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL2420899,,None,348.45,0,2.86,41,c1ccc(C2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1,Inhibition,'=',4,%,,,,UO_0000187,,,,,0,CHEMBL2422098,Inhibition of PIM2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2417369,1,Scientific Literature,Bioorg Med Chem,2013,None,
CHEMBL2017214,,None,422.56,0,3.12,8,CSc1ccccc1Nc1nc(N2CCNCC2)nc2c(NCC3CC3)ncnc12,IC50,'>',40000,nM,,,,UO_0000065,,,,,0,CHEMBL2019682,Inhibition of PIM2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016462,1,Scientific Literature,ACS Med Chem Lett,2011,None,
CHEMBL4455512,,None,315.31,0,2.99,G3_9,N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1,Activity,'=',6,%,,,,UO_0000187,,,,,0,CHEMBL4335230,Inhibition of recombinant human Pim2 (2 to end residues) assessed as residual activity at 1 uM using RSRHSSYPAGT as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4334438,1,Scientific Literature,Eur J Med Chem,2019,None,
CHEMBL4555884,,None,484.09,1,5.19,1,COc1cc(Br)cc2[nH]cc(-c3oc(-c4ccc[nH]4)nc3I)c12,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL4338190,Inhibition of PIM2 (unknown origin) by [33P]-ATP filter binding kinase assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4334516,1,Scientific Literature,J Med Chem,2019,None,
CHEMBL3979954,,None,347.42,0,3.7,BDBM238666,Cc1nc2cccc(-c3cc4c([nH]3)[C@H](C)NC4=O)c2nc1NC1(C)CC1,IC50,'=',0.201,nM,9.7,,416775,UO_0000065,27.91,0.51,6,11.73,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3975756,,None,429.49,0,0.86,BDBM249050,OC1CN(c2cncc(-c3cc4c(cn3)cnn4-c3cccc(N4CCNCC4)n3)n2)C1,Ki,'=',3.37,nM,8.47,,434254,UO_0000065,19.73,0.36,7.61,7.84,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4110363,,None,402.51,0,2.89,BDBM248911,CC[C@@H]1CN(c2cccc(-n3ncc4cnc(-c5cnn(CC)c5)cc43)n2)CCN1,Ki,'=',15,nM,7.82,,434118,UO_0000065,19.44,0.36,4.93,10.2,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2377716,,None,244.25,0,2.9,15,CCCc1c[nH]c2c([N+](=O)[O-])cc3cn[nH]c3c12,Inhibition,'=',27,%,,,,UO_0000187,,,,,0,CHEMBL2378599,Inhibition of human full length Pim-2 using RSRHSSYPAGT as substrate assessed as residual activity at 10 uM after 30 mins in presence of [gamma-33P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2375344,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL595546,,None,778.87,1,2.38,1a,CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(N)=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,Activity,'=',100,%,,,,UO_0000187,,,,,0,CHEMBL1043367,Binding affinity to human PIM2 at 500 nM by cell-based competition binding assay relative to control in presence of DTT,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1152541,1,Scientific Literature,Bioorg Med Chem,2009,None,
CHEMBL56731,,None,280.28,0,2.64,K00065,N#C/C(=C\c1ccc(O)c(O)c1)C(=O)Nc1ccccc1,Thermal melting change,'=',1.5,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL375530,DICHLORORIBOBENZIMIDAZOLE,None,319.14,0,0.95,K00051,OC[C@H]1O[C@@H](n2cnc3cc(Cl)c(Cl)cc32)[C@H](O)[C@@H]1O,Thermal melting change,'=',2.6,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL3982539,,None,400.49,0,2.82,BDBM248974,Cc1cncc(-c2cc3c(cn2)cnn3-c2ccc(C)c(N3CCC[C@H](N)C3)n2)n1,Ki,'=',0.142,nM,9.85,,434181,UO_0000065,24.59,0.45,7.03,9.98,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4448494,,None,506.61,1,4.72,3c,Cc1nc2c(F)cc(-c3nc(Nc4ccc5c(n4)CCN(CCN(C)C)C5)ncc3F)cc2n1C(C)C,IC50,'=',177,nM,6.75,,,UO_0000065,13.33,0.25,2.03,9,0,CHEMBL4305831,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4304763,1,Scientific Literature,Eur J Med Chem,2019,None,
CHEMBL3297763,,None,513.63,1,3.42,15b,CN1CCN(C[C@@H](NC(=O)C[C@H]2CNC(=O)c3cc(-c4ccc(F)c(F)c4)cn32)C2CCCCC2)CC1,IC50,'=',250,nM,6.6,,,UO_0000065,12.85,0.24,3.18,9.48,0,CHEMBL3300844,Inhibition of human PIM2 using ARK-RERTYSFGHHA as substrate incubated for 60 mins prior to substrate addition by topcount scintillation counting analysis in presence of [P33gamma]-ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3297733,1,Scientific Literature,Bioorg Med Chem,2013,None,
CHEMBL3297764,,None,530.09,1,3.93,15c,CN1CCN(C[C@@H](NC(=O)C[C@H]2CNC(=O)c3cc(-c4cc(Cl)ccc4F)cn32)C2CCCCC2)CC1,IC50,'=',132,nM,6.88,,,UO_0000065,12.98,0.25,2.95,9.88,1,CHEMBL3300844,Inhibition of human PIM2 using ARK-RERTYSFGHHA as substrate incubated for 60 mins prior to substrate addition by topcount scintillation counting analysis in presence of [P33gamma]-ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3297733,1,Scientific Literature,Bioorg Med Chem,2013,None,
CHEMBL3982105,,None,426.53,0,3.16,BDBM248969,Cc1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CCC4(CCNC4)CC3)n2)n1,Ki,'=',17,nM,7.77,,434176,UO_0000065,18.22,0.33,4.61,9.18,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3903884,,None,624.58,2,5.25,BDBM191074,CN1CCN(Cc2ccc(-c3c(-c4cccc(OC(F)(F)F)c4)cc4n3C(CCOC(=O)C(F)(F)F)CNC4=O)cc2)CC1,IC50,'=',35,nM,7.46,,341745,UO_0000065,11.94,0.23,2.21,9.81,0,CHEMBL3887520,Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP,,,,,,,,,,,,,,,,,,,,,,
CHEMBL565612,SOTRASTAURIN,2,438.49,0,2.43,Sotrastaurin,CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3965243,,None,403.45,0,1.51,BDBM249081,Cc1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CCC(O)C(O)C3)n2)n1,Ki,'=',3.58,nM,8.45,,434285,UO_0000065,20.93,0.38,6.94,7.47,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3732044,,None,318.87,0,2.88,Example 4,Cl.NCCN1C(=O)S/C(=C\CCC2CCCCC2)C1=O,Inhibition,'=',38,%,,,,UO_0000187,,,,,0,CHEMBL3734496,Inhibition of recombinant human PIM2 using fluorescein-labeled peptide as substrate by fluorescence-electrophoretic mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3727354,38,Patent Bioactivity Data,,2011,None,
CHEMBL2110732,DACOMITINIB,4,469.95,1,5.16,Dacomitinib,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3896150,,None,493.51,0,3.94,BDBM191115,CS(=O)(=O)NCC[C@H]1CNC(=O)c2cc(-c3cccc(OC(F)(F)F)c3)c(-c3ccccc3)n21,IC50,'=',172,nM,6.76,,341786,UO_0000065,13.71,0.27,2.82,7.56,0,CHEMBL3887520,Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3905102,,None,459.42,0,4.08,BDBM191117,NCC[C@H]1CNC(=O)c2cc(-c3cccc(OC(F)(F)F)c3)c(-c3ccc4c(c3)OCO4)n21,IC50,'=',16,nM,7.8,,341788,UO_0000065,16.97,0.32,3.72,8.89,0,CHEMBL3887520,Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3937689,,None,459.47,0,4.24,BDBM191108,NCCC[C@H]1CNC(=O)c2cc(-c3cccc(OC(F)(F)F)c3)c(-c3ccc(CO)cc3)n21,IC50,'=',109,nM,6.96,,341779,UO_0000065,15.15,0.29,2.72,7.78,0,CHEMBL3887520,Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2001019,PF-04217903,1,372.39,0,1.67,PF-04217903,OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL4084193,,None,None,None,None,RDEA-436,,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3814340,,None,267.34,0,2.94,16,CCCCc1cc(-c2c[nH]c3ncccc23)nc(N)n1,Activity,'=',-25,%,,,,UO_0000187,,,,,0,CHEMBL3815502,Inhibition of human PIM2 (2 to 334 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3813616,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL3394171,,None,352.42,0,3.51,BDBM50061622,CC(C)Oc1cncc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)n1,IC50,'=',16.58,nM,7.78,,393182,UO_0000065,22.08,0.43,4.27,7.58,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4109355,,None,400.49,0,3.1,BDBM192591,C[C@@H]1C[C@H](N)CN(c2ccncc2Nc2ncc3ccc(-c4ccccn4)nn23)C1,IC50,'=',1.3,nM,8.89,,344662,UO_0000065,22.19,0.4,5.79,9.14,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3969621,,None,309.38,0,1.8,BDBM192636,N[C@H]1CCCN(c2ccncc2Nc2nnc3ccccn23)C1,IC50,'=',73.7,nM,7.13,,344667,UO_0000065,23.05,0.42,5.33,8.45,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL405665,MERIOLIN 1,None,211.23,0,1.6,15; 8; Meriolin 1,Nc1nccc(-c2c[nH]c3ncccc23)n1,Activity,'=',-39,%,,,,UO_0000187,,,,,0,CHEMBL3815502,Inhibition of human PIM2 (2 to 334 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3813616,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL540501,,None,997.3,None,None,PD-0325901-Cl,O=C(NOC[C@@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl.O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl,Activity,'=',90,%,,,,UO_0000187,,,,,0,CHEMBL1061149,Percentage PIM2 activity remaining in the presence of 10uM inhibitor,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL44541,MERIDIANIN C,None,289.14,0,2.97,B,Nc1nccc(-c2c[nH]c3ccc(Br)cc23)n1,IC50,,,,,,Not Determined,,,,,,0,CHEMBL3269287,Inhibition of PIM2 kinase (unknown origin) using 5-FAM-labeled BAD peptide as substrate after 90 mins by fluorescence polarization assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3259764,1,Scientific Literature,Bioorg Med Chem Lett,2014,None,
CHEMBL583099,,None,273.36,0,2.51,10a,Cc1ccc2sc3c(=O)[nH]c(CN(C)C)nc3c2c1,Ki,'=',122,nM,6.91,,,UO_0000065,25.29,0.5,4.4,14.11,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL584195,,None,313.15,0,4.38,28,O=Cc1c[nH]c2c1ccc1c3cc(Br)ccc3[nH]c12,Activity,'=',53,%,,,,UO_0000187,,,,,0,CHEMBL1057614,Inhibition of Pim-2 assessed as residual enzyme activity at 10 uM relative to untreated control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154186,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL583690,,None,371.85,0,4.42,6r,Cc1c(O)cccc1NCc1nc2c(sc3ccc(Cl)cc32)c(=O)[nH]1,Ki,'>',1424,nM,,,,UO_0000065,,,,,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL583972,,None,234.26,0,3.61,A,O=Cc1c[nH]c2c1ccc1c3ccccc3[nH]c12,IC50,'=',510,nM,6.29,,,UO_0000065,26.86,0.48,2.68,12.93,1,CHEMBL1248424,Inhibition of human GST fused Pim2 expressed in Escherichia coli after 30 mins,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240519,1,Scientific Literature,Bioorg Med Chem,2010,None,
CHEMBL3634775,,None,338.38,0,0.92,25,NC(=O)Nc1cc2c(-c3cccc(N4CCNCC4)n3)n[nH]c2cn1,Ki,'=',1.1,nM,8.96,,,UO_0000065,26.47,0.49,8.04,7.18,0,CHEMBL3636741,Inhibition of Pim2 (unknown origin) using 5FAM-ARKRRRHPSGPPTA as substrate after 90 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632547,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL3355541,,None,405.42,0,4.05,1,CN1CCC(CNc2ccn3ncc(-c4cccc(OC(F)(F)F)c4)c3n2)CC1,IC50,'=',1491,nM,5.83,,,UO_0000065,14.37,0.27,1.78,10.65,0,CHEMBL3375413,Inhibition of Pim2 (unknown origin) using luciferase-luciferin based ATP detection reagent by Kinase-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3351833,1,Scientific Literature,ACS Med Chem Lett,2015,None,
CHEMBL1909352,GW441806A,None,329.79,0,2.75,GW441806A,Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl,Inhibition,'=',-3.3,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1782524,,None,367.24,0,3.7,32,O=C(O)c1cc2cc(Br)cc(NCCC3CCNCC3)c2o1,IC50,'=',540,nM,6.27,,,UO_0000065,17.07,0.39,2.57,8.41,0,CHEMBL1786238,Inhibition of human Pim2 using 5-FAM-RSRHSSYPAGT-CONH2 as substrate after 90 mins by off-chip mobility shift method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1781944,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL1782525,,None,367.2,0,2.83,33,O=C(O)c1cc2cc(Br)cc(NC(=O)C3CCNCC3)c2o1,IC50,'=',260,nM,6.58,,,UO_0000065,17.93,0.41,3.76,7.19,0,CHEMBL1786238,Inhibition of human Pim2 using 5-FAM-RSRHSSYPAGT-CONH2 as substrate after 90 mins by off-chip mobility shift method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1781944,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL3691971,,None,547.59,2,5.52,BDBM151993,C=C(C)c1cn([C@@H]2[C@H](N)C[C@H](c3ccncc3NC(=O)c3ccc(F)c(-c4c(F)cccc4F)n3)C[C@@H]2C)nn1,IC50,'=',2.79,nM,8.55,,292248,UO_0000065,15.62,0.29,3.03,7.66,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3703181,,None,314.41,0,3.29,BDBM149689,CSc1ncc2ccc3c(C(N)=O)c(C)n(C(C)C)c3c2n1,IC50,'=',12,nM,7.92,,288347,UO_0000065,25.19,0.49,4.63,10.73,0,CHEMBL3707582,Kinase Inhibition Assay: The buffer for PIM-2 assay was composed of HEPES 50 mM,,,,,,,,,,,,,,,,,,,,,,
CHEMBL44541,MERIDIANIN C,None,289.14,0,2.97,Merid C,Nc1nccc(-c2c[nH]c3ccc(Br)cc23)n1,IC50,,,,,,Not Determined,,,,,,0,CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4118246,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL4127024,,None,272.14,0,4.6,1,Brc1ccc2[nH]cc(-c3ccccc3)c2c1,IC50,,,,,,Not Determined,,,,,,0,CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4118246,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL3891490,,None,392.49,0,2.48,BDBM224919,CN1CCN(c2cnc(-c3c[nH]c4ccc(-c5nnc(N)s5)cc34)cn2)CC1,IC50,'=',459.37,nM,6.34,,393201,UO_0000065,16.15,0.31,3.86,6.35,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3980111,,None,404.48,0,1.47,BDBM248921,OCCn1cc(-c2cc3c(cn2)cnn3-c2cccc(N3CCCNCC3)n2)cn1,Ki,'=',5.38,nM,8.27,,434128,UO_0000065,20.44,0.38,6.8,8.53,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3959316,,None,388.43,0,3.39,BDBM224978,c1cc2[nH]cc(-c3cncc(C4CC4)n3)c2cc1-c1nnc(N2CCOCC2)o1,IC50,'=',35.77,nM,7.45,,393268,UO_0000065,19.17,0.35,4.06,8.01,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3963493,,None,379.42,1,5.22,BDBM224989,c1ccc(-c2nnc(-c3ccc4[nH]cc(-c5nccc(C6CC6)n5)c4c3)o2)cc1,IC50,'=',676.86,nM,6.17,,393278,UO_0000065,16.26,0.29,0.95,7.66,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3906747,,None,416.49,0,4.17,BDBM224987,CC1(C)COCCN1c1nnc(-c2ccc3[nH]cc(-c4cncc(C5CC5)n4)c3c2)o1,IC50,'=',140.9,nM,6.85,,393276,UO_0000065,16.45,0.3,2.68,7.37,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4127644,,None,436.54,0,2.91,28,CN(C)CCNc1cncc(-c2ccc3[nH]cc(-c4ccc(S(N)(=O)=O)cc4)c3c2)n1,IC50,'=',700,nM,6.16,,,UO_0000065,14.1,0.27,3.24,5.26,0,CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4118246,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL3899758,,None,390.37,0,4.07,BDBM238768,Cc1nc2cccc(-c3cc4c([nH]3)[C@@H](C)NC4=O)c2nc1O[C@H](C)C(F)(F)F,IC50,'=',258,nM,6.59,,416878,UO_0000065,16.88,0.32,2.52,8.25,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3980680,,None,411.51,0,4.79,BDBM238757,CC(C)(C)Nc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2nc1-c1ccccc1,IC50,'=',12,nM,7.92,,416866,UO_0000065,19.25,0.35,3.13,9.58,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3894757,,None,390.49,0,3.33,BDBM238685,CC(C)(C)Nc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2nc1N1CCC1,IC50,'=',10.5,nM,7.98,,416794,UO_0000065,20.43,0.38,4.65,9.28,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3909785,,None,359.43,0,3.63,BDBM238667,Cc1nc2cccc(-c3cc4c([nH]3)C3(CC3)NC4=O)c2nc1NC1(C)CC1,IC50,'=',0.39,nM,9.41,,416776,UO_0000065,26.18,0.48,5.78,11.38,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4128705,,None,439.49,1,5.67,33,CN(C)CCCNc1cncc(-c2ccc3[nH]cc(-c4ccc(C(F)(F)F)cc4)c3c2)n1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4118246,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL4126656,,None,387.46,0,4.23,38,Fc1ccccc1-c1c[nH]c2ccc(-c3cncc(N4CCCNCC4)n3)cc12,IC50,'=',537,nM,6.27,,,UO_0000065,16.18,0.3,2.04,11.03,0,CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4118246,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL3651919,,None,421.48,0,2.68,BDBM106823,C[C@H]1CN(c2ccncc2NC(=O)c2cccc(-c3ccccc3F)n2)C[C@@H](N)[C@@H]1O,IC50,'=',5,nM,8.3,,225844,UO_0000065,19.69,0.37,5.62,7.95,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3652645,,None,461.54,0,3.23,BDBM119405,CN[C@H]1CCCN(c2c(NC(=O)c3nc(-c4c(F)cccc4F)sc3N)cnn2C)CC1,Ki,'=',4.37,nM,8.36,,246172,UO_0000065,18.11,0.36,5.13,8.27,0,CHEMBL3707982,Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3943301,,None,350.43,0,2.7,BDBM238625,CC(C)(C)Nc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2nc1N,IC50,'=',0.305,nM,9.52,,416735,UO_0000065,27.15,0.5,6.82,8.75,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4555990,,None,430.52,0,2.58,56,CN1CCOc2c1cnn1c(-c3ccc4ccnc(NCC5CCNCC5)c4c3)nnc21,IC50,'=',27,nM,7.57,,,UO_0000065,17.58,0.32,4.99,8.18,0,CHEMBL4340984,Inhibition of His tagged human recombinant PIM2 using PIM tide (ARKRRRHPSGPPTA) as substrate incubated for 1 hr by fluorescence based assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4340512,1,Scientific Literature,Eur J Med Chem,2019,None,
CHEMBL1985092,,None,377.83,1,5.55,SID103905577,Oc1ccc(-c2n[nH]c(Nc3cccc(Cl)c3)c2-c2ccc(O)cc2)cc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL223367,,None,431.88,0,3.51,SID103905150,N#Cc1ncc2nc1OCCCCCOc1cc(CCCO)c(Cl)cc1NC(=O)N2,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1983025,,None,483.64,1,6.37,SID103904302,CCC(N)(C#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12)CC,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3974156,,None,334.38,0,4.25,BDBM224826,CC(C)Oc1cccc(-c2c[nH]c3ccc(-c4nnc(N)o4)cc23)c1,IC50,'=',384.94,nM,6.42,,393108,UO_0000065,19.18,0.35,2.16,7.13,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3985000,,None,390.45,0,3.8,BDBM225029,CC(C)Nc1nnc(-c2ccc3[nH]cc(-c4cncc(C(=O)N(C)C)c4)c3c2)o1,IC50,'>',1000,nM,,,393316,UO_0000065,,,,,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3960208,,None,406.52,0,2.94,BDBM224877,CNc1nnc(-c2ccc3[nH]cc(-c4nccc(N5CCN(C)CC5)n4)c3c2)s1,IC50,'=',33.61,nM,7.47,,393155,UO_0000065,18.38,0.35,4.53,8.7,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3297761,,None,495.64,0,3.28,14i,CN1CCN(C[C@@H](NC(=O)C[C@H]2CNC(=O)c3cc(-c4cccc(F)c4)cn32)C2CCCCC2)CC1,IC50,'=',150,nM,6.82,,,UO_0000065,13.77,0.26,3.54,9.8,0,CHEMBL3300844,Inhibition of human PIM2 using ARK-RERTYSFGHHA as substrate incubated for 60 mins prior to substrate addition by topcount scintillation counting analysis in presence of [P33gamma]-ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3297733,1,Scientific Literature,Bioorg Med Chem,2013,None,
CHEMBL3297767,,None,486.06,0,3.26,16b,CN1CCN(C[C@@H](NC(=O)C[C@H]2CNC(=O)c3cc(-c4cccc(Cl)c4)cn32)C(C)(C)C)CC1,IC50,'=',262,nM,6.58,,,UO_0000065,13.54,0.26,3.32,9.46,0,CHEMBL3300844,Inhibition of human PIM2 using ARK-RERTYSFGHHA as substrate incubated for 60 mins prior to substrate addition by topcount scintillation counting analysis in presence of [P33gamma]-ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3297733,1,Scientific Literature,Bioorg Med Chem,2013,None,
CHEMBL3297759,,None,412.51,0,2.99,14g,NC[C@@H](NC(=O)C[C@H]1CNC(=O)c2cc(-c3cccc(F)c3)cn21)C1CCCCC1,IC50,'=',275,nM,6.56,,,UO_0000065,15.9,0.3,3.57,7.36,0,CHEMBL3300844,Inhibition of human PIM2 using ARK-RERTYSFGHHA as substrate incubated for 60 mins prior to substrate addition by topcount scintillation counting analysis in presence of [P33gamma]-ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3297733,1,Scientific Literature,Bioorg Med Chem,2013,None,
CHEMBL1987679,,None,400.44,0,3.61,SID103904478,NC(COc1cncc(-c2ccc3[nH]c(=O)oc3c2)c1)Cc1c[nH]c2ccccc12,Ki,'=',63.1,nM,7.2,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL482767,SNS-314,1,430.95,1,5.1,SID103905586,O=C(Nc1cccc(Cl)c1)Nc1ncc(CCNc2ncnc3ccsc23)s1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL363648,TAK-715,2,399.52,1,6,SID103905024,CCc1nc(-c2cccc(C)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3900527,,None,390.45,0,2.76,BDBM224855,CN1CCCC(Nc2ccnc(-c3c[nH]c4ccc(-c5nnc(N)o5)cc34)n2)C1,IC50,'=',6.595,nM,8.18,,393134,UO_0000065,20.95,0.39,5.42,6.72,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3952591,,None,388.82,0,4.58,BDBM224865,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(-c5cccc(Cl)c5)n4)c3c2)o1,IC50,'=',22.91,nM,7.64,,393143,UO_0000065,19.65,0.37,3.06,7.17,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3982628,,None,312.72,0,2.91,BDBM224843,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(Cl)n4)c3c2)o1,IC50,'=',146.12,nM,6.83,,393125,UO_0000065,21.86,0.42,3.93,6.42,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL581096,GW440139A,None,363.85,1,5.05,GW440139A,Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl,Inhibition,'=',1.15,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL2387473,,None,502.53,1,4.21,8,O=C(Nc1c[nH]c2ccc(-c3c(F)cccc3F)nc12)c1cnn2ccc(NCC3CCNCC3)nc12,Ki,'=',0.52,nM,9.28,,,UO_0000065,18.47,0.34,5.07,8.29,0,CHEMBL2387969,Inhibition of PIM2 (unknown origin) using FAM-pimtide as substrate after 90 mins by spectrophotometry in presence of ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2385019,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL1885746,GW561436X,None,370.39,0,4.04,GW561436X,N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1,Inhibition,'=',0.72,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1973483,,None,400.28,1,5.31,SID103904898,O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(C(F)(F)F)ccc12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL262433,,None,394.44,0,4.43,SID103904346,Cc1ccc(F)c(NC(=O)Nc2ccc(-c3nsc4ncnc(N)c34)cc2)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL225519,,None,213.24,0,1.36,SID103905167,O=C1NCCc2[nH]c(-c3ccncc3)cc21,Ki,'>',794.33,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3937510,,None,389.84,0,4.96,BDBM238474,O=C1NCCc2[nH]c(-c3cccc4ccc(Oc5ccccc5Cl)nc34)cc21,IC50,'=',18.1,nM,7.74,,416211,UO_0000065,19.86,0.38,2.78,11.55,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1940251,,None,488.53,0,3.14,24,CC(C)n1cc(C(=O)c2cncc(N[C@@H]3CCN(C=O)[C@@H]3c3ccc(F)cc3)n2)c2c(N)ncnc21,Inhibition,'=',9,%,,,,UO_0000187,,,,,0,CHEMBL1942193,Inhibition of PIM2 at 1 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1938337,1,Scientific Literature,J Med Chem,2011,None,
CHEMBL1794073,GW770220A,None,459.96,0,2.83,GW770220A,Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl,Inhibition,'=',0.81,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1909398,GW282536X,None,330.37,0,1.41,GW282536X,Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1,Inhibition,'=',0.28,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3652028,,None,424.46,0,3.64,BDBM106936,Nc1cc(F)c(-c2ccncc2F)nc1C(=O)Nc1cnccc1[C@@H]1CCC[C@H](N)C1,IC50,'=',24,nM,7.62,,225957,UO_0000065,17.95,0.34,3.98,6.36,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1909396,GW768505A,None,573.93,2,6.95,GW768505A,COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl,Inhibition,'=',0.28,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3651936,,None,470.5,0,4.32,BDBM106840,Cc1ccc(F)c(-c2nc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@@H](O)[C@@H](C)C3)ccc2F)c1F,IC50,'=',3,nM,8.52,,225861,UO_0000065,18.11,0.34,4.2,8.43,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL191105,,None,287.33,0,1.02,SB-751399,CN(C)CCCn1c(-c2nonc2N)nc2cnccc21,Inhibition,'=',0.24,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3974415,,None,435.48,0,4.13,BDBM192623,C[C@]1(N)CCCN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1,IC50,'=',9.6,nM,8.02,,344699,UO_0000065,18.41,0.34,3.89,9.5,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3676287,,None,429.49,1,5,BDBM131757,C[C@@H]1C[C@H](O)C[C@H](c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C1,IC50,'=',90,nM,7.05,,263990,UO_0000065,16.4,0.32,2.05,9.38,0,CHEMBL3706072,Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3952993,,None,448.53,0,3.25,BDBM238519,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1CN(C(=O)OC(C)(C)C)C1,IC50,'=',33,nM,7.48,,416663,UO_0000065,16.68,0.31,4.23,6.67,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3660097,,None,349.37,0,2.63,BDBM104230,FC1(COc2cccc3ccc(-c4nnc5ccccn45)nc23)CNC1,IC50,'=',1000,nM,6,,222641,UO_0000065,17.17,0.32,3.37,9.33,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3691949,,None,539.56,1,4.96,BDBM151971,COc1cc(F)c(-c2nc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@@H](OCCC#N)[C@@H](C)C3)ccc2F)c(F)c1,IC50,'=',1.13,nM,8.95,,292226,UO_0000065,16.58,0.31,3.99,7.27,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL554,LAPATINIB,4,581.07,2,6.14,Lapatinib,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3913032,,None,369.42,0,4.62,BDBM238475,Cc1cc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1Oc1ccccc1,IC50,'=',9,nM,8.05,,416212,UO_0000065,21.78,0.39,3.43,12.01,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3691974,,None,514.5,1,4.12,BDBM151996,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1OCC(=O)O,IC50,'=',47.26,nM,7.33,,292251,UO_0000065,14.24,0.27,3.21,5.75,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3691915,,None,496.55,0,3.35,BDBM151937,C[C@H]1CN(c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1n1ccnn1,IC50,'=',2.55,nM,8.59,,292192,UO_0000065,17.31,0.34,5.24,7.48,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3947213,,None,310.33,0,2.92,BDBM238524,Cc1nc2cccc(-c3cc4c([nH]3)C(C)CNC4=O)c2nc1F,IC50,'=',0.5,nM,9.3,,416670,UO_0000065,29.97,0.55,6.38,13.16,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4438024,,None,265.19,0,0.29,7a; NSC30049; NSC49L,ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-],Activity,'=',99.34,%,,,,UO_0000187,,,,,0,CHEMBL4327828,Inhibition of human PIM2 assessed as residual activity at 1 uM using RSRHSSYPAGT as substrate by [gamma-33P]-ATP assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4325871,1,Scientific Literature,Eur J Med Chem,2019,None,
CHEMBL4446405,,None,292.81,0,1.21,7b; ASR352,C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-],Activity,'=',97.89,%,,,,UO_0000187,,,,,0,CHEMBL4327828,Inhibition of human PIM2 assessed as residual activity at 1 uM using RSRHSSYPAGT as substrate by [gamma-33P]-ATP assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4325871,1,Scientific Literature,Eur J Med Chem,2019,None,
CHEMBL3651913,,None,466.53,0,4.44,BDBM106817,CCc1ccc(F)c(-c2cccc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@@H](O)[C@@H](C)C3)n2)c1F,IC50,'=',13,nM,7.89,,225838,UO_0000065,16.9,0.32,3.45,7.8,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3651916,,None,440.47,1,5.11,BDBM106820,Cc1ccc(F)c(-c2nc(C(=O)Nc3cnccc3[C@@H]3CCC[C@H](N)C3)ccc2F)c1F,IC50,'=',7,nM,8.15,,225841,UO_0000065,18.51,0.35,3.04,10.08,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL458415,GSK-2186269A,None,483.58,0,3.86,GSK2186269A,COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2,Inhibition,'=',-0.35,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1909361,GW830365A,None,576.12,1,2.99,GW830365A,CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl,Inhibition,'=',0.04,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3958307,,None,390.49,0,2.9,BDBM238510,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@@H]1CCC[C@H](N)C1,IC50,'=',9.3,nM,8.03,,416248,UO_0000065,20.57,0.38,5.13,7.39,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3652639,,None,424.48,0,2.17,BDBM119399,Cn1ncc(NC(=O)c2nc(-c3ccccc3F)cnc2N)c1N1CCC[C@@H](N)CC1,Ki,'=',3.52,nM,8.45,,246166,UO_0000065,19.91,0.37,6.28,6.61,0,CHEMBL3707982,Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4556760,,None,435.53,0,3.59,20,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C[C@@H]5CCCO5)c(NC(C)(C)C)nc34)[nH]c21,IC50,'=',1.1,nM,8.96,,,UO_0000065,20.57,0.38,5.37,8.87,0,CHEMBL4370146,Inhibition of full length recombinant PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues preincubated for 30 mins followed by biotinylated BAD addition and measured after 1 hr by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4368910,1,Scientific Literature,J Med Chem,2019,None,
CHEMBL523520,,None,366.42,0,2.3,9,CC(=O)N1CCCN(c2cncc(-c3cccc(/C=C/C(=O)O)c3)n2)CC1,IC50,'=',880,nM,6.06,,,UO_0000065,16.53,0.31,3.76,6.99,0,CHEMBL960121,Inhibition of Pim2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153342,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL455227,,None,284.32,0,1.61,13,NCCNc1cncc(-c2cccc(/C=C/C(=O)O)c2)n1,IC50,'=',140,nM,6.85,,,UO_0000065,24.11,0.45,5.24,6.78,0,CHEMBL960121,Inhibition of Pim2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153342,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL232601,GW846105X,None,401.49,0,4.71,GW846105X,N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1,Inhibition,'=',1.37,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1909385,GW458787A,None,565.1,2,5.35,GW458787A,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl,Inhibition,'=',0.74,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3924143,,None,345.41,0,3.24,BDBM238663,Cc1nc2cccc(-c3cc4c([nH]3)C3(CC3)NC4=O)c2nc1NC1CC1,IC50,'=',0.242,nM,9.62,,416772,UO_0000065,27.84,0.51,6.38,11.63,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3894748,,None,395.46,0,2.57,BDBM238798,COCC1NC(=O)c2cc(-c3cccc4c(=O)n(C)c(NC(C)(C)C)nc34)[nH]c21,IC50,'=',3.12,nM,8.51,,416907,UO_0000065,21.51,0.4,5.94,8.42,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3919258,,None,432.53,0,3.6,BDBM238799,CC(=O)N[C@@H]1CCC[C@H](Nc2nc3c(-c4cc5c([nH]4)[C@@H](C)NC5=O)cccc3nc2C)C1,IC50,'=',2.38,nM,8.62,,416908,UO_0000065,19.94,0.37,5.02,7.71,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3919994,,None,350.43,0,2.82,BDBM238623,Cc1nc2nccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC(C)(C)C,IC50,'=',0.278,nM,9.56,,416732,UO_0000065,27.27,0.5,6.74,10,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3926451,,None,360.42,0,2.99,BDBM238649,CC(C)(C)Nc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2nc1C#N,IC50,'=',3.76,nM,8.43,,416758,UO_0000065,23.37,0.43,5.43,7.91,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3676268,,None,385.54,0,3.77,BDBM131738,N[C@H]1CCCN(c2ccncc2NC(=O)c2csc(C3CCCCC3)n2)C1,IC50,'=',208,nM,6.68,,263971,UO_0000065,17.33,0.34,2.91,7.94,0,CHEMBL3706072,Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3676271,,None,483.47,0,4.45,BDBM131741,NC1CC(C(F)(F)F)CN(c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C1,IC50,'=',3,nM,8.52,,263974,UO_0000065,17.63,0.35,4.07,10.13,0,CHEMBL3706072,Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1317546,,None,221.26,0,1.43,IC86621,CC(=O)c1ccc(N2CCOCC2)cc1O,Residual Activity,'=',129,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL64758,,None,404.22,0,4.6,Cdk4_Inhibitor,O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21,Residual Activity,'=',6,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL559147,Y-27632,None,247.34,0,2.17,Y-27632,C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1,Residual Activity,'=',121,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL260138,ALSTERPAULLONE 2,None,346.35,0,3.69,Alsterpaullone_2,N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2,Residual Activity,'=',96,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL160333,,None,349.17,0,3.18,SB-409514,O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1,Inhibition,'=',0.87,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL477069,GSK-1173862A,None,517.61,2,5.28,GSK1173862A,CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1,Inhibition,'=',0.9,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL473629,GSK-204925A,None,423.49,0,3.82,GSK204925A,COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC,Inhibition,'=',0.47,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1909368,GW683134A,None,575.91,2,7,GW683134A,Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F,Inhibition,'=',-3.36,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3634763,,None,364.45,0,2.32,28,c1cc(-c2n[nH]c3cnc(C4CCCOC4)cc23)nc(N2CCNCC2)c1,Ki,'=',26,nM,7.58,,,UO_0000065,20.81,0.38,5.27,9.61,0,CHEMBL3636741,Inhibition of Pim2 (unknown origin) using 5FAM-ARKRRRHPSGPPTA as substrate after 90 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632547,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL275200,,None,471.58,1,6.16,SB-278538,CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1,Inhibition,'=',0.14,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL276711,SEMAXANIB,3,238.29,0,3.12,Semaxanib,Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1,Residual Activity,'=',93,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL261849,GW632580X,None,366.42,0,2.83,GW2580,COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,Residual Activity,'=',115,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2218925,,None,343.22,0,4.15,VEGF_Receptor_2_Kinase_Inhibitor_II,O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2,Residual Activity,'=',106,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1645462,AC-480,1,530.56,1,3.86,AC-480,Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL230592,GSK-635416A,None,453.54,0,3.89,GSK635416A,CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N,Inhibition,'=',0.43,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL506414,GW684626B,None,467.98,1,7.53,GW684626B,Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1,Inhibition,'=',0.52,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL271595,GW297361X,None,372.43,0,2.35,GW297361X,NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1,Inhibition,'=',0.27,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3944757,,None,414.52,0,3.2,BDBM248916,c1cc(N2CCCNCC2)nc(-n2ncc3cnc(-c4cnn(C5CCC5)c4)cc32)c1,Ki,'=',3.92,nM,8.41,,434123,UO_0000065,20.28,0.37,5.21,10.96,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3907320,,None,398.47,0,2.38,BDBM248983,Cc1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CCC4(CNC4)C3)n2)n1,Ki,'=',2.65,nM,8.58,,434190,UO_0000065,21.52,0.39,6.2,10.13,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3958435,,None,398.47,0,2.38,BDBM248986,Cc1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CC4(CCNC4)C3)n2)n1,Ki,'=',15.1,nM,7.82,,434193,UO_0000065,19.63,0.36,5.44,9.24,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3934315,,None,470.46,0,2.37,BDBM248988,Cc1cncc(-c2cc3c(cn2)cnn3-c2ccc(C(F)(F)F)c(N3CCNCC(O)C3)n2)n1,Ki,'=',12.5,nM,7.9,,434195,UO_0000065,16.8,0.32,5.53,7.54,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3950820,,None,486.5,0,3.06,BDBM249030,CO[C@@]1(C)CNCCN(c2cccc(-n3ncc4cnc(-c5cnn(CC(F)(F)F)c5)cc43)n2)C1,Ki,'=',16.5,nM,7.78,,434234,UO_0000065,16,0.3,4.72,9.06,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3958986,,None,359.43,0,4.75,BDBM225082,CC(C)Cc1nnc(-c2ccc3[nH]cc(-c4nccc(C5CC5)n4)c3c2)o1,IC50,'=',30.79,nM,7.51,,393075,UO_0000065,20.9,0.38,2.76,9.33,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3907004,,None,388.48,0,2.5,BDBM248894,CCn1cc(-c2cc3c(cn2)cnn3-c2cccc(N3CCCNCC3)n2)cn1,Ki,'=',4.27,nM,8.37,,434101,UO_0000065,21.54,0.39,5.87,10.91,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL275666,,None,483.47,1,5.88,SB-253226,Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1,Inhibition,'=',0.19,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL275168,,None,449.92,1,5.52,SB-278539,Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1,Inhibition,'=',0.62,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1789963,GW406108X,None,400.22,1,5.02,GW406108X,O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1,Inhibition,'=',17.94,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL520037,GW837331X,None,459.43,0,4.89,GW837331X,COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC,Inhibition,'=',0.34,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3747545,,None,441.46,0,3.99,7,C[C@@H]1C[C@H](N)CN(c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C1,Ki,'<',3,nM,,,,UO_0000065,,,,,0,CHEMBL3750240,Inhibition of PIM2 kinase (unknown origin) using NH2-AGAGRSRHSSYPAGT-OH as substrate by kinase-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3745712,1,Scientific Literature,J Med Chem,2015,None,
CHEMBL1794057,GW284408X,None,292.3,0,2.26,GW284408X,O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1,Inhibition,'=',-0.46,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3691921,,None,570.61,2,5.23,BDBM151943,CO[C@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(OC4CCOCC4)cc3F)n2)C[C@@H]1C,IC50,'=',1.03,nM,8.99,,292198,UO_0000065,15.75,0.3,3.76,8.28,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3634771,,None,385.44,0,1.82,21,N#CCn1cc(-c2cc3c(-c4cccc(N5CCNCC5)n4)n[nH]c3cn2)cn1,Ki,'=',0.127,nM,9.9,,,UO_0000065,25.68,0.47,8.08,8.89,0,CHEMBL3636741,Inhibition of Pim2 (unknown origin) using 5FAM-ARKRRRHPSGPPTA as substrate after 90 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632547,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL1782517,,None,310.31,0,1.97,25,O=C(O)c1cc2cc(-c3cncc(NC4CNC4)n3)ccc2o1,IC50,'=',100,nM,7,,,UO_0000065,22.56,0.42,5.03,6.98,0,CHEMBL1786238,Inhibition of human Pim2 using 5-FAM-RSRHSSYPAGT-CONH2 as substrate after 90 mins by off-chip mobility shift method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1781944,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL3652002,,None,472.49,1,5.62,BDBM106908,Cc1ccc(F)c(-c2cccc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)C[C@@H](C(F)(F)F)C3)n2)c1,IC50,'=',7,nM,8.15,,225929,UO_0000065,17.26,0.33,2.53,10.08,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2377713,,None,230.18,0,1.76,12,O=Cc1c[nH]c2c([N+](=O)[O-])cc3cn[nH]c3c12,Inhibition,'=',117,%,,,,UO_0000187,,,,,0,CHEMBL2378598,Inhibition of human full length Pim-2 using RSRHSSYPAGT as substrate assessed as residual activity at 1 uM after 30 mins in presence of [gamma-33P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2375344,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL467581,GSK-2219385A,None,520.57,1,3.52,GSK2219385A,COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1,Inhibition,'=',-3.42,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL272165,GW300657X,None,450.48,0,1.43,GW300657X,NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1,Inhibition,'=',4.93,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1952125,,None,418.42,0,3.66,7e,FC(F)(F)Oc1cccc(-n2nnc3ccc(NC4CC5(CCNCC5)C4)nc32)c1,IC50,'=',218,nM,6.66,,,UO_0000065,15.92,0.3,3,8.66,0,CHEMBL1954567,Inhibition of PIM2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1949661,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL3691965,,None,521.55,1,4.8,BDBM151987,Cc1cc(F)c(-c2nc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@@H](n4ccnn4)[C@@H](C)C3)ccc2F)c(F)c1,IC50,'=',2.1,nM,8.68,,292242,UO_0000065,16.64,0.31,3.88,7.78,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3780032,,None,211.26,0,0.76,5; IACS-4759,Cc1cnc(N)nc1OCC(C)(C)CO,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL3782384,Inhibition of partial length human PIM2 expressed in bacterial system at 1 uM,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3779767,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL258844,,None,551.65,2,6.32,Akt-I-1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3905519,,None,416.49,0,1.61,BDBM248941,CCc1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CCNCC(O)C3)n2)n1,Ki,'=',1.47,nM,8.83,,434148,UO_0000065,21.21,0.39,7.22,8.42,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL188268,,None,307.32,0,1.51,SB-750140,NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1,Inhibition,'=',8.18,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3664633,,None,429.45,0,4.5,BDBM104259,CC(C)(CNCC(F)(F)F)COc1cccc2ccc(-c3nnc4ccccn34)nc12,IC50,'=',361.9,nM,6.44,,222670,UO_0000065,15,0.28,1.94,10.01,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3651912,,None,427.52,0,3.06,BDBM106816,C[C@H]1CN(c2ccncc2NC(=O)c2ccc(F)c(C3CCCCC3)n2)C[C@@H](N)[C@@H]1O,IC50,'=',3,nM,8.52,,225837,UO_0000065,19.94,0.38,5.46,8.17,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3904923,,None,350.38,0,3.5,BDBM225103,CNc1nc(-c2ccc3[nH]cc(-c4cncc(OC(C)C)n4)c3c2)no1,IC50,'=',242.33,nM,6.62,,393095,UO_0000065,18.88,0.35,3.12,6.5,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3891851,,None,420.91,0,3.16,BDBM248945,Cc1cncc(-c2cc3c(cn2)cnn3-c2ccc(Cl)c(N3CCC[C@H](N)C3)n2)n1,Ki,'=',0.317,nM,9.5,,434152,UO_0000065,22.57,0.43,6.34,9.63,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3660015,,None,319.37,0,2.67,BDBM104133,NCCCOc1cccc2ccc(-c3nnc4ccccn34)nc12,IC50,'=',514,nM,6.29,,222550,UO_0000065,19.69,0.36,3.62,8.03,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL2376153,,None,476.93,0,2.66,6j,CC[C@@H](NC(=O)c1c[nH]c2ncc(-c3nn(C)c4cc(Cl)ccc34)nc12)C(=O)N1CC(C#N)C1,Inhibition,'=',3,%,,,,UO_0000187,,,,,0,CHEMBL2378211,Inhibition of PIM2 (unknown origin) at 10 uM relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2375236,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL496996,,None,284.13,0,2.77,23a,O=C1NC(=O)/C(=C/c2ccc(Br)cc2)S1,IC50,'=',90,nM,7.05,,,UO_0000065,24.8,0.64,4.28,15.26,0,CHEMBL957366,Inhibition of human recombinant Pim2 by ATP depletion assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139352,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL2377715,,None,288.26,0,2.44,14,CCOC(=O)c1[nH]c2c([N+](=O)[O-])cc3cn[nH]c3c2c1C,Inhibition,'=',97,%,,,,UO_0000187,,,,,0,CHEMBL2378599,Inhibition of human full length Pim-2 using RSRHSSYPAGT as substrate assessed as residual activity at 10 uM after 30 mins in presence of [gamma-33P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2375344,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL156524,,None,324.77,0,2.77,SB-333612,O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1,Inhibition,'=',0.55,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL205158,GW695874X,None,427.51,0,3.91,GW695874X,c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1,Inhibition,'=',5.56,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL91829,RUBOXISTAURIN,3,468.56,0,3.51,2,CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1,Kd,'=',130,nM,6.89,,,UO_0000065,14.7,0.27,3.38,10.05,0,CHEMBL2184778,Competitive binding affinity to PIM2 in presence of ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2176972,1,Scientific Literature,J Med Chem,2012,None,
CHEMBL3962369,,None,396.45,1,5.02,BDBM225083,CC(C)(Nc1nnc(-c2ccc3[nH]cc(-c4ncccn4)c3c2)o1)c1ccccc1,IC50,'=',271.1,nM,6.57,,393076,UO_0000065,16.56,0.3,1.55,7.1,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3394172,,None,378.46,0,4.05,BDBM50061623,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(OC5CCCC5)n4)c3c2)s1,IC50,'=',24.63,nM,7.61,,393183,UO_0000065,20.1,0.38,3.56,7.42,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3961249,,None,388.35,0,4.51,BDBM224992,CC(C)Nc1nnc(-c2ccc3[nH]cc(-c4nccc(C(F)(F)F)n4)c3c2)o1,IC50,'=',25.25,nM,7.6,,393281,UO_0000065,19.56,0.37,3.09,8.21,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3651929,,None,424.45,0,4.36,BDBM106833,N[C@H]1CCC[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3cc(O)ccc3F)n2)C1,IC50,'=',9,nM,8.05,,225854,UO_0000065,18.96,0.35,3.69,7.96,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3942045,,None,336.42,0,4.4,BDBM224959,CNc1nnc(-c2ccc3[nH]cc(-c4cccc(OC)c4)c3c2)s1,IC50,'>',3000,nM,,,393249,UO_0000065,,,,,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL346551,,None,264.28,0,2.17,SKF-62604,O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1,Inhibition,'=',6.61,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL2377721,,None,172.19,0,1.63,20,Nc1cc2cn[nH]c2c2cc[nH]c12,Inhibition,'=',99,%,,,,UO_0000187,,,,,0,CHEMBL2378598,Inhibition of human full length Pim-2 using RSRHSSYPAGT as substrate assessed as residual activity at 1 uM after 30 mins in presence of [gamma-33P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2375344,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL575675,,None,387.87,0,4.66,14o,CN(C)Cc1nc2c(sc3ccc(-c4ccc(Cl)c(F)c4)cc32)c(=O)[nH]1,Ki,'=',22,nM,7.66,,,UO_0000065,19.74,0.4,3,15.63,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL1909381,GW575808A,None,371.83,0,3.08,GW575808A,Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl,Inhibition,'=',-4.07,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL2218935,,None,365.5,1,5.03,Flt_3_Inhibitor_III,c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1,Residual Activity,'=',105,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3652014,,None,422.46,0,2.07,BDBM106920,C[C@H]1CN(c2ccncc2NC(=O)c2ccc(F)c(-c3ccncc3)n2)C[C@@H](N)[C@@H]1O,IC50,'=',18,nM,7.75,,225941,UO_0000065,18.33,0.34,5.67,6.6,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4110528,,None,405.47,0,0.84,BDBM249012,Cn1cc(-c2cc3c(cn2)cnn3-c2cn(C)c(=O)c(N3CCC[C@@H](N)C3)n2)cn1,Ki,'=',528,nM,6.28,,434218,UO_0000065,15.48,0.29,5.44,5.57,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1909398,GW282536X,None,330.37,0,1.41,GW282536X,Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1,Inhibition,'=',0.28,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1895450,GSK-2220400A,None,529.61,1,3.05,GSK2220400A,CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12,Inhibition,'=',5.43,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1909415,GW693881A,None,487.39,1,6.8,GW693881A,Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1,Inhibition,'=',-3.43,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3981339,,None,389.5,0,4.35,BDBM238504,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1CCCCCC1,IC50,'=',13.9,nM,7.86,,416241,UO_0000065,20.17,0.37,3.51,9.5,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3810085,,None,369.43,0,3.96,BDBM238539,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1Nc1ccccc1,IC50,'=',1.6,nM,8.8,,416262,UO_0000065,23.81,0.43,4.84,10.64,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3933369,,None,368.44,0,4.82,BDBM238403,CC1CNC(=O)c2cc(-c3cccc4ccc(Nc5ccccc5)nc34)[nH]c21,IC50,'=',4,nM,8.4,,416289,UO_0000065,22.79,0.41,3.58,12.03,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4111423,,None,372.44,0,2.12,BDBM248937,Cc1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CC[C@@H](N)C3)n2)n1,Ki,'=',4.74,nM,8.32,,434144,UO_0000065,22.35,0.41,6.2,8.44,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3969289,,None,417.48,0,1.21,BDBM249010,Cc1cncc(-c2cc3c(cn2)cnn3-c2cn(C)c(=O)c(N3CCC[C@H](N)C3)n2)n1,Ki,'=',45.5,nM,7.34,,434216,UO_0000065,17.59,0.32,6.13,6.09,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL102936,,None,370.43,0,2.95,SB-742865,CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1,Inhibition,'=',0.44,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1794050,GW429374A,None,508.6,1,5.47,GW429374A,Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1,Inhibition,'=',8.09,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL2037200,,None,461.95,0,4.87,13,CN1CCCN(C(=O)c2cccc(-c3ccc(/C=C4/C(=O)Nc5ccc(Cl)cc54)o3)c2)CC1,IC50,'=',25,nM,7.6,,,UO_0000065,16.46,0.31,2.73,11.56,0,CHEMBL2038829,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034977,1,Scientific Literature,ACS Med Chem Lett,2012,None,
CHEMBL2037205,,None,475.98,1,5.26,18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3687476,,None,538.53,1,2.92,BDBM151872,C[C@H]1CN(c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1n1cc(CO)nn1,IC50,'=',1.18,nM,8.93,,292128,UO_0000065,16.58,0.31,6.01,6.61,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3793067,,None,432.43,0,4.21,3b,Cc1cc(-c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)ccc2N)cc(N)n1,Ki,'<',3,nM,,,,UO_0000065,,,,,0,CHEMBL3794688,Inhibition of Pim2 (unknown origin) using BAD peptide preincubated for 15 mins followed by ATP addition measured after 60 to 100 mins by Kinase-Glo reagent based luminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3792348,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL284861,,None,222.27,0,0.66,GSK_3b_Inhibitor_I,Cn1sc(=O)n(Cc2ccccc2)c1=O,Residual Activity,'=',143,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3909184,,None,391.48,0,3.69,BDBM238654,CC(=O)N1CCc2[nH]c(-c3cccc4nc(C)c(NC(C)(C)C)nc34)cc2C1=O,IC50,'=',45.4,nM,7.34,,416763,UO_0000065,18.76,0.35,3.65,8.07,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3977692,,None,363.42,0,2.15,BDBM238758,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@H]1C[C@@H](O)C1,IC50,'=',1.4,nM,8.85,,416867,UO_0000065,24.36,0.45,6.7,8.6,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL313417,,None,297.36,0,3.86,SKF-86002,Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1,Residual Activity,'=',108,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL372474,GW678313X,None,452.51,1,5.69,GW678313X,CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1,Inhibition,'=',0.1,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1909341,GW641155A,None,364.83,1,5.88,GW641155A,Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1,Inhibition,'=',0.53,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1909350,GSK-949675A,None,421.89,0,0.8,GSK949675A,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl,Inhibition,'=',1.04,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3808459,,None,335.41,0,3.04,2,CCCNc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2nc1C,IC50,'=',2,nM,8.7,,,UO_0000065,25.94,0.48,5.66,10.52,0,CHEMBL3812018,Inhibition of human full-length Pim2 expressed in Escherichia coli assessed as phosphorylation of biotinylated BAD peptide at Ser 112 preincubated for 30 mins followed by substrate addition measured after 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3808325,1,Scientific Literature,ACS Med Chem Lett,2016,None,
CHEMBL3687450,,None,534.56,1,4,BDBM151846,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1OS(C)(=O)=O,IC50,'=',12.41,nM,7.91,,292102,UO_0000065,14.79,0.29,3.91,6.36,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3943778,,None,414.4,0,2.39,BDBM249027,NC1CN(c2cccc(-n3ncc4cnc(-c5cnn(CC(F)(F)F)c5)cc43)n2)C1,Ki,'=',8.18,nM,8.09,,434231,UO_0000065,19.52,0.37,5.7,8.92,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3967108,,None,646.77,2,5.98,11,CCN1CCN(Cc2ccc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)cc(F)c7C6=O)c5CO)ccnc4[nH]3)nc2)CC1,Activity,'=',0,%,,,,UO_0000187,,,,,0,CHEMBL4178311,Inhibition of recombinant human full length N-terminal GST-tagged PIM2 expressed in baculovirus infected Sf9 cells assessed as change in enzyme activity at 1 uM in presence of 1 uM ATP relative to control,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4177534,1,Scientific Literature,Bioorg Med Chem Lett,2017,None,
CHEMBL493536,,None,337.43,0,1.78,3,CN1CCCN(c2cncc(-c3cccc(/C=C/C(N)=O)c3)n2)CC1,IC50,'=',1200,nM,5.92,,,UO_0000065,17.55,0.32,4.14,7.86,0,CHEMBL960121,Inhibition of Pim2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153342,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL4066450,,None,228.25,0,2.22,2月2日,COc1ccc2c(c1)[nH]c1c(CO)nccc12,Activity,'=',58,%,,,,UO_0000187,,,,,0,CHEMBL4151472,Inhibition of human PIM2 expressed in bacterial expression system assessed as remaining enzyme activity at 10 uM by kinome scan assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4145671,1,Scientific Literature,J Med Chem,2018,None,
CHEMBL496786,,None,223.23,0,2.15,18a,O=C1NC(=O)/C(=C/c2ccc(F)cc2)S1,IC50,'=',2300,nM,5.64,,,UO_0000065,25.26,0.51,3.49,12.21,0,CHEMBL957366,Inhibition of human recombinant Pim2 by ATP depletion assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139352,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL448443,,None,223.23,0,2.15,20a,O=C1NC(=O)/C(=C/c2cccc(F)c2)S1,IC50,'=',400,nM,6.4,,,UO_0000065,28.66,0.58,4.25,13.86,0,CHEMBL957366,Inhibition of human recombinant Pim2 by ATP depletion assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139352,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL3660014,,None,345.41,0,3.08,BDBM104132,c1cc(OC2CCNCC2)c2nc(-c3nnc4ccccn34)ccc2c1,IC50,'=',570,nM,6.24,,191660,UO_0000065,18.08,0.33,3.16,9.7,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL50894,ALSTERPAULLONE,None,293.28,0,3.24,Alsterpaullone,O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1,Residual Activity,'=',117,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL382590,ANILINOQUINAZOLINE1,None,400.44,0,4.64,Aurora_Kinase_Inhibitor_II,COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC,Residual Activity,'=',127,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1802727,,None,365.39,0,1.94,Indirubin_E804,O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO,Residual Activity,'=',44,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2425646,,None,308.38,0,3.14,12,O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1,Inhibition,'=',86,%,,,,UO_0000187,,,,,0,CHEMBL2429482,Competitive binding affinity to PIM2 (unknown origin) at 10 uM in presence of ATP relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2424622,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL2152768,,None,504.61,1,4.13,3,CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1,Inhibition,'=',2.9,%,,,,UO_0000187,,,,,0,CHEMBL2157335,Inhibition of PIM2 at 1 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2151019,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL1164180,,None,502.97,1,5,5e,CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1,Inhibition,'<',50,%,,,,UO_0000187,,,,,0,CHEMBL1166808,Inhibition of PIM2 at 1 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1165965,1,Scientific Literature,Bioorg Med Chem,2010,None,
CHEMBL1163559,,None,584.09,2,6.55,5m,O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1,Inhibition,'<',50,%,,,,UO_0000187,,,,,0,CHEMBL1166808,Inhibition of PIM2 at 1 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1165965,1,Scientific Literature,Bioorg Med Chem,2010,None,
CHEMBL1909352,GW441806A,None,329.79,0,2.75,GW441806A,Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl,Inhibition,'=',-2.91,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1982660,,None,362.31,0,4.3,SID103904872,COc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1997597,,None,316.39,0,2.57,SID103904489,CCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL535,SUNITINIB,4,398.48,0,3.33,SU-11248,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,Kd,'=',5000,nM,5.3,,,UO_0000065,13.3,0.25,1.97,6.86,0,CHEMBL859489,Average Binding Constant for PIM2; NA=Not Active at 10 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144455,1,Scientific Literature,Nat Biotechnol,2005,None,
CHEMBL491758,,None,280.31,0,4.1,SID103904610,Fc1cnc(Nc2ccccc2)nc1Nc1ccccc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1190711,,None,390.4,0,2.65,SID103905231,COc1ccc(-c2cc3nccn3c(Nc3ncccc3C(N)=O)n2)cc1OC,Ki,'=',1000,nM,6,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL426800,GW785404X,None,247.23,0,1.83,GW785404X,CCn1c(-c2nonc2N)nc2ccc(F)cc21,Inhibition,'=',-0.12,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1986139,,None,261.74,0,4.09,SID103905168,Clc1csc2ncnc(Nc3ccccc3)c12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL194062,GW572399X,None,315.35,0,2.73,GW572399X,NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1,Inhibition,'=',0.32,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL269883,GW416981X,None,415.47,0,2.55,GW416981X,CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2,Inhibition,'=',0.83,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL506153,GW876790X,None,330.35,0,0.03,GW876790X,CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21,Inhibition,'=',18.75,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL14762,SELICICLIB,2,354.46,0,3.2,Seliciclib,CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL1614707,MUBRITINIB,1,468.48,1,6.06,Mubritinib,FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3687431,,None,534.56,1,2.51,BDBM151825,C[C@H]1CN(c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1NS(C)(=O)=O,IC50,'=',2.59,nM,8.59,,292081,UO_0000065,16.06,0.32,6.08,6.59,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2138625,,None,507.01,1,4.67,AV-412,C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3651951,,None,426.54,0,4.12,BDBM106855,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c([C@H]3CC[C@H](O)CC3)n2)C1,IC50,'=',11,nM,7.96,,225876,UO_0000065,18.66,0.35,3.84,7.87,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4062256,,None,424.89,0,3.25,9,COc1ccc2c(c1CN1CCNCC1)O/C(=C\c1c[nH]c3nc(Cl)ccc13)C2=O,IC50,'=',140,nM,6.85,,,UO_0000065,16.13,0.31,3.6,8.62,0,CHEMBL3997632,Inhibition of full length recombinant human N-terminal GST-tagged PIM2 (1 to 311 residues) expressed in baculovirus infected sf21 cells using S6K2 peptide as substrate by electrophoretic mobility shift assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3994673,1,Scientific Literature,ACS Med Chem Lett,2017,None,
CHEMBL3930004,,None,391.5,0,4.18,BDBM224960,CNc1nnc(-c2ccc3[nH]cc(-c4cncc(N5CCCCC5)n4)c3c2)s1,IC50,'=',40.97,nM,7.39,,393250,UO_0000065,18.87,0.36,3.21,8.94,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL220465,GSK-248233A,None,484.52,0,4.19,GSK248233A,CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21,Inhibition,'=',-0.19,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL2017354,,None,411.41,1,6,13v,FC(F)(F)c1cccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3sccc23)c1,IC50,'=',52,nM,7.28,,,UO_0000065,17.7,0.34,1.28,10.96,0,CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016532,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL3687483,,None,576.64,1,4.39,BDBM151879,Cc1cc(F)c(-c2nc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@@H](OCCS(C)(=O)=O)[C@@H](C)C3)ccc2F)c(F)c1,IC50,'=',1.37,nM,8.86,,292135,UO_0000065,15.37,0.3,4.47,7.13,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3809044,,None,345.41,0,3.13,8b,Cc1nc2cccc3c2nc1NC/C=C/C[C@@H]1CNC(=O)c2cc-3[nH]c21,IC50,'=',1,nM,9,,,UO_0000065,26.06,0.47,5.87,10.88,0,CHEMBL3812018,Inhibition of human full-length Pim2 expressed in Escherichia coli assessed as phosphorylation of biotinylated BAD peptide at Ser 112 preincubated for 30 mins followed by substrate addition measured after 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3808325,1,Scientific Literature,ACS Med Chem Lett,2016,None,
CHEMBL3808445,,None,345.41,0,3.13,9b,Cc1nc2cccc3c2nc1NC/C=C\C[C@@H]1CNC(=O)c2cc-3[nH]c21,IC50,'=',1,nM,9,,,UO_0000065,26.06,0.47,5.87,10.88,0,CHEMBL3812018,Inhibition of human full-length Pim2 expressed in Escherichia coli assessed as phosphorylation of biotinylated BAD peptide at Ser 112 preincubated for 30 mins followed by substrate addition measured after 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3808325,1,Scientific Literature,ACS Med Chem Lett,2016,None,
CHEMBL2017356,,None,367.44,0,4.96,13x,C#Cc1cccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3sccc23)c1,IC50,'=',5,nM,8.3,,,UO_0000065,22.59,0.42,3.34,12.48,0,CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016532,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL3691960,,None,522.54,1,4.07,BDBM151982,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)c(F)cc2N)C[C@@H](N)[C@H]1n1ccnn1,IC50,'=',0.77,nM,9.11,,292237,UO_0000065,17.44,0.33,5.04,6.62,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2017358,,None,354.82,1,5.54,8a,O=C(O)c1cccc2c1nc(Nc1ccccc1Cl)c1ccsc12,IC50,'=',121,nM,6.92,,,UO_0000065,19.49,0.39,1.38,11.12,0,CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016532,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL2063926,,None,505.7,1,3.58,17,CSc1ccccc1Nc1nc(N2CCN(C3CCNCC3)CC2)nc2c(NCC3CC3)ncnc12,Inhibition,'<',15,%,,,,UO_0000187,,,,,0,CHEMBL2065127,Inhibition of PIM2 at 10 uM by FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2062359,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL50894,ALSTERPAULLONE,None,293.28,0,3.24,SID103905621,O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL509032,TAE-684,None,614.22,2,5.02,SID103904598,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2089000,,None,264.28,0,3.59,27,COC(=O)c1cc2c3ccccc3[nH]c2c2[nH]ccc12,IC50,,,,,,Not Determined,,,,,,0,CHEMBL2090488,Inhibition of human Pim2 using RSRHSSYPAGT as substrate,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2086229,1,Scientific Literature,Eur J Med Chem,2012,None,
CHEMBL1782508,,None,242.23,0,2.53,16,Cn1cc(-c2ccc3oc(C(=O)O)cc3c2)cn1,IC50,'=',2900,nM,5.54,,,UO_0000065,22.86,0.42,3.01,8.11,0,CHEMBL1786238,Inhibition of human Pim2 using 5-FAM-RSRHSSYPAGT-CONH2 as substrate after 90 mins by off-chip mobility shift method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1781944,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL1782510,,None,311.34,0,2.92,18,O=C(O)c1cc2cc(-c3cnn(C4CCNCC4)c3)ccc2o1,IC50,'=',5800,nM,5.24,,,UO_0000065,16.82,0.31,2.32,6.52,0,CHEMBL1786238,Inhibition of human Pim2 using 5-FAM-RSRHSSYPAGT-CONH2 as substrate after 90 mins by off-chip mobility shift method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1781944,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL2442310,,None,351.41,0,4.56,5,c1cncc(CNc2ccn3ncc(-c4ccc5ccccc5c4)c3n2)c1,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL2446210,Inhibition of Pim2 (unknown origin) using STK1 as substrate preincubated for 30 mins followed by substrate and ATP addition at > 5000 nM after 60 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2440090,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL2442293,,None,359.43,0,3.35,11l,NCCNc1ccn2ncc(-c3cccc(OCc4ccccc4)c3)c2n1,IC50,'=',886,nM,6.05,,,UO_0000065,16.84,0.31,2.7,7.81,0,CHEMBL2446212,Inhibition of Pim2 (unknown origin) using STK1 as substrate preincubated for 30 mins followed by substrate and ATP addition after 60 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2440090,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL1952143,,None,381.48,0,2.3,9b,COc1cc(NCC2CCNCC2)nc2c1nnn2-c1cccc(N(C)C)c1,IC50,'=',752,nM,6.12,,,UO_0000065,16.05,0.3,3.82,7.64,0,CHEMBL1954567,Inhibition of PIM2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1949661,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL3103875,,None,360.44,0,2.32,2e,CC(=O)Nc1nc(C(=O)Nc2cnc(N)cc2N2CCCCC2)cs1,Ki,'>',12500,nM,,,,UO_0000065,,,,,0,CHEMBL3106178,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3102815,1,Scientific Literature,ACS Med Chem Lett,2013,None,
CHEMBL273611,,None,459.48,0,4.59,SB-250715,Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1,Inhibition,'=',-0.04,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3652000,,None,393.54,0,4.34,BDBM106906,Nc1ccc(C2CCCCC2)nc1C(=O)Nc1cnccc1[C@@H]1CCC[C@H](N)C1,IC50,'=',22,nM,7.66,,225927,UO_0000065,19.46,0.36,3.32,7.16,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3264260,,None,416.53,0,3.81,7i,CCN(CC)CCCNc1cncc(-c2ccc3[nH]cc(-c4ccnc(N)n4)c3c2)n1,IC50,'=',920,nM,6.04,,,UO_0000065,14.49,0.27,2.23,5.56,0,CHEMBL3269287,Inhibition of PIM2 kinase (unknown origin) using 5-FAM-labeled BAD peptide as substrate after 90 mins by fluorescence polarization assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3259764,1,Scientific Literature,Bioorg Med Chem Lett,2014,None,
CHEMBL3103860,,None,389.46,0,2.3,4b,Nc1ccc(-c2ccccn2)nc1C(=O)Nc1cnccc1N1CCC[C@H](N)C1,Ki,'=',6,nM,8.22,,,UO_0000065,21.11,0.39,5.92,6.68,0,CHEMBL3106178,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3102815,1,Scientific Literature,ACS Med Chem Lett,2013,None,
CHEMBL3775576,,None,319.37,0,2.4,18,CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1,Activity,'=',6,%,,,,UO_0000187,,,,,0,CHEMBL3777504,Inhibition of N-terminal His6-tagged recombinant human PIM2 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3774357,1,Scientific Literature,Bioorg Med Chem Lett,2016,CHEMBL3308860,
CHEMBL4107092,,None,387.45,0,2.54,BDBM249067,Cc1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CCC[C@@H](O)C3)n2)n1,Ki,'=',2.68,nM,8.57,,434271,UO_0000065,22.12,0.4,6.03,9.23,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL480382,GSK-312948A,None,415.5,0,3.84,GSK312948A,COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC,Inhibition,'=',-2.64,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL445813,AT-7519,2,382.25,0,2.45,AT-7519,O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL1909401,,None,465.41,0,4.56,SB-285234-W,O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+],Inhibition,'=',-0.48,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3651966,,None,440.47,1,5.04,8; PIM447,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C1,Ki,'<',3,nM,,,,UO_0000065,,,,,1,CHEMBL3750240,Inhibition of PIM2 kinase (unknown origin) using NH2-AGAGRSRHSSYPAGT-OH as substrate by kinase-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3745712,1,Scientific Literature,J Med Chem,2015,None,
CHEMBL3921252,,None,391.5,0,4.18,BDBM224880,CNc1nnc(-c2ccc3[nH]cc(-c4nccc(N5CCCCC5)n4)c3c2)s1,IC50,'=',59.7,nM,7.22,,393158,UO_0000065,18.45,0.35,3.04,8.74,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3983351,,None,396.46,0,2.05,BDBM249086,CC#Cc1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CCNCC3)n2)n1,Ki,'=',1.71,nM,8.77,,434290,UO_0000065,22.11,0.4,6.72,10.36,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3895094,,None,387.45,0,2.02,BDBM249034,Cc1cncc(-c2cc3c(cn2)cnn3-c2cccc(C3CNCCC3O)n2)n1,Ki,'=',8.79,nM,8.06,,434238,UO_0000065,20.79,0.38,6.04,7.93,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3976267,,None,400.49,0,2.9,BDBM248940,Cc1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CC(N)CCC3C)n2)n1,Ki,'=',0.761,nM,9.12,,434158,UO_0000065,22.77,0.42,6.22,9.24,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL237571,,None,483.59,1,5.69,SB-633825,COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1,Inhibition,'=',4.18,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1909388,GW568377A,None,565.1,2,5.35,GW568377A,CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl,Inhibition,'=',0.1,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1909376,,None,378.82,0,0.13,SB-759335-B,CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl,Inhibition,'=',-0.98,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3394166,,None,337.41,0,3.73,26,CCOc1cccc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)n1,IC50,'=',22,nM,7.66,,,UO_0000065,22.7,0.44,3.93,8.54,1,CHEMBL3395659,Inhibition of full length recombinant PIM2 (unknown origin) using biotinylated-BAD peptide as substrate assessed as phosphorylation at serine 112 after 90 mins by HTRF method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3393014,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL414883,RADICICOL,None,364.78,0,2.69,K00087,C[C@@H]1C[C@H]2O[C@@H]2/C=C\C=C\C(=O)Cc2c(Cl)c(O)cc(O)c2C(=O)O1,Thermal melting change,'=',0.1,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL3394164,,None,377.48,0,4.08,24,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(NC5CCCC5)n4)c3c2)s1,IC50,'=',1220,nM,5.91,,,UO_0000065,15.67,0.3,1.83,5.61,0,CHEMBL3395662,Inhibition of PIM2 in human U2OS cells assessed as phosphorylation of BAD,B,BAO_0000219,cell-based format,Homo sapiens,None,None,U2OS,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3393014,1,Scientific Literature,Bioorg Med Chem Lett,2015,CHEMBL3307757,
CHEMBL524901,GW683109X,None,339.4,0,1.32,GW683109X,c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1,Inhibition,'=',-0.27,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1240962,,None,313.15,0,4.38,3e,O=Cc1c[nH]c2c1ccc1c3ccc(Br)cc3[nH]c12,Activity,'=',37,%,,,,UO_0000187,,,,,0,CHEMBL1248947,Inhibition of human GST fused Pim2 expressed in Escherichia coli assessed as residual activity at 1 uM after 30 mins,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240519,1,Scientific Literature,Bioorg Med Chem,2010,None,
CHEMBL1240921,,None,252.25,0,3.75,3b,O=Cc1c[nH]c2c1ccc1c3cc(F)ccc3[nH]c12,Activity,'=',84,%,,,,UO_0000187,,,,,0,CHEMBL1248947,Inhibition of human GST fused Pim2 expressed in Escherichia coli assessed as residual activity at 1 uM after 30 mins,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240519,1,Scientific Literature,Bioorg Med Chem,2010,None,
CHEMBL475761,GW784684X,None,564.09,2,6.81,GW784684X,CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1,Inhibition,'=',0.42,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL517123,GSK-182497A,None,566.06,2,5.59,GSK182497A,CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1,Inhibition,'=',0.57,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL517123,GSK-182497A,None,566.06,2,5.59,GSK182497A,CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1,Inhibition,'=',0.45,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3394169,,None,391.5,1,5.04,29,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(OC5CCCCC5)n4)c3c2)s1,IC50,'=',114,nM,6.94,,,UO_0000065,17.73,0.34,1.9,7.74,1,CHEMBL3395659,Inhibition of full length recombinant PIM2 (unknown origin) using biotinylated-BAD peptide as substrate assessed as phosphorylation at serine 112 after 90 mins by HTRF method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3393014,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL373751,GSK-319347A,None,469.54,0,3.96,GSK319347A,COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC,Inhibition,'=',0.9,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3355546,,None,434.46,1,5.04,11,CC(C)(O)[C@H]1CC[C@H](Nc2ccn3ncc(-c4cccc(OC(F)(F)F)c4)c3n2)CC1,IC50,'=',4090,nM,5.39,,,UO_0000065,12.4,0.24,0.35,7.52,0,CHEMBL3375413,Inhibition of Pim2 (unknown origin) using luciferase-luciferin based ATP detection reagent by Kinase-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3351833,1,Scientific Literature,ACS Med Chem Lett,2015,None,
CHEMBL3393712,,None,416.46,0,3.74,18e,Fc1cnccc1-c1ccc2[nH]nc(-c3cncc(O[C@H]4CNCCC45CC5)n3)c2c1,IC50,'=',6,nM,8.22,,,UO_0000065,19.74,0.36,4.48,9.28,0,CHEMBL3396420,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as phosphorylation of biotinylated-BAD peptide at Serine 112 residue,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3392976,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL1684543,,None,435.58,1,6.1,11k,Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1,Inhibition,'=',98,%,,,,UO_0000187,,,,,0,CHEMBL1685852,Inhibition of Pim-2 at 0.1 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1681705,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL1078665,,None,477.35,0,4.89,19,Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1,Inhibition,'<',50,%,,,,UO_0000187,,,,,0,CHEMBL1100998,Inhibition of PIM2 at 10 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154277,1,Scientific Literature,Bioorg Med Chem Lett,2009,None,
CHEMBL1738797,ALECTINIB,4,482.63,0,4.77,Alectinib,CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3354521,,None,410.42,0,3.8,4c,O=C(Nc1cnccc1OC1CCNCC1)c1cccc(-c2c(F)cccc2F)n1,IC50,'=',150,nM,6.82,,,UO_0000065,16.63,0.31,3.02,8.96,0,CHEMBL3376647,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352230,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL939,GEFITINIB,4,446.91,0,4.28,Gefitinib,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL1336,SORAFENIB,4,464.83,1,5.55,Sorafenib,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,Kd,'>',10000,nM,,,,UO_0000065,,,,,1,CHEMBL1244923,Binding affinity to PIM2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240346,1,Scientific Literature,Blood,2009,None,
CHEMBL3957118,,None,414.47,0,2.34,BDBM248990,Cc1cncc(-c2cc3c(cn2)cnn3-c2ccc(C)c(N3C[C@@H](N)CCC3=O)n2)n1,Ki,'=',744,nM,6.13,,434197,UO_0000065,14.79,0.27,3.79,5.3,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1234815,,None,275.31,0,2.77,S2,Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21,Inhibition,'=',10,%,,,,UO_0000187,,,,,0,CHEMBL1244250,Inhibition of PIM2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240340,1,Scientific Literature,Nat Chem Biol,2008,None,
CHEMBL3979678,,None,365.44,0,2.94,BDBM238766,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C)c(NC(C)(C)C)nc34)[nH]c21,IC50,'=',0.826,nM,9.08,,416875,UO_0000065,24.86,0.46,6.14,9.89,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2037135,,None,427.5,0,4.26,7,O=C1Nc2ccccc2/C1=C\c1ccc(-c2cccc(C(=O)NCCN3CCCC3)c2)o1,IC50,,,,,,Not Determined,,,,,,0,CHEMBL2038829,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034977,1,Scientific Literature,ACS Med Chem Lett,2012,None,
CHEMBL2037199,,None,422.87,0,4.2,12,O=C1Nc2ccc(Cl)cc2/C1=C\c1ccc(-c2cccc(C(=O)NCCCO)c2)o1,IC50,'=',38,nM,7.42,,,UO_0000065,17.55,0.34,3.22,8.1,0,CHEMBL2038829,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034977,1,Scientific Literature,ACS Med Chem Lett,2012,None,
CHEMBL498112,,None,497.41,1,6,21u,O=C(Nc1cc(C(F)(F)F)ccc1F)Nc1ccc(Oc2ccnc3[nH]c(=O)[nH]c23)c2ccccc12,Residual_activity,'=',100,%,,,,UO_0000187,,,,,0,CHEMBL1003324,Inhibition of PIM2 at 1 uM relative to control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1136991,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL541401,,None,460.97,0,3.22,K00205,Cl.Cn1cc(C2=C(c3ccc4cc5n(c4c3)CCC(CN)C5)C(=O)NC2=O)c2ccccc21,Thermal melting change,'=',3.1,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL298445,,None,328.36,0,3.14,K00602a,Cc1nc(N)sc1-c1ccnc(Nc2cccc([N+](=O)[O-])c2)n1,Thermal melting change,'=',8.1,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL3793938,,None,433.42,0,3.6,3e,Cc1nc(N)cc(-c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)ccc2N)n1,Ki,'<',3,nM,,,,UO_0000065,,,,,0,CHEMBL3794688,Inhibition of Pim2 (unknown origin) using BAD peptide preincubated for 15 mins followed by ATP addition measured after 60 to 100 mins by Kinase-Glo reagent based luminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3792348,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL3691946,,None,570.57,1,3.44,BDBM151968,COC(=O)N[C@@H]1[C@H](N)CN(c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C4COC4)cc3F)n2)C[C@@H]1C,IC50,'=',1.68,nM,8.78,,292223,UO_0000065,15.38,0.29,5.33,6.66,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL521831,,None,352.44,0,2.47,2,COC(=O)/C=C/c1cccc(-c2cncc(N3CCCN(C)CC3)n2)c1,IC50,'>',8000,nM,,,,UO_0000065,,,,,0,CHEMBL960121,Inhibition of Pim2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153342,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL383871,,None,345.78,0,3.86,14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL511337,,None,296.31,0,3.06,16,NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1,Activity,,,,,,Not Evaluated,,,,,,0,CHEMBL982757,Binding affinity to human PIM2 at 10 uM relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1151712,1,Scientific Literature,J Med Chem,2008,None,
CHEMBL1088392,,None,300.7,0,3.74,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3973175,,None,369.43,0,2.96,BDBM248929,Cc1cncc(-c2cc3c(cn2)cnn3-c2cccc(C3=CCNCC3)n2)n1,Ki,'=',8.31,nM,8.08,,434136,UO_0000065,21.87,0.39,5.12,9.93,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3983795,,None,457.54,0,2.01,BDBM249052,O[C@H]1CCC[C@@H]1Nc1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CCNCC3)n2)n1,Ki,'=',8.05,nM,8.09,,434256,UO_0000065,17.69,0.33,6.08,6.92,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2036118,,None,333.44,0,4.43,10,CN(C)CCCCn1c2ccccc2c2ccc3c(C=O)c[nH]c3c21,IC50,,,,,,Not Determined,,,,,,0,CHEMBL2040258,Inhibition of Pim-2 using RSRHSSYPAGT as substrate after 30 mins,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034961,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL583972,,None,234.26,0,3.61,A,O=Cc1c[nH]c2c1ccc1c3ccccc3[nH]c12,Activity,'=',7,%,,,,UO_0000187,,,,,0,CHEMBL2090474,Inhibition of human Pim2 using RSRHSSYPAGT as substrate assessed as residual activity at 10 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2086229,1,Scientific Literature,Eur J Med Chem,2012,None,
CHEMBL2088998,,None,279.3,0,3.17,19,COC(=O)c1cc2c([nH]c3cccc(N)c32)c2[nH]ccc12,Activity,'=',77,%,,,,UO_0000187,,,,,0,CHEMBL2090474,Inhibition of human Pim2 using RSRHSSYPAGT as substrate assessed as residual activity at 10 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2086229,1,Scientific Literature,Eur J Med Chem,2012,None,
CHEMBL608532,,None,537.62,2,5.61,KT-5720,CCCCCCOC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,Activity,'=',62,%,,,,UO_0000187,,,,,0,CHEMBL1061086,Percentage PIM2 activity remaining in the presence of 1uM inhibitor,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL514582,,None,410.46,0,1.45,4,NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1,Activity,,,,,,Not Evaluated,,,,,,0,CHEMBL982757,Binding affinity to human PIM2 at 10 uM relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1151712,1,Scientific Literature,J Med Chem,2008,None,
CHEMBL1909402,GW568326X,None,373.31,0,4.2,GW568326X,Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1,Inhibition,'=',0.77,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3891387,,None,401.48,0,2.11,BDBM249054,CCNc1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CCNCC3)n2)n1,Ki,'=',2.28,nM,8.64,,434258,UO_0000065,21.53,0.39,6.53,8.94,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3687467,,None,466.47,0,3.74,BDBM151863,C[C@H]1CN(c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1C#N,IC50,'=',6.47,nM,8.19,,292119,UO_0000065,17.56,0.33,4.45,7.59,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3651953,,None,422.48,0,4.91,6,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3ccccc3F)n2)C1,Ki,'=',4,nM,8.4,,,UO_0000065,19.88,0.37,3.49,10.38,0,CHEMBL3750240,Inhibition of PIM2 kinase (unknown origin) using NH2-AGAGRSRHSSYPAGT-OH as substrate by kinase-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3745712,1,Scientific Literature,J Med Chem,2015,None,
CHEMBL3747207,,None,394.52,0,3.29,9,Nc1ccc(C2CCCCC2)nc1C(=O)Nc1cnccc1N1CCC[C@H](N)C1,Ki,'=',4,nM,8.4,,,UO_0000065,21.29,0.4,5.11,7.62,0,CHEMBL3750240,Inhibition of PIM2 kinase (unknown origin) using NH2-AGAGRSRHSSYPAGT-OH as substrate by kinase-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3745712,1,Scientific Literature,J Med Chem,2015,None,
CHEMBL3676300,,None,428.51,0,4.97,14,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C1,Ki,'=',6,nM,8.22,,,UO_0000065,19.19,0.37,3.25,10.16,0,CHEMBL3750240,Inhibition of PIM2 kinase (unknown origin) using NH2-AGAGRSRHSSYPAGT-OH as substrate by kinase-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3745712,1,Scientific Literature,J Med Chem,2015,None,
CHEMBL4096175,,None,340.19,0,2.01,63,O=C1NC(=S)N2C(=O)C3Nc4cc(Cl)cc(Cl)c4C3C=C12,Activity,'=',43,%,,,,UO_0000187,,,,,0,CHEMBL4029695,Inhibition of partial length wild type human PIM2 (M1 to E291 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by KINOMEscan assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4028814,1,Scientific Literature,Bioorg Med Chem,2017,None,
CHEMBL592030,,None,439.55,0,4.79,SID103904960,NCCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21,Ki,'=',100,nM,7,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1988537,,None,368.85,1,5.19,SID103905590,COc1ccc(C(=O)N2c3ccccc3Sc3c(Cl)cncc32)cc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2442315,,None,358.45,0,4.26,9e,O[C@H]1CC[C@H](Nc2ccn3ncc(-c4ccc5ccccc5c4)c3n2)CC1,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL2446210,Inhibition of Pim2 (unknown origin) using STK1 as substrate preincubated for 30 mins followed by substrate and ATP addition at > 5000 nM after 60 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2440090,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL522892,DOVITINIB,3,392.44,0,2.54,SID103904684,CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1,Ki,'=',1258.93,nM,5.9,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1979176,,None,362.31,0,4.3,SID103904896,COc1ccc2c(NC(=O)Nc3cc(C(F)(F)F)ccn3)ccnc2c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL319620,LAVENDUSTIN C,None,275.26,0,2.11,K00050,O=C(O)c1cc(NCc2cc(O)ccc2O)ccc1O,Thermal melting change,'=',0.7,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL496588,,None,312.76,0,3.43,E/Z-26c,O=C1NC(=O)N(Cc2ccccc2)/C1=C/c1ccc(Cl)cc1,IC50,'>',100000,nM,,,,UO_0000065,,,,,0,CHEMBL957366,Inhibition of human recombinant Pim2 by ATP depletion assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139352,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL496971,,None,322.36,0,3.18,E/Z-28c,CCOc1ccc(/C=C2\C(=O)NC(=O)N2Cc2ccccc2)cc1,IC50,'=',100000,nM,4,,,UO_0000065,12.41,0.23,0.82,6.82,0,CHEMBL957366,Inhibition of human recombinant Pim2 by ATP depletion assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139352,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL3394070,,None,390.52,1,5.08,19,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(NC5CCCCC5)n4)c3c2)s1,IC50,,,,,,Not Determined,,,,,,0,CHEMBL3395662,Inhibition of PIM2 in human U2OS cells assessed as phosphorylation of BAD,B,BAO_0000219,cell-based format,Homo sapiens,None,None,U2OS,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3393014,1,Scientific Literature,Bioorg Med Chem Lett,2015,CHEMBL3307757,
CHEMBL3394165,,None,391.5,0,4.47,25,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(NC5CCCCC5)n4)c3c2)s1,IC50,'=',18,nM,7.75,,,UO_0000065,19.78,0.38,3.27,7.35,1,CHEMBL3395659,Inhibition of full length recombinant PIM2 (unknown origin) using biotinylated-BAD peptide as substrate assessed as phosphorylation at serine 112 after 90 mins by HTRF method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3393014,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL410456,,None,398.42,0,3.68,K00219,NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1,Thermal melting change,'=',-0.2,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL226838,,None,335.41,0,4.47,SB-505124,Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1,Residual Activity,'=',110,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3808662,,None,359.43,0,3.52,8e,C/C1=C\C[C@H]2CNC(=O)c3cc([nH]c32)-c2cccc3nc(C)c(nc23)NC1,IC50,'=',0.08,nM,10.1,,,UO_0000065,28.09,0.51,6.58,12.21,0,CHEMBL3812018,Inhibition of human full-length Pim2 expressed in Escherichia coli assessed as phosphorylation of biotinylated BAD peptide at Ser 112 preincubated for 30 mins followed by substrate addition measured after 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3808325,1,Scientific Literature,ACS Med Chem Lett,2016,None,
CHEMBL407113,,None,356.41,0,2.23,SB-741905,NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1,Inhibition,'=',0.46,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL233001,GW620972X,None,332.43,0,4.9,GW620972X,N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2,Inhibition,'=',-0.27,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL207247,GW807930X,None,500.96,2,5.63,GW807930X,CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1,Inhibition,'=',0.41,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL318728,GW549390X,None,236.27,0,4.09,GW549390X,c1ccc(Nc2ncc(-c3ccccc3)o2)cc1,Inhibition,'=',-0.45,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL188240,,None,274.28,0,1.48,SB-737198,CCOc1nccc2c1nc(-c1nonc1N)n2CC,Inhibition,'=',0.25,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL65884,GW817396X,None,362.37,0,3.41,GW817396X,COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1,Inhibition,'=',0.1,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL518953,GSK-1023156A,None,428.31,0,4.53,GSK1023156A,NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br,Inhibition,'=',0.78,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3808942,,None,347.42,0,3.36,10b,Cc1nc2cccc3c2nc1NCCCC[C@@H]1CNC(=O)c2cc-3[nH]c21,IC50,'=',0.2,nM,9.7,,,UO_0000065,27.92,0.51,6.34,11.73,0,CHEMBL3812018,Inhibition of human full-length Pim2 expressed in Escherichia coli assessed as phosphorylation of biotinylated BAD peptide at Ser 112 preincubated for 30 mins followed by substrate addition measured after 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3808325,1,Scientific Literature,ACS Med Chem Lett,2016,None,
CHEMBL4229130,,None,325.42,0,2.4,14f,CC(C)Nc1ccc2cnn(-c3cncc(NCCCN)n3)c2c1,IC50,'=',1900,nM,5.72,,,UO_0000065,17.58,0.33,3.32,6.11,0,CHEMBL4222695,Inhibition of PIM2 (unknown origin) expressed in human U2OS cells assessed as reduction in BAD substrate phosphorylation by ELISA,B,BAO_0000219,cell-based format,Homo sapiens,None,None,U2OS,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4219163,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL189415,GW819077X,None,432.41,1,5.62,GW819077X,FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1,Inhibition,'=',1.06,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1909382,GW759710A,None,359.79,0,3.2,GW759710A,Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1,Inhibition,'=',0.31,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1909390,GW576609A,None,691.1,2,6.57,GW576609A,O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1,Inhibition,'=',0.11,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL14762,SELICICLIB,2,354.46,0,3.2,Roscovitine/CYC-202,CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1061184,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150977,1,Scientific Literature,Nat Biotechnol,2008,None,
CHEMBL3982420,,None,394.55,1,6.19,BDBM224974,CNc1nnc(-c2ccc3[nH]cc(-c4ccc(-c5cccs5)s4)c3c2)s1,IC50,'>',10000,nM,,,393264,UO_0000065,,,,,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1241010,,None,259.27,0,3.49,3h,N#Cc1ccc2[nH]c3c(ccc4c(C=O)c[nH]c43)c2c1,Activity,'=',84,%,,,,UO_0000187,,,,,0,CHEMBL1248947,Inhibition of human GST fused Pim2 expressed in Escherichia coli assessed as residual activity at 1 uM after 30 mins,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240519,1,Scientific Literature,Bioorg Med Chem,2010,None,
CHEMBL4087384,,None,372.42,0,4.32,32,O=C1NC(=S)S/C1=C\c1csc(-c2cccc(C(F)(F)F)c2)n1,Delta Tm,'=',11.5,degrees C,,,,UO_0000027,,,,,0,CHEMBL4029682,Inhibition of recombinant PIM2 (unknown origin) assessed as change in melting temperature at 10 uM by SYPRO orange dye-based differential scanning fluorimetry,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4028814,1,Scientific Literature,Bioorg Med Chem,2017,None,
CHEMBL1240960,,None,252.25,0,3.75,3c,O=Cc1c[nH]c2c1ccc1c3cccc(F)c3[nH]c12,Activity,'=',11,%,,,,UO_0000187,,,,,0,CHEMBL1248949,Inhibition of human GST fused Pim2 expressed in Escherichia coli assessed as residual activity at 10 uM after 30 mins,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240519,1,Scientific Literature,Bioorg Med Chem,2010,None,
CHEMBL1233881,,None,325.37,0,2.82,PP494,COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC,Inhibition,'=',2,%,,,,UO_0000187,,,,,0,CHEMBL1244250,Inhibition of PIM2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240340,1,Scientific Literature,Nat Chem Biol,2008,None,
CHEMBL3103868,,None,424.46,0,3.18,4j,Nc1ccc(-c2c(F)cccc2F)nc1C(=O)Nc1cnccc1N1CCC[C@H](N)C1,Ki,'=',0.004,nM,,Outside typical range,,UO_0000065,,,,,0,CHEMBL3106174,Inhibition of PIM2 (unknown origin) using Biotin-AGAGRSRHSSYPAGT-OH as substrate after 2 hrs by AlphaScreen assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3102815,1,Scientific Literature,ACS Med Chem Lett,2013,None,
CHEMBL3915073,,None,353.38,0,4.86,BDBM238578,O=c1[nH]ccc2[nH]c(-c3cccc4ccc(Oc5ccccc5)nc34)cc12,IC50,'=',43.7,nM,7.36,,416279,UO_0000065,20.83,0.37,2.5,10.4,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3963605,,None,389.46,0,2.3,BDBM251574,Nc1ncc(-c2ccccc2)nc1C(=O)Nc1cnccc1N1CCC(N)CC1,IC50,'=',10,nM,8,,438368,UO_0000065,20.54,0.38,5.7,6.5,0,CHEMBL3889161,In Vitro Caliper Kinase Assay: For comparison between certain PKC inhibitors of the present application and structurally comparable PIM kinase inhibitors,,,,,,,,,,,,,,,,,,,,,,
CHEMBL281948,K-252A,None,467.48,0,3.66,K-252a,COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3893318,,None,319.41,0,4.1,BDBM238495,CC(C)CC1CNC(=O)c2cc(-c3cccc4cccnc34)[nH]c21,IC50,'=',278,nM,6.56,,416651,UO_0000065,20.53,0.37,2.46,11.35,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3933056,,None,367.84,0,3.79,BDBM238695,Cc1nc2cccc(-c3[nH]c4c(c3Cl)C(=O)NC4)c2nc1NC1(C)CC1,IC50,'=',0.0783,nM,10.11,,416804,UO_0000065,27.47,0.53,6.32,12.22,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL573012,,None,383.5,0,3.43,20a,O=c1[nH]c(CN2CC[C@H](O)C2)nc2c1sc1ccc(-c3ccsc3)cc12,Ki,'=',3,nM,8.52,,,UO_0000065,22.22,0.45,5.09,12.31,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL2048868,,None,333.41,0,1.95,24,COc1cccc(/C=C2\SC(=O)NC2=O)c1N1CCC[C@@H](N)C1,IC50,'=',5,nM,8.3,,,UO_0000065,24.9,0.49,6.35,9.81,0,CHEMBL2049740,Inhibition of human PIM2 using FITC-(AHX)RSRHSSYPAGT-COOH as substrate after 90 mins by mobility shift assay in presence of 50 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2046384,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL2046468,,None,323.81,0,2.2,13,N[C@H]1CCN(c2cc(Cl)ccc2/C=C2\SC(=O)NC2=O)C1,IC50,'=',79,nM,7.1,,,UO_0000065,21.93,0.46,4.9,9.42,0,CHEMBL2049740,Inhibition of human PIM2 using FITC-(AHX)RSRHSSYPAGT-COOH as substrate after 90 mins by mobility shift assay in presence of 50 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2046384,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL941,IMATINIB,4,493.62,0,4.59,Gleevec,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1,Kd,,,,,,Not Active,,,,,,0,CHEMBL859489,Average Binding Constant for PIM2; NA=Not Active at 10 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144455,1,Scientific Literature,Nat Biotechnol,2005,None,
CHEMBL573659,,None,333.84,0,3.78,6b,O=c1[nH]c(CN2CCCCC2)nc2c1sc1ccc(Cl)cc12,Ki,'=',149,nM,6.83,,,UO_0000065,20.45,0.42,3.05,13.94,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL85496,,None,235.26,0,2.02,10a,COc1ccc(/C=C2\SC(=O)NC2=O)cc1,IC50,'=',300,nM,6.52,,,UO_0000065,27.73,0.56,4.5,11.77,0,CHEMBL957366,Inhibition of human recombinant Pim2 by ATP depletion assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139352,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL3103864,,None,418.5,0,2.91,4f,COc1ccccc1-c1ccc(N)c(C(=O)Nc2cnccc2N2CCC[C@H](N)C2)n1,Ki,'=',8,nM,8.1,,,UO_0000065,19.35,0.36,5.19,6.78,0,CHEMBL3106178,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3102815,1,Scientific Literature,ACS Med Chem Lett,2013,None,
CHEMBL1230790,,None,269.31,0,2.36,S1,CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21,Inhibition,'=',9,%,,,,UO_0000187,,,,,0,CHEMBL1244250,Inhibition of PIM2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240340,1,Scientific Literature,Nat Chem Biol,2008,None,
CHEMBL2442296,,None,303.37,0,2.92,9i,NCCNc1ccn2ncc(-c3ccc4ccccc4c3)c2n1,IC50,'=',87,nM,7.06,,,UO_0000065,23.27,0.42,4.14,10.35,0,CHEMBL2446212,Inhibition of Pim2 (unknown origin) using STK1 as substrate preincubated for 30 mins followed by substrate and ATP addition after 60 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2440090,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL3394068,,None,350.45,0,4.15,17,CC(C)Nc1cccc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)n1,IC50,'=',2190,nM,5.66,,,UO_0000065,16.15,0.31,1.51,6.12,0,CHEMBL3395662,Inhibition of PIM2 in human U2OS cells assessed as phosphorylation of BAD,B,BAO_0000219,cell-based format,Homo sapiens,None,None,U2OS,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3393014,1,Scientific Literature,Bioorg Med Chem Lett,2015,CHEMBL3307757,
CHEMBL3326558,,None,282.23,0,3.31,10,O=[N+]([O-])c1cc2[nH]ncc2c2c1ncc1c(F)cccc12,Activity,'=',66,%,,,,UO_0000187,,,,,0,CHEMBL3369948,Inhibition of full-length human PIM2 using RSRHSSYPAGT as substrate assessed as residual kinase activity at 10 uM after 30 mins in presence of [gamma-33P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352653,1,Scientific Literature,Bioorg Med Chem,2014,None,
CHEMBL3394167,,None,351.44,0,4.12,27,CC(C)Oc1cccc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)n1,IC50,'=',2220,nM,5.65,,,UO_0000065,16.09,0.31,1.53,6.3,0,CHEMBL3395662,Inhibition of PIM2 in human U2OS cells assessed as phosphorylation of BAD,B,BAO_0000219,cell-based format,Homo sapiens,None,None,U2OS,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3393014,1,Scientific Literature,Bioorg Med Chem Lett,2015,CHEMBL3307757,
CHEMBL220227,,None,282.32,0,4.67,1,CC(C)c1onc(-c2ccc(F)cc2)c1-c1ccncc1,Activity,'=',105,%,,,,UO_0000187,,,,,0,CHEMBL1044611,Inhibition of PIM2 assessed as residual activity at 10 uM by Cherenkov counting relative to control in presence of 5 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155278,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL2442299,,None,317.4,0,3.31,9l,NCCCNc1ccn2ncc(-c3ccc4ccccc4c3)c2n1,IC50,'=',2302,nM,5.64,,,UO_0000065,17.76,0.32,2.33,8.26,0,CHEMBL2446212,Inhibition of Pim2 (unknown origin) using STK1 as substrate preincubated for 30 mins followed by substrate and ATP addition after 60 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2440090,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL268885,GSK-711701A,None,416.89,0,3.43,GSK711701A,COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1,Inhibition,'=',-0.64,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1909409,GSK-238583A,None,653.68,1,4.58,GSK238583A,O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1,Inhibition,'=',1.06,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3810121,,None,345.41,0,3.13,9a,Cc1nc2cccc3c2nc1NC/C=C\C[C@H]1CNC(=O)c2cc-3[nH]c21,IC50,'=',0.07,nM,10.15,,,UO_0000065,29.4,0.53,7.02,12.28,0,CHEMBL3812018,Inhibition of human full-length Pim2 expressed in Escherichia coli assessed as phosphorylation of biotinylated BAD peptide at Ser 112 preincubated for 30 mins followed by substrate addition measured after 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3808325,1,Scientific Literature,ACS Med Chem Lett,2016,None,
CHEMBL101804,,None,268.28,0,2.57,SB-743899,O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1,Inhibition,'=',0.1,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL578042,,None,250.3,0,3.34,16,OCCc1c[nH]c2c1ccc1c3ccccc3[nH]c12,Activity,'=',69,%,,,,UO_0000187,,,,,0,CHEMBL1051392,Inhibition of Pim-2 assessed as residual enzyme activity at 1 uM relative to untreated control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154186,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL574123,,None,348.41,0,3.85,17,CCN(CC)C(=O)/C(=N\O)c1c[nH]c2c1ccc1c3ccccc3[nH]c12,Activity,'=',62,%,,,,UO_0000187,,,,,0,CHEMBL1051392,Inhibition of Pim-2 assessed as residual enzyme activity at 1 uM relative to untreated control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154186,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL1909372,GW700494A,None,622.07,2,6.21,GW700494A,CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl,Inhibition,'=',-1.74,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL578042,,None,250.3,0,3.34,16,OCCc1c[nH]c2c1ccc1c3ccccc3[nH]c12,Activity,'=',50,%,,,,UO_0000187,,,,,0,CHEMBL1057614,Inhibition of Pim-2 assessed as residual enzyme activity at 10 uM relative to untreated control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154186,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL269883,GW416981X,None,415.47,0,2.55,GW416981X,CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2,Inhibition,'=',5.85,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1909367,GW680908A,None,587.94,2,5.38,GW680908A,COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl,Inhibition,'=',0.73,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL188381,GW806742X,None,573.56,2,5.18,GW806742X,CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1,Inhibition,'=',0.39,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1909363,GSK-269962B,None,607.07,2,3.84,GSK269962B,CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl,Inhibition,'=',0.68,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL4564586,,None,377.28,0,3.13,2,NC(=O)c1cc(Cl)c2c(Cl)c(C#CC3CC3)n([C@H]3CCCNC3)c2n1,IC50,'=',9,nM,8.05,,,UO_0000065,21.33,0.44,4.92,11.03,0,CHEMBL4373003,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser-112 residue by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4371067,1,Scientific Literature,Bioorg Med Chem Lett,2019,None,
CHEMBL4457529,,None,423.34,0,3.39,18,COCC(C)(C)C#Cc1c(Cl)c2c(Cl)cc(C(N)=O)nc2n1[C@H]1CCCNC1,IC50,'=',4,nM,8.4,,,UO_0000065,19.84,0.41,5.01,10.22,0,CHEMBL4373003,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser-112 residue by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4371067,1,Scientific Literature,Bioorg Med Chem Lett,2019,None,
CHEMBL4541837,,None,423.34,0,3.53,19,COC(C)(C)CC#Cc1c(Cl)c2c(Cl)cc(C(N)=O)nc2n1[C@H]1CCCNC1,IC50,'=',10.4,nM,7.98,,,UO_0000065,18.86,0.39,4.45,9.72,0,CHEMBL4373003,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser-112 residue by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4371067,1,Scientific Literature,Bioorg Med Chem Lett,2019,None,
CHEMBL261129,,None,430.31,0,3.37,SB-732881,CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1,Inhibition,'=',14.54,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1915448,,None,501.98,1,4.68,15e,Clc1cc(OCCN2CCOCC2)ccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12,IC50,'=',14,nM,7.85,,,UO_0000065,15.65,0.3,3.17,7.77,0,CHEMBL1919424,Inhibition of PIM2 by millipore assay in the presence of 15 uM [ATP],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914433,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL4473365,,None,602.16,1,4.93,7c,C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C,Activity,'=',100,%,,,,UO_0000187,,,,,0,CHEMBL4382700,Binding affinity to wild-type human partial length PIM2 (M1 to E291 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4382192,1,Scientific Literature,Eur J Med Chem,2017,None,
CHEMBL1915433,,None,338.37,0,4.31,14f,c1ccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3cnccc23)cc1,IC50,'=',15,nM,7.82,,,UO_0000065,23.12,0.41,3.51,9.86,0,CHEMBL1919424,Inhibition of PIM2 by millipore assay in the presence of 15 uM [ATP],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914433,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL493742,,None,233.29,0,2.57,8a,CCc1ccc(/C=C2\SC(=O)NC2=O)cc1,IC50,'=',300,nM,6.52,,,UO_0000065,27.96,0.56,3.95,14.13,0,CHEMBL957366,Inhibition of human recombinant Pim2 by ATP depletion assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139352,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL573036,,None,337.41,0,2.66,16b,CN(C)Cc1nc2c(sc3ccc(-c4cncnc4)cc32)c(=O)[nH]1,Ki,'=',66,nM,7.18,,,UO_0000065,21.28,0.41,4.52,9.6,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL4583118,,None,422.32,0,1.71,29a,NC(=O)c1cc(Cl)c2c(Cl)c(C#CC3CNCCO3)n([C@H]3CCCNC3)c2n1,IC50,'=',6.1,nM,8.21,,,UO_0000065,19.45,0.4,6.5,8.72,0,CHEMBL4373003,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser-112 residue by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4371067,1,Scientific Literature,Bioorg Med Chem Lett,2019,None,
CHEMBL3745885,,None,467.46,0,3.66,7ao; ON1231320,Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3748049,Inhibition of human PIM2 using [RSRHSSYPAGT] as substrate,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3745707,1,Scientific Literature,Bioorg Med Chem,2016,None,
CHEMBL584161,,None,402.27,0,4.22,19a,O=c1[nH]c(CNc2cccc(O)c2)nc2c1sc1ccc(Br)cc12,Ki,'=',60,nM,7.22,,,UO_0000065,17.95,0.41,3,9.26,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL582966,,None,250.71,0,3.1,3a,Cc1nc2c(sc3ccc(Cl)cc32)c(=O)[nH]1,Ki,'=',1140,nM,5.94,,,UO_0000065,23.71,0.51,2.84,12.99,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL188794,GW829115X,None,496.88,1,6.28,GW829115X,COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1,Inhibition,'=',0.14,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL4470576,,None,407.3,0,2.75,23,CC1(C#Cc2c(Cl)c3c(Cl)cc(C(N)=O)nc3n2[C@H]2CCCNC2)COC1,IC50,'=',5.7,nM,8.24,,,UO_0000065,20.24,0.42,5.49,10.03,0,CHEMBL4373003,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser-112 residue by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4371067,1,Scientific Literature,Bioorg Med Chem Lett,2019,None,
CHEMBL4095072,,None,429.53,0,3.57,1,Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1,Inhibition,'=',-1.7,%,,,,UO_0000187,,,,,0,CHEMBL4120312,Inhibition of PIM2 (unknown origin) at 0.45 uM relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4118098,1,Scientific Literature,Bioorg Med Chem Lett,2017,None,
CHEMBL3902228,,None,435.48,0,3.99,22k,C[C@H]1CCN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C[C@H]1N,IC50,'=',1.6,nM,8.8,,,UO_0000065,20.2,0.38,4.81,10.43,0,CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3864151,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL1909373,GW701427A,None,497.9,0,4.88,GW701427A,COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl,Inhibition,'=',-2.76,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL218859,GW445012X,None,266.34,0,3.23,GW445012X,CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1,Inhibition,'=',-4.04,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL4109117,,None,414.47,0,2.14,BDBM249072,Cc1cncc(-c2cc3c(cn2)cnn3-c2cccc(C(=O)N3CCC[C@@H](N)C3)n2)n1,Ki,'=',193,nM,6.71,,434276,UO_0000065,16.2,0.3,4.57,5.8,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3959725,,None,349.44,0,3.43,4,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC(C)(C)C,IC50,'=',0.6,nM,9.22,,,UO_0000065,26.39,0.48,5.79,11.15,0,CHEMBL4478465,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as reduction in phosphorylation of biotinylated-BAD peptide at Serine 112 residue preincubated for 30 mins followed by substrate addition for 1 hr by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4477213,1,Scientific Literature,J Med Chem,2016,None,
CHEMBL3975199,,None,383.42,0,1.55,BDBM248946,N#Cc1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CCNCC3)n2)n1,Ki,'=',16.1,nM,7.79,,434153,UO_0000065,20.33,0.37,6.24,7.19,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL269450,,None,433.46,1,5,SB-242717,Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1,Inhibition,'=',-4.34,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL496073,,None,467.53,1,6.14,21x,CC(C)(C)c1cccc(NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)[nH]c34)c3ccccc23)c1,Residual_activity,'=',100,%,,,,UO_0000187,,,,,0,CHEMBL1003324,Inhibition of PIM2 at 1 uM relative to control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1136991,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL516248,GW804482X,None,379.44,0,3.77,GW804482X,COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1,Inhibition,'=',1.31,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL573011,,None,399.48,1,5.12,19c,O=c1[nH]c(CNc2cccc(O)c2)nc2c1sc1ccc(-c3ccccc3)cc12,Ki,'=',939,nM,6.03,,,UO_0000065,15.09,0.28,0.91,7.73,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL1782519,,None,348.15,0,3.87,27,O=C(O)c1cc2cc(Br)cc(OCc3ccncc3)c2o1,IC50,'=',12500,nM,4.9,,,UO_0000065,14.08,0.32,1.03,6.76,0,CHEMBL1786238,Inhibition of human Pim2 using 5-FAM-RSRHSSYPAGT-CONH2 as substrate after 90 mins by off-chip mobility shift method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1781944,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL2442311,,None,337.39,0,4.69,9a,c1cncc(Nc2ccn3ncc(-c4ccc5ccccc5c4)c3n2)c1,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL2446210,Inhibition of Pim2 (unknown origin) using STK1 as substrate preincubated for 30 mins followed by substrate and ATP addition at > 5000 nM after 60 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2440090,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL414883,RADICICOL,None,364.78,0,2.69,radicicol,C[C@@H]1C[C@H]2O[C@@H]2/C=C\C=C\C(=O)Cc2c(Cl)c(O)cc(O)c2C(=O)O1,Tm,'<',2,degrees C,,,,UO_0000027,,,,,0,CHEMBL1004482,Binding affinity to human recombinant PIM2 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140872,1,Scientific Literature,Bioorg Med Chem,2009,None,
CHEMBL573702,,None,360.44,0,3.74,14i,CN(C)Cc1nc2c(sc3ccc(-c4ccc(C#N)cc4)cc32)c(=O)[nH]1,Ki,'=',21,nM,7.68,,,UO_0000065,21.3,0.4,3.94,10.55,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL575463,,None,425.51,0,2.6,18a,CN(C)Cc1nc2c(sc3ccc(-c4ccc(OCC(O)CO)cc4)cc32)c(=O)[nH]1,Ki,'=',2,nM,8.7,,,UO_0000065,20.44,0.4,6.1,8.82,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL266707,,None,297.36,0,3.86,SKF-86055,Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1,Inhibition,'=',-3.15,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL513330,GW781673X,None,336.79,0,3.45,GW781673X,Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1,Inhibition,'=',-0.52,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL512076,GSK-192082A,None,566.06,2,5.63,GSK192082A,CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1,Inhibition,'=',-0.1,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL463931,GSK-2163632A,None,548.67,1,4.19,GSK2163632A,COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C,Inhibition,'=',2.12,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL572784,,None,325.39,0,3.46,15c,CN(C)Cc1nc2c(sc3ccc(-c4ccoc4)cc32)c(=O)[nH]1,Ki,'=',6,nM,8.22,,,UO_0000065,25.27,0.49,4.76,13.23,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL583144,,None,271.13,0,3.44,SID103905309,O=c1[nH]cnc2c1sc1c(Cl)ccc(Cl)c12,Ki,'=',164.2,nM,6.79,,,UO_0000065,25.02,0.58,3.34,14.83,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL1956070,,None,451.55,0,3.22,Ro-0505124,CN1CCN(c2ccc(Nc3nc(N)c(C(=O)c4ccc5c(c4)OCCO5)s3)cc2)CC1,Inhibition,'<',50,%,,,,UO_0000187,,,,,0,CHEMBL1959383,Inhibition of PIM2 at 1 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1955770,1,Scientific Literature,J Biol Chem,2006,None,
CHEMBL261491,,None,442.52,0,3.65,Go-6983,COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C,Residual Activity,'=',9,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL473773,,None,376.21,0,3.86,WHI-P154,COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC,Residual Activity,'=',66,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1909379,,None,387.87,0,4.84,GR-269666A,Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1,Inhibition,'=',-0.72,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL306865,GW784752X,None,345.37,0,2.67,GW784752X,COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1,Inhibition,'=',1.69,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3919378,,None,346.4,0,1.36,BDBM249026,Cn1cc(-c2cc3c(cn2)cnn3-c2cccc(N3CC(N)C3)n2)cn1,Ki,'=',23.3,nM,7.63,,434230,UO_0000065,22.03,0.4,6.27,8.42,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3926614,,None,428.42,0,2.64,BDBM249031,NCC1CN(c2cccc(-n3ncc4cnc(-c5cnn(CC(F)(F)F)c5)cc43)n2)C1,Ki,'=',12.5,nM,7.9,,434235,UO_0000065,18.45,0.35,5.26,8.72,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3926007,,None,407.43,0,3.29,BDBM249028,Cc1cncc(-c2cc3c(cn2)cnn3-c2cccc(C3CNCCC3(F)F)n2)n1,Ki,'=',2.45,nM,8.61,,434244,UO_0000065,21.13,0.39,5.32,10.58,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL483847,,None,374.32,0,3.88,GNF_2,NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1,Residual Activity,'=',145,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1277370,,None,278.36,0,3.68,14a,CC1(C)[C@@H]2CC[C@@]1(C)c1nc3cc4cn[nH]c4cc3nc12,Activity,'=',76,%,,,,UO_0000187,,,,,0,CHEMBL1285678,Inhibition of Pim2 assessed as residual enzyme activity at 10 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1275327,1,Scientific Literature,Eur J Med Chem,2010,None,
CHEMBL1275867,,None,224.27,0,2.38,11,c1n[nH]c2cc3nc4c(nc3cc12)CCCC4,Activity,,,,,,Not Active,,,,,,0,CHEMBL1285679,Inhibition of Pim2 assessed as residual enzyme activity at 1 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1275327,1,Scientific Literature,Eur J Med Chem,2010,None,
CHEMBL1275910,,None,210.24,0,1.99,12,c1n[nH]c2cc3nc4c(nc3cc12)CCC4,Activity,,,,,,Not Active,,,,,,0,CHEMBL1285679,Inhibition of Pim2 assessed as residual enzyme activity at 1 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1275327,1,Scientific Literature,Eur J Med Chem,2010,None,
CHEMBL126077,INDIRUBIN-3-MONOXIME,None,277.28,0,4.42,Indirubin_oxime,O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12,Residual Activity,'=',38,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL76589,,None,236.23,0,1.56,Tyrphostin AG-112,N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1,Residual Activity,'=',118,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL493138,,None,268.36,0,2.29,6,CN1CCCN(c2cncc(-c3ccccc3)n2)CC1,IC50,'>',8000,nM,,,,UO_0000065,,,,,0,CHEMBL960121,Inhibition of Pim2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153342,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL522822,,None,310.36,0,1.65,11,O=C(O)/C=C/c1cccc(-c2cncc(N3CCNCC3)n2)c1,IC50,'=',200,nM,6.7,,,UO_0000065,21.58,0.4,5.05,8.55,0,CHEMBL960121,Inhibition of Pim2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153342,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL111364,,None,404.51,1,6.17,ML_3403,CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1,Residual Activity,'=',96,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2218941,,None,398.22,0,3.51,Indirubin_6bromo_aceto,CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1,Residual Activity,'=',67,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL559818,,None,148.17,0,0.73,3,Nc1cc2cn[nH]c2cc1N,Activity,,,,,,Not Active,,,,,,0,CHEMBL1285678,Inhibition of Pim2 assessed as residual enzyme activity at 10 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1275327,1,Scientific Literature,Eur J Med Chem,2010,None,
CHEMBL1275910,,None,210.24,0,1.99,12,c1n[nH]c2cc3nc4c(nc3cc12)CCC4,Activity,,,,,,Not Active,,,,,,0,CHEMBL1285678,Inhibition of Pim2 assessed as residual enzyme activity at 10 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1275327,1,Scientific Literature,Eur J Med Chem,2010,None,
CHEMBL596674,,None,331.46,1,5.32,ZM-39923,CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1,Residual Activity,'=',127,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2377714,,None,216.2,0,2.26,13,Cc1c[nH]c2c([N+](=O)[O-])cc3cn[nH]c3c12,Inhibition,'=',99,%,,,,UO_0000187,,,,,0,CHEMBL2378598,Inhibition of human full length Pim-2 using RSRHSSYPAGT as substrate assessed as residual activity at 1 uM after 30 mins in presence of [gamma-33P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2375344,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL185962,,None,242.24,0,1.4,SB-736302,Nc1nonc1-c1nc2cnccc2n1C1CC1,Inhibition,'=',9.18,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL477182,GW769076X,None,454.57,1,5.05,GW769076X,Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1,Inhibition,'=',-2.62,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL188784,GW828529X,None,468.39,1,5.89,GW828529X,Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F,Inhibition,'=',0.92,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL272414,GW416469X,None,358.42,0,1.81,GW416469X,CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2,Inhibition,'=',1.18,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL477583,GW743024X,None,374.44,0,4.65,GW743024X,Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1,Inhibition,'=',-0.3,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL220465,GSK-248233A,None,484.52,0,4.19,GSK248233A,CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21,Inhibition,'=',1.39,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1801204,AZD-8055,1,465.55,0,2.64,AZD-8055,COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL4548580,,None,547.73,2,6.37,21e,CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1,Inhibition,'=',-1,%,,,,UO_0000187,,,,,0,CHEMBL4377763,Inhibition of recombinant human Pim-2 (2 to end residues) at 1 uM using RSRHSSYPAGT as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4376814,1,Scientific Literature,Eur J Med Chem,2019,None,
CHEMBL1909397,GW279320X,None,364.81,0,2.06,GW279320X,Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1,Inhibition,'=',-0.12,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL473468,,None,226.24,0,2.24,26,O=C(O)/C=C/c1cccc(-c2cnccn2)c1,IC50,'=',2200,nM,5.66,,,UO_0000065,25.01,0.45,3.42,8.97,0,CHEMBL960121,Inhibition of Pim2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153342,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL3703180,,None,316.39,0,1.71,BDBM149688,CSc1ncc2ccc3c(C(N)=O)c(C)n(CCO)c3c2n1,IC50,'=',408,nM,6.39,,288346,UO_0000065,20.19,0.4,4.68,6.8,0,CHEMBL3707582,Kinase Inhibition Assay: The buffer for PIM-2 assay was composed of HEPES 50 mM,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2443139,,None,466.54,0,4.19,31,CC(C)Nc1ccc(Oc2cc(O)cc(O)c2-c2cc(C(=O)NC3CCN(C)CC3)no2)cc1,IC50,'>',10,nM,,,,UO_0000065,,,,,0,CHEMBL2443982,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2439976,1,Scientific Literature,Bioorg Med Chem,2013,None,
CHEMBL397521,,None,1312.57,None,None,ARC-659-1b,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H]1C[C@@H](O)[C@H](n2cnc3c(N)ncnc32)C1)C(N)=O,Activity,'=',20,%,,,,UO_0000187,,,,,0,CHEMBL898213,Inhibition of PIM2 assessed as residual activity at 1 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1149703,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,
CHEMBL373751,GSK-319347A,None,469.54,0,3.96,GSK319347A,COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC,Inhibition,'=',1.39,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3947675,,None,382.45,0,3.65,BDBM225011,CC(C)(C)Nc1nnc(-c2ccc3[nH]cc(-c4ncc(C(N)=O)s4)c3c2)o1,IC50,'=',393,nM,6.41,,393300,UO_0000065,16.75,0.32,2.76,5.22,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3925087,,None,420.54,0,4.07,BDBM225065,CC(C)Oc1cccc(-c2c[nH]c3ccc(-c4nnc(N5CC[C@H](N)C5)s4)cc23)n1,IC50,'=',24.8,nM,7.61,,393058,UO_0000065,18.09,0.35,3.54,8.18,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3891857,,None,412.43,1,5.44,BDBM225003,Fc1cccc(Nc2nnc(-c3ccc4[nH]cc(-c5nccc(C6CC6)n5)c4c3)o2)c1,IC50,'=',449.78,nM,6.35,,393292,UO_0000065,15.39,0.28,0.91,6.86,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1909407,,None,374.85,0,2.65,SB-220025-A,Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1,Inhibition,'=',0.96,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL189231,,None,284.32,0,2.57,SB-734117,Nc1nonc1-c1nc2cnccc2n1C1CCCCC1,Inhibition,'=',5.24,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1794070,GSK-579289A,None,511.05,2,5.45,GSK579289A,C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl,Inhibition,'=',-3.56,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1794059,GW275616X,None,315.35,0,1.74,GW275616X,NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1,Inhibition,'=',-0.33,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1614710,OSI-930,1,443.45,1,6.06,OSI-930,O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL493937,,None,338.41,0,2.38,1,CN1CCCN(c2cncc(-c3cccc(/C=C/C(=O)O)c3)n2)CC1,IC50,'=',140,nM,6.85,,,UO_0000065,20.25,0.37,4.47,9.85,0,CHEMBL960090,Inhibition of GST-tagged Pim2 after 15 mins by scintillation counting-based competition assay in presence of 1 uM [gamma33P]ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153342,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL493559,,None,326.4,0,2.61,16,CN(C)CCCNc1cncc(-c2cccc(/C=C/C(=O)O)c2)n1,IC50,'=',94,nM,7.03,,,UO_0000065,21.53,0.4,4.42,8.97,0,CHEMBL960121,Inhibition of Pim2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153342,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL491405,,None,344.73,0,3.28,8,O=c1o[nH]c2c1c(=O)c1cc(F)c(Cl)cc1n2Cc1ccccc1,Ki,'=',558,nM,6.25,,,UO_0000065,18.14,0.36,2.97,9.2,0,CHEMBL994191,Inhibition of Pim2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144228,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,
CHEMBL2325894,,None,338.37,0,0.94,3p,C[C@@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(=O)N1CC(C#N)C1,Inhibition,'=',-27,%,,Outside typical range,,UO_0000187,,,,,0,CHEMBL2329527,Inhibition of PIM2 (unknown origin) at 10 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2321829,1,Scientific Literature,J Med Chem,2013,None,
CHEMBL1277459,,None,278.36,0,3.68,14b,CC1(C)[C@H]2CC[C@]1(C)c1nc3cc4[nH]ncc4cc3nc12,Activity,,,,,,Not Active,,,,,,0,CHEMBL1285679,Inhibition of Pim2 assessed as residual enzyme activity at 1 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1275327,1,Scientific Literature,Eur J Med Chem,2010,None,
CHEMBL559818,,None,148.17,0,0.73,3,Nc1cc2cn[nH]c2cc1N,Activity,,,,,,Not Active,,,,,,0,CHEMBL1285679,Inhibition of Pim2 assessed as residual enzyme activity at 1 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1275327,1,Scientific Literature,Eur J Med Chem,2010,None,
CHEMBL3919956,,None,405.45,0,4.54,BDBM191085,NCCC1CNC(=O)c2cc(-c3cccc(C(F)(F)F)c3)c(-c3ccsc3)n21,IC50,'=',155,nM,6.81,,341756,UO_0000065,16.8,0.33,2.27,11.34,0,CHEMBL3887520,Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3928863,,None,415.42,0,4.18,BDBM191088,NCCC1CNC(=O)c2cc(-c3cccc(C(F)(F)F)c3)c(-c3ccc(O)cc3)n21,IC50,'=',21,nM,7.68,,341759,UO_0000065,18.48,0.35,3.5,9.56,0,CHEMBL3887520,Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1275867,,None,224.27,0,2.38,11,c1n[nH]c2cc3nc4c(nc3cc12)CCCC4,Activity,,,,,,Not Active,,,,,,0,CHEMBL1285678,Inhibition of Pim2 assessed as residual enzyme activity at 10 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1275327,1,Scientific Literature,Eur J Med Chem,2010,None,
CHEMBL3930142,,None,402.46,0,3.78,BDBM224981,C[C@H]1COCCN1c1nnc(-c2ccc3[nH]cc(-c4cncc(C5CC5)n4)c3c2)o1,IC50,'=',20.86,nM,7.68,,393271,UO_0000065,19.08,0.35,3.9,8.26,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3952989,,None,414.47,0,2.34,BDBM249014,Cc1cncc(-c2cc3c(cn2)cnn3-c2ccc(C)c(N3CCC[C@H](N)C3=O)n2)n1,Ki,'=',52.5,nM,7.28,,434219,UO_0000065,17.56,0.32,4.94,6.29,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3691914,,None,636.69,1,4.11,BDBM151936,COCCOc1cc(F)c(-c2nc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@@H](OCCS(C)(=O)=O)[C@@H](C)C3)ccc2F)c(F)c1,IC50,'=',2.54,nM,8.6,,292191,UO_0000065,13.5,0.27,4.49,6.02,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL14112,SB-210313,None,366.44,0,3.47,SB-210313,Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1,Inhibition,'=',0.24,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL4436502,,None,407.52,0,4.16,13,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C(C)(C)C)c(NC(C)(C)C)nc34)[nH]c21,IC50,'=',0.83,nM,9.08,,,UO_0000065,22.28,0.41,4.92,9.89,0,CHEMBL4370146,Inhibition of full length recombinant PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues preincubated for 30 mins followed by biotinylated BAD addition and measured after 1 hr by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4368910,1,Scientific Literature,J Med Chem,2019,None,
CHEMBL2442289,,None,320.36,0,2.42,11m,NCCNc1ccn2ncc(-c3cc(-c4ccccc4)no3)c2n1,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL2446210,Inhibition of Pim2 (unknown origin) using STK1 as substrate preincubated for 30 mins followed by substrate and ATP addition at > 5000 nM after 60 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2440090,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL2430323,,None,266.3,0,2.89,MRT00033659,CC(=O)Nc1cccc(-c2cnc3[nH]nc(C)c3c2)c1,Activity,'=',79.05,%,,,,UO_0000187,,,,,0,CHEMBL2433455,Inhibition of human PIM2 assessed as residual activity at 1 uM relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2429821,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL1641799,,None,358.42,0,4.26,18,CC(C)(C)c1cc(C(=O)O)c(NC(=O)Nc2ccc3[nH]ncc3c2)s1,Inhibition,'=',0,%,,,,UO_0000187,,,,,0,CHEMBL1646777,Inhibition of PIM2 at 1 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1641460,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL493754,,None,323.4,0,3.62,8,O=C(O)/C=C/c1cccc(-c2cncc(N3CCCCCC3)n2)c1,IC50,'=',3300,nM,5.48,,,UO_0000065,16.95,0.31,1.86,8.27,0,CHEMBL960121,Inhibition of Pim2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153342,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL454281,,None,312.37,0,2.39,15,NCCCCNc1cncc(-c2cccc(/C=C/C(=O)O)c2)n1,IC50,'=',22,nM,7.66,,,UO_0000065,24.51,0.45,5.27,7.57,0,CHEMBL960121,Inhibition of Pim2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153342,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL1794055,GW589933X,None,372.43,0,2.35,GW589933X,NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1,Inhibition,'=',5.46,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1086670,,None,291.68,0,4.11,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL493937,,None,338.41,0,2.38,1,CN1CCCN(c2cncc(-c3cccc(/C=C/C(=O)O)c3)n2)CC1,IC50,'=',153,nM,6.82,,,UO_0000065,20.14,0.37,4.44,9.8,0,CHEMBL960128,Inhibition of GST-tagged Pim2 after 15 mins by scintillation counting-based competition assay in presence of 5 uM [gamma33P]ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153342,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL494501,,None,299.33,0,2.04,19,O=C(O)/C=C/c1cccc(-c2cncc(NCCCO)n2)c1,IC50,'=',310,nM,6.51,,,UO_0000065,21.74,0.4,4.47,6.83,0,CHEMBL960121,Inhibition of Pim2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153342,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL3687527,,None,662.73,1,4.08,BDBM151924,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C4(O)CCOCC4)cc3F)n2)C[C@@H](N)[C@H]1OCCS(C)(=O)=O,IC50,'=',1.24,nM,8.91,,292179,UO_0000065,13.44,0.26,4.83,5.79,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL522340,,None,340.43,0,2.63,17,CN(C)CCCN(C)c1cncc(-c2cccc(/C=C/C(=O)O)c2)n1,IC50,'=',370,nM,6.43,,,UO_0000065,18.89,0.35,3.8,9.25,0,CHEMBL960121,Inhibition of Pim2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153342,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL1909399,GW352430A,None,457.94,0,2.28,GW352430A,Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1,Inhibition,'=',0.64,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL259084,MLN-8054,1,476.87,1,5.87,MLN-8054,O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL604483,,None,559.67,2,5.86,23,COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1,Residual activity,'=',77,%,,,,UO_0000187,,,,,0,CHEMBL1040270,Residual activity of PIM2 at 1 uM by microplate scintillation counting,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1152560,1,Scientific Literature,Bioorg Med Chem,2009,None,
CHEMBL493937,,None,338.41,0,2.38,1,CN1CCCN(c2cncc(-c3cccc(/C=C/C(=O)O)c3)n2)CC1,IC50,'=',4000,nM,5.4,,,UO_0000065,15.95,0.29,3.02,7.76,0,CHEMBL960091,Inhibition of GST-tagged Pim2 after 15 mins by scintillation counting-based competition assay in presence of 10 uM [gamma33P]ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153342,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL588025,GW770249A,None,467.81,1,5.27,GW770249A,Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12,Inhibition,'=',0.09,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL516908,GW796920X,None,362.47,0,4.54,GW796920X,Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1,Inhibition,'=',-0.33,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL479038,GW806776X,None,334.42,0,3.39,GW806776X,O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1,Inhibition,'=',0.75,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL4563904,,None,445.53,0,3.19,23,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(Cc5cn(C)cn5)c(NC(C)(C)C)nc34)[nH]c21,IC50,'=',0.16,nM,9.8,,,UO_0000065,21.99,0.41,6.61,8.94,0,CHEMBL4370146,Inhibition of full length recombinant PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues preincubated for 30 mins followed by biotinylated BAD addition and measured after 1 hr by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4368910,1,Scientific Literature,J Med Chem,2019,None,
CHEMBL526284,,None,344.8,0,2.79,E/Z-27c-2,COc1ccc(/C=C2\C(=O)NC(=O)N2Cc2ccccc2)cc1.Cl,IC50,'>',100000,nM,,,,UO_0000065,,,,,0,CHEMBL957366,Inhibition of human recombinant Pim2 by ATP depletion assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139352,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL186213,GW827105X,None,462.44,1,5.62,GW827105X,COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1,Inhibition,'=',0.02,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL941,IMATINIB,4,493.62,0,4.59,Imatinib,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1,Kd,'>',10000,nM,,,,UO_0000065,,,,,1,CHEMBL1061184,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150977,1,Scientific Literature,Nat Biotechnol,2008,None,
CHEMBL573339,PI-103,None,348.36,0,2.98,PI-103,Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1,Kd,'>',10000,nM,,,,UO_0000065,,,,,1,CHEMBL1061184,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150977,1,Scientific Literature,Nat Biotechnol,2008,None,
CHEMBL101253,VATALANIB,3,346.82,1,5.01,PTK-787,Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1,Kd,'>',10000,nM,,,,UO_0000065,,,,,1,CHEMBL1061184,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150977,1,Scientific Literature,Nat Biotechnol,2008,None,
CHEMBL183906,,None,273.24,0,3.03,4a,O=C1NC(=O)/C(=C/c2cccc(C(F)(F)F)c2)S1,Activity,,,,,,Not Active,,,,,,0,CHEMBL954159,Inhibition of human recombinant Pim2 at 5 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139352,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL1782532,,None,354.2,0,3.61,40,O=C(O)c1cc2cc(Br)cc(N[C@H]3CC[C@@H](O)CC3)c2o1,IC50,'=',6800,nM,5.17,,,UO_0000065,14.59,0.34,1.56,6.25,0,CHEMBL1786238,Inhibition of human Pim2 using 5-FAM-RSRHSSYPAGT-CONH2 as substrate after 90 mins by off-chip mobility shift method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1781944,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL3980874,,None,445.44,0,3.85,BDBM191083,NCCC1CNC(=O)c2cc(-c3cccc(OC(F)(F)F)c3)c(-c3ccc(CO)cc3)n21,IC50,'=',15,nM,7.82,,341754,UO_0000065,17.56,0.33,3.97,8.74,0,CHEMBL3887520,Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1086796,,None,345.78,0,3.86,13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3979444,,None,479.89,1,5.02,BDBM191120,COc1ccc(-c2c(-c3cccc(OC(F)(F)F)c3)cc3n2[C@@H](CCN)CNC3=O)cc1Cl,IC50,'=',12,nM,7.92,,341799,UO_0000065,16.51,0.33,2.9,10.09,0,CHEMBL3887520,Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP,,,,,,,,,,,,,,,,,,,,,,
CHEMBL207247,GW807930X,None,500.96,2,5.63,GW807930X,CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1,Inhibition,'=',0.6,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1999811,,None,329.34,0,2.26,SID103905509,O=C(NN=Cc1ccc(O)cc1O)Nc1cccc2nsnc12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1982874,,None,403.49,1,5.21,SID103905064,Nc1nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc2n1CC1CC1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL148333,,None,265.34,0,0.73,H-8,CNCCNS(=O)(=O)c1cccc2cnccc12,Activity,'=',96,%,,,,UO_0000187,,,,,0,CHEMBL1061149,Percentage PIM2 activity remaining in the presence of 10uM inhibitor,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL464552,,None,532.58,1,3.4,GSK-1838705A,CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL302449,GO-6976,None,378.44,0,4.6,GO-6976,Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O,Activity,'=',53,%,,,,UO_0000187,,,,,0,CHEMBL1051299,Percentage PIM2 activity remaining in the presence of 0.1uM inhibitor,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL240954,,None,516.46,2,1.92,SL-0101,CC(=O)O[C@@H]1[C@@H](OC(C)=O)[C@@H](O)[C@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)O[C@H]1C,Activity,'=',95,%,,,,UO_0000187,,,,,0,CHEMBL1061149,Percentage PIM2 activity remaining in the presence of 10uM inhibitor,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL573108,,None,547.46,1,3.04,BX-320,CC(C)(C(N)=O)C(=O)NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1Br,Activity,'=',104,%,,,,UO_0000187,,,,,0,CHEMBL1061086,Percentage PIM2 activity remaining in the presence of 1uM inhibitor,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL1336,SORAFENIB,4,464.83,1,5.55,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL186526,,None,389.46,0,4.27,ZM-336372,Cc1ccc(NC(=O)c2cccc(N(C)C)c2)cc1NC(=O)c1ccc(O)cc1,Activity,'=',93,%,,,,UO_0000187,,,,,0,CHEMBL1061149,Percentage PIM2 activity remaining in the presence of 10uM inhibitor,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL3664617,,None,421.48,0,3.62,BDBM104237,COC1(COc2cc(F)cc3ccc(-c4nnc5ccccn45)nc23)CCCNCC1,IC50,'=',86,nM,7.07,,222648,UO_0000065,16.76,0.31,3.45,9.6,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL604483,,None,559.67,2,5.86,23,COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1,Residual activity,'=',94,%,,,,UO_0000187,,,,,0,CHEMBL1070476,Residual activity of PIM2 at 0.1 uM by microplate scintillation counting,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1152560,1,Scientific Literature,Bioorg Med Chem,2009,None,
CHEMBL3660056,,None,381.39,0,3.16,BDBM104182,Fc1ccc2nnc(-c3ccc4cccc(OC5CCNCC5F)c4n3)n2c1,IC50,'=',2866,nM,5.54,,222595,UO_0000065,14.53,0.27,2.38,8.61,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL607196,,None,380.45,0,4.53,6,O=C1Nc2ccccc2/C1=C1\C(=O)N(CCCc2ccccc2)c2ccccc21,Inhibition,'=',23,%,,,,UO_0000187,,,,,0,CHEMBL1066089,Inhibition of PIM2 at 10 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1152632,1,Scientific Literature,Bioorg Med Chem,2009,None,
CHEMBL572556,,None,287.39,0,2.76,11a,CCc1ccc2sc3c(=O)[nH]c(CN(C)C)nc3c2c1,Ki,'=',83,nM,7.08,,,UO_0000065,24.64,0.48,4.32,14.45,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL1908397,KW-2449,1,332.41,0,2.78,KW-2449,O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL3103885,,None,297.36,0,3.03,1e,O=C(Nc1ccccc1N1CCCCC1)c1ncccc1O,Ki,'>',12500,nM,,,,UO_0000065,,,,,0,CHEMBL3106178,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3102815,1,Scientific Literature,ACS Med Chem Lett,2013,None,
CHEMBL3103881,,None,344.44,0,3.34,1a,CC(=O)Nc1nc(C(=O)Nc2ccccc2N2CCCCC2)cs1,Ki,'>',12500,nM,,,,UO_0000065,,,,,1,CHEMBL3106178,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3102815,1,Scientific Literature,ACS Med Chem Lett,2013,None,
CHEMBL3687518,,None,588.65,1,4.44,BDBM151914,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C4(O)CCC4)cc3F)n2)C[C@@H](N)[C@H]1S(C)(=O)=O,IC50,'=',2.34,nM,8.63,,292170,UO_0000065,14.66,0.29,4.19,6.38,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1976090,,None,218.25,0,0.8,SID103905284,Nc1ncnc2c1sc1ncnc(N)c12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2062290,,None,598.48,0,4.51,SB-739245-AC,CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O,Inhibition,'=',1.48,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL2425652,,None,309.38,0,1.89,4,N[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1,Inhibition,'=',99,%,,,,UO_0000187,,,,,0,CHEMBL2429482,Competitive binding affinity to PIM2 (unknown origin) at 10 uM in presence of ATP relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2424622,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL3660048,,None,377.42,0,3.41,BDBM104169,FC1CCNCCC1Oc1cccc2ccc(-c3nnc4ccccn34)nc12,IC50,'=',147,nM,6.83,,222585,UO_0000065,18.1,0.33,3.42,10.62,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL493937,,None,338.41,0,2.38,1,CN1CCCN(c2cncc(-c3cccc(/C=C/C(=O)O)c3)n2)CC1,IC50,'=',40,nM,7.4,,,UO_0000065,21.86,0.4,5.02,10.64,1,CHEMBL960129,Inhibition of Pim2 in presence of 1 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153342,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL493937,,None,338.41,0,2.38,1,CN1CCCN(c2cncc(-c3cccc(/C=C/C(=O)O)c3)n2)CC1,IC50,'=',40,nM,7.4,,,UO_0000065,21.86,0.4,5.02,10.64,1,CHEMBL960089,Inhibition of GST-tagged Pim2 by luciferin-luciferase reporter gene-based assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153342,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL523534,,None,338.41,0,2.42,22,NCC1CCN(c2cncc(-c3cccc(/C=C/C(=O)O)c3)n2)CC1,IC50,'=',17,nM,7.77,,,UO_0000065,22.96,0.42,5.35,8.41,0,CHEMBL960121,Inhibition of Pim2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153342,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL492581,,None,337.42,0,2.99,27,CN1CCCN(c2cccc(-c3cccc(/C=C/C(=O)O)c3)n2)CC1,IC50,'=',50,nM,7.3,,,UO_0000065,21.64,0.4,4.31,12.88,0,CHEMBL960121,Inhibition of Pim2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153342,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL558752,RAF-265,2,518.42,2,6.93,CHIR-265/RAF-265,Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL1909378,,None,420.86,0,3.63,SB-431542-A,Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1,Inhibition,'=',0.78,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL574737,UCN-01,2,482.54,0,3.84,UCN-01,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O,Activity,'=',73,%,,,,UO_0000187,,,,,0,CHEMBL1051298,Percentage PIM2 activity remaining in the presence of 0.01uM inhibitor,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL475599,GSK-300014A,None,603.17,2,6.67,GSK300014A,CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1,Inhibition,'=',-0.84,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL103667,DORAMAPIMOD,2,527.67,2,5.99,BIRB-796,Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL221959,TOFACITINIB,4,312.38,0,1.54,CP-690550,C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL458865,GSK-1220512A,None,518.6,1,4.22,GSK1220512A,COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1,Inhibition,'=',-0.44,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL261129,,None,430.31,0,3.37,SB-732881,CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1,Inhibition,'=',-0.97,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL513897,GSK-994854A,None,481.6,1,5.35,GSK994854A,CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1,Inhibition,'=',0.34,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1241011,,None,262.31,0,4.18,3i,CCc1cccc2c1[nH]c1c2ccc2c(C=O)c[nH]c21,Activity,'=',14,%,,,,UO_0000187,,,,,0,CHEMBL1248949,Inhibition of human GST fused Pim2 expressed in Escherichia coli assessed as residual activity at 10 uM after 30 mins,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240519,1,Scientific Literature,Bioorg Med Chem,2010,None,
CHEMBL4573829,,None,405.5,0,3.92,29,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C(C)(C)C)c(NC5(C)CC5)nc34)[nH]c21,IC50,'=',3.5,nM,8.46,,,UO_0000065,20.85,0.38,4.54,9.21,0,CHEMBL4370146,Inhibition of full length recombinant PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues preincubated for 30 mins followed by biotinylated BAD addition and measured after 1 hr by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4368910,1,Scientific Literature,J Med Chem,2019,None,
CHEMBL492753,,None,311.34,0,2.08,12,O=C(O)/C=C/c1cccc(-c2cncc(N3CCOCC3)n2)c1,IC50,'=',1700,nM,5.77,,,UO_0000065,18.53,0.34,3.69,7.64,0,CHEMBL960121,Inhibition of Pim2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153342,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL2005828,,None,359.39,0,4.42,SID103904329,Cc1ccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)cc1,Ki,'=',1258.93,nM,5.9,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3973417,,None,404.48,0,2.79,BDBM224850,CN(C)[C@H]1CCCN(c2ccnc(-c3c[nH]c4ccc(-c5nnc(N)o5)cc34)n2)C1,IC50,'=',3.243,nM,8.49,,393130,UO_0000065,20.99,0.39,5.7,7.51,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL495727,AT-9283,2,381.44,0,2.07,AT-9283,O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL98350,LY-294002,None,307.35,0,3.3,LY-294002,O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12,Activity,'=',65,%,,,,UO_0000187,,,,,0,CHEMBL1061149,Percentage PIM2 activity remaining in the presence of 10uM inhibitor,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL2028663,DABRAFENIB,4,519.57,2,5.36,Dabrafenib,CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3981760,,None,318.41,0,1.09,BDBM213747,CSc1nccc(-c2cc(C(N)=O)nn2C2CCNCC2)n1,IC50,'<',10000,nM,,,375858,UO_0000065,,,,,0,CHEMBL3888142,PIM2 Activity Assay: Kinase Buffer (KB) The buffer for PIM2 assay was composed of HEPES 50 mM,,,,,,,,,,,,,,,,,,,,,,
CHEMBL261849,GW632580X,None,366.42,0,2.83,GW-2580,COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL269827,GW276655X,None,383.39,0,1.76,GW276655X,NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1,Inhibition,'=',-0.37,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL24828,VANDETANIB,4,475.36,0,4.43,ZD-6474,COc1cc2/c(=N/c3ccc(Br)cc3F)nc[nH]c2cc1OCC1CCN(C)CC1,Kd,,,,,,Not Active,,,,,,0,CHEMBL859489,Average Binding Constant for PIM2; NA=Not Active at 10 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144455,1,Scientific Literature,Nat Biotechnol,2005,None,
CHEMBL1983111,,None,474.49,0,4.06,PF-03814735,CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3965804,,None,294.29,0,3.61,BDBM224825,Nc1nnc(-c2ccc3[nH]cc(-c4ccccc4F)c3c2)o1,IC50,'=',139.93,nM,6.85,,393107,UO_0000065,23.29,0.43,3.24,8.49,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1165499,,None,436.51,0,3.61,5d,CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1,Inhibition,'<',50,%,,,,UO_0000187,,,,,0,CHEMBL1166808,Inhibition of PIM2 at 1 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1165965,1,Scientific Literature,Bioorg Med Chem,2010,None,
CHEMBL3899535,,None,369.38,0,3.34,BDBM238669,Cc1nc2cccc(-c3cc4c([nH]3)C3(CC3)NC4=O)c2nc1NCC(F)F,IC50,'=',1.12,nM,8.95,,416778,UO_0000065,24.23,0.45,5.61,10.82,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4470271,,None,403.49,0,3.89,27,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C5CCC5)c(NC5(C)CC5)nc34)[nH]c21,IC50,'=',0.18,nM,9.74,,,UO_0000065,24.15,0.44,5.85,10.61,0,CHEMBL4370146,Inhibition of full length recombinant PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues preincubated for 30 mins followed by biotinylated BAD addition and measured after 1 hr by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4368910,1,Scientific Literature,J Med Chem,2019,None,
CHEMBL4441708,,None,405.5,0,3.82,14,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(CC5CC5)c(NC(C)(C)C)nc34)[nH]c21,IC50,'=',0.08,nM,10.1,,,UO_0000065,24.9,0.46,6.28,11,0,CHEMBL4370146,Inhibition of full length recombinant PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues preincubated for 30 mins followed by biotinylated BAD addition and measured after 1 hr by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4368910,1,Scientific Literature,J Med Chem,2019,None,
CHEMBL233000,,None,282.37,0,3.75,5,N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2,Activity,,,,,,Not Evaluated,,,,,,0,CHEMBL982757,Binding affinity to human PIM2 at 10 uM relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1151712,1,Scientific Literature,J Med Chem,2008,None,
CHEMBL4249925,,None,427.51,0,3.24,28,CS(=O)(=O)Nc1cccc(CC(=O)Nc2nc(-c3c[nH]c4ncccc34)cs2)c1,Ki,'>',2000,nM,,,,UO_0000065,,,,,0,CHEMBL4235411,Inhibition of Pim2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4229506,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL397521,,None,1312.57,None,None,ARC-659-1b,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H]1C[C@@H](O)[C@H](n2cnc3c(N)ncnc32)C1)C(N)=O,Activity,'=',103,%,,,,UO_0000187,,,,,0,CHEMBL898212,Inhibition of PIM2 assessed as residual activity at 0.01 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1149703,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,
CHEMBL3935063,,None,429.44,0,4.66,BDBM191078,Cc1cccc(-c2c(-c3cccc(OC(F)(F)F)c3)cc3n2[C@@H](CCN)CNC3=O)c1,IC50,'=',15,nM,7.82,,341749,UO_0000065,18.22,0.34,3.16,11.29,0,CHEMBL3887520,Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4227028,,None,403.44,0,4.01,12e,COc1cc(C(=O)O)ccc1-c1cncc(-n2ncc3ccc(NC(C)C)cc32)n1,IC50,'>',30000,nM,,,,UO_0000065,,,,,0,CHEMBL4222673,Inhibition of human PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4219163,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL191384,,None,372.46,0,3.94,AS-601245,N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1,Activity,'=',7,%,,,Antagonist,UO_0000187,,,,,0,CHEMBL1061149,Percentage PIM2 activity remaining in the presence of 10uM inhibitor,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL1794062,GW577921A,None,302.76,0,4.09,GW577921A,COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl,Inhibition,'=',0.53,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL583972,,None,234.26,0,3.61,A,O=Cc1c[nH]c2c1ccc1c3ccccc3[nH]c12,Activity,,,,,,Not Determined,,,,,,0,CHEMBL1248947,Inhibition of human GST fused Pim2 expressed in Escherichia coli assessed as residual activity at 1 uM after 30 mins,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240519,1,Scientific Literature,Bioorg Med Chem,2010,None,
CHEMBL3809127,,None,361.45,0,3.74,10d,Cc1nc2cccc3c2nc1N[C@@H](C)CCC[C@H]1CNC(=O)c2cc-3[nH]c21,IC50,'=',0.4,nM,9.4,,,UO_0000065,26,0.48,5.66,11.36,0,CHEMBL3812018,Inhibition of human full-length Pim2 expressed in Escherichia coli assessed as phosphorylation of biotinylated BAD peptide at Ser 112 preincubated for 30 mins followed by substrate addition measured after 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3808325,1,Scientific Literature,ACS Med Chem Lett,2016,None,
CHEMBL3735816,,None,391.43,0,1.99,6,COc1ccc2c(c1CN1CCNCC1)O/C(=C\c1n[nH]c3ncccc13)C2=O,Inhibition,'=',28.4,%,,,,UO_0000187,,,,,0,CHEMBL3739158,Inhibition of PIM2 (unknown origin) at 200 nM by electrophoretic mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3734671,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL231623,GSK-620503A,None,307.33,0,3.24,GSK620503A,NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N,Inhibition,'=',-0.12,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3188267,CAPMATINIB,4,412.43,0,3.43,Capmatinib,CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL271594,GW300653X,None,358.42,0,2.23,GW300653X,CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1,Inhibition,'=',1.32,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3918795,,None,350.43,0,2.82,BDBM238704,Cc1nc2ccnc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC(C)(C)C,IC50,'=',33.7,nM,7.47,,416813,UO_0000065,21.32,0.39,4.65,7.82,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL241517,GW856804X,None,433.92,0,4.65,GW856804X,Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12,Inhibition,'=',0.78,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1909388,GW568377A,None,565.1,2,5.35,GW568377A,CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl,Inhibition,'=',-0.21,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3039525,GOLVATINIB,2,633.7,1,4.75,Golvatinib,CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL2041933,AZD-7762,1,362.43,0,2.53,AZD-7762,NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL185710,,None,230.23,0,1.08,SB-738561,CCn1c(-c2nonc2N)nc2ccncc21,Inhibition,'=',0.35,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1915440,,None,356.36,0,4.45,14m,Fc1cccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3cnccc23)c1,IC50,'=',59,nM,7.23,,,UO_0000065,20.29,0.37,2.78,9.11,0,CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914433,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL175321,,None,263.3,0,3.2,GR-105659X,O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21,Inhibition,'=',-0.2,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL514261,GSK-1819799A,None,519.58,1,4.82,GSK1819799A,COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1,Inhibition,'=',0.01,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1909342,,None,395.44,0,1.77,SB-657836-AAA,N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O,Inhibition,'=',0.29,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL251549,GW782612X,None,345.37,0,2.94,GW782612X,NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1,Inhibition,'=',1.09,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL2017361,,None,375.43,1,5.43,10i,Cc1cc2c(Nc3ccccc3F)nc3c(-c4nnc[nH]4)cccc3c2s1,IC50,'=',6,nM,8.22,,,UO_0000065,21.9,0.42,2.79,12.37,0,CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016532,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL4450494,,None,457.54,0,3.5,35,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n([C@@H](C)c5cn(C)cn5)c(NC5(C)CC5)nc34)[nH]c21,IC50,'=',0.15,nM,9.82,,,UO_0000065,21.47,0.39,6.32,8.96,0,CHEMBL4370146,Inhibition of full length recombinant PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues preincubated for 30 mins followed by biotinylated BAD addition and measured after 1 hr by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4368910,1,Scientific Literature,J Med Chem,2019,None,
CHEMBL3660026,,None,375.48,0,3.91,BDBM104144,CN(C)CC(C)(C)COc1cccc2ccc(-c3nnc4ccccn34)nc12,IC50,'=',1354,nM,5.87,,222561,UO_0000065,15.63,0.29,1.96,10.56,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL486124,GW874091X,None,352.44,0,2.23,GW874091X,Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12,Inhibition,'=',0.19,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3903003,,None,382.47,0,4.67,BDBM238388,CCN(c1ccccc1)c1ccc2cccc(-c3cc4c([nH]3)CCNC4=O)c2n1,IC50,'=',6,nM,8.22,,416166,UO_0000065,21.5,0.39,3.55,13.47,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1782522,,None,368.23,0,3.66,30,O=C(O)c1cc2cc(Br)cc(OCCC3CCNCC3)c2o1,IC50,'=',350,nM,6.46,,,UO_0000065,17.53,0.4,2.8,9,0,CHEMBL1786238,Inhibition of human Pim2 using 5-FAM-RSRHSSYPAGT-CONH2 as substrate after 90 mins by off-chip mobility shift method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1781944,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL2377724,,None,274.36,None,None,8,C[Si](C)(C)c1cc2c([nH]1)c([N+](=O)[O-])cc1cn[nH]c12,Inhibition,'=',103,%,,,,UO_0000187,,,,,0,CHEMBL2378598,Inhibition of human full length Pim-2 using RSRHSSYPAGT as substrate assessed as residual activity at 1 uM after 30 mins in presence of [gamma-33P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2375344,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL3939101,,None,427.51,0,2.79,BDBM248887,c1cc(N2CCCNCC2)nc(-n2ncc3cnc(-c4cncc(C5COC5)c4)cc32)c1,Ki,'=',9.04,nM,8.04,,434094,UO_0000065,18.82,0.34,5.25,9.93,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3922549,,None,426.53,0,3.26,BDBM248966,Cc1cncc(-c2cc3c(cn2)cnn3-c2ccc(C3CC3)c(N3CCCNCC3)n2)n1,Ki,'=',1.22,nM,8.91,,434173,UO_0000065,20.9,0.38,5.65,10.53,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3687504,,None,602.68,1,4.96,BDBM151900,CO[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C4CCS(=O)(=O)CC4)cc3F)n2)C[C@@H]1C,IC50,'=',2.35,nM,8.63,,292156,UO_0000065,14.32,0.28,3.67,6.94,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4113302,,None,404.45,0,2.46,BDBM248967,Cc1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3C[C@@H](N)C[C@@H](F)C3)n2)n1,Ki,'=',2.55,nM,8.59,,434174,UO_0000065,21.25,0.39,6.13,8.71,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4107589,,None,420.9,0,4.15,BDBM192555,O[C@@H]1CCCN(c2ccncc2Nc2ncc3ccc(-c4ccccc4Cl)nn23)C1,IC50,'>',1000,nM,,,344547,UO_0000065,,,,,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL253969,OSI-632,2,532.41,1,3.86,SID103905622,NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3691956,,None,577.61,1,4.86,BDBM151978,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C4(O)CCC4)cc3F)n2)C[C@@H](N)[C@H]1n1ccnn1,IC50,'=',1.69,nM,8.77,,292233,UO_0000065,15.19,0.29,3.91,6.65,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3652635,,None,395.44,0,1.99,BDBM119395,Cn1ncc(NC(=O)c2nc(-c3ccccc3F)ccc2N)c1N1CC[C@@H](N)C1,Ki,'=',28.5,nM,7.54,,246162,UO_0000065,19.08,0.36,5.56,6.56,0,CHEMBL3707982,Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2004311,,None,385.47,1,5.17,SID103904278,Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C)c2)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1988075,,None,469.55,1,6.7,SID103904287,Cc1ccc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL4561806,BTZO-4,None,242.3,0,2.62,EUB0001135,O=C1NC(c2ccccn2)Sc2ccccc21,% Control,,88,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507329,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL4206831,,None,535.61,2,5.49,2; FMF-03-145-1,CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1,Activity,'=',100,%,,,,UO_0000187,,,,,0,CHEMBL4185991,Binding affinity to wild-type human partial length PIM2 (M1 to E291 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4184148,1,Scientific Literature,Bioorg Med Chem Lett,2017,None,
CHEMBL91829,RUBOXISTAURIN,3,468.56,0,3.51,LY-333531,CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1,Kd,'=',130,nM,6.89,,,UO_0000065,14.7,0.27,3.38,10.05,1,CHEMBL859489,Average Binding Constant for PIM2; NA=Not Active at 10 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144455,1,Scientific Literature,Nat Biotechnol,2005,None,
CHEMBL2442287,,None,271.33,0,1.09,11o,CN(C)CCNc1ccn2ncc(-c3cn[nH]c3)c2n1,IC50,'=',185,nM,6.73,,,UO_0000065,24.81,0.46,5.64,9.08,0,CHEMBL2446212,Inhibition of Pim2 (unknown origin) using STK1 as substrate preincubated for 30 mins followed by substrate and ATP addition after 60 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2440090,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL3975764,,None,413.53,0,3.8,BDBM248872,CC(C)c1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CCCNCC3)n2)c1,Ki,'=',2.76,nM,8.56,,434079,UO_0000065,20.7,0.38,4.76,11.93,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3652646,,None,367.36,0,3.09,BDBM119406,Nc1sc(-c2c(F)cccc2F)nc1C(=O)Nc1cnn(CCF)c1,Ki,'=',38,nM,7.42,,246173,UO_0000065,20.2,0.41,4.33,8.65,0,CHEMBL3707982,Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL270724,,None,463.75,0,4.83,TBCA,O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br,Residual Activity,'=',1,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL204934,GW813360X,None,345.37,0,2.67,GW813360X,COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1,Inhibition,'=',-3.51,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1909350,GSK-949675A,None,421.89,0,0.8,GSK949675A,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl,Inhibition,'=',-0.54,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1952329,SGI-1776,1,405.42,0,4.05,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3685749,,None,432.48,0,4.64,BDBM124913,N[C@H]1CCCN(c2ccncc2Nc2cccc3cnc(-c4c(F)cccc4F)nc23)C1,IC50,'=',31,nM,7.51,,254215,UO_0000065,17.36,0.32,2.87,9.39,0,CHEMBL3705221,ATP Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 ul per well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3892590,,None,389.46,0,2.66,BDBM248898,CCn1cc(-c2cc3c(cn2)cnn3-c2cccc(N3CCC(O)CC3)n2)cn1,Ki,'=',28.3,nM,7.55,,434105,UO_0000065,19.38,0.36,4.89,8.89,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3629616,,None,248.24,0,3,1; Wrightiadione,O=C1c2ccccc2-c2c1oc1ccccc1c2=O,Activity,'=',82,%,,,,UO_0000187,,,,,0,CHEMBL3631439,Inhibition of PIM2 (unknown origin) assessed as remaining activity at 10 uM by high-throughput assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3627674,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL3651953,,None,422.48,0,4.91,BDBM106857,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3ccccc3F)n2)C1,IC50,'=',4,nM,8.4,,225878,UO_0000065,19.88,0.37,3.49,10.38,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4083330,,None,397.91,0,3.05,2,Cc1c(-c2ccc(N3CCN(C)CC3)cc2)n(C)c2nc(C(N)=O)cc(Cl)c12,IC50,'=',1950,nM,5.71,,,UO_0000065,14.35,0.28,2.66,8.47,0,CHEMBL4047363,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4043238,1,Scientific Literature,Bioorg Med Chem Lett,2017,None,
CHEMBL4126778,,None,443.45,1,5.42,41,CN(C)CCNc1cncc(-c2ccc3[nH]cc(-c4ccc(F)c(C(F)(F)F)c4)c3c2)n1,IC50,'=',4320,nM,5.37,,,UO_0000065,12.1,0.23,-0.06,9.44,0,CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4118246,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL3940411,,None,335.41,0,3.39,7,Cc1nc2cccc(-c3cc4c([nH]3)CNC4=O)c2nc1NC(C)(C)C,IC50,'=',0.9,nM,9.05,,,UO_0000065,26.97,0.49,5.66,10.94,0,CHEMBL4478465,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as reduction in phosphorylation of biotinylated-BAD peptide at Serine 112 residue preincubated for 30 mins followed by substrate addition for 1 hr by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4477213,1,Scientific Literature,J Med Chem,2016,None,
CHEMBL3913500,,None,349.44,0,3.36,5,Cc1nc2cccc(-c3cc4n(c3)CCNC4=O)c2nc1NC(C)(C)C,IC50,'=',6.1,nM,8.21,,,UO_0000065,23.51,0.43,4.85,11.43,0,CHEMBL4478465,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as reduction in phosphorylation of biotinylated-BAD peptide at Serine 112 residue preincubated for 30 mins followed by substrate addition for 1 hr by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4477213,1,Scientific Literature,J Med Chem,2016,None,
CHEMBL4593677,BAY-474,None,289.34,0,3.15,EUB0000293,CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1,Inhibition,,-3,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4880712,Pim-2 (h) Millipore kinase activity assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507263,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1.0 碌M
CHEMBL573339,PI-103,None,348.36,0,2.98,K00086,Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1,Thermal melting change,'=',0.1,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL404939,,None,289.67,0,1.67,K00025,O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21,Thermal melting change,'=',-4.1,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL4559936,,None,613.73,2,6.2,(+/-)-6,O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O,Activity,'=',16,%,,,,UO_0000187,,,,,0,CHEMBL4391522,Binding affinity to wild-type human partial length PIM2 (M1 to E291 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4390652,1,Scientific Literature,Eur J Med Chem,2019,None,
CHEMBL365663,GW780159X,None,338.82,0,4.66,GW780159X,Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1,Inhibition,'=',0.44,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3920733,,None,420.91,0,3.51,21i,N[C@H]1CCCN(c2ccncc2Nc2ncc3ccc(-c4ncccc4Cl)nn23)C1,IC50,'=',2.6,nM,8.59,,,UO_0000065,20.4,0.39,5.08,8.83,0,CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3864151,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL489784,,None,388.78,0,3.48,11,CCn1c2cc(Cl)c(F)cc2c(=O)c2c(=O)on(Cc3cccc(O)c3)c21,Ki,'>',1424,nM,,,,UO_0000065,,,,,0,CHEMBL994191,Inhibition of Pim2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144228,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,
CHEMBL4096145,,None,377.49,0,3.42,2,CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N,Activity,'=',100,%,,,,UO_0000187,,,,,0,CHEMBL4055243,Inhibition of wild-type human partial length PIM2 (M1 to E291 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4052645,1,Scientific Literature,Bioorg Med Chem Lett,2017,None,
CHEMBL1987813,,None,292.24,0,-0.74,4,O=C1C2=C(C(=O)c3c(O)ccc(O)c31)[C@@H](O)[C@@H](O)[C@@H](O)C2,Activity,'=',67,%,,,,UO_0000187,,,,,0,CHEMBL3812886,Inhibition of human PIM2 (1 to 291 amino acid residues) expressed in bacterial system assessed as enzyme activity at 10 uM by KINOMEScan assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3808372,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL3793267,,None,419.4,0,3.3,2i,Nc1nccc(-c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)ccc2N)n1,Ki,'=',50,nM,7.3,,,UO_0000065,17.41,0.32,4,5.5,0,CHEMBL3794688,Inhibition of Pim2 (unknown origin) using BAD peptide preincubated for 15 mins followed by ATP addition measured after 60 to 100 mins by Kinase-Glo reagent based luminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3792348,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL3685796,MRL-SYKi,None,452.58,1,5.06,EUB0000714,Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1,% Control,,100,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507285,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 100.0 nM
CHEMBL4586794,ABT-100,None,504.47,2,5.04,EUB0000289,Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1,% Control,,84,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507257,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL3609637,GSM1,None,514.48,1,4.67,EUB0000753,COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1,% Control,,100,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507289,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL208437,GW711782X,None,408.47,0,4.48,GW711782X,c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1,Inhibition,'=',0.26,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3946958,,None,368.44,0,4.65,BDBM238407,CC1Cc2[nH]c(-c3cccc4ccc(Nc5ccccc5)nc34)cc2C(=O)N1,IC50,'=',73.3,nM,7.13,,416184,UO_0000065,19.37,0.35,2.48,10.22,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL269538,HARMINE,0.5,212.25,0,3.03,Harmine,COc1ccc2c(c1)[nH]c1c(C)nccc12,Activity,'=',39,%,,,,UO_0000187,,,,,0,CHEMBL4151472,Inhibition of human PIM2 expressed in bacterial expression system assessed as remaining enzyme activity at 10 uM by kinome scan assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4145671,1,Scientific Literature,J Med Chem,2018,None,
CHEMBL3639508,,None,423.56,0,3.56,BDBM106890,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2nc(C3CCCCC3)ccc2N)C[C@@H](N)[C@@H]1O,IC50,'=',10,nM,8,,225911,UO_0000065,18.89,0.35,4.44,6.29,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1834199,BI 99990,None,391.47,0,4.15,EUB0000738,CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1,% Control,,100,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507280,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL4560241,BI 0153,None,430.47,0,2.14,EUB0000740,CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1,% Control,,100,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507276,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL1909371,GW694590A,None,453.89,1,5.18,GW694590A,COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl,Inhibition,'=',0.64,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3901622,,None,401.51,1,5.04,6l,C[C@@H](Nc1ncnc2oc(-c3ccc(NCCN(C)C)cc3)cc12)c1ccccc1,Inhibition,'=',-3,%,,,,UO_0000187,,,,,0,CHEMBL3857070,Inhibition of GST tagged recombinant full length human PIM2 expressed in baculovirus at 500 nM by Z'-LYTE assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3856204,1,Scientific Literature,Eur J Med Chem,2016,None,
CHEMBL1939876,BI 4394,None,446.46,0,3.37,EUB0000730,CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1,% Control,,96,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507281,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 100.0 nM
CHEMBL3325695,,None,219.25,0,3.26,18,c1ccc2c(c1)cnc1ccc3[nH]ncc3c12,Activity,'=',38,%,,,,UO_0000187,,,,,0,CHEMBL3369948,Inhibition of full-length human PIM2 using RSRHSSYPAGT as substrate assessed as residual kinase activity at 10 uM after 30 mins in presence of [gamma-33P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352653,1,Scientific Literature,Bioorg Med Chem,2014,None,
CHEMBL453737,,None,629.66,2,5.92,51,COc1cc2c(Oc3ccc(-c4cnc(Nc5ccc(F)cc5)n(C)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,,,,,,Not Determined,,,,,,0,CHEMBL970669,Inhibition of PIM2 kinase,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140082,1,Scientific Literature,J Med Chem,2008,None,
CHEMBL1084106,,None,367.84,0,3.61,22,O=C(Nc1cc2cc[nH]c(=O)c2cc1Cl)C(NC1CC1)c1ccccc1,Inhibition,'=',87,%,,,,UO_0000187,,,,,0,CHEMBL1118077,Inhibition of PIM2 at 3 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155525,1,Scientific Literature,Bioorg Med Chem Lett,2010,None,
CHEMBL3685740,,None,432.48,0,4.64,BDBM124903,N[C@@H]1CCCN(c2ccncc2Nc2cccc3cnc(-c4c(F)cccc4F)nc23)C1,IC50,'=',3600,nM,5.44,,254205,UO_0000065,12.59,0.23,0.8,6.81,0,CHEMBL3705221,ATP Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 ul per well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL279185,,None,1330.54,None,None,5,N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(N)=O,Activity,'=',38,%,,,,UO_0000187,,,,,0,CHEMBL856384,Percent residual activity,,,,,,,,,,,,,,,,,,,,,,
CHEMBL481491,,None,417.41,0,4.78,SID103905430,NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1C(F)(F)F,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1993584,,None,371.44,0,4.11,SID103904750,OC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1996831,,None,279.34,0,4.21,SID103904809,O=C(O)c1c2c(nc3ccccc13)C(=C1CCCC1)CC2,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3691913,,None,664.72,2,5.06,BDBM151935,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C4(F)CCOCC4)cc3F)n2)C[C@@H](N)[C@H]1OCCS(C)(=O)=O,IC50,'=',2.46,nM,8.61,,292190,UO_0000065,12.95,0.26,3.55,6.45,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4129737,,None,311.35,0,3.32,32; 35,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3651907,,None,468.52,1,5.74,BDBM106811,Cc1ccc(F)c(-c2nc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)CC(C)(C)C3)ccc2F)c1F,IC50,'=',5,nM,8.3,,225832,UO_0000065,17.72,0.33,2.56,10.26,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL14762,SELICICLIB,2,354.46,0,3.2,Roscovitine/CYC-202,CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1,Activity,'=',106,%,,,,UO_0000187,,,,,0,CHEMBL1061086,Percentage PIM2 activity remaining in the presence of 1uM inhibitor,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL50894,ALSTERPAULLONE,None,293.28,0,3.24,Alsterpaullone,O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1,Activity,'=',91,%,,,,UO_0000187,,,,,0,CHEMBL1061086,Percentage PIM2 activity remaining in the presence of 1uM inhibitor,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL1782505,,None,230.14,0,3.15,12,O=C(O)c1cc2cc(C(F)(F)F)ccc2o1,IC50,'=',13500,nM,4.87,,,UO_0000065,21.16,0.42,1.72,9.65,0,CHEMBL1786238,Inhibition of human Pim2 using 5-FAM-RSRHSSYPAGT-CONH2 as substrate after 90 mins by off-chip mobility shift method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1781944,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL418348,,None,493.56,0,4.27,SB-254169,CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1,Inhibition,'=',0.6,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL270164,GW607117X,None,394.43,1,5.14,GW607117X,Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1,Inhibition,'=',0.22,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1909413,,None,349.82,0,4.51,SB-610251-B,Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1,Inhibition,'=',-0.34,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1909382,GW759710A,None,359.79,0,3.2,GW759710A,Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1,Inhibition,'=',-0.05,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL405042,GW335962X,None,329.38,0,2.13,GW335962X,C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21,Inhibition,'=',0.75,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL188268,,None,307.32,0,1.51,SB-750140,NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1,Inhibition,'=',45.25,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL95207,,None,352.42,0,3,SB-220455,CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1,Inhibition,'=',6.09,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL4177361,,None,363.44,0,4.21,49,OC[C@@H](Nc1ncnc2sc(-c3ccc(O)cc3)cc12)c1ccccc1,Inhibition,'=',3,%,,,,UO_0000187,,,,,0,CHEMBL4156125,Inhibition of recombinant full length human GST-tagged PIM2 expressed in baculovirus expression system at 500 nM by Z-LYTE assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4152312,1,Scientific Literature,Eur J Med Chem,2018,None,
CHEMBL29197,,None,360.21,0,4.15,K00043,COc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OC,Thermal melting change,'=',0.9,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL3981095,,None,379.42,1,5.22,BDBM224988,c1ccc(-c2nnc(-c3ccc4[nH]cc(-c5cncc(C6CC6)n5)c4c3)o2)cc1,IC50,'>',1000,nM,,,393277,UO_0000065,,,,,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3963678,,None,374.43,0,3.22,BDBM224937,Cc1ccn(-c2cnc(-c3c[nH]c4ccc(-c5nnc(N)s5)cc34)cn2)n1,IC50,'=',2903.68,nM,5.54,,393220,UO_0000065,14.79,0.28,2.32,4.98,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL374453,GSK-299115A,None,415.28,0,4.39,GSK299115A,CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1,Inhibition,'=',-1.37,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1240921,,None,252.25,0,3.75,3b,O=Cc1c[nH]c2c1ccc1c3cc(F)ccc3[nH]c12,Activity,'=',21,%,,,,UO_0000187,,,,,0,CHEMBL1248949,Inhibition of human GST fused Pim2 expressed in Escherichia coli assessed as residual activity at 10 uM after 30 mins,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240519,1,Scientific Literature,Bioorg Med Chem,2010,None,
CHEMBL1990482,,None,238.25,0,1.72,SID103904688,NC(=O)c1cccc2[nH]c(-c3ccncc3)nc12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2006785,,None,361.25,1,5.64,SID103904745,Cc1ccc(C(=O)Nc2c(C#N)sc3ccc(Cl)c(Cl)c23)cc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1997617,,None,482.63,1,5.2,SID103904991,CN1CCN(C2CCC(n3cc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL554,LAPATINIB,4,581.07,2,6.14,SID103905567,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL13972,,None,440.48,0,4.73,SB-242721,N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1,Inhibition,'=',-0.01,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL573578,,None,331.42,0,3.91,NM-PP1,CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21,Activity,'=',104,%,,,,UO_0000187,,,,,0,CHEMBL1061149,Percentage PIM2 activity remaining in the presence of 10uM inhibitor,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL554,LAPATINIB,4,581.07,2,6.14,Lapatinib,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,Kd,'>',10000,nM,,,,UO_0000065,,,,,1,CHEMBL1061184,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150977,1,Scientific Literature,Nat Biotechnol,2008,None,
CHEMBL412142,LADUVIGLUSIB,-1,465.35,0,4.94,CT 99021,Cc1cnc(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)[nH]1,Activity,'=',63,%,,,,UO_0000187,,,,,0,CHEMBL1061086,Percentage PIM2 activity remaining in the presence of 1uM inhibitor,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL2348862,,None,383.45,0,1.95,10b,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3944819,,None,414.52,0,2.89,BDBM248930,c1cc(N2CCCNCC2)nc(-n2ncc3cnc(-c4cnn(CC5CC5)c4)cc32)c1,Ki,'=',18.8,nM,7.73,,434137,UO_0000065,18.64,0.34,4.84,10.07,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3976267,,None,400.49,0,2.9,BDBM248940,Cc1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CC(N)CCC3C)n2)n1,Ki,'=',0.204,nM,9.69,,434147,UO_0000065,24.2,0.44,6.79,9.82,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL407113,,None,356.41,0,2.23,SB-741905,NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1,Inhibition,'=',0.35,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL10,SB-203580,None,377.44,0,4.68,SB-203580,C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,Activity,'=',97,%,,,,UO_0000187,,,,,0,CHEMBL1061086,Percentage PIM2 activity remaining in the presence of 1uM inhibitor,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL939,GEFITINIB,4,446.91,0,4.28,Gefitinib,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1,Kd,'>',10000,nM,,,,UO_0000065,,,,,1,CHEMBL1061184,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150977,1,Scientific Literature,Nat Biotechnol,2008,None,
CHEMBL428496,WORTMANNIN,None,428.44,0,2.54,Wortmannin,COC[C@H]1OC(=O)c2coc3c2[C@@]1(C)C1=C(C3=O)[C@@H]2CCC(=O)[C@@]2(C)C[C@H]1OC(C)=O,Activity,'=',83,%,,,,UO_0000187,,,,,0,CHEMBL1061086,Percentage PIM2 activity remaining in the presence of 1uM inhibitor,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL296586,KENPAULLONE,None,327.18,0,4.09,Kenpaullone,O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1,Activity,'=',80,%,,,,UO_0000187,,,,,0,CHEMBL1061086,Percentage PIM2 activity remaining in the presence of 1uM inhibitor,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL97771,,None,373.41,1,5.18,Src-I1,COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC,Activity,'=',85,%,,,,UO_0000187,,,,,0,CHEMBL1061086,Percentage PIM2 activity remaining in the presence of 1uM inhibitor,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL1988437,,None,386.48,0,4.64,SID103905539,CNC(=O)c1ccccc1Sc1ccc2c(C=Cc3ccccn3)n[nH]c2c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1472492,,None,397.67,1,7.61,SID103905627,CCCCCCCCCCCCCCCC[n+]1ccn(Cc2ccccc2)c1C,Ki,'=',630.96,nM,6.2,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1980896,,None,473.78,1,5.54,SID103904856,Nc1ncnc2sc(Br)c(-c3ccc(NC(=O)Cc4cccc(Cl)c4)cc3)c12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL258721,,None,473.36,0,4.5,RGB-286147,CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12,Residual Activity,'=',103,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2364611,GALUNISERTIB,2,369.43,0,3.51,Galunisertib,Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL1965495,,None,234.26,0,2.81,SID103905398,Cc1n[nH]c2ncc(C#N)c(-c3ccccc3)c12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1236782,,None,442.49,0,2.93,46,COc1cc2nc(-c3cc(F)ccc3O)nc(N[C@@H]3CNC[C@H]3C(C)(C)O)c2cc1OC,Inhibition,'=',9,%,,,,UO_0000187,,,,,0,CHEMBL1664071,Inhibition of PIM2 at 1 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1649416,1,Scientific Literature,J Med Chem,2011,None,
CHEMBL1650131,,None,430.51,0,3.16,49,CC(C)(O)[C@@H]1CNC[C@H]1Nc1nc(-c2cc(-c3cc[nH]n3)ccc2O)nc2ccccc12,Inhibition,'=',93,%,,,,UO_0000187,,,,,0,CHEMBL1664071,Inhibition of PIM2 at 1 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1649416,1,Scientific Literature,J Med Chem,2011,None,
CHEMBL183906,,None,273.24,0,3.03,5,O=C1NC(=O)/C(=C/c2cccc(C(F)(F)F)c2)S1,Ki,'=',100,nM,7,,,UO_0000065,25.62,0.53,3.97,15.16,0,CHEMBL2184777,Competitive inhibition of PIM2 in presence of ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2176972,1,Scientific Literature,J Med Chem,2012,None,
CHEMBL3889658,,None,379.42,0,2,BDBM224822,Nc1nnc(-c2ccc3[nH]cc(-c4cnn(CCN5CCOCC5)c4)c3c2)o1,IC50,'=',272.78,nM,6.56,,393104,UO_0000065,17.3,0.32,4.56,5.91,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3703173,,None,303.32,0,2.46,BDBM149681,NC(=O)c1c(-c2ccccc2)[nH]c2c1ccc1cnc(N)nc12,IC50,'>',10000,nM,,,288339,UO_0000065,,,,,0,CHEMBL3707582,Kinase Inhibition Assay: The buffer for PIM-2 assay was composed of HEPES 50 mM,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4564973,,None,544.64,1,4.2,50,O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1,Inhibition,'=',100,%,,,,UO_0000187,,,,,0,CHEMBL4389896,Inhibition of wild-type human partial length PIM2 (M1 to E291 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4387741,1,Scientific Literature,Bioorg Med Chem,2019,None,
CHEMBL590109,,None,425.52,0,4.4,SID103904961,NCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1984038,,None,545.62,2,5.73,SID103904721,COc1cc(-c2ccc3c(c2)NC(=O)c2ccc(-c4ccccc4NS(C)(=O)=O)cc2N3)cc(OC)c1OC,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1986781,,None,420.45,0,3.61,SID103904423,CC(=O)N1CCC(Nc2nccc(-c3c(-c4ccc(F)cc4)nc4occn34)n2)CC1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3651939,,None,438.48,0,4.61,BDBM106843,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2nc(-c3cc(O)ccc3F)ccc2F)C1,IC50,'=',6,nM,8.22,,225864,UO_0000065,18.75,0.35,3.61,8.13,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1968590,,None,380.5,0,4.22,SID103905091,CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4sc(C)nc4c3)csc12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3775317,,None,401.47,0,2.76,31,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1,Activity,'=',-8,%,,,,UO_0000187,,,,,0,CHEMBL3777504,Inhibition of N-terminal His6-tagged recombinant human PIM2 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3774357,1,Scientific Literature,Bioorg Med Chem Lett,2016,CHEMBL3308860,
CHEMBL526133,,None,288.31,0,2.98,SID103904527,O=c1nc(-c2ccc3[nH]ncc3c2)cc(-c2ccccc2)[nH]1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3651966,,None,440.47,1,5.04,8; PIM447,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C1,Ki,'=',0.018,nM,10.74,,,UO_0000065,24.39,0.46,5.7,13.28,0,CHEMBL3750380,Inhibition of PIM2 kinase (unknown origin) using Biotin-AGAGRSRHSSYPAGT-OH as substrate after 2 hrs by alphascreen assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3745712,1,Scientific Literature,J Med Chem,2015,None,
CHEMBL1970879,,None,621.75,1,4.48,SID103905316,COc1cc(-c2nn(C3CCC(N4CCN(C(C)=O)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3953990,,None,363.45,0,2.35,BDBM248878,c1cc(N2CCNCC2)nc(-n2ncc3cnc(-c4cncs4)cc32)c1,Ki,'=',4.03,nM,8.39,,434085,UO_0000065,23.1,0.44,6.04,11.7,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL382590,ANILINOQUINAZOLINE1,None,400.44,0,4.64,K00590a,COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC,Thermal melting change,'=',0.3,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL1972119,,None,417.39,0,4.13,SID103904895,O=C(Nc1cccc(N2CCOCC2)n1)Nc1ccnc2c(C(F)(F)F)cccc12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL271381,,None,453.3,1,5.49,SID103904335,COc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)noc12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1980144,,None,418.48,0,4.48,SID103904705,Cc1ccccc1NC(=O)Nc1ccc(NC(=O)c2csc3ncnc(N)c23)cc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL468280,,None,282.66,0,2.25,SID103905547,CCn1c2cc(Cl)c(F)cc2c(=O)c2c(=O)o[nH]c21,Ki,'=',199.53,nM,6.7,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1969843,,None,283.34,0,2.25,SID103904517,c1cc2[nH]ncc2cc1-c1cn(CC2CCOCC2)nn1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1974870,,None,392.89,0,4.54,SID103904479,Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(Cl)c4)c3)cc12,Ki,'=',10,nM,8,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL316264,,None,333.34,1,5.08,SID103905184,Fc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL260092,,None,441.42,0,4.66,SID103904742,Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc1)CCN2,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1985074,,None,278.76,0,2.9,SID103905287,CSc1ccc2nc3c(c(Cl)c2c1)CCNC3=O,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL535,SUNITINIB,4,398.48,0,3.33,Sunitinib,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,Kd,'>',10000,nM,,,,UO_0000065,,,,,1,CHEMBL1061184,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150977,1,Scientific Literature,Nat Biotechnol,2008,None,
CHEMBL1975787,,None,290.29,0,3.34,SID103905044,NC(=O)c1cc2c(-c3ccc(F)cc3F)cncc2s1,Ki,'>',1258.93,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL56543,,None,294.31,0,2.32,Tyrphostin_B42,N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1,Residual Activity,'=',96,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1363184,,None,306.37,0,2.87,LY-303511,O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12,Residual Activity,'=',122,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL440084,SB-431542,None,384.4,0,3.63,SB-431542,NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1061184,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150977,1,Scientific Literature,Nat Biotechnol,2008,None,
CHEMBL1682558,,None,391.45,0,3.56,SID103904550,Fc1ccc(-c2ncn(CCN3CCOCC3)c2-c2ccc3[nH]ncc3c2)cc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL484390,,None,457.58,1,5.5,SID103905078,CCCCn1c(NC(=O)c2ccc(C#N)cc2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1950359,,None,619.75,2,5.86,13,CN(C)c1cccc2c(S(=O)(=O)NCc3cn(CCCCn4c5ccccc5c5ccc6c(C=O)c[nH]c6c54)nn3)cccc12,Activity,'=',66,%,,,,UO_0000187,,,,,0,CHEMBL1955501,Inhibition of human recombinant PIM2 expressed in Escherichia coli assessed as residual activity using RSRHSSYPAGT as substrate at 10 uM after 30 mins,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1949527,1,Scientific Literature,Eur J Med Chem,2012,None,
CHEMBL3691959,,None,528.54,1,3.96,BDBM151981,COC(=O)N[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)c(F)cc2N)C[C@@H]1C,IC50,'=',2.15,nM,8.67,,292236,UO_0000065,16.4,0.31,4.71,5.97,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4130160,,None,453.51,1,5.7,34,CN(C)CCCN(C)c1cncc(-c2ccc3[nH]cc(-c4ccc(C(F)(F)F)cc4)c3c2)n1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4118246,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL2397524,,None,282.26,0,3.11,15b,COc1ccc2[nH]c3c([N+](=O)[O-])cc4[nH]ncc4c3c2c1,Activity,'=',54,%,,,,UO_0000187,,,,,0,CHEMBL2401343,Inhibition of human PIM2 assessed as residual activity using RSRHSSYPAGT as substrate at 1 uM after 30 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2396576,1,Scientific Literature,Bioorg Med Chem,2013,None,
CHEMBL2218940,,None,335.35,0,4.23,SL327,N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F,Residual Activity,'=',130,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4060711,,None,404.47,0,2.9,3,COc1ccc2c(c1CN1CCNCC1)O/C(=C\c1c[nH]c3nc(C)ccc13)C2=O,IC50,'=',300,nM,6.52,,,UO_0000065,16.13,0.3,3.62,8.21,0,CHEMBL3997632,Inhibition of full length recombinant human N-terminal GST-tagged PIM2 (1 to 311 residues) expressed in baculovirus infected sf21 cells using S6K2 peptide as substrate by electrophoretic mobility shift assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3994673,1,Scientific Literature,ACS Med Chem Lett,2017,None,
CHEMBL223360,LINIFANIB,3,375.41,0,4.9,ABT-869,Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1,Kd,'>',10000,nM,,,,UO_0000065,,,,,1,CHEMBL1061184,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150977,1,Scientific Literature,Nat Biotechnol,2008,None,
CHEMBL296468,BMS-387032,1,380.54,0,3.66,BMS-387032/SNS-032,CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1,Kd,'>',10000,nM,,,,UO_0000065,,,,,1,CHEMBL1061184,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150977,1,Scientific Literature,Nat Biotechnol,2008,None,
CHEMBL3687459,,None,507.52,1,4.49,BDBM151855,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1n1cncn1,IC50,'=',1.2,nM,8.92,,292111,UO_0000065,17.58,0.33,4.43,7.99,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1909383,GW784307A,None,494.99,0,2.56,GW784307A,COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl,Inhibition,'=',0.17,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1909414,,None,508.02,0,4.87,SB-590885-AAD,CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O,Inhibition,'=',0.05,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL194062,GW572399X,None,315.35,0,2.73,GW572399X,NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1,Inhibition,'=',-0.58,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL4060711,,None,404.47,0,2.9,3,COc1ccc2c(c1CN1CCNCC1)O/C(=C\c1c[nH]c3nc(C)ccc13)C2=O,Inhibition,'=',25,%,,,,UO_0000187,,,,,0,CHEMBL3997633,Inhibition of full length recombinant human N-terminal GST-tagged PIM2 (1 to 311 residues) expressed in baculovirus infected sf21 cells at 200 nM using S6K2 peptide as substrate by electrophoretic mobility shift assay relative to control,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3994673,1,Scientific Literature,ACS Med Chem Lett,2017,None,
CHEMBL189459,GW833373X,None,396.43,1,5.04,GW833373X,Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1,Inhibition,'=',-0.3,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL119385,NEFLAMAPIMOD,2,436.27,1,5.49,VX-745,O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl,Kd,'>',10000,nM,,,,UO_0000065,,,,,1,CHEMBL1061184,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150977,1,Scientific Literature,Nat Biotechnol,2008,None,
CHEMBL124660,TANDUTINIB,2,562.72,2,5.03,MLN-518,COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1,Kd,'>',10000,nM,,,,UO_0000065,,,,,1,CHEMBL1244923,Binding affinity to PIM2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240346,1,Scientific Literature,Blood,2009,None,
CHEMBL3427172,,None,294.36,0,2.04,4,COC(=O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1,Activity,'=',83,%,,,,UO_0000187,,,,,0,CHEMBL3427823,Inhibition of PIM2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3425453,1,Scientific Literature,Eur J Med Chem,2015,None,
CHEMBL3427176,,None,308.38,0,2.34,8,COC(=O)[C@@H]1CSC(c2nc3ccc(OC)cc3s2)=N1,Activity,'=',94,%,,,,UO_0000187,,,,,0,CHEMBL3427823,Inhibition of PIM2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3425453,1,Scientific Literature,Eur J Med Chem,2015,None,
CHEMBL3687495,,None,509.53,1,4.95,BDBM151891,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1OCCC#N,IC50,'=',1.13,nM,8.95,,292147,UO_0000065,17.56,0.33,4,7.85,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL558752,RAF-265,2,518.42,2,6.93,CHIR-265/RAF-265,Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21,Kd,'>',10000,nM,,,,UO_0000065,,,,,1,CHEMBL1061184,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150977,1,Scientific Literature,Nat Biotechnol,2008,None,
CHEMBL278315,GELDANAMYCIN,2,560.64,1,2.41,K00074,COC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,Thermal melting change,'=',-0.1,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL1684654,,None,331.42,0,3.79,11o,Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1,Inhibition,'=',99,%,,,,UO_0000187,,,,,0,CHEMBL1685852,Inhibition of Pim-2 at 0.1 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1681705,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL417804,,None,445.5,0,4.87,SB-251527,COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1,Inhibition,'=',0.22,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL4457634,,None,482.95,0,3.33,49,CN1CCOc2c1cnn1c(-c3ccc4cc(Cl)cc(NCC5(F)CCNCC5)c4n3)nnc21,IC50,'=',1270,nM,5.9,,,UO_0000065,12.21,0.24,2.57,6.37,0,CHEMBL4340984,Inhibition of His tagged human recombinant PIM2 using PIM tide (ARKRRRHPSGPPTA) as substrate incubated for 1 hr by fluorescence based assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4340512,1,Scientific Literature,Eur J Med Chem,2019,None,
CHEMBL427159,GW827396X,None,430.42,0,4.88,GW827396X,COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1,Inhibition,'=',1.57,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3945513,,None,327.75,0,3.61,BDBM249078,Cn1ncc(-c2cc3c(cn2)cnn3-c2ccccc2F)c1Cl,Ki,'=',2200,nM,5.66,,434282,UO_0000065,17.26,0.34,2.05,11.66,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL477978,GW782907X,None,390.53,0,4.86,GW782907X,Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1,Inhibition,'=',1.02,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL2000832,,None,483.5,1,5.45,SID103904711,COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCc4cccc(F)c4)cc2NC3=O)ccc1O,Ki,'=',316.23,nM,6.5,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL4129044,,None,423.44,0,4.72,29,FC(F)(F)c1ccc(-c2c[nH]c3ccc(-c4cncc(N5CCNCC5)n4)cc23)cc1,IC50,'=',2120,nM,5.67,,,UO_0000065,13.4,0.25,0.95,9.98,0,CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4118246,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL2001539,,None,176.24,0,2.24,SID103905580,c1cc2c(s1)CCc1cn[nH]c1-2,Ki,'>',15848.93,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3634789,,None,198.23,0,2.26,7,Cc1n[nH]c2ccc(-c3cn[nH]c3)cc12,Ki,'=',2700,nM,5.57,,,UO_0000065,28.09,0.51,3.31,9.71,0,CHEMBL3636741,Inhibition of Pim2 (unknown origin) using 5FAM-ARKRRRHPSGPPTA as substrate after 90 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632547,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL44,GENISTEIN,2,270.24,0,2.58,K00046,O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12,Thermal melting change,'=',3.1,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL3330255,,None,406.47,0,3.06,32,NS(=O)(=O)c1cccc(-c2n[nH]c3ccc(NC(=O)Cc4ccccc4)cc23)c1,Inhibition,'=',20,%,,,,UO_0000187,,,,,0,CHEMBL3369104,Inhibition of human Pim-2 at 1 uM by radiometric Assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352261,1,Scientific Literature,Bioorg Med Chem,2014,None,
CHEMBL3634784,,None,196.21,0,2.02,2,c1cncc(-c2cc3cn[nH]c3cn2)c1,Ki,'=',6000,nM,5.22,,,UO_0000065,26.61,0.48,3.2,9.59,0,CHEMBL3636741,Inhibition of Pim2 (unknown origin) using 5FAM-ARKRRRHPSGPPTA as substrate after 90 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632547,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL1908391,MASITINIB,4,498.66,1,5.26,AB-1010,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL3651901,,None,454.48,0,3.58,BDBM106805,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3cc(O)ccc3F)n2)C[C@@H](N)[C@@H]1O,IC50,'=',20,nM,7.7,,225826,UO_0000065,16.94,0.32,4.12,6.34,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3687436,,None,497.52,0,4.16,BDBM151831,CC(=O)N[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H]1C,IC50,'=',25.04,nM,7.6,,292087,UO_0000065,15.28,0.29,3.44,6.91,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3691953,,None,495.56,0,4.41,BDBM151975,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1n1ccnn1,IC50,'=',65.66,nM,7.18,,292230,UO_0000065,14.49,0.28,2.77,6.44,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3775393,,None,278.38,0,2.79,16,O=C1NC(=S)S/C1=C\c1ccc2ncsc2c1,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL3778661,Inhibition of full length recombinant human GST-tagged PIM2 expressed in baculovirus expression system at 5 uM by lantha screen kinase binding assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3774321,1,Scientific Literature,Eur J Med Chem,2016,None,
CHEMBL3651918,,None,471.48,0,3.27,BDBM106822,Cc1ccc(F)c(-c2nc(C(=O)Nc3cnccc3N3C[C@@H](N)[C@H](O)[C@@H](C)C3)ccc2F)c1F,IC50,'=',2,nM,8.7,,225843,UO_0000065,18.45,0.35,5.43,8.33,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3687532,,None,533.55,2,5.5,BDBM151929,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1Oc1ccccn1,IC50,'=',1.53,nM,8.81,,292184,UO_0000065,16.52,0.31,3.32,8.56,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2089001,,None,250.26,0,3.5,29,O=C(O)c1cc2c3ccccc3[nH]c2c2[nH]ccc12,IC50,,,,,,Not Determined,,,,,,0,CHEMBL2090488,Inhibition of human Pim2 using RSRHSSYPAGT as substrate,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2086229,1,Scientific Literature,Eur J Med Chem,2012,None,
CHEMBL196022,GW642125X,None,241.25,0,2.48,GW642125X,COc1ccc(-c2coc3ncnc(N)c23)cc1,Inhibition,'=',1.01,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL2443138,,None,452.51,0,3.44,30,CN1CCC(NC(=O)c2cc(-c3c(O)cc(O)cc3Oc3ccc(N(C)C)cc3)on2)CC1,IC50,'>',10,nM,,,,UO_0000065,,,,,0,CHEMBL2443982,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2439976,1,Scientific Literature,Bioorg Med Chem,2013,None,
CHEMBL385426,GW450241X,None,294.4,0,3.74,GW450241X,CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1,Inhibition,'=',-0.07,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL4476426,,None,437.09,1,5.35,5,COc1cc(Br)cc2[nH]cc(-c3cnc(-c4cc(Br)c[nH]4)o3)c12,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL4338190,Inhibition of PIM2 (unknown origin) by [33P]-ATP filter binding kinase assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4334516,1,Scientific Literature,J Med Chem,2019,None,
CHEMBL3946175,,None,418.45,0,4.71,BDBM192639,NC1C=C(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)CCC1,IC50,'=',189,nM,6.72,,344680,UO_0000065,16.07,0.3,2.01,8.29,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3966346,,None,580.66,2,5.27,13,O=C1c2c(F)cc(C3CC3)cc2OCCN1c1cccc(-c2ccnc3[nH]c(C4=CCN(C5COC5)CC4)cc23)c1CO,Activity,'=',1,%,,,,UO_0000187,,,,,0,CHEMBL4178311,Inhibition of recombinant human full length N-terminal GST-tagged PIM2 expressed in baculovirus infected Sf9 cells assessed as change in enzyme activity at 1 uM in presence of 1 uM ATP relative to control,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4177534,1,Scientific Literature,Bioorg Med Chem Lett,2017,None,
CHEMBL449471,,None,313.36,0,2.69,20,COCCCNc1cncc(-c2cccc(/C=C/C(=O)O)c2)n1,IC50,'=',480,nM,6.32,,,UO_0000065,20.16,0.38,3.63,7.49,0,CHEMBL960121,Inhibition of Pim2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153342,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL455255,,None,338.41,0,2.65,21,O=C(O)/C=C/c1cccc(-c2cncc(NCC3CCNCC3)n2)c1,IC50,'=',25,nM,7.6,,,UO_0000065,22.46,0.42,4.95,8.72,0,CHEMBL960121,Inhibition of Pim2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153342,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL1979516,,None,449.51,1,5.08,SID103904336,CCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)csc12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL493937,,None,338.41,0,2.38,1,CN1CCCN(c2cncc(-c3cccc(/C=C/C(=O)O)c3)n2)CC1,IC50,'=',4000,nM,5.4,,,UO_0000065,15.95,0.29,3.02,7.76,0,CHEMBL960095,Inhibition of GST-tagged Pim2 preincubated for 30 mins before addition of ATP measured after 30 mins by scintillation counting-reversal assay in presence of 50 uM [gamma33P]ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153342,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL3687486,,None,470.5,0,4.67,BDBM151882,CO[C@H]1[C@H](C)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H]1N,IC50,'=',6600,nM,5.18,,292138,UO_0000065,11.01,0.21,0.51,5.75,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2325895,,None,380.45,0,1.96,3q,CC(C)(C)[C@@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(=O)N1CC(C#N)C1,Inhibition,'=',-7,%,,,,UO_0000187,,,,,0,CHEMBL2329065,Inhibition of PIM2 (unknown origin) at 1 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2321829,1,Scientific Literature,J Med Chem,2013,None,
CHEMBL3676304,,None,482.59,0,3.66,BDBM131774,CC(C)NC(=O)c1ccc(F)c(-c2nc(C(=O)Nc3cnccc3N3CCC[C@H](N)C3)cs2)c1,IC50,'=',83.8,nM,7.08,,264007,UO_0000065,14.66,0.28,3.42,6.25,0,CHEMBL3706072,Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4459538,,None,477.54,0,2.6,23,CO[C@H]1C[C@H](N)CCN(c2c(NC(=O)c3nc(-c4c(F)cccc4F)sc3N)cnn2C)C1,Ki,'=',0.04,nM,10.4,,,UO_0000065,21.77,0.43,7.8,8.36,0,CHEMBL4317000,Inhibition of recombinant human PIM2 using FAM-pimtide as substrate after 90 mins by Z-LYTE assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4316591,1,Scientific Literature,J Med Chem,2019,None,
CHEMBL405759,,None,318.34,0,3.71,TWS119,Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1,Residual Activity,'=',118,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL259389,QUINOXALINE1,None,185.19,0,1.09,Cdk1_5_Inhibitor,Nc1n[nH]c2nc3ccccc3nc12,Residual Activity,'=',130,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1982135,,None,401.5,0,4.99,SID103904356,Cc1ccccc1NC(=O)Nc1ccc2c(c1)CCc1sc3ncnc(N)c3c1-2,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1915434,,None,368.4,0,4.32,14g,COc1cccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3cnccc23)c1,IC50,'=',26,nM,7.58,,,UO_0000065,20.59,0.37,3.27,8.56,0,CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914433,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL1976732,,None,410.38,0,3.29,SID103905067,CC(C)(O)Cc1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1090356,,None,587.71,2,6.28,SID103904417,O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL210618,,None,356.38,0,2.13,6o,CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N,Ki,'>',1400,nM,,,,UO_0000065,,,,,0,CHEMBL863188,Inhibition of Pim2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148638,1,Scientific Literature,J Med Chem,2006,None,
CHEMBL10,SB-203580,None,377.44,0,4.68,SB-203580,C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL3264253,,None,375.44,0,2.6,7b,CN(C)CCOc1cncc(-c2ccc3[nH]cc(-c4ccnc(N)n4)c3c2)n1,IC50,'=',380,nM,6.42,,,UO_0000065,17.1,0.31,3.82,6.07,0,CHEMBL3269287,Inhibition of PIM2 kinase (unknown origin) using 5-FAM-labeled BAD peptide as substrate after 90 mins by fluorescence polarization assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3259764,1,Scientific Literature,Bioorg Med Chem Lett,2014,None,
CHEMBL14762,SELICICLIB,2,354.46,0,3.2,K00020,CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1,Thermal melting change,'=',0.3,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL258844,,None,551.65,2,6.32,Akti_1_2,O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1,Residual Activity,'=',98,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL302449,GO-6976,None,378.44,0,4.6,Go-6976,Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O,Residual Activity,'=',40,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3297765,,None,496.63,0,2.68,15d,CN1CCN(C[C@@H](NC(=O)C[C@H]2CNC(=O)c3cc(-c4ccnc(F)c4)cn32)C2CCCCC2)CC1,IC50,'=',95,nM,7.02,,,UO_0000065,14.14,0.27,4.34,8.51,0,CHEMBL3300844,Inhibition of human PIM2 using ARK-RERTYSFGHHA as substrate incubated for 60 mins prior to substrate addition by topcount scintillation counting analysis in presence of [P33gamma]-ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3297733,1,Scientific Literature,Bioorg Med Chem,2013,None,
CHEMBL3297768,,None,443.98,0,2.24,16c,C[C@@H](CN1CCN(C)CC1)NC(=O)C[C@H]1CNC(=O)c2cc(-c3cccc(Cl)c3)cn21,IC50,'>',5000,nM,,,,UO_0000065,,,,,0,CHEMBL3300844,Inhibition of human PIM2 using ARK-RERTYSFGHHA as substrate incubated for 60 mins prior to substrate addition by topcount scintillation counting analysis in presence of [P33gamma]-ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3297733,1,Scientific Literature,Bioorg Med Chem,2013,None,
CHEMBL3264252,,None,332.37,0,3.06,7a,CCOc1cncc(-c2ccc3[nH]cc(-c4ccnc(N)n4)c3c2)n1,IC50,'=',740,nM,6.13,,,UO_0000065,18.45,0.33,3.07,5.98,0,CHEMBL3269287,Inhibition of PIM2 kinase (unknown origin) using 5-FAM-labeled BAD peptide as substrate after 90 mins by fluorescence polarization assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3259764,1,Scientific Literature,Bioorg Med Chem Lett,2014,None,
CHEMBL1915436,,None,362.4,0,4.29,14i,C#Cc1cccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3cnccc23)c1,IC50,'=',10,nM,8,,,UO_0000065,22.08,0.39,3.71,10.08,0,CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914433,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL410456,,None,398.42,0,3.68,D4476,NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1,Activity,'=',90,%,,,,UO_0000187,,,,,0,CHEMBL2433486,Inhibition of human PIM2 assessed as residual activity at 10 uM relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2429821,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL495030,,None,298.35,0,2,14,NCCCNc1cncc(-c2cccc(/C=C/C(=O)O)c2)n1,IC50,'=',27,nM,7.57,,,UO_0000065,25.37,0.47,5.57,7.48,0,CHEMBL960121,Inhibition of Pim2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153342,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL269985,GW701032X,None,413.48,0,4.96,GW701032X,COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1,Inhibition,'=',3.03,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1336,SORAFENIB,4,464.83,1,5.55,Sorafenib,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL200381,,None,404.84,1,5.04,Tpl2_Kinase_Inhibitor,N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1,Residual Activity,'=',84,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1231533,,None,285.23,0,2.33,AS-604850,O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1,Residual Activity,'=',10,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2218941,,None,398.22,0,3.51,Indirubin_6bromo_aceto,CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1,Residual Activity,'=',134,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL203644,,None,355.76,0,3.52,EGFR_ErbB_2_ErbB_4_Inhibitor,CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1,Residual Activity,'=',109,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL21156,,None,309.34,0,3.99,JAK_Inhibitor_I,CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1,Residual Activity,'=',16,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1945555,,None,268.1,0,2.72,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1996791,,None,359.17,0,1.49,SID103904789,Nc1ncnc2c1c(I)nn2C1CCC(O)CC1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3687466,,None,508.51,1,3.43,BDBM151862,C[C@H]1CN(c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1n1cncn1,IC50,'=',1.51,nM,8.82,,292118,UO_0000065,17.35,0.33,5.39,7.68,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3651935,,None,438.48,0,4.61,BDBM106839,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2nc(-c3ccc(O)cc3F)ccc2F)C1,IC50,'=',28,nM,7.55,,225860,UO_0000065,17.23,0.32,2.94,7.47,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1950358,,None,572.59,0,3.73,12,C[N+](C)(CCO)Cc1cn(CCCCn2c3ccccc3c3ccc4c(C=O)c[nH]c4c32)nn1.O=C([O-])C(F)(F)F,IC50,,,,,,Not Determined,,,,,,0,CHEMBL1955504,Inhibition of human recombinant PIM2 expressed in Escherichia coli using RSRHSSYPAGT as substrate after 30 mins,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1949527,1,Scientific Literature,Eur J Med Chem,2012,None,
CHEMBL398951,,None,415.5,0,3.41,SID103904813,N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCCCN4CCOCC4)cc2-3)cn1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2430323,,None,266.3,0,2.89,MRT00033659,CC(=O)Nc1cccc(-c2cnc3[nH]nc(C)c3c2)c1,Activity,'=',58.71,%,,,,UO_0000187,,,,,0,CHEMBL2433486,Inhibition of human PIM2 assessed as residual activity at 10 uM relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2429821,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL3818239,,None,493.61,0,5,1; CFI-401870,O=C(N[C@@H](c1ccccn1)C1CC1)c1ccc2[nH]nc(-c3ccc(N4C5CCC4CC(O)C5)cc3)c2c1,Inhibition,'=',4,%,,,,UO_0000187,,,,,0,CHEMBL3820354,Inhibition of full length recombinant human N-terminal GST-tagged PIM2 expressed in Escherichia coli at 1 uM by radiometric assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3817791,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL3652008,,None,440.45,0,2.85,BDBM106914,C[C@H]1CN(c2ccncc2NC(=O)c2ccc(F)c(-c3ccccc3F)n2)C[C@@H](O)[C@@H]1O,IC50,'=',3,nM,8.52,,225935,UO_0000065,19.35,0.36,5.67,8.65,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3687462,,None,541.57,2,5.03,BDBM151858,COC(=O)N(C)[C@@H]1[C@H](C)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C)cc3F)n2)C[C@@H]1N,IC50,'=',726.23,nM,6.14,,292114,UO_0000065,11.34,0.21,1.11,5.56,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL471901,,None,340.31,0,1.71,Syk_Inhibitor_II,NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1,Residual Activity,'=',95,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL266325,,None,346.39,0,4.59,D65476,CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1,Residual Activity,'=',110,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL75680,ALOISINE A,None,267.33,0,3.67,Aloisine_A,CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12,Residual Activity,'=',140,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3355989,,None,342.83,0,3.89,13b,Clc1cccc(-c2cnn3ccc(NCC4CCOCC4)nc23)c1,IC50,'=',1640,nM,5.79,,,UO_0000065,16.87,0.33,1.9,11.24,0,CHEMBL3375413,Inhibition of Pim2 (unknown origin) using luciferase-luciferin based ATP detection reagent by Kinase-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3351833,1,Scientific Literature,ACS Med Chem Lett,2015,None,
CHEMBL2048861,,None,289.36,0,1.42,10,O=C1NC(=O)/C(=C/c2ccccc2N2CCNCC2)S1,IC50,'=',180,nM,6.75,,,UO_0000065,23.31,0.46,5.32,10.98,0,CHEMBL2049740,Inhibition of human PIM2 using FITC-(AHX)RSRHSSYPAGT-COOH as substrate after 90 mins by mobility shift assay in presence of 50 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2046384,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL388978,STAUROSPORINE,None,466.54,0,4.35,Staurosporine,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,Kd,'=',1.9,nM,8.72,,,UO_0000065,18.69,0.34,4.37,12.56,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL7917,TYRPHOSTIN AG-1478,None,315.76,0,4.04,Tyrphostin AG-1478,COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC,Residual Activity,'=',95,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL449471,,None,313.36,0,2.69,20,COCCCNc1cncc(-c2cccc(/C=C/C(=O)O)c2)n1,IC50,'=',480,nM,6.32,,,UO_0000065,20.16,0.38,3.63,7.49,0,CHEMBL960129,Inhibition of Pim2 in presence of 1 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153342,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL477772,PAZOPANIB,4,437.53,0,3.14,Pazopanib,Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL2048873,,None,380.47,0,3,29,N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccncc2)C1,IC50,'=',19,nM,7.72,,,UO_0000065,20.29,0.39,4.72,8.74,0,CHEMBL2049740,Inhibition of human PIM2 using FITC-(AHX)RSRHSSYPAGT-COOH as substrate after 90 mins by mobility shift assay in presence of 50 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2046384,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL524901,GW683109X,None,339.4,0,1.32,GW683109X,c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1,Inhibition,'=',-1.06,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1910892,,None,370.46,0,4.01,3,Oc1ccc(-c2ccc3c(-c4ccc(N5CCNCC5)cc4)c[nH]c3n2)cc1,IC50,'=',283,nM,6.55,,,UO_0000065,17.68,0.32,2.54,10.2,0,CHEMBL1912526,Inhibition of PIM2 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1909629,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL4465866,,None,901.82,None,None,8a,CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,Kd,'=',15,nM,7.82,,,UO_0000065,8.68,None,None,None,0,CHEMBL4322740,Binding affinity to recombinant human full-length N-terminal GST-tagged PIM2 expressed in baculovirus expression system using S6K2 peptide as substrate incubated for 1 hr by TR-FRET assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4321812,1,Scientific Literature,Bioorg Med Chem Lett,2019,None,
CHEMBL3974958,,None,382.47,0,4.69,BDBM238482,C[C@H](Nc1ccc2cccc(-c3cc4c([nH]3)CCNC4=O)c2n1)c1ccccc1,IC50,'=',182,nM,6.74,,416220,UO_0000065,17.62,0.32,2.05,9.65,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3947727,,None,368.44,0,4.28,BDBM238378,CN(c1ccccc1)c1ccc2cccc(-c3cc4c([nH]3)CCNC4=O)c2n1,IC50,'=',6.8,nM,8.17,,416156,UO_0000065,22.17,0.4,3.89,13.38,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3944428,,None,407.83,1,5.1,BDBM238383,O=C1NCCc2[nH]c(-c3cccc4ccc(Oc5c(F)cccc5Cl)nc34)cc21,IC50,'=',8.6,nM,8.07,,416161,UO_0000065,19.78,0.38,2.97,12.04,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3973448,,None,296.72,0,3.12,BDBM238397,O=c1[nH]cnc2[nH]c(-c3cccc4ccc(Cl)nc34)cc12,IC50,'=',908,nM,6.04,,416171,UO_0000065,20.36,0.39,2.92,8.12,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1909405,GW618013A,None,554.57,0,4.98,GW618013A,CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O,Inhibition,'=',-3.76,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL4104431,,None,388.42,0,4.2,45,O=C1NC(=S)S/C1=C\c1csc(-c2ccc(OC(F)(F)F)cc2)n1,Delta Tm,'=',9.7,degrees C,,,,UO_0000027,,,,,0,CHEMBL4029682,Inhibition of recombinant PIM2 (unknown origin) assessed as change in melting temperature at 10 uM by SYPRO orange dye-based differential scanning fluorimetry,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4028814,1,Scientific Literature,Bioorg Med Chem,2017,None,
CHEMBL1782514,,None,352.39,0,3.27,22,N[C@H]1CC[C@@H](Nc2cncc(-c3ccc4oc(C(=O)O)cc4c3)n2)CC1,IC50,'=',110,nM,6.96,,,UO_0000065,19.75,0.37,3.69,6.09,0,CHEMBL1786238,Inhibition of human Pim2 using 5-FAM-RSRHSSYPAGT-CONH2 as substrate after 90 mins by off-chip mobility shift method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1781944,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL3981772,,None,343.35,0,3.05,BDBM224818,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(-n5cccn5)n4)c3c2)o1,IC50,'=',13.74,nM,7.86,,393100,UO_0000065,22.9,0.41,4.81,7.05,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL443563,GW627512B,None,326.35,0,4.11,GW627512B,COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC,Inhibition,'=',0.06,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3394061,,None,343.42,0,4.48,3,Nc1nnc(-c2ccc3[nH]cc(-c4cnc5ccccc5c4)c3c2)s1,IC50,'>',31600,nM,,,,UO_0000065,,,,,0,CHEMBL3395662,Inhibition of PIM2 in human U2OS cells assessed as phosphorylation of BAD,B,BAO_0000219,cell-based format,Homo sapiens,None,None,U2OS,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3393014,1,Scientific Literature,Bioorg Med Chem Lett,2015,CHEMBL3307757,
CHEMBL1909355,GW461104A,None,528.46,0,4.42,GW461104A,CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl,Inhibition,'=',-0.24,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3103871,,None,345.43,0,2.74,2a,CC(=O)Nc1nc(C(=O)Nc2ccncc2N2CCCCC2)cs1,Ki,'=',6300,nM,5.2,,,UO_0000065,15.06,0.3,2.46,5.96,0,CHEMBL3106178,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3102815,1,Scientific Literature,ACS Med Chem Lett,2013,None,
CHEMBL2003524,,None,286.29,0,1.7,SID103905551,CCc1nc2c(c3cc(OC)c(OC)cc13)C(=O)NC2=O,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1995172,,None,235.08,0,2.74,SID103905581,Brc1ccc2c(c1)-c1[nH]ncc1C2,Ki,'>',7943.28,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2001547,,None,424.46,0,3.88,SID103904774,CCc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3703177,,None,461.57,0,2.49,BDBM149685,COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)-c1c(c(C(N)=O)c(C)n1C)CC2,IC50,'>',5000,nM,,,288343,UO_0000065,,,,,0,CHEMBL3707582,Kinase Inhibition Assay: The buffer for PIM-2 assay was composed of HEPES 50 mM,,,,,,,,,,,,,,,,,,,,,,
CHEMBL517507,GW782912X,None,362.47,0,4.08,GW782912X,Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1,Inhibition,'=',-0.13,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1909410,GSK-259178A,None,728.7,2,5.27,GSK259178A,O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1,Inhibition,'=',0.17,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL608154,,None,366.81,0,4.33,MLN-120B,COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL3687481,,None,487.58,0,4.56,BDBM151877,CCO[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)sc2N)C[C@@H]1C,IC50,'=',1.7,nM,8.77,,292133,UO_0000065,17.99,0.35,4.21,7.55,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3634768,,None,359.44,0,2.89,33,Cn1cc(-c2cc3c(-c4cccc(C5CCNCC5)n4)n[nH]c3cn2)cn1,Ki,'=',2.2,nM,8.66,,,UO_0000065,24.09,0.44,5.77,10.27,0,CHEMBL3636741,Inhibition of Pim2 (unknown origin) using 5FAM-ARKRRRHPSGPPTA as substrate after 90 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632547,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL405759,,None,318.34,0,3.71,K00245,Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1,Thermal melting change,'=',0.8,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL408019,,None,294.31,0,2.68,13,O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1,Kd,'=',16,nM,7.8,,,UO_0000065,26.49,0.48,5.12,8.58,0,CHEMBL988943,Binding affinity to human PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1151712,1,Scientific Literature,J Med Chem,2008,None,
CHEMBL3355545,,None,406.41,0,4.4,10,C[C@]1(O)CC[C@H](Nc2ccn3ncc(-c4cccc(OC(F)(F)F)c4)c3n2)CC1,IC50,'=',2040,nM,5.69,,,UO_0000065,14,0.27,1.29,7.94,0,CHEMBL3375413,Inhibition of Pim2 (unknown origin) using luciferase-luciferin based ATP detection reagent by Kinase-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3351833,1,Scientific Literature,ACS Med Chem Lett,2015,None,
CHEMBL2087480,,None,487.59,1,-0.01,20,Cc1nc(N)ncc1-c1cn2cc(CN3CCN(S(C)(=O)=O)CC3)nc2c(N2CCOCC2)n1,Inhibition,'<',30,%,,,,UO_0000187,,,,,0,CHEMBL2092411,Inhibition of PIM2 at 1 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2086238,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL2017350,,None,373.44,0,4.99,13r,COc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2sccc12,IC50,'=',49,nM,7.31,,,UO_0000065,19.57,0.37,2.32,9.65,0,CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016532,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL553,ERLOTINIB,4,393.44,0,3.41,SID103905339,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL407534,,None,208.21,0,0.77,K00021,O=C(O)/C=C/c1cc(CO)ccc1CO,Thermal melting change,'=',1.6,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL1994830,,None,344.78,0,4.37,SID103905372,Nc1nnc(-c2cc3c(Oc4ccc(Cl)cc4)cncc3s2)o1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2006237,,None,393.5,0,1.77,SID103904687,CN1CCN(CCCNc2cccc(-c3nc4c(C(N)=O)cccc4[nH]3)n2)CC1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3298818,,None,433.47,0,4.55,13c,O=C(CC1CNC(=O)c2cc(-c3cccc(C(F)(F)F)c3)cn21)NCC1CCCCC1,IC50,'>',5000,nM,,,,UO_0000065,,,,,0,CHEMBL3300844,Inhibition of human PIM2 using ARK-RERTYSFGHHA as substrate incubated for 60 mins prior to substrate addition by topcount scintillation counting analysis in presence of [P33gamma]-ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3297733,1,Scientific Literature,Bioorg Med Chem,2013,None,
CHEMBL3899005,,None,355.4,0,3.65,BDBM238538,O=C1NCCc2[nH]c(-c3cccc4ncc(Nc5ccccc5)nc34)cc21,IC50,'=',2.8,nM,8.55,,416261,UO_0000065,24.07,0.43,4.9,10.34,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL191105,,None,287.33,0,1.02,SB-751399,CN(C)CCCn1c(-c2nonc2N)nc2cnccc21,Inhibition,'=',-0.04,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3986342,,None,369.43,0,3.84,BDBM238480,Nc1cccc(Nc2ccc3cccc(-c4cc5c([nH]4)CCNC5=O)c3n2)c1,IC50,'=',2.9,nM,8.54,,416218,UO_0000065,23.11,0.42,4.7,8.91,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL215152,AZD-1152-HQPA,None,507.57,1,3.5,AZD-1152 HQPA,CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1,Kd,'>',10000,nM,,,,UO_0000065,,,,,1,CHEMBL1061184,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150977,1,Scientific Literature,Nat Biotechnol,2008,None,
CHEMBL483321,CP-724714,2,469.55,0,4.95,CP-724714,COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1061184,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150977,1,Scientific Literature,Nat Biotechnol,2008,None,
CHEMBL404941,,None,311.34,0,3.21,K00030,COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1,Thermal melting change,'=',0.5,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL2397600,,None,286.68,0,3.76,6c,O=[N+]([O-])c1cc2cn[nH]c2c2c1[nH]c1ccc(Cl)cc12,Activity,'=',93,%,,,,UO_0000187,,,,,0,CHEMBL2401344,Inhibition of human PIM2 assessed as residual activity using RSRHSSYPAGT as substrate at 10 uM after 30 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2396576,1,Scientific Literature,Bioorg Med Chem,2013,None,
CHEMBL3394073,,None,379.45,0,2.56,22,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(N5CCOCC5)n4)c3c2)s1,IC50,'=',12,nM,7.92,,,UO_0000065,20.87,0.4,5.36,7.48,1,CHEMBL3395659,Inhibition of full length recombinant PIM2 (unknown origin) using biotinylated-BAD peptide as substrate assessed as phosphorylation at serine 112 after 90 mins by HTRF method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3393014,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL3687536,,None,572.6,2,5.64,BDBM151933,CO[C@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C4(F)CCOCC4)cc3F)n2)C[C@@H]1C,IC50,'=',1.98,nM,8.7,,292188,UO_0000065,15.2,0.29,3.06,8.76,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3687537,,None,626.76,1,3.53,BDBM151934,CC(C)NC(=O)c1ccc(F)c(-c2ccc(N)c(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@@H](OCCS(C)(=O)=O)[C@@H](C)C3)n2)c1,IC50,'=',1.21,nM,8.92,,292189,UO_0000065,14.23,0.28,5.39,4.97,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3634761,,None,374.45,0,2.31,40,CCn1cc(-c2cc3c(-c4cccc(N5CCNCC5)n4)n[nH]c3cn2)cn1,Ki,'=',0.473,nM,9.32,,,UO_0000065,24.9,0.45,7.02,10.65,0,CHEMBL3636741,Inhibition of Pim2 (unknown origin) using 5FAM-ARKRRRHPSGPPTA as substrate after 90 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632547,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL3687415,,None,527.55,1,3.79,BDBM151808,COCC(=O)N[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H]1C,IC50,'=',30.07,nM,7.52,,292064,UO_0000065,14.26,0.27,3.73,6.31,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3651961,,None,457.46,0,3.35,BDBM106865,Nc1cc(F)c(-c2c(F)cccc2F)nc1C(=O)Nc1cnccc1[C@@H]1CC[C@H](O)[C@H](N)C1,IC50,'=',4,nM,8.4,,225886,UO_0000065,18.36,0.35,5.05,6.6,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3355987,,None,384.91,0,4.79,11b,CC(C)(O)[C@H]1CC[C@H](Nc2ccn3ncc(-c4cccc(Cl)c4)c3n2)CC1,IC50,'=',228,nM,6.64,,,UO_0000065,17.26,0.34,1.85,10.64,0,CHEMBL3375413,Inhibition of Pim2 (unknown origin) using luciferase-luciferin based ATP detection reagent by Kinase-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3351833,1,Scientific Literature,ACS Med Chem Lett,2015,None,
CHEMBL3355557,,None,341.85,0,3.73,7b,N[C@H]1CC[C@H](Nc2ccn3ncc(-c4cccc(Cl)c4)c3n2)CC1,IC50,'=',732,nM,6.13,,,UO_0000065,17.95,0.35,2.41,8.99,0,CHEMBL3375413,Inhibition of Pim2 (unknown origin) using luciferase-luciferin based ATP detection reagent by Kinase-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3351833,1,Scientific Literature,ACS Med Chem Lett,2015,None,
CHEMBL1230122,R-1487,1,388.37,0,2.99,SID103905625,Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1993722,,None,405.39,0,4.29,SID103904859,Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cc(C(=O)O)ccc4F)cc3)c12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1996780,,None,400.43,0,4.24,SID103905358,CCOC(=O)c1cn(-c2ccc(O)cc2C)c2cc(-c3ccncc3)ccc2c1=O,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL259084,MLN-8054,1,476.87,1,5.87,MLN-8054,O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1,Kd,'>',10000,nM,,,,UO_0000065,,,,,1,CHEMBL1061184,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150977,1,Scientific Literature,Nat Biotechnol,2008,None,
CHEMBL3660088,,None,363.4,0,3.02,BDBM104217,FC1CNCCC1Oc1cccc2ccc(-c3nnc4ccccn34)nc12,IC50,'=',481.8,nM,6.32,,222629,UO_0000065,17.38,0.32,3.3,9.82,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3103857,,None,313.37,0,0.63,3f,Nc1nccnc1C(=O)Nc1cnccc1N1CCC[C@H](N)C1,Ki,'=',70,nM,7.16,,,UO_0000065,22.83,0.42,6.52,5.81,0,CHEMBL3106178,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3102815,1,Scientific Literature,ACS Med Chem Lett,2013,None,
CHEMBL1952121,,None,378.36,0,2.88,7a,FC(F)(F)Oc1cccc(-n2nnc3ccc(NC4CCNCC4)nc32)c1,IC50,'=',640,nM,6.19,,,UO_0000065,16.37,0.31,3.31,8.06,0,CHEMBL1954567,Inhibition of PIM2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1949661,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL1991395,,None,392.44,0,3.42,SID103904759,CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL91829,RUBOXISTAURIN,3,468.56,0,3.51,LY-333531,CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1,Kd,'=',1700,nM,5.77,,,UO_0000065,12.31,0.23,2.26,8.42,1,CHEMBL1061184,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150977,1,Scientific Literature,Nat Biotechnol,2008,None,
CHEMBL3652029,,None,439.44,0,4.99,BDBM106937,CC1CC(c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)=CC(O)C1,IC50,'=',20,nM,7.7,,225958,UO_0000065,17.52,0.33,2.71,10.25,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL261508,,None,390.53,1,5.29,K00236,CC(C)c1cc(/C=C(\C#N)C(=O)NCCCc2ccccc2)cc(C(C)C)c1O,Thermal melting change,'=',0.7,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL3652010,,None,458.44,0,2.99,BDBM106916,C[C@H]1CN(c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](O)[C@@H]1O,IC50,'=',1,nM,9,,225937,UO_0000065,19.63,0.37,6.01,9.13,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2006276,,None,332.36,0,4.14,SID103904673,COc1cccc2c1Nc1cc(Nc3ccncc3)ccc1C(=O)N2,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3919646,,None,421.46,0,3.74,8b,N[C@H]1CCCN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1,IC50,'=',0.5,nM,9.3,,,UO_0000065,22.07,0.41,5.56,11.02,0,CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3864151,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL275724,,None,458.5,0,3.96,SB-242718,NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1,Inhibition,'=',-0.49,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3687522,,None,548.59,1,4.08,BDBM151918,COc1cc(F)c(-c2nc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@@H](S(C)(=O)=O)[C@@H](C)C3)ccc2F)c(F)c1,IC50,'=',7.37,nM,8.13,,292174,UO_0000065,14.82,0.29,4.05,6.54,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3687496,,None,509.53,1,4.95,BDBM151892,C[C@@H]1C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@H](N)[C@@H]1OCCC#N,IC50,'=',99.56,nM,7,,292148,UO_0000065,13.74,0.26,2.05,6.15,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1979093,,None,406.42,1,5.18,SID103904351,COc1ccc(-c2ccc(NC(=O)Nc3ccc(F)c(C)c3)cc2)c2c(N)noc12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL220057,,None,357.42,0,4.76,SID103904333,Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1682545,,None,292.37,0,4.43,SID103904520,c1ccc(Nc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1965631,,None,375.44,0,2.37,SID103904529,CN(C)CC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL551079,,None,514.6,2,5.79,36,C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F,Inhibition,'<',50,%,,,,UO_0000187,,,,,0,CHEMBL1054314,Inhibition of Pim-2 at 1 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154027,1,Scientific Literature,Bioorg Med Chem Lett,2009,None,
CHEMBL3687468,,None,542.56,1,3.97,BDBM151864,COC(=O)N(C)[C@@H]1[C@H](N)CN(c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C)cc3F)n2)C[C@@H]1C,IC50,'=',1.51,nM,8.82,,292120,UO_0000065,16.26,0.31,4.85,7.76,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3691923,,None,632.71,1,4.46,BDBM151945,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C4(O)CCC4)cc3F)n2)C[C@@H](N)[C@@H]1OCCS(C)(=O)=O,IC50,'=',1.24,nM,8.91,,292200,UO_0000065,14.08,0.28,4.45,6.16,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3917379,,None,396.88,0,3,BDBM191086,NCCC1CNC(=O)c2cc(-c3ccnc(Cl)c3)c(-c3ccc(CO)cc3)n21,IC50,'=',110,nM,6.96,,341757,UO_0000065,17.53,0.34,3.96,7.47,0,CHEMBL3887520,Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1163567,,None,545.01,2,6.1,5l,COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1,Inhibition,'<',50,%,,,,UO_0000187,,,,,0,CHEMBL1166808,Inhibition of PIM2 at 1 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1165965,1,Scientific Literature,Bioorg Med Chem,2010,None,
CHEMBL3986310,,None,348.41,0,2.35,BDBM238457,O=C1NCCc2[nH]c(-c3cccc4ccc(N5CCOCC5)nc34)cc21,IC50,'=',115,nM,6.94,,416201,UO_0000065,19.92,0.36,4.59,9.88,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL379093,GW651576X,None,429.88,1,5.99,GW651576X,Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1,Inhibition,'=',1.48,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL531804,GW301888X,None,395.47,0,4.3,GW301888X,CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1,Inhibition,'=',-0.82,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1834657,INFIGRATINIB PHOSPHATE,4,658.48,2,5.35,1h,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1275911,,None,226.28,0,2.63,13,CCc1nc2cc3cn[nH]c3cc2nc1CC,Activity,,,,,,Not Active,,,,,,0,CHEMBL1285678,Inhibition of Pim2 assessed as residual enzyme activity at 10 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1275327,1,Scientific Literature,Eur J Med Chem,2010,None,
CHEMBL573705,,None,353.42,0,4.01,14c,CN(C)Cc1nc2c(sc3ccc(-c4cccc(F)c4)cc32)c(=O)[nH]1,Ki,'=',13,nM,7.89,,,UO_0000065,22.31,0.43,3.88,16.1,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL3687503,,None,544.57,1,4.69,BDBM151899,COCCOc1cc(F)c(-c2nc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@@H](OC)[C@@H](C)C3)ccc2F)c(F)c1,IC50,'=',3.68,nM,8.43,,292155,UO_0000065,15.49,0.3,3.74,7.77,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3691977,,None,538.53,1,3.44,BDBM151999,COc1cc(F)c(-c2nc(C(=O)Nc3cnccc3N3C[C@@H](N)[C@@H](n4ccnn4)[C@@H](C)C3)ccc2F)c(F)c1,IC50,'=',1.79,nM,8.75,,292254,UO_0000065,16.24,0.31,5.31,7.05,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1275911,,None,226.28,0,2.63,13,CCc1nc2cc3cn[nH]c3cc2nc1CC,Activity,,,,,,Not Active,,,,,,0,CHEMBL1285679,Inhibition of Pim2 assessed as residual enzyme activity at 1 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1275327,1,Scientific Literature,Eur J Med Chem,2010,None,
CHEMBL156524,,None,324.77,0,2.77,SB-333612,O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1,Inhibition,'=',0.77,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1909355,GW461104A,None,528.46,0,4.42,GW461104A,CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl,Inhibition,'=',-0.01,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1995832,,None,440.45,0,3.57,SID103904767,COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL607707,PELITINIB,2,467.93,1,5.1,EKB-569,CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1061184,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150977,1,Scientific Literature,Nat Biotechnol,2008,None,
CHEMBL572878,TOZASERTIB,2,464.6,0,3.5,VX-680/MK-0457,Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1,Kd,'>',10000,nM,,,,UO_0000065,,,,,1,CHEMBL1061184,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150977,1,Scientific Literature,Nat Biotechnol,2008,None,
CHEMBL450519,,None,309.37,0,2.31,17,Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1,Activity,,,,,,Not Evaluated,,,,,,0,CHEMBL982757,Binding affinity to human PIM2 at 10 uM relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1151712,1,Scientific Literature,J Med Chem,2008,None,
CHEMBL1909345,,None,422.87,0,2.97,SB-686709-A,CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl,Inhibition,'=',0.25,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL185939,GW828525X,None,490.45,1,5.39,GW828525X,FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1,Inhibition,'=',6.45,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL352222,,None,394.17,0,3.09,SB-358518,O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1,Inhibition,'=',0.69,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL218932,GW432441X,None,339.4,0,2.95,GW432441X,CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1,Inhibition,'=',0.61,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL4096630,,None,383.28,0,3.03,Tab 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL179453,GW622055X,None,392.86,0,4.54,GW622055X,CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1,Inhibition,'=',0.67,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL243907,GW673715X,None,445.48,1,5.74,GW673715X,CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1,Inhibition,'=',-0.24,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL2048866,,None,337.83,0,2.59,22,N[C@@H]1CCCN(c2c(Cl)cccc2/C=C2\SC(=O)NC2=O)C1,IC50,'=',310,nM,6.51,,,UO_0000065,19.27,0.4,3.92,8.63,0,CHEMBL2049743,Inhibition of human PIM2 using FITC-(AHX)RSRHSSYPAGT-COOH as substrate after 90 mins by mobility shift assay in presence of 5 mM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2046384,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL2048868,,None,333.41,0,1.95,24,COc1cccc(/C=C2\SC(=O)NC2=O)c1N1CCC[C@@H](N)C1,IC50,'=',320,nM,6.5,,,UO_0000065,19.48,0.39,4.54,7.67,0,CHEMBL2049743,Inhibition of human PIM2 using FITC-(AHX)RSRHSSYPAGT-COOH as substrate after 90 mins by mobility shift assay in presence of 5 mM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2046384,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL1909375,GSK-614526A,None,525.49,0,1.34,GSK614526A,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F,Inhibition,'=',1.1,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL483747,GSK-980961A,None,390.46,0,4.13,GSK980961A,NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1,Inhibition,'=',0.27,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL456252,GSK-2110236A,None,520.62,1,3.45,GSK2110236A,COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2,Inhibition,'=',3.29,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL477979,GW785974X,None,350.46,0,3.94,GW785974X,Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1,Inhibition,'=',0.1,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3355556,,None,410.42,0,3.4,15a,O=S1(=O)CCC(Nc2ccn3ncc(-c4cccc(C(F)(F)F)c4)c3n2)CC1,IC50,,,,,,Not Active,,,,,,0,CHEMBL3375413,Inhibition of Pim2 (unknown origin) using luciferase-luciferin based ATP detection reagent by Kinase-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3351833,1,Scientific Literature,ACS Med Chem Lett,2015,None,
CHEMBL3355560,,None,356.86,0,4.16,10b,C[C@]1(O)CC[C@H](Nc2ccn3ncc(-c4cccc(Cl)c4)c3n2)CC1,IC50,'=',1260,nM,5.9,,,UO_0000065,16.53,0.32,1.74,9.45,0,CHEMBL3375413,Inhibition of Pim2 (unknown origin) using luciferase-luciferin based ATP detection reagent by Kinase-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3351833,1,Scientific Literature,ACS Med Chem Lett,2015,None,
CHEMBL3355558,,None,327.82,0,2.98,8b,N[C@H]1CCCN(c2ccn3ncc(-c4cccc(Cl)c4)c3n2)C1,IC50,'=',2005,nM,5.7,,,UO_0000065,17.38,0.34,2.72,9.58,0,CHEMBL3375413,Inhibition of Pim2 (unknown origin) using luciferase-luciferin based ATP detection reagent by Kinase-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3351833,1,Scientific Literature,ACS Med Chem Lett,2015,None,
CHEMBL3394172,,None,378.46,0,4.05,32,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(OC5CCCC5)n4)c3c2)s1,IC50,'=',25,nM,7.6,,,UO_0000065,20.09,0.38,3.55,7.41,1,CHEMBL3395659,Inhibition of full length recombinant PIM2 (unknown origin) using biotinylated-BAD peptide as substrate assessed as phosphorylation at serine 112 after 90 mins by HTRF method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3393014,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL3394173,,None,352.42,0,3.51,33,CC(C)Oc1cnc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)cn1,IC50,'=',1290,nM,5.89,,,UO_0000065,16.71,0.32,2.38,5.74,0,CHEMBL3395659,Inhibition of full length recombinant PIM2 (unknown origin) using biotinylated-BAD peptide as substrate assessed as phosphorylation at serine 112 after 90 mins by HTRF method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3393014,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL66004,GW578748X,None,284.28,0,1.51,GW578748X,COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O,Inhibition,'=',0.15,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL516908,GW796920X,None,362.47,0,4.54,GW796920X,Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1,Inhibition,'=',0.37,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3427178,,None,322.41,0,3.03,10,COc1ccc2nc(C3=N[C@H](C(=O)O)C(C)(C)S3)sc2c1,Activity,'=',44,%,,,,UO_0000187,,,,,0,CHEMBL3427823,Inhibition of PIM2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3425453,1,Scientific Literature,Eur J Med Chem,2015,None,
CHEMBL408565,,None,343.22,0,3.76,K00006,O=C1Nc2ccccc2/C1=C/c1cc2c([nH]1)CCC(Br)C2,Thermal melting change,'=',1.3,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL259850,,None,308.32,0,2.38,K00082,COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1,Thermal melting change,'=',0.2,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL1909357,GW410563A,None,347.8,0,3.4,GW410563A,COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl,Inhibition,'=',1.6,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL4088455,,None,322.37,0,3.75,13,Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1,Inhibition,'=',-6,%,,,,UO_0000187,,,,,0,CHEMBL4057552,Inhibition of PIM2 (unknown origin) at 0.49 uM relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4052759,1,Scientific Literature,Bioorg Med Chem Lett,2017,None,
CHEMBL3687485,,None,470.5,0,4.67,BDBM151881,CO[C@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H]1C,IC50,'=',3.37,nM,8.47,,292137,UO_0000065,18.01,0.34,3.8,9.4,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL183993,GW811761X,None,400.36,0,4.35,GW811761X,CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1,Inhibition,'=',0.55,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1950229,,None,331.38,1,5.18,7,[N-]=[N+]=NCCCCn1c2ccccc2c2ccc3c(C=O)c[nH]c3c21,IC50,,,,,,Not Determined,,,,,,0,CHEMBL1955504,Inhibition of human recombinant PIM2 expressed in Escherichia coli using RSRHSSYPAGT as substrate after 30 mins,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1949527,1,Scientific Literature,Eur J Med Chem,2012,None,
CHEMBL3393713,,None,416.46,0,3.74,18f,Fc1ncccc1-c1ccc2[nH]nc(-c3cncc(O[C@H]4CNCCC45CC5)n3)c2c1,IC50,'=',4,nM,8.4,,,UO_0000065,20.17,0.37,4.66,9.48,0,CHEMBL3396420,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as phosphorylation of biotinylated-BAD peptide at Serine 112 residue,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3392976,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL98350,LY-294002,None,307.35,0,3.3,K00235,O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12,Thermal melting change,'=',1.3,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL3687491,,None,514.51,1,3.32,BDBM151887,COC(=O)N[C@@H]1[C@H](N)CN(c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H]1C,IC50,'=',0.89,nM,9.05,,292143,UO_0000065,17.59,0.33,5.73,7.39,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL17331,PD-169316,None,360.35,0,4.85,K00039,O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,Thermal melting change,'=',0.5,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL116438,CURCUMIN,3,368.39,0,3.85,Curcumin,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,Thermal melting change,'=',2.9,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL3758800,,None,445.59,0,4.82,22b,C[C@@H](Nc1ncnc2sc(-c3ccc(C(=O)NCCN(C)C)cc3)cc12)c1ccccc1,Inhibition,'=',3,%,,,,UO_0000187,,,,,0,CHEMBL3761595,Inhibition of PIM2 (unknown origin) at 500 nM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3758163,1,Scientific Literature,Eur J Med Chem,2016,None,
CHEMBL3758768,,None,363.44,0,4.6,3d,COc1cc(CO)ccc1-c1cc2c(Nc3ccccc3)ncnc2s1,Inhibition,'=',5,%,,,,UO_0000187,,,,,0,CHEMBL3761595,Inhibition of PIM2 (unknown origin) at 500 nM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3758163,1,Scientific Literature,Eur J Med Chem,2016,None,
CHEMBL1945562,,None,368.26,0,3.23,24,CC(=O)NCC1c2c(n(C)c3c(Cl)c(Cl)ccc23)C(=O)NC1(C)C,Delta Tm,'=',0.7,degrees C,,,,UO_0000027,,,,,0,CHEMBL1947284,Binding affinity to PIM2 assessed as change in thermal denaturation at 10 uM by thermal stability shift assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1944596,1,Scientific Literature,J Med Chem,2012,None,
CHEMBL300138,ENZASTAURIN,3,515.62,1,4.93,LY-317615,Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21,Kd,'=',870,nM,6.06,,,UO_0000065,11.75,0.21,1.13,8.4,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL3430782,,None,None,None,None,K00238,,Thermal melting change,'=',0.5,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL525191,,None,334.38,0,2.73,GDC-0879,OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL450786,PHA-665752,None,641.62,2,6.11,PHA-665752,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL1978099,,None,460.49,0,2.18,SID103904603,CNC(=O)COc1ccc(Nc2nc(Nc3ccc(C)c(S(N)(=O)=O)c3)ncc2F)cc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1998159,,None,427.43,0,4.3,SID103905453,Cc1n[nH]c2cnc(-c3cncc(OCC(N)Cc4cccc(C(F)(F)F)c4)c3)cc12,Ki,'=',1.259,nM,8.9,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1988387,,None,506.54,2,6.19,SID103904292,Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(OC(F)F)cc5)cc4)csc23)cn1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1986869,,None,367.46,0,3.96,SID103905569,Cc1csc(NC(=O)c2sc3nc(-c4ccncc4)ccc3c2N)n1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1996500,,None,410.43,0,3.62,SID103904762,Cc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1993941,,None,486.58,1,6.6,SID103904315,CCCn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2002165,,None,502.58,2,5.57,SID103904322,CC(O)Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1933552,,None,432.54,0,4.05,26,C[C@@H]1CCC(N2CC[C@]3(CN(C(=O)c4cc5ccc(F)cc5[nH]4)c4ccccc43)C2)CN1,IC50,'>',30000,nM,,,,UO_0000065,,,,,0,CHEMBL1936080,Inhibition of Pim-2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1933021,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL3393709,,None,397.48,0,4.21,18b,c1ccc(-c2ccc3[nH]nc(-c4cncc(O[C@H]5CNCCC56CC6)n4)c3c2)cc1,IC50,'=',4.3,nM,8.37,,,UO_0000065,21.05,0.38,4.16,11.05,0,CHEMBL3396420,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as phosphorylation of biotinylated-BAD peptide at Serine 112 residue,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3392976,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL3393703,,None,419.44,0,4.26,13l,C=C1CCNCC1Oc1cncc(-c2n[nH]c3ccc(-c4c(F)cccc4F)cc23)n1,IC50,'=',10,nM,8,,,UO_0000065,19.07,0.35,3.74,10.57,0,CHEMBL3396420,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as phosphorylation of biotinylated-BAD peptide at Serine 112 residue,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3392976,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL3394070,,None,390.52,1,5.08,19,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(NC5CCCCC5)n4)c3c2)s1,IC50,'=',227,nM,6.64,,,UO_0000065,17.01,0.32,1.56,7.18,1,CHEMBL3395659,Inhibition of full length recombinant PIM2 (unknown origin) using biotinylated-BAD peptide as substrate assessed as phosphorylation at serine 112 after 90 mins by HTRF method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3393014,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL3394168,,None,377.47,0,4.65,28,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(OC5CCCC5)n4)c3c2)s1,IC50,'=',41,nM,7.39,,,UO_0000065,19.57,0.37,2.74,8.23,1,CHEMBL3395659,Inhibition of full length recombinant PIM2 (unknown origin) using biotinylated-BAD peptide as substrate assessed as phosphorylation at serine 112 after 90 mins by HTRF method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3393014,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL3394062,,None,357.44,0,4.94,4,CNc1nnc(-c2ccc3[nH]cc(-c4cnc5ccccc5c4)c3c2)s1,IC50,'=',1630,nM,5.79,,,UO_0000065,16.19,0.3,0.85,8.7,1,CHEMBL3395659,Inhibition of full length recombinant PIM2 (unknown origin) using biotinylated-BAD peptide as substrate assessed as phosphorylation at serine 112 after 90 mins by HTRF method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3393014,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL13485,SU-11652,None,414.94,0,3.85,K00239,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C,Thermal melting change,'=',2.3,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL478629,DORSOMORPHIN,None,399.5,0,4.32,C,c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1,Activity,'=',109,%,,,,UO_0000187,,,,,0,CHEMBL1061086,Percentage PIM2 activity remaining in the presence of 1uM inhibitor,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL553,ERLOTINIB,4,393.44,0,3.41,Erlotinib,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,Thermal melting change,'=',0,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL3676297,,None,444.51,0,3.94,BDBM131767,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C[C@@H](N)[C@@H]1O,IC50,'=',27,nM,7.57,,264000,UO_0000065,17.03,0.33,3.63,7.48,0,CHEMBL3706072,Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3986567,,None,346.39,0,3.13,BDBM238603,Cc1nc2cccc(-c3cc4c(=O)[nH]cnc4[nH]3)c2nc1NC1CCC1,IC50,'=',1.23,nM,8.91,,416710,UO_0000065,25.72,0.47,5.78,8.97,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3394172,,None,378.46,0,4.05,32,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(OC5CCCC5)n4)c3c2)s1,IC50,'=',6540,nM,5.18,,,UO_0000065,13.7,0.26,1.13,5.05,0,CHEMBL3395662,Inhibition of PIM2 in human U2OS cells assessed as phosphorylation of BAD,B,BAO_0000219,cell-based format,Homo sapiens,None,None,U2OS,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3393014,1,Scientific Literature,Bioorg Med Chem Lett,2015,CHEMBL3307757,
CHEMBL3394069,,None,376.49,0,4.69,18,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(NC5CCCC5)n4)c3c2)s1,IC50,'=',21,nM,7.68,,,UO_0000065,20.39,0.39,2.99,8.3,1,CHEMBL3395659,Inhibition of full length recombinant PIM2 (unknown origin) using biotinylated-BAD peptide as substrate assessed as phosphorylation at serine 112 after 90 mins by HTRF method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3393014,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL3970766,,None,353.4,0,3.18,BDBM238709,Cc1nc2ccc(F)c(-c3cc4c([nH]3)CCNC4=O)c2nc1NC(C)C,IC50,'=',1.63,nM,8.79,,416818,UO_0000065,24.87,0.46,5.61,10.63,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3908350,,None,433.95,0,4.02,BDBM248886,CCc1cncc(-c2cc3c(cn2)cnn3-c2ccc(Cl)c(N3CCC[C@H](N)C3)n2)c1,Ki,'=',1.03,nM,8.99,,434093,UO_0000065,20.71,0.4,4.97,10.48,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3980526,,None,377.45,0,2.81,BDBM238552,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1CCCOC1,IC50,'=',2.8,nM,8.55,,416674,UO_0000065,22.66,0.42,5.74,9.3,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3966696,,None,386.46,0,2.51,BDBM248963,Cc1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CCC(N)CC3)n2)n1,Ki,'=',3.12,nM,8.51,,434170,UO_0000065,22.01,0.4,6,8.62,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3909280,,None,458.45,0,2.01,BDBM248958,O[C@H]1CNCCN(c2cccc(-n3ncc4cnc(-c5cnn(CC(F)(F)F)c5)cc43)n2)C1,Ki,'=',0.373,nM,9.43,,434165,UO_0000065,20.57,0.39,7.42,9.73,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4109688,,None,406.52,0,3.16,BDBM192590,C[C@@H]1C[C@H](N)CN(c2ccncc2Nc2ncc3ccc(-c4nccs4)nn23)C1,IC50,'=',0.4,nM,9.4,,344661,UO_0000065,23.12,0.44,6.24,9.66,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3914834,,None,422.44,0,3.14,BDBM192595,N[C@H]1CCCN(c2ccncc2Nc2nnc3ccc(-c4c(F)cccc4F)nn23)C1,IC50,'=',35.4,nM,7.45,,344666,UO_0000065,17.64,0.33,4.31,7.66,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3915618,,None,350.45,0,3.77,BDBM224964,CCc1nnc(-c2ccc3[nH]cc(-c4cncc(N(C)C)n4)c3c2)s1,IC50,'=',137.46,nM,6.86,,393254,UO_0000065,19.58,0.37,3.09,9.72,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3925861,,None,435.48,0,4.13,BDBM192609,C[C@H]1CC[C@@H](N)CN1c1ccncc1Nc1ncc2ccc(-c3c(F)cccc3F)nn12,IC50,'=',29,nM,7.54,,344684,UO_0000065,17.31,0.32,3.41,8.93,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3394067,,None,378.46,0,3.17,BDBM50061628,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(N5CCOCC5)n4)c3c2)s1,IC50,'=',58.69,nM,7.23,,393048,UO_0000065,19.11,0.37,4.06,7.78,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL488436,AZD-5438,1,371.47,0,3.38,AZD-5438,Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3264261,,None,388.48,0,2.66,7j,CN(C)CCN(C)c1cncc(-c2ccc3[nH]cc(-c4ccnc(N)n4)c3c2)n1,IC50,'=',180,nM,6.75,,,UO_0000065,17.36,0.32,4.08,6.75,0,CHEMBL3269287,Inhibition of PIM2 kinase (unknown origin) using 5-FAM-labeled BAD peptide as substrate after 90 mins by fluorescence polarization assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3259764,1,Scientific Literature,Bioorg Med Chem Lett,2014,None,
CHEMBL3892509,,None,374.45,0,2.02,BDBM248993,Cn1cc(-c2cc3c(cn2)cnn3-c2cccc(N3CCCNCC3)n2)cn1,Ki,'=',5.01,nM,8.3,,434200,UO_0000065,22.17,0.4,6.28,10.82,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL572878,TOZASERTIB,2,464.6,0,3.5,8,Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1,Activity,,,,,,Not Evaluated,,,,,,0,CHEMBL982757,Binding affinity to human PIM2 at 10 uM relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1151712,1,Scientific Literature,J Med Chem,2008,None,
CHEMBL2442290,,None,319.37,0,3.03,11i,NCCNc1ccn2ncc(-c3cccc(-c4ccco4)c3)c2n1,IC50,'=',89,nM,7.05,,,UO_0000065,22.08,0.4,4.02,8.66,0,CHEMBL2446212,Inhibition of Pim2 (unknown origin) using STK1 as substrate preincubated for 30 mins followed by substrate and ATP addition after 60 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2440090,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL2442305,,None,293.33,0,1.64,11d,NCCNc1ccn2ncc(-c3ccc4cn[nH]c4c3)c2n1,IC50,'=',24,nM,7.62,,,UO_0000065,25.98,0.47,5.98,7.86,0,CHEMBL2446212,Inhibition of Pim2 (unknown origin) using STK1 as substrate preincubated for 30 mins followed by substrate and ATP addition after 60 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2440090,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL1915423,,None,376.85,0,4.88,4c,CN(C)C(=O)c1cccc2c1nc(Nc1cccc(Cl)c1)c1ccncc12,IC50,'>',2500,nM,,,,UO_0000065,,,,,0,CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914433,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL572881,MOTESANIB,3,373.46,0,4.04,AMG-706,CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL1956068,GW296115X,None,385.38,0,3.86,GW296115X,COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O,Inhibition,'=',68.33,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1915650,,None,346.37,0,4.03,17h,CNC(=O)c1cccc2c1nc(Nc1ccccc1F)c1ccncc12,IC50,'=',4,nM,8.4,,,UO_0000065,24.25,0.44,4.37,12.55,0,CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914433,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL347580,,None,320.35,0,2.13,SB-361058,COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1,Inhibition,'=',0.67,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL249097,,None,335.37,0,3.08,9,Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1,Activity,,,,,,Not Evaluated,,,,,,0,CHEMBL982757,Binding affinity to human PIM2 at 10 uM relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1151712,1,Scientific Literature,J Med Chem,2008,None,
CHEMBL3914287,,None,404.45,0,3,BDBM192577,N[C@H]1CCCN(c2ccncc2Nc2ncc3ccc(-c4ncccc4F)nn23)C1,IC50,'=',1.1,nM,8.96,,344639,UO_0000065,22.15,0.41,5.96,9.21,1,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL413,SIROLIMUS,4,914.19,3,6.18,Rapamycin,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,Activity,'=',117,%,,,,UO_0000187,,,,,0,CHEMBL1061086,Percentage PIM2 activity remaining in the presence of 1uM inhibitor,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL189148,GW829055X,None,398.86,1,5.25,GW829055X,Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1,Inhibition,'=',0.34,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL498406,,None,219.26,0,2.32,2a,Cc1cccc(/C=C2\SC(=O)NC2=O)c1,IC50,'=',100,nM,7,,,UO_0000065,31.93,0.64,4.68,15.16,0,CHEMBL957366,Inhibition of human recombinant Pim2 by ATP depletion assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139352,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL2377724,,None,274.36,None,None,8,C[Si](C)(C)c1cc2c([nH]1)c([N+](=O)[O-])cc1cn[nH]c12,Inhibition,'=',64,%,,,,UO_0000187,,,,,0,CHEMBL2378599,Inhibition of human full length Pim-2 using RSRHSSYPAGT as substrate assessed as residual activity at 10 uM after 30 mins in presence of [gamma-33P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2375344,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL4063249,TP-021n,None,284.71,0,3.12,EUB0000742,N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1,% Control,,83,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507304,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL3691933,,None,571.6,2,5.17,BDBM151955,COC(=O)N[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(OC(C)C)cc3F)n2)C[C@@H]1C,IC50,'=',8.88,nM,8.05,,292210,UO_0000065,14.09,0.27,2.88,6.27,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL261131,DIACYLGLYCEROL KINASE INHIBITOR II,None,489.59,1,5.94,K00032,O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1,Thermal melting change,'=',1.4,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL3687498,,None,484.52,1,5.06,BDBM151894,CCO[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H]1C,IC50,'=',2.37,nM,8.62,,292150,UO_0000065,17.8,0.34,3.57,9.57,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3759085,,None,374.47,0,4.63,17b,C[C@@H](Nc1ncnc2sc(-c3ccccc3C(N)=O)cc12)c1ccccc1,Inhibition,'=',0,%,,,,UO_0000187,,,,,0,CHEMBL3761595,Inhibition of PIM2 (unknown origin) at 500 nM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3758163,1,Scientific Literature,Eur J Med Chem,2016,None,
CHEMBL3354516,,None,431.46,0,4.54,3d,O=C(Nc1cnccc1OCC1CCOCC1)c1csc(-c2c(F)cccc2F)n1,IC50,'=',56,nM,7.25,,,UO_0000065,16.81,0.33,2.71,9.89,0,CHEMBL3376647,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352230,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL4741714,,None,439.48,1,5.65,LGH447,C[C@@H]1C[C@H](N)C[C@H](c2ccccc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C1,IC50,'=',0.018,nM,10.74,,,UO_0000065,24.45,0.46,5.09,15.8,0,CHEMBL4687900,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4680285,1,Scientific Literature,Bioorg Med Chem,2020,None,
CHEMBL447571,,None,219.26,0,2.52,1a,Cc1ccc(/C=C2\SC(O)=NC2=O)cc1,IC50,'=',4400,nM,5.36,,,UO_0000065,24.43,0.49,2.84,10.79,0,CHEMBL957366,Inhibition of human recombinant Pim2 by ATP depletion assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139352,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL493847,,None,248.31,0,2.08,17a,CN(C)c1ccc(/C=C2\SC(=O)NC2=O)cc1,IC50,'=',100,nM,7,,,UO_0000065,28.19,0.56,4.92,14.17,0,CHEMBL957366,Inhibition of human recombinant Pim2 by ATP depletion assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139352,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL3907057,BAY-826,None,558.54,2,7.59,EUB0000713,Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1,% Control,,100,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507270,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 100.0 nM
CHEMBL2377718,,None,278.27,0,3.62,17,O=[N+]([O-])c1cc2cn[nH]c2c2c(-c3ccccc3)c[nH]c12,Inhibition,'=',70,%,,,,UO_0000187,,,,,0,CHEMBL2378599,Inhibition of human full length Pim-2 using RSRHSSYPAGT as substrate assessed as residual activity at 10 uM after 30 mins in presence of [gamma-33P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2375344,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL192417,GW632046X,None,250.3,0,4.39,GW632046X,Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1,Inhibition,'=',0.42,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3393715,,None,404.5,0,3.66,18h,c1csc(-c2ccc3[nH]nc(-c4cncc(O[C@H]5CNCCC56CC6)n4)c3c2)n1,IC50,'=',8,nM,8.1,,,UO_0000065,20.02,0.38,4.44,9.14,0,CHEMBL3396420,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as phosphorylation of biotinylated-BAD peptide at Serine 112 residue,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3392976,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL3910838,,None,334.38,0,4.38,BDBM225073,Cc1nnc(-c2ccc3[nH]cc(-c4cccc(OC(C)C)n4)c3c2)o1,IC50,'=',38.6,nM,7.41,,393066,UO_0000065,22.17,0.4,3.03,9.65,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3970756,,None,404.43,0,4.07,BDBM225078,CC(C)Nc1nnc(-c2ccc3[nH]cc(-c4nc(C(=O)O)cc(C5CC5)n4)c3c2)o1,IC50,'=',1.156,nM,8.94,,393071,UO_0000065,22.1,0.41,4.87,6.88,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3685745,,None,464.5,0,4.84,BDBM124909,N[C@H]1C[C@@H](CF)CN(c2ccncc2Nc2cccc3cnc(-c4c(F)cccc4F)nc23)C1,IC50,'=',20,nM,7.7,,254211,UO_0000065,16.57,0.31,2.86,9.63,0,CHEMBL3705221,ATP Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 ul per well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3676296,,None,398.58,1,5.07,BDBM131766,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2csc(C3CCCCC3)n2)C1,IC50,'=',97,nM,7.01,,263999,UO_0000065,17.6,0.34,1.94,8.67,0,CHEMBL3706072,Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL103667,DORAMAPIMOD,2,527.67,2,5.99,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL126077,INDIRUBIN-3-MONOXIME,None,277.28,0,4.42,K00076,O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12,Thermal melting change,'=',0,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL3898719,,None,377.45,0,2.81,BDBM238497,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1CCOCC1,IC50,'=',12.6,nM,7.9,,416234,UO_0000065,20.93,0.39,5.09,8.59,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL514499,GW843682X,None,477.46,0,4.8,GW843682X,COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC,Inhibition,'=',-2.85,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL4228564,,None,427.43,0,4.9,12k,CC(C)Nc1ccc2cnn(-c3cncc(-c4ccc(C(O)C(F)(F)F)cc4)n3)c2c1,IC50,'>',30000,nM,,,,UO_0000065,,,,,0,CHEMBL4222673,Inhibition of human PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4219163,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL244378,,None,346.35,0,3.54,SID103904604,O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3cn[nH]c3c2)n1,Ki,'=',630.96,nM,6.2,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2001957,,None,490.46,0,4.36,SID103904765,CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(OCC(F)(F)F)nccn23)n1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1991674,,None,343.82,0,3.39,SID103904216,OC1CCC(Nc2cc(Cl)nc(-c3c[nH]c4ncccc34)n2)CC1,Ki,'=',251.19,nM,6.6,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1909364,GW589961A,None,488.33,1,5.83,GW589961A,COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl,Inhibition,'=',-1.04,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL223360,LINIFANIB,3,375.41,0,4.9,SID103904340,Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3394167,,None,351.44,0,4.12,BDBM50061603,CC(C)Oc1cccc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)n1,IC50,'=',10.07,nM,8,,393180,UO_0000065,22.75,0.44,3.88,8.91,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3394061,,None,343.42,0,4.48,BDBM50061626,Nc1nnc(-c2ccc3[nH]cc(-c4cnc5ccccc5c4)c3c2)s1,IC50,'=',1006.03,nM,6,,393045,UO_0000065,17.46,0.33,1.52,7.45,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL210887,,None,340.34,0,2.58,SID103905079,O=C(Nc1nc2ccccc2n1CCCO)c1cccc([N+](=O)[O-])c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3965556,,None,393.45,0,3.61,BDBM225022,CC(C)Nc1nc(-c2c[nH]c3ccc(-c4nnc(NC(C)C)o4)cc23)cc(=O)[nH]1,IC50,'=',14.3,nM,7.84,,393311,UO_0000065,19.94,0.37,4.23,6.3,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3676294,,None,445.5,0,3.27,BDBM131764,Nc1sc(-c2c(F)cccc2F)nc1C(=O)Nc1cnccc1[C@@H]1CC[C@H](O)[C@H](N)C1,IC50,'=',4,nM,8.4,,263997,UO_0000065,18.85,0.37,5.13,6.6,0,CHEMBL3706072,Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1992536,,None,348.36,0,2.52,SID103904655,COc1ccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)cc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1971943,BAY-549,None,402.79,0,4.71,SID103905649,Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3651969,,None,452.51,0,4.18,BDBM106873,Cc1ccc(F)c(-c2nc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@@H](O)[C@@H](C)C3)ccc2F)c1,IC50,'=',8,nM,8.1,,225894,UO_0000065,17.89,0.34,3.92,8.01,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4754195,,None,352.4,0,4.96,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3978766,,None,386.46,0,2.59,1,Cc1cncc(-c2cc3c(-c4cccc(N5CCCNCC5)n4)n[nH]c3cn2)n1,Ki,'=',0.11,nM,9.96,,,UO_0000065,25.77,0.47,7.37,10.43,0,CHEMBL4052120,Inhibition of PIM2 (unknown origin) using 5FAM-ARKRRRHPSGPPTA as substrate after 90 mins in presence of ATP by caliper microfluidic mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4049450,1,Scientific Literature,J Med Chem,2017,None,
CHEMBL458865,GSK-1220512A,None,518.6,1,4.22,GSK1220512A,COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1,Inhibition,'=',1.98,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL4084988,,None,439.08,0,2.97,10; Tab 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL406845,,None,301.78,0,3.48,K00048,CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21,Thermal melting change,'=',0.2,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL261211,,None,287.41,0,3.33,K00615a,CN1CCc2[nH]c(=S)c(C#N)c(-c3cccs3)c2C1,Thermal melting change,'=',-0.3,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL2006631,,None,393.47,0,3.91,SID103904717,CN(C)S(=O)(=O)c1ccccc1-c1ccc2c(c1)Nc1ccccc1NC2=O,Ki,'=',794.33,nM,6.1,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1970317,,None,458.52,1,5.73,SID103904314,Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3930402,,None,402.51,0,3.25,BDBM248912,CCn1cc(-c2cc3c(cn2)cnn3-c2cccc(NC3CCCCNC3)n2)cn1,Ki,'=',31.1,nM,7.51,,434119,UO_0000065,18.65,0.34,4.26,8.78,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3940227,,None,417.48,0,0.96,BDBM248928,NC(=O)Cn1cc(-c2cc3c(cn2)cnn3-c2cccc(N3CCCNCC3)n2)cn1,Ki,'=',8.33,nM,8.08,,434135,UO_0000065,19.35,0.36,7.12,6.75,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3929011,,None,385.48,0,3.57,BDBM248979,Cc1cncc(-c2cc3c(cn2)cnn3-c2cccc(C3CCCC(N)C3)n2)n1,Ki,'=',0.672,nM,9.17,,434189,UO_0000065,23.8,0.43,5.6,9.61,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3922364,,None,402.46,0,2.09,BDBM248933,Cc1cnc(O)c(-c2cc3c(cn2)cnn3-c2cncc(N3CCCNCC3)n2)c1,Ki,'=',527,nM,6.28,,434140,UO_0000065,15.6,0.29,4.19,5.99,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3917695,,None,349.39,0,2.28,BDBM238703,Cc1nc2cccc(-c3cc4c([nH]3)[C@H](CO)NC4=O)c2nc1NC1CC1,IC50,'=',3.68,nM,8.43,,416812,UO_0000065,24.14,0.44,6.15,8.19,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2035615,,None,326.74,0,4,4n,COc1ccc2c(c1)oc1c(=O)[nH]c(-c3ccccc3Cl)nc12,IC50,'=',5000,nM,5.3,,,UO_0000065,16.22,0.31,1.3,7.78,0,CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034948,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL1978200,,None,424.46,0,4.01,SID103904764,Cc1nccn2c(-c3ccnc(NCCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1421,DASATINIB,4,488.02,0,3.31,Dasatinib,Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3953144,,None,373.39,0,4.45,BDBM238385,O=C1NCCc2[nH]c(-c3cccc4ccc(Oc5ccccc5F)nc34)cc21,IC50,'=',10.3,nM,7.99,,416163,UO_0000065,21.39,0.39,3.54,11.92,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1986186,,None,273.34,0,2.27,SID103904939,CC(Nc1c(Nc2ccncc2)c(=O)c1=O)C(C)(C)C,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3355549,,None,440.45,0,3.53,14,O=S1(=O)CCC(CNc2ccn3ncc(-c4cccc(OC(F)(F)F)c4)c3n2)CC1,IC50,'=',8160,nM,5.09,,,UO_0000065,11.55,0.23,1.56,5.94,0,CHEMBL3375413,Inhibition of Pim2 (unknown origin) using luciferase-luciferin based ATP detection reagent by Kinase-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3351833,1,Scientific Literature,ACS Med Chem Lett,2015,None,
CHEMBL1945556,,None,377.27,0,3.3,17,CN1CCC2(CC1)NC(=O)c1c(c3ccc(Cl)c(Cl)c3n1C)C2C#N,Delta Tm,'=',5.2,degrees C,,,,UO_0000027,,,,,0,CHEMBL1947284,Binding affinity to PIM2 assessed as change in thermal denaturation at 10 uM by thermal stability shift assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1944596,1,Scientific Literature,J Med Chem,2012,None,
CHEMBL3904025,,None,362.43,0,2.65,BDBM238454,O=C1NCCc2[nH]c(-c3cccc4ccc(OC5CCNCC5)nc34)cc21,IC50,'=',95.6,nM,7.02,,416198,UO_0000065,19.37,0.36,4.37,8.88,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3903517,,None,375.35,0,3.71,BDBM238634,Cc1nc2cccc(-c3cc4c([nH]3)[C@@H](C)NC4=O)c2nc1NCC(F)(F)F,IC50,'=',2.23,nM,8.65,,416743,UO_0000065,23.05,0.44,4.94,10.46,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3941979,,None,335.37,0,2.18,BDBM238761,CC(=O)Nc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2nc1C,IC50,'=',20.1,nM,7.7,,416870,UO_0000065,22.95,0.42,5.52,7.71,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4109687,,None,436.44,0,4.66,BDBM192618,N[C@@H]1C=C(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)CC[C@H]1F,IC50,'=',15.5,nM,7.81,,344689,UO_0000065,17.89,0.33,3.15,9.63,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL259605,,None,396.38,0,1.07,K00616a,Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(O)c1c(F)cccc1F,Thermal melting change,'=',1.8,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL3394064,,None,328.35,0,4.21,BDBM50061606,Nc1nnc(-c2ccc3[nH]cc(-c4c(F)cccc4F)c3c2)s1,IC50,'=',347.65,nM,6.46,,393161,UO_0000065,19.67,0.38,2.25,9.56,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3971118,,None,431.41,0,4.06,BDBM191095,NCC[C@H]1CNC(=O)c2cc(-c3cccc(OC(F)(F)F)c3)c(-c3ccc(O)cc3)n21,IC50,'=',16,nM,7.8,,341766,UO_0000065,18.07,0.34,3.74,8.71,0,CHEMBL3887520,Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3971547,,None,435.48,0,4,BDBM192583,C[C@H]1CN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)[C@@H](C)CN1,IC50,'=',113,nM,6.95,,344648,UO_0000065,15.95,0.3,2.95,9.87,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL454281,,None,312.37,0,2.39,15,NCCCCNc1cncc(-c2cccc(/C=C/C(=O)O)c2)n1,IC50,'=',22,nM,7.66,,,UO_0000065,24.51,0.45,5.27,7.57,0,CHEMBL960129,Inhibition of Pim2 in presence of 1 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153342,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL3946958,,None,368.44,0,4.65,BDBM238407,CC1Cc2[nH]c(-c3cccc4ccc(Nc5ccccc5)nc34)cc2C(=O)N1,IC50,'=',34.2,nM,7.47,,416288,UO_0000065,20.26,0.36,2.82,10.69,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3897323,,None,435.48,0,3.99,BDBM192571,C[C@H]1C[C@H](N)CN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1,IC50,'=',1.4,nM,8.85,,344660,UO_0000065,20.33,0.38,4.86,10.49,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3920733,,None,420.91,0,3.51,BDBM192604,N[C@H]1CCCN(c2ccncc2Nc2ncc3ccc(-c4ncccc4Cl)nn23)C1,IC50,'=',2.6,nM,8.59,,344675,UO_0000065,20.4,0.39,5.08,8.83,1,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3904472,,None,421.46,0,3.74,BDBM192606,N[C@H]1CCCN(c2cnccc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1,IC50,'>',1000,nM,,,344677,UO_0000065,,,,,1,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3909297,,None,439.45,0,3.69,BDBM192628,NC1CN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)CCC1F,IC50,'=',1.1,nM,8.96,,344644,UO_0000065,20.39,0.38,5.27,10.62,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL266487,RO-316233,None,327.34,0,3.22,K00203,O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12,Thermal melting change,'=',4,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL75680,ALOISINE A,None,267.33,0,3.67,K00059,CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12,Thermal melting change,'=',4.5,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL408678,,None,365.8,0,4.69,K00567a,O=c1c(-c2ccc(F)cc2)c(-c2ccncc2)[nH]n1-c1ccc(Cl)cc1,Thermal melting change,'=',0.2,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL21156,,None,309.34,0,3.99,K00013,CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1,Thermal melting change,'=',5.1,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL259526,,None,68.08,0,0.2,K00210,C=CNC#N,Thermal melting change,'=',0.3,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL155333,,None,501.05,1,4.68,K00078,COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1,Thermal melting change,'=',0.6,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL3953849,,None,400.45,0,1.91,BDBM248975,Cc1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CCNCCC3=O)n2)n1,Ki,'=',40.4,nM,7.39,,434182,UO_0000065,18.46,0.34,5.48,7.27,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL454173,ZEARALENONE,None,318.37,0,3.58,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3909176,,None,414.52,0,2.98,BDBM248939,CC(C)(C)c1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CCNCC3)n2)n1,Ki,'=',91.2,nM,7.04,,434146,UO_0000065,16.98,0.31,4.06,8.32,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3354513,,None,416.45,0,3.87,3a,O=C(Nc1cnccc1OC1CCNCC1)c1csc(-c2c(F)cccc2F)n1,IC50,'=',18,nM,7.75,,,UO_0000065,18.6,0.36,3.87,10.17,0,CHEMBL3376647,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352230,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL3393710,,None,416.46,0,3.74,18c,Fc1cccnc1-c1ccc2[nH]nc(-c3cncc(O[C@H]4CNCCC45CC5)n3)c2c1,IC50,'=',6,nM,8.22,,,UO_0000065,19.74,0.36,4.48,9.28,0,CHEMBL3396420,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as phosphorylation of biotinylated-BAD peptide at Serine 112 residue,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3392976,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL3949896,,None,405.5,0,3.89,BDBM238728,Cc1nc2cccc(-c3cc4c([nH]3)C3(CCOCC3)NC4=O)c2nc1NC(C)(C)C,IC50,'=',62.6,nM,7.2,,416837,UO_0000065,17.76,0.33,3.31,7.84,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3926007,,None,407.43,0,3.29,BDBM249028,Cc1cncc(-c2cc3c(cn2)cnn3-c2cccc(C3CNCCC3(F)F)n2)n1,Ki,'=',0.234,nM,9.63,,434245,UO_0000065,23.64,0.44,6.34,11.83,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3935180,,None,472.51,0,4.42,BDBM191104,CN(C)Cc1ccc(-c2c(-c3cccc(OC(F)(F)F)c3)cc3n2[C@@H](CCN)CNC3=O)cc1,IC50,'=',9,nM,8.05,,341775,UO_0000065,17.03,0.32,3.63,11.09,0,CHEMBL3887520,Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3931390,,None,435.48,0,3.99,BDBM192621,C[C@H]1CCN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C[C@@H]1N,IC50,'=',32.4,nM,7.49,,344697,UO_0000065,17.2,0.32,3.5,8.88,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3919646,,None,421.46,0,3.74,BDBM192539,N[C@H]1CCCN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1,IC50,'=',0.5,nM,9.3,,344531,UO_0000065,22.07,0.41,5.56,11.02,1,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL478629,DORSOMORPHIN,None,399.5,0,4.32,C,c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1,Residual Activity,'=',117,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL281948,K-252A,None,467.48,0,3.66,K252a,COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,Residual Activity,'=',2,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL278724,SB-202474,None,279.34,0,3.71,SB-202474,CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1,Residual Activity,'=',126,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4083726,,None,320.42,0,3,38,O=C1NC(=S)S/C1=C\c1csc(-c2cccc(O)c2)n1,Delta Tm,'=',12.2,degrees C,,,,UO_0000027,,,,,0,CHEMBL4029682,Inhibition of recombinant PIM2 (unknown origin) assessed as change in melting temperature at 10 uM by SYPRO orange dye-based differential scanning fluorimetry,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4028814,1,Scientific Literature,Bioorg Med Chem,2017,None,
CHEMBL3947201,,None,378.41,0,4.51,BDBM224996,CC(C)Nc1nnc(-c2ccc3[nH]cc(-c4ncc(F)c(C5CC5)n4)c3c2)o1,IC50,'=',2.77,nM,8.56,,393285,UO_0000065,22.61,0.42,4.05,9.25,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3889589,,None,377.41,0,2.85,BDBM225015,CNC(=O)c1ccnc(-c2c[nH]c3ccc(-c4nnc(NC(C)C)o4)cc23)n1,IC50,'=',652,nM,6.19,,393305,UO_0000065,16.39,0.3,3.34,5.09,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL388978,STAUROSPORINE,None,466.54,0,4.35,Staurosporine,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,Residual Activity,'=',0,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3394068,,None,350.45,0,4.15,17,CC(C)Nc1cccc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)n1,IC50,'=',37,nM,7.43,,,UO_0000065,21.21,0.41,3.28,8.03,1,CHEMBL3395659,Inhibition of full length recombinant PIM2 (unknown origin) using biotinylated-BAD peptide as substrate assessed as phosphorylation at serine 112 after 90 mins by HTRF method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3393014,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL17331,PD-169316,None,360.35,0,4.85,PD-169316,O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,Residual Activity,'=',139,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1950230,,None,387.44,0,3.65,11,O=Cc1c[nH]c2c1ccc1c3ccccc3n(CCCCn3cc(CO)nn3)c12,Activity,'=',36,%,,,,UO_0000187,,,,,0,CHEMBL1955501,Inhibition of human recombinant PIM2 expressed in Escherichia coli assessed as residual activity using RSRHSSYPAGT as substrate at 10 uM after 30 mins,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1949527,1,Scientific Literature,Eur J Med Chem,2012,None,
CHEMBL1725279,SP-600125,None,220.23,0,4.43,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1991678,,None,424.46,0,3.87,SID103904779,Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1987054,,None,548.05,2,6.07,SID103904785,COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(C)cc(Cl)c5o4)cc3)c3c(N)ncnc32)CC1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1970083,,None,523.52,2,7.41,SID103904279,Nc1ncc(-c2ccncc2)c2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL385478,,None,293.37,0,3.76,SID103904205,c1cnc2[nH]cc(-c3ccnc(NC4CCCCC4)n3)c2c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL336961,AZAKENPAULLONE,None,328.17,0,3.49,SID103905441,O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ncccc2N1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2425654,,None,310.36,0,1.93,3,O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1,Inhibition,'=',98,%,,,,UO_0000187,,,,,0,CHEMBL2429482,Competitive binding affinity to PIM2 (unknown origin) at 10 uM in presence of ATP relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2424622,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL3936992,,None,422.52,0,2.14,BDBM192559,C[C@H]1CN(c2ccncc2Nc2ncc3ccc(-c4nccs4)nn23)C[C@@H](N)[C@@H]1O,IC50,'=',0.6,nM,9.22,,344551,UO_0000065,21.83,0.42,7.08,7.85,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3652016,,None,470.5,1,5.14,BDBM106922,CC1(C)C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(O)cc3F)n2)C1,IC50,'=',2,nM,8.7,,225943,UO_0000065,18.49,0.35,3.56,8.6,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3703182,,None,343.46,0,1.79,BDBM149690,CSc1ncc2c(n1)-c1c(c(C(N)=O)cn1C1CCNCC1)CC2,IC50,'=',159,nM,6.8,,288348,UO_0000065,19.79,0.39,5.01,7.92,0,CHEMBL3707582,Kinase Inhibition Assay: The buffer for PIM-2 assay was composed of HEPES 50 mM,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3355555,,None,424.45,0,3.65,14a,O=S1(=O)CCC(CNc2ccn3ncc(-c4cccc(C(F)(F)F)c4)c3n2)CC1,IC50,'=',6020,nM,5.22,,,UO_0000065,12.3,0.25,1.57,6.84,0,CHEMBL3375413,Inhibition of Pim2 (unknown origin) using luciferase-luciferin based ATP detection reagent by Kinase-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3351833,1,Scientific Literature,ACS Med Chem Lett,2015,None,
CHEMBL3652631,,None,434.47,0,2.79,BDBM119391,Cn1ncc(NC(=O)c2nc(-c3c(F)cccc3F)sc2N)c1OC1CCNCC1,Ki,'=',28.3,nM,7.55,,246158,UO_0000065,17.37,0.34,4.76,7.05,0,CHEMBL3707982,Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1163518,,None,514.98,2,6.48,5k,O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1,Inhibition,'<',50,%,,,,UO_0000187,,,,,0,CHEMBL1166808,Inhibition of PIM2 at 1 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1165965,1,Scientific Literature,Bioorg Med Chem,2010,None,
CHEMBL3925989,,None,441.56,0,2.84,BDBM238676,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC(C)(C)CCS(C)(=O)=O,IC50,'=',98.6,nM,7.01,,416785,UO_0000065,15.87,0.31,4.17,6,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3956461,,None,388.48,0,2.66,5,CCn1cc(-c2cc3c(-c4cccc(N5CCN(C)CC5)n4)n[nH]c3cn2)cn1,Ki,'=',3,nM,8.52,,,UO_0000065,21.94,0.4,5.86,10.82,0,CHEMBL4052120,Inhibition of PIM2 (unknown origin) using 5FAM-ARKRRRHPSGPPTA as substrate after 90 mins in presence of ATP by caliper microfluidic mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4049450,1,Scientific Literature,J Med Chem,2017,None,
CHEMBL280074,OLOMOUCINE,None,298.35,0,1.38,K00016,Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc21,Thermal melting change,'=',0.1,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL296586,KENPAULLONE,None,327.18,0,4.09,K00061,O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1,Thermal melting change,'=',1.2,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL3981104,,None,410.43,0,2.87,BDBM248942,FC(F)n1cc(-c2cc3c(cn2)cnn3-c2cccc(N3CCCNCC3)n2)cn1,Ki,'=',9.54,nM,8.02,,434149,UO_0000065,19.54,0.37,5.15,10.46,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3897988,,None,351.41,0,2.38,BDBM238738,Cn1c(NC(C)(C)C)nc2c(-c3cc4c([nH]3)CNC4=O)cccc2c1=O,IC50,'=',0.193,nM,9.71,,416847,UO_0000065,27.64,0.51,7.33,10.58,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL259389,QUINOXALINE1,None,185.19,0,1.09,K00033,Nc1n[nH]c2nc3ccccc3nc12,Thermal melting change,'=',1.3,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL413188,ISOGRANULATIMIDE,None,276.26,0,1.85,Isogranulatimide,O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21,Residual Activity,'=',0,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL120077,,None,325.34,0,3.88,JNJ-10198409,COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2,Residual Activity,'=',96,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3664623,,None,397.84,0,3.68,BDBM104247,F[C@@H]1CNCCC1Oc1cccc2ccc(-c3nnc4cc(Cl)ccn34)nc12,IC50,'=',1000,nM,6,,222658,UO_0000065,15.08,0.29,2.32,9.33,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3545360,ASP-3026,1,580.76,2,3.77,ASP-3026,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3676303,,None,397.48,0,3.52,BDBM131773,N[C@H]1CCCN(c2ccncc2NC(=O)c2csc(-c3ccccc3F)n2)C1,IC50,'=',9.9,nM,8,,264006,UO_0000065,20.14,0.39,4.48,9.51,0,CHEMBL3706072,Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3676302,,None,379.49,0,3.38,BDBM131772,N[C@H]1CCCN(c2ccncc2NC(=O)c2csc(-c3ccccc3)n2)C1,IC50,'=',17.7,nM,7.75,,264005,UO_0000065,20.43,0.39,4.37,9.21,0,CHEMBL3706072,Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3691936,,None,533.55,2,5.06,BDBM151958,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1n1ccccc1=O,IC50,'=',6800,nM,5.17,,292213,UO_0000065,9.69,0.18,0.11,5.02,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3907479,FGFR INHIBITOR DEBIO 1347,2,356.39,0,3.35,CH-5183284,Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3915323,,None,377.48,0,2.66,BDBM248888,Cc1cc(-c2cc3c(cn2)cnn3-c2cccc(N3CCNCC3)n2)sn1,Ki,'=',8.49,nM,8.07,,434095,UO_0000065,21.38,0.41,5.41,11.25,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3606021,,None,395.43,0,2.92,20by,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3687516,,None,587.6,1,4.4,BDBM151912,COCCOc1cc(F)c(-c2nc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@@H](NC(=O)OC)[C@@H](C)C3)ccc2F)c(F)c1,IC50,'=',24.4,nM,7.61,,292168,UO_0000065,12.96,0.25,3.21,5.53,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3545083,RGB-286638,1,545.64,1,2.42,RGB-286638,COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1,Kd,'=',42,nM,7.38,,Active,UO_0000065,13.52,0.25,4.96,6.41,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3634758,,None,374.45,0,2.35,8,Cn1cc(-c2cc3c(-c4cccc(N5CCC[C@H](N)C5)n4)n[nH]c3cn2)cn1,Ki,'=',0.2,nM,9.7,,,UO_0000065,25.9,0.47,7.35,9.55,0,CHEMBL4052120,Inhibition of PIM2 (unknown origin) using 5FAM-ARKRRRHPSGPPTA as substrate after 90 mins in presence of ATP by caliper microfluidic mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4049450,1,Scientific Literature,J Med Chem,2017,None,
CHEMBL4088342,,None,388.48,0,2.36,9b,Cn1cc(-c2cc3c(-c4cccc(N5CCC[C@H](N)C5)n4)nn(C)c3cn2)cn1,Ki,'=',170,nM,6.77,,,UO_0000065,17.43,0.32,4.41,7.47,0,CHEMBL4052120,Inhibition of PIM2 (unknown origin) using 5FAM-ARKRRRHPSGPPTA as substrate after 90 mins in presence of ATP by caliper microfluidic mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4049450,1,Scientific Literature,J Med Chem,2017,None,
CHEMBL388978,STAUROSPORINE,None,466.54,0,4.35,staurosporine,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,IC50,'=',28,nM,7.55,,,UO_0000065,16.19,0.29,3.2,10.88,0,CHEMBL931462,Inhibition of Pim2 kinase,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144687,1,Scientific Literature,J Nat Prod,2008,None,
CHEMBL3774885,,None,401.47,0,3.03,39,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1,Activity,'=',0,%,,,,UO_0000187,,,,,0,CHEMBL3777504,Inhibition of N-terminal His6-tagged recombinant human PIM2 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3774357,1,Scientific Literature,Bioorg Med Chem Lett,2016,CHEMBL3308860,
CHEMBL3394072,,None,363.45,0,3.33,21,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(N5CCCC5)n4)c3c2)s1,IC50,'=',42,nM,7.38,,,UO_0000065,20.3,0.39,4.05,7.64,0,CHEMBL3395659,Inhibition of full length recombinant PIM2 (unknown origin) using biotinylated-BAD peptide as substrate assessed as phosphorylation at serine 112 after 90 mins by HTRF method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3393014,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL3968140,,None,388.48,0,2.63,BDBM248901,CCn1cc(-c2cc3c(cn2)cnn3-c2cccc(N3CCC(N)CC3)n2)cn1,Ki,'=',19.3,nM,7.71,,434108,UO_0000065,19.86,0.36,5.08,8.51,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3687453,,None,498.51,0,4.4,BDBM151849,C[C@@H]1C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@H](N)C12OCCO2,IC50,'=',327.41,nM,6.49,,292105,UO_0000065,13.01,0.25,2.08,6.53,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3687514,,None,501.56,1,3.32,BDBM151910,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccnc(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1S(C)(=O)=O,IC50,'=',135.2,nM,6.87,,292166,UO_0000065,13.7,0.27,3.55,5.37,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4467003,,None,536.64,1,4.03,39,c1ccc(OCCN2CCOc3c2cnn2c(-c4ccc5cccc(NCC6CCNCC6)c5n4)nnc32)cc1,IC50,'=',4690,nM,5.33,,,UO_0000065,9.93,0.18,1.3,5.24,0,CHEMBL4340984,Inhibition of His tagged human recombinant PIM2 using PIM tide (ARKRRRHPSGPPTA) as substrate incubated for 1 hr by fluorescence based assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4340512,1,Scientific Literature,Eur J Med Chem,2019,None,
CHEMBL3687430,,None,456.47,0,2.92,BDBM151824,C[C@H]1CN(c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1N,IC50,'=',0.86,nM,9.07,,292080,UO_0000065,19.86,0.38,6.15,8.23,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3985111,,None,391.5,0,3.05,BDBM248889,Cc1cc(-c2cc3c(cn2)cnn3-c2cccc(N3CCCNCC3)n2)sn1,Ki,'=',4.66,nM,8.33,,434096,UO_0000065,21.28,0.41,5.28,11.61,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3676262,,None,431.47,0,2.63,BDBM131732,N[C@@H]1CN(c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)CC[C@@H]1O,IC50,'=',3,nM,8.52,,263965,UO_0000065,19.75,0.39,5.89,8.17,0,CHEMBL3706072,Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3676264,,None,445.5,0,3.29,BDBM131734,CO[C@@H]1C[C@H](N)CN(c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C1,IC50,'=',46,nM,7.34,,263967,UO_0000065,16.47,0.32,4.05,7.86,0,CHEMBL3706072,Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL274064,SB-220025,None,338.39,0,2.65,K00569a,Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1,Thermal melting change,'=',0.2,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL3660073,,None,456.32,0,4.18,BDBM104200,FC1(COc2cccc3ccc(-c4nnc5ccc(Br)cn45)nc23)CCNCC1,IC50,'=',1389,nM,5.86,,222613,UO_0000065,12.84,0.28,1.68,9.1,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL1164181,,None,469.42,0,4.63,5g,CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1,Inhibition,'<',50,%,,,,UO_0000187,,,,,0,CHEMBL1166808,Inhibition of PIM2 at 1 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1165965,1,Scientific Literature,Bioorg Med Chem,2010,None,
CHEMBL1974935,,None,370.46,0,4.08,SID103904749,NC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12,Ki,'=',1000,nM,6,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1614705,,None,415.86,0,3.02,SID103905593,O=C(CO)N1CCC(c2[nH]nc(-c3ccc(Cl)cc3F)c2-c2ccncn2)CC1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3394071,,None,309.36,0,2.31,20,Nc1cncc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)n1,IC50,,,,,,Not Determined,,,,,,0,CHEMBL3395662,Inhibition of PIM2 in human U2OS cells assessed as phosphorylation of BAD,B,BAO_0000219,cell-based format,Homo sapiens,None,None,U2OS,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3393014,1,Scientific Literature,Bioorg Med Chem Lett,2015,CHEMBL3307757,
CHEMBL3394073,,None,379.45,0,2.56,22,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(N5CCOCC5)n4)c3c2)s1,IC50,'=',1900,nM,5.72,,,UO_0000065,15.08,0.29,3.16,5.41,0,CHEMBL3395662,Inhibition of PIM2 in human U2OS cells assessed as phosphorylation of BAD,B,BAO_0000219,cell-based format,Homo sapiens,None,None,U2OS,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3393014,1,Scientific Literature,Bioorg Med Chem Lett,2015,CHEMBL3307757,
CHEMBL2408045,SAPITINIB,2,473.94,0,3.76,Sapitinib,CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL1614713,CC-401,2,388.48,0,3.88,CC-401,c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3935874,,None,427.48,0,3.8,8e,N[C@H]1CCCN(c2sncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1,IC50,'=',148,nM,6.83,,,UO_0000065,15.98,0.31,3.03,8.09,0,CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3864151,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL3430788,,None,None,None,None,K00612a,,Thermal melting change,'=',0.2,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL1822054,,None,460.88,0,3.34,10,CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1,Activity,'=',98,%,,,,UO_0000187,,,,,0,CHEMBL1827578,Activity of PIM2 kinase at 1 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1821651,1,Scientific Literature,J Med Chem,2011,None,
CHEMBL1785003,,None,486.55,0,4.28,SB-264866,NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1,Inhibition,'=',-0.27,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1077375,,None,1511.89,None,None,6b,N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H](CCCCN)NC(=O)CCCCCNC(=O)c1ccc(-c2ccnc(N)n2)s1)C(N)=O,Inhibition,'=',95,%,,,,UO_0000187,,,,,0,CHEMBL1110435,Inhibition of PIM2 at 100 nM relative to control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154334,1,Scientific Literature,Bioorg Med Chem Lett,2009,None,
CHEMBL3651934,,None,438.48,0,4.61,BDBM106838,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3ccc(O)cc3F)n2)C1,IC50,'=',4,nM,8.4,,225859,UO_0000065,19.15,0.36,3.79,8.3,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3651981,,None,456.47,0,4.01,BDBM106885,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1O,IC50,'=',3,nM,8.52,,225906,UO_0000065,18.67,0.35,4.51,8.43,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3965643,,None,333.4,0,2.88,BDBM238564,CC1(Nc2cnc3cccc(-c4cc5c([nH]4)CCNC5=O)c3n2)CC1,IC50,'=',0.3,nM,9.52,,416686,UO_0000065,28.56,0.52,6.64,11.51,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3910799,,None,293.33,0,1.8,BDBM238571,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N,IC50,'=',17.4,nM,7.76,,416693,UO_0000065,26.45,0.48,5.96,8.03,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3925198,,None,363.47,0,3.45,BDBM238575,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N(C)C(C)(C)C,IC50,'=',2.1,nM,8.68,,416697,UO_0000065,23.87,0.44,5.23,11.74,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3904737,,None,372.36,0,4.06,BDBM224868,Nc1nnc(-c2ccc3[nH]cc(-c4nccc(-c5ccccc5F)n4)c3c2)o1,IC50,'=',7.002,nM,8.15,,393146,UO_0000065,21.9,0.4,4.09,7.66,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4516982,BI 1935,None,498.47,0,3.8,EUB0000542,CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O,% Control,,100,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507283,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL1204914,,None,239.23,0,3.19,14,O=C(O)c1cc2cc(-c3cccnc3)ccc2o1,IC50,'=',7100,nM,5.15,,,UO_0000065,21.52,0.39,1.96,8.13,0,CHEMBL1786238,Inhibition of human Pim2 using 5-FAM-RSRHSSYPAGT-CONH2 as substrate after 90 mins by off-chip mobility shift method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1781944,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL3980526,,None,377.45,0,2.81,BDBM238552,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1CCCOC1,IC50,'=',4,nM,8.4,,416684,UO_0000065,22.25,0.41,5.59,9.14,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3969013,,None,364.45,0,2.37,BDBM238679,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC(C)(C)CN,IC50,'=',10.7,nM,7.97,,416788,UO_0000065,21.87,0.4,5.6,7.33,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4086917,,None,474.05,1,5.37,15,CN(C)Cc1ccc(-c2c(-c3ccc(N4CCN(C)CC4)cc3)n(C)c3nccc(Cl)c23)cc1,IC50,'=',3300,nM,5.48,,,UO_0000065,11.56,0.22,0.11,19.9,0,CHEMBL4047686,Inhibition of PIM2 (unknown origin) assessed as reduction in full length human BAD phosphorylation at Ser112 residues by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4043256,1,Scientific Literature,Bioorg Med Chem Lett,2017,None,
CHEMBL3984839,,None,468.49,0,3.57,BDBM249038,FC(F)(F)Cn1cc(-c2cc3c(cn2)cnn3-c2cccc(N3CC4(CCCCN4)C3)n2)cn1,Ki,'=',194,nM,6.71,,434242,UO_0000065,14.33,0.27,3.14,8.75,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1888586,,None,353.4,0,3.2,SB-223133,Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1,Inhibition,'=',1.27,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3393699,,None,392.41,0,3.74,13h,Fc1cccc(F)c1-c1ccc2[nH]nc(-c3cncc(NC4CCNC4)n3)c2c1,IC50,'=',18,nM,7.75,,,UO_0000065,19.74,0.36,4,9.86,0,CHEMBL3396420,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as phosphorylation of biotinylated-BAD peptide at Serine 112 residue,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3392976,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL3393701,,None,407.42,0,4.1,13j,Fc1cccc(F)c1-c1ccc2[nH]nc(-c3cncc(OC4CCNCC4)n3)c2c1,IC50,'=',33,nM,7.48,,,UO_0000065,18.36,0.34,3.38,9.88,0,CHEMBL3396420,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as phosphorylation of biotinylated-BAD peptide at Serine 112 residue,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3392976,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL3950494,,None,373.39,0,4.45,BDBM238415,O=C1NCCc2[nH]c(-c3cccc4ccc(Oc5cccc(F)c5)nc34)cc21,IC50,'=',9.1,nM,8.04,,416190,UO_0000065,21.54,0.39,3.59,12,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1336,SORAFENIB,4,464.83,1,5.55,3,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3676258,,None,415.47,0,3.66,11,N[C@H]1CCCN(c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C1,Ki,'=',5,nM,8.3,,,UO_0000065,19.98,0.39,4.64,9.87,0,CHEMBL3750240,Inhibition of PIM2 kinase (unknown origin) using NH2-AGAGRSRHSSYPAGT-OH as substrate by kinase-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3745712,1,Scientific Literature,J Med Chem,2015,None,
CHEMBL3137331,DEFACTINIB,2,510.5,1,2.4,EUB0000138,CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1,% Control,,100,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507299,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 100.0 nM
CHEMBL4563315,,None,325.85,0,3.97,29,CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N,Activity,'=',100,%,,,,UO_0000187,,,,,0,CHEMBL4333574,Binding affinity to wild-type human partial length PIM2 (M1 to E291 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4330132,1,Scientific Literature,Bioorg Med Chem Lett,2019,None,
CHEMBL1084546,PF-00562271,1,507.5,1,3.14,PF-562271,CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL2103842,VARLITINIB,2,466.95,1,5.25,Varlitinib,C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL482968,ENMD-2076,2,375.48,0,3.17,ENMD-2076,Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3977073,,None,390.39,0,4.54,BDBM238382,O=C1NCCc2[nH]c(-c3cccc4ccc(Nc5ccc(F)cc5F)nc34)cc21,IC50,'=',12.7,nM,7.9,,416160,UO_0000065,20.23,0.37,3.36,11.31,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL573176,,None,249.27,0,2.9,11,NC(=O)c1c[nH]c2c1ccc1c3ccccc3[nH]c12,Activity,'=',27,%,,,,UO_0000187,,,,,0,CHEMBL1057614,Inhibition of Pim-2 assessed as residual enzyme activity at 10 uM relative to untreated control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154186,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL410456,,None,398.42,0,3.68,D4476,NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1,Activity,'=',90,%,,,,UO_0000187,,,,,1,CHEMBL1061149,Percentage PIM2 activity remaining in the presence of 10uM inhibitor,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL1782513,,None,352.39,0,3.27,21,N[C@H]1CC[C@H](Nc2cncc(-c3ccc4oc(C(=O)O)cc4c3)n2)CC1,IC50,'=',54,nM,7.27,,,UO_0000065,20.62,0.38,4,6.36,0,CHEMBL1786238,Inhibition of human Pim2 using 5-FAM-RSRHSSYPAGT-CONH2 as substrate after 90 mins by off-chip mobility shift method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1781944,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL507361,MIRDAMETINIB,2,482.2,0,2.47,PD-0325901,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,Activity,'=',104,%,,,,UO_0000187,,,,,0,CHEMBL1061149,Percentage PIM2 activity remaining in the presence of 10uM inhibitor,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL377383,,None,383.86,0,2.05,12,CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1Cl,Ki,'>',1400,nM,,,,UO_0000065,,,,,0,CHEMBL866663,Inhibition of Pim2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1138045,1,Scientific Literature,J Med Chem,2006,None,
CHEMBL3394171,,None,352.42,0,3.51,BDBM50061622,CC(C)Oc1cncc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)n1,IC50,'=',1294.16,nM,5.89,,393210,UO_0000065,16.71,0.32,2.38,5.74,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL572881,MOTESANIB,3,373.46,0,4.04,AMG-706,CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21,Kd,'>',10000,nM,,,,UO_0000065,,,,,1,CHEMBL1061184,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150977,1,Scientific Literature,Nat Biotechnol,2008,None,
CHEMBL3978132,,None,428.5,0,3.27,BDBM238723,CC(C)(C)Nc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2c(=O)n1-c1cccnc1,IC50,'=',2.6,nM,8.59,,416832,UO_0000065,20.04,0.37,5.32,8.2,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4077123,,None,647.78,2,6.25,9; CHMFL-BTK-01,C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1,Activity,'=',90,%,,,,UO_0000187,,,,,0,CHEMBL4025322,Inhibition of wild-type human partial length PIM2 (M1 to E291 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4024706,1,Scientific Literature,Eur J Med Chem,2017,None,
CHEMBL3930816,,None,439.57,0,4.24,BDBM248908,CCc1cncc(-c2cc3c(cn2)cnn3-c2ccc(C3CC3)c(N3CCC[C@H](N)C3)n2)c1,Ki,'=',0.187,nM,9.73,,434115,UO_0000065,22.13,0.4,5.49,11.34,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL265470,,None,374.35,0,3.29,STO-609,CC(=O)O.O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21,Activity,'=',9,%,,,Antagonist,UO_0000187,,,,,0,CHEMBL1061086,Percentage PIM2 activity remaining in the presence of 1uM inhibitor,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL148333,,None,265.34,0,0.73,H-8,CNCCNS(=O)(=O)c1cccc2cnccc12,Activity,'=',91,%,,,,UO_0000187,,,,,0,CHEMBL1061086,Percentage PIM2 activity remaining in the presence of 1uM inhibitor,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL1782507,,None,240.22,0,2.59,15,O=C(O)c1cc2cc(-c3cnccn3)ccc2o1,IC50,'=',11900,nM,4.92,,,UO_0000065,20.5,0.37,2.33,6.46,0,CHEMBL1786238,Inhibition of human Pim2 using 5-FAM-RSRHSSYPAGT-CONH2 as substrate after 90 mins by off-chip mobility shift method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1781944,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL3898847,,None,381.47,0,3.55,BDBM224942,COc1cc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)nc(NC(C)C)n1,IC50,'=',87.47,nM,7.06,,393225,UO_0000065,18.5,0.36,3.51,6.16,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3947592,,None,400.47,0,3.94,BDBM224971,CNc1nnc(-c2ccc3[nH]cc(-c4cccc(-n5ccccc5=O)n4)c3c2)s1,IC50,'=',855.58,nM,6.07,,393261,UO_0000065,15.15,0.29,2.13,6.86,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3936230,,None,373.45,0,3.82,BDBM224912,Cc1nccn1-c1cccc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)n1,IC50,'=',23.77,nM,7.62,,393192,UO_0000065,20.41,0.39,3.8,7.76,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3896794,,None,318.34,0,3.13,BDBM224839,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(C5CC5)n4)c3c2)o1,IC50,'=',4.849,nM,8.31,,393121,UO_0000065,26.12,0.47,5.18,7.81,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3933369,,None,368.44,0,4.82,BDBM238403,CC1CNC(=O)c2cc(-c3cccc4ccc(Nc5ccccc5)nc34)[nH]c21,IC50,'=',23.7,nM,7.62,,416181,UO_0000065,20.7,0.37,2.81,10.92,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3980066,,None,369.43,0,4.22,BDBM238541,CC1CNC(=O)c2cc(-c3cccc4ncc(Nc5ccccc5)nc34)[nH]c21,IC50,'=',4.3,nM,8.37,,416264,UO_0000065,22.65,0.41,4.15,10.12,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3651992,,None,453.49,0,3.46,BDBM106898,C[C@@H]1C[C@@H](c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)ccc2N)C[C@@H](N)[C@H]1O,IC50,'=',5,nM,8.3,,225919,UO_0000065,18.3,0.34,4.84,6.53,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3970183,,None,400.45,0,2.04,BDBM248971,Cc1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3C[C@@H](N)CCC3=O)n2)n1,Ki,'=',421,nM,6.38,,434178,UO_0000065,15.92,0.29,4.34,5.51,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4113332,,None,458.45,0,2.01,BDBM248957,O[C@@H]1CNCCN(c2cccc(-n3ncc4cnc(-c5cnn(CC(F)(F)F)c5)cc43)n2)C1,Ki,'=',4.64,nM,8.33,,434164,UO_0000065,18.18,0.34,6.32,8.6,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4112816,,None,386.46,0,2.38,BDBM248960,Cc1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CCNC[C@H]3C)n2)n1,Ki,'=',0.659,nM,9.18,,434167,UO_0000065,23.76,0.43,6.8,10.85,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2004355,,None,375.41,0,0.51,SID103905187,CCOc1nc(C(=O)NCc2ccc(S(N)(=O)=O)cc2)cc(N)c1C#N,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL483158,ALISERTIB,3,518.93,2,5.75,SID137276087,COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL4793492,,None,379.49,0,3.61,AZD1208,N[C@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1,IC50,'=',5,nM,8.3,,,UO_0000065,21.87,0.42,4.69,11,0,CHEMBL4687897,Inhibition of human PIM2 using full length BAD peptide substrate in presence of ATP at Km concentration,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4680285,1,Scientific Literature,Bioorg Med Chem,2020,None,
CHEMBL267228,,None,371.4,0,4.03,SB-431533,OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1,Inhibition,'=',0.72,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL477979,GW785974X,None,350.46,0,3.94,GW785974X,Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1,Inhibition,'=',1.24,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3956717,,None,426.53,0,3.16,BDBM248968,Cc1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CCC4(CCNCC4)C3)n2)n1,Ki,'=',13.7,nM,7.86,,434175,UO_0000065,18.44,0.34,4.7,9.29,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL583788,,None,302.26,0,4.55,12,O=C(c1c[nH]c2c1ccc1c3ccccc3[nH]c12)C(F)(F)F,Activity,'=',30,%,,,,UO_0000187,,,,,0,CHEMBL1057614,Inhibition of Pim-2 assessed as residual enzyme activity at 10 uM relative to untreated control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154186,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL3634776,,None,392.42,0,0.83,26,CN1C(=O)CN(c2cc3c(-c4cccc(N5CCNCC5)n4)n[nH]c3cn2)C1=O,Ki,'=',33,nM,7.48,,,UO_0000065,19.06,0.35,6.65,6.78,0,CHEMBL3636741,Inhibition of Pim2 (unknown origin) using 5FAM-ARKRRRHPSGPPTA as substrate after 90 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632547,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL2218934,,None,257.27,0,1.95,PI3_Kg_Inhibitor,O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1,Residual Activity,'=',22,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3355553,,None,390.41,0,4.78,12a,CO[C@H]1CC[C@H](Nc2ccn3ncc(-c4cccc(C(F)(F)F)c4)c3n2)CC1,IC50,'=',4660,nM,5.33,,,UO_0000065,13.66,0.26,0.55,10.36,0,CHEMBL3375413,Inhibition of Pim2 (unknown origin) using luciferase-luciferin based ATP detection reagent by Kinase-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3351833,1,Scientific Literature,ACS Med Chem Lett,2015,None,
CHEMBL3634780,,None,331.38,0,2.45,15,NCCNc1cccc(-c2n[nH]c3cnc(-c4cccnc4)cc23)n1,Ki,'=',3,nM,8.52,,,UO_0000065,25.72,0.47,6.07,8.09,0,CHEMBL3636741,Inhibition of Pim2 (unknown origin) using 5FAM-ARKRRRHPSGPPTA as substrate after 90 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632547,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL3634782,,None,371.45,0,2.8,17,Cc1cncc(-c2cc3c(-c4cccc(N5CCNCC5)n4)n[nH]c3cn2)c1,Ki,'=',0.3,nM,9.52,,,UO_0000065,25.64,0.46,6.72,11.53,0,CHEMBL3636741,Inhibition of Pim2 (unknown origin) using 5FAM-ARKRRRHPSGPPTA as substrate after 90 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632547,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL3913112,,None,439.45,0,3.69,BDBM192582,N[C@H]1C[C@@H](F)CN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1,IC50,'=',3.2,nM,8.49,,344647,UO_0000065,19.33,0.36,4.8,10.07,1,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL191384,,None,372.46,0,3.94,K00543,N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1,Thermal melting change,'=',7.4,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL1952136,,None,416.45,0,4.03,8c,FC(F)(F)c1cccc(-n2nnc3ccc(NCC4CC5(CCNCC5)C4)nc32)c1,IC50,'=',853,nM,6.07,,,UO_0000065,14.57,0.28,2.04,8.97,0,CHEMBL1954567,Inhibition of PIM2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1949661,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL3941443,,None,422.44,0,3.14,BDBM192573,N[C@H]1CCCN(c2ncncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1,IC50,'=',110,nM,6.96,,344635,UO_0000065,16.47,0.31,3.82,7.15,1,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL258805,SU-9516,1,241.25,0,1.91,SU9516,COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2,Residual Activity,'=',19,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL608533,MIDOSTAURIN,4,570.65,2,5.91,PKC-412,CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,Kd,'>',10000,nM,,,,UO_0000065,,,,,1,CHEMBL1061184,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150977,1,Scientific Literature,Nat Biotechnol,2008,None,
CHEMBL2002479,,None,448.91,0,4.86,SID103904647,NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccc(Cl)cc5o4)cc3)c1)CNC2=O,Ki,'=',1000,nM,6,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1997623,,None,411.39,1,5.47,SID103904367,Nc1n[nH]c2cc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)ccc12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1967094,,None,367.86,0,4.87,SID103904999,O=C(NCc1ccc(Cl)cc1)c1cc2c(-c3ccccc3)n[nH]c2s1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3651985,,None,426.54,0,4.12,BDBM106889,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(C3CCCCC3)n2)C[C@@H](N)[C@@H]1O,IC50,'=',21,nM,7.68,,225910,UO_0000065,18,0.34,3.56,7.59,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1972659,,None,358.44,0,4.25,SID103905060,Cc1c(O)ccc2c1CCCC2=NNC(=O)Cc1cccc2ccccc12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL174426,,None,354.21,0,4.02,BPIQ_I,Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21,Residual Activity,'=',97,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL86943,,None,310.35,0,3.3,VEGF_Receptor_2_Kinase_Inhibitor_I,CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C,Residual Activity,'=',101,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3974890,,None,355.4,0,3.28,BDBM238748,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1-c1ccccn1,IC50,'=',167,nM,6.78,,416857,UO_0000065,19.07,0.34,3.5,8.11,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2442313,,None,314.39,0,4.37,9c,c1ccc2cc(-c3cnn4ccc(NCC5CC5)nc34)ccc2c1,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL2446210,Inhibition of Pim2 (unknown origin) using STK1 as substrate preincubated for 30 mins followed by substrate and ATP addition at > 5000 nM after 60 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2440090,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL3904737,,None,372.36,0,4.06,BDBM224868,Nc1nnc(-c2ccc3[nH]cc(-c4nccc(-c5ccccc5F)n4)c3c2)o1,IC50,'=',7.002,nM,8.15,,393032,UO_0000065,21.9,0.4,4.09,7.66,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1966703,,None,325.39,0,4.06,SID103905100,Cc1n[nH]c2c1C(c1ccccc1F)C1=C(CC(C)(C)CC1=O)N2,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3972504,,None,371.4,0,4.01,BDBM238828,O=C1NCCc2[nH]c(-c3cccc4ccc(Oc5cccc(O)c5)nc34)cc21,IC50,'=',15.8,nM,7.8,,416217,UO_0000065,21.01,0.38,3.79,8.94,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3918158,,None,369.86,0,3.77,BDBM238683,CC(C)(C)Nc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2nc1Cl,IC50,'=',2.25,nM,8.65,,416792,UO_0000065,23.38,0.45,4.88,10.46,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL331237,TRICIRIBINE,None,320.31,0,-1.89,API_2,CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23,Residual Activity,'=',123,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL35820,,None,388.26,0,4.93,56,CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC,Residual Activity,'=',79,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3941570,,None,411.49,0,1.45,BDBM238657,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N1CC(S(C)(=O)=O)C1,IC50,'=',26.7,nM,7.57,,416766,UO_0000065,18.41,0.36,6.12,7.01,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL261454,,None,272.31,0,3.69,LY-364947,c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1,Residual Activity,'=',109,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL278724,SB-202474,None,279.34,0,3.71,SB-202474,CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1,Residual Activity,'=',125,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3907732,,None,375.48,0,3.2,BDBM238491,N[C@H]1CCC[C@@H](Nc2ccc3cccc(-c4cc5c([nH]4)CCNC5=O)c3n2)C1,IC50,'=',22.6,nM,7.65,,416229,UO_0000065,20.36,0.37,4.45,7.98,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4107310,,None,418.48,0,3.39,BDBM192644,C[C@@H]1CC[C@@H](N)CN1c1ccncc1Nc1ncc2ccc(-c3ncccc3F)nn12,IC50,'=',1.3,nM,8.89,,344691,UO_0000065,21.23,0.39,5.5,9.14,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3676290,,None,414.48,0,4.72,12,N[C@H]1CCC[C@@H](c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C1,Ki,'=',29,nM,7.54,,,UO_0000065,18.19,0.35,2.82,9.32,0,CHEMBL3750240,Inhibition of PIM2 kinase (unknown origin) using NH2-AGAGRSRHSSYPAGT-OH as substrate by kinase-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3745712,1,Scientific Literature,J Med Chem,2015,None,
CHEMBL3735890,,None,405.46,0,2.55,11,COc1ccc2c(c1C(C)N1CCNCC1)O/C(=C\c1n[nH]c3ncccc13)C2=O,Inhibition,'=',30.2,%,,,,UO_0000187,,,,,0,CHEMBL3739158,Inhibition of PIM2 (unknown origin) at 200 nM by electrophoretic mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3734671,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL3896244,,None,435.48,0,3.99,22j,C[C@@H]1CCN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C[C@H]1N,IC50,'=',0.18,nM,9.74,,,UO_0000065,22.38,0.42,5.75,11.55,0,CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3864151,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL1794060,GW575533A,None,332.79,0,4.1,GW575533A,COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl,Inhibition,'=',1.95,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL66004,GW578748X,None,284.28,0,1.51,GW578748X,COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O,Inhibition,'=',4.24,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3664631,,None,407.45,0,3.44,BDBM104257,CC(C)(CNC(=O)CF)COc1cccc2ccc(-c3nnc4ccccn34)nc12,IC50,'=',951.8,nM,6.02,,222668,UO_0000065,14.78,0.27,2.58,7.4,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3946889,,None,449.56,1,5.6,BDBM238655,Cc1nc2cccc(-c3cc4c([nH]3)C(C)N(C(=O)OC(C)(C)C)C4=O)c2nc1NC(C)(C)C,IC50,'=',75,nM,7.12,,416764,UO_0000065,15.85,0.29,1.52,7.11,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3664612,,None,407.45,0,3.42,BDBM104232,COc1ccc2nnc(-c3ccc4cccc(OCC5(F)CCNCC5)c4n3)n2c1,IC50,'=',384.1,nM,6.42,,222643,UO_0000065,15.75,0.29,3,8.72,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3926782,,None,335.41,0,3.12,BDBM238563,CC(C)(C)Nc1cnc2cccc(-c3cc4c([nH]3)CCNC4=O)c2n1,IC50,'=',0.3,nM,9.52,,416685,UO_0000065,28.39,0.52,6.4,11.51,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3800585,,None,471.57,0,2.17,9,C[C@H]1CN(c2cccc3nc(-c4nc(-c5cc(C(=O)N(C)C)ccn5)cnc4N)n(C)c23)CCN1,IC50,'=',730,nM,6.14,,,UO_0000065,13.01,0.24,3.97,5.2,0,CHEMBL3803176,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3797138,1,Scientific Literature,J Med Chem,2016,None,
CHEMBL3325693,,None,268.71,0,3.5,14,Nc1cc2[nH]ncc2c2c1ncc1ccc(Cl)cc12,Activity,'=',57,%,,,,UO_0000187,,,,,0,CHEMBL3369948,Inhibition of full-length human PIM2 using RSRHSSYPAGT as substrate assessed as residual kinase activity at 10 uM after 30 mins in presence of [gamma-33P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352653,1,Scientific Literature,Bioorg Med Chem,2014,None,
CHEMBL475761,GW784684X,None,564.09,2,6.81,GW784684X,CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1,Inhibition,'=',-0.52,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL4439094,,None,345.79,0,2.4,4t,O=C1NC2(CCCCC2)n2c1c(Cl)cc(Nc1ccncn1)c2=O,Activity,'=',100,%,,,,UO_0000187,,,,,0,CHEMBL4350419,Inhibition of human PIM2 assessed as residual activity at 10 uM using RSRHSSYPAGT as substrate by [gamma-33P]-ATP assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4346756,1,Scientific Literature,Bioorg Med Chem Lett,2019,None,
CHEMBL3393721,,None,391.43,0,4.96,2,Fc1cccc(F)c1-c1ccc2[nH]nc(-c3cncc(N4CCCCC4)n3)c2c1,IC50,'=',3000,nM,5.52,,,UO_0000065,14.11,0.26,0.56,9.57,0,CHEMBL3396420,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as phosphorylation of biotinylated-BAD peptide at Serine 112 residue,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3392976,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL3651971,,None,438.48,0,3.88,BDBM106875,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3ccccc3F)n2)C[C@@H](N)[C@H]1O,IC50,'=',8,nM,8.1,,225896,UO_0000065,18.47,0.35,4.22,8.01,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1077604,ROHITUKINE,None,305.33,0,1.29,1,Cc1cc(=O)c2c(O)cc(O)c([C@H]3CCN(C)C[C@H]3O)c2o1,Activity,'=',67,%,,,,UO_0000187,,,,,0,CHEMBL3829299,Inhibition of human PIM2 (2 to 334 residues) assessed as remaining enzyme activity at 50 uM after 30 mins by 33P-ATP filter-binding assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3826966,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL3746909,,None,423.47,0,3.85,5,C[C@@H]1C[C@H](N)CN(c2ccncc2NC(=O)c2ccc(F)c(-c3ccccc3F)n2)C1,Ki,'<',3,nM,,,,UO_0000065,,,,,0,CHEMBL3750240,Inhibition of PIM2 kinase (unknown origin) using NH2-AGAGRSRHSSYPAGT-OH as substrate by kinase-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3745712,1,Scientific Literature,J Med Chem,2015,None,
CHEMBL3676284,,None,429.5,0,3.91,13,C[C@@H]1C[C@H](N)CN(c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C1,Ki,'<',3,nM,,,,UO_0000065,,,,,0,CHEMBL3750240,Inhibition of PIM2 kinase (unknown origin) using NH2-AGAGRSRHSSYPAGT-OH as substrate by kinase-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3745712,1,Scientific Literature,J Med Chem,2015,None,
CHEMBL495771,GW708336X,None,337.39,0,1.6,GW708336X,c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1,Inhibition,'=',-0.29,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1909358,GW654652C,None,489,0,3.98,GW654652C,CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl,Inhibition,'=',0.05,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1642,IMATINIB MESYLATE,4,589.72,0,4.59,K00477,CS(=O)(=O)O.Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1,Thermal melting change,'=',0.6,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL69757,GW817394X,None,362.37,0,3.41,GW817394X,COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1,Inhibition,'=',-2.82,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3897323,,None,435.48,0,3.99,22o,C[C@H]1C[C@H](N)CN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1,IC50,'=',0.79,nM,9.1,,,UO_0000065,20.9,0.39,5.11,10.79,0,CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3864151,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL1969664,AZD-1080,1,334.38,0,2.64,SID103905163,N#Cc1ccc2[nH]c(O)c(-c3ccc(CN4CCOCC4)cn3)c2c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3691984,,None,615.63,2,5.35,BDBM152007,COC(=O)N[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C4(F)CCOCC4)cc3F)n2)C[C@@H]1C,IC50,'=',23.47,nM,7.63,,292262,UO_0000065,12.39,0.24,2.28,5.94,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1972250,,None,312.33,0,2.9,SID103904815,C#Cc1cc2c(cc1OC)-c1[nH]nc(-c3ccc(C#N)nc3)c1C2,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1973098,,None,267.33,0,1.89,SID103905205,COc1cc(C=C2SC(=S)NC2=O)ccc1O,Ki,'=',25.12,nM,7.6,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1991728,,None,746.89,2,1.02,SID103905366,CC(=NNC(=N)N)c1cc(NC(=O)NCCCCCCNC(=O)Nc2cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c2)cc(C(C)=NNC(=N)N)c1,Ki,'=',199.53,nM,6.7,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1992937,,None,269.26,0,2.92,SID103905536,Cc1ccc(Nc2nc3ccc([N+](=O)[O-])cc3[nH]2)nc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3903273,,None,404.38,0,4.78,BDBM192622,Cc1oncc1-c1ccncc1Nc1ncc2ccc(-c3c(F)cccc3F)nn12,IC50,'>',1000,nM,,,344698,UO_0000065,,,,,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1987359,,None,355.44,0,2.23,SID103905554,CCCCNc1ccc2c3c(cccc13)C(=O)N(CCNCCO)C2=O,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1985311,,None,391.41,0,4.09,SID103904855,Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cc(CO)ccc4F)cc3)c12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1991434,,None,388.22,0,3.81,SID103905415,COc1ccc(C=C2C(=O)ON=C2c2ccc(Br)cc2)cc1OC,Ki,'=',316.23,nM,6.5,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3660095,,None,423.47,0,4.1,BDBM104228,FCCN1CCC(F)(COc2cccc3ccc(-c4nnc5ccccn45)nc23)CC1,IC50,'=',409,nM,6.39,,222639,UO_0000065,15.09,0.28,2.29,11.5,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL13972,,None,440.48,0,4.73,SB-242721,N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1,Inhibition,'=',0.58,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3660087,,None,399.38,0,3.46,BDBM104216,Fc1cc(OC2CCNCC2(F)F)c2nc(-c3nnc4ccccn34)ccc2c1,IC50,'=',506,nM,6.3,,222627,UO_0000065,15.76,0.3,2.84,9.79,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3660092,,None,395.41,0,3.55,BDBM104225,Fc1ccc2nnc(-c3ccc4cccc(OC5CCNCCC5F)c4n3)n2c1,IC50,'=',439.6,nM,6.36,,222636,UO_0000065,16.08,0.3,2.81,9.88,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL441702,GSK-270822A,None,396.45,0,4.23,GSK270822A,CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1,Inhibition,'=',0.51,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL69757,GW817394X,None,362.37,0,3.41,GW817394X,COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1,Inhibition,'=',-3.26,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL230911,GSK-625137A,None,289.34,0,3.1,GSK625137A,NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N,Inhibition,'=',0.75,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3660077,,None,453.52,1,5.08,BDBM104204,FC1(COc2cccc3ccc(-c4nnc5ccc(-c6ccccc6)cn45)nc23)CCNCC1,IC50,'=',142,nM,6.85,,222617,UO_0000065,15.1,0.28,1.77,10.64,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3687414,,None,507.52,1,4.49,BDBM151807,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1n1ccnn1,IC50,'=',2.53,nM,8.6,,292063,UO_0000065,16.94,0.32,4.11,7.7,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3354525,,None,317.32,0,3.74,9b,O=C(Nc1cccnc1)c1csc(-c2c(F)cccc2F)n1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3376647,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352230,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL3354517,,None,431.46,0,4.42,3e,O=C(Nc1cnccc1O[C@H]1CC[C@H](O)CC1)c1csc(-c2c(F)cccc2F)n1,IC50,'=',36,nM,7.44,,,UO_0000065,17.25,0.34,3.02,8.83,0,CHEMBL3376647,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352230,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL3926975,,None,426.47,0,3.02,BDBM238791,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@H]1C[C@@H](NCC(F)F)C1,IC50,'=',2,nM,8.7,,416900,UO_0000065,20.4,0.38,5.68,9.18,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3965218,,None,336.36,0,3.04,BDBM224817,CC(C)Oc1cncc(-c2c[nH]c3ccc(-c4nnc(N)o4)cc23)n1,IC50,'=',5.177,nM,8.29,,393099,UO_0000065,24.63,0.45,5.25,7.16,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3652623,,None,415.5,0,2.44,BDBM119383,Cn1ncc(NC(=O)c2nc(-c3ccccc3F)sc2N)c1N1CCC[C@H](N)C1,Ki,'=',20.1,nM,7.7,,246150,UO_0000065,18.52,0.36,5.26,6.69,0,CHEMBL3707982,Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1794050,GW429374A,None,508.6,1,5.47,GW429374A,Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1,Inhibition,'=',46.51,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL207410,GW772405X,None,486.93,1,5.35,GW772405X,CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1,Inhibition,'=',-1.75,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3912242,,None,435.48,0,4,22e,CN[C@H]1CCCN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1,IC50,'=',31,nM,7.51,,,UO_0000065,17.24,0.32,3.51,10.67,0,CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3864151,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL3944210,,None,366.38,0,3.88,BDBM192564,CN(C)c1ccncc1Nc1ncc2ccc(-c3c(F)cccc3F)nn12,IC50,'>',1000,nM,,,344556,UO_0000065,,,,,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1684662,,None,352.4,0,4.53,4g,O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1,Inhibition,'=',96,%,,,,UO_0000187,,,,,0,CHEMBL1686068,Inhibition of Pim-2 at 1 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1681705,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL408953,,None,311.34,0,2.38,K00232,O=C1C=C2C(=Nc3c2c2c(c4c3=NC3=C4CCC=C3)C=NC=2)CC1,Thermal melting change,'=',5.2,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL86943,,None,310.35,0,3.3,K00004,CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C,Thermal melting change,'=',0.1,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL120077,,None,325.34,0,3.88,K00595a,COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2,Thermal melting change,'=',0.2,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL3651900,,None,472.47,0,3.72,BDBM106804,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(O)cc3F)n2)C[C@@H](N)[C@@H]1O,IC50,'=',3,nM,8.52,,225825,UO_0000065,18.04,0.34,4.8,7.02,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4075290,,None,372.42,0,4.32,33,O=C1NC(=S)S/C1=C\c1csc(-c2ccc(C(F)(F)F)cc2)n1,Delta Tm,'=',9.7,degrees C,,,,UO_0000027,,,,,0,CHEMBL4029682,Inhibition of recombinant PIM2 (unknown origin) assessed as change in melting temperature at 10 uM by SYPRO orange dye-based differential scanning fluorimetry,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4028814,1,Scientific Literature,Bioorg Med Chem,2017,None,
CHEMBL1909414,,None,508.02,0,4.87,SB-590885-AAD,CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O,Inhibition,'=',-0.23,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1182777,,None,314.3,0,3.29,STO_609,O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21,Residual Activity,'=',14,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL306498,ALOISINE,None,281.36,0,3.98,Aloisine,CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12,Residual Activity,'=',112,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2006933,,None,242.3,0,3.21,SID103905576,CSc1cnc2c(ccc3cnccc32)c1O,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL4278882,,None,384.53,0,2.74,30,CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1,Inhibition,'=',-5,%,,,,UO_0000187,,,,,0,CHEMBL4266609,Inhibition of human PIM2 expressed in Escherichia coli at 1 uM relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4265877,1,Scientific Literature,Bioorg Med Chem,2018,None,
CHEMBL4247704,,None,410.48,0,4.63,7g,CC(C)CN(C(=O)c1cccnc1)c1c2ccccc2c(=O)n2c1[nH]c1ccccc12,Activity,'=',100,%,,,,UO_0000187,,,,,0,CHEMBL4232932,Inhibition of human PIM2 (M1 to E291 residues) expressed in bacterial expression system assessed as residual activity at 5 uM by KINOMEscan assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4229410,1,Scientific Literature,Bioorg Med Chem,2018,None,
CHEMBL3394067,,None,378.46,0,3.17,16,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(N5CCOCC5)n4)c3c2)s1,IC50,'=',59,nM,7.23,,,UO_0000065,19.1,0.37,4.06,7.78,1,CHEMBL3395659,Inhibition of full length recombinant PIM2 (unknown origin) using biotinylated-BAD peptide as substrate assessed as phosphorylation at serine 112 after 90 mins by HTRF method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3393014,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL3394074,,None,351.44,0,3.55,23,CC(C)Nc1cncc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)n1,IC50,'=',945,nM,6.03,,,UO_0000065,17.14,0.33,2.47,5.72,0,CHEMBL3395662,Inhibition of PIM2 in human U2OS cells assessed as phosphorylation of BAD,B,BAO_0000219,cell-based format,Homo sapiens,None,None,U2OS,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3393014,1,Scientific Literature,Bioorg Med Chem Lett,2015,CHEMBL3307757,
CHEMBL1909356,GW569530A,None,650.15,2,6.23,GW569530A,CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl,Inhibition,'=',-0.54,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL422897,,None,401.85,0,3.3,SID103905277,CN1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)C(O)C1,Ki,'=',1000,nM,6,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1996931,,None,366.85,0,3.74,SID103904574,O=C(NC(CO)Cc1ccc(Cl)cc1)c1ccc(-c2ccncc2)cc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1964413,,None,411.31,0,4.91,SID103904546,FC(F)(F)c1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c(C(F)(F)F)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2004934,,None,350.39,0,4.39,SID103904558,COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(F)c2)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1957498,,None,575.49,1,1.95,20,CS(=O)(=O)N1CCN(Cc2nc3c(N4CCOCC4)nc(-c4cccc5[nH]ncc45)cn3c2Br)CC1,Inhibition,'=',50,%,,,,UO_0000187,,,,,0,CHEMBL1959621,Inhibition of PIM2 at 5 to 10 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1955823,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL524057,GW683768X,None,280.34,0,2.32,GW683768X,CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1,Inhibition,'=',1.22,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1977619,,None,245.26,0,2.16,SID103905074,O=C(O)c1cc(-c2cccs2)n2nccc2n1,Ki,'=',5011.87,nM,5.3,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1974328,,None,340.43,0,2.31,SID103904806,Cc1cccc(Nc2nc(NC3CCCCC3N)cnc2C(N)=O)c1,Ki,'=',100,nM,7,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1994241,,None,370.21,0,4.1,SID103904926,COc1cc(C=C(C#N)c2nc3ccccc3[nH]2)c(Br)cc1O,Ki,'=',79.43,nM,7.1,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1952126,,None,432.45,0,3.91,7f,FC(F)(F)Oc1cccc(-n2nnc3ccc(NCC4CC5(CCNCC5)C4)nc32)c1,IC50,'=',404,nM,6.39,,,UO_0000065,14.78,0.28,2.48,8.32,0,CHEMBL1954567,Inhibition of PIM2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1949661,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL67241,GW794607X,None,372.44,0,3.48,GW794607X,CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1,Inhibition,'=',0.32,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1957502,,None,377.41,0,1.47,25b,CNC(=O)c1cn2cc(-c3cccc4[nH]ncc34)nc(N3CCOCC3)c2n1,Inhibition,'=',50,%,,,,UO_0000187,,,,,0,CHEMBL1959621,Inhibition of PIM2 at 5 to 10 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1955823,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL1957508,,None,435.49,0,1.88,25h,COCCCNC(=O)c1cn2cc(-c3cccc4[nH]ncc34)nc(N3CCOCC3)c2n1,Inhibition,'=',50,%,,,,UO_0000187,,,,,0,CHEMBL1959621,Inhibition of PIM2 at 5 to 10 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1955823,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL220243,GW406731X,None,283.33,0,3.36,GW406731X,COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1,Inhibition,'=',-0.56,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL306380,,None,281.36,0,3.14,SID103904783,Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1965988,,None,427.53,0,4.81,SID103904300,Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN)cnc(N)c34)cc2)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2397522,,None,256.7,0,3.43,7c,Nc1cc2cn[nH]c2c2c1[nH]c1ccc(Cl)cc12,Activity,'=',115,%,,,,UO_0000187,,,,,0,CHEMBL2401343,Inhibition of human PIM2 assessed as residual activity using RSRHSSYPAGT as substrate at 1 uM after 30 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2396576,1,Scientific Literature,Bioorg Med Chem,2013,None,
CHEMBL2397600,,None,286.68,0,3.76,6c,O=[N+]([O-])c1cc2cn[nH]c2c2c1[nH]c1ccc(Cl)cc12,Activity,'=',90,%,,,,UO_0000187,,,,,0,CHEMBL2401343,Inhibition of human PIM2 assessed as residual activity using RSRHSSYPAGT as substrate at 1 uM after 30 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2396576,1,Scientific Literature,Bioorg Med Chem,2013,None,
CHEMBL2397598,,None,252.23,0,3.11,6a,O=[N+]([O-])c1cc2cn[nH]c2c2c1[nH]c1ccccc12,Activity,'=',76,%,,,,UO_0000187,,,,,0,CHEMBL2401343,Inhibition of human PIM2 assessed as residual activity using RSRHSSYPAGT as substrate at 1 uM after 30 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2396576,1,Scientific Literature,Bioorg Med Chem,2013,None,
CHEMBL257113,GW734508X,None,333.39,0,3.85,GW734508X,Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1,Inhibition,'=',0.91,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL2397528,,None,256.7,0,3.43,16c,Nc1cc2[nH]ncc2c2c1[nH]c1ccc(Cl)cc12,Activity,'=',107,%,,,,UO_0000187,,,,,0,CHEMBL2401343,Inhibition of human PIM2 assessed as residual activity using RSRHSSYPAGT as substrate at 1 uM after 30 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2396576,1,Scientific Literature,Bioorg Med Chem,2013,None,
CHEMBL261440,,None,313.31,0,3.86,SB-735465,O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1,Inhibition,'=',0.05,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3652022,,None,456.47,0,4.75,BDBM106928,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(O)cc3F)n2)C1,IC50,'=',1,nM,9,,225949,UO_0000065,19.72,0.37,4.25,8.9,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3634777,,None,389.43,0,3.96,12,Fc1ccccc1-c1n[nH]c2cnc(-c3cnccc3O[C@@H]3CCCNC3)cc12,Ki,'=',1.7,nM,8.77,,,UO_0000065,22.52,0.41,4.81,11.58,0,CHEMBL3636741,Inhibition of Pim2 (unknown origin) using 5FAM-ARKRRRHPSGPPTA as substrate after 90 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632547,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL496009,,None,475.45,1,5.43,21n,CSc1cc(Oc2ccnc3[nH]c(=O)[nH]c23)ccc1NC(=O)Nc1cccc(C(F)(F)F)c1,Residual_activity,'=',100,%,,,,UO_0000187,,,,,0,CHEMBL1003324,Inhibition of PIM2 at 1 uM relative to control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1136991,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL210963,,None,434.47,0,1.54,SID103905193,CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1C#N,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1984711,,None,425.49,1,5.03,SID103905215,COc1cc(Nc2nccc(Nc3cc(C4CCCCC4)no3)n2)cc(OC)c1OC,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3297764,,None,530.09,1,3.93,BDBM50021620,CN1CCN(C[C@@H](NC(=O)C[C@H]2CNC(=O)c3cc(-c4cc(Cl)ccc4F)cn32)C2CCCCC2)CC1,IC50,'=',132,nM,6.88,,330372,UO_0000065,12.98,0.25,2.95,9.88,0,CHEMBL3887311,Kinase Inhibition Assay: Method for PIM2 Kinase Inhibition Assay: Dowex Technique i. Kinase Buffer (KB)The buffer for PIM2 assay was composed of HEPES 50 mM,,,,,,,,,,,,,,,,,,,,,,
CHEMBL372474,GW678313X,None,452.51,1,5.69,GW678313X,CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1,Inhibition,'=',0.73,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL477978,GW782907X,None,390.53,0,4.86,GW782907X,Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1,Inhibition,'=',1.66,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL441702,GSK-270822A,None,396.45,0,4.23,GSK270822A,CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1,Inhibition,'=',0.77,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL179583,,None,363.8,0,4.77,K00247,NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1,Thermal melting change,'=',1,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL205158,GW695874X,None,427.51,0,3.91,GW695874X,c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1,Inhibition,'=',7.01,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL218969,GW445015X,None,252.32,0,2.92,GW445015X,CNC(=O)c1cncc(/C=C/c2ccccc2C)c1,Inhibition,'=',1.06,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL14112,SB-210313,None,366.44,0,3.47,SB-210313,Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1,Inhibition,'=',0.84,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL608533,MIDOSTAURIN,4,570.65,2,5.91,PKC-412,CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,Kd,'=',3100,nM,5.51,,,UO_0000065,9.65,0.17,-0.4,7.09,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL2420900,,None,362.48,0,2.93,42,c1ccc(CC2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1,Inhibition,'=',21,%,,,,UO_0000187,,,,,0,CHEMBL2422098,Inhibition of PIM2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2417369,1,Scientific Literature,Bioorg Med Chem,2013,None,
CHEMBL3691952,,None,581.6,1,4.51,BDBM151974,COCCOc1cc(F)c(-c2nc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@@H](n4ccnn4)[C@@H](C)C3)ccc2F)c(F)c1,IC50,'=',5.31,nM,8.28,,292229,UO_0000065,14.23,0.27,3.76,6.36,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3393716,,None,430.49,0,3.93,18i,Nc1ccc(-c2ccc3[nH]nc(-c4cncc(O[C@H]5CNCCC56CC6)n4)c3c2)c(F)c1,IC50,'=',0.4,nM,9.4,,,UO_0000065,21.83,0.4,5.47,9.24,0,CHEMBL3396420,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as phosphorylation of biotinylated-BAD peptide at Serine 112 residue,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3392976,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL3892307,,None,438.44,0,2.75,BDBM192563,O[C@H]1CCN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C[C@@H]1O,IC50,'=',8,nM,8.1,,344555,UO_0000065,18.47,0.35,5.35,8.19,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3891942,,None,363.42,0,2.93,BDBM238622,CC(C)(C)Nc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2nc1C=O,IC50,'=',11.8,nM,7.93,,416729,UO_0000065,21.82,0.4,5,7.95,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL124660,TANDUTINIB,2,562.72,2,5.03,Tandutinib,COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3813873,PEXIDARTINIB,4,417.82,1,5.23,Pexidartinib,FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL939,GEFITINIB,4,446.91,0,4.28,Iressa,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1,Kd,,,,,,Not Active,,,,,,0,CHEMBL859489,Average Binding Constant for PIM2; NA=Not Active at 10 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144455,1,Scientific Literature,Nat Biotechnol,2005,None,
CHEMBL496782,,None,235.26,0,2.02,12a,COc1cccc(/C=C2\SC(=O)NC2=O)c1,IC50,'=',40,nM,7.4,,,UO_0000065,31.45,0.63,5.38,13.35,0,CHEMBL957366,Inhibition of human recombinant Pim2 by ATP depletion assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139352,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL101253,VATALANIB,3,346.82,1,5.01,vatalanib,Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1,Kd,,,,,,Not Active,,,,,,0,CHEMBL859489,Average Binding Constant for PIM2; NA=Not Active at 10 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144455,1,Scientific Literature,Nat Biotechnol,2005,None,
CHEMBL65884,GW817396X,None,362.37,0,3.41,GW817396X,COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1,Inhibition,'=',-0.5,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL119385,NEFLAMAPIMOD,2,436.27,1,5.49,VX-745,O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl,Kd,,,,,,Not Active,,,,,,0,CHEMBL859489,Average Binding Constant for PIM2; NA=Not Active at 10 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144455,1,Scientific Literature,Nat Biotechnol,2005,None,
CHEMBL388978,STAUROSPORINE,None,466.54,0,4.35,staurosporine,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,Kd,'=',4,nM,8.4,,,UO_0000065,18,0.33,4.05,12.09,0,CHEMBL859489,Average Binding Constant for PIM2; NA=Not Active at 10 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144455,1,Scientific Literature,Nat Biotechnol,2005,None,
CHEMBL3660048,,None,377.42,0,3.41,BDBM104169,FC1CCNCCC1Oc1cccc2ccc(-c3nnc4ccccn34)nc12,IC50,'=',96,nM,7.02,,222583,UO_0000065,18.59,0.34,3.61,10.91,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3960373,,None,397.45,0,3.57,BDBM238825,CCn1c(NC(C)(C)C)nc2c(-c3cc4c([nH]3)[C@@H](C)NC4=O)c(F)ccc2c1=O,IC50,'=',0.0741,nM,10.13,,416934,UO_0000065,25.49,0.48,6.56,11.03,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3902417,,None,358.41,0,1.68,BDBM248913,c1cc(N2CCNCC2)nc(-n2ncc3cnc(-c4cnccn4)cc32)c1,Ki,'=',1.16,nM,8.94,,434120,UO_0000065,24.93,0.45,7.26,10.56,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3660041,,None,365.41,0,3.45,BDBM104162,CC(C)(CN)COc1cc(F)cc2ccc(-c3nnc4ccccn34)nc12,IC50,'=',26,nM,7.58,,222576,UO_0000065,20.76,0.38,4.14,9.68,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL495771,GW708336X,None,337.39,0,1.6,GW708336X,c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1,Inhibition,'=',0.92,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1794058,GW278681X,None,329.38,0,2.46,GW278681X,CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1,Inhibition,'=',-0.01,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL475761,GW784684X,None,564.09,2,6.81,GW784684X,CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1,Inhibition,'=',0.67,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1667969,SAR-407899,2,244.29,0,1.66,SAR-407899,O=c1[nH]ccc2cc(OC3CCNCC3)ccc12,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL1996390,,None,255.3,0,3.66,SID103905050,O=C(O)c1cc2c(-c3ccccc3)cncc2s1,Ki,'=',199.53,nM,6.7,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL191384,,None,372.46,0,3.94,AS-601245,N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1,Activity,'=',40,%,,,Antagonist,UO_0000187,,,,,0,CHEMBL1061086,Percentage PIM2 activity remaining in the presence of 1uM inhibitor,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL493326,GSK-317314A,None,427.91,0,4.99,GSK317314A,COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1,Inhibition,'=',-2.83,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1909403,GW569293E,None,547.47,0,4.41,GW569293E,O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1,Inhibition,'=',0.32,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL518968,GSK-1030061A,None,491.49,1,5.06,GSK1030061A,CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F,Inhibition,'=',0.37,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1995740,,None,377.36,0,4.29,SID103904713,COc1cc(-c2ccc3c(c2)Nc2ccc([N+](=O)[O-])cc2NC3=O)ccc1O,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL4786776,,None,344.42,0,4.16,76,OCC[C@@H](Nc1ncnc2[nH]c(-c3ccccc3)cc12)c1ccccc1,Inhibition,'=',6,%,,,,UO_0000187,,,,,0,CHEMBL4718881,Inhibition of recombinant full length GST-tagged human PIM2 expressed in baculovirus expression system at 500 nM using Ser/Thr 07 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4715760,1,Scientific Literature,Eur J Med Chem,2016,None,Dose = 500.0 nM | TIME = 1.0 hr
CHEMBL3926146,,None,374.42,0,3.34,BDBM249083,Cn1ncc(-c2cc3c(cn2)cnn3-c2ccccc2F)c1C1=CCNCC1,Ki,'=',1100,nM,5.96,,434287,UO_0000065,15.91,0.29,2.62,9.84,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL419903,,None,295.32,0,3.72,SB-735467,O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1,Inhibition,'=',-0.18,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3958302,,None,402.51,0,3.02,BDBM248909,CCn1cc(-c2cc3c(cn2)cnn3-c2cccc(N3CCCC(N)CC3)n2)cn1,Ki,'=',13.4,nM,7.87,,434116,UO_0000065,19.56,0.36,4.85,8.68,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1230607,PHA-793887,1,361.49,0,2.31,PHA-793887,CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL1088752,LOSMAPIMOD,3,383.47,0,3.86,Losmapimod,Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL447567,,None,273.24,0,3.03,3a,O=C1NC(=O)/C(=C/c2ccc(C(F)(F)F)cc2)S1,IC50,'=',80,nM,7.1,,,UO_0000065,25.97,0.54,4.07,15.37,0,CHEMBL957366,Inhibition of human recombinant Pim2 by ATP depletion assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139352,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL86257,,None,249.29,0,2.41,14a,CCOc1ccc(/C=C2\SC(=O)NC2=O)cc1,IC50,'=',43000,nM,4.37,,,UO_0000065,17.52,0.35,1.96,7.88,0,CHEMBL957366,Inhibition of human recombinant Pim2 by ATP depletion assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139352,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL3544944,BMS-863233,2,289.72,0,2.75,XL-413,O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3687500,,None,484.52,1,5.06,BDBM151896,CCO[C@@H]1[C@H](C)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H]1N,IC50,'=',1900,nM,5.72,,292152,UO_0000065,11.81,0.22,0.66,6.35,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3691941,,None,566.59,1,3.97,BDBM151963,CCOCc1cc(F)c(-c2nc(C(=O)Nc3cnccc3N3C[C@@H](N)[C@@H](n4ccnn4)[C@@H](C)C3)ccc2F)c(F)c1,IC50,'=',1.2,nM,8.92,,292218,UO_0000065,15.74,0.3,4.95,7.19,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3691950,,None,524.55,1,4.54,BDBM151972,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)c(F)cc2N)C[C@@H](N)[C@H]1OCCC#N,IC50,'=',0.4,nM,9.4,,292227,UO_0000065,17.92,0.34,4.86,6.72,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3981915,,None,426.53,0,3.3,BDBM248985,Cc1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CCC4(CCCN4)CC3)n2)n1,Ki,'=',2.95,nM,8.53,,434192,UO_0000065,20,0.36,5.23,10.08,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3355554,,None,376.38,0,4.25,13a,FC(F)(F)c1cccc(-c2cnn3ccc(NCC4CCOCC4)nc23)c1,IC50,'=',1970,nM,5.71,,,UO_0000065,15.16,0.29,1.46,11.09,0,CHEMBL3375413,Inhibition of Pim2 (unknown origin) using luciferase-luciferin based ATP detection reagent by Kinase-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3351833,1,Scientific Literature,ACS Med Chem Lett,2015,None,
CHEMBL3325693,,None,268.71,0,3.5,14,Nc1cc2[nH]ncc2c2c1ncc1ccc(Cl)cc12,Activity,'=',96,%,,,,UO_0000187,,,,,0,CHEMBL3370182,Inhibition of full-length human PIM2 using RSRHSSYPAGT as substrate assessed as residual kinase activity at 1 uM after 30 mins in presence of [gamma-33P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352653,1,Scientific Literature,Bioorg Med Chem,2014,None,
CHEMBL1233300,HYDROXYFASUDIL,None,307.38,0,0.92,Hydroxyfasudil,O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3393717,,None,431.47,0,4.05,18j,Oc1ccc(-c2ccc3[nH]nc(-c4cncc(O[C@H]5CNCCC56CC6)n4)c3c2)c(F)c1,IC50,'=',0.7,nM,9.15,,,UO_0000065,21.22,0.39,5.1,9.54,0,CHEMBL3396420,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as phosphorylation of biotinylated-BAD peptide at Serine 112 residue,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3392976,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL2047864,,None,265.29,0,2.11,1,CCOc1cc(/C=C2\SC(=O)NC2=O)ccc1O,IC50,'=',160,nM,6.8,,,UO_0000065,25.62,0.52,4.69,8.99,0,CHEMBL2049740,Inhibition of human PIM2 using FITC-(AHX)RSRHSSYPAGT-COOH as substrate after 90 mins by mobility shift assay in presence of 50 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2046384,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL1976040,ADAVOSERTIB,2,500.61,1,2.89,MK-1775,C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3545307,MERESTINIB,2,552.54,2,5.75,LY-2801653,Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3651940,,None,470.5,0,4.32,BDBM106844,Cc1ccc(F)c(-c2nc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@H](O)[C@@H](C)C3)ccc2F)c1F,IC50,'=',2,nM,8.7,,225865,UO_0000065,18.49,0.35,4.38,8.6,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4109503,,None,451.48,0,2.96,BDBM192578,C[C@@H]1CN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C[C@@H](N)[C@H]1O,IC50,'=',0.5,nM,9.3,,344640,UO_0000065,20.6,0.38,6.34,8.89,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4113731,,None,417.49,0,3.85,BDBM192581,C[C@@H]1C[C@H](N)CN(c2ccncc2Nc2ncc3ccc(-c4ccccc4F)nn23)C1,IC50,'=',54.2,nM,7.27,,344646,UO_0000065,17.4,0.32,3.42,8.61,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2377719,,None,350.33,0,3.8,18,CCOC(=O)c1[nH]c2c([N+](=O)[O-])cc3cn[nH]c3c2c1-c1ccccc1,Inhibition,'=',92,%,,,,UO_0000187,,,,,0,CHEMBL2378598,Inhibition of human full length Pim-2 using RSRHSSYPAGT as substrate assessed as residual activity at 1 uM after 30 mins in presence of [gamma-33P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2375344,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL2087474,,None,473.56,1,-0.32,14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL514162,GW852849X,None,443.91,0,4.44,GW852849X,COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC,Inhibition,'=',4.79,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL419903,,None,295.32,0,3.72,SB-735467,O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1,Inhibition,'=',1.49,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1909359,GW771127A,None,459.96,0,2.83,GW771127A,Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl,Inhibition,'=',-3.44,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3652637,,None,433.49,0,2.44,BDBM119397,Cn1ncc(NC(=O)c2nc(-c3c(F)cccc3F)sc2N)c1N1CC[C@H](CN)C1,Ki,'=',10.6,nM,7.97,,246164,UO_0000065,18.4,0.36,5.53,6.93,0,CHEMBL3707982,Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL491473,CEDIRANIB,3,450.51,1,5.22,AZD-2171,COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL3326555,,None,264.24,0,3.17,7,O=[N+]([O-])c1cc2[nH]ncc2c2c1ncc1ccccc12,Activity,'=',46,%,,,,UO_0000187,,,,,0,CHEMBL3370182,Inhibition of full-length human PIM2 using RSRHSSYPAGT as substrate assessed as residual kinase activity at 1 uM after 30 mins in presence of [gamma-33P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352653,1,Scientific Literature,Bioorg Med Chem,2014,None,
CHEMBL3354514,,None,415.47,1,5.45,3b,O=C(Nc1cnccc1OC1CCCCC1)c1csc(-c2c(F)cccc2F)n1,IC50,'=',250,nM,6.6,,,UO_0000065,15.89,0.31,1.15,10.3,0,CHEMBL3376647,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352230,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL3634790,,None,272.31,0,3.69,8,c1ccc(-c2n[nH]c3cnc(-c4cccnc4)cc23)cc1,Ki,'=',50,nM,7.3,,,UO_0000065,26.81,0.47,3.61,13.41,0,CHEMBL3636741,Inhibition of Pim2 (unknown origin) using 5FAM-ARKRRRHPSGPPTA as substrate after 90 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632547,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL2377709,,None,320.35,0,3.47,27,CCOC(=O)c1[nH]c2c(N)cc3cn[nH]c3c2c1-c1ccccc1,Inhibition,'=',101,%,,,,UO_0000187,,,,,0,CHEMBL2378598,Inhibition of human full length Pim-2 using RSRHSSYPAGT as substrate assessed as residual activity at 1 uM after 30 mins in presence of [gamma-33P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2375344,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL3960554,,None,386.46,0,2.38,11,Cc1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CCCNCC3)n2)n1,Ki,'=',0.44,nM,9.36,,,UO_0000065,24.21,0.44,6.98,11.05,0,CHEMBL4052120,Inhibition of PIM2 (unknown origin) using 5FAM-ARKRRRHPSGPPTA as substrate after 90 mins in presence of ATP by caliper microfluidic mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4049450,1,Scientific Literature,J Med Chem,2017,None,
CHEMBL3325694,,None,252.25,0,2.99,15,Nc1cc2[nH]ncc2c2c1ncc1c(F)cccc12,Activity,'=',110,%,,,,UO_0000187,,,,,0,CHEMBL3370182,Inhibition of full-length human PIM2 using RSRHSSYPAGT as substrate assessed as residual kinase activity at 1 uM after 30 mins in presence of [gamma-33P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352653,1,Scientific Literature,Bioorg Med Chem,2014,None,
CHEMBL319467,,None,402.48,0,2.7,K00275,NS(=O)(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1,Thermal melting change,'=',0.6,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL3926281,,None,435.47,0,4.81,BDBM191106,NCCC[C@H]1CNC(=O)c2cc(-c3cccc(OC(F)(F)F)c3)c(-c3ccsc3)n21,IC50,'=',153,nM,6.82,,341777,UO_0000065,15.65,0.31,2.01,9.84,0,CHEMBL3887520,Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2425144,,None,481.56,0,4.83,13,Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-n3cnc4c(N)ncnc43)cc2)cc1,Inhibition,'=',-15,%,,Outside typical range,,UO_0000187,,,,,0,CHEMBL2429585,Inhibition of PIM-2 (unknown origin) at 1 uM by [33P]-ATP filter-binding assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2424535,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL3964367,,None,428.33,0,4.19,BDBM238687,Cc1nc2cccc(-c3[nH]c4c(c3Br)C(=O)NCC4)c2nc1NC(C)(C)C,IC50,'=',0.874,nM,9.06,,416796,UO_0000065,21.15,0.46,4.87,10.95,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3949234,,None,389.38,0,3.58,BDBM238600,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@@H](C)C(F)(F)F,IC50,'=',27.2,nM,7.57,,416707,UO_0000065,19.43,0.37,3.99,9.15,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3966555,,None,429.44,0,4.66,BDBM191080,Cc1cccc(-c2c(-c3cccc(OC(F)(F)F)c3)cc3n2C(CCN)CNC3=O)c1,IC50,'=',51,nM,7.29,,341751,UO_0000065,16.98,0.32,2.63,10.53,0,CHEMBL3887520,Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3983324,,None,373.39,0,3.3,BDBM238460,Nc1ccc(-c2ccc3cccc(-c4cc5c([nH]4)CCNC5=O)c3n2)c(F)n1,IC50,'=',14.7,nM,7.83,,416204,UO_0000065,20.98,0.38,4.53,8.1,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4074201,,None,418.5,0,3.16,4,CCc1ccc2c(/C=C3\Oc4c(ccc(OC)c4CN4CCNCC4)C3=O)c[nH]c2n1,Inhibition,'=',23,%,,,,UO_0000187,,,,,0,CHEMBL3997633,Inhibition of full length recombinant human N-terminal GST-tagged PIM2 (1 to 311 residues) expressed in baculovirus infected sf21 cells at 200 nM using S6K2 peptide as substrate by electrophoretic mobility shift assay relative to control,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3994673,1,Scientific Literature,ACS Med Chem Lett,2017,None,
CHEMBL1171837,PONATINIB,4,532.57,1,4.46,Ponatinib,Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3218578,BGT-226,2,534.54,1,4.38,BGT-226,COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3264254,,None,403.49,0,3.38,7c,CCN(CC)CCOc1cncc(-c2ccc3[nH]cc(-c4ccnc(N)n4)c3c2)n1,IC50,'=',590,nM,6.23,,,UO_0000065,15.44,0.28,2.85,5.89,0,CHEMBL3269287,Inhibition of PIM2 kinase (unknown origin) using 5-FAM-labeled BAD peptide as substrate after 90 mins by fluorescence polarization assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3259764,1,Scientific Literature,Bioorg Med Chem Lett,2014,None,
CHEMBL3925205,,None,443.43,0,4.17,BDBM191101,NCC[C@H]1CNC(=O)c2cc(-c3cccc(OC(F)(F)F)c3)c(-c3ccc(C=O)cc3)n21,IC50,'=',22,nM,7.66,,341772,UO_0000065,17.27,0.33,3.49,8.87,0,CHEMBL3887520,Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP,,,,,,,,,,,,,,,,,,,,,,
CHEMBL430226,6-BROMOINDIRUBIN-3'-ACETOXIME,None,398.22,0,3.51,K00199,CC(=O)O/N=C1C(=C2/C(=O)Nc3cc(Br)ccc32)/Nc2ccccc2/1,Thermal melting change,'=',-1.4,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL3703185,,None,341.44,0,2.33,BDBM149693,CSc1ncc2ccc3c(C(N)=O)cn(C4CCNCC4)c3c2n1,IC50,'=',23,nM,7.64,,288351,UO_0000065,22.37,0.43,5.31,8.9,0,CHEMBL3707582,Kinase Inhibition Assay: The buffer for PIM-2 assay was composed of HEPES 50 mM,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3703186,,None,258.31,0,1.93,BDBM149694,CSc1ncc2ccc3c(C(N)=O)c[nH]c3c2n1,IC50,'=',46,nM,7.34,,288352,UO_0000065,28.4,0.56,5.41,8.67,0,CHEMBL3707582,Kinase Inhibition Assay: The buffer for PIM-2 assay was composed of HEPES 50 mM,,,,,,,,,,,,,,,,,,,,,,
CHEMBL261237,,None,335.35,0,4.23,K00090,N#C/C(=C(/N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F,Thermal melting change,'=',0.2,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL181361,GW693481X,None,305.37,0,3.4,GW693481X,Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1,Inhibition,'=',0.01,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3264255,,None,389.46,0,2.99,7d,CN(C)CCCOc1cncc(-c2ccc3[nH]cc(-c4ccnc(N)n4)c3c2)n1,IC50,'=',540,nM,6.27,,,UO_0000065,16.09,0.3,3.28,5.92,0,CHEMBL3269287,Inhibition of PIM2 kinase (unknown origin) using 5-FAM-labeled BAD peptide as substrate after 90 mins by fluorescence polarization assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3259764,1,Scientific Literature,Bioorg Med Chem Lett,2014,None,
CHEMBL2000894,,None,386.41,0,2.67,SID103905355,Cc1cc(O)ccc1-n1cc(C(=O)NN)c(=O)c2ccc(-c3ccncc3)cc21,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3793221,,None,419.4,0,3.3,2h,Nc1cc(-c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)ccc2N)ncn1,Ki,'=',27,nM,7.57,,,UO_0000065,18.05,0.33,4.27,5.7,0,CHEMBL3794688,Inhibition of Pim2 (unknown origin) using BAD peptide preincubated for 15 mins followed by ATP addition measured after 60 to 100 mins by Kinase-Glo reagent based luminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3792348,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL1255867,,None,321.23,0,1.73,K00079,Cl.NCCNS(=O)(=O)c1cccc2c(Cl)cccc12,Thermal melting change,'=',1.7,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL3953482,,None,416.53,0,3.23,BDBM248914,CC(C)(C)n1cc(-c2cc3c(cn2)cnn3-c2cccc(N3CCCNCC3)n2)cn1,Ki,'=',10.5,nM,7.98,,434121,UO_0000065,19.16,0.35,4.75,10.4,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3899519,,None,440.43,0,2.65,BDBM249036,FC(F)(F)Cn1cc(-c2cc3c(cn2)cnn3-c2cccc(N3CC4(CNC4)C3)n2)cn1,Ki,'=',30.3,nM,7.52,,434240,UO_0000065,17.07,0.32,4.87,9.8,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1591531,,None,553.67,0,3.72,K00204,CS(=O)(=O)O.Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21,Thermal melting change,'=',5.6,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL4070117,,None,385.48,0,2.99,14,Cc1cncc(-c2cc3c(ccn3-c3cccc(N4CCCNCC4)n3)cn2)n1,Ki,'=',9.6,nM,8.02,,,UO_0000065,20.8,0.38,5.03,11.17,0,CHEMBL4052120,Inhibition of PIM2 (unknown origin) using 5FAM-ARKRRRHPSGPPTA as substrate after 90 mins in presence of ATP by caliper microfluidic mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4049450,1,Scientific Literature,J Med Chem,2017,None,
CHEMBL3929011,,None,385.48,0,3.57,BDBM248979,Cc1cncc(-c2cc3c(cn2)cnn3-c2cccc(C3CCCC(N)C3)n2)n1,Ki,'=',0.936,nM,9.03,,434187,UO_0000065,23.42,0.43,5.46,9.46,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3953164,,None,404.45,0,2.65,BDBM248984,Cc1cncc(-c2cc3c(cn2)cnn3-c2ccc(F)c(N3CCC[C@H](N)C3)n2)n1,Ki,'=',0.314,nM,9.5,,434191,UO_0000065,23.5,0.43,6.85,9.63,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3918384,,None,388.44,0,1.67,BDBM249058,Cc1cncc(-c2cc3c(cn2)cnn3-c2ccc(=O)n([C@H]3CCCNC3)n2)n1,Ki,'=',1000,nM,6,,434262,UO_0000065,15.45,0.28,4.33,5.8,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL483748,GSK-953913A,None,390.46,0,4.13,GSK953913A,NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1,Inhibition,'=',-0.34,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1909406,,None,333.82,0,3.86,SKF-86002-A2,Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1,Inhibition,'=',-3.25,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3963170,,None,373.42,0,2.53,BDBM249073,N[C@H]1CCC[C@@H]1Oc1cncc(-c2cc3c(cn2)cnn3-c2ccccn2)n1,Ki,'=',0.744,nM,9.13,,434277,UO_0000065,24.45,0.45,6.6,8.72,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3947770,,None,402.46,0,1.47,BDBM248920,CCn1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CCNCC3)n2)c1=O,Ki,'=',3.32,nM,8.48,,434127,UO_0000065,21.07,0.39,7.01,9.04,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL223360,LINIFANIB,3,375.41,0,4.9,ABT-869,Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL2430324,,None,294.31,0,3.07,MRT00055778,CC(=O)Nc1nccc(-c2c(-c3ccccc3)noc2C)n1,Activity,'=',103.05,%,,,,UO_0000187,,,,,0,CHEMBL2433486,Inhibition of human PIM2 assessed as residual activity at 10 uM relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2429821,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL1173655,AFATINIB,4,485.95,0,4.39,BIBW-2992,CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL3664634,,None,377.42,0,3.42,BDBM41535,FC1(COc2cccc3ccc(-c4nnc5ccccn45)nc23)CCNCC1,IC50,'=',0.5,nM,9.3,,191662,UO_0000065,24.64,0.45,5.88,14.46,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL2442291,,None,335.37,0,2.13,11j,Cc1nnc(-c2cccc(-c3cnn4ccc(NCCN)nc34)c2)o1,IC50,'=',7.3,nM,8.14,,,UO_0000065,24.26,0.44,6.01,7.59,0,CHEMBL2446212,Inhibition of Pim2 (unknown origin) using STK1 as substrate preincubated for 30 mins followed by substrate and ATP addition after 60 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2440090,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL565286,,None,276.3,0,3.09,6,O=C1OC(/C=C/c2ccccc2)=N/C1=C\c1cccnc1,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL1040626,Inhibition of PIM2 at 10 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154675,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL3975198,,None,404.45,0,2.46,BDBM248961,Cc1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3C[C@@H](N)C[C@H](F)C3)n2)n1,Ki,'=',3.35,nM,8.47,,434168,UO_0000065,20.95,0.39,6.01,8.59,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3980040,,None,397.49,0,3.16,BDBM248880,c1cc(N2CCNCC2)nc(-n2ncc3cnc(-c4cncc(C5CC5)c4)cc32)c1,Ki,'=',9.11,nM,8.04,,434087,UO_0000065,20.23,0.37,4.88,11.2,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2442304,,None,309.33,0,0.94,11c,NCCNc1ccn2ncc(-c3ccc4[nH]c(=O)[nH]c4c3)c2n1,IC50,'=',19,nM,7.72,,,UO_0000065,24.96,0.46,6.78,6.61,0,CHEMBL2446212,Inhibition of Pim2 (unknown origin) using STK1 as substrate preincubated for 30 mins followed by substrate and ATP addition after 60 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2440090,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL505896,,None,610.69,2,5.63,22,COc1cc2c(Oc3ccc(-c4cnc(Cc5ccccc5)n(C)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,'>',25000,nM,,,,UO_0000065,,,,,0,CHEMBL970669,Inhibition of PIM2 kinase,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140082,1,Scientific Literature,J Med Chem,2008,None,
CHEMBL2442314,,None,342.45,1,5.29,9d,c1ccc2cc(-c3cnn4ccc(NC5CCCCC5)nc34)ccc2c1,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL2446210,Inhibition of Pim2 (unknown origin) using STK1 as substrate preincubated for 30 mins followed by substrate and ATP addition at > 5000 nM after 60 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2440090,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL3927952,,None,400.49,0,2.9,BDBM248964,Cc1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CCCC(N)C3C)n2)n1,Ki,'=',1.03,nM,8.99,,434171,UO_0000065,22.44,0.41,6.09,9.11,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3947370,,None,421.9,0,2.56,BDBM248995,Cc1cncc(-c2cc3c(cn2)cnn3-c2cnc(Cl)c(N3CCC[C@H](N)C3)n2)n1,Ki,'=',10.4,nM,7.98,,434202,UO_0000065,18.92,0.36,5.42,7.16,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3939262,,None,443.44,0,2.44,BDBM248948,FC(F)(F)Cn1cc(-c2cc3c(cn2)cnn3-c2ccnc(N3CCCNCC3)n2)cn1,Ki,'=',5.1,nM,8.29,,434155,UO_0000065,18.7,0.35,5.85,9.26,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3943759,,None,372.44,0,2.12,BDBM248936,Cc1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CC[C@H](N)C3)n2)n1,Ki,'=',2.27,nM,8.64,,434143,UO_0000065,23.21,0.42,6.52,8.76,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3651989,,None,453.49,0,3.46,BDBM106894,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)ccc2N)C[C@@H](N)[C@H]1O,IC50,'=',3,nM,8.52,,225915,UO_0000065,18.79,0.35,5.06,6.7,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1909407,,None,374.85,0,2.65,SB-220025-R,Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1,Inhibition,'=',-0.19,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1976328,,None,388.5,1,5.81,SID103904381,Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4snc(N)c34)cc2)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1997129,,None,315.38,0,3.53,SID103905259,O=C1NCCc2[nH]c(-c3ccnc(C=Cc4ccccc4)c3)cc21,Ki,'=',1258.93,nM,5.9,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2003286,,None,251.26,0,1.72,SID103905210,COc1cc(C=C2SC(=O)NC2=O)ccc1O,Ki,'=',125.89,nM,6.9,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2006581,,None,384.85,0,1.29,SID103905388,CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1Cl,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1986588,,None,195.25,0,1.04,SID103905470,Cc1nn(C)c2sc(C(N)=O)cc12,Ki,'=',1995.26,nM,5.7,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL269827,GW276655X,None,383.39,0,1.76,GW276655X,NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1,Inhibition,'=',24.5,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL261131,DIACYLGLYCEROL KINASE INHIBITOR II,None,489.59,1,5.94,R-59949,O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1,Residual Activity,'=',133,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL259850,,None,308.32,0,2.38,AR_A0_14418,COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1,Residual Activity,'=',134,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL602937,FASCAPLYSIN,None,271.3,0,3.14,Fascaplysin,O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21,Residual Activity,'=',144,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL97771,,None,373.41,1,5.18,Src_Inhibitor_I,COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC,Residual Activity,'=',135,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL403183,,None,207.25,0,1.81,BAY-117082,Cc1ccc(S(=O)(=O)/C=C/C#N)cc1,Residual Activity,'=',111,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL200381,,None,404.84,1,5.04,Tpl2_Kinase_Inhibitor,N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1,Residual Activity,'=',63,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL439259,,None,341.8,0,4.85,IGF_1R_Inhibitor_II,COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12,Residual Activity,'=',108,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL514162,GW852849X,None,443.91,0,4.44,GW852849X,COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC,Inhibition,'=',1.11,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL261425,,None,294.74,0,4.31,Cdk1_Inhibitor,O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12,Residual Activity,'=',73,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL278041,SB-202190,None,331.35,0,4.65,SB-202190,Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,Residual Activity,'=',107,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL53753,,None,330.19,0,3.57,PD-158780,CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1,Residual Activity,'=',88,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1915633,,None,402.85,0,4.97,15g,COc1cccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3cnccc23)c1Cl,IC50,'=',1,nM,9,,,UO_0000065,22.34,0.42,4.03,10.16,0,CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914433,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL1915635,,None,370.39,0,4.76,15i,Cc1ccc(F)cc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12,IC50,'=',8,nM,8.1,,,UO_0000065,21.86,0.39,3.34,10.2,0,CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914433,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL230011,TG100-115,2,346.35,0,2.33,TG-100115,Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL559147,Y-27632,None,247.34,0,2.17,Y-27632,C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1,Residual Activity,'=',118,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2206921,,None,470.35,0,2.49,3j,Cc1nc(N)nc(-c2cc(Cl)cnc2Nc2cnc(Cl)c(NS(=O)(=O)N(C)C)c2)n1,Activity,'<',50,%,,,,UO_0000187,,,,,0,CHEMBL2211138,Binding affinity to PIM2 at 1 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2203208,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL3691932,,None,572.59,1,4.11,BDBM151954,COC(=O)N[C@@H]1[C@H](N)CN(c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(OC(C)C)cc3F)n2)C[C@@H]1C,IC50,'=',0.79,nM,9.1,,292209,UO_0000065,15.9,0.3,4.99,6.91,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3687506,,None,572.6,2,5.64,BDBM151902,CO[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C4(F)CCOCC4)cc3F)n2)C[C@@H]1C,IC50,'=',2.42,nM,8.62,,292158,UO_0000065,15.05,0.29,2.98,8.67,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2037202,,None,463.93,0,3.66,15,CN1CCCN(C(=O)c2cncc(-c3ccc(/C=C4/C(=O)Nc5ccc(Cl)cc54)o3)n2)CC1,IC50,'=',225,nM,6.65,,,UO_0000065,14.33,0.28,2.99,7.26,0,CHEMBL2038829,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034977,1,Scientific Literature,ACS Med Chem Lett,2012,None,
CHEMBL2403108,CERITINIB,4,558.15,2,6.36,Ceritinib,Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL185962,,None,242.24,0,1.4,SB-736302,Nc1nonc1-c1nc2cnccc2n1C1CC1,Inhibition,'=',1.57,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL601719,CRIZOTINIB,4,450.35,1,5.04,PF-02341066,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3651966,,None,440.47,1,5.04,PIM447,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C1,IC50,'=',0.018,nM,10.74,,,UO_0000065,24.39,0.46,5.7,13.28,0,CHEMBL4331756,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4330088,1,Scientific Literature,Eur J Med Chem,2019,None,
CHEMBL179311,GW580509X,None,388.45,0,3.9,GW580509X,CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1,Inhibition,'=',0.96,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1915642,,None,443.49,0,4.39,15p,CN(C)CCOc1ccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3cnccc23)c(F)c1,IC50,'=',20,nM,7.7,,,UO_0000065,17.36,0.32,3.31,8.38,0,CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914433,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL1915644,,None,362.82,0,4.54,17b,CNC(=O)c1cccc2c1nc(Nc1ccccc1Cl)c1ccncc12,IC50,'=',1,nM,9,,,UO_0000065,24.81,0.47,4.46,13.45,0,CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914433,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL1915647,,None,390.87,1,5.32,17e,CC(C)NC(=O)c1cccc2c1nc(Nc1ccccc1Cl)c1ccncc12,IC50,'=',2,nM,8.7,,,UO_0000065,22.26,0.42,3.38,13,0,CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914433,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL4128288,,None,400.46,0,4.28,44,CN(C)CCNc1cncc(-c2ccc3[nH]cc(-c4cc(C#N)ccc4F)c3c2)n1,IC50,'=',841,nM,6.08,,,UO_0000065,15.17,0.28,1.8,7.53,0,CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4118246,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL4129087,,None,390.47,0,3.99,48,CN(C)CCNc1cncc(-c2ccc3[nH]cc(-c4ccc(N)cc4F)c3c2)n1,IC50,'=',267,nM,6.57,,,UO_0000065,16.83,0.31,2.58,7.93,0,CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4118246,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL266707,,None,297.36,0,3.86,SKF-86055,Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1,Inhibition,'=',-3.85,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL426800,GW785404X,None,247.23,0,1.83,GW785404X,CCn1c(-c2nonc2N)nc2ccc(F)cc21,Inhibition,'=',0.34,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL2048872,,None,379.49,0,3.61,AZD1208,N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1,IC50,'=',5,nM,8.3,,,UO_0000065,21.87,0.42,4.69,11,0,CHEMBL4331756,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4330088,1,Scientific Literature,Eur J Med Chem,2019,None,
CHEMBL267228,,None,371.4,0,4.03,SB-431533,OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1,Inhibition,'=',1.41,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL208437,GW711782X,None,408.47,0,4.48,GW711782X,c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1,Inhibition,'=',0.56,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL381948,GW680975X,None,316.34,0,4.34,GW680975X,Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1,Inhibition,'=',-1.45,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL2000481,,None,463.52,0,2.08,SID103905096,NCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3651967,,None,440.47,1,5.04,BDBM106871,C[C@H]1C[C@@H](N)C[C@@H](c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)ccc2F)C1,IC50,'=',1947,nM,5.71,,225892,UO_0000065,12.96,0.24,0.67,7.06,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3691917,,None,550.65,1,4.01,BDBM151939,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1OCCS(C)(=O)=O,IC50,'=',28.66,nM,7.54,,292194,UO_0000065,13.7,0.28,3.53,6.07,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL483748,GSK-953913A,None,390.46,0,4.13,GSK953913A,NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1,Inhibition,'=',-1.33,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3936842,,None,407.43,0,3.22,BDBM192540,Fc1cccc(F)c1-c1ccc2cnc(Nc3cnccc3N3CCNCC3)n2n1,IC50,'=',126,nM,6.9,,344532,UO_0000065,16.93,0.31,3.68,9.8,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3952051,,None,405.89,0,3.6,BDBM192543,Clc1ccccc1-c1ccc2cnc(Nc3cnccc3N3CCNCC3)n2n1,IC50,'=',640,nM,6.19,,344535,UO_0000065,15.26,0.29,2.59,8.8,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1940253,,None,484.56,0,3.39,26,CC(=O)N1CC[C@@H](Nc2cncc(C(=O)c3cn(C(C)C)c4ncnc(N)c34)n2)[C@H]1c1ccccc1,Inhibition,'=',-2,%,,,,UO_0000187,,,,,0,CHEMBL1942193,Inhibition of PIM2 at 1 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1938337,1,Scientific Literature,J Med Chem,2011,None,
CHEMBL3651994,,None,441.46,0,4.38,BDBM106900,Nc1cc(F)c(-c2c(F)cccc2F)nc1C(=O)Nc1cnccc1[C@@H]1CCC[C@H](N)C1,IC50,'=',1,nM,9,,225921,UO_0000065,20.39,0.38,4.62,8.42,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL411901,,None,385.9,0,3.49,K00083,CCn1cnc2c(N)nc(N(c3cccc(Cl)c3)[C@@H]3CCCC[C@@H]3N)nc21,Thermal melting change,'=',5.5,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL3691976,,None,537.55,1,4.5,BDBM151998,COc1cc(F)c(-c2nc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@@H](n4ccnn4)[C@@H](C)C3)ccc2F)c(F)c1,IC50,'=',4.42,nM,8.36,,292253,UO_0000065,15.54,0.29,3.85,6.91,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3687494,,None,523.56,2,5.26,BDBM151890,Cc1cc(F)c(-c2nc(C(=O)Nc3cnccc3[C@H]3C[C@@H](C)[C@@H](OCCC#N)[C@@H](N)C3)ccc2F)c(F)c1,IC50,'=',64.13,nM,7.19,,292146,UO_0000065,13.74,0.26,1.93,6.31,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2442308,,None,329.41,0,3.43,11g,NCCNc1ccn2ncc(-c3ccccc3-c3ccccc3)c2n1,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL2446210,Inhibition of Pim2 (unknown origin) using STK1 as substrate preincubated for 30 mins followed by substrate and ATP addition at > 5000 nM after 60 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2440090,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL4522524,,None,365.44,0,3.01,16,Cc1c(NC(C)(C)C)nc2c(-c3cc4c([nH]3)[C@@H](C)NC4=O)cccn2c1=O,IC50,'=',2.1,nM,8.68,,,UO_0000065,23.75,0.44,5.67,9.51,0,CHEMBL4478465,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as reduction in phosphorylation of biotinylated-BAD peptide at Serine 112 residue preincubated for 30 mins followed by substrate addition for 1 hr by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4477213,1,Scientific Literature,J Med Chem,2016,None,
CHEMBL359482,,None,301.35,0,4.07,GSK_3_inhibitor_XIII,Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1,Residual Activity,'=',126,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL366266,,None,411.47,0,3.41,K00248,O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1,Thermal melting change,'=',1.5,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL191705,GW621431X,None,400.46,0,4.09,GW621431X,CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1,Inhibition,'=',-0.01,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1721885,SU-014813,2,442.49,0,1.69,SU-14813,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL1915438,,None,372.82,0,4.97,14k,Clc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12,Inhibition,'=',98,%,,,,UO_0000187,,,,,0,CHEMBL1919008,Inhibition of human recombinant PIM2 at 0.5 uM by radiometric filter-binding assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914433,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL3326558,,None,282.23,0,3.31,10,O=[N+]([O-])c1cc2[nH]ncc2c2c1ncc1c(F)cccc12,Activity,'=',84,%,,,,UO_0000187,,,,,0,CHEMBL3370182,Inhibition of full-length human PIM2 using RSRHSSYPAGT as substrate assessed as residual kinase activity at 1 uM after 30 mins in presence of [gamma-33P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352653,1,Scientific Literature,Bioorg Med Chem,2014,None,
CHEMBL2442317,,None,357.46,0,4.23,9g,N[C@@H]1CCCC[C@H]1Nc1ccn2ncc(-c3ccc4ccccc4c3)c2n1,IC50,'=',157,nM,6.8,,,UO_0000065,19.03,0.34,2.57,9.97,0,CHEMBL2446212,Inhibition of Pim2 (unknown origin) using STK1 as substrate preincubated for 30 mins followed by substrate and ATP addition after 60 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2440090,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL3703179,,None,304.38,0,0.86,BDBM149687,CSc1ncc2c(n1)-c1c(c(C(N)=O)cn1CCO)CC2,IC50,'=',540,nM,6.27,,288345,UO_0000065,20.59,0.41,5.41,6.67,0,CHEMBL3707582,Kinase Inhibition Assay: The buffer for PIM-2 assay was composed of HEPES 50 mM,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3651922,,None,439.47,0,2.82,BDBM106826,C[C@H]1CN(c2ccncc2NC(=O)c2cccc(-c3c(F)cccc3F)n2)C[C@@H](N)[C@@H]1O,IC50,'=',2,nM,8.7,,225847,UO_0000065,19.79,0.37,5.88,8.33,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3651998,,None,439.47,0,3.21,BDBM106904,Nc1ccc(-c2c(F)cccc2F)nc1C(=O)Nc1cnccc1[C@@H]1CC[C@H](O)[C@@H](N)C1,IC50,'=',13,nM,7.89,,225925,UO_0000065,17.94,0.34,4.68,6.2,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3691945,,None,522.54,1,3.74,BDBM151967,Cc1cc(F)c(-c2nc(C(=O)Nc3cnccc3N3C[C@@H](N)[C@@H](n4ccnn4)[C@@H](C)C3)ccc2F)c(F)c1,IC50,'=',0.87,nM,9.06,,292222,UO_0000065,17.34,0.33,5.32,7.89,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3691982,,None,616.62,1,4.3,BDBM152005,COC(=O)N[C@@H]1[C@H](N)CN(c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C4(F)CCOCC4)cc3F)n2)C[C@@H]1C,IC50,'=',2.81,nM,8.55,,292260,UO_0000065,13.87,0.27,4.25,6.49,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2037195,,None,461.95,0,4.92,8,O=C1Nc2ccc(Cl)cc2/C1=C\c1ccc(-c2cccc(C(=O)NCCN3CCCC3)c2)o1,IC50,'=',62,nM,7.21,,,UO_0000065,15.6,0.3,2.29,9.66,0,CHEMBL2038829,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034977,1,Scientific Literature,ACS Med Chem Lett,2012,None,
CHEMBL311228,,None,346.82,0,2.63,52,CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21,Residual Activity,'=',137,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3326556,,None,294.27,0,3.18,8,COc1ccc2c(cnc3c([N+](=O)[O-])cc4[nH]ncc4c32)c1,Activity,'=',64,%,,,,UO_0000187,,,,,0,CHEMBL3370182,Inhibition of full-length human PIM2 using RSRHSSYPAGT as substrate assessed as residual kinase activity at 1 uM after 30 mins in presence of [gamma-33P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352653,1,Scientific Literature,Bioorg Med Chem,2014,None,
CHEMBL1915430,,None,330.4,0,3.92,14c,c1cc(-c2nnc[nH]2)c2nc(NC3CCCC3)c3ccncc3c2c1,IC50,'=',26,nM,7.58,,,UO_0000065,22.96,0.41,3.67,9.56,0,CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914433,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL2442297,,None,315.38,0,2.93,9j,c1ccc2cc(-c3cnn4ccc(NC5CNC5)nc34)ccc2c1,IC50,'=',781,nM,6.11,,,UO_0000065,19.37,0.35,3.18,11.26,0,CHEMBL2446212,Inhibition of Pim2 (unknown origin) using STK1 as substrate preincubated for 30 mins followed by substrate and ATP addition after 60 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2440090,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL1909368,GW683134A,None,575.91,2,7,GW683134A,Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F,Inhibition,'=',-3.75,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1915427,,None,373.8,1,5.23,9,Clc1cccc(Nc2nc3c(-c4nnco4)cccc3c3cnccc23)c1,IC50,'=',117,nM,6.93,,,UO_0000065,18.54,0.35,1.7,9.03,0,CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914433,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL179311,GW580509X,None,388.45,0,3.9,GW580509X,CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1,Inhibition,'=',0.07,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1915422,,None,362.82,0,4.54,4b,CNC(=O)c1cccc2c1nc(Nc1cccc(Cl)c1)c1ccncc12,IC50,'=',18,nM,7.75,,,UO_0000065,21.35,0.41,3.2,11.57,0,CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914433,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL3103862,,None,389.46,0,2.3,4d,Nc1ccc(-c2ccncc2)nc1C(=O)Nc1cnccc1N1CCC[C@H](N)C1,Ki,'=',6,nM,8.22,,,UO_0000065,21.11,0.39,5.92,6.68,0,CHEMBL3106178,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3102815,1,Scientific Literature,ACS Med Chem Lett,2013,None,
CHEMBL3651963,,None,497.55,0,4,BDBM106867,CCCOc1ccc(F)c(-c2nc(C(=O)Nc3cnccc3[C@@H]3CC[C@H](O)[C@H](N)C3)c(N)cc2F)c1,IC50,'=',7,nM,8.15,,225888,UO_0000065,16.39,0.31,4.15,5.98,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4556293,,None,474.57,0,2.6,42,COCCN1CCOc2c1cnn1c(-c3ccc4cccc(NCC5CCNCC5)c4n3)nnc21,IC50,'=',5530,nM,5.26,,,UO_0000065,11.08,0.21,2.66,5.17,0,CHEMBL4340984,Inhibition of His tagged human recombinant PIM2 using PIM tide (ARKRRRHPSGPPTA) as substrate incubated for 1 hr by fluorescence based assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4340512,1,Scientific Literature,Eur J Med Chem,2019,None,
CHEMBL4567516,,None,458.57,0,3.36,43,CC(C)N1CCOc2c1cnn1c(-c3ccc4cccc(NCC5CCNCC5)c4n3)nnc21,IC50,'=',1650,nM,5.78,,,UO_0000065,12.61,0.23,2.42,6.25,0,CHEMBL4340984,Inhibition of His tagged human recombinant PIM2 using PIM tide (ARKRRRHPSGPPTA) as substrate incubated for 1 hr by fluorescence based assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4340512,1,Scientific Literature,Eur J Med Chem,2019,None,
CHEMBL4483071,,None,482.95,0,3.33,47,CN1CCOc2c1cnn1c(-c3ccc4ccc(Cl)c(NCC5(F)CCNCC5)c4n3)nnc21,IC50,'=',696,nM,6.16,,,UO_0000065,12.75,0.25,2.83,6.66,0,CHEMBL4340984,Inhibition of His tagged human recombinant PIM2 using PIM tide (ARKRRRHPSGPPTA) as substrate incubated for 1 hr by fluorescence based assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4340512,1,Scientific Literature,Eur J Med Chem,2019,None,
CHEMBL4449598,,None,414.51,0,4.52,61,CN1CCOc2c1cnn1c(-c3ccc4cccc(NC5CCCCC5)c4c3)nnc21,IC50,'=',8040,nM,5.09,,,UO_0000065,12.29,0.22,0.57,7.54,0,CHEMBL4340984,Inhibition of His tagged human recombinant PIM2 using PIM tide (ARKRRRHPSGPPTA) as substrate incubated for 1 hr by fluorescence based assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4340512,1,Scientific Literature,Eur J Med Chem,2019,None,
CHEMBL176553,GW631581B,None,296.33,0,4.1,GW631581B,COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1,Inhibition,'=',0.6,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL2397526,,None,222.25,0,2.78,16a,Nc1cc2[nH]ncc2c2c1[nH]c1ccccc12,Activity,'=',96,%,,,,UO_0000187,,,,,0,CHEMBL2401343,Inhibition of human PIM2 assessed as residual activity using RSRHSSYPAGT as substrate at 1 uM after 30 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2396576,1,Scientific Literature,Bioorg Med Chem,2013,None,
CHEMBL3685750,,None,414.49,0,4.5,BDBM124914,N[C@H]1CCCN(c2ccncc2Nc2cccc3cnc(-c4ccccc4F)nc23)C1,IC50,'=',131,nM,6.88,,254216,UO_0000065,16.61,0.3,2.38,8.61,0,CHEMBL3705221,ATP Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 ul per well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4175024,,None,360.42,0,3.26,51,OCc1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3[nH]2)cc1,Inhibition,'=',10,%,,,,UO_0000187,,,,,0,CHEMBL4156125,Inhibition of recombinant full length human GST-tagged PIM2 expressed in baculovirus expression system at 500 nM by Z-LYTE assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4152312,1,Scientific Literature,Eur J Med Chem,2018,None,
CHEMBL1909412,,None,413.31,0,4.62,SB-476429-A,Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1,Inhibition,'=',-0.05,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL2442307,,None,329.41,0,3.43,11f,NCCNc1ccn2ncc(-c3cccc(-c4ccccc4)c3)c2n1,IC50,'=',137,nM,6.86,,,UO_0000065,20.84,0.37,3.43,10.06,0,CHEMBL2446212,Inhibition of Pim2 (unknown origin) using STK1 as substrate preincubated for 30 mins followed by substrate and ATP addition after 60 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2440090,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL275473,GW572401X,None,401.49,0,4.12,GW572401X,CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1,Inhibition,'=',-0.31,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL95502,,None,394.5,0,4.21,SB-221466,CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1,Inhibition,'=',0.4,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL230597,GSK-586581A,None,381.46,0,3.07,GSK586581A,CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1,Inhibition,'=',0.82,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL4577938,,None,430.52,0,2.58,27,CN1CCOc2c1cnn1c(-c3ccc4cccc(NCC5CCNCC5)c4n3)nnc21,IC50,'=',4260,nM,5.37,,,UO_0000065,12.47,0.23,2.79,5.81,0,CHEMBL4340984,Inhibition of His tagged human recombinant PIM2 using PIM tide (ARKRRRHPSGPPTA) as substrate incubated for 1 hr by fluorescence based assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4340512,1,Scientific Literature,Eur J Med Chem,2019,None,
CHEMBL1794064,GSK-561866B,None,470.41,0,0.12,GSK561866B,CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F,Inhibition,'=',5.54,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL2017334,,None,307.38,0,3.81,13a,c1cc(-c2nnc[nH]2)c2nc(NC3CC3)c3ccsc3c2c1,IC50,'=',25,nM,7.6,,,UO_0000065,24.73,0.47,3.79,11.43,0,CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016532,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL3808459,,None,335.41,0,3.04,BDBM238545,CCCNc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2nc1C,IC50,'=',6.6,nM,8.18,,416268,UO_0000065,24.39,0.45,5.14,9.89,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3918521,,None,339.4,0,4.18,BDBM238579,O=C1NCCc2[nH]c(-c3cccc4ccc(-c5ccccc5)nc34)cc21,IC50,'=',38.1,nM,7.42,,416280,UO_0000065,21.86,0.39,3.24,12.84,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3651930,,None,424.45,0,4.36,BDBM106834,N[C@H]1CCC[C@@H](c2ccncc2NC(=O)c2nc(-c3cc(O)ccc3F)ccc2F)C1,IC50,'=',67,nM,7.17,,225855,UO_0000065,16.9,0.32,2.81,7.09,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1969042,,None,359.39,0,4.6,SID103905578,Oc1ccc(Nc2[nH]nc(-c3ccc(O)cc3)c2-c2ccc(O)cc2)cc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL4115315,,None,388.48,0,2.63,BDBM248903,CCn1cc(-c2cc3c(cn2)cnn3-c2cccc(N3CCC[C@@H](N)C3)n2)cn1,Ki,'=',10.8,nM,7.97,,434110,UO_0000065,20.51,0.38,5.34,8.79,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3927952,,None,400.49,0,2.9,BDBM248964,Cc1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CCCC(N)C3C)n2)n1,Ki,'=',0.477,nM,9.32,,434180,UO_0000065,23.28,0.42,6.42,9.45,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3906798,,None,401.48,0,2.09,BDBM248978,Cc1nc(-c2cc3c(cn2)cnn3-c2cccc(N3CCC[C@H](N)C3)n2)cnc1N,Ki,'=',0.575,nM,9.24,,434185,UO_0000065,23.02,0.42,7.15,7.41,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1909343,,None,394.31,0,1.76,SB-675259-M,O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F,Inhibition,'=',28.72,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1684525,,None,420.5,0,3.86,9k,Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1,Inhibition,'=',110,%,,,,UO_0000187,,,,,0,CHEMBL1685852,Inhibition of Pim-2 at 0.1 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1681705,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL3687423,,None,513.52,1,4.38,BDBM151816,COC(=O)N[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H]1C,IC50,'=',13.88,nM,7.86,,292084,UO_0000065,15.3,0.29,3.48,6.59,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4105379,,None,465.12,0,3.31,Tab 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2017325,,None,343.42,0,4.98,10d,c1ccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3cscc23)cc1,IC50,'=',17,nM,7.77,,,UO_0000065,22.62,0.42,2.79,11.69,0,CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016532,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL573578,,None,331.42,0,3.91,NM-PP1,CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21,Activity,'=',101,%,,,,UO_0000187,,,,,0,CHEMBL1061086,Percentage PIM2 activity remaining in the presence of 1uM inhibitor,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL576349,IC261,None,311.34,0,3.21,IC261,COc1cc(OC)c(C=C2C(=O)Nc3ccccc32)c(OC)c1,Activity,'=',75,%,,,,UO_0000187,,,,,1,CHEMBL1060257,Percentage PIM2 activity remaining in the presence of 25uM inhibitor,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL2017326,,None,377.86,1,5.63,10e,Clc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cscc12,IC50,'=',8,nM,8.1,,,UO_0000065,21.43,0.43,2.47,12.18,0,CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016532,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL237347,GW559768X,None,328.39,0,3.4,GW559768X,Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12,Inhibition,'=',0.23,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL365248,GW810372X,None,402.34,0,3.84,GW810372X,COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1,Inhibition,'=',0.02,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL2087493,,None,508.01,2,0.34,38,CS(=O)(=O)N1CCN(Cc2cn3c(Cl)c(-c4cnc(N)nc4)nc(N4CCOCC4)c3n2)CC1,Inhibition,'<',30,%,,,,UO_0000187,,,,,0,CHEMBL2092411,Inhibition of PIM2 at 1 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2086238,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL495398,,None,239.68,0,2.66,22a,O=C1NC(=O)/C(=C/c2cccc(Cl)c2)S1,IC50,'=',40,nM,7.4,,,UO_0000065,30.87,0.67,4.74,16.02,0,CHEMBL957366,Inhibition of human recombinant Pim2 by ATP depletion assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139352,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL496994,,None,331.34,0,4.2,19a,O=C1S/C(=C\c2ccc(F)cc2)C(=O)N1Cc1ccccc1F,IC50,'>',100000,nM,,,,UO_0000065,,,,,0,CHEMBL957366,Inhibition of human recombinant Pim2 by ATP depletion assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139352,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL2000104,,None,346.43,0,2.86,SID103905051,CCS(=O)(=O)c1ccc(-c2cncc3sc(C(N)=O)cc23)cc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL17370,,None,361.45,1,5.67,SID103905410,CSc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3651955,,None,436.51,1,5.21,BDBM106859,Cc1ccc(F)c(-c2nc(C(=O)Nc3cnccc3[C@@H]3C[C@H](C)C[C@H](N)C3)ccc2F)c1,IC50,'=',3,nM,8.52,,225880,UO_0000065,19.53,0.36,3.31,10.54,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1969755,,None,350.39,0,3.22,SID103904580,O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1F,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1972849,,None,410.38,0,3.25,SID103905069,CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL259922,,None,411.43,0,4.11,SID103905455,Cc1ccc(C(=O)Nc2ccon2)cc1Nc1ncnc2c1cnn2-c1ccccc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL481510,GW853606X,None,496.31,1,5.55,GW853606X,NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br,Inhibition,'=',-0.42,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3652644,,None,418.47,0,3.12,BDBM119404,Cn1ncc(NC(=O)c2nc(-c3c(F)cccc3F)sc2N)c1C1CCNCC1,Ki,'=',185,nM,6.73,,246171,UO_0000065,16.09,0.32,3.61,6.88,0,CHEMBL3707982,Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2000393,,None,420.38,0,3.11,SID103905603,O=c1[nH]c2cnc(-n3cnc4ccc(F)cc43)nc2n1C1CCOc2c(F)cccc21,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL387187,,None,413.4,1,5.33,K00598a,O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1,Thermal melting change,'=',2.3,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL1336,SORAFENIB,4,464.83,1,5.55,BAY-439006,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,Kd,,,,,,Not Active,,,,,,0,CHEMBL859489,Average Binding Constant for PIM2; NA=Not Active at 10 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144455,1,Scientific Literature,Nat Biotechnol,2005,None,
CHEMBL3103863,,None,405.47,0,1.28,4e,Nc1nccc(-c2ccc(N)c(C(=O)Nc3cnccc3N3CCC[C@H](N)C3)n2)n1,Ki,'=',16,nM,7.8,,,UO_0000065,19.23,0.35,6.52,4.81,0,CHEMBL3106178,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3102815,1,Scientific Literature,ACS Med Chem Lett,2013,None,
CHEMBL3889998,,None,390.49,0,2.72,BDBM238792,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@H]1C[C@@H](N(C)C)C1,IC50,'=',4,nM,8.4,,416901,UO_0000065,21.51,0.4,5.68,9.77,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3430787,,None,None,None,None,K00596a,,Thermal melting change,'=',2,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL583972,,None,234.26,0,3.61,A,O=Cc1c[nH]c2c1ccc1c3ccccc3[nH]c12,Activity,'=',7,%,,,,UO_0000187,,,,,1,CHEMBL1248949,Inhibition of human GST fused Pim2 expressed in Escherichia coli assessed as residual activity at 10 uM after 30 mins,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240519,1,Scientific Literature,Bioorg Med Chem,2010,None,
CHEMBL1241009,,None,313.15,0,4.38,3f,O=Cc1c[nH]c2c1ccc1c3cccc(Br)c3[nH]c12,Activity,'=',28,%,,,,UO_0000187,,,,,0,CHEMBL1248949,Inhibition of human GST fused Pim2 expressed in Escherichia coli assessed as residual activity at 10 uM after 30 mins,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240519,1,Scientific Literature,Bioorg Med Chem,2010,None,
CHEMBL79004,,None,322.75,0,4.02,PS 1145,O=C(Nc1cc(Cl)cc2c1[nH]c1cnccc12)c1cccnc1,Activity,'=',47,%,,,Antagonist,UO_0000187,,,,,0,CHEMBL1061149,Percentage PIM2 activity remaining in the presence of 10uM inhibitor,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL3924903,,None,401.47,0,3.23,BDBM249074,Cc1cncc(-c2cc3c(cn2)cnn3-c2cccc(OC3CCCC(N)C3)n2)n1,Ki,'=',33.3,nM,7.48,,434283,UO_0000065,18.63,0.34,4.25,7.15,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1933551,,None,414.55,0,3.91,25,C[C@@H]1CCC(N2CC[C@]3(CN(C(=O)c4cc5ccccc5[nH]4)c4ccccc43)C2)CN1,IC50,'>',30000,nM,,,,UO_0000065,,,,,0,CHEMBL1936080,Inhibition of Pim-2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1933021,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL1725279,SP-600125,None,220.23,0,4.43,SP-600125,Oc1c2ccccc2c2c3c(cccc13)N=N2,Activity,'=',58,%,,,,UO_0000187,,,,,0,CHEMBL1061086,Percentage PIM2 activity remaining in the presence of 1uM inhibitor,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL3687507,,None,528.58,1,4.9,BDBM151903,CO[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C(C)(C)O)cc3F)n2)C[C@@H]1C,IC50,'=',1.33,nM,8.88,,292159,UO_0000065,16.79,0.32,3.98,8.04,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3651975,,None,426.44,0,4.8,BDBM106879,N[C@H]1CCC[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3cccc(F)c3F)n2)C1,IC50,'=',20,nM,7.7,,225900,UO_0000065,18.05,0.34,2.9,9.52,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2147760,,None,375.43,0,2.89,3,O=C1/C(=C/c2c[nH]c3ccccc23)Oc2c1ccc(O)c2CN1CCNCC1,Inhibition,'=',30,%,,,,UO_0000187,,,,,0,CHEMBL2149986,Inhibition of PIM2 at 600 nM by electrophoretic mobility shift assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2146430,1,Scientific Literature,J Med Chem,2012,None,
CHEMBL3103858,,None,312.38,0,1.24,3g,Nc1cccnc1C(=O)Nc1cnccc1N1CCC[C@H](N)C1,Ki,'=',110,nM,6.96,,,UO_0000065,22.28,0.41,5.72,6.32,0,CHEMBL3106178,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3102815,1,Scientific Literature,ACS Med Chem Lett,2013,None,
CHEMBL3103869,,None,440.45,0,2.15,5a,Nc1ccc(-c2c(F)cccc2F)nc1C(=O)Nc1cnccc1N1CC[C@@H](O)[C@H](N)C1,Ki,'=',0.006,nM,,Outside typical range,,UO_0000065,,,,,0,CHEMBL3106178,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3102815,1,Scientific Literature,ACS Med Chem Lett,2013,None,
CHEMBL3628628,,None,453.93,0,3.77,5,COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC,Inhibition,'=',0.63,%,,,,UO_0000187,,,,,0,CHEMBL3630921,Inhibition of PIM2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3627608,1,Scientific Literature,Bioorg Med Chem,2015,None,
CHEMBL1909403,GW569293E,None,547.47,0,4.41,GW569293E,O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1,Inhibition,'=',-0.96,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL226471,,None,307.33,0,3.17,SID103904965,O=C1NCCc2[nH]c(-c3ccnc(-c4ccccc4F)c3)cc21,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL4095072,,None,429.53,0,3.57,11,Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1,Inhibition,'=',-1.7,%,,,,UO_0000187,,,,,0,CHEMBL4057358,Inhibition of PIM2 (unknown origin) at 0.45 uM relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4052759,1,Scientific Literature,Bioorg Med Chem Lett,2017,None,
CHEMBL583972,,None,234.26,0,3.61,BDBM50299249,O=Cc1c[nH]c2c1ccc1c3ccccc3[nH]c12,IC50,'=',510,nM,6.29,,213994,UO_0000065,26.86,0.48,2.68,12.93,0,CHEMBL3707524,Inhibition Assay: Inhibition assay using PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3651956,,None,440.47,1,5.04,BDBM106860,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3cccc(F)c3F)n2)C1,IC50,'=',5,nM,8.3,,225881,UO_0000065,18.85,0.35,3.26,10.26,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3651911,,None,466.53,0,4.44,BDBM106815,CCc1ccc(F)c(-c2cccc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@H](O)[C@@H](C)C3)n2)c1F,IC50,'=',27,nM,7.57,,225836,UO_0000065,16.22,0.3,3.13,7.48,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3687528,,None,592.64,1,4.09,BDBM151925,COCCOc1cc(F)c(-c2nc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@@H](S(C)(=O)=O)[C@@H](C)C3)ccc2F)c(F)c1,IC50,'=',9.07,nM,8.04,,292180,UO_0000065,13.57,0.27,3.95,6.02,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3652007,,None,457.46,0,2.96,BDBM106913,C[C@@H]1CN(c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@H](N)[C@H]1O,IC50,'=',89,nM,7.05,,225934,UO_0000065,15.41,0.29,4.09,6.76,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL205765,GW794726X,None,487.92,1,5.34,GW794726X,CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1,Inhibition,'=',-0.75,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3765499,,None,563.72,2,6.04,12,CN1CCN(CCCOc2ccc(N3C(=O)/C(=C/c4ccc(Oc5ccc(F)cc5)cc4)SC3=S)cc2)CC1,Inhibition,'=',0,%,,,,UO_0000187,,,,,0,CHEMBL3767327,Inhibition of PIM2 (unknown origin) at 10 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3763027,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL941,IMATINIB,4,493.62,0,4.59,Imatinib,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL1230609,FORETINIB,2,632.66,2,5.77,EXEL-2880/GSK-1363089,COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL2002702,,None,238.29,0,3.12,SID103905112,Cc1cc(C)c(C=C2C(=O)Nc3ccccc32)[nH]1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL207995,,None,331.72,0,2.47,SID103904885,COc1cc(C=O)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2001923,,None,675.71,2,7.94,SID103905427,O=C1Nc2cc(CCOc3ccc(N4CCOCC4)cc3)ccc2Nc2cc(-c3cn(Cc4cc(F)c(F)c(F)c4)c4cnccc34)ccc21,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL211378,,None,360.38,0,3.82,SID103904365,Cc1cccc(NC(=O)Nc2ccc(-c3noc4ncnc(N)c34)cc2)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL474432,,None,478.45,1,5.4,SID103905428,COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)O)s3)c2cc1OC,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1988153,,None,377.35,1,5.47,SID103905370,Cc1nnc(-c2cc3c(Oc4ccc(C(F)(F)F)cc4)cncc3s2)o1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1992242,,None,373.48,1,6.22,SID103904384,Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4sncc34)cc2)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL188426,GW807982X,None,430.39,0,4.36,GW807982X,CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1,Inhibition,'=',-0.46,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL237570,,None,467.59,1,6.02,SB-630812,COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1,Inhibition,'=',-0.27,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL2312290,,None,510.64,1,3.25,18,COc1ccc(CCNc2ncc(C(=O)NCCCN3CCCC3=O)c(NC3CCCC3)n2)cc1OC,IC50,'=',14110,nM,4.85,,,UO_0000065,9.5,0.18,1.6,4.12,0,CHEMBL2319122,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2311468,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL2017347,,None,361.41,1,5.12,13m,Fc1ccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3sccc23)cc1,IC50,'=',7,nM,8.15,,,UO_0000065,22.56,0.43,3.03,12.26,0,CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016532,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL476259,GSK-1326255A,None,517.61,2,5.28,GSK1326255A,CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1,Inhibition,'=',1.98,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3934918,,None,348.41,0,3.38,BDBM238604,Cc1nc2cccc(-c3cc4c(=O)[nH]cnc4[nH]3)c2nc1NC(C)(C)C,IC50,'=',1.29,nM,8.89,,416711,UO_0000065,25.51,0.47,5.51,8.95,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL572878,TOZASERTIB,2,464.6,0,3.5,VX-680,Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1,Activity,'=',99,%,,,,UO_0000187,,,,,0,CHEMBL1061086,Percentage PIM2 activity remaining in the presence of 1uM inhibitor,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL408732,,None,308.34,0,2.98,SB-711237,COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1,Inhibition,'=',0.38,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL399410,,None,453.57,1,5.72,SB-437013,COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1,Inhibition,'=',0.99,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL492581,,None,337.42,0,2.99,27,CN1CCCN(c2cccc(-c3cccc(/C=C/C(=O)O)c3)n2)CC1,IC50,'=',46,nM,7.34,,,UO_0000065,21.75,0.4,4.35,12.95,0,CHEMBL960129,Inhibition of Pim2 in presence of 1 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153342,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL2017341,,None,393.86,1,5.34,13h,Oc1ccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3sccc23)c(Cl)c1,IC50,'=',4,nM,8.4,,,UO_0000065,21.32,0.42,3.06,9.68,0,CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016532,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL3687499,,None,498.55,1,5.37,BDBM151895,CCO[C@@H]1[C@H](C)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C)cc3F)n2)C[C@@H]1N,IC50,'=',1471.24,nM,5.83,,292151,UO_0000065,11.7,0.22,0.46,6.47,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1516890,GW441756X,None,275.31,0,3.07,GW441756X,Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21,Inhibition,'=',0.38,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1964399,,None,425.49,0,3.42,SID103904938,COc1ccc(Nc2nccc(Nc3c(NC(C)C(C)(C)C)c(=O)c3=O)n2)cc1OC,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL185238,GW786460X,None,287.33,0,3.39,GW786460X,Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1,Inhibition,'=',0.22,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL272026,GW290597X,None,467.51,0,1.12,GW290597X,NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1,Inhibition,'=',7.42,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL216543,,None,277.28,0,2.65,K00545,O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\O,Thermal melting change,'=',2.8,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL492354,,None,324.38,0,1.99,10,CN1CCN(c2cncc(-c3cccc(/C=C/C(=O)O)c3)n2)CC1,IC50,'=',150,nM,6.82,,,UO_0000065,21.04,0.39,4.83,9.81,0,CHEMBL960121,Inhibition of Pim2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153342,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL477069,GSK-1173862A,None,517.61,2,5.28,GSK1173862A,CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1,Inhibition,'=',7.35,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1727312,,None,210.24,0,3,SID103904709,O=C1Nc2ccccc2Nc2ccccc21,Ki,'>',7943.28,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL103667,DORAMAPIMOD,2,527.67,2,5.99,BIRB-796,Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1,Kd,,,,,,Not Active,,,,,,0,CHEMBL859489,Average Binding Constant for PIM2; NA=Not Active at 10 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144455,1,Scientific Literature,Nat Biotechnol,2005,None,
CHEMBL411903,,None,459.41,0,4.8,SID103905219,Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc1)CCN2,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2000071,,None,268.32,0,2.42,SID103904212,OCCCNc1ncnc2[nH]cc(-c3ccccc3)c12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1984432,,None,303.37,0,3.49,SID103904530,Cc1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c(C)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1978014,,None,415.5,0,2.91,SID103904547,CN1CCC(C(=O)n2nc(N)c3cc(-c4cn(Cc5ccccc5)nn4)ccc32)CC1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL24828,VANDETANIB,4,475.36,0,4.43,Vandetanib,COc1cc2/c(=N/c3ccc(Br)cc3F)nc[nH]c2cc1OCC1CCN(C)CC1,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL1994040,,None,450.49,0,4.27,SID103904773,CC(C)(O)CNc1nccc(-c2c(-c3ccc(F)cc3F)nc3c(CC4CC4)nccn23)n1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1967302,,None,398.47,0,3.67,SID103904477,NC(COc1cncc(-c2ccc3c(c2)CC(=O)N3)c1)Cc1c[nH]c2ccccc12,Ki,'=',39.81,nM,7.4,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3931386,,None,421.46,0,3.74,BDBM192550,N[C@H]1CCCN(c2ccncc2Nc2ncc3ccc(-c4ccc(F)cc4F)nn23)C1,IC50,'=',3,nM,8.52,,344542,UO_0000065,20.22,0.38,4.78,10.1,1,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3916900,,None,390.39,0,4.54,BDBM238535,O=C1NCCc2[nH]c(-c3cccc4ccc(Nc5c(F)cccc5F)nc34)cc21,IC50,'=',3.2,nM,8.49,,416258,UO_0000065,21.76,0.4,3.95,12.17,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3966072,,None,376.46,0,2.51,BDBM238512,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@@H]1CC[C@H](N)C1,IC50,'=',1.4,nM,8.85,,416656,UO_0000065,23.52,0.43,6.34,8.14,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3962064,,None,365.44,0,2.96,BDBM238726,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)[nH]c(N(C)C(C)(C)C)nc34)[nH]c21,IC50,'=',0.4,nM,9.4,,416835,UO_0000065,25.72,0.48,6.44,10.01,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3913164,,None,365.44,0,2.94,BDBM238785,C[C@@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C)c(NC(C)(C)C)nc34)[nH]c21,IC50,'=',0.864,nM,9.06,,416894,UO_0000065,24.8,0.46,6.12,9.87,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3893675,,None,364.45,0,3.16,BDBM238682,CNc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC(C)(C)C,IC50,'=',5.61,nM,8.25,,416791,UO_0000065,22.64,0.42,5.09,8.71,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4102902,,None,376.42,0,2.29,10,O=C1/C(=C/c2c[nH]c3ncccc23)Oc2c1ccc(O)c2CN1CCNCC1,IC50,'=',420,nM,6.38,,,UO_0000065,16.94,0.31,4.09,7.05,0,CHEMBL3997632,Inhibition of full length recombinant human N-terminal GST-tagged PIM2 (1 to 311 residues) expressed in baculovirus infected sf21 cells using S6K2 peptide as substrate by electrophoretic mobility shift assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3994673,1,Scientific Literature,ACS Med Chem Lett,2017,None,
CHEMBL3914639,,None,416.49,0,2.52,20,COc1ccc(-n2ncc3cnc(-c4cncc(C)n4)cc32)nc1N1CCC[C@H](N)C1,Ki,'=',0.11,nM,9.96,,,UO_0000065,23.91,0.44,7.44,9.23,0,CHEMBL4052120,Inhibition of PIM2 (unknown origin) using 5FAM-ARKRRRHPSGPPTA as substrate after 90 mins in presence of ATP by caliper microfluidic mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4049450,1,Scientific Literature,J Med Chem,2017,None,
CHEMBL1909405,GW618013A,None,554.57,0,4.98,GW618013A,CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O,Inhibition,'=',-3.32,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3948078,,None,418.5,0,2.64,BDBM238423,CC(=O)N1CCC(Nc2nc3c(-c4cc5c([nH]4)CCNC5=O)cccc3nc2C)CC1,IC50,'=',24.4,nM,7.61,,416621,UO_0000065,18.19,0.34,4.97,7.39,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL409892,GW305178X,None,367.39,0,1.65,GW305178X,NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1,Inhibition,'=',1.2,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL2017335,,None,337.41,0,3.07,13b,c1cc(-c2nnc[nH]2)c2nc(N3CCOCC3)c3ccsc3c2c1,IC50,'=',10,nM,8,,,UO_0000065,23.71,0.46,4.93,11.95,0,CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016532,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL2017328,,None,377.86,1,5.63,10g,Clc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2ccsc12,IC50,'=',6,nM,8.22,,,UO_0000065,21.76,0.43,2.59,12.37,0,CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016532,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL2017342,,None,395.85,1,5.77,13i,Fc1ccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3sccc23)c(Cl)c1,IC50,'=',9,nM,8.05,,,UO_0000065,20.33,0.41,2.28,12.1,0,CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016532,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL3962494,,None,393.48,0,3.02,BDBM224879,CNc1nnc(-c2ccc3[nH]cc(-c4nccc(N5CCOCC5)n4)c3c2)s1,IC50,'=',16.31,nM,7.79,,393157,UO_0000065,19.79,0.38,4.77,8.48,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3957081,,None,406.47,0,2.68,BDBM224975,NC(=O)c1nnc(-c2ccc3[nH]cc(-c4cccc(N5CCOCC5)n4)c3c2)s1,IC50,'>',3000,nM,,,393265,UO_0000065,,,,,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3890346,,None,365.44,0,2.42,BDBM238764,Cn1c(NC(C)(C)C)nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2c1=O,IC50,'=',0.169,nM,9.77,,416873,UO_0000065,26.74,0.49,7.35,10.64,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3940702,,None,514.55,1,4.19,BDBM191102,NCC[C@H]1CNC(=O)c2cc(-c3cccc(OC(F)(F)F)c3)c(-c3ccc(CN4CCOCC4)cc3)n21,IC50,'=',7,nM,8.15,,341773,UO_0000065,15.85,0.3,3.96,9.98,0,CHEMBL3887520,Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3660012,,None,318.38,0,2.71,BDBM104130,NCCCNc1cccc2ccc(-c3nnc4ccccn34)nc12,IC50,'=',1045,nM,5.98,,222548,UO_0000065,18.79,0.34,3.27,7.37,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3943493,,None,465.48,1,5.51,BDBM191118,NCC[C@H]1CNC(=O)c2cc(-c3cccc(OC(F)(F)F)c3)c(-c3ccc4ccccc4c3)n21,IC50,'=',152,nM,6.82,,341789,UO_0000065,14.65,0.27,1.31,9.84,0,CHEMBL3887520,Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2312304,,None,507.42,1,4.32,32,O=C(NCCCN1CCOC1=O)c1cnc(NCc2cc(Cl)ccc2Cl)nc1NC1CCCC1,IC50,'>',30000,nM,,,,UO_0000065,,,,,0,CHEMBL2319122,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2311468,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL3676277,,None,453.53,0,4.55,BDBM131747,NC1CC(C(F)(F)F)CN(c2ccncc2NC(=O)c2csc(C3CCCCC3)n2)C1,IC50,'=',21,nM,7.68,,263980,UO_0000065,16.93,0.34,3.13,9.13,0,CHEMBL3706072,Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3685741,,None,447.49,0,3.58,BDBM124904,NC1CC(N)CN(c2ccncc2Nc2cccc3cnc(-c4c(F)cccc4F)nc23)C1,IC50,'=',2500,nM,5.6,,254206,UO_0000065,12.52,0.23,2.02,5.29,0,CHEMBL3705221,ATP Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 ul per well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3685748,,None,403.52,0,3.82,BDBM124912,NC1CCCN(c2ccncc2Nc2cccc3cnc(-c4nccs4)nc23)C1,IC50,'=',1900,nM,5.72,,254214,UO_0000065,14.18,0.27,1.9,6.16,0,CHEMBL3705221,ATP Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 ul per well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3792428,,None,400.42,0,3.76,2c,Nc1cc(-c2ccncc2NC(=O)c2nc(-c3ccccc3F)ccc2N)ccn1,Ki,'=',35,nM,7.46,,,UO_0000065,18.62,0.34,3.7,6.22,0,CHEMBL3794688,Inhibition of Pim2 (unknown origin) using BAD peptide preincubated for 15 mins followed by ATP addition measured after 60 to 100 mins by Kinase-Glo reagent based luminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3792348,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL494089,GSK-690693,1,425.49,0,1.58,GSK-690693,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21,Kd,'=',680,nM,6.17,,,UO_0000065,14.5,0.27,4.59,4.5,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL3900255,,None,312.28,0,3.75,BDBM224819,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(F)c4F)c3c2)o1,IC50,'=',164.41,nM,6.78,,393101,UO_0000065,21.72,0.4,3.03,8.4,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL494354,,None,338.41,0,2.92,23,N[C@H]1CC[C@H](Nc2cncc(-c3cccc(/C=C/C(=O)O)c3)n2)CC1,IC50,'=',12,nM,7.92,,,UO_0000065,23.41,0.43,5,7.83,0,CHEMBL960129,Inhibition of Pim2 in presence of 1 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153342,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL2017349,,None,379.4,1,5.26,13p,Fc1ccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3sccc23)cc1F,IC50,'=',15,nM,7.82,,,UO_0000065,20.62,0.4,2.56,11.77,0,CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016532,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL2017324,,None,361.41,1,5.12,10c,Fc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2sccc12,IC50,'=',2,nM,8.7,,,UO_0000065,24.07,0.46,3.58,13.08,0,CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016532,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL2017329,,None,378.85,1,5.03,10h,Clc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2scnc12,IC50,'=',9,nM,8.05,,,UO_0000065,21.24,0.42,3.02,10.14,0,CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016532,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL2017332,,None,344.35,0,4.16,20c,Fc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2n2cccc12,IC50,'=',20,nM,7.7,,,UO_0000065,22.36,0.4,3.54,10.86,0,CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016532,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL2017322,,None,343.42,0,4.98,10a,c1ccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3sccc23)cc1,IC50,'=',15,nM,7.82,,,UO_0000065,22.78,0.43,2.84,11.77,0,CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016532,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL489783,,None,372.78,0,3.77,10,CCn1c2cc(Cl)c(F)cc2c(=O)c2c(=O)on(Cc3ccccc3)c21,Ki,'>',1424,nM,,,,UO_0000065,,,,,0,CHEMBL994191,Inhibition of Pim2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144228,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,
CHEMBL3691940,,None,511.56,1,2.93,BDBM151962,C[C@H]1CN(c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)sc2N)C[C@@H](N)[C@H]1n1ccnn1,IC50,'=',0.77,nM,9.11,,292217,UO_0000065,17.82,0.35,6.18,6.47,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL486124,GW874091X,None,352.44,0,2.23,GW874091X,Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12,Inhibition,'=',0.05,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1967116,,None,454.56,1,5.9,SID103904313,Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL373073,GW642138X,None,241.25,0,2.48,GW642138X,COc1ccc(-c2cc3c(N)ncnc3o2)cc1,Inhibition,'=',2.23,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL318728,GW549390X,None,236.27,0,4.09,GW549390X,c1ccc(Nc2ncc(-c3ccccc3)o2)cc1,Inhibition,'=',-1.31,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1909351,GW824645A,None,368.82,0,2.61,GW824645A,Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1,Inhibition,'=',1.85,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1789962,GW643971X,None,374.4,0,3.03,GW643971X,COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O,Inhibition,'=',0.65,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL505915,GSK-1751853A,None,601.69,1,3.61,GSK1751853A,COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2,Inhibition,'=',0.2,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3991929,Cerdulatinib Hydrochloride,None,482.01,0,1.37,Cerdulatinib Hydrochloride,CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3916316,,None,377.45,0,2.55,BDBM238516,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1(CO)CCC1,IC50,'=',3,nM,8.52,,416660,UO_0000065,22.58,0.42,5.97,8.28,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1993166,,None,775.93,3,0.17,SID103905218,CC(=NNC(=N)N)c1cc(NC(=O)NCCCN(C)CCCNC(=O)Nc2cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c2)cc(C(C)=NNC(=N)N)c1,Ki,'=',1258.93,nM,5.9,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL207400,,None,317.65,0,2.8,SID103905391,Cn1nc(C(F)(F)F)c2c(=O)c3cc(Cl)ccc3n(O)c21,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1975490,,None,414.47,0,4.21,SID103904650,NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccccc5o4)cc3)c1)CNC2=O,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3938933,,None,297.74,0,3.17,BDBM238376,O=C1NCCc2[nH]c(-c3cccc4ccc(Cl)nc34)cc21,IC50,'=',636,nM,6.2,,416153,UO_0000065,20.81,0.4,3.03,10.72,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3687480,,None,468.51,0,3.51,BDBM151876,CO[C@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)ncc2N)C[C@@H]1C,IC50,'=',10.7,nM,7.97,,292132,UO_0000065,17.01,0.32,4.46,6.18,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1974416,,None,349.34,0,4.76,SID103904194,O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1cccc(F)c1F,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1968850,,None,246.66,0,2.44,SID103905413,O=C1Nc2ccccc2Nc2nnc(Cl)cc21,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2001288,,None,393.14,0,-1.38,SID103905653,Nc1ncnc2c1c(I)nn2C1OC(CO)C(O)C1O,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL396523,,None,346.35,0,3.54,SID103904593,O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3[nH]ncc3c2)n1,Ki,'=',125.89,nM,6.9,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1986530,,None,448.5,0,2.13,SID103905570,O=C(c1cc(Cc2n[nH]c(=O)c3c2CCCC3)ccc1F)N1CCN(c2ncccn2)CC1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1990496,,None,461.57,0,4.64,SID103905562,Cn1c(NCC(N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL270544,GW396574X,None,370.43,0,2.53,GW396574X,CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2,Inhibition,'=',0.72,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL477583,GW743024X,None,374.44,0,4.65,GW743024X,Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1,Inhibition,'=',0.6,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL101804,,None,268.28,0,2.57,SB-743899,O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1,Inhibition,'=',-0.06,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL204934,GW813360X,None,345.37,0,2.67,GW813360X,COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1,Inhibition,'=',-3.43,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3687475,,None,512.54,1,3.44,BDBM151871,CC(=O)N(C)[C@@H]1[C@H](N)CN(c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H]1C,IC50,'=',2800,nM,5.55,,292127,UO_0000065,10.83,0.2,2.11,5.32,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL275798,,None,415.47,0,4.86,SB-239272,Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1,Inhibition,'=',-3.22,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3808669,,None,347.42,0,3.36,10a,Cc1nc2cccc3c2nc1NCCCC[C@H]1CNC(=O)c2cc-3[nH]c21,IC50,'=',0.05,nM,10.3,,,UO_0000065,29.65,0.54,6.94,12.46,0,CHEMBL3812018,Inhibition of human full-length Pim2 expressed in Escherichia coli assessed as phosphorylation of biotinylated BAD peptide at Ser 112 preincubated for 30 mins followed by substrate addition measured after 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3808325,1,Scientific Literature,ACS Med Chem Lett,2016,None,
CHEMBL3810095,,None,361.45,0,3.74,10c,Cc1nc2cccc3c2nc1N[C@H](C)CCC[C@H]1CNC(=O)c2cc-3[nH]c21,IC50,'=',0.2,nM,9.7,,,UO_0000065,26.83,0.49,5.96,11.73,0,CHEMBL3812018,Inhibition of human full-length Pim2 expressed in Escherichia coli assessed as phosphorylation of biotinylated BAD peptide at Ser 112 preincubated for 30 mins followed by substrate addition measured after 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3808325,1,Scientific Literature,ACS Med Chem Lett,2016,None,
CHEMBL2036116,,None,315.38,0,4.78,3,N#CCCCCn1c2ccccc2c2ccc3c(C=O)c[nH]c3c21,Activity,'=',32,%,,,,UO_0000187,,,,,0,CHEMBL2040257,Inhibition of Pim-2 using RSRHSSYPAGT as substrate assessed as residual activity at 1 uM after 30 mins,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034961,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL514938,GSK-969786A,None,451.91,1,7.07,GSK969786A,Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1,Inhibition,'=',0.73,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3959725,,None,349.44,0,3.43,BDBM238547,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC(C)(C)C,IC50,'=',1.3,nM,8.89,,416270,UO_0000065,25.43,0.47,5.46,10.74,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2147763,,None,389.46,0,3.2,6,COc1ccc2c(c1CN1CCNCC1)O/C(=C\c1c[nH]c3ccccc13)C2=O,Inhibition,'=',30,%,,,,UO_0000187,,,,,0,CHEMBL2149328,Inhibition of PIM2 at 250 nM by electrophoretic mobility shift assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2146430,1,Scientific Literature,J Med Chem,2012,None,
CHEMBL3953669,,None,378.46,0,4.05,BDBM224935,Nc1nnc(-c2ccc3[nH]cc(-c4cnc(OC5CCCC5)cn4)c3c2)s1,IC50,'=',1343.13,nM,5.87,,393218,UO_0000065,15.52,0.3,1.82,5.72,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3965960,,None,375.35,0,3.71,BDBM238633,Cc1nc2cccc(-c3cc4c([nH]3)[C@H](C)NC4=O)c2nc1NCC(F)(F)F,IC50,'=',6.02,nM,8.22,,416742,UO_0000065,21.9,0.42,4.51,9.94,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL573470,,None,285.37,0,2.84,12a,C=Cc1ccc2sc3c(=O)[nH]c(CN(C)C)nc3c2c1,Ki,'=',34,nM,7.47,,,UO_0000065,26.17,0.51,4.63,15.24,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL76904,TYRPHOSTIN 23,None,186.17,0,1.53,K00063,N#CC(C#N)=Cc1ccc(O)c(O)c1,Thermal melting change,'=',1,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL3651908,,None,450.53,1,5.6,BDBM106812,Cc1ccc(F)c(-c2cccc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)CC(C)(C)C3)n2)c1F,IC50,'=',10,nM,8,,225833,UO_0000065,17.76,0.33,2.4,9.89,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL392642,,None,416.55,0,3.9,SID103905471,CSc1ccccc1CNc1ncc([N+](=O)[O-])c(NCC2CCC(CN)CC2)n1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1969301,,None,457.58,1,5.5,SID103905076,CCCCn1c(NC(=O)c2cccc(C#N)c2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1980297,ILORASERTIB,2,488.55,1,5.18,SID103904272,Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3921910,,None,415.42,0,4.35,BDBM191070,NCCC1CNC(=O)c2cc(-c3cccc(OC(F)(F)F)c3)c(-c3ccccc3)n21,IC50,'=',55,nM,7.26,,341741,UO_0000065,17.48,0.33,2.91,10.48,0,CHEMBL3887520,Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3942496,,None,359.42,0,3.52,BDBM224921,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(-n5cccn5)n4)c3c2)s1,IC50,'=',49.46,nM,7.31,,393203,UO_0000065,20.33,0.38,3.79,7.43,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3903730,,None,427.53,0,2.45,BDBM238615,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC(C)(C)CS(C)(=O)=O,IC50,'=',39.5,nM,7.4,,416722,UO_0000065,17.32,0.34,4.95,6.34,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3919558,,None,392.47,0,3.54,BDBM224918,Nc1nnc(-c2ccc3[nH]cc(-c4csc(-n5ccccc5=O)n4)c3c2)s1,IC50,'=',91.22,nM,7.04,,393200,UO_0000065,17.94,0.36,3.5,6.87,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL583691,,None,301.42,0,3.32,11b,CC(C)c1ccc2sc3c(=O)[nH]c(CN(C)C)nc3c2c1,Ki,'=',21,nM,7.68,,,UO_0000065,25.47,0.5,4.36,15.67,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL330422,,None,396.47,0,2.82,SB-226879,CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1,Inhibition,'=',0.95,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL275200,,None,471.58,1,6.16,SB-278538,CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1,Inhibition,'=',0.77,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL595373,,None,512.64,2,6.57,25,COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1,Residual activity,'=',89,%,,,,UO_0000187,,,,,0,CHEMBL1040270,Residual activity of PIM2 at 1 uM by microplate scintillation counting,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1152560,1,Scientific Literature,Bioorg Med Chem,2009,None,
CHEMBL520037,GW837331X,None,459.43,0,4.89,GW837331X,COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC,Inhibition,'=',3.02,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1909409,GSK-238583A,None,653.68,1,4.58,GSK238583A,O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1,Inhibition,'=',0.21,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1794062,GW577921A,None,302.76,0,4.09,GW577921A,COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl,Inhibition,'=',0.78,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL2387464,,None,502.53,1,4.02,17,O=C(Nc1c[nH]c2ncc(-c3ccccc3F)cc12)c1cnn2ccc(NC[C@H]3CCNC[C@@H]3F)nc12,Ki,'=',0.032,nM,10.49,,,UO_0000065,20.88,0.39,6.47,9.37,0,CHEMBL2387969,Inhibition of PIM2 (unknown origin) using FAM-pimtide as substrate after 90 mins by spectrophotometry in presence of ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2385019,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL23327,PURVALANOLA,None,388.9,0,4.23,Purvalanol,CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1,Activity,'=',96,%,,,,UO_0000187,,,,,0,CHEMBL1051299,Percentage PIM2 activity remaining in the presence of 0.1uM inhibitor,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL2036118,,None,333.44,0,4.43,10,CN(C)CCCCn1c2ccccc2c2ccc3c(C=O)c[nH]c3c21,Activity,'=',22,%,,,,UO_0000187,,,,,0,CHEMBL2040256,Inhibition of Pim-2 using RSRHSSYPAGT as substrate assessed as residual activity at 10 uM after 30 mins,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034961,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL2036116,,None,315.38,0,4.78,3,N#CCCCCn1c2ccccc2c2ccc3c(C=O)c[nH]c3c21,IC50,,,,,,Not Determined,,,,,,0,CHEMBL2040258,Inhibition of Pim-2 using RSRHSSYPAGT as substrate after 30 mins,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034961,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL2035634,,None,391.27,0,2.74,6e,CC(c1nc2c(oc3ccc(Br)cc32)c(=O)[nH]1)N1CCN(C)CC1,IC50,'=',503,nM,6.3,,,UO_0000065,16.1,0.36,3.56,9.64,0,CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034948,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL4555459,,None,481.6,1,5.59,43,O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1,Inhibition,'=',100,%,,,,UO_0000187,,,,,0,CHEMBL4389419,Inhibition of wild-type human partial length PIM2 (M1 to E291 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4387741,1,Scientific Literature,Bioorg Med Chem,2019,None,
CHEMBL91829,RUBOXISTAURIN,3,468.56,0,3.51,LY-333531,CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1,Activity,'=',41,%,,,Antagonist,UO_0000187,,,,,0,CHEMBL1051299,Percentage PIM2 activity remaining in the presence of 0.1uM inhibitor,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL2087492,,None,487.59,1,-0.01,32,Cc1c(CN2CCN(S(C)(=O)=O)CC2)nc2c(N3CCOCC3)nc(-c3cnc(N)nc3)cn12,Inhibition,'<',30,%,,,,UO_0000187,,,,,0,CHEMBL2092411,Inhibition of PIM2 at 1 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2086238,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL288441,BOSUTINIB,4,530.46,2,5.19,SKI-606,COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL1909411,,None,393.87,0,4.96,GI261520A,COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl,Inhibition,'=',0.96,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3974415,,None,435.48,0,4.13,rac-22i,C[C@]1(N)CCCN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1,IC50,'=',2.2,nM,8.66,,,UO_0000065,19.88,0.37,4.53,10.26,0,CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3864151,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL1952329,SGI-1776,1,405.42,0,4.05,SGI1776,CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1,IC50,'=',363,nM,6.44,,,UO_0000065,15.88,0.3,2.39,11.78,1,CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4118246,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL1909371,GW694590A,None,453.89,1,5.18,GW694590A,COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl,Inhibition,'=',0.15,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL468963,GW779439X,None,454.46,0,3.7,GW779439X,CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1,Inhibition,'=',10.36,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL419931,,None,356.43,0,2.52,K00017,CC(C)n1cnc2c(NCc3ccccc3O)nc(NCCCO)nc21,Thermal melting change,'=',0.1,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL578252,,None,340.38,1,5.29,29,COc1cccc(-c2ccc3[nH]c4c(ccc5c(C=O)c[nH]c54)c3c2)c1,Activity,'=',31,%,,,,UO_0000187,,,,,0,CHEMBL1057614,Inhibition of Pim-2 assessed as residual enzyme activity at 10 uM relative to untreated control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154186,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL2397527,,None,252.28,0,2.79,16b,COc1ccc2[nH]c3c(N)cc4[nH]ncc4c3c2c1,Activity,'=',54,%,,,,UO_0000187,,,,,0,CHEMBL2401344,Inhibition of human PIM2 assessed as residual activity using RSRHSSYPAGT as substrate at 10 uM after 30 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2396576,1,Scientific Literature,Bioorg Med Chem,2013,None,
CHEMBL2397523,,None,252.23,0,3.11,15a,O=[N+]([O-])c1cc2[nH]ncc2c2c1[nH]c1ccccc12,Activity,'=',38,%,,,,UO_0000187,,,,,0,CHEMBL2401344,Inhibition of human PIM2 assessed as residual activity using RSRHSSYPAGT as substrate at 10 uM after 30 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2396576,1,Scientific Literature,Bioorg Med Chem,2013,None,
CHEMBL2397598,,None,252.23,0,3.11,6a,O=[N+]([O-])c1cc2cn[nH]c2c2c1[nH]c1ccccc12,Activity,'=',46,%,,,,UO_0000187,,,,,0,CHEMBL2401344,Inhibition of human PIM2 assessed as residual activity using RSRHSSYPAGT as substrate at 10 uM after 30 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2396576,1,Scientific Literature,Bioorg Med Chem,2013,None,
CHEMBL568477,,None,328.35,1,5.42,32,O=Cc1c[nH]c2c1ccc1c3cc(-c4ccc(F)cc4)ccc3[nH]c12,Activity,'=',55,%,,,,UO_0000187,,,,,0,CHEMBL1057614,Inhibition of Pim-2 assessed as residual enzyme activity at 10 uM relative to untreated control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154186,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL575739,,None,346.34,1,5.56,33,O=Cc1c[nH]c2c1ccc1c3cc(-c4ccc(F)cc4F)ccc3[nH]c12,Activity,'=',32,%,,,,UO_0000187,,,,,0,CHEMBL1057614,Inhibition of Pim-2 assessed as residual enzyme activity at 10 uM relative to untreated control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154186,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL575460,,None,371.85,0,4.42,6s,Cc1ccc(NCc2nc3c(sc4ccc(Cl)cc43)c(=O)[nH]2)cc1O,Ki,'>',1424,nM,,,,UO_0000065,,,,,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL573038,,None,259.33,0,2.2,9,CN(C)Cc1nc2c(sc3ccccc32)c(=O)[nH]1,Ki,'=',238,nM,6.62,,,UO_0000065,25.54,0.5,4.42,13.52,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL583581,,None,327.33,0,3.22,10b,CN(C)Cc1nc2c(sc3ccc(C(F)(F)F)cc32)c(=O)[nH]1,Ki,'=',36,nM,7.44,,,UO_0000065,22.74,0.46,4.22,15.19,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL375428,,None,282.32,0,4.67,2,CC(C)c1noc(-c2ccc(F)cc2)c1-c1ccncc1,Activity,'=',96,%,,,,UO_0000187,,,,,0,CHEMBL1044611,Inhibition of PIM2 assessed as residual activity at 10 uM by Cherenkov counting relative to control in presence of 5 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155278,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL466412,GSK-238063A,None,566.06,2,5.59,GSK238063A,CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1,Inhibition,'=',0.15,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL398606,,None,414.51,1,5.4,10a,CC(C)NCc1ccc(Nc2cc(-c3ccc(-c4ccc(O)cc4O)cc3)[nH]n2)cc1,IC50,'=',1720,nM,5.76,,,UO_0000065,13.91,0.25,0.36,6.19,0,CHEMBL898066,Inhibition of PIM2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137531,1,Scientific Literature,J Med Chem,2007,None,
CHEMBL1275913,,None,238.29,0,2.8,(+/-)-17b,CC1Cc2nc3cc4[nH]ncc4cc3nc2C1C,Activity,,,,,,Not Active,,,,,,0,CHEMBL1285679,Inhibition of Pim2 assessed as residual enzyme activity at 1 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1275327,1,Scientific Literature,Eur J Med Chem,2010,None,
CHEMBL567173,,None,206.25,0,3.8,5,c1ccc2c(c1)[nH]c1c3cc[nH]c3ccc21,Activity,'=',77,%,,,,UO_0000187,,,,,0,CHEMBL1057614,Inhibition of Pim-2 assessed as residual enzyme activity at 10 uM relative to untreated control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154186,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL188048,,None,216.2,0,0.6,SB-736290,Cn1c(-c2nonc2N)nc2cnccc21,Inhibition,'=',-0.31,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL4126848,,None,375.45,0,4.4,25,CN(C)CCNc1cncc(-c2ccc3[nH]cc(-c4ccccc4F)c3c2)n1,IC50,'=',370,nM,6.43,,,UO_0000065,17.13,0.31,2.03,11.32,0,CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4118246,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL1794071,,None,409.92,0,3.73,SB-614067-R,Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21,Inhibition,'=',0.25,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL4079062,,None,369.86,0,2.4,19,Cn1c(-c2ccc(N3CCNCC3)cc2)cc2c(Cl)cc(C(N)=O)nc21,IC50,'>',30000,nM,,,,UO_0000065,,,,,0,CHEMBL4047686,Inhibition of PIM2 (unknown origin) assessed as reduction in full length human BAD phosphorylation at Ser112 residues by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4043256,1,Scientific Literature,Bioorg Med Chem Lett,2017,None,
CHEMBL4521353,,None,230.31,0,2.99,9,CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1,Inhibition,,,%,,,Active,UO_0000187,,,,,0,CHEMBL4352495,Inhibition of human PIM2 at 10 uM using RSRHSSYPAGT as substrate in presence of [gamma-33P]-ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4350963,1,Scientific Literature,J Med Chem,2019,None,
CHEMBL578237,,None,394.35,1,6.18,35,O=Cc1c[nH]c2c1ccc1c3cc(-c4ccc(OC(F)(F)F)cc4)ccc3[nH]c12,Activity,'=',73,%,,,,UO_0000187,,,,,0,CHEMBL1051392,Inhibition of Pim-2 assessed as residual enzyme activity at 1 uM relative to untreated control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154186,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL2017348,,None,379.4,1,5.26,13n,Fc1ccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3sccc23)c(F)c1,IC50,'=',2,nM,8.7,,,UO_0000065,22.93,0.44,3.44,13.08,0,CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016532,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL1909341,GW641155A,None,364.83,1,5.88,GW641155A,Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1,Inhibition,'=',0.31,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1968705,,None,535.65,2,6.13,SID103905541,CCCC(=O)Nc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3cc(OCCN4CCCC4)ccc3n2)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL595545,,None,2030.37,None,None,4,CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)N[C@H]2CSSC[C@@H](C(=O)NCC(N)=O)NC(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC2=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,Activity,'=',100,%,,,,UO_0000187,,,,,0,CHEMBL1037990,Binding affinity to human PIM2 at 200 nM by cell-based competition binding assay relative to control in presence of DTT,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1152541,1,Scientific Literature,Bioorg Med Chem,2009,None,
CHEMBL278041,SB-202190,None,331.35,0,4.65,SB-202190,Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,Kd,,,,,,Not Active,,,,,,0,CHEMBL859489,Average Binding Constant for PIM2; NA=Not Active at 10 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144455,1,Scientific Literature,Nat Biotechnol,2005,None,
CHEMBL1997340,,None,312.33,0,1.81,SID103904524,O=C(c1cc(-c2ccc3[nH]ncc3c2)on1)N1CCCC(O)C1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3978539,,None,418.5,0,2.64,BDBM238592,CC(=O)N1CCC[C@@H](Nc2nc3c(-c4cc5c([nH]4)CCNC5=O)cccc3nc2C)C1,IC50,'=',68.4,nM,7.17,,416703,UO_0000065,17.12,0.32,4.52,6.96,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL563845,,None,387.44,0,4.97,EGFR_ErbB_2_Inhibitor,COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC,Residual Activity,'=',105,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3940464,,None,364.41,0,2.35,BDBM238606,Cc1nc2cccc(-c3cc4c(=O)[nH]cnc4[nH]3)c2nc1NC(C)(C)CO,IC50,'=',5.8,nM,8.24,,416713,UO_0000065,22.6,0.42,5.89,6.89,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3933742,,None,395.46,0,2.31,BDBM238816,Cn1c(NC(C)(C)C)nc2c(-c3cc4c([nH]3)[C@@H](CCO)NC4=O)cccc2c1=O,IC50,'=',0.5,nM,9.3,,416925,UO_0000065,23.52,0.44,6.99,8.3,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2377711,,None,306.32,0,4.18,10,CCc1[nH]c2c([N+](=O)[O-])cc3cn[nH]c3c2c1-c1ccccc1,Inhibition,'=',84,%,,,,UO_0000187,,,,,0,CHEMBL2378599,Inhibition of human full length Pim-2 using RSRHSSYPAGT as substrate assessed as residual activity at 10 uM after 30 mins in presence of [gamma-33P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2375344,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL1909372,GW700494A,None,622.07,2,6.21,GW700494A,CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl,Inhibition,'=',-1.87,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1909360,GW830263A,None,665.22,1,4.56,GW830263A,CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl,Inhibition,'=',-0.2,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL595143,,None,541.68,2,5.72,24,COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1,Residual activity,'=',64,%,,,,UO_0000187,,,,,0,CHEMBL1070476,Residual activity of PIM2 at 0.1 uM by microplate scintillation counting,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1152560,1,Scientific Literature,Bioorg Med Chem,2009,None,
CHEMBL272414,GW416469X,None,358.42,0,1.81,GW416469X,CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2,Inhibition,'=',0.23,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3660090,,None,391.45,0,3.72,BDBM104222,Cc1ccc2nnc(-c3ccc4cccc(OC5CCNCCC5F)c4n3)n2c1,IC50,'=',1000,nM,6,,222633,UO_0000065,15.33,0.28,2.28,9.33,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3394073,,None,379.45,0,2.56,BDBM50061601,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(N5CCOCC5)n4)c3c2)s1,IC50,'=',12.31,nM,7.91,,393179,UO_0000065,20.85,0.4,5.35,7.47,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3924622,,None,457.53,1,6.06,BDBM224892,CC(=O)Nc1cccc(CNc2nnc(-c3ccc4[nH]cc(-c5ccccc5F)c4c3)s2)c1,IC50,'=',2167.72,nM,5.66,,393168,UO_0000065,12.38,0.23,-0.4,6.85,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1794052,GW405841X,None,453.09,0,4.2,GW405841X,COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2,Inhibition,'=',10.67,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL573475,,None,349.84,0,2.75,6h,O=c1[nH]c(CN2CCC(O)CC2)nc2c1sc1ccc(Cl)cc12,Ki,'=',206,nM,6.69,,,UO_0000065,19.11,0.4,3.94,9.66,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL495902,GW820759X,None,291.35,0,3.43,GW820759X,Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1,Inhibition,'=',0.98,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL86943,,None,310.35,0,3.3,VEGF_Receptor_2_Kinase_Inhibitor_I,CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C,Residual Activity,'=',112,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3545076,LY-2584702,1,445.42,0,4.3,LY-2584702,Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL2103840,DINACICLIB,3,396.5,0,2.28,Dinaciclib,CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3137331,DEFACTINIB,2,510.5,1,2.4,Defactinib,CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3545085,XL-228,1,437.55,0,3.3,XL-228,CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL2140408,AMG-900,1,503.59,2,6.64,AMG-900,Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL4446938,,None,444.54,0,2.97,41,CCN1CCOc2c1cnn1c(-c3ccc4cccc(NCC5CCNCC5)c4n3)nnc21,IC50,'=',1930,nM,5.71,,,UO_0000065,12.85,0.24,2.74,6.18,0,CHEMBL4340984,Inhibition of His tagged human recombinant PIM2 using PIM tide (ARKRRRHPSGPPTA) as substrate incubated for 1 hr by fluorescence based assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4340512,1,Scientific Literature,Eur J Med Chem,2019,None,
CHEMBL176857,GW442130X,None,502.16,2,5.48,GW442130X,COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O,Inhibition,'=',-0.06,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL583385,,None,387.87,0,4.66,14p,CN(C)Cc1nc2c(sc3ccc(-c4cc(F)cc(Cl)c4)cc32)c(=O)[nH]1,Ki,'=',45,nM,7.35,,,UO_0000065,18.94,0.39,2.69,15,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL573037,,None,321.83,0,3.29,6k,CN(C)CCCc1nc2c(sc3ccc(Cl)cc32)c(=O)[nH]1,Ki,'=',211,nM,6.68,,,UO_0000065,20.74,0.43,3.39,13.63,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL373598,,None,447.88,0,3.35,16a,N#Cc1ncc2nc1OCCCCCOc1cc(OCCCO)c(Cl)cc1NC(=O)N2,Ki,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL915361,Inhibition of Pim2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142994,1,Scientific Literature,J Med Chem,2007,None,
CHEMBL595143,,None,541.68,2,5.72,24,COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1,Residual activity,'=',63,%,,,,UO_0000187,,,,,0,CHEMBL1040270,Residual activity of PIM2 at 1 uM by microplate scintillation counting,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1152560,1,Scientific Literature,Bioorg Med Chem,2009,None,
CHEMBL445813,AT-7519,2,382.25,0,2.45,AT-7519,O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL3929510,,None,389.84,0,4.96,BDBM238392,O=C1NCCc2[nH]c(-c3cccc4ccc(Oc5ccc(Cl)cc5)nc34)cc21,IC50,'=',44.9,nM,7.35,,416170,UO_0000065,18.85,0.36,2.39,10.97,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL573956,,None,357.82,0,4.11,6o,O=c1[nH]c(CNc2ccc(O)cc2)nc2c1sc1ccc(Cl)cc12,Ki,'>',1424,nM,,,,UO_0000065,,,,,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL3651964,,None,479.56,0,3.86,BDBM106868,CCCOc1ccc(F)c(-c2ccc(N)c(C(=O)Nc3cnccc3[C@@H]3CC[C@H](O)[C@H](N)C3)n2)c1,IC50,'=',8,nM,8.1,,225889,UO_0000065,16.88,0.32,4.24,5.94,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL191003,JNJ-7706621,None,394.36,0,1.22,JNJ-7706621,Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F,Residual Activity,'=',99,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2037200,,None,461.95,0,4.87,13,CN1CCCN(C(=O)c2cccc(-c3ccc(/C=C4/C(=O)Nc5ccc(Cl)cc54)o3)c2)CC1,Inhibition,'>',80,%,,,,UO_0000187,,,,,0,CHEMBL2038838,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate at 0.5 uM by radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034977,1,Scientific Literature,ACS Med Chem Lett,2012,None,
CHEMBL454394,,None,362.47,0,4.22,19,COc1cc2c(c(OC)c1)C(=O)O[C@@H](C)CCC[C@@H](O)[C@@H](C)CC/C=C/2,Tm,'<',2,degrees C,,,,UO_0000027,,,,,0,CHEMBL1004482,Binding affinity to human recombinant PIM2 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140872,1,Scientific Literature,Bioorg Med Chem,2009,None,
CHEMBL583972,,None,234.26,0,3.61,A,O=Cc1c[nH]c2c1ccc1c3ccccc3[nH]c12,Activity,,,,,,Not Determined,,,,,,0,CHEMBL2090475,Inhibition of human Pim2 using RSRHSSYPAGT as substrate assessed as residual activity at 1 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2086229,1,Scientific Literature,Eur J Med Chem,2012,None,
CHEMBL2088999,,None,265.27,0,3.08,20,Nc1cccc2[nH]c3c(cc(C(=O)O)c4cc[nH]c43)c12,Activity,'=',101,%,,,,UO_0000187,,,,,0,CHEMBL2090475,Inhibition of human Pim2 using RSRHSSYPAGT as substrate assessed as residual activity at 1 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2086229,1,Scientific Literature,Eur J Med Chem,2012,None,
CHEMBL3968789,,None,360.43,0,2.01,BDBM248949,c1cc(N2CCCNCC2)nc(-n2ncc3cnc(-c4cn[nH]c4)cc32)c1,Ki,'=',1.6,nM,8.8,,434156,UO_0000065,24.4,0.44,6.79,10.05,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL428877,,None,443.53,1,5.43,SB-242719,CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1,Inhibition,'=',0.04,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3687508,,None,540.59,2,5.04,BDBM151904,CO[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C4(O)CCC4)cc3F)n2)C[C@@H]1C,IC50,'=',1.72,nM,8.76,,292160,UO_0000065,16.21,0.31,3.72,7.94,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL597754,,None,530.66,1,0.41,59,CNC(=O)c1nn(C)c2c1CCc1cnc(NC3CCN(C(=O)C4CCN(S(C)(=O)=O)CC4)CC3)nc1-2,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1072222,Inhibition of PIM2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1157561,1,Scientific Literature,J Med Chem,2010,None,
CHEMBL3967572,,None,356.39,0,3.05,BDBM238387,O=C1NCCc2[nH]c(-c3cccc4ccc(Nc5cncnc5)nc34)cc21,IC50,'=',2.8,nM,8.55,,416165,UO_0000065,24,0.43,5.5,8.95,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3971351,,None,383.46,0,4.07,BDBM238406,CCN(c1cccnc1)c1ccc2cccc(-c3cc4c([nH]3)CCNC4=O)c2n1,IC50,'=',0.6,nM,9.22,,416182,UO_0000065,24.05,0.43,5.15,12.48,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3966109,,None,406.49,0,2.3,BDBM238684,CC(C)(C)Nc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2nc1N1CC(O)C1,IC50,'=',10.8,nM,7.97,,416793,UO_0000065,19.6,0.36,5.67,7.5,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1880739,GW305074X,None,520.95,2,5.01,GW305074X,O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1,Inhibition,'=',18.25,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL4561045,,None,402.46,0,1.58,26,CN1CCOc2c1cnn1c(-c3ccc4cccc(N5CCNCC5)c4n3)nnc21,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL4340984,Inhibition of His tagged human recombinant PIM2 using PIM tide (ARKRRRHPSGPPTA) as substrate incubated for 1 hr by fluorescence based assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4340512,1,Scientific Literature,Eur J Med Chem,2019,None,
CHEMBL3918771,,None,381.41,0,2.81,BDBM238690,Cc1nc2ccc(F)c(-c3cc4c([nH]3)[C@H]([C@@H](C)O)NC4=O)c2nc1NC1CC1,IC50,'=',2.45,nM,8.61,,416799,UO_0000065,22.58,0.42,5.8,8.37,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3923683,,None,418.48,0,3.39,BDBM192643,C[C@H]1CC[C@H](N)CN1c1ccncc1Nc1ncc2ccc(-c3ncccc3F)nn12,IC50,'=',102,nM,6.99,,344690,UO_0000065,16.71,0.31,3.6,7.19,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3975814,,None,358.41,0,2.62,BDBM238751,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1-c1nccn1C,IC50,'=',244,nM,6.61,,416860,UO_0000065,18.45,0.33,3.99,7.47,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3985665,,None,344.38,0,1.66,BDBM249077,c1ccc(-n2ncc3cnc(-c4cncc(NC5CNC5)n4)cc32)nc1,Ki,'=',4.31,nM,8.37,,434281,UO_0000065,24.29,0.44,6.71,8.95,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3894381,,None,391.45,0,2.89,BDBM249085,Cn1ncc(-c2cc3c(cn2)cnn3-c2ccccc2F)c1N1CCC(N)CC1,Ki,'=',336,nM,6.47,,434289,UO_0000065,16.54,0.3,3.58,8.32,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3976306,,None,391.48,0,2.93,BDBM238558,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1CCCC(O)C1,IC50,'=',3.5,nM,8.46,,416680,UO_0000065,21.6,0.4,5.53,8.22,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3941050,,None,381.41,0,2.84,BDBM238823,C[C@H]1NC(=O)c2cc(-c3c(F)ccc4c(=O)n(C)c(NC5(C)CC5)nc34)[nH]c21,IC50,'=',0.1,nM,10,,416932,UO_0000065,26.22,0.49,7.16,10.89,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3976832,,None,377.41,0,2.98,BDBM225007,CC(C)(C)Nc1nnc(-c2ccc3[nH]cc(-c4nccc(C(N)=O)n4)c3c2)o1,IC50,'=',28.51,nM,7.54,,393296,UO_0000065,19.99,0.37,4.57,5.56,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1516890,GW441756X,None,275.31,0,3.07,GW441756X,Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21,Inhibition,'=',3.47,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3946958,,None,368.44,0,4.65,BDBM238407,CC1Cc2[nH]c(-c3cccc4ccc(Nc5ccccc5)nc34)cc2C(=O)N1,IC50,'=',35.3,nM,7.45,,416183,UO_0000065,20.23,0.36,2.8,10.68,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1794071,,None,409.92,0,3.73,SB-614067-R,Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21,Inhibition,'=',2.02,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3937423,,None,386.46,0,2.86,BDBM192592,N[C@H]1CCCN(c2ccncc2Nc2ncc3ccc(-c4ccccn4)nn23)C1,IC50,'=',6.4,nM,8.19,,344663,UO_0000065,21.2,0.39,5.33,8.42,1,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL480382,GSK-312948A,None,415.5,0,3.84,GSK312948A,COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC,Inhibition,'=',-1.58,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3939742,,None,405.47,0,0.84,BDBM249011,Cn1cc(-c2cc3c(cn2)cnn3-c2cn(C)c(=O)c(N3CCC[C@H](N)C3)n2)cn1,Ki,'=',1600,nM,5.8,,434217,UO_0000065,14.29,0.26,4.96,5.14,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3970681,,None,372.44,0,1.63,BDBM249037,Cn1cc(-c2cc3c(cn2)cnn3-c2cccc(N3CC4(CNC4)C3)n2)cn1,Ki,'=',149,nM,6.83,,434241,UO_0000065,18.33,0.33,5.2,8.9,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3956673,,None,436.52,1,5.9,BDBM225081,CC(C)(Nc1nnc(-c2ccc3[nH]cc(-c4cncc(C5CC5)n4)c3c2)o1)c1ccccc1,IC50,'=',302.1,nM,6.52,,393074,UO_0000065,14.94,0.27,0.62,7.05,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL182283,GW819230X,None,293.33,0,3.55,GW819230X,Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1,Inhibition,'=',0.35,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL4593810,,None,381.26,0,2.1,13,CC(O)C#Cc1c(Cl)c2c(Cl)cc(C(N)=O)nc2n1[C@H]1CCCNC1,IC50,'=',9.3,nM,8.03,,,UO_0000065,21.07,0.44,5.93,8.62,0,CHEMBL4373003,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser-112 residue by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4371067,1,Scientific Literature,Bioorg Med Chem Lett,2019,None,
CHEMBL4461326,,None,417.47,0,2.76,33,CN1CCOc2c1cnn1c(-c3ccc4cccc(NC5CCOCC5)c4n3)nnc21,IC50,'=',2470,nM,5.61,,,UO_0000065,13.43,0.25,2.85,6.25,0,CHEMBL4340984,Inhibition of His tagged human recombinant PIM2 using PIM tide (ARKRRRHPSGPPTA) as substrate incubated for 1 hr by fluorescence based assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4340512,1,Scientific Literature,Eur J Med Chem,2019,None,
CHEMBL3355559,,None,342.83,0,3.77,9b,O[C@H]1CC[C@H](Nc2ccn3ncc(-c4cccc(Cl)c4)c3n2)CC1,IC50,'=',506,nM,6.3,,,UO_0000065,18.36,0.36,2.53,10.08,0,CHEMBL3375413,Inhibition of Pim2 (unknown origin) using luciferase-luciferin based ATP detection reagent by Kinase-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3351833,1,Scientific Literature,ACS Med Chem Lett,2015,None,
CHEMBL2087491,,None,552.46,2,0.44,31,CS(=O)(=O)N1CCN(Cc2nc3c(N4CCOCC4)nc(-c4cnc(N)nc4)cn3c2Br)CC1,Inhibition,'<',30,%,,,,UO_0000187,,,,,0,CHEMBL2092411,Inhibition of PIM2 at 1 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2086238,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL3651997,,None,454.48,0,2.4,BDBM106903,C[C@@H]1CN(c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)ccc2N)C[C@@H](N)[C@H]1O,IC50,'=',8,nM,8.1,,225924,UO_0000065,17.82,0.34,5.7,6.21,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL509032,TAE-684,None,614.22,2,5.02,TAE-684,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL3651990,,None,453.49,0,3.46,BDBM106895,C[C@@H]1C[C@H](c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)ccc2N)C[C@H](N)[C@H]1O,IC50,'=',5,nM,8.3,,225916,UO_0000065,18.3,0.34,4.84,6.53,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3651945,,None,454.5,1,5.43,BDBM106849,CC1(C)C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C1,IC50,'=',3,nM,8.52,,225870,UO_0000065,18.75,0.35,3.09,10.54,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1241674,,None,308.35,0,2.84,PP-242,CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21,Kd,'=',240,nM,6.62,,,UO_0000065,21.47,0.39,3.78,6.27,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL3687530,,None,618.68,1,4.07,BDBM151927,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C4(O)CCOCC4)cc3F)n2)C[C@@H](N)[C@H]1S(C)(=O)=O,IC50,'=',5.93,nM,8.23,,292182,UO_0000065,13.3,0.26,4.16,5.69,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3652620,,None,335.34,0,2.66,BDBM119380,Cn1cc(NC(=O)c2nc(-c3c(F)cccc3F)sc2N)cn1,Ki,'=',110,nM,6.96,,246147,UO_0000065,20.75,0.41,4.3,8.11,0,CHEMBL3707982,Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3691972,,None,565.6,1,4.71,BDBM151994,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1n1cc(C(C)(C)O)nn1,IC50,'=',5.27,nM,8.28,,292249,UO_0000065,14.64,0.28,3.57,6.28,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1909377,,None,341.8,0,3.29,SB-400868-A,Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1,Inhibition,'=',-0.34,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1794053,GW407323A,None,529.64,1,5.12,GW407323A,Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1,Inhibition,'=',10.75,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL272028,GW300660X,None,453.48,0,0.8,GW300660X,NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1,Inhibition,'=',24.71,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL2443044,,None,454.44,0,3.28,18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4564783,,None,466.5,0,2.81,46,CN1CCOc2c1cnn1c(-c3ccc4cc(F)cc(NCC5(F)CCNCC5)c4n3)nnc21,IC50,'=',858,nM,6.07,,,UO_0000065,13,0.24,3.26,6.56,0,CHEMBL4340984,Inhibition of His tagged human recombinant PIM2 using PIM tide (ARKRRRHPSGPPTA) as substrate incubated for 1 hr by fluorescence based assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4340512,1,Scientific Literature,Eur J Med Chem,2019,None,
CHEMBL3942186,,None,435.48,0,3.99,22m,C[C@@H]1C[C@H](N)CN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1,Activity,'=',4.6,%,,,,UO_0000187,,,,,0,CHEMBL3864867,Competitive binding affinity to partial length wild type human PIM2 expressed in bacterial expression system at 10 uM by kinomescan method relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3864151,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL3105022,,None,457.46,0,2.96,BDBM106896,C[C@H]1CN(c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@@H]1O,IC50,'=',1,nM,9,,225917,UO_0000065,19.67,0.37,6.04,8.62,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2147845,,None,390.44,0,2.59,14,COc1ccc2c(c1CN1CCNCC1)O/C(=C\c1n[nH]c3ccccc13)C2=O,IC50,'=',1160,nM,5.94,,,UO_0000065,15.2,0.28,3.35,7.47,0,CHEMBL2149336,Inhibition of PIM2 by electrophoretic mobility shift assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2146430,1,Scientific Literature,J Med Chem,2012,None,
CHEMBL3970981,,None,399.46,0,2,BDBM248924,N#CCn1cc(-c2cc3c(cn2)cnn3-c2cccc(N3CCCNCC3)n2)cn1,Ki,'=',1.49,nM,8.83,,434131,UO_0000065,22.1,0.4,6.83,8.78,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2089001,,None,250.26,0,3.5,29,O=C(O)c1cc2c3ccccc3[nH]c2c2[nH]ccc12,Activity,'=',100,%,,,,UO_0000187,,,,,0,CHEMBL2090475,Inhibition of human Pim2 using RSRHSSYPAGT as substrate assessed as residual activity at 1 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2086229,1,Scientific Literature,Eur J Med Chem,2012,None,
CHEMBL502835,NINTEDANIB,4,539.64,1,3.62,BIBF-1120,COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL3691986,,None,572.59,1,3.86,BDBM152009,CCOCc1cc(F)c(-c2nc(C(=O)Nc3cnccc3N3C[C@@H](N)[C@@H](NC(=O)OC)[C@@H](C)C3)ccc2F)c(F)c1,IC50,'=',1.67,nM,8.78,,292264,UO_0000065,15.33,0.29,4.92,6.66,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3793927,,None,418.41,0,3.9,2g,Nc1cc(-c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)ccc2N)ccn1,Ki,'=',8,nM,8.1,,,UO_0000065,19.35,0.36,4.2,6.76,0,CHEMBL3794688,Inhibition of Pim2 (unknown origin) using BAD peptide preincubated for 15 mins followed by ATP addition measured after 60 to 100 mins by Kinase-Glo reagent based luminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3792348,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL3895191,,None,361.38,0,3.06,BDBM238582,Cn1cc(-c2ccc3ccc(F)c(-c4cc5c([nH]4)CCNC5=O)c3n2)cn1,IC50,'=',92,nM,7.04,,416283,UO_0000065,19.47,0.36,3.98,9.31,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3945081,,None,380.45,0,3.99,BDBM238595,O=C1NCCc2[nH]c(-c3cccc4cnc(C5(c6ccccc6)CC5)nc34)cc21,IC50,'=',17.9,nM,7.75,,416291,UO_0000065,20.36,0.36,3.76,10.96,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3976162,,None,333.4,0,2.79,BDBM238548,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1CC1,IC50,'=',2,nM,8.7,,416271,UO_0000065,26.09,0.48,5.91,10.52,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3652025,,None,471.48,0,3.6,BDBM106932,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)c(F)cc2N)C[C@@H](N)[C@H]1O,IC50,'=',5,nM,8.3,,225953,UO_0000065,17.61,0.33,4.7,6.53,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL264406,,None,317.4,0,3.98,K00047,CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21,Thermal melting change,'=',-0.2,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL3942186,,None,435.48,0,3.99,22m,C[C@@H]1C[C@H](N)CN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1,IC50,'=',0.094,nM,10.03,,,UO_0000065,23.02,0.43,6.04,11.88,0,CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3864151,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL3965757,,None,435.48,0,4.13,22p,C[C@@H]1CC[C@H](N)CN1c1ccncc1Nc1ncc2ccc(-c3c(F)cccc3F)nn12,IC50,'=',0.31,nM,9.51,,,UO_0000065,21.83,0.41,5.38,11.27,0,CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3864151,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL258726,,None,312.41,0,4.08,K00012,CC(C)(C)c1cc(C=C2C(=O)C=CC2=O)cc(C(C)(C)C)c1O,Thermal melting change,'=',-5.7,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL3906819,,None,390.45,0,1.91,BDBM238553,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1CCC(=O)NC1,IC50,'=',50,nM,7.3,,416276,UO_0000065,18.7,0.34,5.39,6.53,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL10,SB-203580,None,377.44,0,4.68,SB-203580,C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,Residual Activity,'=',125,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3758351,,None,415.88,1,5.4,3f,COc1cc(CO)ccc1-c1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1,Inhibition,'=',6,%,,,,UO_0000187,,,,,0,CHEMBL3761595,Inhibition of PIM2 (unknown origin) at 500 nM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3758163,1,Scientific Literature,Eur J Med Chem,2016,None,
CHEMBL3922101,,None,415.41,0,4.46,BDBM192568,Nc1cc(-c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)ccn1,IC50,'=',185,nM,6.73,,344560,UO_0000065,16.21,0.3,2.27,7.16,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL535,SUNITINIB,4,398.48,0,3.33,Sunitinib,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL1614701,SELUMETINIB,4,457.69,0,3.53,AZD-6244/ARRY-886,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL38380,FASUDIL,3,291.38,0,1.22,K00075,O=S(=O)(c1cccc2cnccc12)N1CCCNCC1,Thermal melting change,'=',0.6,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL3968570,,None,372.4,0,4.4,BDBM238380,O=C1NCCc2[nH]c(-c3cccc4ccc(Nc5ccccc5F)nc34)cc21,IC50,'=',4.6,nM,8.34,,416158,UO_0000065,22.39,0.41,3.94,11.94,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3703175,,None,317.35,0,2.47,BDBM149683,Cn1c(-c2ccccc2)c(C(N)=O)c2ccc3cnc(N)nc3c21,IC50,'>',10000,nM,,,288341,UO_0000065,,,,,0,CHEMBL3707582,Kinase Inhibition Assay: The buffer for PIM-2 assay was composed of HEPES 50 mM,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3651974,,None,424.45,0,3.63,BDBM106878,N[C@@H]1C[C@H](c2ccncc2NC(=O)c2cccc(-c3c(F)cccc3F)n2)CC[C@@H]1O,IC50,'=',15,nM,7.82,,225899,UO_0000065,18.43,0.34,4.19,7.74,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3652011,,None,457.45,0,4.05,BDBM106917,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](O)[C@@H]1O,IC50,'=',6,nM,8.22,,225938,UO_0000065,17.97,0.34,4.17,8.62,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3634783,,None,372.44,0,2.19,18,Cc1cncc(-c2cc3c(-c4cccc(N5CCNCC5)n4)n[nH]c3cn2)n1,Ki,'=',0.049,nM,10.31,,,UO_0000065,27.68,0.5,8.12,10.79,0,CHEMBL3636741,Inhibition of Pim2 (unknown origin) using 5FAM-ARKRRRHPSGPPTA as substrate after 90 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632547,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL1373282,,None,266.34,0,3.03,K00005,CN(C)c1ccc(CC2C(=O)Nc3ccccc32)cc1,Thermal melting change,'=',0.4,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL1088529,,None,335.77,0,3.08,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL558969,,None,376.77,0,1.71,K00592a,Cl.NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1,Thermal melting change,'=',0.7,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL132904,,None,333.34,0,4.53,K00072,CCOC(=O)c1cnc2oc3ccc(O)cc3c2c1-c1ccccc1,Thermal melting change,'=',6.3,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL609010,,None,1952.21,None,None,7,CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)N[C@H]2CNC(=O)C[C@@H](C(N)=O)NC(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC2=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,Activity,'=',100,%,,,,UO_0000187,,,,,0,CHEMBL1042490,Binding affinity to human PIM2 at 50 nM by cell-based competition binding assay relative to control in presence of DTT,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1152541,1,Scientific Literature,Bioorg Med Chem,2009,None,
CHEMBL3928595,,None,362.44,0,2.12,BDBM238756,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@H]1C[C@H](N)C1,IC50,'=',0.4,nM,9.4,,416865,UO_0000065,25.93,0.48,7.28,8.64,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3892102,,None,413.48,0,3.49,BDBM238721,CC(C)Nc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2c(=O)n1-c1ccccc1,IC50,'=',5.87,nM,8.23,,416830,UO_0000065,19.91,0.36,4.74,8.97,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3911461,,None,403.49,0,3.89,BDBM238809,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C5CC5)c(NC5(C)CCC5)nc34)[nH]c21,IC50,'=',0.2,nM,9.7,,416918,UO_0000065,24.04,0.44,5.81,10.56,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1915445,,None,388.82,0,4.67,15b,Oc1ccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3cnccc23)c(Cl)c1,IC50,'=',1,nM,9,,,UO_0000065,23.15,0.44,4.33,9.04,0,CHEMBL1919424,Inhibition of PIM2 by millipore assay in the presence of 15 uM [ATP],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914433,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL1915638,,None,374.35,0,4.59,15l,Fc1ccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3cnccc23)c(F)c1,IC50,'=',15,nM,7.82,,,UO_0000065,20.9,0.38,3.23,9.86,0,CHEMBL1919424,Inhibition of PIM2 by millipore assay in the presence of 15 uM [ATP],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914433,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL3895552,,None,404.47,0,2.25,BDBM238438,CC(=O)N1CC[C@H](Nc2nc3c(-c4cc5c([nH]4)CCNC5=O)cccc3nc2C)C1,IC50,'=',72.8,nM,7.14,,416636,UO_0000065,17.65,0.32,4.89,6.93,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL185962,,None,242.24,0,1.4,SB-736302,Nc1nonc1-c1nc2cnccc2n1C1CC1,Inhibition,'=',-2.36,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3920604,,None,296.36,0,3.12,BDBM224955,CNc1nnc(-c2ccc3[nH]cc(-c4ccn[nH]4)c3c2)s1,IC50,'=',1436.73,nM,5.84,,393245,UO_0000065,19.71,0.38,2.72,7.1,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3906121,,None,296.36,0,3.12,BDBM224951,CNc1nnc(-c2ccc3[nH]cc(-c4cn[nH]c4)c3c2)s1,IC50,'=',622.52,nM,6.21,,393241,UO_0000065,20.94,0.4,3.09,7.54,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1909383,GW784307A,None,494.99,0,2.56,GW784307A,COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl,Inhibition,'=',0.88,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3427181,,None,274.3,0,1.89,13,O=C(O)[C@H]1CSC(c2ccc3cc(O)ccc3n2)=N1,Activity,'=',36,%,,,,UO_0000187,,,,,0,CHEMBL3427823,Inhibition of PIM2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3425453,1,Scientific Literature,Eur J Med Chem,2015,None,
CHEMBL126254,,None,388.9,0,4.01,K00014,CC(C)N(CCO)c1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1,Thermal melting change,'=',0.2,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL1909404,GW581744X,None,406.42,0,2.49,GW581744X,NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1,Inhibition,'=',-0.18,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL566515,,None,417.43,0,2.35,66,COc1ccccc1-n1c(-c2cc(O)ccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12,Activity,'=',93,%,,,,UO_0000187,,,,,0,CHEMBL1055335,Inhibition of PIM2 assessed as remaining enzyme activity at 1 uM relative to DMSO,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154183,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL183906,,None,273.24,0,3.03,4a,O=C1NC(=O)/C(=C/c2cccc(C(F)(F)F)c2)S1,Inhibition,'=',68,%,,,,UO_0000187,,,,,0,CHEMBL1012712,Inhibition of PIM2 at 5 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139352,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL3906821,,None,355.4,0,3.59,BDBM238530,O=C1NCCn2cc(-c3cccc4ccc(Nc5cccnc5)nc34)cc21,IC50,'=',2.2,nM,8.66,,416256,UO_0000065,24.36,0.44,5.07,12.05,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL515414,,None,342.37,0,2.52,FMK,Cc1ccc(-c2c(C(=O)CF)n(CCCO)c3ncnc(N)c23)cc1,Activity,'=',85,%,,,,UO_0000187,,,,,0,CHEMBL1061166,Percentage PIM2 activity remaining in the presence of 3uM inhibitor,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL2204495,,None,399.43,1,5.11,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3941886,,None,323.38,0,3.34,BDBM224939,COc1cncc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)c1,IC50,'=',618.48,nM,6.21,,393222,UO_0000065,19.2,0.37,2.87,6.92,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1909394,GW621823A,None,659.61,2,7.26,GW621823A,CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl,Inhibition,'=',0.55,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL4533018,,None,404.94,0,2.21,IM-93,CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl,Activity,'=',100,%,,,,UO_0000187,,,,,0,CHEMBL4307989,Binding affinity to wild-type human partial length PIM2 (M1 to E291 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4304811,1,Scientific Literature,ACS Med Chem Lett,2019,None,
CHEMBL522502,,None,356.43,0,4.66,NF_kB_Activation_Inhibitor,Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1,Residual Activity,'=',93,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3651987,,None,437.45,0,3.12,BDBM106892,Nc1ccc(-c2c(F)cccc2F)nc1C(=O)Nc1cnccc1C1=CC(N)C(O)CC1,IC50,'=',9,nM,8.05,,225913,UO_0000065,18.39,0.34,4.93,6.33,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3975766,,None,400.49,0,2.55,BDBM249035,Cn1cc(-c2cc3c(cn2)cnn3-c2cccc(N3CC4(CCCCN4)C3)n2)cn1,Ki,'=',29.3,nM,7.53,,434239,UO_0000065,18.81,0.34,4.98,9.82,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL255863,NILOTINIB,4,529.53,2,6.36,Nilotinib,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL340384,,None,391.81,0,3.51,SID103905354,NC(=O)c1cn(-c2ccc(O)cc2Cl)c2cc(-c3ccncc3)ccc2c1=O,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1966722,,None,411.91,0,3.59,SID103904450,O=C(NNC(=S)Nc1ccc(Cl)cc1)C(O)(c1ccccc1)c1ccccc1,Ki,'=',501.19,nM,6.3,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL362155,GW827102X,None,490.45,1,5.39,GW827102X,FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1,Inhibition,'=',-0.06,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3660058,,None,345.41,0,3.08,BDBM104184,c1cc(OC[C@@H]2CCCN2)c2nc(-c3nnc4ccccn34)ccc2c1,IC50,'=',10000,nM,5,,222597,UO_0000065,14.48,0.26,1.92,7.77,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL1976420,,None,281.36,0,3.41,SID103905182,CCc1c(-c2ccc(C(C)(C)O)cc2)[nH]c2nccnc12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2003657,,None,455.54,0,4.39,SID103905061,CC(C)S(=O)(=O)n1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2002346,,None,301.35,0,3.63,SID103904201,c1ccc(CNc2cc(-c3c[nH]c4ncccc34)ncn2)cc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3909365,,None,346.27,0,3.28,BDBM224837,Nc1nnc(-c2ccc3[nH]cc(-c4nccc(C(F)(F)F)n4)c3c2)o1,IC50,'=',31.88,nM,7.5,,393119,UO_0000065,21.65,0.41,4.22,7.04,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL269985,GW701032X,None,413.48,0,4.96,GW701032X,COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1,Inhibition,'=',2.9,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1077739,,None,444.88,0,3.71,32,O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O,Inhibition,'=',10,%,,,,UO_0000187,,,,,0,CHEMBL1116758,Inhibition of PIM2 at 5 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154316,1,Scientific Literature,Bioorg Med Chem Lett,2009,None,
CHEMBL513909,BI-2536,2,521.67,1,3.56,BI-2536,CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL28324,,None,721.86,2,5.13,KN_62,CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12,Residual Activity,'=',111,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3660029,,None,348.41,0,3.34,BDBM104147,CC(C)(CO)COc1cccc2ccc(-c3nnc4ccccn34)nc12,IC50,'=',77,nM,7.11,,222564,UO_0000065,20.42,0.37,3.77,9.81,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL2205426,,None,414.47,0,3.83,49,CC(C)(C)Nc1c(Nc2ccnc(Nc3ccc(-c4ccncc4)cc3)n2)c(=O)c1=O,Ki,'>',1400,nM,,,,UO_0000065,,,,,0,CHEMBL2209632,Inhibition of recombinant PIM2 after 1 hr by scintillation counter analysis in presence of gamma-[33P]ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2203238,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL574738,AST-487,1,529.57,2,5.11,AST-487,CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1,Kd,'>',10000,nM,,,,UO_0000065,,,,,1,CHEMBL1061184,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150977,1,Scientific Literature,Nat Biotechnol,2008,None,
CHEMBL1421,DASATINIB,4,488.02,0,3.31,Dasatinib,Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1,Kd,'>',10000,nM,,,,UO_0000065,,,,,1,CHEMBL1061184,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150977,1,Scientific Literature,Nat Biotechnol,2008,None,
CHEMBL261849,GW632580X,None,366.42,0,2.83,GW2580,COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,Kd,'>',10000,nM,,,,UO_0000065,,,,,1,CHEMBL1061184,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150977,1,Scientific Literature,Nat Biotechnol,2008,None,
CHEMBL3427184,,None,274.3,0,1.89,16,O=C(O)[C@@H]1CSC(c2ccc3cccc(O)c3n2)=N1,Activity,'=',45,%,,,,UO_0000187,,,,,0,CHEMBL3427823,Inhibition of PIM2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3425453,1,Scientific Literature,Eur J Med Chem,2015,None,
CHEMBL406375,,None,234.26,0,3.98,K00035,c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1,Thermal melting change,'=',1.1,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL575461,,None,336.42,0,3.26,16a,CN(C)Cc1nc2c(sc3ccc(-c4cccnc4)cc32)c(=O)[nH]1,Ki,'=',3,nM,8.52,,,UO_0000065,25.33,0.48,5.26,13.77,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL202891,GW679410X,None,328.38,0,4.21,GW679410X,COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1,Inhibition,'=',1.29,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3634773,,None,346.4,0,1.62,23,c1cc(-c2n[nH]c3cnc(-n4ccnc4)cc23)nc(N2CCNCC2)c1,Ki,'=',5.4,nM,8.27,,,UO_0000065,23.87,0.43,6.65,9.44,0,CHEMBL3636741,Inhibition of Pim2 (unknown origin) using 5FAM-ARKRRRHPSGPPTA as substrate after 90 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632547,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL3691918,,None,458.53,0,4.59,BDBM151940,CO[C@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C[C@@H]1C,IC50,'=',22.07,nM,7.66,,292195,UO_0000065,16.7,0.33,3.07,8.49,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3651943,,None,486.49,0,4.02,BDBM106847,COc1ccc(F)c(-c2nc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@H](O)[C@@H](C)C3)ccc2F)c1F,IC50,'=',4,nM,8.4,,225868,UO_0000065,17.26,0.33,4.38,7.61,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3634755,,None,375.44,0,2.55,34,Cn1cc(-c2cc3c(-c4cccc(O[C@@H]5CCCNC5)n4)n[nH]c3cn2)cn1,Ki,'=',6.2,nM,8.21,,,UO_0000065,21.86,0.4,5.66,8.77,0,CHEMBL3636741,Inhibition of Pim2 (unknown origin) using 5FAM-ARKRRRHPSGPPTA as substrate after 90 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632547,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL3942435,,None,383.36,0,3.1,BDBM224829,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(N5CCC(F)(F)C5)n4)c3c2)o1,IC50,'=',6.435,nM,8.19,,393111,UO_0000065,21.37,0.4,5.09,7.46,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3943672,,None,403.45,0,3.39,BDBM225016,CC(C)Nc1nnc(-c2ccc3[nH]cc(-c4nccc(C(=O)NC5CC5)n4)c3c2)o1,IC50,'=',453,nM,6.34,,393306,UO_0000065,15.72,0.29,2.95,5.22,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3394066,,None,362.46,0,3.93,15,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(N5CCCC5)n4)c3c2)s1,IC50,'>',31600,nM,,,,UO_0000065,,,,,0,CHEMBL3395662,Inhibition of PIM2 in human U2OS cells assessed as phosphorylation of BAD,B,BAO_0000219,cell-based format,Homo sapiens,None,None,U2OS,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3393014,1,Scientific Literature,Bioorg Med Chem Lett,2015,CHEMBL3307757,
CHEMBL3977572,,None,309.35,0,3.04,BDBM224936,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(O)n4)c3c2)s1,IC50,'>',3000,nM,,,393219,UO_0000065,,,,,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1909395,GW633459A,None,679.6,2,7.57,GW633459A,Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1,Inhibition,'=',0.58,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3904282,,None,361.45,0,3.57,BDBM238514,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1(C)CCC1,IC50,'=',0.6,nM,9.22,,416658,UO_0000065,25.51,0.47,5.65,11.15,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL498203,,None,308.34,0,2.79,27c-1,COc1ccc(/C=C2\C(=O)NC(=O)N2Cc2ccccc2)cc1,IC50,'>',100000,nM,,,,UO_0000065,,,,,0,CHEMBL957366,Inhibition of human recombinant Pim2 by ATP depletion assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139352,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL522916,,None,357.21,0,3.54,29c-1,O=C1NC(=O)N(Cc2ccccc2)/C1=C/c1ccc(Br)cc1,IC50,'>',100000,nM,,,,UO_0000065,,,,,0,CHEMBL957366,Inhibition of human recombinant Pim2 by ATP depletion assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139352,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL584980,,None,206.25,0,3.8,7,c1ccc2c(c1)[nH]c1c2ccc2cc[nH]c21,Activity,'=',62,%,,,,UO_0000187,,,,,0,CHEMBL1057614,Inhibition of Pim-2 assessed as residual enzyme activity at 10 uM relative to untreated control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154186,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL3934994,,None,406.39,0,4.06,BDBM224946,CC(Oc1cncc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)n1)C(F)(F)F,IC50,'=',53.74,nM,7.27,,393234,UO_0000065,17.89,0.35,3.21,7.09,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3394062,,None,357.44,0,4.94,BDBM50061630,CNc1nnc(-c2ccc3[nH]cc(-c4cnc5ccccc5c4)c3c2)s1,IC50,'=',1632.17,nM,5.79,,393240,UO_0000065,16.19,0.3,0.85,8.7,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3969190,,None,342.37,0,4.67,BDBM224970,CNc1nnc(-c2ccc3[nH]cc(-c4c(F)cccc4F)c3c2)s1,IC50,'=',1219.16,nM,5.91,,393260,UO_0000065,17.27,0.34,1.24,11.03,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3904282,,None,361.45,0,3.57,BDBM238514,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1(C)CCC1,IC50,'=',1.6,nM,8.8,,416251,UO_0000065,24.33,0.44,5.23,10.64,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1908395,,None,497.04,0,3.76,JNJ-28312141,CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl,Kd,'=',620,nM,6.21,,,UO_0000065,13.48,0.25,2.45,5.91,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL3651946,,None,456.47,0,4.01,4,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@@H]1O,Ki,'<',3,nM,,,,UO_0000065,,,,,0,CHEMBL3750240,Inhibition of PIM2 kinase (unknown origin) using NH2-AGAGRSRHSSYPAGT-OH as substrate by kinase-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3745712,1,Scientific Literature,J Med Chem,2015,None,
CHEMBL563845,,None,387.44,0,4.97,EGFR_ErbB_2_Inhibitor,COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC,Residual Activity,'=',110,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3758682,,None,407.5,0,4,3c,COc1cc(CO)ccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2s1,Inhibition,'=',1,%,,,,UO_0000187,,,,,0,CHEMBL3761595,Inhibition of PIM2 (unknown origin) at 500 nM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3758163,1,Scientific Literature,Eur J Med Chem,2016,None,
CHEMBL155333,,None,501.05,1,4.68,KN_93,COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1,Residual Activity,'=',143,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL274064,SB-220025,None,338.39,0,2.65,SB-220025,Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1,Residual Activity,'=',120,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL36450,,None,236.27,0,3.71,SC-68376,Cc1nc(-c2ccccc2)c(-c2ccncc2)o1,Residual Activity,'=',121,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL261720,,None,425.45,0,1.77,Cdk1_2_Inhibitor_III,Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F,Residual Activity,'=',125,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL276711,SEMAXANIB,3,238.29,0,3.12,Semaxanib,Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1,Residual Activity,'=',121,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL166031,,None,352.39,0,4.8,3,CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1,Inhibition,'=',3.72,%,,,,UO_0000187,,,,,0,CHEMBL3630921,Inhibition of PIM2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3627608,1,Scientific Literature,Bioorg Med Chem,2015,None,
CHEMBL3634781,,None,357.42,0,2.49,16,c1cncc(-c2cc3c(-c4cccc(N5CCNCC5)n4)n[nH]c3cn2)c1,Ki,'=',0.5,nM,9.3,,,UO_0000065,26.02,0.47,6.81,11.26,0,CHEMBL3636741,Inhibition of Pim2 (unknown origin) using 5FAM-ARKRRRHPSGPPTA as substrate after 90 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632547,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL3298888,,None,397.86,0,3.7,13l,Cc1ccc(Cl)cc1-c1cc2n(c1)C(CC(=O)NCc1ccco1)CNC2=O,IC50,'>',5000,nM,,,,UO_0000065,,,,,0,CHEMBL3300844,Inhibition of human PIM2 using ARK-RERTYSFGHHA as substrate incubated for 60 mins prior to substrate addition by topcount scintillation counting analysis in presence of [P33gamma]-ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3297733,1,Scientific Literature,Bioorg Med Chem,2013,None,
CHEMBL111364,,None,404.51,1,6.17,K00568a,CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1,Thermal melting change,'=',-0.2,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL3676301,,None,442.54,1,5.36,BDBM131771,CC1(C)C[C@H](N)C[C@H](c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C1,IC50,'=',16,nM,7.8,,264004,UO_0000065,17.62,0.34,2.44,9.64,0,CHEMBL3706072,Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL275168,,None,449.92,1,5.52,SB-278539,Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1,Inhibition,'=',1.13,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL413188,ISOGRANULATIMIDE,None,276.26,0,1.85,Isogranulatimide,O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21,Residual Activity,'=',5,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2425644,,None,309.37,0,2.74,13,O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1,Inhibition,'=',100,%,,,,UO_0000187,,,,,0,CHEMBL2429482,Competitive binding affinity to PIM2 (unknown origin) at 10 uM in presence of ATP relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2424622,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL553,ERLOTINIB,4,393.44,0,3.41,Erlotinib,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL3950704,,None,363.42,0,2.7,25,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C)c(NC5(C)CC5)nc34)[nH]c21,IC50,'=',0.38,nM,9.42,,,UO_0000065,25.92,0.48,6.72,10.26,0,CHEMBL4370146,Inhibition of full length recombinant PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues preincubated for 30 mins followed by biotinylated BAD addition and measured after 1 hr by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4368910,1,Scientific Literature,J Med Chem,2019,None,
CHEMBL406375,,None,234.26,0,3.98,GTP_14564,c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1,Residual Activity,'=',123,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4458081,,None,433.49,0,2.46,10,Cn1ncc(NC(=O)c2nc(-c3c(F)cccc3F)sc2N)c1N1CCCNCC1,Ki,'=',5,nM,8.3,,,UO_0000065,19.15,0.38,5.84,8.21,0,CHEMBL4317000,Inhibition of recombinant human PIM2 using FAM-pimtide as substrate after 90 mins by Z-LYTE assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4316591,1,Scientific Literature,J Med Chem,2019,None,
CHEMBL3906357,,None,361.45,0,3.43,BDBM238626,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NCC1(C)CC1,IC50,'=',0.902,nM,9.04,,416734,UO_0000065,25.02,0.46,5.61,10.94,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL203644,,None,355.76,0,3.52,EGFR_ErbB_2_ErbB_4_Inhibitor,CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1,Residual Activity,'=',82,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3628627,,None,684.77,3,5.33,4,CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1,Inhibition,'=',6.09,%,,,,UO_0000187,,,,,0,CHEMBL3630921,Inhibition of PIM2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3627608,1,Scientific Literature,Bioorg Med Chem,2015,None,
CHEMBL3354511,,None,402.43,0,3.48,1S,O=C(Nc1cnccc1O[C@H]1CCNC1)c1csc(-c2c(F)cccc2F)n1,IC50,'=',14,nM,7.85,,,UO_0000065,19.52,0.38,4.37,10.32,0,CHEMBL3376647,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352230,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL3354518,,None,417.44,0,3.06,2,Nc1sc(-c2c(F)cccc2F)nc1C(=O)Nc1cnccc1O[C@H]1CCNC1,IC50,'=',1,nM,9,,,UO_0000065,21.56,0.42,5.94,8.81,0,CHEMBL3376647,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352230,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL2147767,,None,390.44,0,2.59,10,COc1ccc2c(c1CN1CCNCC1)O/C(=C\c1c[nH]c3ncccc13)C2=O,Inhibition,'=',39,%,,,,UO_0000187,,,,,0,CHEMBL2149331,Inhibition of PIM2 at 200 nM by electrophoretic mobility shift assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2146430,1,Scientific Literature,J Med Chem,2012,None,
CHEMBL65063,,None,211.23,0,1.4,PP3,Nc1ncnc2c1cnn2-c1ccccc1,Residual Activity,'=',94,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2442300,,None,331.42,0,3.52,9m,CN(C)CCNc1ccn2ncc(-c3ccc4ccccc4c3)c2n1,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL2446210,Inhibition of Pim2 (unknown origin) using STK1 as substrate preincubated for 30 mins followed by substrate and ATP addition at > 5000 nM after 60 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2440090,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL2442302,,None,309.4,0,2.98,11a,NCCNc1ccn2ncc(-c3ccc4sccc4c3)c2n1,IC50,'=',114,nM,6.94,,,UO_0000065,22.44,0.43,3.96,10.17,0,CHEMBL2446212,Inhibition of Pim2 (unknown origin) using STK1 as substrate preincubated for 30 mins followed by substrate and ATP addition after 60 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2440090,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL3964167,,None,390.52,0,4.57,BDBM224917,CC1CCN(c2cccc(-c3c[nH]c4ccc(-c5nnc(N)s5)cc34)n2)CC1,IC50,'=',117.31,nM,6.93,,393198,UO_0000065,17.75,0.34,2.36,8.28,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3991927,,None,424.48,0,3.24,HMN-214,COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3676306,,None,486.59,1,5.75,BDBM131776,CC(C)Oc1ccc(F)c(-c2nc(C(=O)Nc3cnccc3[C@@H]3C[C@H](C)C[C@H](N)C3)cs2)c1F,IC50,'=',20,nM,7.7,,264009,UO_0000065,15.82,0.31,1.95,8.54,0,CHEMBL3706072,Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL31965,CANERTINIB,3,485.95,0,4.39,CI-1033,C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL475761,GW784684X,None,564.09,2,6.81,GW784684X,CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1,Inhibition,'=',1.37,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3897814,,None,363.42,0,2.42,BDBM238551,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1(C)COC1,IC50,'=',5.7,nM,8.24,,416274,UO_0000065,22.68,0.42,5.82,8.97,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3809623,,None,349.44,0,3.43,BDBM238525,CCCCNc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2nc1C,IC50,'=',1.7,nM,8.77,,416669,UO_0000065,25.1,0.46,5.34,10.6,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL260135,,None,287.33,0,3.27,SID103905492,Nc1n[nH]c2nnc(-c3ccccc3)c(-c3ccccc3)c12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3972050,,None,442.45,0,3.04,BDBM248923,FC(F)(F)Cn1cc(-c2cc3c(cn2)cnn3-c2cccc(N3CCCNCC3)n2)cn1,Ki,'=',1.01,nM,9,,434130,UO_0000065,20.33,0.38,5.96,11.73,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2048872,,None,379.49,0,3.61,28,N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1,IC50,'=',5,nM,8.3,,,UO_0000065,21.87,0.42,4.69,11,1,CHEMBL2049740,Inhibition of human PIM2 using FITC-(AHX)RSRHSSYPAGT-COOH as substrate after 90 mins by mobility shift assay in presence of 50 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2046384,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL3652018,,None,442.44,0,4.5,BDBM106924,N[C@H]1CCC[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)ccc(O)c3F)n2)C1,IC50,'=',2,nM,8.7,,225945,UO_0000065,19.66,0.37,4.2,8.6,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3676293,,None,430.48,0,3.69,BDBM131763,N[C@@H]1C[C@H](c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)CC[C@@H]1O,IC50,'=',98,nM,7.01,,263996,UO_0000065,16.28,0.32,3.32,6.93,0,CHEMBL3706072,Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3103881,,None,344.44,0,3.34,1a,CC(=O)Nc1nc(C(=O)Nc2ccccc2N2CCCCC2)cs1,Ki,'>',12500,nM,,,,UO_0000065,,,,,0,CHEMBL3794688,Inhibition of Pim2 (unknown origin) using BAD peptide preincubated for 15 mins followed by ATP addition measured after 60 to 100 mins by Kinase-Glo reagent based luminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3792348,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL2048866,,None,337.83,0,2.59,22,N[C@@H]1CCCN(c2c(Cl)cccc2/C=C2\SC(=O)NC2=O)C1,IC50,'=',5,nM,8.3,,,UO_0000065,24.57,0.52,5.71,11,0,CHEMBL2049740,Inhibition of human PIM2 using FITC-(AHX)RSRHSSYPAGT-COOH as substrate after 90 mins by mobility shift assay in presence of 50 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2046384,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL4464030,,None,459.55,0,3.75,24,CC(c1cn(C)cn1)n1c(NC(C)(C)C)nc2c(-c3cc4c([nH]3)[C@@H](C)NC4=O)cccc2c1=O,IC50,'=',0.7,nM,9.15,,,UO_0000065,19.92,0.37,5.4,8.35,0,CHEMBL4370146,Inhibition of full length recombinant PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues preincubated for 30 mins followed by biotinylated BAD addition and measured after 1 hr by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4368910,1,Scientific Literature,J Med Chem,2019,None,
CHEMBL2048860,,None,389.48,0,3.11,9,CC(C)(C)OC(=O)N[C@H]1CCN(c2ccccc2/C=C2\SC(=O)NC2=O)C1,IC50,'=',15000,nM,4.82,,,UO_0000065,12.39,0.24,1.71,5.5,0,CHEMBL2049740,Inhibition of human PIM2 using FITC-(AHX)RSRHSSYPAGT-COOH as substrate after 90 mins by mobility shift assay in presence of 50 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2046384,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL2048863,,None,323.81,0,2.2,12,N[C@H]1CCN(c2c(Cl)cccc2/C=C2\SC(=O)NC2=O)C1,IC50,'=',25,nM,7.6,,,UO_0000065,23.48,0.49,5.4,10.08,0,CHEMBL2049740,Inhibition of human PIM2 using FITC-(AHX)RSRHSSYPAGT-COOH as substrate after 90 mins by mobility shift assay in presence of 50 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2046384,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL2048870,,None,375.49,0,2.97,26,CC(C)COc1cccc(/C=C2\SC(=O)NC2=O)c1N1CCC[C@@H](N)C1,IC50,'<',4,nM,,,,UO_0000065,,,,,0,CHEMBL2049740,Inhibition of human PIM2 using FITC-(AHX)RSRHSSYPAGT-COOH as substrate after 90 mins by mobility shift assay in presence of 50 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2046384,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL572878,TOZASERTIB,2,464.6,0,3.5,VX-680/MK-0457,Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL2048865,,None,303.39,0,1.94,15,N[C@@H]1CCCN(c2ccccc2/C=C2\SC(=O)NC2=O)C1,IC50,'=',14,nM,7.85,,,UO_0000065,25.89,0.51,5.91,10.41,0,CHEMBL2049740,Inhibition of human PIM2 using FITC-(AHX)RSRHSSYPAGT-COOH as substrate after 90 mins by mobility shift assay in presence of 50 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2046384,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL4065094,,None,454.1,0,3.52,Tab 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL91829,RUBOXISTAURIN,3,468.56,0,3.51,LY-333531,CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1,Kd,'=',1700,nM,5.77,,,UO_0000065,12.31,0.23,2.26,8.42,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL3691939,,None,565.6,2,5.02,BDBM151961,CCOCc1cc(F)c(-c2nc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@@H](n4ccnn4)[C@@H](C)C3)ccc2F)c(F)c1,IC50,'=',2.2,nM,8.66,,292216,UO_0000065,15.31,0.29,3.64,7.16,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3687501,,None,498.55,1,5.37,BDBM151897,CCO[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C)cc3F)n2)C[C@@H]1C,IC50,'=',2.26,nM,8.65,,292153,UO_0000065,17.34,0.33,3.28,9.59,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4444272,,None,453.45,0,3.11,8; EC-70124,C[C@]12O[C@H](C[C@H](O)[C@H]1O)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4=O,Kd,'=',3.1,nM,8.51,,,UO_0000065,18.76,0.34,5.4,8.05,0,CHEMBL4360624,Binding affinity to Pim-2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4359824,1,Scientific Literature,Eur J Med Chem,2019,None,
CHEMBL4126500,,None,333.37,0,3.97,37,OCCc1cncc(-c2ccc3[nH]cc(-c4ccccc4F)c3c2)n1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4118246,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL4129929,,None,387.46,0,4.36,39,NC1CCCN(c2cncc(-c3ccc4[nH]cc(-c5ccccc5F)c4c3)n2)C1,IC50,'=',1380,nM,5.86,,,UO_0000065,15.12,0.28,1.5,8.27,0,CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4118246,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL3355544,,None,392.38,0,4.01,9,O[C@H]1CC[C@H](Nc2ccn3ncc(-c4cccc(OC(F)(F)F)c4)c3n2)CC1,IC50,'=',269,nM,6.57,,,UO_0000065,16.74,0.32,2.56,9.17,0,CHEMBL3375413,Inhibition of Pim2 (unknown origin) using luciferase-luciferin based ATP detection reagent by Kinase-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3351833,1,Scientific Literature,ACS Med Chem Lett,2015,None,
CHEMBL3813842,PAXALISIB,2,382.43,0,0.97,16,CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12,Inhibition,'<',50,%,,,,UO_0000187,,,,,0,CHEMBL3816388,Inhibition of full length recombinant human GST-tagged PIM2 expressed in baculovirus expression system at 1 uM relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3813614,1,Scientific Literature,ACS Med Chem Lett,2016,None,
CHEMBL1684543,,None,435.58,1,6.1,11k,Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1,Inhibition,'=',101,%,,,,UO_0000187,,,,,0,CHEMBL1686068,Inhibition of Pim-2 at 1 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1681705,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL3623150,,None,483.5,0,3.22,18,Cn1ncc(NC(=O)c2nc(-c3c(F)cccc3F)sc2N)c1N1CC[C@@H](N)CC(F)(F)C1,Ki,'=',0.04,nM,10.4,,,UO_0000065,21.51,0.43,7.18,9.03,0,CHEMBL4317000,Inhibition of recombinant human PIM2 using FAM-pimtide as substrate after 90 mins by Z-LYTE assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4316591,1,Scientific Literature,J Med Chem,2019,None,
CHEMBL99203,IODOTUBERCIDIN,None,392.15,0,-0.77,K00049,Nc1ncnc2c1c(I)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,Thermal melting change,'=',1,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL4472966,,None,448.5,0,3.01,11,Cn1ncc(NC(=O)c2nc(-c3c(F)cccc3F)sc2N)c1N1CCCC(O)CC1,Ki,'=',2,nM,8.7,,,UO_0000065,19.4,0.38,5.69,7.96,0,CHEMBL4317000,Inhibition of recombinant human PIM2 using FAM-pimtide as substrate after 90 mins by Z-LYTE assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4316591,1,Scientific Literature,J Med Chem,2019,None,
CHEMBL3687438,,None,533.58,1,3.57,BDBM151833,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1NS(C)(=O)=O,IC50,'=',41.98,nM,7.38,,292089,UO_0000065,13.83,0.27,3.81,5.81,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1984363,,None,374.42,0,4.44,SID103905034,Cc1cc(NC(=O)Cc2ccc(-c3cccc4[nH]nc(N)c34)cc2)ccc1F,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1987813,,None,292.24,0,-0.74,4,O=C1C2=C(C(=O)c3c(O)ccc(O)c31)[C@@H](O)[C@@H](O)[C@@H](O)C2,Inhibition,'=',29,%,,,,UO_0000187,,,,,0,CHEMBL3813081,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3808372,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL1979718,,None,345.41,0,3.68,SID103905662,Cc1c(C)n(Cc2ccccc2)c2ccc(C(=O)Nc3nc[nH]n3)cc12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3394071,,None,309.36,0,2.31,20,Nc1cncc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)n1,IC50,'=',192,nM,6.72,,,UO_0000065,21.71,0.42,4.41,5.63,1,CHEMBL3395659,Inhibition of full length recombinant PIM2 (unknown origin) using biotinylated-BAD peptide as substrate assessed as phosphorylation at serine 112 after 90 mins by HTRF method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3393014,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL3634769,,None,402.46,0,1.67,19,CCn1cncc(-c2cc3c(-c4cccc(N5CCNCC5)n4)n[nH]c3cn2)c1=O,Ki,'=',0.145,nM,9.84,,,UO_0000065,24.45,0.45,8.17,9.4,0,CHEMBL3636741,Inhibition of Pim2 (unknown origin) using 5FAM-ARKRRRHPSGPPTA as substrate after 90 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632547,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL1725279,SP-600125,None,220.23,0,4.43,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3652633,,None,410.46,0,1.78,BDBM119393,Cn1ncc(NC(=O)c2nc(-c3ccccc3F)cnc2N)c1N1CCC(N)CC1,Ki,'=',14.7,nM,7.83,,246160,UO_0000065,19.08,0.36,6.05,6.12,0,CHEMBL3707982,Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3691954,,None,613.64,1,4.94,BDBM151976,COC(=O)N[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(OC4CCOCC4)cc3F)n2)C[C@@H]1C,IC50,'=',13.84,nM,7.86,,292231,UO_0000065,12.81,0.24,2.92,5.71,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3942104,,None,472.48,0,2.32,BDBM249032,Cc1ccc(-n2ncc3cnc(-c4cnn(CC(F)(F)F)c4)cc32)nc1N1CCNC[C@H](O)C1,Ki,'=',6.51,nM,8.19,,434236,UO_0000065,17.33,0.33,5.87,8.45,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL558752,RAF-265,2,518.42,2,6.93,RAF-265,Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL571546,TIRBANIBULIN,4,431.54,0,3.32,KX2-391,O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3648680,,None,465.51,0,2.92,16; GDC-0339,Cn1ncc(NC(=O)c2nc(-c3c(F)cccc3F)sc2N)c1N1CC[C@@H](N)[C@H](F)CC1,Ki,'=',0.1,nM,10,,,UO_0000065,21.48,0.43,7.08,8.69,0,CHEMBL4317000,Inhibition of recombinant human PIM2 using FAM-pimtide as substrate after 90 mins by Z-LYTE assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4316591,1,Scientific Literature,J Med Chem,2019,None,
CHEMBL273611,,None,459.48,0,4.59,SB-250715,Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1,Inhibition,'=',0.71,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL4461181,,None,435.53,0,3.59,19,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C[C@H]5CCCO5)c(NC(C)(C)C)nc34)[nH]c21,IC50,'=',0.13,nM,9.89,,,UO_0000065,22.7,0.42,6.3,9.78,0,CHEMBL4370146,Inhibition of full length recombinant PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues preincubated for 30 mins followed by biotinylated BAD addition and measured after 1 hr by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4368910,1,Scientific Literature,J Med Chem,2019,None,
CHEMBL2048873,,None,380.47,0,3,29,N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccncc2)C1,IC50,'=',690,nM,6.16,,,UO_0000065,16.19,0.31,3.16,6.98,0,CHEMBL2049743,Inhibition of human PIM2 using FITC-(AHX)RSRHSSYPAGT-COOH as substrate after 90 mins by mobility shift assay in presence of 5 mM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2046384,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL4448325,,None,381.26,0,2.1,15,NC(=O)c1cc(Cl)c2c(Cl)c(C#CCCO)n([C@H]3CCCNC3)c2n1,IC50,'=',2.7,nM,8.57,,,UO_0000065,22.47,0.47,6.47,9.2,0,CHEMBL4373003,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser-112 residue by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4371067,1,Scientific Literature,Bioorg Med Chem Lett,2019,None,
CHEMBL4533366,,None,436.34,0,2.62,28,CC(C)(CC#Cc1c(Cl)c2c(Cl)cc(C(N)=O)nc2n1[C@H]1CCCNC1)C(N)=O,IC50,'=',21,nM,7.68,,,UO_0000065,17.6,0.36,5.06,6.62,0,CHEMBL4373003,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser-112 residue by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4371067,1,Scientific Literature,Bioorg Med Chem Lett,2019,None,
CHEMBL3394059,,None,343.42,0,4.48,1,Nc1ncc(-c2ccc3[nH]nc(-c4cnc5ccccc5c4)c3c2)s1,IC50,'=',31,nM,7.51,,,UO_0000065,21.86,0.41,3.03,9.33,0,CHEMBL3395659,Inhibition of full length recombinant PIM2 (unknown origin) using biotinylated-BAD peptide as substrate assessed as phosphorylation at serine 112 after 90 mins by HTRF method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3393014,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL1957504,,None,476.54,0,1.17,25d,O=C(NCCN1CCOCC1)c1cn2cc(-c3cccc4[nH]ncc34)nc(N3CCOCC3)c2n1,Inhibition,'=',50,%,,,,UO_0000187,,,,,0,CHEMBL1959621,Inhibition of PIM2 at 5 to 10 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1955823,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL3394060,,None,342.43,1,5.09,2,Nc1ncc(-c2ccc3[nH]cc(-c4cnc5ccccc5c4)c3c2)s1,IC50,'=',2710,nM,5.57,,,UO_0000065,16.26,0.3,0.48,8.24,1,CHEMBL3395659,Inhibition of full length recombinant PIM2 (unknown origin) using biotinylated-BAD peptide as substrate assessed as phosphorylation at serine 112 after 90 mins by HTRF method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3393014,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL600852,,None,443.51,0,3.01,50,NC(=O)c1ccc(NC(=O)NCc2cccc(C(=O)Nc3ccc4c(c3)CNCC4)c2)cc1,Inhibition,'>',50,%,,,,UO_0000187,,,,,0,CHEMBL1065778,Inhibition of PIM2 at 3 uM relative to control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1157712,1,Scientific Literature,J Med Chem,2010,None,
CHEMBL3691947,,None,565.6,2,5.07,BDBM151969,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C4COC4)cc3F)n2)C[C@@H](N)[C@H]1OCCC#N,IC50,'=',1.83,nM,8.74,,292224,UO_0000065,15.45,0.29,3.67,7.1,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL318892,,None,428.52,1,5.16,SB-236687,CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1,Inhibition,'=',-0.56,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL604087,,None,445.52,0,3.53,18,COc1ccc(C(=O)NCc2cccc(C(=O)Nc3ccc4c(c3)CNCC4)c2)cc1OC,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1065740,Inhibition of PIM2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1157712,1,Scientific Literature,J Med Chem,2010,None,
CHEMBL3651917,,None,450.53,1,5.47,BDBM106821,CCc1ccc(F)c(-c2cccc(C(=O)Nc3cnccc3[C@@H]3C[C@H](C)C[C@H](N)C3)n2)c1F,IC50,'=',13,nM,7.89,,225842,UO_0000065,17.5,0.33,2.42,9.75,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3393718,,None,458.5,0,3.45,18k,NC(=O)c1ccc(-c2ccc3[nH]nc(-c4cncc(O[C@H]5CNCCC56CC6)n4)c3c2)c(F)c1,IC50,'=',0.6,nM,9.22,,,UO_0000065,20.11,0.37,5.77,7.76,0,CHEMBL3396420,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as phosphorylation of biotinylated-BAD peptide at Serine 112 residue,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3392976,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL264406,,None,317.4,0,3.98,NA-PP1,CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21,Activity,'=',105,%,,,,UO_0000187,,,,,0,CHEMBL1061149,Percentage PIM2 activity remaining in the presence of 10uM inhibitor,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL34704,,None,380.5,0,3.12,U-0126,N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(\N)Sc1ccccc1N,Activity,'=',101,%,,,,UO_0000187,,,,,0,CHEMBL1061149,Percentage PIM2 activity remaining in the presence of 10uM inhibitor,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL1909386,GW566221A,None,565.1,2,5.35,GW566221A,CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl,Inhibition,'=',-0.56,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL269450,,None,433.46,1,5,SB-242717,Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1,Inhibition,'=',-4.57,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3651898,,None,441.45,1,5.08,BDBM106801,C[C@@H]1C[C@H](O)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C1,IC50,'=',18,nM,7.75,,225822,UO_0000065,17.54,0.33,2.66,10.31,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1970189,,None,286.72,0,2.59,SID103905102,Cc1n[nH]c2c1C(c1ccccc1Cl)C(C#N)=C(N)O2,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3965530,,None,376.49,1,5.11,BDBM224950,CNc1nnc(-c2ccc3[nH]cc(-c4ccc5c(c4)OC(C)(C)C5)c3c2)s1,IC50,'=',1841.04,nM,5.74,,393239,UO_0000065,15.23,0.29,0.62,9.13,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3918784,,None,307.38,0,3.79,BDBM224952,CNc1nnc(-c2ccc3[nH]cc(-c4ccncc4)c3c2)s1,IC50,'=',686.35,nM,6.16,,393242,UO_0000065,20.05,0.38,2.37,9.27,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3986966,,None,325.37,0,3.93,BDBM224972,CNc1nnc(-c2ccc3[nH]cc(-c4cccc(F)n4)c3c2)s1,IC50,'=',739.49,nM,6.13,,393262,UO_0000065,18.84,0.36,2.2,9.22,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL265470,,None,374.35,0,3.29,STO-609,CC(=O)O.O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21,IC50,'=',110,nM,6.96,,Antagonist,UO_0000065,22.14,0.4,3.67,9.71,0,CHEMBL1062793,Inhibition of PIM2 in the presence of 5uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL1241674,,None,308.35,0,2.84,PP242,CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21,Inhibition,'=',4,%,,,,UO_0000187,,,,,0,CHEMBL1244250,Inhibition of PIM2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240340,1,Scientific Literature,Nat Chem Biol,2008,None,
CHEMBL428690,ALVOCIDIB,3,401.85,0,3.3,Flavopiridol,CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1,Kd,'=',770,nM,6.11,,,UO_0000065,15.21,0.3,2.81,6.49,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL3676278,,None,445.5,0,3.29,BDBM131748,CO[C@H]1C[C@H](N)CN(c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C1,IC50,'=',378,nM,6.42,,263981,UO_0000065,14.42,0.28,3.13,6.88,0,CHEMBL3706072,Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL261849,GW632580X,None,366.42,0,2.83,GW632580X,COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,Inhibition,'=',2.71,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3985113,,None,430.52,0,2.13,BDBM248927,c1cc(N2CCCNCC2)nc(-n2ncc3cnc(-c4cnn(CC5COC5)c4)cc32)c1,Ki,'=',2900,nM,5.54,,434134,UO_0000065,12.86,0.24,3.41,6.45,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3897123,,None,335.37,0,3.65,BDBM225100,CC(C)Oc1cccc(-c2c[nH]c3ccc(-c4noc(N)n4)cc23)n1,IC50,'=',668.04,nM,6.17,,393092,UO_0000065,18.41,0.34,2.53,6,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3941198,,None,403.45,0,3.47,BDBM225079,CC(C)Nc1nnc(-c2ccc3[nH]cc(-c4nc(C(N)=O)cc(C5CC5)n4)c3c2)o1,IC50,'=',2.959,nM,8.53,,393072,UO_0000065,21.14,0.39,5.06,6.29,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3940744,,None,436.47,0,3.45,BDBM248996,Cc1cncc(-c2cc3c(cn2)cnn3-c2ccc(C(F)F)c(N3CCC[C@H](N)C3)n2)n1,Ki,'=',0.233,nM,9.63,,434203,UO_0000065,22.07,0.41,6.18,9.77,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1802485,,None,234.26,0,2.78,JNK_Inhibitor_Negative_Control,Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2,Residual Activity,'=',91,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3664613,,None,425.44,0,3.56,BDBM104233,COc1ccc2nnc(-c3ccc4cc(F)cc(OCC5(F)CCNCC5)c4n3)n2c1,IC50,'=',163.4,nM,6.79,,222644,UO_0000065,15.95,0.3,3.23,9.22,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3676308,,None,446.5,1,5.11,BDBM131778,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2csc(-c3c(F)ccc(F)c3F)n2)C1,IC50,'=',15,nM,7.82,,264011,UO_0000065,17.52,0.34,2.71,9.67,0,CHEMBL3706072,Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3676265,,None,431.47,0,2.63,BDBM131735,N[C@H]1C[C@H](O)CN(c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C1,IC50,'=',1502,nM,5.82,,263968,UO_0000065,13.5,0.27,3.19,5.58,0,CHEMBL3706072,Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3676259,,None,431.47,0,2.63,BDBM131729,N[C@@H]1CN(c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)CC[C@H]1O,IC50,'=',11,nM,7.96,,263962,UO_0000065,18.45,0.36,5.33,7.63,0,CHEMBL3706072,Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL583719,,None,236.27,0,3.29,10,OCc1c[nH]c2c1ccc1c3ccccc3[nH]c12,Activity,'=',47,%,,,,UO_0000187,,,,,0,CHEMBL1057614,Inhibition of Pim-2 assessed as residual enzyme activity at 10 uM relative to untreated control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154186,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL1909370,GW694234A,None,532.78,1,5.94,GW694234A,COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl,Inhibition,'=',-0.42,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3948227,,None,353.41,0,3.35,BDBM224911,COc1ccc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)nc1OC,IC50,'=',44.07,nM,7.36,,393191,UO_0000065,20.81,0.4,4.01,7.43,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3652015,,None,472.47,0,3.63,BDBM106921,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)c(F)cc2N)C[C@@H](O)[C@@H]1O,IC50,'=',1,nM,9,,225942,UO_0000065,19.05,0.36,5.37,7.42,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3687449,,None,532.5,2,5.58,BDBM151845,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1OP(C)(C)=O,IC50,'=',30.92,nM,7.51,,292101,UO_0000065,14.1,0.28,1.93,7.01,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3685744,,None,446.51,1,5.03,BDBM124907,NC1CCCCN(c2ccncc2Nc2cccc3cnc(-c4c(F)cccc4F)nc23)C1,IC50,'>',25000,nM,,,254209,UO_0000065,,,,,0,CHEMBL3705221,ATP Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 ul per well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3956155,,None,415.5,0,2.21,BDBM248890,CCc1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CCNC[C@H](O)C3)n2)c1,Ki,'=',10.5,nM,7.98,,434097,UO_0000065,19.2,0.35,5.77,8.67,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3892536,,None,360.43,0,1.63,BDBM248871,Cn1cc(-c2cc3c(cn2)cnn3-c2cccc(N3CCNCC3)n2)cn1,Ki,'=',12.1,nM,7.92,,434078,UO_0000065,21.97,0.4,6.29,10.32,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3947484,,None,399.5,0,3.41,BDBM248874,CC(C)c1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CCNCC3)n2)c1,Ki,'=',7.14,nM,8.15,,434081,UO_0000065,20.39,0.37,4.74,11.35,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3961525,,None,374.45,0,2.11,BDBM248870,CCn1cc(-c2cc3c(cn2)cnn3-c2cccc(N3CCNCC3)n2)cn1,Ki,'=',14.6,nM,7.84,,434077,UO_0000065,20.93,0.38,5.73,10.22,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1984367,,None,376.49,0,4.29,SID103905001,CN(C)c1ccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)cc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1964290,,None,307.36,0,2.44,SID103905598,Cc1cccc(-c2[nH]c(-c3ccnc(N)n3)cc2C(N)=O)c1C,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3664615,,None,396.42,0,2.84,BDBM104235,CC(C)(COc1cc(F)cc2ccc(-c3nnc4ccccn34)nc12)[C@@H](O)CO,IC50,'=',299.9,nM,6.52,,222646,UO_0000065,16.45,0.31,3.68,7.03,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3664611,,None,367.36,0,2.77,BDBM104231,Fc1cc(OCC2(F)CNC2)c2nc(-c3nnc4ccccn34)ccc2c1,IC50,'=',489.2,nM,6.31,,222642,UO_0000065,17.18,0.32,3.54,9.81,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL206544,GW682841X,None,340.43,1,5.32,GW682841X,CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1,Inhibition,'=',-0.1,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL572781,,None,377.47,0,3.37,20b,O=c1[nH]c(CN2CC[C@H](O)C2)nc2c1sc1ccc(-c3ccccc3)cc12,Ki,'=',10,nM,8,,,UO_0000065,21.19,0.4,4.63,11.56,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL3973544,,None,391.5,0,3.17,BDBM248893,Cc1cc(-c2cc3c(cn2)cnn3-c2cccc(N3CCC[C@H](N)C3)n2)sn1,Ki,'=',3.48,nM,8.46,,434100,UO_0000065,21.61,0.41,5.29,9.86,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2048865,,None,303.39,0,1.94,15,N[C@@H]1CCCN(c2ccccc2/C=C2\SC(=O)NC2=O)C1,IC50,'=',1200,nM,5.92,,,UO_0000065,19.52,0.39,3.98,7.85,0,CHEMBL2049743,Inhibition of human PIM2 using FITC-(AHX)RSRHSSYPAGT-COOH as substrate after 90 mins by mobility shift assay in presence of 5 mM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2046384,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL2048867,,None,382.28,0,2.7,23,N[C@@H]1CCCN(c2c(Br)cccc2/C=C2\SC(=O)NC2=O)C1,IC50,'=',150,nM,6.82,,,UO_0000065,17.85,0.42,4.12,9.05,0,CHEMBL2049743,Inhibition of human PIM2 using FITC-(AHX)RSRHSSYPAGT-COOH as substrate after 90 mins by mobility shift assay in presence of 5 mM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2046384,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL3922469,,None,403.47,0,3.6,BDBM192553,N[C@H]1CCCN(c2ccncc2Nc2ncc3ccc(-c4ccccc4F)nn23)C1,IC50,'=',2,nM,8.7,,344545,UO_0000065,21.56,0.4,5.1,10.31,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3664628,,None,376.46,0,4.12,BDBM104254,CCC(CC)(CO)COc1cccc2ccc(-c3nnc4ccccn34)nc12,IC50,'=',1000,nM,6,,222665,UO_0000065,15.94,0.29,1.88,8.27,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL453375,,None,332.4,0,3.83,5,C[C@H]1CCCC(=O)[C@@H](C)CC/C=C/c2cc(O)cc(O)c2C(=O)O1,Tm,'<',2,degrees C,,,,UO_0000027,,,,,0,CHEMBL1004482,Binding affinity to human recombinant PIM2 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140872,1,Scientific Literature,Bioorg Med Chem,2009,None,
CHEMBL12014,HARMAN,None,182.23,0,3.02,Harmane,Cc1nccc2c1[nH]c1ccccc12,Activity,'=',85,%,,,,UO_0000187,,,,,0,CHEMBL1061086,Percentage PIM2 activity remaining in the presence of 1uM inhibitor,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL259850,,None,308.32,0,2.38,AR-A0-14418,COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1,Activity,'=',92,%,,,,UO_0000187,,,,,0,CHEMBL1061149,Percentage PIM2 activity remaining in the presence of 10uM inhibitor,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL573045,,None,402.48,0,3.24,20d,N#Cc1ccc(-c2ccc3sc4c(=O)[nH]c(CN5CC[C@H](O)C5)nc4c3c2)cc1,Ki,'=',29,nM,7.54,,,UO_0000065,18.73,0.35,4.3,8.1,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL2030388,,None,363.22,0,1.96,6i,N[C@@H]1CCN(Cc2nc3c(oc4ccc(Br)cc43)c(=O)[nH]2)C1,IC50,'=',72,nM,7.14,,,UO_0000065,19.66,0.44,5.18,8.1,0,CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034948,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL2035640,,None,424.24,0,2.02,7b,CN1CCN(Cc2nc3c(oc4ccc(I)cc43)c(=O)[nH]2)CC1,IC50,'=',140,nM,6.85,,,UO_0000065,16.16,0.41,4.83,10.48,0,CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034948,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL272629,,None,349.35,0,0.78,GSK_3b_Inhibitor_XI,O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1,Residual Activity,'=',43,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL383899,ANILINOPYRIMIDINE1,None,413.4,1,5.33,Aurora_Kinase_Inhibitor_III,O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1,Residual Activity,'=',119,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2035627,,None,529.82,1,4.97,5j,O=C(NCCN1CCCCC1)c1ccc(-c2nc3c(oc4ccc(Br)cc43)c(=O)[nH]2)c(Cl)c1,IC50,'=',134,nM,6.87,,,UO_0000065,12.97,0.28,1.9,7.53,0,CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034948,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL483747,GSK-980961A,None,390.46,0,4.13,GSK980961A,NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1,Inhibition,'=',0.25,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3925905,,None,361.45,0,3.57,BDBM238500,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1CCCC1,IC50,'=',5.5,nM,8.26,,416237,UO_0000065,22.85,0.42,4.69,9.99,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1909366,GW659386A,None,539.87,2,6.34,GW659386A,COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl,Inhibition,'=',-0.3,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3651972,,None,438.48,0,3.88,BDBM106876,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2cccc(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1O,IC50,'=',3,nM,8.52,,225897,UO_0000065,19.44,0.36,4.64,8.43,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3902931,,None,329.33,0,4.34,BDBM225057,Oc1nnc(-c2ccc3[nH]cc(-c4ccc(F)cc4F)c3c2)s1,IC50,'>',3000,nM,,,393050,UO_0000065,,,,,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL160876,,None,377.18,0,3.17,SB-360741,O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1,Inhibition,'=',0.1,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL223460,,None,466.91,0,2.96,18d,CS(=O)(=O)Nc1cc2c(cc1Cl)NC(=O)Nc1cnc(C#N)c(n1)OCCCCCO2,Ki,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL915361,Inhibition of Pim2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142994,1,Scientific Literature,J Med Chem,2007,None,
CHEMBL1965131,,None,379.27,0,4.87,SID103904746,Cc1ccc(C(=O)Nc2c(C(N)=O)sc3ccc(Cl)c(Cl)c23)cc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1994074,,None,273.13,0,3.99,SID103904963,Brc1ccc2[nH]nc(-c3ccccc3)c2c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1995813,,None,308.39,0,2.7,SID103904202,NC1CCCCC1Nc1nccc(-c2c[nH]c3ncccc23)n1,Ki,'=',1000,nM,6,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL413188,ISOGRANULATIMIDE,None,276.26,0,1.85,K00457,O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21,Thermal melting change,'=',8,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL260138,ALSTERPAULLONE 2,None,346.35,0,3.69,K00544,N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2,Thermal melting change,'=',1.4,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL4517719,,None,421.29,1,6.27,22m,O=C(Nc1ccc2[nH]nc(-c3ccc4[nH]ccc4c3)c2c1)c1c(Cl)cccc1Cl,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4304941,Inhibition of wild-type human partial length PIM2 (M1 to E291 residues) expressed in bacterial expression system at 1 uM by Kinomescan method,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4304739,1,Scientific Literature,J Med Chem,2019,None,
CHEMBL3937321,,None,382.4,0,4.03,BDBM224993,CCOc1nc(-c2c[nH]c3ccc(-c4nnc(NC(C)C)o4)cc23)ncc1F,IC50,'=',36.95,nM,7.43,,393282,UO_0000065,19.44,0.36,3.4,7.3,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3430785,,None,353.4,0,2.32,K00564a,Cn1cc(/C=C2/C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21,Thermal melting change,'=',8.2,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL111456,,None,423.54,1,5.31,K00044,C[S+]([O-])c1ccc(CSc2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,Thermal melting change,'=',0.4,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL3687454,,None,528.53,1,4.51,BDBM151850,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@@H]1OCCC(=O)O,IC50,'=',289.11,nM,6.54,,292106,UO_0000065,12.37,0.24,2.03,5.13,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL104264,,None,446.37,0,3.58,K00084,O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12,Thermal melting change,'=',-0.3,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL3430781,,None,458.52,0,3.05,K00202,CC(=O)O.Cn1cc(C2=C(c3cn(CCCN)c4ccccc34)C(=O)NC2=O)c2ccccc21,Thermal melting change,'=',5.6,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL1998611,,None,305.58,0,3,SID103905308,NC(=O)c1sc2c(Br)ccc(Cl)c2c1N,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL509032,TAE-684,None,614.22,2,5.02,TAE684,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,Activity,'=',91,%,,,,UO_0000187,,,,,0,CHEMBL2016316,Inhibition of PIM2 assessed as residual activity at 1 uM relative to control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2010643,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL4064534,,None,491.6,0,4.91,YKL-04-085,Cc1ccc(-n2c(=O)ccc3ccc4ccc(-c5cnn(C)c5)cc4c32)cc1NC(=O)/C=C/CN(C)C,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL4043032,Inhibition of recombinant full length GST-tagged human PIM2 expressed in baculovirus expression system by Z'-Lyte assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4041550,1,Scientific Literature,ACS Med Chem Lett,2017,None,
CHEMBL3215582,,None,588.33,1,6.41,1,Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl,Activity,'=',100,%,,,,UO_0000187,,,,,0,CHEMBL1057592,Inhibition of PIM2 assessed as enzyme activity at 1 uM relative to untreated control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155237,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL3691929,,None,485.51,0,4.25,BDBM151951,CO[C@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)c(F)cc2N)C[C@@H]1C,IC50,'=',0.9,nM,9.05,,292206,UO_0000065,18.63,0.35,4.8,7.79,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1909395,GW633459A,None,679.6,2,7.57,GW633459A,Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1,Inhibition,'=',0.44,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL179465,GW621970X,None,376.41,0,4.03,GW621970X,CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1,Inhibition,'=',-0.96,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL14014,,None,433.46,1,5,SB-251505,Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1,Inhibition,'=',-0.15,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3660093,,None,395.41,0,3.55,BDBM104226,Fc1ccc2nnc(-c3ccc4cccc(OCC5(F)CCNCC5)c4n3)n2c1,IC50,'=',65.6,nM,7.18,,222637,UO_0000065,18.17,0.34,3.63,11.16,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3950704,,None,363.42,0,2.7,BDBM238767,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C)c(NC5(C)CC5)nc34)[nH]c21,IC50,'=',0.364,nM,9.44,,416876,UO_0000065,25.97,0.48,6.74,10.28,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4077328,,None,334.45,0,3.31,36,COc1ccc(-c2nc(/C=C3\SC(=S)NC3=O)cs2)cc1,Delta Tm,'=',11.5,degrees C,,,,UO_0000027,,,,,0,CHEMBL4029682,Inhibition of recombinant PIM2 (unknown origin) assessed as change in melting temperature at 10 uM by SYPRO orange dye-based differential scanning fluorimetry,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4028814,1,Scientific Literature,Bioorg Med Chem,2017,None,
CHEMBL3651982,,None,456.47,0,4.01,BDBM106886,C[C@@H]1C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@H](N)[C@@H]1O,IC50,'=',124,nM,6.91,,225907,UO_0000065,15.13,0.29,2.9,6.83,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3981312,,None,344.4,0,3.88,BDBM224898,Nc1nnc(-c2ccc3[nH]cc(-c4ccc5nccnc5c4)c3c2)s1,IC50,'=',144.17,nM,6.84,,393174,UO_0000065,19.86,0.37,2.96,7.33,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4540910,,None,395.29,0,2.75,17,COCCC#Cc1c(Cl)c2c(Cl)cc(C(N)=O)nc2n1[C@H]1CCCNC1,IC50,'=',5.1,nM,8.29,,,UO_0000065,20.98,0.44,5.54,10.09,0,CHEMBL4373003,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser-112 residue by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4371067,1,Scientific Literature,Bioorg Med Chem Lett,2019,None,
CHEMBL4075977,,None,334.45,0,3.31,35,COc1cccc(-c2nc(/C=C3\SC(=S)NC3=O)cs2)c1,Delta Tm,'=',13.3,degrees C,,,,UO_0000027,,,,,0,CHEMBL4029682,Inhibition of recombinant PIM2 (unknown origin) assessed as change in melting temperature at 10 uM by SYPRO orange dye-based differential scanning fluorimetry,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4028814,1,Scientific Literature,Bioorg Med Chem,2017,None,
CHEMBL3912306,,None,429.48,1,5.33,BDBM224882,Nc1nnc(-c2ccc3[nH]cc(-c4cc(C(=O)Nc5ccccc5)ccc4F)c3c2)s1,IC50,'=',236.82,nM,6.63,,393160,UO_0000065,15.43,0.29,1.3,6.85,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3935080,,None,325.37,0,3.39,BDBM225024,CC(C)Nc1nnc(-c2ccc3[nH]cc(NC(=O)C4CC4)c3c2)o1,IC50,'=',25.6,nM,7.59,,393314,UO_0000065,23.33,0.43,4.2,7.92,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3394169,,None,391.5,1,5.04,BDBM50061604,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(OC5CCCCC5)n4)c3c2)s1,IC50,'=',114.43,nM,6.94,,393196,UO_0000065,17.73,0.34,1.9,7.74,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3921475,,None,373.45,0,3.82,BDBM224920,Cc1ccn(-c2cccc(-c3c[nH]c4ccc(-c5nnc(N)s5)cc34)n2)n1,IC50,'=',64.6,nM,7.19,,393202,UO_0000065,19.25,0.36,3.37,7.31,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL103080,,None,370.43,0,2.95,SB-742864,CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1,Inhibition,'=',1.38,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL4591512,,None,421.5,0,2.93,15,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(CC5(O)CC5)c(NC(C)(C)C)nc34)[nH]c21,IC50,'=',0.23,nM,9.64,,,UO_0000065,22.87,0.42,6.71,8.6,0,CHEMBL4370146,Inhibition of full length recombinant PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues preincubated for 30 mins followed by biotinylated BAD addition and measured after 1 hr by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4368910,1,Scientific Literature,J Med Chem,2019,None,
CHEMBL517666,GW796921X,None,336.44,0,4.15,GW796921X,CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1,Inhibition,'=',-2.01,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3900533,,None,447.34,1,5.33,BDBM238477,Cc1cc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1Nc1ccc(Br)cc1,IC50,'=',10.5,nM,7.98,,416214,UO_0000065,17.84,0.38,2.65,11.43,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3925684,,None,389.85,0,3.93,BDBM238729,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1-c1cccnc1Cl,IC50,'=',187,nM,6.73,,416838,UO_0000065,17.26,0.33,2.8,8.05,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3970207,,None,349.44,0,3.29,BDBM238439,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NCC(C)C,IC50,'=',0.7,nM,9.15,,416637,UO_0000065,26.2,0.48,5.86,11.07,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3927716,,None,383.43,0,2.54,BDBM238706,Cc1nc2ccc(F)c(-c3cc4c([nH]3)CCNC4=O)c2nc1NC(C)(C)CO,IC50,'=',0.272,nM,9.56,,416815,UO_0000065,24.95,0.47,7.03,9.29,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3938995,,None,372.4,0,4.03,BDBM238747,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1-c1ccccc1F,IC50,'=',47.4,nM,7.32,,416856,UO_0000065,19.67,0.36,3.29,10.36,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4061891,,None,228.32,0,1.63,11,O=C1NC(=S)S/C1=C\c1cscn1,Activity,,,,,,Not Determined,,,,,,0,CHEMBL4029695,Inhibition of partial length wild type human PIM2 (M1 to E291 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by KINOMEscan assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4028814,1,Scientific Literature,Bioorg Med Chem,2017,None,
CHEMBL3919994,,None,350.43,0,2.82,BDBM238623,Cc1nc2nccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC(C)(C)C,IC50,'=',0.8,nM,9.1,,416730,UO_0000065,25.96,0.48,6.28,9.52,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3934338,,None,335.41,0,3.56,BDBM238627,Cc1nc2cccc(-c3cc4c([nH]3)[C@@H](C)NC4=O)c2nc1NC(C)C,IC50,'=',1.64,nM,8.79,,416736,UO_0000065,26.19,0.48,5.23,10.62,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3924828,,None,433.43,0,3.97,BDBM238814,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(CC(F)(F)F)c(NC(C)(C)C)nc34)[nH]c21,IC50,'=',0.19,nM,9.72,,416923,UO_0000065,22.43,0.43,5.75,10.59,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3891457,,None,462.55,0,3.69,BDBM238755,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@H]1C[C@H](NC(=O)OC(C)(C)C)C1,IC50,'=',8.2,nM,8.09,,416864,UO_0000065,17.48,0.32,4.4,6.68,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3957539,,None,476.58,0,4.03,BDBM238424,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@H]1CCCN(C(=O)OC(C)(C)C)C1,IC50,'=',220,nM,6.66,,416622,UO_0000065,13.97,0.26,2.63,5.93,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1909412,,None,413.31,0,4.62,SB-476429-A,Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1,Inhibition,'=',1.13,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3901863,,None,348.45,0,4.66,BDBM238643,Cc1nc2cccc(-c3cc4c([nH]3)CCCC4=O)c2nc1NC(C)(C)C,IC50,'=',1.47,nM,8.83,,416752,UO_0000065,25.35,0.46,4.17,12.5,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3687531,,None,532.59,1,4.38,BDBM151928,Cc1cc(F)c(-c2nc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@@H](S(C)(=O)=O)[C@@H](C)C3)ccc2F)c(F)c1,IC50,'=',3.85,nM,8.41,,292183,UO_0000065,15.8,0.31,4.03,7.31,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3652624,,None,391.48,0,2.24,BDBM119384,Cn1ncc(NC(=O)c2nc(-c3ccccc3)ccc2N)c1N1CCC(N)CC1,Ki,'=',41.1,nM,7.39,,246151,UO_0000065,18.87,0.35,5.15,6.42,0,CHEMBL3707982,Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4517926,,None,458.57,0,3.36,40,CCCN1CCOc2c1cnn1c(-c3ccc4cccc(NCC5CCNCC5)c4n3)nnc21,IC50,'=',4010,nM,5.4,,,UO_0000065,11.77,0.22,2.04,5.83,0,CHEMBL4340984,Inhibition of His tagged human recombinant PIM2 using PIM tide (ARKRRRHPSGPPTA) as substrate incubated for 1 hr by fluorescence based assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4340512,1,Scientific Literature,Eur J Med Chem,2019,None,
CHEMBL3660008,,None,359.43,0,3.66,BDBM104126,OC1CCC(Nc2cccc3ccc(-c4nnc5ccccn45)nc23)CC1,IC50,'=',807,nM,6.09,,222544,UO_0000065,16.95,0.31,2.43,8.09,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3660078,,None,439.49,0,4.69,BDBM104205,FC1CNCCC1Oc1cccc2ccc(-c3nnc4ccc(-c5ccccc5)cn34)nc12,IC50,'=',1035,nM,5.99,,222618,UO_0000065,13.62,0.25,1.3,9.3,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL573578,,None,331.42,0,3.91,NM_PP1,CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21,Residual Activity,'=',114,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL101683,,None,337.81,0,4.6,VEGF_Receptor_Tyrosine_Kinase_Inhibitor_II,O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1,Residual Activity,'=',132,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL377193,,None,292.29,0,3.29,Flt_3_Inhibitor_II,O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1,Residual Activity,'=',80,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL377300,BRIVANIB,3,370.38,0,3.52,BMS-540215,Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL1794055,GW589933X,None,372.43,0,2.35,GW589933X,NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1,Inhibition,'=',1.26,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL4463004,,None,457.54,0,3.5,34,C[C@H](c1cn(C)cn1)n1c(NC2(C)CC2)nc2c(-c3cc4c([nH]3)[C@@H](C)NC4=O)cccc2c1=O,IC50,'=',3.2,nM,8.49,,,UO_0000065,18.57,0.34,4.99,7.75,0,CHEMBL4370146,Inhibition of full length recombinant PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues preincubated for 30 mins followed by biotinylated BAD addition and measured after 1 hr by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4368910,1,Scientific Literature,J Med Chem,2019,None,
CHEMBL3664626,,None,373.46,0,3.84,BDBM104252,NCC1(COc2cccc3ccc(-c4nnc5ccccn45)nc23)CCCC1,IC50,'=',1000,nM,6,,222663,UO_0000065,16.07,0.29,2.16,7.66,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3660088,,None,363.4,0,3.02,BDBM104217,FC1CNCCC1Oc1cccc2ccc(-c3nnc4ccccn34)nc12,IC50,'=',1000,nM,6,,222628,UO_0000065,16.51,0.3,2.98,9.33,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3103876,,None,298.35,0,1.7,3a,Nc1nccnc1C(=O)Nc1cnccc1N1CCCCC1,Ki,'=',1600,nM,5.8,,,UO_0000065,19.43,0.36,4.1,5.97,0,CHEMBL3106178,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3102815,1,Scientific Literature,ACS Med Chem Lett,2013,None,
CHEMBL3937034,,None,390.45,0,0.99,BDBM248998,Cn1cc(-c2cc3c(cn2)cnn3-c2cccc(N3CCNCC(O)C3)n2)cn1,Ki,'=',9.39,nM,8.03,,434205,UO_0000065,20.56,0.38,7.04,8.28,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3937034,,None,390.45,0,0.99,BDBM248998,Cn1cc(-c2cc3c(cn2)cnn3-c2cccc(N3CCNCC(O)C3)n2)cn1,Ki,'=',1.39,nM,8.86,,434207,UO_0000065,22.68,0.42,7.87,9.14,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2377706,,None,214.27,0,2.58,24,CCCc1c[nH]c2c(N)cc3cn[nH]c3c12,Inhibition,'=',90,%,,,,UO_0000187,,,,,0,CHEMBL2378598,Inhibition of human full length Pim-2 using RSRHSSYPAGT as substrate assessed as residual activity at 1 uM after 30 mins in presence of [gamma-33P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2375344,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL3634766,,None,276.3,0,2.42,31,Cn1cc(-c2cc3c(-c4ccccn4)n[nH]c3cn2)cn1,Ki,'=',48,nM,7.32,,,UO_0000065,26.49,0.48,4.9,10.13,0,CHEMBL3636741,Inhibition of Pim2 (unknown origin) using 5FAM-ARKRRRHPSGPPTA as substrate after 90 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632547,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL3652648,,None,432.5,0,3.64,BDBM119408,Cn1ncc(NC(=O)c2nc(-c3c(F)cccc3F)sc2N)c1C1CCC(N)CC1,Ki,'=',12.5,nM,7.9,,246175,UO_0000065,18.27,0.36,4.26,7.07,0,CHEMBL3707982,Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1945559,,None,363.25,0,2.96,20,Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C1(CCNCC1)NC2=O,IC50,'=',240,nM,6.62,,,UO_0000065,18.22,0.38,3.66,9.48,0,CHEMBL1948023,Inhibition of PIM2 using ATP as substrate,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1944596,1,Scientific Literature,J Med Chem,2012,None,
CHEMBL2030375,,None,265.07,0,2.43,1,O=c1[nH]cnc2c1oc1ccc(Br)cc12,IC50,'=',2963,nM,5.53,,,UO_0000065,20.86,0.5,3.1,9.39,0,CHEMBL2038187,Inhibition of PIM2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034948,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL1782523,,None,362.18,0,3.91,31,O=C(O)c1cc2cc(Br)cc(OCCc3ccncc3)c2o1,IC50,'=',21100,nM,4.68,,,UO_0000065,12.91,0.29,0.77,6.44,0,CHEMBL1786238,Inhibition of human Pim2 using 5-FAM-RSRHSSYPAGT-CONH2 as substrate after 90 mins by off-chip mobility shift method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1781944,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL1789963,GW406108X,None,400.22,1,5.02,GW406108X,O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1,Inhibition,'=',2.1,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL384073,GSK-180736A,None,365.37,0,2.97,GSK180736A,CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1,Inhibition,'=',-0.16,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3651928,,None,442.44,0,4.5,BDBM106832,N[C@H]1CCC[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(O)cc3F)n2)C1,IC50,'=',4,nM,8.4,,225853,UO_0000065,18.98,0.36,3.9,8.3,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1794067,GSK-978744A,None,487.97,0,3.71,GSK978744A,C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl,Inhibition,'=',1.97,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL374060,GW439255X,None,325.41,0,4.53,GW439255X,Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1,Inhibition,'=',1.55,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3651933,,None,420.49,0,4.47,BDBM106837,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2cccc(-c3ccc(O)cc3F)n2)C1,IC50,'=',7,nM,8.15,,225858,UO_0000065,19.39,0.36,3.68,8.06,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3691943,,None,614.62,1,3.88,BDBM151965,COC(=O)N[C@@H]1[C@H](N)CN(c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(OC4CCOCC4)cc3F)n2)C[C@@H]1C,IC50,'=',1.09,nM,8.96,,292220,UO_0000065,14.58,0.28,5.08,6.36,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL517666,GW796921X,None,336.44,0,4.15,GW796921X,CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1,Inhibition,'=',0.38,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3676273,,None,433.46,0,3.61,BDBM131743,N[C@H]1C[C@H](F)CN(c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C1,IC50,'=',70,nM,7.16,,263976,UO_0000065,16.51,0.33,3.54,8.5,0,CHEMBL3706072,Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL466412,GSK-238063A,None,566.06,2,5.59,GSK238063A,CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1,Inhibition,'=',0.58,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1241010,,None,259.27,0,3.49,3h,N#Cc1ccc2[nH]c3c(ccc4c(C=O)c[nH]c43)c2c1,Activity,'=',101,%,,,,UO_0000187,,,,,0,CHEMBL1248949,Inhibition of human GST fused Pim2 expressed in Escherichia coli assessed as residual activity at 10 uM after 30 mins,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240519,1,Scientific Literature,Bioorg Med Chem,2010,None,
CHEMBL3687424,,None,454.45,0,4.22,BDBM151817,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)C1=O,IC50,'=',33.31,nM,7.48,,292073,UO_0000065,16.45,0.31,3.26,7.63,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL531804,GW301888X,None,395.47,0,4.3,GW301888X,CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1,Inhibition,'=',0.97,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1909411,,None,393.87,0,4.96,GI261520A,COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl,Inhibition,'=',-0.18,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1915639,,None,390.81,1,5.1,15m,Fc1ccc(Cl)cc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12,IC50,'=',12,nM,7.92,,,UO_0000065,20.27,0.39,2.82,9.98,0,CHEMBL1919424,Inhibition of PIM2 by millipore assay in the presence of 15 uM [ATP],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914433,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL1945558,,None,463.37,0,4.61,19,Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C1(CCN(C(=O)OC(C)(C)C)CC1)NC2=O,Delta Tm,'=',-0.2,degrees C,,,,UO_0000027,,,,,0,CHEMBL1947284,Binding affinity to PIM2 assessed as change in thermal denaturation at 10 uM by thermal stability shift assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1944596,1,Scientific Literature,J Med Chem,2012,None,
CHEMBL47940,,None,370.46,1,5.59,Lck_Inhibitor,Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1,Residual Activity,'=',106,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL605003,,None,371.46,0,2.64,SU6656,CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2,Residual Activity,'=',121,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL259551,,None,327.35,0,2.92,FR-180204,Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12,Residual Activity,'=',74,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3966072,,None,376.46,0,2.51,BDBM238512,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@@H]1CC[C@H](N)C1,IC50,'=',0.8,nM,9.1,,416250,UO_0000065,24.16,0.44,6.59,8.37,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL471901,,None,340.31,0,1.71,Syk_Inhibitor_II,NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1,Residual Activity,'=',60,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL311228,,None,346.82,0,2.63,52,CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21,Residual Activity,'=',93,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL266325,,None,346.39,0,4.59,D65476,CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1,Residual Activity,'=',98,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL306498,ALOISINE,None,281.36,0,3.98,Aloisine,CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12,Residual Activity,'=',104,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3976267,,None,400.49,0,2.9,BDBM248940,Cc1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CC(N)CCC3C)n2)n1,Ki,'=',0.109,nM,9.96,,434159,UO_0000065,24.88,0.45,7.06,10.1,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1909359,GW771127A,None,459.96,0,2.83,GW771127A,Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl,Inhibition,'=',-3.16,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL379787,,None,395.42,0,2.53,IRAK_1_4_Inhibitor,O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1,Residual Activity,'=',100,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2420901,,None,362.48,0,2.93,45,c1ccc(CC2CCC3(CCN(c4ncnc5[nH]cnc45)CC3)NC2)cc1,Inhibition,'=',13,%,,,,UO_0000187,,,,,0,CHEMBL2422098,Inhibition of PIM2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2417369,1,Scientific Literature,Bioorg Med Chem,2013,None,
CHEMBL2425156,,None,425.54,1,6.18,27,Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-c3cccnc3)cc2)cc1,Inhibition,'=',3,%,,,,UO_0000187,,,,,0,CHEMBL2429585,Inhibition of PIM-2 (unknown origin) at 1 uM by [33P]-ATP filter-binding assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2424535,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL3103886,,None,296.37,0,2.91,1g,Nc1cccc(C(=O)Nc2ccccc2N2CCCCC2)n1,Ki,'>',12500,nM,,,,UO_0000065,,,,,0,CHEMBL3106178,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3102815,1,Scientific Literature,ACS Med Chem Lett,2013,None,
CHEMBL3944889,,None,365.44,0,2.96,BDBM238801,CCN(c1nc2c(-c3cc4c([nH]3)[C@@H](C)NC4=O)cccc2c(=O)[nH]1)C(C)C,IC50,'=',1.54,nM,8.81,,416910,UO_0000065,24.11,0.45,5.85,9.39,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3891362,,None,353.4,0,3.44,BDBM238736,Cc1nc2ccc(F)c(-c3cc(C(N)=O)c(C)[nH]3)c2nc1NC1(C)CC1,IC50,'=',3.56,nM,8.45,,416845,UO_0000065,23.91,0.44,5.01,8.74,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3912094,,None,349.39,0,3.33,BDBM238741,Cc1nc2cccc(-c3cc4n(c3)C(=O)NC4=O)c2nc1NC(C)(C)C,IC50,'=',37.1,nM,7.43,,416850,UO_0000065,21.27,0.39,4.1,8.36,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3942186,,None,435.48,0,3.99,BDBM192574,C[C@@H]1C[C@H](N)CN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1,IC50,'=',0.2,nM,9.7,,344636,UO_0000065,22.27,0.41,5.71,11.5,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3896244,,None,435.48,0,3.99,BDBM192648,C[C@@H]1CCN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C[C@H]1N,IC50,'=',0.2,nM,9.7,,344696,UO_0000065,22.27,0.41,5.71,11.5,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3103874,,None,361.43,0,1.72,2d,CC(=O)Nc1nc(C(=O)Nc2cnc(N)nc2N2CCCCC2)cs1,Ki,'>',12500,nM,,,,UO_0000065,,,,,0,CHEMBL3106178,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3102815,1,Scientific Literature,ACS Med Chem Lett,2013,None,
CHEMBL3103870,,None,270.34,0,2.65,1h,O=C(Nc1ccccc1N1CCCCC1)c1ncc[nH]1,Ki,'>',12500,nM,,,,UO_0000065,,,,,0,CHEMBL3106178,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3102815,1,Scientific Literature,ACS Med Chem Lett,2013,None,
CHEMBL3103883,,None,297.36,0,2.3,1c,Nc1nccnc1C(=O)Nc1ccccc1N1CCCCC1,Ki,'=',7000,nM,5.16,,,UO_0000065,17.34,0.32,2.85,6.13,0,CHEMBL3106178,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3102815,1,Scientific Literature,ACS Med Chem Lett,2013,None,
CHEMBL3957082,,None,369.42,0,4.09,BDBM238393,O=C1NCCc2[nH]c(-c3cccc4ccc(OCc5ccccc5)nc34)cc21,IC50,'=',98.4,nM,7.01,,416172,UO_0000065,18.97,0.34,2.92,10.46,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1910902,,None,354.46,0,4.31,24,c1cncc(-c2ccc3[nH]cc(-c4ccc(N5CCNCC5)cc4)c3c2)c1,IC50,'=',15000,nM,4.82,,,UO_0000065,13.61,0.24,0.51,10.98,0,CHEMBL1912526,Inhibition of PIM2 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1909629,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL1289494,TIVOZANIB,4,454.87,1,5.64,Tivozanib,COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC,Residual Activity,'=',114,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3652642,,None,432.5,0,3.47,BDBM119402,CN1CCC(c2c(NC(=O)c3nc(-c4c(F)cccc4F)sc3N)cnn2C)CC1,Ki,'=',201,nM,6.7,,246169,UO_0000065,15.48,0.3,3.23,7.52,0,CHEMBL3707982,Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3915354,,None,420.91,0,3.51,BDBM192544,N[C@H]1CCCN(c2ccncc2Nc2ncc3ccc(-c4cccnc4Cl)nn23)C1,IC50,'=',77,nM,7.11,,344536,UO_0000065,16.9,0.32,3.6,7.31,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3948849,,None,420.47,0,4.8,BDBM192570,N[C@H]1CCC[C@@H](c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1,IC50,'=',27,nM,7.57,,344562,UO_0000065,18,0.33,2.77,9.33,1,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL188247,GW832467X,None,504.47,2,5.7,GW832467X,Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1,Inhibition,'=',1.63,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1794060,GW575533A,None,332.79,0,4.1,GW575533A,COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl,Inhibition,'=',1.11,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL2331664,,None,446.51,0,2.2,18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3979678,,None,365.44,0,2.94,17,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C)c(NC(C)(C)C)nc34)[nH]c21,Kd,'=',1.7,nM,8.77,,,UO_0000065,24,0.44,5.83,9.55,0,CHEMBL4478508,Binding affinity to human PIM2 (1 to 291 residues) expressed in bacterial system by KINOMEScan assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4477213,1,Scientific Literature,J Med Chem,2016,None,
CHEMBL3916248,,None,474.54,0,3.3,BDBM192610,CN(C)C(=O)c1ccc(F)c(-c2ccc3cnc(Nc4cnccc4N4CCC[C@H](N)C4)n3n2)c1,IC50,'=',5.3,nM,8.28,,344685,UO_0000065,17.44,0.32,4.98,7.91,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2376648,,None,547.42,1,4.28,X-396,C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3929257,,None,412.45,0,4.42,BDBM238419,COC(=O)N(c1ccccc1)c1ccc2cccc(-c3cc4c([nH]3)CCNC4=O)c2n1,IC50,'=',125,nM,6.9,,416194,UO_0000065,16.74,0.3,2.48,7.91,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL243907,GW673715X,None,445.48,1,5.74,GW673715X,CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1,Inhibition,'=',-0.87,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL384407,GW616030X,None,620.11,2,6.38,GW616030X,CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,Inhibition,'=',-3.72,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3899758,,None,390.37,0,4.07,BDBM238768,Cc1nc2cccc(-c3cc4c([nH]3)[C@@H](C)NC4=O)c2nc1O[C@H](C)C(F)(F)F,IC50,'=',32.5,nM,7.49,,416877,UO_0000065,19.18,0.37,3.42,9.37,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3942256,,None,349.39,0,4.11,BDBM225072,CNc1nnc(-c2ccc3[nH]cc(-c4cccc(OC(C)C)n4)c3c2)o1,IC50,'=',19.58,nM,7.71,,393065,UO_0000065,22.06,0.4,3.6,8.67,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3931494,,None,408.49,0,4.05,BDBM225009,CC(C)Nc1nnc(-c2ccc3[nH]cc(-c4ncc(C(=O)NC5CC5)s4)c3c2)o1,IC50,'=',705,nM,6.15,,393298,UO_0000065,15.06,0.29,2.1,5.66,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4526351,BAY-309,None,519.5,2,7.41,EUB0000703,Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1,% Control,,100,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507270,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL4436748,SR-318,None,459.59,0,4.47,EUB0000132,Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1,% Control,,100,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507315,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 100.0 nM
CHEMBL282342,,None,335.46,0,3.51,12,CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1,Activity,,,,,,Not Evaluated,,,,,,0,CHEMBL982757,Binding affinity to human PIM2 at 10 uM relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1151712,1,Scientific Literature,J Med Chem,2008,None,
CHEMBL97453,WEDELOLACTONE,None,314.25,0,2.82,K00058,COc1cc(O)c2c(c1)oc(=O)c1c3cc(O)c(O)cc3oc21,Thermal melting change,'=',2.2,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL3958651,,None,346.43,0,3.87,BDBM238451,O=C1NCCc2[nH]c(-c3cccc4ccc(NC5CCCC5)nc34)cc21,IC50,'=',19,nM,7.72,,416195,UO_0000065,22.29,0.41,3.85,11.06,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1794068,GSK-326090A,None,558.63,2,6.07,GSK326090A,C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F,Inhibition,'=',0.26,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3943301,,None,350.43,0,2.7,BDBM238625,CC(C)(C)Nc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2nc1N,IC50,'=',4.9,nM,8.31,,416731,UO_0000065,23.71,0.44,5.61,7.64,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3687441,,None,497.52,0,4.16,BDBM151836,CC(=O)N[C@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H]1C,IC50,'=',72.8,nM,7.14,,292092,UO_0000065,14.35,0.27,2.98,6.49,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3687488,,None,562.61,1,4.08,BDBM151884,C[C@@H]1C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@H](N)[C@@H]1OCCS(C)(=O)=O,IC50,'=',1100,nM,5.96,,292140,UO_0000065,10.59,0.21,1.88,4.79,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3935312,,None,363.42,0,2.67,BDBM238698,Cc1nc2cccc(-c3cc4c([nH]3)[C@H](CO)NC4=O)c2nc1NC1(C)CC1,IC50,'=',1.82,nM,8.74,,416807,UO_0000065,24.05,0.44,6.07,8.49,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3676269,,None,445.5,0,2.88,BDBM131739,NC1CC(CO)CN(c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C1,IC50,'=',58,nM,7.24,,263972,UO_0000065,16.24,0.32,4.36,6.93,0,CHEMBL3706072,Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1981079,,None,331.74,0,2.61,SID103904988,NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1F,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1980489,,None,313.74,0,2.69,SID103904952,O=c1c(NCc2ccc(Cl)cc2)c(Nc2ccncc2)c1=O,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1968127,,None,408.48,0,4.19,SID103904424,CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1993243,,None,353.4,0,3.03,SID103905095,CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4c(c3)OCO4)csc12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3923254,,None,379.42,0,2.19,BDBM238507,COC(=O)[C@@H](C)Nc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2nc1C,IC50,'=',74.1,nM,7.13,,416244,UO_0000065,18.79,0.35,4.94,6.54,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1910910,,None,378.41,0,3.13,32,C[C@H](N)COc1cncc(-c2ccc3[nH]cc(-c4ccc(N)nc4F)c3c2)n1,IC50,'=',56,nM,7.25,,,UO_0000065,19.16,0.35,4.12,6.27,0,CHEMBL1912526,Inhibition of PIM2 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1909629,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL1910914,,None,440.48,0,4.49,36,Nc1ccc(-c2c[nH]c3ccc(-c4cncc(OC[C@@H](N)c5ccccc5)n4)cc23)c(F)n1,IC50,'=',10,nM,8,,,UO_0000065,18.16,0.33,3.51,6.91,0,CHEMBL1912526,Inhibition of PIM2 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1909629,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL1915428,,None,302.34,0,3.14,14a,c1cc(-c2nnc[nH]2)c2nc(NC3CC3)c3ccncc3c2c1,IC50,'=',8,nM,8.1,,,UO_0000065,26.78,0.48,4.96,10.2,0,CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914433,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL1915429,,None,316.37,0,3.53,14b,c1cc(-c2nnc[nH]2)c2nc(NC3CCC3)c3ccncc3c2c1,IC50,'=',20,nM,7.7,,,UO_0000065,24.34,0.44,4.17,9.7,0,CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914433,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL1915431,,None,306.33,0,1.97,14d,OCCNc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12,IC50,'=',55,nM,7.26,,,UO_0000065,23.7,0.43,5.29,7.29,0,CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914433,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL1915641,,None,469.52,0,4.93,15o,Fc1cc(OCCN2CCCC2)ccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12,IC50,'=',28,nM,7.55,,,UO_0000065,16.09,0.29,2.62,8.22,0,CHEMBL1919424,Inhibition of PIM2 by millipore assay in the presence of 15 uM [ATP],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914433,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL1910904,,None,354.46,0,4.31,26,c1ccc(-c2ccc3[nH]cc(-c4ccc(N5CCNCC5)cc4)c3c2)nc1,IC50,'>',25000,nM,,,,UO_0000065,,,,,0,CHEMBL1912526,Inhibition of PIM2 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1909629,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL3905194,,None,435.48,0,4.13,BDBM192586,C[C@@H]1[C@@H](N)CCCN1c1ccncc1Nc1ncc2ccc(-c3c(F)cccc3F)nn12,IC50,'=',0.3,nM,9.52,,344653,UO_0000065,21.87,0.41,5.39,11.29,1,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3676285,,None,430.48,0,3.25,8,Nc1sc(-c2c(F)cccc2F)nc1C(=O)Nc1cnccc1N1CCC[C@H](N)C1,Ki,'=',0.05,nM,10.3,,,UO_0000065,23.93,0.47,7.05,9.35,0,CHEMBL4317000,Inhibition of recombinant human PIM2 using FAM-pimtide as substrate after 90 mins by Z-LYTE assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4316591,1,Scientific Literature,J Med Chem,2019,None,
CHEMBL3940639,,None,362.43,0,2.65,BDBM238462,O=C1NCCc2[nH]c(-c3cccc4ccc(O[C@@H]5CCCNC5)nc34)cc21,IC50,'=',340,nM,6.47,,416206,UO_0000065,17.85,0.33,3.82,8.18,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4109810,,None,438.44,0,2.75,BDBM192626,O[C@@H]1CCN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C[C@H]1O,IC50,'=',8.8,nM,8.06,,344634,UO_0000065,18.37,0.34,5.31,8.15,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3949174,,None,391.48,0,2.93,BDBM238560,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@H]1CC[C@H](O)CC1,IC50,'=',4,nM,8.4,,416682,UO_0000065,21.45,0.4,5.47,8.16,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3946152,,None,377.45,0,2.87,BDBM238772,Cn1c(NC(C)(C)C)nc2c(-c3cc4c([nH]3)C3(CC3)NC4=O)cccc2c1=O,IC50,'=',0.407,nM,9.39,,416881,UO_0000065,24.88,0.46,6.52,10.23,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4745141,,None,338.81,0,2.61,30,Cc1cn([C@H](C)[C@@H]2CCNC[C@H]2F)c2nc(C(N)=O)cc(Cl)c12,IC50,'=',3,nM,8.52,,,UO_0000065,25.16,0.51,5.91,11.68,0,CHEMBL4704282,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4699590,1,Scientific Literature,Bioorg Med Chem Lett,2020,None,
CHEMBL3899655,,None,435.48,0,4,BDBM192631,CC1CN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C(C)CN1,IC50,'=',105,nM,6.98,,344651,UO_0000065,16.03,0.3,2.98,9.92,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL331237,TRICIRIBINE,None,320.31,0,-1.89,API_2,CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23,Residual Activity,'=',89,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL258805,SU-9516,1,241.25,0,1.91,SU9516,COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2,Residual Activity,'=',69,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL13868,,None,507.57,2,6.66,SB-245392,Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1,Inhibition,'=',-0.39,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL210833,,None,360.44,0,3,Flt_3_inhibitor,COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC,Residual Activity,'=',87,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1236107,SGX-523,1,359.42,0,3.22,SGX-523,Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL17331,PD-169316,None,360.35,0,4.85,PD-169316,O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,Residual Activity,'=',127,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1096290,GSK-1000163A,None,395.47,0,1.8,GSK1000163A,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21,Inhibition,'=',0.26,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL4757567,,None,482.55,0,4.61,OX0999,CN1CCC(CNC2=NC(=O)/C(=C/c3csc(-c4ccc(OC(F)(F)F)cc4)n3)S2)CC1,Activity,,,,,,Not Determined,,,,,,0,CHEMBL4687864,Inhibition of human PIM2 assessed as residual activity at 10 uM relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4680285,1,Scientific Literature,Bioorg Med Chem,2020,None,Dose = 10.0 microM
CHEMBL583481,,None,378.35,1,6.3,34,O=Cc1c[nH]c2c1ccc1c3cc(-c4ccc(C(F)(F)F)cc4)ccc3[nH]c12,Activity,'=',49,%,,,,UO_0000187,,,,,0,CHEMBL1051392,Inhibition of Pim-2 assessed as residual enzyme activity at 1 uM relative to untreated control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154186,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL1915438,,None,372.82,0,4.97,14k,Clc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12,IC50,'=',6,nM,8.22,,,UO_0000065,22.05,0.42,3.25,10.36,0,CHEMBL1919424,Inhibition of PIM2 by millipore assay in the presence of 15 uM [ATP],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914433,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL1915644,,None,362.82,0,4.54,17b,CNC(=O)c1cccc2c1nc(Nc1ccccc1Cl)c1ccncc12,IC50,'=',5,nM,8.3,,,UO_0000065,22.88,0.44,3.76,12.41,0,CHEMBL1919424,Inhibition of PIM2 by millipore assay in the presence of 15 uM [ATP],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914433,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL3940277,,None,392.49,0,3.63,BDBM224948,CNc1nnc(-c2ccc3[nH]cc(-c4cccc(N5CCOCC5)n4)c3c2)s1,IC50,'=',91.9,nM,7.04,,393237,UO_0000065,17.93,0.34,3.41,8.91,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3943596,,None,441.54,0,2.99,BDBM224949,CS(=O)(=O)c1nnc(-c2ccc3[nH]cc(-c4cccc(N5CCOCC5)n4)c3c2)s1,IC50,'=',8780,nM,5.06,,393238,UO_0000065,11.45,0.23,2.07,5,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL491473,CEDIRANIB,3,450.51,1,5.22,Cediranib,COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3969942,,None,374.45,0,4.76,BDBM225085,CC(C)(C)Nc1nnc(-c2ccc3[nH]cc(-c4nccc(C5CC5)n4)c3c2)o1,IC50,'=',2.395,nM,8.62,,393078,UO_0000065,23.02,0.42,3.86,9.32,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3890953,,None,382.43,0,1.66,BDBM249084,C#Cc1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CCNCC3)n2)n1,Ki,'=',1.72,nM,8.76,,434288,UO_0000065,22.92,0.41,7.1,10.35,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3933088,,None,399.46,0,3.18,BDBM238661,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC(C)c1ccncn1,IC50,'=',62.7,nM,7.2,,416770,UO_0000065,18.03,0.33,4.02,6.64,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3918384,,None,388.44,0,1.67,BDBM249058,Cc1cncc(-c2cc3c(cn2)cnn3-c2ccc(=O)n([C@H]3CCCNC3)n2)n1,Ki,'=',43.2,nM,7.37,,434263,UO_0000065,18.96,0.35,5.69,7.12,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3948083,,None,376.46,0,2.1,BDBM238567,CC1(C)CN(c2cnc3cccc(-c4cc5c([nH]4)CCNC5=O)c3n2)CCN1,IC50,'=',58,nM,7.24,,416689,UO_0000065,19.22,0.35,5.14,8.42,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1971017,,None,272.3,0,3.2,SID103905042,NC(=O)c1cc2c(-c3cccc(F)c3)cncc2s1,Ki,'=',794.33,nM,6.1,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1682546,,None,306.39,0,4.3,SID103904545,c1ccc(CNc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1966524,,None,400.51,0,4.79,SID103904752,NC(COc1cncc(-c2cc3ccncc3s2)c1)Cc1c[nH]c2ccccc12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3651944,,None,426.44,0,4.8,BDBM106848,N[C@H]1CCC[C@@H](c2ccncc2NC(=O)c2cccc(-c3cc(F)cc(F)c3F)n2)C1,IC50,'=',76,nM,7.12,,225869,UO_0000065,16.69,0.31,2.32,8.8,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3651946,,None,456.47,0,4.01,BDBM106850,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@@H]1O,IC50,'=',3,nM,8.52,,225871,UO_0000065,18.67,0.35,4.51,8.43,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2002726,,None,358.45,0,3.88,SID103904468,Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccccc4)c3)cc12,Ki,'=',79.43,nM,7.1,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1915437,,None,372.82,0,4.97,14j,Clc1ccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3cnccc23)cc1,IC50,'=',21,nM,7.68,,,UO_0000065,20.59,0.39,2.71,9.67,0,CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914433,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL1915438,,None,372.82,0,4.97,14k,Clc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12,IC50,'=',6,nM,8.22,,,UO_0000065,22.05,0.42,3.25,10.36,0,CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914433,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL1915446,,None,450.91,0,4.37,15c,CS(=O)(=O)c1ccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3cnccc23)c(Cl)c1,IC50,'=',44,nM,7.36,,,UO_0000065,16.31,0.32,2.99,6.48,0,CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914433,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL243088,,None,322.32,0,3.37,SID103904594,O=C(O)c1ccccc1Nc1ccnc(Nc2cccc(O)c2)n1,Ki,'=',316.23,nM,6.5,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2005528,,None,258.28,0,1.63,SID103905407,CCOC(=O)c1ccc2[nH]c3c(c2c1)CCNC3=O,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1990288,,None,399.43,1,5.36,SID103904410,CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1997349,,None,476.32,1,5.49,SID103905298,CC1=NN(c2ccc(Cl)c(Cl)c2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O,Ki,'=',398.11,nM,6.4,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1969506,,None,497.53,0,2.42,SID103905267,CC(C)(C)OC(=O)n1ncc2cc(Nc3c(NCc4ccc(S(N)(=O)=O)cc4)c(=O)c3=O)ccc21,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1682552,,None,332.41,0,4.02,SID103904509,c1cnc2nc(-c3ccc4[nH]ncc4c3)c(NC3CCCCC3)n2c1,Ki,'>',794.33,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1999428,,None,302.38,0,4.24,SID103904562,CC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3394070,,None,390.52,1,5.08,BDBM50061614,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(NC5CCCCC5)n4)c3c2)s1,IC50,'=',226.69,nM,6.64,,393228,UO_0000065,17.01,0.32,1.56,7.18,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1825138,,None,450.35,1,5.04,SID103905245,CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1236126,,None,440.46,0,3.53,SID103905081,CC(C)(C)C(=O)Oc1ccc2c(c1)nc(NC(=O)c1cccc([N+](=O)[O-])c1)n2CCCO,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3660085,,None,395.41,0,3.55,BDBM104213,Fc1cc(OC2CCNCCC2F)c2nc(-c3nnc4ccccn34)ccc2c1,IC50,'=',39,nM,7.41,,222625,UO_0000065,18.74,0.35,3.86,11.52,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL4869634,,None,486.55,0,4.41,21o,CC(C)Oc1cc(F)ccc1Nc1ncnc2ccc(-c3ccc(C(=O)N4CCNCC4)cc3)nc12,IC50,'=',232,nM,6.63,,,UO_0000065,13.64,0.25,2.22,7.19,0,CHEMBL4828265,Inhibition of recombinant human Pim2 (2 to end residues) using RSRHSSYPAGT as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4825757,1,Scientific Literature,J Med Chem,2021,None,TIME = 0.6667 hr
CHEMBL3660068,,None,375.43,0,2.44,BDBM104195,OC1(COc2cccc3ccc(-c4nnc5ccccn45)nc23)CCNCC1,IC50,'=',588,nM,6.23,,222608,UO_0000065,16.6,0.3,3.79,7.37,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3660096,,None,395.41,0,3.55,BDBM104229,Fc1cc(OCC2(F)CCNCC2)c2nc(-c3nnc4ccccn34)ccc2c1,IC50,'=',25.4,nM,7.59,,222640,UO_0000065,19.21,0.36,4.05,11.8,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL1910909,,None,403.47,0,3.34,31,Nc1ccc(-c2c[nH]c3ccc(-c4cncc(N5CCCC(N)C5)n4)cc23)c(F)n1,IC50,'=',81,nM,7.09,,,UO_0000065,17.58,0.32,3.75,6.46,0,CHEMBL1912526,Inhibition of PIM2 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1909629,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL1910906,,None,305.32,0,3.41,28,Nc1ccc(-c2c[nH]c3ccc(-c4cnccn4)cc23)c(F)n1,IC50,'=',5000,nM,5.3,,,UO_0000065,17.36,0.31,1.89,6.59,0,CHEMBL1912526,Inhibition of PIM2 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1909629,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL53753,,None,330.19,0,3.57,PD-158780,CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1,Residual Activity,'=',86,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3660088,,None,363.4,0,3.02,BDBM104217,FC1CNCCC1Oc1cccc2ccc(-c3nnc4ccccn34)nc12,IC50,'=',1000,nM,6,,222630,UO_0000065,16.51,0.3,2.98,9.33,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL366266,,None,411.47,0,3.41,PKC_beta_inhibitor,O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1,Residual Activity,'=',77,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL304428,,None,393.4,0,4.61,SB-218078,O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1,Residual Activity,'=',6,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3660057,,None,381.39,0,3.16,BDBM104183,Fc1ccn2c(-c3ccc4cccc(OC5CCNCC5F)c4n3)nnc2c1,IC50,'=',1760,nM,5.75,,222596,UO_0000065,15.09,0.28,2.59,8.94,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3660050,,None,359.43,0,3.47,BDBM104175,c1cc(OC2CCCNCC2)c2nc(-c3nnc4ccccn34)ccc2c1,IC50,'=',110,nM,6.96,,222589,UO_0000065,19.36,0.35,3.49,10.82,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL124660,TANDUTINIB,2,562.72,2,5.03,MLN-518,COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1,Kd,'>',10000,nM,,,,UO_0000065,,,,,1,CHEMBL1061184,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150977,1,Scientific Literature,Nat Biotechnol,2008,None,
CHEMBL3986937,,None,434.54,0,2.74,BDBM238773,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC(C)(C)CN1CCOCC1,IC50,'=',134,nM,6.87,,416882,UO_0000065,15.82,0.29,4.13,7.22,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3929264,,None,402.51,0,3.06,BDBM248915,CC(C)n1cc(-c2cc3c(cn2)cnn3-c2cccc(N3CCCNCC3)n2)cn1,Ki,'=',7.81,nM,8.11,,434122,UO_0000065,20.14,0.37,5.05,10.57,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1094408,NMS-1286937,None,448.53,0,1.58,NMS-1286937,COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL1950228,,None,288.35,0,4.36,4,O=Cc1cn2c3c1ccc1c4ccccc4n(c13)CCCC2,Activity,'=',6,%,,,,UO_0000187,,,,,0,CHEMBL1955501,Inhibition of human recombinant PIM2 expressed in Escherichia coli assessed as residual activity using RSRHSSYPAGT as substrate at 10 uM after 30 mins,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1949527,1,Scientific Literature,Eur J Med Chem,2012,None,
CHEMBL1950230,,None,387.44,0,3.65,11,O=Cc1c[nH]c2c1ccc1c3ccccc3n(CCCCn3cc(CO)nn3)c12,IC50,,,,,,Not Determined,,,,,,0,CHEMBL1955504,Inhibition of human recombinant PIM2 expressed in Escherichia coli using RSRHSSYPAGT as substrate after 30 mins,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1949527,1,Scientific Literature,Eur J Med Chem,2012,None,
CHEMBL1624529,,None,416.36,0,1.89,SID103905367,NC1C2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)CC12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1980391,RG-1530,1,356.79,0,4.75,SID103905607,COc1cc2c(cc1F)C(c1ccccc1Cl)=Nc1c(n[nH]c1C)N2,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1991640,,None,399.42,0,4.13,SID103905583,O=c1[nH]sc2c1c(=O)c1cc(F)c(NCc3ccccc3)c(F)c1n2C1CC1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1970203,,None,432.51,0,4.79,SID103904353,Cc1cc(C)cc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3961921,,None,524.69,1,3.45,BDBM182824,CN(C)C1CCN(C[C@@H](NC(=O)C[C@H]2CNC(=O)c3cc(-c4ccnc(F)c4)cn32)C2CCCCC2)CC1,IC50,'=',57,nM,7.24,,330370,UO_0000065,13.81,0.26,3.79,8.78,0,CHEMBL3887311,Kinase Inhibition Assay: Method for PIM2 Kinase Inhibition Assay: Dowex Technique i. Kinase Buffer (KB)The buffer for PIM2 assay was composed of HEPES 50 mM,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1981047,,None,474.57,0,2.64,SID103905608,COC(C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3393694,,None,406.44,0,3.76,13c,Fc1cccc(F)c1-c1ccc2[nH]nc(-c3cncc(N4CCCNCC4)n3)c2c1,IC50,'=',59,nM,7.23,,,UO_0000065,17.79,0.33,3.47,10.37,0,CHEMBL3396420,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as phosphorylation of biotinylated-BAD peptide at Serine 112 residue,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3392976,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL3940808,,None,363.47,0,3.68,BDBM238517,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NCC(C)(C)C,IC50,'=',1.4,nM,8.85,,416254,UO_0000065,24.36,0.45,5.17,10.71,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2048870,,None,375.49,0,2.97,26,CC(C)COc1cccc(/C=C2\SC(=O)NC2=O)c1N1CCC[C@@H](N)C1,IC50,'=',140,nM,6.85,,,UO_0000065,18.25,0.36,3.88,8.1,0,CHEMBL2049743,Inhibition of human PIM2 using FITC-(AHX)RSRHSSYPAGT-COOH as substrate after 90 mins by mobility shift assay in presence of 5 mM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2046384,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL3393705,,None,435.48,0,4.73,13n,CC1(C)CCNCC1Oc1cncc(-c2n[nH]c3ccc(-c4c(F)cccc4F)cc23)n1,IC50,'=',16,nM,7.8,,,UO_0000065,17.9,0.33,3.07,10.3,0,CHEMBL3396420,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as phosphorylation of biotinylated-BAD peptide at Serine 112 residue,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3392976,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL1950229,,None,331.38,1,5.18,7,[N-]=[N+]=NCCCCn1c2ccccc2c2ccc3c(C=O)c[nH]c3c21,Activity,'=',22,%,,,,UO_0000187,,,,,0,CHEMBL1955501,Inhibition of human recombinant PIM2 expressed in Escherichia coli assessed as residual activity using RSRHSSYPAGT as substrate at 10 uM after 30 mins,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1949527,1,Scientific Literature,Eur J Med Chem,2012,None,
CHEMBL408564,,None,347.17,0,3.33,SB-739452,O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1,Inhibition,'=',-0.2,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1967878,CENISERTIB,1,451.55,0,2.51,SID103904402,Cc1cc(Nc2ncc(F)c(NC3C4C=CC(C4)C3C(N)=O)n2)ccc1N1CCN(C)CC1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3814423,,None,296.33,0,4.83,3,c1ccc2c(c1)[nH]c1c3[nH]c4ccccc4c3c3[nH]ncc3c21,IC50,'=',590,nM,6.23,,,UO_0000065,21.02,0.37,1.4,10.34,0,CHEMBL3815561,Inhibition of human full length GST-tagged Pim-2 expressed in Escherichia coli using RSRHSSYPAGT as substrate measured for 30 mins by [gamma-33P]ATP-based kinase assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3813662,1,Scientific Literature,Bioorg Med Chem,2016,None,
CHEMBL3105021,,None,472.47,0,2.54,5b,C[C@H]1CN(c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)c(F)cc2N)C[C@@H](N)[C@@H]1O,Ki,'=',0.002,nM,,Outside typical range,,UO_0000065,,,,,0,CHEMBL3106178,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3102815,1,Scientific Literature,ACS Med Chem Lett,2013,None,
CHEMBL3103879,,None,370.42,0,-0.3,3d,NCCC(=O)N1CCN(c2ccncc2NC(=O)c2nccnc2N)CC1,Ki,'=',680,nM,6.17,,,UO_0000065,16.65,0.31,6.47,4.3,0,CHEMBL3106178,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3102815,1,Scientific Literature,ACS Med Chem Lett,2013,None,
CHEMBL3932794,,None,375.44,0,3.64,BDBM225041,CC1CCCCN1c1ccnc(-c2c[nH]c3ccc(-c4nnc(N)o4)cc23)n1,IC50,'=',2.186,nM,8.66,,393027,UO_0000065,23.07,0.42,5.02,7.89,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3991931,,None,456.51,0,3.31,ONO-4059-analogue,C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL939,GEFITINIB,4,446.91,0,4.28,Gefitinib,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL288441,BOSUTINIB,4,530.46,2,5.19,Bosutinib,COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3984537,,None,278.28,0,2.26,BDBM224834,Nc1nnc(-c2ccc3[nH]cc(-c4ncccn4)c3c2)o1,IC50,'=',110.99,nM,6.96,,393116,UO_0000065,24.99,0.45,4.69,6.53,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3985673,,None,377.43,0,2.85,BDBM224934,Nc1nnc(-c2ccc3[nH]cc(-c4cnc(N5CCCC5=O)cn4)c3c2)s1,IC50,'=',1042.57,nM,5.98,,393217,UO_0000065,15.85,0.3,3.13,5.26,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1967720,,None,529.6,2,5.41,SID103904341,CC(C)(C(N)=O)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1984633,,None,339.42,0,3.7,SID103904908,COc1cccc(C(C)NC(=O)c2cnc(-c3ccncc3)s2)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2006715,,None,607.65,2,6.92,SID103904419,O=C(Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1)c1c(F)cccc1F,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1990904,,None,360.4,0,3.81,SID103904763,Fc1ccc(-c2nc3cnccn3c2-c2ccnc(NCC3CC3)n2)cc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3918394,,None,372.36,0,4.06,BDBM225045,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(-c5ccc(F)cc5)n4)c3c2)o1,IC50,'=',42.48,nM,7.37,,393031,UO_0000065,19.8,0.36,3.31,6.92,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2035618,,None,371.19,0,4.11,5a,COc1ccccc1-c1nc2c(oc3ccc(Br)cc32)c(=O)[nH]1,IC50,'>',5000,nM,,,,UO_0000065,,,,,0,CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034948,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL3914110,,None,486.5,0,3.06,BDBM249033,COC1(C)CNCCN(c2cccc(-n3ncc4cnc(-c5cnn(CC(F)(F)F)c5)cc43)n2)C1,Ki,'=',58.2,nM,7.24,,434237,UO_0000065,14.87,0.28,4.18,8.42,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL296586,KENPAULLONE,None,327.18,0,4.09,SID103905487,O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2218929,,None,287.32,0,3.57,JAK3_Inhibitor_VI,O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1,Residual Activity,'=',13,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL573339,PI-103,None,348.36,0,2.98,PI_103,Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1,Residual Activity,'=',102,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3963283,,None,418.48,0,3.39,BDBM192645,C[C@@H]1CC[C@H](N)CN1c1ccncc1Nc1ncc2ccc(-c3ncccc3F)nn12,IC50,'=',136,nM,6.87,,344692,UO_0000065,16.41,0.3,3.48,7.06,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL382590,ANILINOQUINAZOLINE1,None,400.44,0,4.64,Aurora_Kinase_Inhibitor_II,COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC,Residual Activity,'=',85,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL406375,,None,234.26,0,3.98,GTP_14564,c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1,Residual Activity,'=',83,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1981725,,None,612.71,2,6.74,SID103904418,CCN1CCN(c2ccc(Nc3nccc(-c4c(-c5cccc(C(=O)Nc6ccccc6F)c5)nc5ccccn45)n3)cc2)CC1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1984206,,None,297.32,0,1.26,SID103905186,CCOc1nc(C(=O)NCc2ccncc2)cc(N)c1C#N,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1082440,,None,319.43,0,1.92,SID103905676,Cc1cncc2cccc(S(=O)(=O)N3CCCNCC3C)c12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3959074,,None,369.42,0,4.62,BDBM238416,Cc1cccc(Oc2ccc3cccc(-c4cc5c([nH]4)CCNC5=O)c3n2)c1,IC50,'=',47.8,nM,7.32,,416191,UO_0000065,19.82,0.36,2.7,10.92,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3902525,,None,382.47,1,5.21,BDBM238399,CCC1CNC(=O)c2cc(-c3cccc4ccc(Nc5ccccc5)nc34)[nH]c21,IC50,'=',2.4,nM,8.62,,416176,UO_0000065,22.54,0.41,3.41,12.35,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3933369,,None,368.44,0,4.82,BDBM238403,CC1CNC(=O)c2cc(-c3cccc4ccc(Nc5ccccc5)nc34)[nH]c21,IC50,'=',2.4,nM,8.62,,416180,UO_0000065,23.4,0.42,3.8,12.35,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3394169,,None,391.5,1,5.04,29,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(OC5CCCCC5)n4)c3c2)s1,IC50,'>',31600,nM,,,,UO_0000065,,,,,0,CHEMBL3395662,Inhibition of PIM2 in human U2OS cells assessed as phosphorylation of BAD,B,BAO_0000219,cell-based format,Homo sapiens,None,None,U2OS,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3393014,1,Scientific Literature,Bioorg Med Chem Lett,2015,CHEMBL3307757,
CHEMBL573339,PI-103,None,348.36,0,2.98,PI-103,Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1,Activity,'=',106,%,,,,UO_0000187,,,,,0,CHEMBL1061086,Percentage PIM2 activity remaining in the presence of 1uM inhibitor,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL2377722,,None,276.34,0,3.86,21,CCc1[nH]c2c(N)cc3cn[nH]c3c2c1-c1ccccc1,Inhibition,'=',75,%,,,,UO_0000187,,,,,0,CHEMBL2378599,Inhibition of human full length Pim-2 using RSRHSSYPAGT as substrate assessed as residual activity at 10 uM after 30 mins in presence of [gamma-33P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2375344,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL3970651,,None,454.37,0,4.77,BDBM192549,N[C@H]1CCCN(c2ccncc2Nc2ncc3ccc(-c4ccc(Cl)cc4Cl)nn23)C1,IC50,'=',11,nM,7.96,,344541,UO_0000065,17.52,0.35,3.19,9.43,1,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3890648,,None,335.41,0,3.04,BDBM238546,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC(C)C,IC50,'=',4.9,nM,8.31,,416269,UO_0000065,24.78,0.45,5.27,10.05,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3660090,,None,391.45,0,3.72,BDBM104222,Cc1ccc2nnc(-c3ccc4cccc(OC5CCNCCC5F)c4n3)n2c1,IC50,'=',351.9,nM,6.45,,222634,UO_0000065,16.49,0.3,2.73,10.03,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL4637411,,None,428.66,1,7.2,14,CN(C)[C@@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)C(c4ccc5ccncc5c4)=CC[C@@H]32)C1,Inhibition,'>',80,%,,,,UO_0000187,,,,,0,CHEMBL4620284,Inhibition of biotinylated ligand binding to wild-type human partial length PIM2 (M1 to E291 residues) expressed in bacterial expression system at 50 nM measured after 1 hr by kinomescan assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4619723,1,Scientific Literature,Bioorg Med Chem,2020,None,
CHEMBL3943763,,None,365.41,0,3.84,BDBM238716,Cc1nc2ccc(F)c(-c3cc4c([nH]3)[C@H](C)NC4=O)c2nc1NC1(C)CC1,IC50,'=',0.385,nM,9.41,,416825,UO_0000065,25.76,0.48,5.57,11.38,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3942637,,None,364.45,0,3.64,BDBM238522,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1OCC(C)(C)C,IC50,'=',44.7,nM,7.35,,416666,UO_0000065,20.17,0.37,3.71,9.2,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3926513,,None,368.44,0,4.19,BDBM238745,Cc1ccccc1-c1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2nc1C,IC50,'=',127,nM,6.9,,416854,UO_0000065,18.72,0.34,2.71,9.76,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1242373,,None,401.5,0,4.99,SID103904348,Cc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1,Ki,'=',501.19,nM,6.3,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2001239,,None,438.8,0,3.4,SID103905496,Nc1ncnc(Nc2cc(CNC(=O)C(F)(F)F)c(O)c(-c3ccc(Cl)cc3)c2)n1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL373073,GW642138X,None,241.25,0,2.48,GW642138X,COc1ccc(-c2cc3c(N)ncnc3o2)cc1,Inhibition,'=',0.27,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL235658,,None,349.41,1,5.16,MK2a_Inhibitor,O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1,Residual Activity,'=',139,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1966514,,None,444.49,1,6.59,SID103904285,Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2430324,,None,294.31,0,3.07,MRT00055778,CC(=O)Nc1nccc(-c2c(-c3ccccc3)noc2C)n1,Activity,'=',118.72,%,,,,UO_0000187,,,,,0,CHEMBL2433455,Inhibition of human PIM2 assessed as residual activity at 1 uM relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2429821,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL1992796,,None,399.88,1,5.29,SID103905482,O=c1[nH]c2ccc(Cl)cc2c(-c2ccccc2)c1C1=NNC(c2ccccc2)C1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL583042,,None,500.36,2,5.43,11e,Cc1cnc(Nc2ccc(F)cc2Cl)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(Cl)c2)c1,Inhibition,'=',3,%,,,,UO_0000187,,,,,0,CHEMBL1041404,Inhibition of PIM2 at 1 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154622,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL407391,DIMETHYLADENINE,None,163.18,0,0.42,K00055,CN(C)c1ncnc2nc[nH]c12,Thermal melting change,'=',0.3,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL2017346,,None,361.41,1,5.12,13l,Fc1cccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3sccc23)c1,IC50,'=',5,nM,8.3,,,UO_0000065,22.97,0.44,3.18,12.48,0,CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016532,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL1974702,,None,330.59,0,4.13,SID103905310,Cc1nc2c(sc3c(Br)ccc(Cl)c32)c(=O)o1,Ki,'=',199.53,nM,6.7,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2017343,,None,407.89,1,5.64,13j,COc1cccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3sccc23)c1Cl,IC50,'=',21,nM,7.68,,,UO_0000065,18.82,0.37,2.04,10.14,0,CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016532,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL1986597,,None,505.56,1,2.6,SID103904690,NC(=O)c1cccc2[nH]c(-c3ccc(NC(=O)c4cccc(S(=O)(=O)N5CCOCC5)c4)cc3)nc12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1240920,,None,303.15,0,4.92,3a,O=Cc1c[nH]c2c1ccc1c2[nH]c2cc(Cl)cc(Cl)c21,Activity,'=',34,%,,,,UO_0000187,,,,,0,CHEMBL1248949,Inhibition of human GST fused Pim2 expressed in Escherichia coli assessed as residual activity at 10 uM after 30 mins,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240519,1,Scientific Literature,Bioorg Med Chem,2010,None,
CHEMBL2089000,,None,264.28,0,3.59,27,COC(=O)c1cc2c3ccccc3[nH]c2c2[nH]ccc12,Activity,'=',75,%,,,,UO_0000187,,,,,0,CHEMBL2090474,Inhibition of human Pim2 using RSRHSSYPAGT as substrate assessed as residual activity at 10 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2086229,1,Scientific Literature,Eur J Med Chem,2012,None,
CHEMBL3933697,,None,351.44,0,4.12,BDBM224907,CCCOc1cccc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)n1,IC50,'=',35.27,nM,7.45,,393188,UO_0000065,21.21,0.41,3.33,8.31,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3931274,,None,317.36,0,2.62,BDBM249066,CNc1cccc(-n2ncc3cnc(-c4cncc(C)n4)cc32)n1,Ki,'=',3.43,nM,8.46,,434270,UO_0000065,26.67,0.48,5.84,10.4,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3910525,,None,396.55,0,4.77,BDBM224925,C[C@H]1CCCCN1c1nc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)cs1,IC50,'=',601.87,nM,6.22,,393207,UO_0000065,15.69,0.31,1.45,7.43,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1782512,,None,326.36,0,2.74,20,NCCCCNc1nccc(-c2ccc3oc(C(=O)O)cc3c2)n1,IC50,'=',590,nM,6.23,,,UO_0000065,19.09,0.35,3.49,5.45,0,CHEMBL1786238,Inhibition of human Pim2 using 5-FAM-RSRHSSYPAGT-CONH2 as substrate after 90 mins by off-chip mobility shift method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1781944,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL1952329,SGI-1776,1,405.42,0,4.05,SGI-1776,CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1,Ki,'=',610,nM,6.21,,,UO_0000065,15.33,0.29,2.16,11.36,0,CHEMBL3750380,Inhibition of PIM2 kinase (unknown origin) using Biotin-AGAGRSRHSSYPAGT-OH as substrate after 2 hrs by alphascreen assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3745712,1,Scientific Literature,J Med Chem,2015,None,
CHEMBL3975438,,None,400.48,1,6.1,BDBM224896,Fc1ccccc1-c1c[nH]c2ccc(-c3nnc(NCc4ccccc4)s3)cc12,IC50,'>',3000,nM,,,393172,UO_0000065,,,,,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL375284,,None,342.4,1,5.18,SID103904328,Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]ncc34)cc2)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3325694,,None,252.25,0,2.99,15,Nc1cc2[nH]ncc2c2c1ncc1c(F)cccc12,Activity,'=',76,%,,,,UO_0000187,,,,,0,CHEMBL3369948,Inhibition of full-length human PIM2 using RSRHSSYPAGT as substrate assessed as residual kinase activity at 10 uM after 30 mins in presence of [gamma-33P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352653,1,Scientific Literature,Bioorg Med Chem,2014,None,
CHEMBL3652006,,None,491.46,1,5.03,BDBM106912,Nc1ccc(-c2c(F)cccc2F)nc1C(=O)Nc1cnccc1[C@H]1C[C@@H](N)C[C@@H](C(F)(F)F)C1,IC50,'=',1,nM,9,,225933,UO_0000065,18.31,0.35,3.97,8.42,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3938424,,None,382.4,0,3.95,BDBM224994,COc1nc(-c2c[nH]c3ccc(-c4nnc(NC(C)C)o4)cc23)nc(C)c1F,IC50,'=',106.12,nM,6.97,,393283,UO_0000065,18.24,0.34,3.02,6.85,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3915869,,None,349.4,0,3.7,BDBM224997,CC(C)Nc1nnc(-c2ccc3[nH]cc(-c4nc(C5CC5)n[nH]4)c3c2)o1,IC50,'=',383.18,nM,6.42,,393286,UO_0000065,18.36,0.34,2.72,5.92,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3944528,,None,351.44,0,3.55,BDBM225095,CC(C)Nc1cncc(-c2c[nH]c3ccc(-c4nc(N)ns4)cc23)n1,IC50,'=',58.7,nM,7.23,,393088,UO_0000065,20.58,0.4,3.68,6.86,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3952167,,None,382.43,0,4.85,BDBM225000,CC(Nc1nnc(-c2ccc3[nH]cc(-c4ncccn4)c3c2)o1)c1ccccc1,IC50,'=',228.8,nM,6.64,,393289,UO_0000065,17.36,0.31,1.79,7.18,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3980995,,None,381.44,1,5.45,BDBM225001,CC(Nc1nnc(-c2ccc3[nH]cc(-c4ccccn4)c3c2)o1)c1ccccc1,IC50,'=',230.51,nM,6.64,,393290,UO_0000065,17.4,0.31,1.19,8.34,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3900171,,None,390.52,0,4.71,BDBM224900,C[C@H]1CCCCN1c1cccc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)n1,IC50,'=',9.735,nM,8.01,,393176,UO_0000065,20.52,0.39,3.3,9.57,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL605003,,None,371.46,0,2.64,K00088,CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2,Thermal melting change,'=',0.4,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL3325692,,None,264.29,0,2.86,13,COc1ccc2c(cnc3c(N)cc4[nH]ncc4c32)c1,Activity,'=',100,%,,,,UO_0000187,,,,,0,CHEMBL3370182,Inhibition of full-length human PIM2 using RSRHSSYPAGT as substrate assessed as residual kinase activity at 1 uM after 30 mins in presence of [gamma-33P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352653,1,Scientific Literature,Bioorg Med Chem,2014,None,
CHEMBL80713,,None,400.48,0,1.82,K00018,COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1,Thermal melting change,'=',0.3,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL3394063,,None,374.49,1,5.62,5,CSc1nnc(-c2ccc3[nH]cc(-c4cnc5ccccc5c4)c3c2)s1,IC50,'>',22000,nM,,,,UO_0000065,,,,,0,CHEMBL3395659,Inhibition of full length recombinant PIM2 (unknown origin) using biotinylated-BAD peptide as substrate assessed as phosphorylation at serine 112 after 90 mins by HTRF method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3393014,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL3934975,,None,353.39,0,4.21,BDBM238390,O=c1[nH]cnc2[nH]c(-c3cccc4ccc(Nc5ccccc5)nc34)cc12,IC50,'=',13.5,nM,7.87,,416168,UO_0000065,22.27,0.4,3.66,9.1,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL443738,,None,280.33,0,1.95,1,O=C(O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1,Activity,'=',35,%,,,,UO_0000187,,,,,0,CHEMBL3427823,Inhibition of PIM2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3425453,1,Scientific Literature,Eur J Med Chem,2015,None,
CHEMBL124660,TANDUTINIB,2,562.72,2,5.03,SID103905342,COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1684662,,None,352.4,0,4.53,4g,O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1,Inhibition,'=',111,%,,,,UO_0000187,,,,,0,CHEMBL1685852,Inhibition of Pim-2 at 0.1 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1681705,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL941,IMATINIB,4,493.62,0,4.59,SID103905596,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1994321,,None,505.63,1,4.4,SID103904304,Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCNS(C)(=O)=O)cnc(N)c34)cc2)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2003341,,None,387.27,0,4.52,SID103904553,O=C(NC(CO)c1cc(Cl)cc(Cl)c1)c1ccc(-c2ccncc2)cc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1993424,,None,379.45,0,2.87,SID103905251,NS(=O)(=O)c1cccc(Nc2ncc3ccn(Cc4ccccc4)c3n2)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3958260,,None,379.47,1,5.11,BDBM224973,CNc1nnc(-c2ccc3[nH]cc(-c4csc(-c5ccoc5)n4)c3c2)s1,IC50,'=',2635.25,nM,5.58,,393263,UO_0000065,14.7,0.29,0.47,7.01,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3973961,,None,387.83,0,4.86,BDBM238389,O=c1[nH]cnc2[nH]c(-c3cccc4ccc(Nc5ccc(Cl)cc5)nc34)cc12,IC50,'=',20.4,nM,7.69,,416167,UO_0000065,19.83,0.38,2.83,8.89,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3676258,,None,415.47,0,3.66,BDBM131728,N[C@H]1CCCN(c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C1,IC50,'=',8,nM,8.1,,263961,UO_0000065,19.49,0.38,4.44,9.62,0,CHEMBL3706072,Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3952715,,None,390.45,0,1.91,BDBM238554,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1CCCNC1=O,IC50,'=',85.7,nM,7.07,,416277,UO_0000065,18.1,0.33,5.16,6.32,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1909387,GW567808A,None,633.09,2,6.37,GW567808A,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl,Inhibition,'=',-0.68,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL220244,GW427984X,None,296.37,0,3.28,GW427984X,Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1,Inhibition,'=',0.03,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL405021,,None,277.33,0,3.58,SB-732941,O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1,Inhibition,'=',0.64,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL220243,GW406731X,None,283.33,0,3.36,GW406731X,COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1,Inhibition,'=',0.09,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3326557,,None,298.69,0,3.83,9,O=[N+]([O-])c1cc2[nH]ncc2c2c1ncc1ccc(Cl)cc12,Activity,'=',83,%,,,,UO_0000187,,,,,0,CHEMBL3370182,Inhibition of full-length human PIM2 using RSRHSSYPAGT as substrate assessed as residual kinase activity at 1 uM after 30 mins in presence of [gamma-33P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352653,1,Scientific Literature,Bioorg Med Chem,2014,None,
CHEMBL3326559,,None,308.25,0,2.9,11,O=[N+]([O-])c1cc2[nH]ncc2c2c1ncc1cc3c(cc12)OCO3,Activity,'=',92,%,,,,UO_0000187,,,,,0,CHEMBL3370182,Inhibition of full-length human PIM2 using RSRHSSYPAGT as substrate assessed as residual kinase activity at 1 uM after 30 mins in presence of [gamma-33P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352653,1,Scientific Literature,Bioorg Med Chem,2014,None,
CHEMBL3103866,,None,422.92,0,3.56,4h,Nc1ccc(-c2ccccc2Cl)nc1C(=O)Nc1cnccc1N1CCC[C@H](N)C1,Ki,'<',1,nM,,,,UO_0000065,,,,,0,CHEMBL3106180,Inhibition of PIM2 (unknown origin) using NH2-AGAGRSRHSSYPAGT-OH as substrate by Kinase-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3102815,1,Scientific Literature,ACS Med Chem Lett,2013,None,
CHEMBL3103873,,None,346.42,0,2.13,2c,CC(=O)Nc1nc(C(=O)Nc2cncnc2N2CCCCC2)cs1,Ki,'>',12500,nM,,,,UO_0000065,,,,,0,CHEMBL3106178,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3102815,1,Scientific Literature,ACS Med Chem Lett,2013,None,
CHEMBL4528544,,None,421.33,0,3.14,21,NC(=O)c1cc(Cl)c2c(Cl)c(C#CC3CCOCC3)n([C@H]3CCCNC3)c2n1,IC50,'=',10.2,nM,7.99,,,UO_0000065,18.97,0.39,4.85,9.73,0,CHEMBL4373003,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser-112 residue by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4371067,1,Scientific Literature,Bioorg Med Chem Lett,2019,None,
CHEMBL3967959,,None,377.48,0,3.72,BDBM224938,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(N5CCCCC5)n4)c3c2)s1,IC50,'=',10.9,nM,7.96,,393221,UO_0000065,21.09,0.4,4.24,8.24,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL607535,MEISOINDIGO,None,276.3,0,2.53,2,CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21,Inhibition,'=',2,%,,,,UO_0000187,,,,,0,CHEMBL1066089,Inhibition of PIM2 at 10 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1152632,1,Scientific Literature,Bioorg Med Chem,2009,None,
CHEMBL1910901,,None,394.48,0,4.18,15,c1cc(-c2ccc3c(-c4ccc(N5CCNCC5)cc4)n[nH]c3n2)c2cc[nH]c2c1,IC50,'=',650,nM,6.19,,,UO_0000065,15.68,0.28,2.01,8.52,0,CHEMBL1912526,Inhibition of PIM2 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1909629,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL1915445,,None,388.82,0,4.67,15b,Oc1ccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3cnccc23)c(Cl)c1,IC50,'=',2,nM,8.7,,,UO_0000065,22.37,0.42,4.03,8.73,0,CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914433,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL3393708,,None,415.47,0,4.35,18a,Fc1ccccc1-c1ccc2[nH]nc(-c3cncc(O[C@H]4CNCCC45CC5)n3)c2c1,IC50,'=',1.3,nM,8.89,,,UO_0000065,21.39,0.39,4.54,11.74,0,CHEMBL3396420,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as phosphorylation of biotinylated-BAD peptide at Serine 112 residue,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3392976,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL1969502,,None,344.37,0,2.99,SID103905055,O=C1NN=Cc2c[nH]c3cc(NC(=O)C4CC4c4ccccc4)cc1c23,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1987034,,None,475.33,0,3.28,SID103904592,N#CCOc1ccc(Nc2nc(Nc3cccc(S(N)(=O)=O)c3)ncc2Br)cc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1682345,,None,275.31,0,2.87,SID103904508,c1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)cc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3427170,,None,280.33,0,1.95,2,O=C(O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1,Activity,'=',11,%,,,,UO_0000187,,,,,0,CHEMBL3427823,Inhibition of PIM2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3425453,1,Scientific Literature,Eur J Med Chem,2015,None,
CHEMBL3393707,,None,433.46,0,4.49,13p,Fc1cccc(F)c1-c1ccc2[nH]nc(-c3cncc(O[C@@H]4CNCCC45CC5)n3)c2c1,IC50,'=',204,nM,6.69,,,UO_0000065,15.43,0.29,2.2,8.84,0,CHEMBL3396420,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as phosphorylation of biotinylated-BAD peptide at Serine 112 residue,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3392976,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL2002649,,None,241.25,0,1.91,SID103905117,COc1ccc2c(c1)C(=Cc1c[nH]cn1)C(=O)N2,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3945136,,None,393.48,0,3.02,BDBM224874,CNc1nnc(-c2ccc3[nH]cc(-c4ccnc(N5CCOCC5)n4)c3c2)s1,IC50,'=',82.39,nM,7.08,,393152,UO_0000065,18,0.35,4.06,7.71,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3103865,,None,456.47,0,3.92,4g,Nc1ccc(-c2ccccc2C(F)(F)F)nc1C(=O)Nc1cnccc1N1CCC[C@H](N)C1,Ki,'=',7,nM,8.15,,,UO_0000065,17.87,0.34,4.23,7.4,0,CHEMBL3106178,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3102815,1,Scientific Literature,ACS Med Chem Lett,2013,None,
CHEMBL3984864,,None,318.37,0,3.2,BDBM224924,N#Cc1cccc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)n1,IC50,'=',174.2,nM,6.76,,393206,UO_0000065,21.23,0.4,3.56,6.48,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL427058,GSK-466317A,None,448.83,0,4.75,GSK466317A,CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1,Inhibition,'=',-0.24,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL4126847,,None,425.46,1,5.28,14,CN(C)CCNc1cncc(-c2ccc3[nH]cc(-c4cccc(C(F)(F)F)c4)c3c2)n1,IC50,'=',2260,nM,5.65,,,UO_0000065,13.27,0.25,0.37,9.93,0,CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4118246,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL4129352,,None,441.46,1,5.16,21,CN(C)CCNc1cncc(-c2ccc3[nH]cc(-c4ccc(OC(F)(F)F)cc4)c3c2)n1,IC50,'=',4440,nM,5.35,,,UO_0000065,12.12,0.23,0.19,8.1,0,CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4118246,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL3915913,,None,372.44,0,2.56,BDBM249076,N[C@H]1CCC[C@@H]1Nc1cncc(-c2cc3c(cn2)cnn3-c2ccccn2)n1,Ki,'=',2.97,nM,8.53,,434280,UO_0000065,22.9,0.42,5.97,7.94,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3949902,,None,408.49,0,4.05,BDBM225012,CC(C)Nc1nnc(-c2ccc3[nH]cc(-c4nc(C(=O)NC5CC5)cs4)c3c2)o1,IC50,'=',408,nM,6.39,,393301,UO_0000065,15.64,0.3,2.34,5.88,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL521179,SR-3677,None,408.46,0,2.8,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2386917,,None,290.33,0,2.4,8,Cc1cccc2nc(Cn3cnc4ccccc43)cc(=O)n12,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL2388479,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2385076,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL3946064,,None,395.49,1,5.69,BDBM225089,c1ccc(-c2nnc(-c3ccc4[nH]cc(-c5cncc(C6CC6)n5)c4c3)s2)cc1,IC50,'>',1000,nM,,,393082,UO_0000065,,,,,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3961854,,None,350.38,0,3.5,BDBM225090,COc1ccnc(-c2c[nH]c3ccc(-c4nnc(NC(C)C)o4)cc23)n1,IC50,'=',16.67,nM,7.78,,393083,UO_0000065,22.2,0.41,4.28,7.64,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3914961,,None,372.43,0,4.15,BDBM225068,c1cc2[nH]cc(-c3cncc(C4CC4)n3)c2cc1-c1nnc(N2CCCC2)o1,IC50,'=',80.05,nM,7.1,,393061,UO_0000065,19.05,0.35,2.95,8.48,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL261641,,None,568.1,1,3.99,K00593a,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)c(C)c1C(=O)N1CCN(C)CC1,Thermal melting change,'=',1,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL3903663,,None,383.4,0,3.43,BDBM238515,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1CC(F)(F)C1,IC50,'=',8.9,nM,8.05,,416252,UO_0000065,21,0.39,4.62,9.73,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3898587,,None,367.45,0,4.67,BDBM238485,CC(c1ccccc1)c1ccc2cccc(-c3cc4c([nH]3)CCNC4=O)c2n1,IC50,'=',17.8,nM,7.75,,416224,UO_0000065,21.09,0.38,3.08,13.41,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3980526,,None,377.45,0,2.81,BDBM238552,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1CCCOC1,IC50,'=',2.1,nM,8.68,,416683,UO_0000065,22.99,0.42,5.87,9.44,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3903663,,None,383.4,0,3.43,BDBM238515,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1CC(F)(F)C1,IC50,'=',4.6,nM,8.34,,416659,UO_0000065,21.75,0.41,4.91,10.08,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL388978,STAUROSPORINE,None,466.54,0,4.35,Staurosporine,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,Kd,'=',1.9,nM,8.72,,,UO_0000065,18.69,0.34,4.37,12.56,1,CHEMBL1061184,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150977,1,Scientific Literature,Nat Biotechnol,2008,None,
CHEMBL3676307,,None,472.56,1,5.37,BDBM131777,CCOc1ccc(F)c(-c2nc(C(=O)Nc3cnccc3[C@@H]3C[C@H](C)C[C@H](N)C3)cs2)c1F,IC50,'=',9,nM,8.05,,264010,UO_0000065,17.03,0.33,2.68,8.93,0,CHEMBL3706072,Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2089000,,None,264.28,0,3.59,27,COC(=O)c1cc2c3ccccc3[nH]c2c2[nH]ccc12,Activity,'=',95,%,,,,UO_0000187,,,,,0,CHEMBL2090475,Inhibition of human Pim2 using RSRHSSYPAGT as substrate assessed as residual activity at 1 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2086229,1,Scientific Literature,Eur J Med Chem,2012,None,
CHEMBL1915420,,None,363.8,0,4.97,8,COC(=O)c1cccc2c1nc(Nc1cccc(Cl)c1)c1ccncc12,IC50,'=',894,nM,6.05,,,UO_0000065,16.63,0.32,1.08,9.43,0,CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914433,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL3660010,,None,330.4,0,2.72,BDBM104128,c1cc(N[C@@H]2CCNC2)c2nc(-c3nnc4ccccn34)ccc2c1,IC50,'=',2021,nM,5.69,,222546,UO_0000065,17.23,0.31,2.97,8.48,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL1649765,,None,349.78,0,4.88,2,O=C(O)c1cccc2c1nc(Nc1cccc(Cl)c1)c1ccncc12,IC50,'=',94,nM,7.03,,,UO_0000065,20.09,0.38,2.15,9.36,0,CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914433,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL1915424,,None,388.86,1,5.07,4d,O=C(NC1CC1)c1cccc2c1nc(Nc1cccc(Cl)c1)c1ccncc12,IC50,'=',74,nM,7.13,,,UO_0000065,18.34,0.35,2.06,10.66,0,CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914433,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL188257,GW827106X,None,452.47,0,4.38,GW827106X,COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1,Inhibition,'=',0.54,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL179453,GW622055X,None,392.86,0,4.54,GW622055X,CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1,Inhibition,'=',-0.56,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3974046,,None,365.41,0,3.63,BDBM238668,Cc1nc2ccc(F)c(-c3cc4c([nH]3)C3(CC3)NC4=O)c2nc1NC(C)C,IC50,'=',1.17,nM,8.93,,416777,UO_0000065,24.44,0.45,5.3,10.8,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3963838,,None,365.44,0,2.4,BDBM238555,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC(C)(C)CO,IC50,'=',1.7,nM,8.77,,416677,UO_0000065,24,0.44,6.37,8.52,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3981805,,None,388.86,0,4.91,BDBM238479,O=C1NCCc2[nH]c(-c3cccc4ccc(Nc5ccccc5Cl)nc34)cc21,IC50,'=',13.4,nM,7.87,,416216,UO_0000065,20.25,0.38,2.96,11.28,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3966072,,None,376.46,0,2.51,BDBM238512,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@@H]1CC[C@H](N)C1,IC50,'=',5.3,nM,8.28,,416249,UO_0000065,21.98,0.4,5.77,7.61,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1789962,GW643971X,None,374.4,0,3.03,GW643971X,COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O,Inhibition,'=',4.62,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL473420,GSK-1030058A,None,492.48,1,5.49,GSK1030058A,COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F,Inhibition,'=',-0.34,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL365297,GW827099X,None,440.44,0,4.51,GW827099X,Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1,Inhibition,'=',-0.97,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL188426,GW807982X,None,430.39,0,4.36,GW807982X,CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1,Inhibition,'=',-0.11,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1987910,,None,428.44,1,6.21,SID103904327,Nc1nccc2scc(-c3ccc(NC(=O)Nc4ccccc4C(F)(F)F)cc3)c12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL318892,,None,428.52,1,5.16,SB-236687,CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1,Inhibition,'=',0.35,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL402108,GW708893X,None,417.9,1,5.6,GW708893X,Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1,Inhibition,'=',-2.67,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL2037204,,None,479.94,1,5.01,17,CN1CCCN(C(=O)c2ccc(F)c(-c3ccc(/C=C4/C(=O)Nc5ccc(Cl)cc54)o3)c2)CC1,IC50,'=',5,nM,8.3,,,UO_0000065,17.3,0.33,3.29,12.62,0,CHEMBL2038829,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034977,1,Scientific Literature,ACS Med Chem Lett,2012,None,
CHEMBL101253,VATALANIB,3,346.82,1,5.01,PTK-787,Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL1909399,GW352430A,None,457.94,0,2.28,GW352430A,Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1,Inhibition,'=',0.11,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1940252,,None,502.55,1,3.53,25,CC(=O)N1CC[C@@H](Nc2cncc(C(=O)c3cn(C(C)C)c4ncnc(N)c34)n2)[C@H]1c1ccc(F)cc1,Inhibition,'=',7,%,,,,UO_0000187,,,,,0,CHEMBL1942193,Inhibition of PIM2 at 1 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1938337,1,Scientific Literature,J Med Chem,2011,None,
CHEMBL3660011,,None,418.5,0,4.27,BDBM104129,CC(C)(C)OC(=O)NCCCNc1cccc2ccc(-c3nnc4ccccn34)nc12,IC50,'=',10000,nM,5,,222547,UO_0000065,11.95,0.22,0.73,5.35,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3660013,,None,388.52,0,4.15,BDBM104131,CC(C)CCN(CCCN)c1cccc2ccc(-c3nnc4ccccn34)nc12,IC50,'=',5573,nM,5.25,,222549,UO_0000065,13.52,0.25,1.1,7.26,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL446024,GW683003X,None,294.24,0,2.16,GW683003X,FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1,Inhibition,'=',-0.09,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3664616,,None,378.43,0,2.7,BDBM104236,CC(C)(COc1cccc2ccc(-c3nnc4ccccn34)nc12)[C@@H](O)CO,IC50,'=',166.9,nM,6.78,,222647,UO_0000065,17.91,0.33,4.08,7.31,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL479038,GW806776X,None,334.42,0,3.39,GW806776X,O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1,Inhibition,'=',0.96,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1929247,,None,282.41,0,2.88,15,NCCN1C(=O)S/C(=C\CCC2CCCCC2)C1=O,Inhibition,'=',38,%,,,,UO_0000187,,,,,0,CHEMBL1929910,Inhibition of PIM2 at 10 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1926538,1,Scientific Literature,Eur J Med Chem,2012,None,
CHEMBL1096290,GSK-1000163A,None,395.47,0,1.8,GSK1000163A,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21,Inhibition,'=',1.6,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL2218932,,None,340.59,0,4.85,PKR_Inhibitor_Negative_Control,O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1,Residual Activity,'=',17,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1945336,,None,282.13,0,2.91,4,Cn1c2c(Cl)c(Cl)ccc2c2cc(N)[nH]c(=O)c21,Delta Tm,'=',3,degrees C,,,,UO_0000027,,,,,0,CHEMBL1947284,Binding affinity to PIM2 assessed as change in thermal denaturation at 10 uM by thermal stability shift assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1944596,1,Scientific Literature,J Med Chem,2012,None,
CHEMBL124660,TANDUTINIB,2,562.72,2,5.03,MLN-518,COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL583913,,None,351.43,0,3.57,14f,CN(C)Cc1nc2c(sc3ccc(-c4cccc(O)c4)cc32)c(=O)[nH]1,Ki,'=',4,nM,8.4,,,UO_0000065,23.9,0.46,4.83,12.13,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL575336,,None,285.14,0,4.56,19,Brc1ccc2[nH]c3c(ccc4cc[nH]c43)c2c1,Activity,'=',67,%,,,,UO_0000187,,,,,0,CHEMBL1051392,Inhibition of Pim-2 assessed as residual enzyme activity at 1 uM relative to untreated control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154186,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL575754,,None,234.26,0,3.61,8,O=Cc1c[nH]c2ccc3c4ccccc4[nH]c3c12,Activity,'=',102,%,,,,UO_0000187,,,,,0,CHEMBL1057614,Inhibition of Pim-2 assessed as residual enzyme activity at 10 uM relative to untreated control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154186,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL103667,DORAMAPIMOD,2,527.67,2,5.99,SID103904828,Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1988173,,None,425.94,0,3.9,SID103904448,Cc1cc(Cl)ccc1NC(=S)NNC(=O)C(O)(c1ccccc1)c1ccccc1,Ki,'=',501.19,nM,6.3,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2004871,,None,297.33,0,3.13,SID103905252,OCCCn1cnc(-c2ccc(F)cc2)c1-c1ccncc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL424872,,None,374.42,0,1.27,SID103905191,CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1C#N,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL4446434,,None,358.2,0,4.59,4,COc1cc(Br)cc2[nH]cc(-c3cnc(-c4ccc[nH]4)o3)c12,IC50,'=',22000,nM,4.66,,,UO_0000065,13,0.29,0.07,6.97,0,CHEMBL4338190,Inhibition of PIM2 (unknown origin) by [33P]-ATP filter binding kinase assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4334516,1,Scientific Literature,J Med Chem,2019,None,
CHEMBL2397523,,None,252.23,0,3.11,15a,O=[N+]([O-])c1cc2[nH]ncc2c2c1[nH]c1ccccc12,Activity,'=',49,%,,,,UO_0000187,,,,,0,CHEMBL2401343,Inhibition of human PIM2 assessed as residual activity using RSRHSSYPAGT as substrate at 1 uM after 30 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2396576,1,Scientific Literature,Bioorg Med Chem,2013,None,
CHEMBL1909363,GSK-269962B,None,607.07,2,3.84,GSK269962B,CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl,Inhibition,'=',-0.49,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL4109914,,None,420.9,0,4.32,BDBM192548,Clc1ccccc1-c1ccc2cnc(Nc3cnccc3O[C@@H]3CCCNC3)n2n1,IC50,'>',1000,nM,,,344540,UO_0000065,,,,,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4130169,,None,371.49,0,4.57,3,Cc1ccc(-c2c[nH]c3ccc(-c4cncc(NCCN(C)C)n4)cc23)cc1,IC50,'=',1800,nM,5.75,,,UO_0000065,15.46,0.28,1.17,10.11,0,CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4118246,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL176553,GW631581B,None,296.33,0,4.1,GW631581B,COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1,Inhibition,'=',0.58,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3660082,,None,417.51,0,3.42,BDBM104209,CC1(COc2cccc3ccc(-c4nnc5ccccn45)nc23)CCN(CCO)CC1,IC50,'=',142,nM,6.85,,222622,UO_0000065,16.4,0.3,3.43,9.04,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL4109812,,None,391.44,0,2.87,BDBM224858,COC[C@H]1CCCN1c1ccnc(-c2c[nH]c3ccc(-c4nnc(N)o4)cc23)n1,IC50,'=',25.65,nM,7.59,,393136,UO_0000065,19.39,0.36,4.72,6.38,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3900834,,None,443.44,0,2.44,BDBM248947,FC(F)(F)Cn1cc(-c2cc3c(cn2)cnn3-c2cncc(N3CCCNCC3)n2)cn1,Ki,'=',6.68,nM,8.18,,434154,UO_0000065,18.44,0.35,5.74,9.13,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3908853,,None,443.51,0,1.76,BDBM248885,OC1CNCCN(c2cccc(-n3ncc4cnc(-c5cncc(C6COC6)c5)cc43)n2)C1,Ki,'=',27.6,nM,7.56,,434092,UO_0000065,17.04,0.31,5.8,7.47,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4110326,,None,413.53,0,3.93,BDBM248876,CC(C)c1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CCC[C@@H](N)C3)n2)c1,Ki,'=',9.58,nM,8.02,,434083,UO_0000065,19.39,0.35,4.09,9.35,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL584159,,None,335.82,0,2.62,6d,O=c1[nH]c(CN2CCOCC2)nc2c1sc1ccc(Cl)cc12,Ki,'=',1250,nM,5.9,,,UO_0000065,17.58,0.37,3.28,10.14,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL584564,,None,349.84,0,2.75,6g,O=c1[nH]c(CN2CCCC(O)C2)nc2c1sc1ccc(Cl)cc12,Ki,'>',1424,nM,,,,UO_0000065,,,,,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL604483,,None,559.67,2,5.86,23,COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1,Residual activity,'=',85,%,,,,UO_0000187,,,,,0,CHEMBL1050333,Residual activity of PIM2 at 10 uM by microplate scintillation counting,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1152560,1,Scientific Literature,Bioorg Med Chem,2009,None,
CHEMBL3934590,,None,365.51,0,3.96,BDBM238632,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=S)c2nc1NC(C)(C)C,IC50,'=',2.54,nM,8.6,,416741,UO_0000065,23.52,0.45,4.64,13.1,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1277460,,None,286.34,0,3.39,(+/-)-15,c1ccc(C2Cc3nc4cc5cn[nH]c5cc4nc3C2)cc1,Activity,,,,,,Not Active,,,,,,0,CHEMBL1285678,Inhibition of Pim2 assessed as residual enzyme activity at 10 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1275327,1,Scientific Literature,Eur J Med Chem,2010,None,
CHEMBL603469,LESTAURTINIB,3,439.47,0,3.47,CEP-701,C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O,Kd,'=',250,nM,6.6,,,UO_0000065,15.02,0.27,3.13,7.45,1,CHEMBL1244923,Binding affinity to PIM2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240346,1,Scientific Literature,Blood,2009,None,
CHEMBL1909344,,None,372.86,0,2.3,SB-678557-A,CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl,Inhibition,'=',0.6,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL182283,GW819230X,None,293.33,0,3.55,GW819230X,Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1,Inhibition,'=',1.12,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL405042,GW335962X,None,329.38,0,2.13,GW335962X,C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21,Inhibition,'=',0.33,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL359963,GW805758X,None,330.4,0,4.05,GW805758X,CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1,Inhibition,'=',1.73,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3967508,,None,380.88,0,3.81,BDBM191087,Cc1cccc(-c2c(-c3ccnc(Cl)c3)cc3n2C(CCN)CNC3=O)c1,IC50,'=',102,nM,6.99,,341758,UO_0000065,18.36,0.35,3.18,9.59,0,CHEMBL3887520,Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3909000,,None,491.94,1,5.7,BDBM191096,CN(C)Cc1ccc(-c2c(-c3cccc(OC(F)(F)F)c3)cc3n2C(CCCl)CNC3=O)cc1,IC50,'=',113,nM,6.95,,341767,UO_0000065,14.12,0.28,1.25,14.94,0,CHEMBL3887520,Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3634765,,None,365.44,0,1.27,30,c1cc(-c2n[nH]c3cnc(N4CCOCC4)cc23)nc(N2CCNCC2)c1,Ki,'=',14,nM,7.85,,,UO_0000065,21.49,0.4,6.58,9.55,0,CHEMBL3636741,Inhibition of Pim2 (unknown origin) using 5FAM-ARKRRRHPSGPPTA as substrate after 90 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632547,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL3687447,,None,518.56,1,4.07,BDBM151843,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1S(C)(=O)=O,IC50,'=',3,nM,8.52,,292099,UO_0000065,16.44,0.32,4.45,7.41,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3961142,,None,485.56,1,7.34,BDBM224894,Cc1[nH]c2ccc(CNc3nnc(-c4ccc5[nH]cc(-c6ccc(F)cc6F)c5c4)s3)cc2c1C,IC50,'>',3000,nM,,,393170,UO_0000065,,,,,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL268885,GSK-711701A,None,416.89,0,3.43,GSK711701A,COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1,Inhibition,'=',-0.88,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3966732,,None,451.48,0,2.96,BDBM192558,C[C@H]1CN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C[C@@H](N)[C@@H]1O,IC50,'=',0.08,nM,10.1,,344550,UO_0000065,22.36,0.42,7.14,9.65,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1233882,,None,304.36,0,3.2,PP102,CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21,Inhibition,'=',3,%,,,,UO_0000187,,,,,0,CHEMBL1244250,Inhibition of PIM2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240340,1,Scientific Literature,Nat Chem Biol,2008,None,
CHEMBL3984183,,None,400.49,0,2.81,BDBM248943,c1cc(N2CCCNCC2)nc(-n2ncc3cnc(-c4cnn(C5CC5)c4)cc32)c1,Ki,'=',0.978,nM,9.01,,434150,UO_0000065,22.5,0.41,6.2,11.75,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3634788,,None,199.22,0,1.66,6,Cc1n[nH]c2cnc(-c3cn[nH]c3)cc12,Ki,'=',900,nM,6.05,,,UO_0000065,30.35,0.55,4.39,8.61,0,CHEMBL3636741,Inhibition of Pim2 (unknown origin) using 5FAM-ARKRRRHPSGPPTA as substrate after 90 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632547,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL3634791,,None,273.3,0,3.08,9,c1ccc(-c2n[nH]c3cnc(-c4cccnc4)cc23)nc1,Ki,'=',70,nM,7.16,,,UO_0000065,26.18,0.47,4.07,10.62,0,CHEMBL3636741,Inhibition of Pim2 (unknown origin) using 5FAM-ARKRRRHPSGPPTA as substrate after 90 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632547,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL2036117,,None,405.5,1,5.39,7,CC(C)(C)OC(=O)NCCCCn1c2ccccc2c2ccc3c(C=O)c[nH]c3c21,IC50,,,,,,Not Determined,,,,,,0,CHEMBL2040258,Inhibition of Pim-2 using RSRHSSYPAGT as substrate after 30 mins,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034961,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL3906911,,None,362.44,0,3.69,BDBM238735,Cc1nc2cccc(-c3cc4c(=O)[nH]nc(C)c4[nH]3)c2nc1NC(C)(C)C,IC50,'=',15.8,nM,7.8,,416844,UO_0000065,21.52,0.39,4.11,7.85,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL522709,GSK-317315A,None,461.47,1,5.35,GSK317315A,COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1,Inhibition,'=',-0.14,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1909392,GW580496A,None,643.99,2,6.11,GW580496A,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl,Inhibition,'=',-3.1,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL575471,,None,404.32,1,5.17,14q,CN(C)Cc1nc2c(sc3ccc(-c4cc(Cl)cc(Cl)c4)cc32)c(=O)[nH]1,Ki,'>',1420,nM,,,,UO_0000065,,,,,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL2397599,,None,282.26,0,3.11,6b,COc1ccc2[nH]c3c([N+](=O)[O-])cc4cn[nH]c4c3c2c1,Activity,'=',77,%,,,,UO_0000187,,,,,0,CHEMBL2401343,Inhibition of human PIM2 assessed as residual activity using RSRHSSYPAGT as substrate at 1 uM after 30 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2396576,1,Scientific Literature,Bioorg Med Chem,2013,None,
CHEMBL4227886,,None,407.86,0,4.65,12d,CC(C)Nc1ccc2cnn(-c3cncc(-c4ccc(C(=O)O)cc4Cl)n3)c2c1,IC50,'=',26000,nM,4.58,,,UO_0000065,11.24,0.22,-0.06,4.93,0,CHEMBL4222673,Inhibition of human PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4219163,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL1089524,,None,427.35,1,5.02,3e,CN(C)CCCC(=O)Nc1ccc2nccc(Nc3cccc(Br)c3)c2c1,Activity,'=',75,%,,,,UO_0000187,,,,,0,CHEMBL1104323,Inhibition of PIM2 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1156950,1,Scientific Literature,J Med Chem,2010,None,
CHEMBL525893,,None,395.42,0,3.99,25,Cc1ccn(-c2ccc(-c3ncco3)cc2)c(=O)c1-c1ccc2nc(N)ncc2c1,Inhibition,'>',50,%,,,,UO_0000187,,,,,0,CHEMBL958285,Inhibition of PIM2 at 1 uM relative to control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150317,1,Scientific Literature,J Med Chem,2008,None,
CHEMBL4228363,,None,374.4,0,3.4,12i,CC(C)Nc1ccc2cnn(-c3cncc(-c4ccc(C(=O)O)cn4)n3)c2c1,IC50,'=',6900,nM,5.16,,,UO_0000065,13.79,0.25,1.76,4.88,0,CHEMBL4222673,Inhibition of human PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4219163,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL187081,PYRAZOLOPYRIDAZINE 1,None,318.34,0,2.94,GW810576X,COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1,Inhibition,'=',2.39,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3676310,,None,444.51,0,4.67,BDBM131780,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2csc(-c3c(F)cc(O)cc3F)n2)C1,IC50,'=',4,nM,8.4,,264013,UO_0000065,18.89,0.37,3.73,8.3,0,CHEMBL3706072,Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3676311,,None,446.5,0,4.91,BDBM131781,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1F,IC50,'=',47,nM,7.33,,264014,UO_0000065,16.41,0.32,2.42,9.06,0,CHEMBL3706072,Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3911078,,None,421.44,0,4.42,BDBM191076,NCC[C@H]1CNC(=O)c2cc(-c3cccc(OC(F)(F)F)c3)c(-c3ccsc3)n21,IC50,'=',69,nM,7.16,,341747,UO_0000065,16.99,0.34,2.74,10.34,0,CHEMBL3887520,Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3932237,,None,463.43,0,4.5,BDBM191134,COc1ccc(-c2c(-c3cccc(OC(F)(F)F)c3)cc3n2[C@@H](CCN)CNC3=O)cc1F,IC50,'=',36,nM,7.44,,341805,UO_0000065,16.06,0.31,2.94,9.48,0,CHEMBL3887520,Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP,,,,,,,,,,,,,,,,,,,,,,
CHEMBL572550,,None,363.49,0,4.43,14h,CCc1ccc(-c2ccc3sc4c(=O)[nH]c(CN(C)C)nc4c3c2)cc1,Ki,'=',12,nM,7.92,,,UO_0000065,21.79,0.42,3.49,16.17,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL3915900,,None,351.44,0,3.18,BDBM224929,CCN(C)c1cnc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)cn1,IC50,'=',1218.57,nM,5.91,,393211,UO_0000065,16.83,0.32,2.73,6.12,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3981152,,None,369.45,0,5,BDBM224875,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(-c5ccccc5)n4)c3c2)s1,IC50,'=',39.01,nM,7.41,,393153,UO_0000065,20.05,0.37,2.41,9.21,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3933159,,None,439.52,0,4.51,BDBM238700,Cc1nc2cccc(-c3cc4c([nH]3)C(COCc3ccccc3)NC4=O)c2nc1NC1CC1,IC50,'=',2.18,nM,8.66,,416809,UO_0000065,19.71,0.36,4.15,9.42,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3891696,,None,430.43,0,3.94,BDBM191081,NCCC1CNC(=O)c2cc(-c3cccc(OC(F)(F)F)c3)c(-c3cccc(N)c3)n21,IC50,'=',69,nM,7.16,,341752,UO_0000065,16.64,0.32,3.22,7.51,0,CHEMBL3887520,Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3394065,,None,308.37,0,2.91,14,Nc1cccc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)n1,IC50,,,,,,Not Determined,,,,,,0,CHEMBL3395662,Inhibition of PIM2 in human U2OS cells assessed as phosphorylation of BAD,B,BAO_0000219,cell-based format,Homo sapiens,None,None,U2OS,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3393014,1,Scientific Literature,Bioorg Med Chem Lett,2015,CHEMBL3307757,
CHEMBL3394069,,None,376.49,0,4.69,18,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(NC5CCCC5)n4)c3c2)s1,IC50,'=',3090,nM,5.51,,,UO_0000065,14.64,0.28,0.82,5.96,0,CHEMBL3395662,Inhibition of PIM2 in human U2OS cells assessed as phosphorylation of BAD,B,BAO_0000219,cell-based format,Homo sapiens,None,None,U2OS,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3393014,1,Scientific Literature,Bioorg Med Chem Lett,2015,CHEMBL3307757,
CHEMBL3966072,,None,376.46,0,2.51,BDBM238512,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@@H]1CC[C@H](N)C1,IC50,'=',0.4,nM,9.4,,416657,UO_0000065,24.96,0.46,6.89,8.64,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3326559,,None,308.25,0,2.9,11,O=[N+]([O-])c1cc2[nH]ncc2c2c1ncc1cc3c(cc12)OCO3,Activity,'=',54,%,,,,UO_0000187,,,,,0,CHEMBL3369948,Inhibition of full-length human PIM2 using RSRHSSYPAGT as substrate assessed as residual kinase activity at 10 uM after 30 mins in presence of [gamma-33P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352653,1,Scientific Literature,Bioorg Med Chem,2014,None,
CHEMBL3910008,,None,392.49,0,2.92,21j,N[C@H]1CCCN(c2ccncc2Nc2ncc3ccc(-c4nccs4)nn23)C1,IC50,'=',2.9,nM,8.54,,,UO_0000065,21.75,0.42,5.62,8.78,0,CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3864151,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL3904050,,None,405.5,0,4.13,BDBM238820,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C5CCC5)c(NC(C)(C)C)nc34)[nH]c21,IC50,'=',0.6,nM,9.22,,416929,UO_0000065,22.74,0.42,5.09,10.04,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL230597,GSK-586581A,None,381.46,0,3.07,GSK586581A,CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1,Inhibition,'=',-0.48,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL192417,GW632046X,None,250.3,0,4.39,GW632046X,Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1,Inhibition,'=',0.15,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL4459587,,None,323.42,0,4.32,DC-TEADin02,C=CS(=O)(=O)Nc1ccc(Cc2ccc3ccccc3c2)cc1,Inhibition,'=',13,%,,,,UO_0000187,,,,,0,CHEMBL4378868,Inhibition of recombinant human PIM2 (2 to end residues) at 10 uM using RSRHSSYPAGT as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4376829,1,Scientific Literature,Eur J Med Chem,2019,None,
CHEMBL4283739,,None,430.49,0,2.14,20,COc1cc(C)c(S(N)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1,Inhibition,'=',3,%,,,,UO_0000187,,,,,0,CHEMBL4255128,Inhibition of recombinant human full length GST-tagged PIM2 expressed in baculovirus expression system at 1 uM relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4251655,1,Scientific Literature,Eur J Med Chem,2018,None,
CHEMBL3676261,,None,431.47,0,2.63,BDBM131731,N[C@H]1C[C@@H](O)CN(c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C1,IC50,'=',77,nM,7.11,,263964,UO_0000065,16.49,0.32,4.48,6.82,0,CHEMBL3706072,Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3676279,,None,459.52,0,3.68,BDBM131749,CCO[C@@H]1C[C@H](N)CN(c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C1,IC50,'=',85,nM,7.07,,263982,UO_0000065,15.39,0.3,3.39,7.57,0,CHEMBL3706072,Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3890140,,None,347.38,0,3.08,BDBM224841,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(NCC5CC5)n4)c3c2)o1,IC50,'=',2.067,nM,8.69,,393123,UO_0000065,25,0.46,5.6,7.33,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1796254,,None,553.13,1,3.2,11,COCCN1CCc2cc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4NS(C)(=O)=O)n3)c(OC)cc2CC1,Inhibition,'<',65,%,,,,UO_0000187,,,,,0,CHEMBL1798281,Inhibition of PIM2 at 1 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1795227,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL3975613,,None,348.45,0,3.81,BDBM238613,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1CC(C)(C)C,IC50,'=',7.8,nM,8.11,,416720,UO_0000065,23.27,0.43,4.3,11.47,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3931746,,None,401.51,0,4.38,BDBM238618,CC#CCC1CNC(=O)c2cc(-c3cccc4nc(C)c(NC(C)(C)C)nc34)[nH]c21,IC50,'=',10.5,nM,7.98,,416725,UO_0000065,19.87,0.36,3.6,9.65,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4752776,,None,358.47,0,4.75,11s; SGC-STK17B-1,O=C(O)CSc1ncnc2cc(-c3cc4ccccc4s3)sc12,Inhibition,'=',100,%,,,,UO_0000187,,,,,0,CHEMBL4723765,Binding affinity to human PIM2 assessed as displacement of immobilized ligand at 1 uM by KINOMEscan scanMAX assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4715866,1,Scientific Literature,J Med Chem,2020,None,Dose = 1.0 microM
CHEMBL3939931,,None,382.49,1,6.06,BDBM225054,CNc1nnc(-c2ccc3[nH]cc(-c4cccc(-c5ccccc5)c4)c3c2)s1,IC50,'>',3000,nM,,,393046,UO_0000065,,,,,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4580637,,None,352.39,0,2.91,5,Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc2c(c1)OCCO2,Inhibition,'=',2,%,,,,UO_0000187,,,,,0,CHEMBL4337348,Inhibition of full-length N-terminal GST-tagged human PIM2 (1 to 311 residues) expressed in baculovirus expression system at 10 uM using propeptide-20 as substrate after 2 hrs by electrophoretic mobility shift assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4334485,1,Scientific Literature,Eur J Med Chem,2019,None,
CHEMBL3975552,,None,368.4,0,4.23,BDBM224869,Cc1ccccc1-c1ccnc(-c2c[nH]c3ccc(-c4nnc(N)o4)cc23)n1,IC50,'=',33.4,nM,7.48,,393147,UO_0000065,20.29,0.36,3.25,7.02,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4744172,,None,404.76,0,3.63,20,O=C(Nc1c[nH]nc1-c1cc(Cl)ccc1OC(F)F)c1cnn2cccnc12,Inhibition,'=',18,%,,,,UO_0000187,,,,,0,CHEMBL4666957,Inhibition of recombinant human GST-tagged full length PIM2 expressed in baculovirus expression system using Ser/Thr 07 as substrate at 0.1 uM incubated for 60 mins by Z'-lyte assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4665643,1,Scientific Literature,Bioorg Med Chem Lett,2019,None,Dose = 0.1 microM | TIME = 1.0 hr
CHEMBL4781112,,None,451.5,0,3.14,11,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2nc(-c3ncccc3F)ccc2N)C[C@@H](O)[C@]1(C)O,Ki,'=',3,nM,8.52,,,UO_0000065,18.88,0.35,5.38,6.35,0,CHEMBL4723884,Inhibition of PIM2 (unknown origin) using Bad peptide NH2-AGAGRSRHSSYPAGT-OH as substrate measured after 10 mins in presence of ATP by luciferase-luciferin based Kinase-Glo luminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4715870,1,Scientific Literature,J Med Chem,2020,None,TIME = 0.1667 hr
CHEMBL2218925,,None,343.22,0,4.15,VEGF_Receptor_2_Kinase_Inhibitor_II,O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2,Residual Activity,'=',129,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3651941,,None,452.51,0,4.91,BDBM106845,COc1ccc(F)c(-c2nc(C(=O)Nc3cnccc3[C@@H]3C[C@H](C)C[C@H](N)C3)ccc2F)c1,IC50,'=',2,nM,8.7,,225866,UO_0000065,19.22,0.36,3.79,9.65,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL514938,GSK-969786A,None,451.91,1,7.07,GSK969786A,Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1,Inhibition,'=',0.56,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1880739,GW305074X,None,520.95,2,5.01,GW305074X,O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1,Inhibition,'=',0.13,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL205966,GW659893X,None,444.9,1,5.57,GW659893X,Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1,Inhibition,'=',0.43,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL156987,,None,377.18,0,3.17,SB-409513,O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1,Inhibition,'=',-0.18,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL2348865,,None,391.44,0,2.39,9a,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3676263,,None,445.5,0,3.29,BDBM131733,COC1CCN(c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)CC1N,IC50,'=',243,nM,6.61,,263966,UO_0000065,14.85,0.29,3.32,7.08,0,CHEMBL3706072,Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3943301,,None,350.43,0,2.7,BDBM238625,CC(C)(C)Nc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2nc1N,IC50,'=',0.429,nM,9.37,,416753,UO_0000065,26.73,0.49,6.67,8.62,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4785602,,None,358.51,0,3.97,46,Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1,Activity,'=',100.07,%,,,,UO_0000187,,,,,0,CHEMBL4674246,Inhibition of human PIM2 using RSRHSSYPAGT as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4673210,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,Dose = 1.0 microM
CHEMBL4538591,BAY-440,None,574.01,1,4.47,EUB0000701,CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl,% Control,,100,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507318,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL554,LAPATINIB,4,581.07,2,6.14,Lapatinib,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL1794061,GW627834A,None,297.74,0,3.96,GW627834A,Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1,Inhibition,'=',0.1,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1794052,GW405841X,None,453.09,0,4.2,GW405841X,COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2,Inhibition,'=',53.19,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL408982,,None,249.34,0,3.06,TG003,CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21,Residual Activity,'=',85,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL179583,,None,363.8,0,4.77,Chk2_Inhibitor_II,NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1,Residual Activity,'=',108,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3891846,,None,441.58,1,5.96,6n,C[C@@H](Nc1ncnc2oc(-c3ccc(NCCN4CCCCC4)cc3)cc12)c1ccccc1,Inhibition,'=',-11,%,,Outside typical range,,UO_0000187,,,,,0,CHEMBL3857070,Inhibition of GST tagged recombinant full length human PIM2 expressed in baculovirus at 500 nM by Z'-LYTE assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3856204,1,Scientific Literature,Eur J Med Chem,2016,None,
CHEMBL1243129,,None,302.25,0,4.63,3l,O=Cc1c[nH]c2c1ccc1c3cccc(C(F)(F)F)c3[nH]c12,Activity,'=',56,%,,,,UO_0000187,,,,,0,CHEMBL1248947,Inhibition of human GST fused Pim2 expressed in Escherichia coli assessed as residual activity at 1 uM after 30 mins,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240519,1,Scientific Literature,Bioorg Med Chem,2010,None,
CHEMBL2425649,,None,407.48,0,2.04,8,O=C([C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1)N1CCOCC1,Inhibition,'=',78,%,,,,UO_0000187,,,,,0,CHEMBL2429482,Competitive binding affinity to PIM2 (unknown origin) at 10 uM in presence of ATP relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2424622,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL2003817,,None,333.27,0,3.69,SID103904890,O=C(Nc1cnccn1)Nc1ccnc2cc(C(F)(F)F)ccc12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1999931,,None,394.44,0,4.12,SID103904511,O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1ccccc1,Ki,'=',630.96,nM,6.2,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1915640,,None,430.44,0,4.48,15n,COCCOc1ccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3cnccc23)c(F)c1,IC50,'=',10,nM,8,,,UO_0000065,18.59,0.34,3.52,8.18,0,CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914433,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL3103878,,None,356.39,0,-0.69,3c,NCC(=O)N1CCN(c2ccncc2NC(=O)c2nccnc2N)CC1,Ki,'=',2000,nM,5.7,,,UO_0000065,15.99,0.3,6.39,3.98,0,CHEMBL3106178,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3102815,1,Scientific Literature,ACS Med Chem Lett,2013,None,
CHEMBL302449,GO-6976,None,378.44,0,4.6,SID103905532,Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1794056,GW301789X,None,303.32,0,2.67,GW301789X,O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1,Inhibition,'=',2.25,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL500183,,None,326.71,0,1.71,13,CCn1c2cc(Cl)c(F)cc2c(=O)c2c(=O)on(CCO)c21,Ki,'>',1424,nM,,,,UO_0000065,,,,,0,CHEMBL994191,Inhibition of Pim2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144228,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,
CHEMBL1945554,,None,348.23,0,4.15,10,Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C1(CCCC1)NC2=O,Delta Tm,'=',1.6,degrees C,,,,UO_0000027,,,,,0,CHEMBL1947284,Binding affinity to PIM2 assessed as change in thermal denaturation at 10 uM by thermal stability shift assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1944596,1,Scientific Literature,J Med Chem,2012,None,
CHEMBL474872,BAUERINE C,None,267.12,0,3.33,1,Cn1c2c(Cl)c(Cl)ccc2c2cc[nH]c(=O)c21,Delta Tm,'=',2.9,degrees C,,,,UO_0000027,,,,,0,CHEMBL1947284,Binding affinity to PIM2 assessed as change in thermal denaturation at 10 uM by thermal stability shift assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1944596,1,Scientific Literature,J Med Chem,2012,None,
CHEMBL3916196,,None,403.41,0,4.14,BDBM238577,CC(C)(C)Nc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2nc1C(F)(F)F,IC50,'=',2.8,nM,8.55,,416699,UO_0000065,21.2,0.4,4.41,10.34,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1909369,GW693917A,None,556.93,2,7.07,GW693917A,COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl,Inhibition,'=',-0.21,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL440687,ABT-724,None,293.37,0,2.28,EUB0000290,c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1,% Control,,85,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507260,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL1909367,GW680908A,None,587.94,2,5.38,GW680908A,COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl,Inhibition,'=',-0.06,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL2218934,,None,257.27,0,1.95,PI3_Kg_Inhibitor,O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1,Residual Activity,'=',75,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL394790,,None,394.89,1,5.84,SID103904359,Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL413,SIROLIMUS,4,914.19,3,6.18,Rapamycin,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,Residual Activity,'=',110,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL483847,,None,374.32,0,3.88,GNF_2,NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1,Residual Activity,'=',111,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL383899,ANILINOPYRIMIDINE1,None,413.4,1,5.33,Aurora_Kinase_Inhibitor_III,O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1,Residual Activity,'=',110,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1231533,,None,285.23,0,2.33,AS-604850,O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1,Residual Activity,'=',58,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1999556,,None,254.31,0,3.06,SID103905041,NC(=O)c1cc2c(-c3ccccc3)cncc2s1,Ki,'=',501.19,nM,6.3,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL601719,CRIZOTINIB,4,450.35,1,5.04,Crizotinib,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL4776396,,None,374.44,0,4.17,53,CCOc1ccccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2[nH]1,Inhibition,'=',2,%,,,,UO_0000187,,,,,0,CHEMBL4718881,Inhibition of recombinant full length GST-tagged human PIM2 expressed in baculovirus expression system at 500 nM using Ser/Thr 07 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4715760,1,Scientific Literature,Eur J Med Chem,2016,None,Dose = 500.0 nM | TIME = 1.0 hr
CHEMBL3664618,,None,465.53,0,3.33,BDBM104238,COC1(COc2cc(F)cc3ccc(-c4nnc5ccccn45)nc23)CCCN(CCO)CC1,IC50,'=',222.4,nM,6.65,,222649,UO_0000065,14.29,0.27,3.32,7.83,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3664621,,None,391.45,0,3.76,BDBM104241,CN1CCC(F)C(Oc2cccc3ccc(-c4nnc5ccccn45)nc23)CC1,IC50,'=',330,nM,6.48,,222652,UO_0000065,16.56,0.31,2.72,11.67,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3660086,,None,391.45,0,3.72,BDBM104215,Cc1ccn2c(-c3ccc4cccc(OC5CCNCCC5F)c4n3)nnc2c1,IC50,'=',1000,nM,6,,222656,UO_0000065,15.33,0.28,2.28,9.33,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL1910897,,None,356.43,0,3.1,11,c1cc(-c2ccc3c(-c4ccc(N5CCNCC5)cc4)n[nH]c3n2)ccn1,IC50,'>',25000,nM,,,,UO_0000065,,,,,0,CHEMBL1912526,Inhibition of PIM2 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1909629,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL1277460,,None,286.34,0,3.39,(+/-)-15,c1ccc(C2Cc3nc4cc5cn[nH]c5cc4nc3C2)cc1,Activity,,,,,,Not Active,,,,,,0,CHEMBL1285679,Inhibition of Pim2 assessed as residual enzyme activity at 1 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1275327,1,Scientific Literature,Eur J Med Chem,2010,None,
CHEMBL157258,,None,383.62,0,3.83,SB-390523,O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1,Inhibition,'=',-0.59,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL471789,GSK-1030059A,None,476.48,1,5.9,GSK1030059A,COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC,Inhibition,'=',0.86,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL179465,GW621970X,None,376.41,0,4.03,GW621970X,CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1,Inhibition,'=',0.08,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL4749141,,None,367.48,0,3.23,44,Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1,Activity,'=',94.64,%,,,,UO_0000187,,,,,0,CHEMBL4674246,Inhibition of human PIM2 using RSRHSSYPAGT as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4673210,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,Dose = 1.0 microM
CHEMBL4453890,,None,463.51,0,1.94,21,Cn1ncc(NC(=O)c2nc(-c3c(F)cccc3F)sc2N)c1N1CC[C@@H](N)[C@@H](O)CC1,Ki,'=',0.2,nM,9.7,,,UO_0000065,20.93,0.41,7.76,7.17,0,CHEMBL4317000,Inhibition of recombinant human PIM2 using FAM-pimtide as substrate after 90 mins by Z-LYTE assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4316591,1,Scientific Literature,J Med Chem,2019,None,
CHEMBL4439756,,None,465.51,0,2.92,22,Cn1ncc(NC(=O)c2nc(-c3c(F)cccc3F)sc2N)c1N1CCC(N)CC(F)C1,Ki,'=',0.05,nM,10.3,,,UO_0000065,22.13,0.44,7.38,8.95,0,CHEMBL4317000,Inhibition of recombinant human PIM2 using FAM-pimtide as substrate after 90 mins by Z-LYTE assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4316591,1,Scientific Literature,J Med Chem,2019,None,
CHEMBL3651902,,None,406.46,0,4.23,BDBM106806,N[C@H]1CCC[C@@H](c2ccncc2NC(=O)c2cccc(-c3ccc(O)cc3F)n2)C1,IC50,'=',12,nM,7.92,,225827,UO_0000065,19.49,0.36,3.69,7.83,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3809623,,None,349.44,0,3.43,3,CCCCNc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2nc1C,IC50,'=',2,nM,8.7,,,UO_0000065,24.89,0.46,5.27,10.52,0,CHEMBL3812018,Inhibition of human full-length Pim2 expressed in Escherichia coli assessed as phosphorylation of biotinylated BAD peptide at Ser 112 preincubated for 30 mins followed by substrate addition measured after 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3808325,1,Scientific Literature,ACS Med Chem Lett,2016,None,
CHEMBL1241578,,None,348.2,0,3.12,PP487,CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21,Inhibition,'=',6,%,,,,UO_0000187,,,,,0,CHEMBL1244250,Inhibition of PIM2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240340,1,Scientific Literature,Nat Chem Biol,2008,None,
CHEMBL1240961,,None,313.15,0,4.38,3d,O=Cc1c[nH]c2c1ccc1c2[nH]c2cccc(Br)c21,Activity,'=',6,%,,,,UO_0000187,,,,,0,CHEMBL1248949,Inhibition of human GST fused Pim2 expressed in Escherichia coli assessed as residual activity at 10 uM after 30 mins,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240519,1,Scientific Literature,Bioorg Med Chem,2010,None,
CHEMBL1243128,,None,292.29,0,3.4,3k,COC(=O)c1cccc2c1[nH]c1c2ccc2c(C=O)c[nH]c21,Activity,'=',12,%,,,,UO_0000187,,,,,0,CHEMBL1248949,Inhibition of human GST fused Pim2 expressed in Escherichia coli assessed as residual activity at 10 uM after 30 mins,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240519,1,Scientific Literature,Bioorg Med Chem,2010,None,
CHEMBL3984361,,None,363.47,0,3.44,BDBM238653,Cc1nc2cccc(-c3cc4c(n3C)CCNC4=O)c2nc1NC(C)(C)C,IC50,'=',8.58,nM,8.07,,416762,UO_0000065,22.19,0.41,4.63,11.23,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1915426,,None,372.82,0,4.97,7,Clc1cccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3cnccc23)c1,IC50,'=',18,nM,7.75,,,UO_0000065,20.77,0.39,2.77,9.76,0,CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914433,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL442363,GW809885X,None,373.42,0,3.36,GW809885X,COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1,Inhibition,'=',-0.42,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3660059,,None,336.35,0,1.68,BDBM104185,OCC(O)COc1cccc2ccc(-c3nnc4ccccn34)nc12,IC50,'=',1721,nM,5.76,,222598,UO_0000065,17.14,0.31,4.08,6.21,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3660054,,None,389.46,0,3.09,BDBM104180,COC[C@@H]1CC(Oc2cccc3ccc(-c4nnc5ccccn45)nc23)CCN1,IC50,'=',484,nM,6.32,,222593,UO_0000065,16.22,0.3,3.23,8.58,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3660062,,None,423.52,0,4.98,BDBM104188,CC(C)(CN)COc1cccc2ccc(-c3nnc4ccc(-c5ccccc5)cn34)nc12,IC50,'=',174,nM,6.76,,222601,UO_0000065,15.96,0.29,1.78,8.63,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3660066,,None,401.51,0,4.35,BDBM104193,CC(C)C1(COc2cccc3ccc(-c4nnc5ccccn45)nc23)CCNCC1,IC50,'=',67,nM,7.17,,222606,UO_0000065,17.87,0.33,2.82,11.15,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3298890,,None,407.45,0,2.18,14b,NC[C@@H](NC(=O)C[C@@H]1CNC(=O)c2cc(-c3ccnc(F)c3)cn21)c1ccccc1,IC50,'=',502,nM,6.3,,,UO_0000065,15.46,0.29,4.12,6.17,0,CHEMBL3300844,Inhibition of human PIM2 using ARK-RERTYSFGHHA as substrate incubated for 60 mins prior to substrate addition by topcount scintillation counting analysis in presence of [P33gamma]-ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3297733,1,Scientific Literature,Bioorg Med Chem,2013,None,
CHEMBL3940707,,None,367.43,0,4.09,BDBM238638,Cc1nc2ccc(F)c(-c3cc4c([nH]3)[C@H](C)NC4=O)c2nc1NC(C)(C)C,IC50,'=',0.201,nM,9.7,,416747,UO_0000065,26.39,0.49,5.61,11.73,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL210618,,None,356.38,0,2.13,JNK_inhibitor_VIII,CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N,Residual Activity,'=',84,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL10,SB-203580,None,377.44,0,4.68,SB-203580,C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,Kd,,,,,,Not Active,,,,,,0,CHEMBL859489,Average Binding Constant for PIM2; NA=Not Active at 10 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144455,1,Scientific Literature,Nat Biotechnol,2005,None,
CHEMBL3913006,,None,376.42,0,3.67,BDBM225033,CC(C)Nc1nnc(-c2ccc3[nH]cc(-c4cc(=O)[nH]c(C5CC5)n4)c3c2)o1,IC50,'=',2.24,nM,8.65,,393320,UO_0000065,22.98,0.42,4.98,7.69,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL274863,,None,382.44,0,2.45,SB-216385,Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1,Inhibition,'=',1.68,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL233002,,None,350.42,1,5.04,SB-814597,N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2,Inhibition,'=',-0.1,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1909353,GW458344A,None,379.85,0,4.31,GW458344A,Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl,Inhibition,'=',0.57,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL271594,GW300653X,None,358.42,0,2.23,GW300653X,CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1,Inhibition,'=',-0.21,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3905357,,None,369.42,0,4.87,BDBM238402,CC1CNC(=O)c2cc(-c3cccc4ccc(Oc5ccccc5)nc34)[nH]c21,IC50,'=',61,nM,7.21,,416179,UO_0000065,19.53,0.35,2.34,10.77,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL495696,GW778894X,None,313.32,0,2.8,GW778894X,N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1,Inhibition,'=',0.59,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL191705,GW621431X,None,400.46,0,4.09,GW621431X,CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1,Inhibition,'=',-0.72,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1421,DASATINIB,4,488.02,0,3.31,A8,Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1,Activity,'>',75,%,,,,UO_0000187,,,,,0,CHEMBL4807956,Inhibition of PIM2 (unknown origin) assessed as residual activity measured at 1 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4806967,38,Patent Bioactivity Data,,,None,Dose = 1.0 microM
CHEMBL1997764,,None,343.39,0,4.49,SID103904211,COc1ccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)cc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1965423,,None,405.5,1,5.46,SID103905062,CC(C)Cn1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL66292,PYRAZOLOPYRIMIDINE 2,None,422.47,0,2.67,GW811168X,COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1,Inhibition,'=',-3.69,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL386051,,None,443.36,1,5.77,PD-173955,CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL373598,,None,447.88,0,3.35,SID103905148,N#Cc1ncc2nc1OCCCCCOc1cc(OCCCO)c(Cl)cc1NC(=O)N2,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1163566,,None,488.95,0,4.66,5n,FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21,Inhibition,'<',50,%,,,,UO_0000187,,,,,0,CHEMBL1166808,Inhibition of PIM2 at 1 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1165965,1,Scientific Literature,Bioorg Med Chem,2010,None,
CHEMBL1973937,,None,436.31,1,5.53,SID103904334,Cc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)n[nH]c12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL485246,,None,292.3,0,1.77,2,Nc1ncnc2ncn(CC(=O)c3c[nH]c4ccccc34)c12,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL950850,Inhibition of PIM2 at 10 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1137681,1,Scientific Literature,Eur J Med Chem,2009,None,
CHEMBL103104,GW831090X,None,330.37,0,2.17,GW831090X,NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1,Inhibition,'=',1.32,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL495696,GW778894X,None,313.32,0,2.8,GW778894X,N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1,Inhibition,'=',7.85,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1982957,,None,313.36,0,4,SID103904195,NC(=O)c1cccc(-c2cnc3[nH]cc(-c4ccccc4)c3c2)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1975138,,None,395.46,0,3.08,SID103904449,O=C(NNC(=S)Nc1ccc(F)cc1)C(O)(c1ccccc1)c1ccccc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL218088,GW435821X,None,268.32,0,2.67,GW435821X,Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1,Inhibition,'=',0.8,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1973348,,None,497,1,5.65,SID103904501,Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1cccc(Cl)c1,Ki,'=',158.49,nM,6.8,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1994864,,None,293.33,0,2.34,SID103904955,Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL523841,,None,364.46,0,1.22,5,CN1CCCN(c2cncc(-c3cccc(/C=C/C4=NNNN4)c3)n2)CC1,IC50,'=',160,nM,6.8,,,UO_0000065,18.65,0.34,5.58,8.42,0,CHEMBL960121,Inhibition of Pim2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153342,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL2003271,,None,399.69,1,5.21,SID103904677,NC(=O)c1sc2ccc(Cl)c(Cl)c2c1NC(=O)c1ccc(Cl)cc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL506100,,None,340.43,0,2.3,4,CN1CCCN(c2cncc(-c3cccc(CCC(=O)O)c3)n2)CC1,IC50,'=',1400,nM,5.85,,,UO_0000065,17.2,0.32,3.55,8.42,0,CHEMBL960121,Inhibition of Pim2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153342,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL493937,,None,338.41,0,2.38,1,CN1CCCN(c2cncc(-c3cccc(/C=C/C(=O)O)c3)n2)CC1,Activity,,,,,,Active,,,,,,0,CHEMBL960096,Inhibition of GST-tagged Pim2 at 140 uM after 1 hr by LC/MS analysis-based reversible binding assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153342,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL493937,,None,338.41,0,2.38,1,CN1CCCN(c2cncc(-c3cccc(/C=C/C(=O)O)c3)n2)CC1,IC50,'=',760,nM,6.12,,,UO_0000065,18.08,0.33,3.74,8.8,0,CHEMBL960130,Inhibition of Pim2 in presence of 100 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153342,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL553,ERLOTINIB,4,393.44,0,3.41,Erlotinib,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,Kd,'>',10000,nM,,,,UO_0000065,,,,,1,CHEMBL1061184,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150977,1,Scientific Literature,Nat Biotechnol,2008,None,
CHEMBL477772,PAZOPANIB,4,437.53,0,3.14,GW-786034,Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O,Kd,'>',10000,nM,,,,UO_0000065,,,,,1,CHEMBL1061184,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150977,1,Scientific Literature,Nat Biotechnol,2008,None,
CHEMBL1721885,SU-014813,2,442.49,0,1.69,SU-14813,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1,Kd,'>',10000,nM,,,,UO_0000065,,,,,1,CHEMBL1061184,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150977,1,Scientific Literature,Nat Biotechnol,2008,None,
CHEMBL24828,VANDETANIB,4,475.36,0,4.43,ZD-6474,COc1cc2/c(=N/c3ccc(Br)cc3F)nc[nH]c2cc1OCC1CCN(C)CC1,Kd,'>',10000,nM,,,,UO_0000065,,,,,1,CHEMBL1061184,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150977,1,Scientific Literature,Nat Biotechnol,2008,None,
CHEMBL496587,,None,284.13,0,2.77,24a,O=C1NC(=O)/C(=C/c2cccc(Br)c2)S1,IC50,'=',100,nM,7,,,UO_0000065,24.64,0.64,4.23,15.16,0,CHEMBL957366,Inhibition of human recombinant Pim2 by ATP depletion assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139352,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL514409,HESPERADIN,None,516.67,2,5.37,7,CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2,Activity,,,,,,Not Evaluated,,,,,,0,CHEMBL982757,Binding affinity to human PIM2 at 10 uM relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1151712,1,Scientific Literature,J Med Chem,2008,None,
CHEMBL574123,,None,348.41,0,3.85,17,CCN(CC)C(=O)/C(=N\O)c1c[nH]c2c1ccc1c3ccccc3[nH]c12,Activity,'=',27,%,,,,UO_0000187,,,,,0,CHEMBL1057614,Inhibition of Pim-2 assessed as residual enzyme activity at 10 uM relative to untreated control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154186,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL583788,,None,302.26,0,4.55,12,O=C(c1c[nH]c2c1ccc1c3ccccc3[nH]c12)C(F)(F)F,Activity,'=',54,%,,,,UO_0000187,,,,,0,CHEMBL1051392,Inhibition of Pim-2 assessed as residual enzyme activity at 1 uM relative to untreated control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154186,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL41783,,None,360.37,0,2.58,SID103905385,CN(C)CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2004872,,None,333.39,0,3.64,SID103905121,COc1cccc(C(C)NC(=O)c2ccc(-c3ccncn3)cc2)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL496784,,None,321.25,0,3.25,15a,O=C1NC(=O)/C(=C/c2cccc(OC(F)(F)C(F)F)c2)S1,IC50,'=',2200,nM,5.66,,,UO_0000065,17.61,0.37,2.41,10.21,0,CHEMBL957366,Inhibition of human recombinant Pim2 by ATP depletion assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139352,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL4468122,,None,420.52,0,2.9,16,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(CC5(N)CC5)c(NC(C)(C)C)nc34)[nH]c21,IC50,'=',0.24,nM,9.62,,,UO_0000065,22.88,0.42,6.72,8.16,0,CHEMBL4370146,Inhibition of full length recombinant PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues preincubated for 30 mins followed by biotinylated BAD addition and measured after 1 hr by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4368910,1,Scientific Literature,J Med Chem,2019,None,
CHEMBL3330410,,None,481.6,0,3.71,73,NS(=O)(=O)c1cccc(-c2n[nH]c3ccc(NC(=O)C(c4ccsc4)N4CCCC4)cc23)c1,Inhibition,'=',10,%,,,,UO_0000187,,,,,0,CHEMBL3369104,Inhibition of human Pim-2 at 1 uM by radiometric Assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352261,1,Scientific Literature,Bioorg Med Chem,2014,None,
CHEMBL1908396,,None,480.55,1,5.39,Ki-20227,COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL583719,,None,236.27,0,3.29,10,OCc1c[nH]c2c1ccc1c3ccccc3[nH]c12,Activity,'=',46,%,,,,UO_0000187,,,,,0,CHEMBL1051392,Inhibition of Pim-2 assessed as residual enzyme activity at 1 uM relative to untreated control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154186,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL2147758,,None,388.47,0,4.87,1,O=C1/C(=C/c2c[nH]c3ccccc23)Oc2c1ccc(O)c2CN1CCCCCC1,Inhibition,'=',46,%,,,,UO_0000187,,,,,0,CHEMBL2149983,Inhibition of PIM2 at 22500 nM by electrophoretic mobility shift assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2146430,1,Scientific Literature,J Med Chem,2012,None,
CHEMBL222419,GSK-237701A,None,457.94,0,5,GSK237701A,COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC,Inhibition,'=',0.96,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL496972,,None,321.38,0,2.85,30c,CN(C)c1ccc(/C=C2\C(=O)NC(=O)N2Cc2ccccc2)cc1,IC50,'>',100000,nM,,,,UO_0000065,,,,,0,CHEMBL957366,Inhibition of human recombinant Pim2 by ATP depletion assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139352,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL3660049,,None,377.42,0,3.41,BDBM104174,FC1CNCCCC1Oc1cccc2ccc(-c3nnc4ccccn34)nc12,IC50,'=',406,nM,6.39,,222588,UO_0000065,16.93,0.31,2.98,9.93,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL1909408,GSK-200398A,None,616.15,1,4.38,GSK200398A,Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1,Inhibition,'=',-0.51,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3660027,,None,346.39,0,3.1,BDBM104145,OCC1(COc2cccc3ccc(-c4nnc5ccccn45)nc23)CC1,IC50,'=',501,nM,6.3,,222562,UO_0000065,18.19,0.33,3.2,8.69,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3660028,,None,332.41,0,4.37,BDBM104146,CC(C)(C)COc1cccc2ccc(-c3nnc4ccccn34)nc12,IC50,'=',144,nM,6.84,,222563,UO_0000065,20.58,0.37,2.47,13.08,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3325692,,None,264.29,0,2.86,13,COc1ccc2c(cnc3c(N)cc4[nH]ncc4c32)c1,Activity,'=',84,%,,,,UO_0000187,,,,,0,CHEMBL3369948,Inhibition of full-length human PIM2 using RSRHSSYPAGT as substrate assessed as residual kinase activity at 10 uM after 30 mins in presence of [gamma-33P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352653,1,Scientific Literature,Bioorg Med Chem,2014,None,
CHEMBL2397525,,None,286.68,0,3.76,15c,O=[N+]([O-])c1cc2[nH]ncc2c2c1[nH]c1ccc(Cl)cc12,Activity,'=',54,%,,,,UO_0000187,,,,,0,CHEMBL2401344,Inhibition of human PIM2 assessed as residual activity using RSRHSSYPAGT as substrate at 10 uM after 30 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2396576,1,Scientific Literature,Bioorg Med Chem,2013,None,
CHEMBL3298889,,None,407.45,0,2.18,14a,NC[C@@H](NC(=O)C[C@H]1CNC(=O)c2cc(-c3ccnc(F)c3)cn21)c1ccccc1,IC50,'=',97,nM,7.01,,,UO_0000065,17.21,0.32,4.83,6.87,0,CHEMBL3300844,Inhibition of human PIM2 using ARK-RERTYSFGHHA as substrate incubated for 60 mins prior to substrate addition by topcount scintillation counting analysis in presence of [P33gamma]-ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3297733,1,Scientific Literature,Bioorg Med Chem,2013,None,
CHEMBL365072,,None,258.29,0,1.65,SB-751148,CCc1nccc2c1nc(-c1nonc1N)n2CC,Inhibition,'=',1.27,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3691957,,None,544.53,1,3.33,BDBM151979,COC(=O)N[C@@H]1[C@H](N)CN(c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(OC)cc3F)n2)C[C@@H]1C,IC50,'=',2.67,nM,8.57,,292234,UO_0000065,15.74,0.3,5.24,6.51,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3687473,,None,512.59,1,4.46,BDBM151869,C[C@@H]1C[C@H](c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)sc2N)C[C@H](N)[C@@H]1OCCC#N,IC50,'=',364.41,nM,6.44,,292125,UO_0000065,12.56,0.24,1.98,4.6,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3687533,,None,544.57,1,4.69,BDBM151930,COCCOc1cc(F)c(-c2nc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@H](OC)[C@@H](C)C3)ccc2F)c(F)c1,IC50,'=',4.03,nM,8.39,,292185,UO_0000065,15.42,0.29,3.7,7.73,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4225224,,None,374.4,0,3.4,12h,CC(C)Nc1ccc2cnn(-c3cncc(-c4ccc(C(=O)O)nc4)n3)c2c1,IC50,'>',30000,nM,,,,UO_0000065,,,,,0,CHEMBL4222673,Inhibition of human PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4219163,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL1915449,,None,470.97,0,4.72,15f,CN1CCN(c2ccc(Nc3nc4c(-c5nnc[nH]5)cccc4c4cnccc34)c(Cl)c2)CC1,IC50,'=',12,nM,7.92,,,UO_0000065,16.82,0.32,3.2,9.23,0,CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914433,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL3660085,,None,395.41,0,3.55,BDBM104213,Fc1cc(OC2CCNCCC2F)c2nc(-c3nnc4ccccn34)ccc2c1,IC50,'=',520.2,nM,6.28,,222655,UO_0000065,15.89,0.3,2.73,9.77,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3664627,,None,348.41,0,3.34,BDBM104253,CCC(CO)COc1cccc2ccc(-c3nnc4ccccn34)nc12,IC50,'=',1000,nM,6,,222664,UO_0000065,17.22,0.32,2.66,8.27,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL2005375,,None,506.65,1,4.8,SID103904641,CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCCCC4)cc3OC)nc2N1C1CCCC1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1965570,,None,444.49,1,6.59,SID103904286,Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4ccccc4F)cc3)c12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL451401,,None,161.16,0,0.66,SID103904656,NC(=O)c1cccc2cn[nH]c12,Ki,'>',15848.93,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL305477,GW829874X,None,374.4,0,3.28,GW829874X,COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1,Inhibition,'=',-0.53,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1915641,,None,469.52,0,4.93,15o,Fc1cc(OCCN2CCCC2)ccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12,IC50,'=',12,nM,7.92,,,UO_0000065,16.87,0.31,2.99,8.62,0,CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914433,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL377300,BRIVANIB,3,370.38,0,3.52,Brivanib,Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3691927,,None,500.52,1,4.68,BDBM151949,COc1cc(F)c(-c2nc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@H](OC)[C@@H](C)C3)ccc2F)c(F)c1,IC50,'=',3.02,nM,8.52,,292204,UO_0000065,17.02,0.32,3.84,8.57,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3691924,,None,662.73,1,4.64,BDBM151946,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(OC4CCOCC4)cc3F)n2)C[C@@H](N)[C@@H]1OCCS(C)(=O)=O,IC50,'=',2.69,nM,8.57,,292201,UO_0000065,12.93,0.25,3.93,6,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL468963,GW779439X,None,454.46,0,3.7,GW779439X,CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1,Inhibition,'=',51.76,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL476259,GSK-1326255A,None,517.61,2,5.28,GSK1326255A,CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1,Inhibition,'=',13.26,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL2218931,,None,376.48,0,1.11,Glycyl_H_1152,Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12,Residual Activity,'=',116,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1915646,,None,376.85,0,4.93,17d,CCNC(=O)c1cccc2c1nc(Nc1ccccc1Cl)c1ccncc12,IC50,'=',2,nM,8.7,,,UO_0000065,23.08,0.44,3.77,13,0,CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914433,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL3354512,,None,402.43,0,3.48,1R,O=C(Nc1cnccc1O[C@@H]1CCNC1)c1csc(-c2c(F)cccc2F)n1,IC50,'=',360,nM,6.44,,,UO_0000065,16.01,0.31,2.96,8.46,0,CHEMBL3376647,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352230,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL3651926,,None,452.51,0,4.18,BDBM106830,Cc1ccc(F)c(-c2cccc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@H](O)[C@@H](C)C3)n2)c1F,IC50,'=',12,nM,7.92,,225851,UO_0000065,17.5,0.33,3.74,7.83,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3298823,,None,367.38,0,2.01,13h,O=C(CC1CNC(=O)c2cc(-c3cn[nH]c3)cn21)NCc1cccc(F)c1,IC50,'=',675,nM,6.17,,,UO_0000065,16.8,0.31,4.16,6.72,0,CHEMBL3300844,Inhibition of human PIM2 using ARK-RERTYSFGHHA as substrate incubated for 60 mins prior to substrate addition by topcount scintillation counting analysis in presence of [P33gamma]-ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3297733,1,Scientific Literature,Bioorg Med Chem,2013,None,
CHEMBL3297766,,None,540.15,1,4.57,16a,CN(C)C1CCN(C[C@@H](NC(=O)C[C@H]2CNC(=O)c3cc(-c4cccc(Cl)c4)cn32)C2CCCCC2)CC1,IC50,'=',36,nM,7.44,,,UO_0000065,13.78,0.27,2.87,10.69,1,CHEMBL3300844,Inhibition of human PIM2 using ARK-RERTYSFGHHA as substrate incubated for 60 mins prior to substrate addition by topcount scintillation counting analysis in presence of [P33gamma]-ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3297733,1,Scientific Literature,Bioorg Med Chem,2013,None,
CHEMBL3298820,,None,383.47,0,3.67,13e,O=C(CC1CNC(=O)c2cc(-c3cccc(F)c3)cn21)NCC1CCCCC1,IC50,'=',2460,nM,5.61,,,UO_0000065,14.63,0.27,1.94,8.88,0,CHEMBL3300844,Inhibition of human PIM2 using ARK-RERTYSFGHHA as substrate incubated for 60 mins prior to substrate addition by topcount scintillation counting analysis in presence of [P33gamma]-ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3297733,1,Scientific Literature,Bioorg Med Chem,2013,None,
CHEMBL3691978,,None,523.52,1,3.01,BDBM152000,C[C@H]1CN(c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)c(F)cc2N)C[C@@H](N)[C@H]1n1ccnn1,IC50,'=',1.54,nM,8.81,,292255,UO_0000065,16.83,0.32,5.8,6.26,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1649761,,None,348.79,0,4.28,5,NC(=O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12,IC50,'=',1250,nM,5.9,,,UO_0000065,16.92,0.32,1.62,7.3,0,CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914433,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL1915425,,None,406.87,0,4.56,4e,COCCNC(=O)c1cccc2c1nc(Nc1cccc(Cl)c1)c1ccncc12,IC50,'=',158,nM,6.8,,,UO_0000065,16.72,0.32,2.24,8.93,0,CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914433,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL3685735,,None,448.48,0,3.61,BDBM124898,N[C@@H]1CN(c2ccncc2Nc2cccc3cnc(-c4c(F)cccc4F)nc23)CC[C@@H]1O,IC50,'=',90,nM,7.05,,254200,UO_0000065,15.71,0.29,3.44,7.03,0,CHEMBL3705221,ATP Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 ul per well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1909389,GW574782A,None,633.09,2,6.37,GW574782A,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl,Inhibition,'=',0.54,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL156263,,None,294.31,0,2.17,SB-376719,COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O,Inhibition,'=',0.14,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL156263,,None,294.31,0,2.17,SB-376719,COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O,Inhibition,'=',-0.65,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL218720,GSK-466314A,None,428.41,0,4.41,GSK466314A,CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1,Inhibition,'=',0,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1915439,,None,386.85,0,4.99,14l,CN(c1ccccc1Cl)c1nc2c(-c3nnc[nH]3)cccc2c2cnccc12,IC50,'=',15,nM,7.82,,,UO_0000065,20.22,0.38,2.83,11.08,0,CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914433,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL1915441,,None,356.36,0,4.45,14n,Fc1ccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3cnccc23)cc1,IC50,'=',16,nM,7.8,,,UO_0000065,21.88,0.39,3.35,9.82,0,CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914433,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL1952137,,None,402.42,0,3.78,8d,FC(F)(F)c1cccc(-n2nnc3ccc(NC4CC5(CCNCC5)C4)nc32)c1,IC50,'=',358,nM,6.45,,,UO_0000065,16.02,0.3,2.67,9.53,0,CHEMBL1954567,Inhibition of PIM2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1949661,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL492223,,None,310.71,0,3.03,7,CCCCn1c2cc(Cl)c(F)cc2c(=O)c2c(=O)o[nH]c21,Ki,'=',165,nM,6.78,,,UO_0000065,21.83,0.44,3.75,9.97,0,CHEMBL994191,Inhibition of Pim2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144228,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,
CHEMBL535,SUNITINIB,4,398.48,0,3.33,SU-11248,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,Kd,'>',10000,nM,,,,UO_0000065,,,,,1,CHEMBL1244923,Binding affinity to PIM2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240346,1,Scientific Literature,Blood,2009,None,
CHEMBL2004716,,None,542.71,2,5.97,SID103904320,CCN(CC)CCNC(=O)C=Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1933550,,None,404.49,0,3.27,24,O=C(c1cc2ccc(F)cc2[nH]1)N1C[C@]2(CCN(C3CCNC3)C2)c2ccccc21,IC50,'>',30000,nM,,,,UO_0000065,,,,,0,CHEMBL1936080,Inhibition of Pim-2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1933021,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL10,SB-203580,None,377.44,0,4.68,SID103904989,C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL185569,,None,357.41,0,4.55,SID103904337,Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1982506,,None,258.23,0,1.14,SID103905550,COc1cc2cnc3c(c2cc1OC)C(=O)NC3=O,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1967560,,None,522.65,1,3.61,SID103904643,CCN1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1992634,,None,273.13,0,3.99,SID103904215,Brc1cnc2[nH]cc(-c3ccccc3)c2c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3939130,,None,351.44,0,3.55,BDBM225097,CC(C)Nc1cncc(-c2c[nH]c3ccc(-c4nsc(N)n4)cc23)n1,IC50,'=',649.23,nM,6.19,,393089,UO_0000065,17.61,0.34,2.64,5.87,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL526901,,None,277.33,0,3.65,15,CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C,Activity,'=',19.2,%,,,,UO_0000187,,,,,0,CHEMBL982757,Binding affinity to human PIM2 at 10 uM relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1151712,1,Scientific Literature,J Med Chem,2008,None,
CHEMBL3660045,,None,365.41,0,3.45,BDBM104166,CC(C)(CN)COc1ccc(F)c2ccc(-c3nnc4ccccn34)nc12,IC50,'=',10000,nM,5,,222580,UO_0000065,13.68,0.25,1.55,6.38,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL396107,GW795486X,None,481.36,1,6.15,GW795486X,Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12,Inhibition,'=',0.27,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1915432,,None,316.37,0,3.17,14e,c1cc(-c2nnc[nH]2)c2nc(N3CCCC3)c3ccncc3c2c1,IC50,'=',174,nM,6.76,,,UO_0000065,21.37,0.38,3.59,9.58,0,CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914433,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL3660055,,None,426.32,0,4.07,BDBM104181,CC(C)(CN)COc1c(Br)ccc2ccc(-c3nnc4ccccn34)nc12,IC50,'=',204,nM,6.69,,222594,UO_0000065,15.69,0.34,2.62,8.54,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3660081,,None,421.48,0,3.12,BDBM104208,OCCN1CCC(F)(COc2cccc3ccc(-c4nnc5ccccn45)nc23)CC1,IC50,'=',105,nM,6.98,,222621,UO_0000065,16.56,0.31,3.86,9.21,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3660085,,None,395.41,0,3.55,BDBM104213,Fc1cc(OC2CCNCCC2F)c2nc(-c3nnc4ccccn34)ccc2c1,IC50,'=',131,nM,6.88,,222624,UO_0000065,17.41,0.32,3.33,10.7,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3652628,,None,448.5,0,3.03,BDBM119388,Cn1ncc(NC(=O)c2nc(-c3c(F)cccc3F)sc2N)c1OCC1CCNCC1,Ki,'=',46.1,nM,7.34,,246155,UO_0000065,16.36,0.32,4.31,6.85,0,CHEMBL3707982,Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1230165,SILMITASERTIB,2,349.78,0,4.88,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3651952,,None,412.51,0,3.87,BDBM106856,N[C@H]1CCC[C@@H](c2ccncc2NC(=O)c2ccc(F)c([C@H]3CC[C@H](O)CC3)n2)C1,IC50,'=',81,nM,7.09,,225877,UO_0000065,17.19,0.32,3.22,7.01,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL359999,GW801372X,None,348.37,0,2.95,GW801372X,COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1,Inhibition,'=',1.22,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL103115,GW831091X,None,348.36,0,2.31,GW831091X,NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1,Inhibition,'=',0.39,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL102936,,None,370.43,0,2.95,SB-742865,CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1,Inhibition,'=',4,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1915444,,None,390.81,1,5.1,15a,Fc1ccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3cnccc23)c(Cl)c1,IC50,'=',31,nM,7.51,,,UO_0000065,19.21,0.37,2.41,9.46,0,CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914433,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL3394067,,None,378.46,0,3.17,16,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(N5CCOCC5)n4)c3c2)s1,IC50,'=',7570,nM,5.12,,,UO_0000065,13.53,0.26,1.95,5.51,0,CHEMBL3395662,Inhibition of PIM2 in human U2OS cells assessed as phosphorylation of BAD,B,BAO_0000219,cell-based format,Homo sapiens,None,None,U2OS,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3393014,1,Scientific Literature,Bioorg Med Chem Lett,2015,CHEMBL3307757,
CHEMBL3394170,,None,338.4,0,3.12,30,CCOc1cncc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)n1,IC50,'=',2750,nM,5.56,,,UO_0000065,16.43,0.32,2.44,5.42,0,CHEMBL3395662,Inhibition of PIM2 in human U2OS cells assessed as phosphorylation of BAD,B,BAO_0000219,cell-based format,Homo sapiens,None,None,U2OS,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3393014,1,Scientific Literature,Bioorg Med Chem Lett,2015,CHEMBL3307757,
CHEMBL3394171,,None,352.42,0,3.51,31,CC(C)Oc1cncc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)n1,IC50,'=',2220,nM,5.65,,,UO_0000065,16.04,0.31,2.14,5.51,0,CHEMBL3395662,Inhibition of PIM2 in human U2OS cells assessed as phosphorylation of BAD,B,BAO_0000219,cell-based format,Homo sapiens,None,None,U2OS,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3393014,1,Scientific Literature,Bioorg Med Chem Lett,2015,CHEMBL3307757,
CHEMBL3912707,,None,527.59,1,4.1,BDBM191103,CN1CCN(Cc2ccc(-c3c(-c4cccc(OC(F)(F)F)c4)cc4n3[C@@H](CCN)CNC4=O)cc2)CC1,IC50,'=',2,nM,8.7,,341774,UO_0000065,16.49,0.31,4.6,11.48,0,CHEMBL3887520,Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3687526,,None,576.64,1,4.6,BDBM151922,CCOCc1cc(F)c(-c2nc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@@H](S(C)(=O)=O)[C@@H](C)C3)ccc2F)c(F)c1,IC50,'=',5.78,nM,8.24,,292177,UO_0000065,14.29,0.28,3.64,6.63,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3394167,,None,351.44,0,4.12,27,CC(C)Oc1cccc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)n1,IC50,'=',10,nM,8,,,UO_0000065,22.76,0.44,3.88,8.92,1,CHEMBL3395659,Inhibition of full length recombinant PIM2 (unknown origin) using biotinylated-BAD peptide as substrate assessed as phosphorylation at serine 112 after 90 mins by HTRF method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3393014,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL3394171,,None,352.42,0,3.51,31,CC(C)Oc1cncc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)n1,IC50,'=',17,nM,7.77,,,UO_0000065,22.05,0.42,4.26,7.57,1,CHEMBL3395659,Inhibition of full length recombinant PIM2 (unknown origin) using biotinylated-BAD peptide as substrate assessed as phosphorylation at serine 112 after 90 mins by HTRF method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3393014,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL264949,,None,520.95,2,5.01,K00053,O=C1Nc2ccc(I)cc2/C1=C\c1cc(Br)c(O)c(Br)c1,Thermal melting change,'=',6.8,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL162,,None,466.54,0,4.35,K00207,CN[C@@H]1CC2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,Thermal melting change,'=',12.2,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL1170139,,None,545.61,2,5.68,12,CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1,Inhibition,'=',100,%,,,,UO_0000187,,,,,0,CHEMBL1175214,Inhibition of PIM2 at 10 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1177794,1,Scientific Literature,Bioorg Med Chem Lett,2010,None,
CHEMBL1915421,,None,348.79,0,4.28,4a,NC(=O)c1cccc2c1nc(Nc1cccc(Cl)c1)c1ccncc12,IC50,'=',54,nM,7.27,,,UO_0000065,20.84,0.4,2.99,8.98,0,CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914433,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL2004419,,None,423.49,1,5.6,SID103905063,CC(C)Cn1c(N)nc2c(F)cc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL347580,,None,320.35,0,2.13,SB-361058,COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1,Inhibition,'=',0.18,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL2325904,,None,288.35,0,1.72,3f,C[C@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(C)(C)O,Inhibition,'=',3,%,,,,UO_0000187,,,,,0,CHEMBL2329527,Inhibition of PIM2 (unknown origin) at 10 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2321829,1,Scientific Literature,J Med Chem,2013,None,
CHEMBL4783935,,None,459.52,0,4.36,6,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C[C@@H](O)[C@]1(C)O,Ki,'=',3,nM,8.52,,,UO_0000065,18.55,0.36,4.16,8.94,0,CHEMBL4723884,Inhibition of PIM2 (unknown origin) using Bad peptide NH2-AGAGRSRHSSYPAGT-OH as substrate measured after 10 mins in presence of ATP by luciferase-luciferin based Kinase-Glo luminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4715870,1,Scientific Literature,J Med Chem,2020,None,TIME = 0.1667 hr
CHEMBL3393698,,None,406.44,0,4.13,13g,Fc1cccc(F)c1-c1ccc2[nH]nc(-c3cncc(NC4CCCNC4)n3)c2c1,IC50,'=',15,nM,7.82,,,UO_0000065,19.25,0.36,3.69,9.96,0,CHEMBL3396420,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as phosphorylation of biotinylated-BAD peptide at Serine 112 residue,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3392976,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL1977223,,None,360.42,0,3.61,SID103904519,CCCC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3651973,,None,440.47,1,5.04,BDBM106877,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3ccc(F)cc3F)n2)C1,IC50,'=',13,nM,7.89,,225898,UO_0000065,17.9,0.34,2.85,9.75,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3393693,,None,392.41,0,3.5,13b,NC1CCN(c2cncc(-c3n[nH]c4ccc(-c5c(F)cccc5F)cc34)n2)C1,IC50,'=',71,nM,7.15,,,UO_0000065,18.22,0.34,3.65,8.54,0,CHEMBL3396420,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as phosphorylation of biotinylated-BAD peptide at Serine 112 residue,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3392976,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL573578,,None,331.42,0,3.91,NM_PP1,CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21,Residual Activity,'=',134,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL596380,,None,193.16,0,1.66,Syk_Inhibitor_III,O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2,Residual Activity,'=',110,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL405759,,None,318.34,0,3.71,TWS119,Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1,Residual Activity,'=',84,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1241075,,None,248.28,0,3.92,3j,Cc1ccc2c(c1)[nH]c1c2ccc2c(C=O)c[nH]c21,Activity,'=',104,%,,,,UO_0000187,,,,,0,CHEMBL1248947,Inhibition of human GST fused Pim2 expressed in Escherichia coli assessed as residual activity at 1 uM after 30 mins,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240519,1,Scientific Literature,Bioorg Med Chem,2010,None,
CHEMBL485598,GSK-317354A,None,494.45,1,5.12,GSK317354A,CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1,Inhibition,'=',0.66,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL473420,GSK-1030058A,None,492.48,1,5.49,GSK1030058A,COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F,Inhibition,'=',0.49,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL2062290,,None,598.48,0,4.51,SB-739245-AC,CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O,Inhibition,'=',0.19,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL270054,GW280670X,None,350.79,0,1.76,GW280670X,NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1,Inhibition,'=',2.1,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1999321,,None,385.42,0,3.87,SID103905268,O=c1c(NCCc2ccc(Oc3ccccc3)cc2)c(Nc2ccncc2)c1=O,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1999749,,None,544.66,2,6.51,SID103905566,COc1cc(Nc2ncnc3ccc(-c4ccc(CN5CC6C(CO)C6C5)cc4)cc23)ccc1Oc1ccccc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL230911,GSK-625137A,None,289.34,0,3.1,GSK625137A,NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N,Inhibition,'=',-0.25,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL479533,HERBIMYCIN,None,574.67,1,2.71,Herbimycin_A,CO[C@H]1[C@@H](OC)C[C@H](C)[C@@H](OC)C2=CC(=O)C=C(NC(=O)/C(C)=C/C=C/[C@H](OC)[C@@H](OC(N)=O)/C(C)=C/[C@@H]1C)C2=O,Residual Activity,'=',99,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL261491,,None,442.52,0,3.65,Go-6983,COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C,Residual Activity,'=',36,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL56543,,None,294.31,0,2.32,Tyrphostin_B42,N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1,Residual Activity,'=',112,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL92461,,None,307.38,0,4.13,VEGF_Receptor_2_Kinase_Inhibitor_IV,COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1,Residual Activity,'=',116,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL188762,,None,371.24,0,4.48,PD-174265,CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,Residual Activity,'=',94,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL13045,CHELERYTHRINE,None,348.38,0,3.72,Chelerythrine,COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC,Residual Activity,'=',88,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL404941,,None,311.34,0,3.21,SU5607,COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1,Residual Activity,'=',137,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL599894,,None,224.18,0,0.13,PDK1_Akt_Flt_Dual_Pathway_Inhibitor,O=C1c2ccccc2-c2nc3nnnn3nc21,Residual Activity,'=',104,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2218930,,None,473.55,1,5.48,PDGF_RTK_Inhibitor,COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC,Residual Activity,'=',115,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL7724,AG1295,None,234.3,0,3.91,Tyrphostin AG-1295,Cc1cc2ncc(-c3ccccc3)nc2cc1C,Residual Activity,'=',126,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1289494,TIVOZANIB,4,454.87,1,5.64,Tivozanib,COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC,Residual Activity,'=',103,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3918913,,None,362.46,0,4.15,BDBM224943,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(NCC5CC5)n4)c3c2)s1,IC50,'=',144.67,nM,6.84,,393227,UO_0000065,18.87,0.36,2.69,7.39,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL215814,GW576484X,None,614.62,2,6.5,GW576484X,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1,Inhibition,'=',0.66,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3687517,,None,618.68,1,4.63,BDBM151913,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(OC4CCOCC4)cc3F)n2)C[C@@H](N)[C@H]1S(C)(=O)=O,IC50,'=',7.69,nM,8.11,,292169,UO_0000065,13.12,0.26,3.48,6.08,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2017355,,None,368.43,0,4.85,13w,N#Cc1cccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3sccc23)c1,IC50,'=',12,nM,7.92,,,UO_0000065,21.5,0.4,3.07,8.77,0,CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016532,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL3652625,,None,409.47,0,2.38,BDBM119385,Cn1ncc(NC(=O)c2nc(-c3ccccc3F)ccc2N)c1N1CCC[C@@H](N)C1,Ki,'=',2.49,nM,8.6,,246152,UO_0000065,21.01,0.39,6.22,7.48,0,CHEMBL3707982,Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2036117,,None,405.5,1,5.39,7,CC(C)(C)OC(=O)NCCCCn1c2ccccc2c2ccc3c(C=O)c[nH]c3c21,Activity,'=',97,%,,,,UO_0000187,,,,,0,CHEMBL2040257,Inhibition of Pim-2 using RSRHSSYPAGT as substrate assessed as residual activity at 1 uM after 30 mins,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034961,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL2036118,,None,333.44,0,4.43,10,CN(C)CCCCn1c2ccccc2c2ccc3c(C=O)c[nH]c3c21,Activity,'=',74,%,,,,UO_0000187,,,,,0,CHEMBL2040257,Inhibition of Pim-2 using RSRHSSYPAGT as substrate assessed as residual activity at 1 uM after 30 mins,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034961,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL476351,GW775608X,None,470.57,0,4.29,GW775608X,Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1,Inhibition,'=',-0.82,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL572006,,None,506.56,1,4.68,18,COc1ccc(/C=C/C(=O)Nc2cc(-c3[nH]c([S+](C)[O-])nc3-c3ccc(F)cc3)ccn2)c(OC)c1,Activity,'=',101,%,,,,UO_0000187,,,,,0,CHEMBL1049899,Inhibition of PIM2 assessed as residual activity at 0.1 uM by Cherenkov counting relative to control in presence of 5 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1155278,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL235641,,None,268.3,0,2.51,PKR_Inhibitor,O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1,Residual Activity,'=',13,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL516312,,None,339.36,0,3.75,2,N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1,Activity,'=',3.1,%,,,,UO_0000187,,,,,0,CHEMBL982757,Binding affinity to human PIM2 at 10 uM relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1151712,1,Scientific Literature,J Med Chem,2008,None,
CHEMBL458438,GSK-1511931A,None,508.63,2,5.53,GSK1511931A,COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1,Inhibition,'=',-0.9,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL330422,,None,396.47,0,2.82,SB-226879,CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1,Inhibition,'=',2.65,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1909381,GW575808A,None,371.83,0,3.08,GW575808A,Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl,Inhibition,'=',-3.06,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL385426,GW450241X,None,294.4,0,3.74,GW450241X,CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1,Inhibition,'=',-0.07,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1171523,,None,506.57,2,5.2,3,CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1,Inhibition,'=',100,%,,,,UO_0000187,,,,,0,CHEMBL1175214,Inhibition of PIM2 at 10 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1177794,1,Scientific Literature,Bioorg Med Chem Lett,2010,None,
CHEMBL1186409,,None,487.65,1,7.32,AG_G_60025,CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21,Residual Activity,'=',101,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL7724,AG1295,None,234.3,0,3.91,Tyrphostin AG-1295,Cc1cc2ncc(-c3ccccc3)nc2cc1C,Residual Activity,'=',115,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2397528,,None,256.7,0,3.43,16c,Nc1cc2[nH]ncc2c2c1[nH]c1ccc(Cl)cc12,Activity,'=',34,%,,,,UO_0000187,,,,,0,CHEMBL2401344,Inhibition of human PIM2 assessed as residual activity using RSRHSSYPAGT as substrate at 10 uM after 30 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2396576,1,Scientific Literature,Bioorg Med Chem,2013,None,
CHEMBL1649762,,None,305.77,1,5.18,11,Clc1cccc(Nc2nc3ccccc3c3cnccc23)c1,IC50,'>',2500,nM,,,,UO_0000065,,,,,0,CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914433,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL2397601,,None,222.25,0,2.78,7a,Nc1cc2cn[nH]c2c2c1[nH]c1ccccc12,Activity,'=',116,%,,,,UO_0000187,,,,,0,CHEMBL2401343,Inhibition of human PIM2 assessed as residual activity using RSRHSSYPAGT as substrate at 1 uM after 30 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2396576,1,Scientific Literature,Bioorg Med Chem,2013,None,
CHEMBL3928490,,None,407.43,0,3.35,22f,N[C@H]1CCN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1,IC50,'>',1000,nM,,,,UO_0000065,,,,,0,CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3864151,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL3913540,,None,418.48,0,3.24,30a,C[C@@H]1C[C@H](N)CN(c2ccncc2Nc2ncc3ccc(-c4ncccc4F)nn23)C1,IC50,'=',0.43,nM,9.37,,,UO_0000065,22.38,0.41,6.13,9.63,0,CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3864151,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL1164265,,None,470.96,0,4.26,5h,CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1,Inhibition,'<',50,%,,,,UO_0000187,,,,,0,CHEMBL1166808,Inhibition of PIM2 at 1 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1165965,1,Scientific Literature,Bioorg Med Chem,2010,None,
CHEMBL271843,GW275944X,None,330.37,0,1.41,GW275944X,Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2,Inhibition,'=',0.28,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL602937,FASCAPLYSIN,None,271.3,0,3.14,Fascaplysin,O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21,Residual Activity,'=',130,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3651986,,None,410.54,1,5.15,BDBM106891,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(C3CCCCC3)n2)C1,IC50,'=',12,nM,7.92,,225912,UO_0000065,19.29,0.36,2.77,9.79,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1997846,,None,327.82,0,4.42,SID103904204,Clc1cc(NC2CCCCC2)nc(-c2c[nH]c3ncccc23)n1,Ki,'>',1995.26,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2002407,,None,281.28,0,1.64,SID103905206,COc1cc(C=C(C#N)c2n[nH]c(N)c2C#N)ccc1O,Ki,'=',398.11,nM,6.4,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1909406,,None,333.82,0,3.86,SKF-86002-A2,Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1,Inhibition,'=',-3.08,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1909345,,None,422.87,0,2.97,SB-686709-A,CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl,Inhibition,'=',0.04,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3651991,,None,453.49,0,3.46,BDBM106897,C[C@@H]1C[C@H](c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)ccc2N)C[C@@H](N)[C@H]1O,IC50,'=',10,nM,8,,225918,UO_0000065,17.64,0.33,4.54,6.29,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3666763,,None,432.53,0,1.96,BDBM141326,CN1CCN(c2ccc(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3C)CCC4)cc2)CC1,IC50,'=',3599,nM,5.44,,276607,UO_0000065,12.59,0.23,3.48,5.17,0,CHEMBL3707966,Kinase Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates are trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP,,,,,,,,,,,,,,,,,,,,,,
CHEMBL365297,GW827099X,None,440.44,0,4.51,GW827099X,Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1,Inhibition,'=',0.26,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1909351,GW824645A,None,368.82,0,2.61,GW824645A,Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1,Inhibition,'=',0.15,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1971021,,None,439.44,1,5.88,SID103904332,Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C(F)(F)F)c2)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL188784,GW828529X,None,468.39,1,5.89,GW828529X,Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F,Inhibition,'=',5.02,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1974310,,None,272.3,0,3.2,SID103904987,NC(=O)c1cc2c(-c3ccc(F)cc3)cncc2s1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL187985,,None,299.34,0,1.68,SB-744941,CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21,Inhibition,'=',0.29,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3914287,,None,404.45,0,3,21g,N[C@H]1CCCN(c2ccncc2Nc2ncc3ccc(-c4ncccc4F)nn23)C1,IC50,'=',1.1,nM,8.96,,,UO_0000065,22.15,0.41,5.96,9.21,0,CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3864151,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL3911258,,None,421.46,0,3.74,22a,N[C@@H]1CCCN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1,IC50,'=',35,nM,7.46,,,UO_0000065,17.69,0.33,3.72,8.84,0,CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3864151,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL2442309,,None,336.44,0,2.76,11h,NCCNc1ccn2ncc(-c3cccc(N4CCCCC4)c3)c2n1,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL2446210,Inhibition of Pim2 (unknown origin) using STK1 as substrate preincubated for 30 mins followed by substrate and ATP addition at > 5000 nM after 60 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2440090,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL2000354,,None,326.38,0,3.29,SID103905208,COc1ccc(C=C2SC(=Nc3ccccc3)NC2=O)cc1O,Ki,'=',251.19,nM,6.6,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2001257,,None,483.64,1,6.19,SID103904319,CCN(CC)CC#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2397524,,None,282.26,0,3.11,15b,COc1ccc2[nH]c3c([N+](=O)[O-])cc4[nH]ncc4c3c2c1,Activity,'=',35,%,,,,UO_0000187,,,,,0,CHEMBL2401344,Inhibition of human PIM2 assessed as residual activity using RSRHSSYPAGT as substrate at 10 uM after 30 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2396576,1,Scientific Literature,Bioorg Med Chem,2013,None,
CHEMBL219722,,None,343.39,0,4.46,SID103904370,Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL117697,,None,251.29,0,3.38,SID103904646,COc1cccc(Nc2ncnc3ccccc23)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2005936,,None,436.52,1,5.28,SID103904513,CCCC(=O)Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12,Ki,'=',1258.93,nM,5.9,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1966628,,None,308.39,0,2.7,SID103904203,NC1CCC(Nc2nccc(-c3c[nH]c4ncccc34)n2)CC1,Ki,'=',501.19,nM,6.3,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL4089255,,None,453.07,0,2.5,Tab 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3935173,,None,363.45,0,3.43,BDBM224941,CC1(C)CNc2ncc(-c3c[nH]c4ccc(-c5nnc(N)s5)cc34)nc21,IC50,'=',32.39,nM,7.49,,393224,UO_0000065,20.61,0.39,4.06,7.11,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1967887,,None,268.32,0,2.27,SID103904469,Cc1n[nH]c2ccc(-c3cncc(OCCN)c3)cc12,Ki,'=',251.19,nM,6.6,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1988717,,None,492.47,1,5.04,SID103904289,Cn1cc(-c2cnn3c(N)c(-c4ccc(NC(=O)Nc5cccc(C(F)(F)F)c5)cc4)cnc23)cn1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL231013,GSK-605714A,None,228.25,0,1.86,GSK605714A,COc1ccc(-c2ccncc2)cc1C(N)=O,Inhibition,'=',-0.52,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL160876,,None,377.18,0,3.17,SB-360741,O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1,Inhibition,'=',1.05,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3120215,OSI-027,2,406.45,0,3.22,OSI-027,COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL1999718,,None,357.3,0,4.16,SID103904897,N#Cc1ccc(NC(=O)Nc2ccnc3cc(C(F)(F)F)ccc23)nc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3932475,,None,426.53,0,3.39,BDBM248950,Cc1cncc(-c2cc3c(cn2)cnn3-c2ccc(C3CC3)c(N3CCC[C@H](N)C3)n2)n1,Ki,'=',0.077,nM,10.11,,434157,UO_0000065,23.71,0.43,6.72,10.25,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL510884,,None,324.38,0,2.04,7,O=C(O)/C=C/c1cccc(-c2cncc(N3CCCNCC3)n2)c1,IC50,'=',10,nM,8,,,UO_0000065,24.66,0.46,5.96,10.21,0,CHEMBL960121,Inhibition of Pim2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153342,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL381604,GW799251X,None,446.87,0,4.36,GW799251X,Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1,Inhibition,'=',1.29,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL4077977,,None,439.08,0,2.97,Tab 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL377193,,None,292.29,0,3.29,Flt_3_Inhibitor_II,O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1,Residual Activity,'=',64,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3687452,,None,498.51,0,4.4,BDBM151848,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)C12OCCO2,IC50,'=',1.96,nM,8.71,,292104,UO_0000065,17.47,0.33,4.31,8.76,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL261425,,None,294.74,0,4.31,Cdk1_Inhibitor,O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12,Residual Activity,'=',16,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1909396,GW768505A,None,573.93,2,6.95,GW768505A,COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl,Inhibition,'=',1.06,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1794069,GSK-571989A,None,525.07,2,5.7,GSK571989A,C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl,Inhibition,'=',2.74,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL2004771,,None,341.37,0,4.48,SID103904651,O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3o2)cc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL127907,,None,297.31,0,3.1,K00036,COc1cc2ncnc(Nc3cccc(O)c3)c2cc1OC,Thermal melting change,'=',0.6,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL521851,PICTILISIB,2,513.65,1,2.15,Pictilisib,CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL255863,NILOTINIB,4,529.53,2,6.36,Nilotinib,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL4078687,,None,411.03,0,2.19,Tab 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1782518,,None,354.2,0,3.27,26,O=C(O)c1cc2cc(Br)cc(OCC3CCNCC3)c2o1,IC50,'=',250,nM,6.6,,,UO_0000065,18.64,0.43,3.33,9.21,0,CHEMBL1786238,Inhibition of human Pim2 using 5-FAM-RSRHSSYPAGT-CONH2 as substrate after 90 mins by off-chip mobility shift method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1781944,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL1990254,,None,317.39,0,3.18,SID103904555,NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1229517,VEMURAFENIB,4,489.93,1,5.54,Vemurafenib,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL572878,TOZASERTIB,2,464.6,0,3.5,SID103905648,Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL4064302,,None,467.14,0,3.44,Tab 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2376143,,None,461.91,0,2.87,5,C[C@@H](NC(=O)c1c[nH]c2ncc(-c3cn(C)c4cc(Cl)ccc34)nc12)C(=O)N1CC(C#N)C1,Inhibition,'=',-18,%,,Outside typical range,,UO_0000187,,,,,0,CHEMBL2378211,Inhibition of PIM2 (unknown origin) at 10 uM relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2375236,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL1782520,,None,354.2,0,3.27,28,O=C(O)c1cc2cc(Br)cc(OCC3CCCNC3)c2o1,IC50,'=',330,nM,6.48,,,UO_0000065,18.3,0.42,3.21,9.04,0,CHEMBL1786238,Inhibition of human Pim2 using 5-FAM-RSRHSSYPAGT-CONH2 as substrate after 90 mins by off-chip mobility shift method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1781944,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL1885746,GW561436X,None,370.39,0,4.04,GW561436X,N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1,Inhibition,'=',-0.15,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL189353,GW809897X,None,571.49,2,6.48,GW809897X,CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1,Inhibition,'=',0.1,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL2377710,,None,202.17,0,1.95,9,O=[N+]([O-])c1cc2cn[nH]c2c2cc[nH]c12,Inhibition,'=',92,%,,,,UO_0000187,,,,,0,CHEMBL2378598,Inhibition of human full length Pim-2 using RSRHSSYPAGT as substrate assessed as residual activity at 1 uM after 30 mins in presence of [gamma-33P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2375344,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL3325695,,None,219.25,0,3.26,18,c1ccc2c(c1)cnc1ccc3[nH]ncc3c12,Activity,'=',84.6,%,,,,UO_0000187,,,,,0,CHEMBL3370182,Inhibition of full-length human PIM2 using RSRHSSYPAGT as substrate assessed as residual kinase activity at 1 uM after 30 mins in presence of [gamma-33P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352653,1,Scientific Literature,Bioorg Med Chem,2014,None,
CHEMBL3651903,,None,406.46,0,4.23,BDBM106807,N[C@H]1CCC[C@@H](c2ccncc2NC(=O)c2cccc(-c3cc(O)ccc3F)n2)C1,IC50,'=',8,nM,8.1,,225828,UO_0000065,19.92,0.37,3.87,8.01,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL539474,,None,281.31,0,1.9,SID103904913,O=C1CCCN1Cc1ccc2c(c1)[nH]c(=O)c1cccn12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1989708,,None,498.61,1,5.74,SID103904354,Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3687439,,None,481.48,1,5.33,BDBM151834,C[C@@H]1C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@H](N)[C@@H]1N=[N+]=[N-],IC50,'=',237.5,nM,6.62,,292090,UO_0000065,13.76,0.26,1.29,5.11,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1076555,,None,302.79,0,4.91,SKI_II,Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1,Residual Activity,'=',126,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1331734,,None,271.34,0,4.07,Cdk4_Inhibitor_II,COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12,Residual Activity,'=',117,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1363184,,None,306.37,0,2.87,LY-303511,O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12,Residual Activity,'=',100,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3687492,,None,473.55,0,4.17,BDBM151888,CO[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)sc2N)C[C@@H]1C,IC50,'=',0.62,nM,9.21,,292144,UO_0000065,19.44,0.38,5.04,7.93,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3651966,,None,440.47,1,5.04,BDBM106870,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C1,IC50,'=',2,nM,8.7,,225891,UO_0000065,19.75,0.37,3.66,10.75,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3687422,,None,541.57,2,5.16,BDBM151815,CC(C)OC(=O)N[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H]1C,IC50,'=',59.37,nM,7.23,,292071,UO_0000065,13.34,0.25,2.07,6.06,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1977148,,None,500.58,2,5.05,SID103904318,COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CCO)c5)cnc(N)c34)cc2)cc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL504950,,None,230.3,0,2.44,SID103905425,Cc1cc(C)c2c(n1)sc1c(N)ncnc12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1977041,,None,416.44,0,3.72,SID103904316,COC(=O)c1c(-c2ccc(NC(=O)Nc3ccccc3)cc2)c2c(N)ncnn2c1C,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1277459,,None,278.36,0,3.68,14b,CC1(C)[C@H]2CC[C@]1(C)c1nc3cc4[nH]ncc4cc3nc12,Activity,'=',78,%,,,,UO_0000187,,,,,0,CHEMBL1285678,Inhibition of Pim2 assessed as residual enzyme activity at 10 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1275327,1,Scientific Literature,Eur J Med Chem,2010,None,
CHEMBL1275912,,None,238.29,0,2.8,(+/-)-17a,CC1Cc2nc3cc4cn[nH]c4cc3nc2C1C,Activity,,,,,,Not Active,,,,,,0,CHEMBL1285679,Inhibition of Pim2 assessed as residual enzyme activity at 1 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1275327,1,Scientific Literature,Eur J Med Chem,2010,None,
CHEMBL2312301,,None,466.59,0,3.19,29,COc1ccccc1CNc1ncc(C(=O)NCCCN2CCCC2=O)c(NC2CCCC2)n1,IC50,'>',30000,nM,,,,UO_0000065,,,,,0,CHEMBL2319122,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2311468,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL3931386,,None,421.46,0,3.74,21d,N[C@H]1CCCN(c2ccncc2Nc2ncc3ccc(-c4ccc(F)cc4F)nn23)C1,IC50,'=',3.1,nM,8.51,,,UO_0000065,20.19,0.37,4.77,10.08,0,CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3864151,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL1782530,,None,353.22,0,3.58,38,N[C@H]1CC[C@@H](Nc2cc(Br)cc3cc(C(=O)O)oc23)CC1,IC50,'=',4,nM,8.4,,,UO_0000065,23.78,0.55,4.82,9.49,0,CHEMBL1786238,Inhibition of human Pim2 using 5-FAM-RSRHSSYPAGT-CONH2 as substrate after 90 mins by off-chip mobility shift method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1781944,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL1278026,,None,412.41,0,2.23,15,NC(=O)c1cccc(CNC(=O)c2cc3c(c4c2[nH]c2ccccc24)C(=O)NC3=O)c1,Inhibition,,,%,,,Active,UO_0000187,,,,,0,CHEMBL1285298,Inhibition of PIM2 at 0.1 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1275361,1,Scientific Literature,Bioorg Med Chem,2010,None,
CHEMBL13485,SU-11652,None,414.94,0,3.85,SU11652,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C,Residual Activity,'=',99,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL599894,,None,224.18,0,0.13,PDK1_Akt_Flt_Dual_Pathway_Inhibitor,O=C1c2ccccc2-c2nc3nnnn3nc21,Residual Activity,'=',108,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4060295,,None,396.45,0,4.55,9d,CNc1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)on3)c(C)c2)ncn1,Activity,'=',78,%,,,,UO_0000187,,,,,0,CHEMBL3995049,Inhibition of human PIM2 (M1 to E291 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by KINOMEscan assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3994581,1,Scientific Literature,Eur J Med Chem,2017,None,
CHEMBL573929,,None,414.33,0,4.23,21,O=c1[nH]c(CNCCc2ccccc2)nc2c1sc1ccc(Br)cc12,Ki,'=',41,nM,7.39,,,UO_0000065,17.83,0.4,3.16,12.79,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL3651965,,None,440.47,1,5.04,BDBM106869,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)ccc2F)C1,IC50,'=',7,nM,8.15,,225890,UO_0000065,18.51,0.35,3.11,10.08,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3651924,,None,422.48,0,4.97,BDBM106828,Cc1ccc(F)c(-c2cccc(C(=O)Nc3cnccc3[C@@H]3CCC[C@H](N)C3)n2)c1F,IC50,'=',11,nM,7.96,,225849,UO_0000065,18.84,0.35,2.99,9.84,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3774448,,None,272.35,0,2.72,17,O=C1NC(=S)S/C1=C\c1ccc2ncccc2c1,Inhibition,'=',31,%,,,,UO_0000187,,,,,0,CHEMBL3778662,Inhibition of full length recombinant human GST-tagged PIM2 expressed in baculovirus expression system at 1 uM by lantha screen kinase binding assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3774321,1,Scientific Literature,Eur J Med Chem,2016,None,
CHEMBL2377709,,None,320.35,0,3.47,27,CCOC(=O)c1[nH]c2c(N)cc3cn[nH]c3c2c1-c1ccccc1,Inhibition,'=',74,%,,,,UO_0000187,,,,,0,CHEMBL2378599,Inhibition of human full length Pim-2 using RSRHSSYPAGT as substrate assessed as residual activity at 10 uM after 30 mins in presence of [gamma-33P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2375344,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL38380,FASUDIL,3,291.38,0,1.22,HA-1077,O=S(=O)(c1cccc2cnccc12)N1CCCNCC1,Residual Activity,'=',138,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1964307,,None,356.43,0,4.3,SID103905033,Cc1cccc(NC(=O)Cc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL210928,,None,443.91,0,2.32,SID103905197,CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1Cl,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL554,LAPATINIB,4,581.07,2,6.14,GW-2016,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,Kd,,,,,,Not Active,,,,,,0,CHEMBL859489,Average Binding Constant for PIM2; NA=Not Active at 10 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144455,1,Scientific Literature,Nat Biotechnol,2005,None,
CHEMBL2377718,,None,278.27,0,3.62,17,O=[N+]([O-])c1cc2cn[nH]c2c2c(-c3ccccc3)c[nH]c12,Inhibition,'=',82,%,,,,UO_0000187,,,,,0,CHEMBL2378598,Inhibition of human full length Pim-2 using RSRHSSYPAGT as substrate assessed as residual activity at 1 uM after 30 mins in presence of [gamma-33P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2375344,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL2377717,,None,302.29,0,2.69,16,CCCc1c(C(=O)OC)[nH]c2c([N+](=O)[O-])cc3cn[nH]c3c12,Inhibition,'=',113,%,,,,UO_0000187,,,,,0,CHEMBL2378598,Inhibition of human full length Pim-2 using RSRHSSYPAGT as substrate assessed as residual activity at 1 uM after 30 mins in presence of [gamma-33P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2375344,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL2377715,,None,288.26,0,2.44,14,CCOC(=O)c1[nH]c2c([N+](=O)[O-])cc3cn[nH]c3c2c1C,Inhibition,'=',105,%,,,,UO_0000187,,,,,0,CHEMBL2378598,Inhibition of human full length Pim-2 using RSRHSSYPAGT as substrate assessed as residual activity at 1 uM after 30 mins in presence of [gamma-33P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2375344,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL1971694,,None,282.34,0,3.3,SID103904461,CCCCNc1n[s+]([O-])nc1Nc1ccc(F)cc1,Ki,'=',1258.93,nM,5.9,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1978448,,None,331.4,0,1.7,SID103904912,CS(=O)(=O)N(Cc1ccc2[nH]c(=O)c3cccn3c2c1)C1CC1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL437747,,None,513.52,2,6.94,SID103905437,CCCn1c(C2CCNCC2)nc(-c2ccc(Cl)c(Cl)c2)c1-c1ccnc(NC2CCCCC2)n1,Ki,'=',125.89,nM,6.9,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2000508,,None,295.34,0,4.26,SID103905065,Fc1ccc(-c2nc3sccn3c2-c2ccncc2)cc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1990346,,None,288.15,0,3.57,SID103905032,Nc1n[nH]c2cccc(-c3ccc(Br)cc3)c12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1967531,,None,361.43,0,4.58,SID103904284,Nc1ncnc2scc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL104468,,None,281.31,0,2.78,NU7026,O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12,Residual Activity,'=',45,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1910915,,None,440.48,0,4.49,37,Nc1ccc(-c2c[nH]c3ccc(-c4cncc(OC[C@H](N)c5ccccc5)n4)cc23)c(F)n1,IC50,'=',20,nM,7.7,,,UO_0000065,17.48,0.32,3.21,6.65,0,CHEMBL1912526,Inhibition of PIM2 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1909629,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL1910913,,None,420.49,0,4.16,35,CC(C)(C)[C@H](N)COc1cncc(-c2ccc3[nH]cc(-c4ccc(N)nc4F)c3c2)n1,IC50,'=',122,nM,6.91,,,UO_0000065,16.44,0.3,2.75,5.97,0,CHEMBL1912526,Inhibition of PIM2 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1909629,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL3651983,,None,424.45,0,3.63,BDBM106887,N[C@@H]1C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3ccccc3F)n2)CC[C@@H]1O,IC50,'=',35,nM,7.46,,225908,UO_0000065,17.57,0.33,3.83,7.37,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1910911,,None,392.44,0,3.52,33,CC[C@H](N)COc1cncc(-c2ccc3[nH]cc(-c4ccc(N)nc4F)c3c2)n1,IC50,'=',26,nM,7.58,,,UO_0000065,19.33,0.36,4.07,6.55,0,CHEMBL1912526,Inhibition of PIM2 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1909629,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL1910896,,None,385.47,0,3.71,10,COc1ccc(-c2ccc3c(-c4ccc(N5CCNCC5)cc4)n[nH]c3n2)cc1,IC50,'>',25000,nM,,,,UO_0000065,,,,,0,CHEMBL1912526,Inhibition of PIM2 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1909629,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL1081678,,None,438.23,0,3.05,12r,Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1,Inhibition,'<',50,%,,,,UO_0000187,,,,,0,CHEMBL1100998,Inhibition of PIM2 at 10 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154277,1,Scientific Literature,Bioorg Med Chem Lett,2009,None,
CHEMBL4061455,,None,369.98,0,2.58,Tab 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1241011,,None,262.31,0,4.18,3i,CCc1cccc2c1[nH]c1c2ccc2c(C=O)c[nH]c21,Activity,'=',66,%,,,,UO_0000187,,,,,0,CHEMBL1248947,Inhibition of human GST fused Pim2 expressed in Escherichia coli assessed as residual activity at 1 uM after 30 mins,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240519,1,Scientific Literature,Bioorg Med Chem,2010,None,
CHEMBL3906850,,None,415.38,0,2.42,BDBM249024,OC1CN(c2cccc(-n3ncc4cnc(-c5cnn(CC(F)(F)F)c5)cc43)n2)C1,Ki,'=',9.62,nM,8.02,,434228,UO_0000065,19.3,0.36,5.6,9.44,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL210618,,None,356.38,0,2.13,JNK_inhibitor_VIII,CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N,Residual Activity,'=',142,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1725279,SP-600125,None,220.23,0,4.43,SP600125,Oc1c2ccccc2c2c3c(cccc13)N=N2,Residual Activity,'=',58,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3809565,,None,361.45,0,3.6,10e,Cc1nc2cccc3c2nc1NC[C@@H](C)CC[C@H]1CNC(=O)c2cc-3[nH]c21,IC50,'=',0.3,nM,9.52,,,UO_0000065,26.35,0.48,5.92,11.51,0,CHEMBL3812018,Inhibition of human full-length Pim2 expressed in Escherichia coli assessed as phosphorylation of biotinylated BAD peptide at Ser 112 preincubated for 30 mins followed by substrate addition measured after 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3808325,1,Scientific Literature,ACS Med Chem Lett,2016,None,
CHEMBL3809940,,None,359.43,0,3.52,9d,C/C1=C/C[C@H]2CNC(=O)c3cc([nH]c32)-c2cccc3nc(C)c(nc23)NC1,IC50,'=',0.2,nM,9.7,,,UO_0000065,26.98,0.49,6.18,11.73,0,CHEMBL3812018,Inhibition of human full-length Pim2 expressed in Escherichia coli assessed as phosphorylation of biotinylated BAD peptide at Ser 112 preincubated for 30 mins followed by substrate addition measured after 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3808325,1,Scientific Literature,ACS Med Chem Lett,2016,None,
CHEMBL4129891,,None,375.45,0,4.4,23,CN(C)CCNc1cncc(-c2ccc3[nH]cc(-c4ccc(F)cc4)c3c2)n1,IC50,'=',1620,nM,5.79,,,UO_0000065,15.42,0.28,1.39,10.19,0,CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4118246,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL4127890,,None,373.39,0,3.96,36,O=C1NCCN1c1cncc(-c2ccc3[nH]cc(-c4ccccc4F)c3c2)n1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4118246,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL4745474,,None,420.38,0,4.13,57,O=C(Nc1c[nH]nc1-c1cc2ccccc2cc1OC(F)F)c1cnn2cccnc12,Inhibition,'=',-1,%,,,,UO_0000187,,,,,0,CHEMBL4666957,Inhibition of recombinant human GST-tagged full length PIM2 expressed in baculovirus expression system using Ser/Thr 07 as substrate at 0.1 uM incubated for 60 mins by Z'-lyte assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4665643,1,Scientific Literature,Bioorg Med Chem Lett,2019,None,Dose = 0.1 microM | TIME = 1.0 hr
CHEMBL3793600,,None,400.42,0,3.76,2d,Nc1ccc(-c2ccncc2NC(=O)c2nc(-c3ccccc3F)ccc2N)cn1,Ki,'=',158,nM,6.8,,,UO_0000065,16.99,0.31,3.04,5.68,0,CHEMBL3794688,Inhibition of Pim2 (unknown origin) using BAD peptide preincubated for 15 mins followed by ATP addition measured after 60 to 100 mins by Kinase-Glo reagent based luminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3792348,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL3792474,,None,401.41,0,3.16,2f,Nc1cncc(-c2ccncc2NC(=O)c2nc(-c3ccccc3F)ccc2N)n1,Ki,'=',94,nM,7.03,,,UO_0000065,17.51,0.32,3.87,5.3,0,CHEMBL3794688,Inhibition of Pim2 (unknown origin) using BAD peptide preincubated for 15 mins followed by ATP addition measured after 60 to 100 mins by Kinase-Glo reagent based luminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3792348,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL3792905,,None,416.42,0,2.74,3d,Nc1cc(-c2ccncc2NC(=O)c2nc(-c3ccccc3F)ccc2N)nc(N)n1,Ki,'=',120,nM,6.92,,,UO_0000065,16.62,0.3,4.18,4.36,0,CHEMBL3794688,Inhibition of Pim2 (unknown origin) using BAD peptide preincubated for 15 mins followed by ATP addition measured after 60 to 100 mins by Kinase-Glo reagent based luminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3792348,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL3793035,,None,415.43,0,3.46,4c,Cc1cc(-c2ccncc2NC(=O)c2nc(-c3ccccc3F)ccc2N)nc(N)n1,Ki,'<',3,nM,,,,UO_0000065,,,,,0,CHEMBL3794688,Inhibition of Pim2 (unknown origin) using BAD peptide preincubated for 15 mins followed by ATP addition measured after 60 to 100 mins by Kinase-Glo reagent based luminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3792348,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL1980802,,None,391.77,0,1.14,SID103905156,N#Cc1ncc2nc1OCC(O)C(O)COc1ccc(Cl)cc1NC(=O)N2,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1979357,,None,354.46,0,4.23,SID103905237,Cn1cc(C(CN)c2cncc(C=Cc3ccncc3)c2)c2ccccc21,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2005631,,None,449.51,0,5,SID103904310,CNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cc(C)ccc4F)cc3)csc12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1969588,,None,334.81,0,4.89,SID103904192,Clc1cc(-c2c[nH]c3ncccc23)cc(NCc2ccccc2)n1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1987007,,None,340.45,0,3.12,SID103904998,CN1CCC(NC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)CC1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1990254,,None,317.39,0,3.18,SID103904554,NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1970217,,None,346.43,0,4.56,SID103904557,COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3C)cc2)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1988370,,None,453.59,1,5.31,SID103904996,Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2C1CC(CN2CCCC2)C1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3942495,,None,390.47,0,3.92,BDBM224962,CNc1nnc(-c2ccc3[nH]cc(-c4cccc(N5CCCC5=O)n4)c3c2)s1,IC50,'=',80.44,nM,7.09,,393252,UO_0000065,18.17,0.35,3.17,8.17,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1173655,AFATINIB,4,485.95,0,4.39,Afatinib,CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3687427,,None,552.56,1,3.58,BDBM151820,COCc1cn([C@@H]2[C@H](N)CN(c3ccncc3NC(=O)c3ccc(F)c(-c4c(F)cccc4F)n3)C[C@@H]2C)nn1,IC50,'=',1.72,nM,8.76,,292076,UO_0000065,15.86,0.3,5.18,7.06,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL522502,,None,356.43,0,4.66,NF_kB_Activation_Inhibitor,Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1,Residual Activity,'=',136,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1096634,GSK-943949A,None,447.5,0,2.28,GSK943949A,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21,Inhibition,'=',0.71,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL2087480,,None,487.59,1,-0.01,20,Cc1nc(N)ncc1-c1cn2cc(CN3CCN(S(C)(=O)=O)CC3)nc2c(N2CCOCC2)n1,Inhibition,'<',30,%,,,,UO_0000187,,,,,0,CHEMBL2092435,Inhibition of PIM2 at 5 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2086238,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL413779,,None,433.85,0,2.96,SID103905149,N#Cc1ncc2nc1OCCCCCOc1cc(OCCO)c(Cl)cc1NC(=O)N2,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1982711,,None,271.71,0,2.98,SID103904191,NC(=O)c1ccc(-c2c[nH]c3nccc(Cl)c23)cc1,Ki,'=',1258.93,nM,5.9,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1987899,,None,401.25,0,3.85,SID103904660,CN(c1ccc2[nH]ncc2c1)c1c(NCc2ccc(Cl)cc2Cl)c(=O)c1=O,Ki,'=',1258.93,nM,5.9,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1964687,,None,415.52,1,5.3,SID103904330,Cc1cc(C)cc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL95502,,None,394.5,0,4.21,SB-221466,CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1,Inhibition,'=',0.96,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL575110,,None,346.41,0,4.51,6,O=S(=O)(c1ccccc1)n1ccc2ccc3c4ccccc4[nH]c3c21,Activity,'=',65,%,,,,UO_0000187,,,,,0,CHEMBL1051392,Inhibition of Pim-2 assessed as residual enzyme activity at 1 uM relative to untreated control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154186,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL2035609,,None,380.71,0,4.89,4h,O=c1[nH]c(-c2ccccc2Cl)nc2c1oc1ccc(OC(F)(F)F)cc12,IC50,'=',5000,nM,5.3,,,UO_0000065,13.92,0.28,0.41,7.78,0,CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034948,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL2035613,,None,353.77,0,3.95,4l,CC(=O)Nc1ccc2oc3c(=O)[nH]c(-c4ccccc4Cl)nc3c2c1,IC50,'=',5000,nM,5.3,,,UO_0000065,14.98,0.29,1.35,6.02,0,CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034948,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL535,SUNITINIB,4,398.48,0,3.33,K00588a,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,Thermal melting change,'=',0,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL1965589,,None,408.41,0,3.38,SID103904761,Cc1nccn2c(-c3ccnc(NCC4(O)CC4)n3)c(-c3ccc(F)cc3F)nc12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL91730,,None,365.8,1,5.1,p38_Inhibitor,Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1,Residual Activity,'=',100,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3430784,,None,421.81,1,5.65,K00081,CNC(=O)c1cc(Oc2ccc(Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,Thermal melting change,'=',1.3,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL3651937,,None,438.48,0,3.94,BDBM106841,Cc1ccc(F)c(-c2cccc(C(=O)Nc3cnccc3[C@@H]3CC[C@H](O)[C@H](N)C3)n2)c1F,IC50,'=',27,nM,7.57,,225862,UO_0000065,17.26,0.32,3.63,7.48,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL482326,GSK-1030062A,None,505.52,2,5.4,GSK1030062A,COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC,Inhibition,'=',0.27,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1915636,,None,374.35,0,4.59,15j,Fc1cccc(F)c1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12,IC50,'=',1,nM,9,,,UO_0000065,24.04,0.44,4.41,11.34,0,CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914433,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL4075290,,None,372.42,0,4.32,33,O=C1NC(=S)S/C1=C\c1csc(-c2ccc(C(F)(F)F)cc2)n1,Activity,'=',2,%,,,,UO_0000187,,,,,0,CHEMBL4029695,Inhibition of partial length wild type human PIM2 (M1 to E291 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by KINOMEscan assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4028814,1,Scientific Literature,Bioorg Med Chem,2017,None,
CHEMBL3545110,RIBOCICLIB,4,434.55,0,2.8,Ribociclib,CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL1641989,,None,452.36,0,4.89,8,CN(C)CCCC(=O)Nc1ccc2c(C#N)cnc(Nc3cccc(Br)c3)c2c1,Activity,'=',89,%,,,,UO_0000187,,,,,0,CHEMBL1648729,Inhibition of PIM2 assessed as residual activity at 10 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1641579,1,Scientific Literature,Bioorg Med Chem,2011,None,
CHEMBL3338802,,None,439.91,1,5.7,4j,Cc1ccc(-c2cc(C(=O)Nc3ccnc(Cl)c3)nn2-c2ccc3ccccc3n2)cc1,Activity,'=',114,%,,,,UO_0000187,,,,,0,CHEMBL3388072,Inhibition of PIM2 (unknown origin) assessed as remaining enzyme activity at 10 uM by radioactive [33P]-ATP filter binding assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3351385,1,Scientific Literature,Eur J Med Chem,2014,None,
CHEMBL1240961,,None,313.15,0,4.38,3d,O=Cc1c[nH]c2c1ccc1c2[nH]c2cccc(Br)c21,Activity,'=',12,%,,,,UO_0000187,,,,,0,CHEMBL1248947,Inhibition of human GST fused Pim2 expressed in Escherichia coli assessed as residual activity at 1 uM after 30 mins,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240519,1,Scientific Literature,Bioorg Med Chem,2010,None,
CHEMBL403183,,None,207.25,0,1.81,BAY-117082,Cc1ccc(S(=O)(=O)/C=C/C#N)cc1,Residual Activity,'=',103,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1968151,,None,269.29,0,1.69,SID103904980,O=c1[nH]c2sccc2c2nc(-c3ccncc3)nn12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1915649,,None,332.34,0,3.76,17g,NC(=O)c1cccc2c1nc(Nc1ccccc1F)c1ccncc12,IC50,'=',10,nM,8,,,UO_0000065,24.07,0.44,4.24,9.89,0,CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914433,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL1915442,,None,356.36,0,4.45,14o,Fc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12,IC50,'=',5,nM,8.3,,,UO_0000065,23.29,0.42,3.85,10.46,0,CHEMBL1919424,Inhibition of PIM2 by millipore assay in the presence of 15 uM [ATP],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914433,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL2218926,,None,305.17,0,3.88,Tyrphostin AG-1024,CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O,Residual Activity,'=',86,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL478980,,None,283.33,0,2.46,DNA_PK_Inhibitor_V,O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O,Residual Activity,'=',114,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1982992,,None,277.74,0,3.79,SID103905084,Oc1cccc(Nc2ncnc3scc(Cl)c23)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1915419,,None,348.79,0,4.28,6,NC(=O)c1ccc2nc(Nc3cccc(Cl)c3)c3ccncc3c2c1,IC50,'>',2500,nM,,,,UO_0000065,,,,,0,CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914433,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL1970104,,None,290.37,0,4.4,SID103904904,CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1289926,AXITINIB,4,386.48,0,4.64,AG-013736,CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL1996111,,None,346.39,0,2.57,SID103904518,CN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3687534,,None,620.69,1,4.62,BDBM151931,CCOCc1cc(F)c(-c2nc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@@H](OCCS(C)(=O)=O)[C@@H](C)C3)ccc2F)c(F)c1,IC50,'=',1.79,nM,8.75,,292186,UO_0000065,14.09,0.28,4.13,6.55,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1982465,,None,497.62,1,5.18,SID103904307,Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCOCC5)cnc(N)c34)cc2)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1998121,,None,363.25,0,3.94,SID103904657,NCCC(C(=O)Nc1ccc2[nH]ncc2c1)c1ccc(Cl)c(Cl)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1983006,,None,347.72,0,2.35,SID103904900,COc1cc(C(=O)O)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL258248,GALLOYL TYRAMINE,None,403.31,0,1.52,1,NCCc1ccc(OC(=O)c2cc(O)c(O)c(O)c2)cc1.O=C(O)C(F)(F)F,IC50,'=',161000,nM,,Outside typical range,,UO_0000065,,,,,0,CHEMBL931462,Inhibition of Pim2 kinase,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144687,1,Scientific Literature,J Nat Prod,2008,None,
CHEMBL2003638,,None,412.43,0,4.26,SID103904514,O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1cccc(F)c1,Ki,'=',1258.93,nM,5.9,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1998193,,None,356.43,0,2.98,SID103904795,O=C(NCCCCCCNC(=O)Nc1cccnc1)Nc1cccnc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1964937,,None,362.43,0,3.1,SID103904206,O=C(NC(CO)c1ccccc1)N1CC=C(c2c[nH]c3ncccc23)CC1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2397525,,None,286.68,0,3.76,15c,O=[N+]([O-])c1cc2[nH]ncc2c2c1[nH]c1ccc(Cl)cc12,Activity,'=',57,%,,,,UO_0000187,,,,,0,CHEMBL2401343,Inhibition of human PIM2 assessed as residual activity using RSRHSSYPAGT as substrate at 1 uM after 30 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2396576,1,Scientific Literature,Bioorg Med Chem,2013,None,
CHEMBL328710,,None,264.33,0,3.25,SU4312,CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1,Residual Activity,'=',112,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL584195,,None,313.15,0,4.38,28,O=Cc1c[nH]c2c1ccc1c3cc(Br)ccc3[nH]c12,Activity,'=',82,%,,,,UO_0000187,,,,,0,CHEMBL1051392,Inhibition of Pim-2 assessed as residual enzyme activity at 1 uM relative to untreated control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154186,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL3758502,,None,347.38,0,3.25,1,CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21,Inhibition,'=',3.1,%,,,,UO_0000187,,,,,0,CHEMBL3760865,Inhibition of PIM2 (unknown origin) at 100 nM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3758169,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL1993781,,None,361.45,0,3.57,SID103904968,NC(COCc1ccccc1)COc1cncc(C=Cc2ccncc2)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL575254,,None,419.43,0,4.77,14l,CN(C)Cc1nc2c(sc3ccc(-c4ccc(OC(F)(F)F)cc4)cc32)c(=O)[nH]1,Ki,'=',29,nM,7.54,,,UO_0000065,17.97,0.35,2.77,12.95,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL1649586,,None,349.78,0,4.88,3,O=C(O)c1ccc2nc(Nc3cccc(Cl)c3)c3ccncc3c2c1,IC50,'=',294,nM,6.53,,,UO_0000065,18.67,0.36,1.65,8.7,0,CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914433,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL560813,,None,333.31,0,2.84,SID103904886,N#Cc1cnc(NC(=O)Nc2ccc3cc(C(=O)O)ccc3c2)cn1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1966816,,None,350.28,0,4.43,SID103904882,O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(F)cccc12,Ki,'=',1258.93,nM,5.9,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL213505,,None,414.35,0,4.53,SID103904357,Nc1ncnc2onc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2005886,,None,479.97,0,3.86,SID103905488,Cc1cc(N2CCOCC2)cc2[nH]c(-c3c(NCC(O)c4cccc(Cl)c4)cc[nH]c3=O)nc12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1644616,,None,304.38,0,4.15,1,S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1,Inhibition,'=',111,%,,,,UO_0000187,,,,,0,CHEMBL1648671,Inhibition of human Pim-2 at 10 uM after 60 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1641539,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL271595,GW297361X,None,372.43,0,2.35,GW297361X,NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1,Inhibition,'=',1.21,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1796257,,None,567.16,1,3.54,23,COCCN1CCc2cc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4N(C)S(C)(=O)=O)n3)c(OC)cc2CC1,Inhibition,'<',65,%,,,,UO_0000187,,,,,0,CHEMBL1798281,Inhibition of PIM2 at 1 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1795227,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL290904,,None,284.34,0,3.13,Cdk4_inhibitor_III,Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1,Residual Activity,'=',111,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1221601,,None,555.85,2,5.66,CGK733,O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1,Residual Activity,'=',90,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL278041,SB-202190,None,331.35,0,4.65,SB-202190,Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,Residual Activity,'=',125,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL97771,,None,373.41,1,5.18,Src_Inhibitor_I,COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC,Residual Activity,'=',142,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL205765,GW794726X,None,487.92,1,5.34,GW794726X,CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1,Inhibition,'=',0.58,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL410456,,None,398.42,0,3.68,D4476,NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1,Residual Activity,'=',130,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL174426,,None,354.21,0,4.02,BPIQ_I,Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21,Residual Activity,'=',84,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL434729,GW829906X,None,446.44,1,5.92,GW829906X,Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1,Inhibition,'=',-0.7,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL10,SB-203580,None,377.44,0,4.68,SB-203580,C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,Residual Activity,'=',96,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1972125,,None,462.55,0,4.99,SID103904473,Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1ccccc1,Ki,'=',3.981,nM,8.4,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1974457,,None,273.29,0,3.8,SID103905049,O=C(O)c1cc2c(-c3cccc(F)c3)cncc2s1,Ki,'=',316.23,nM,6.5,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1240703,CGP-52421,None,586.65,2,5.4,CGP-52421,CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1244923,Binding affinity to PIM2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240346,1,Scientific Literature,Blood,2009,None,
CHEMBL367625,,None,385.9,0,3.93,CGP-74514A,CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21,Residual Activity,'=',39,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2348862,,None,383.45,0,1.95,10b,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL478980,,None,283.33,0,2.46,DNA_PK_Inhibitor_V,O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O,Residual Activity,'=',110,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL388978,STAUROSPORINE,None,466.54,0,4.35,1 Staurosporine,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,IC50,'=',7,nM,8.15,,,UO_0000065,17.48,0.32,3.8,11.74,0,CHEMBL960129,Inhibition of Pim2 in presence of 1 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153342,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL492580,,None,339.4,0,2.96,25,O=C(O)/C=C/c1cccc(-c2cncc(N[C@H]3CC[C@H](O)CC3)n2)c1,IC50,'=',265,nM,6.58,,,UO_0000065,19.38,0.36,3.62,6.9,0,CHEMBL960121,Inhibition of Pim2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153342,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL77456,TYRPHOSTIN 1,None,184.2,0,2.13,Tyrphostin_A1,COc1ccc(C=C(C#N)C#N)cc1,Residual Activity,'=',103,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3652621,,None,419.46,0,2.57,BDBM119381,Nc1sc(-c2c(F)cccc2F)nc1C(=O)Nc1cn[nH]c1N1CCC[C@H](N)C1,Ki,'=',55.1,nM,7.26,,246148,UO_0000065,17.31,0.34,4.69,5.76,0,CHEMBL3707982,Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3691919,,None,565.67,1,3.59,BDBM151941,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)sc2N)C[C@@H](N)[C@H]1OCCS(C)(=O)=O,IC50,'=',0.78,nM,9.11,,292196,UO_0000065,16.1,0.33,5.52,6.06,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3634786,,None,210.24,0,2.33,4,Cc1n[nH]c2cnc(-c3cccnc3)cc12,Ki,'=',800,nM,6.1,,,UO_0000065,29,0.52,3.77,11.2,0,CHEMBL3636741,Inhibition of Pim2 (unknown origin) using 5FAM-ARKRRRHPSGPPTA as substrate after 90 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632547,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL180022,NERATINIB,4,557.05,2,5.93,HKI-272,CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL3634785,,None,188.19,0,1.06,3,O=C(Nc1cn[nH]c1)c1cccnc1,Ki,'=',15000,nM,4.82,,,UO_0000065,25.63,0.47,3.76,6.83,0,CHEMBL3636741,Inhibition of Pim2 (unknown origin) using 5FAM-ARKRRRHPSGPPTA as substrate after 90 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632547,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL3956349,,None,371.45,0,3.01,7,N[C@H]1CCCN(c2cccc(-c3n[nH]c4cnc(-c5cccnc5)cc34)n2)C1,Ki,'=',0.2,nM,9.7,,,UO_0000065,26.11,0.47,6.69,10.04,0,CHEMBL4052120,Inhibition of PIM2 (unknown origin) using 5FAM-ARKRRRHPSGPPTA as substrate after 90 mins in presence of ATP by caliper microfluidic mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4049450,1,Scientific Literature,J Med Chem,2017,None,
CHEMBL4089586,,None,386.46,0,2.38,15,Cc1cncc(-c2cnc3cnn(-c4cccc(N5CCCNCC5)n4)c3c2)n1,Ki,'=',13,nM,7.89,,,UO_0000065,20.41,0.37,5.51,9.32,0,CHEMBL4052120,Inhibition of PIM2 (unknown origin) using 5FAM-ARKRRRHPSGPPTA as substrate after 90 mins in presence of ATP by caliper microfluidic mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4049450,1,Scientific Literature,J Med Chem,2017,None,
CHEMBL2387477,,None,408.44,0,2.22,12,O=C(Nc1c[nH]c2ncccc12)c1cnn2ccc(NC[C@H]3CCNC[C@H]3F)nc12,Ki,'=',21,nM,7.68,,,UO_0000065,18.8,0.35,5.46,6.85,0,CHEMBL2387969,Inhibition of PIM2 (unknown origin) using FAM-pimtide as substrate after 90 mins by spectrophotometry in presence of ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2385019,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL2387469,,None,397.44,0,3.51,4,O=C(Nc1c[nH]c2ncccc12)c1cnn2ccc(NCCc3ccccc3)nc12,Ki,'=',2.2,nM,8.66,,,UO_0000065,21.78,0.39,5.15,8.66,0,CHEMBL2387969,Inhibition of PIM2 (unknown origin) using FAM-pimtide as substrate after 90 mins by spectrophotometry in presence of ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2385019,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL1910900,,None,434.53,0,2.35,14,NS(=O)(=O)c1ccc(-c2ccc3c(-c4ccc(N5CCNCC5)cc4)n[nH]c3n2)cc1,IC50,'>',25000,nM,,,,UO_0000065,,,,,0,CHEMBL1912526,Inhibition of PIM2 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1909629,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL1909654,,None,355.45,0,3.7,23,c1ncc(-c2ccc3[nH]cc(-c4ccc(N5CCNCC5)cc4)c3c2)cn1,IC50,'>',25000,nM,,,,UO_0000065,,,,,0,CHEMBL1912526,Inhibition of PIM2 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1909629,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL444673,,None,251.28,0,3.19,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL23327,PURVALANOLA,None,388.9,0,4.23,Purvalanol_A,CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1,Residual Activity,'=',122,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL274654,ORANTINIB,3,310.35,0,3.14,SU-6668,Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O,Activity,'=',111,%,,,,UO_0000187,,,,,0,CHEMBL1061086,Percentage PIM2 activity remaining in the presence of 1uM inhibitor,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL259389,QUINOXALINE1,None,185.19,0,1.09,Cdk1_5_Inhibitor,Nc1n[nH]c2nc3ccccc3nc12,Residual Activity,'=',93,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL288064,,None,395.23,0,4.03,GSK_3b_Inhibitor_II,Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1,Residual Activity,'=',86,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1076555,,None,302.79,0,4.91,SKI_II,Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1,Residual Activity,'=',82,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL261720,,None,425.45,0,1.77,Cdk1_2_Inhibitor_III,Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F,Residual Activity,'=',112,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3931404,,None,404.42,0,4.19,BDBM192624,Fc1cccc(F)c1-c1ccc2cnc(Nc3cnccc3C3=CCNCC3)n2n1,IC50,'=',1050,nM,5.98,,344702,UO_0000065,14.78,0.27,1.79,8.9,0,CHEMBL3887611,PIM-Mn Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL269538,HARMINE,0.5,212.25,0,3.03,Harmine,COc1ccc2c(c1)[nH]c1c(C)nccc12,Activity,'=',88,%,,,,UO_0000187,,,,,0,CHEMBL1061086,Percentage PIM2 activity remaining in the presence of 1uM inhibitor,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL1910899,,None,371.45,0,2.68,13,Nc1cc(-c2ccc3c(-c4ccc(N5CCNCC5)cc4)n[nH]c3n2)ccn1,IC50,'=',20000,nM,4.7,,,UO_0000065,12.65,0.23,2.02,4.91,0,CHEMBL1912526,Inhibition of PIM2 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1909629,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL3891145,,None,325.37,0,3.78,BDBM224931,Cc1nc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)ccc1F,IC50,'=',821.74,nM,6.08,,393214,UO_0000065,18.7,0.36,2.31,7.56,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL261238,,None,404.84,1,5.2,K00599a,CN(c1cccnc1)c1cc2c(Nc3ccc(F)c(Cl)c3)c(C#N)cnc2cn1,Thermal melting change,'=',10.7,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL1317546,,None,221.26,0,1.43,IC86621,CC(=O)c1ccc(N2CCOCC2)cc1O,Residual Activity,'=',91,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL428690,ALVOCIDIB,3,401.85,0,3.3,flavopiridol,CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1,Kd,'=',650,nM,6.19,,,UO_0000065,15.4,0.3,2.89,6.57,0,CHEMBL859489,Average Binding Constant for PIM2; NA=Not Active at 10 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144455,1,Scientific Literature,Nat Biotechnol,2005,None,
CHEMBL3634787,,None,209.25,0,2.93,5,Cc1c[nH]c2cnc(-c3cccnc3)cc12,Ki,'=',3900,nM,5.41,,,UO_0000065,25.85,0.46,2.48,13.01,0,CHEMBL3636741,Inhibition of Pim2 (unknown origin) using 5FAM-ARKRRRHPSGPPTA as substrate after 90 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632547,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL3652629,,None,410.45,0,2.59,BDBM119389,Cn1ncc(NC(=O)c2nc(-c3ccccc3F)ccc2N)c1OC1CCNCC1,Ki,'=',26.2,nM,7.58,,246156,UO_0000065,18.47,0.35,4.99,7.08,0,CHEMBL3707982,Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1992732,,None,411.43,1,1,SID103905628,CCOc1ccccc1C=NNC(=O)c1nnn(-c2nonc2N)c1N1CCCC1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL196363,,None,375.46,0,4.89,SID103904276,Cc1cccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1996837,,None,210.26,0,0.62,SID103905651,Cc1nn(C)c2sc(C(N)=O)c(N)c12,Ki,'>',15848.93,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1682357,,None,275.31,0,3.81,SID103904525,c1ccc(Cc2cc(-c3ccc4[nH]ncc4c3)on2)cc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1994693,,None,387.47,0,4.68,SID103904349,Nc1ncnc2sc3c(c12)-c1ccc(NC(=O)Nc2ccccc2)cc1CC3,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1994538,,None,333.27,0,3.69,SID103904888,O=C(Nc1cnccn1)Nc1ccnc2c(C(F)(F)F)cccc12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1967564,,None,254.29,0,2.85,SID103905382,CCCC(=O)Nc1n[nH]c2nc3ccccc3cc12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1983111,,None,474.49,0,4.06,SID103904739,CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1973860,,None,270.36,0,3.37,SID103905449,OCCNc1cc2cc(-c3ccsc3)ccc2cn1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3545308,ROCILETINIB,3,555.56,1,4.78,Rociletinib,C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3921086,,None,393.5,0,4.35,BDBM224966,CNc1nnc(-c2ccc3[nH]cc(-c4csc(-n5cnc(C)c5)n4)c3c2)s1,IC50,'=',502.39,nM,6.3,,393256,UO_0000065,16.01,0.32,1.95,7.47,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4060267,,None,383.88,0,2.71,22,Cc1c(-c2ccc(N3CCNCC3)cc2)n(C)c2nc(C(N)=O)cc(Cl)c12,IC50,'=',1270,nM,5.9,,,UO_0000065,15.36,0.3,3.19,7.74,0,CHEMBL4047686,Inhibition of PIM2 (unknown origin) assessed as reduction in full length human BAD phosphorylation at Ser112 residues by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4043256,1,Scientific Literature,Bioorg Med Chem Lett,2017,None,
CHEMBL304428,,None,393.4,0,4.61,K00060,O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1,Thermal melting change,'=',5.5,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL2387476,,None,408.44,0,2.22,11,O=C(Nc1c[nH]c2ncccc12)c1cnn2ccc(NC[C@@H]3CCNC[C@@H]3F)nc12,Ki,'=',18,nM,7.75,,,UO_0000065,18.96,0.35,5.52,6.91,0,CHEMBL2387969,Inhibition of PIM2 (unknown origin) using FAM-pimtide as substrate after 90 mins by spectrophotometry in presence of ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2385019,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL2387465,,None,520.52,1,4.16,18,O=C(Nc1c[nH]c2ncc(-c3c(F)cccc3F)cc12)c1cnn2ccc(NC[C@H]3CCNC[C@@H]3F)nc12,Ki,'=',0.037,nM,10.43,,,UO_0000065,20.04,0.37,6.27,9.31,0,CHEMBL2387969,Inhibition of PIM2 (unknown origin) using FAM-pimtide as substrate after 90 mins by spectrophotometry in presence of ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2385019,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL507361,MIRDAMETINIB,2,482.2,0,2.47,PD-325901,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL101797,,None,210.24,0,2.51,K00027,O=C1Nc2ccccc2/C1=C\c1ccc[nH]1,Thermal melting change,'=',0.8,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL3651914,,None,452.51,0,4.19,BDBM106818,CCc1ccc(F)c(-c2cccc(C(=O)Nc3cnccc3[C@@H]3CC[C@H](O)[C@H](N)C3)n2)c1F,IC50,'=',62,nM,7.21,,225839,UO_0000065,15.93,0.3,3.02,7.13,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL264685,,None,408.26,0,4.42,K00024,O=C1CC(=O)c2[nH]c3c4[nH]c5c(c4c4cn(Br)cc4c3c2C1)CCC=C5,Thermal melting change,'=',6.3,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL2442306,,None,329.41,0,3.43,11e,NCCNc1ccn2ncc(-c3ccc(-c4ccccc4)cc3)c2n1,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL2446210,Inhibition of Pim2 (unknown origin) using STK1 as substrate preincubated for 30 mins followed by substrate and ATP addition at > 5000 nM after 60 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2440090,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL1993548,,None,289.77,0,3.03,SID103904966,CC(N)COc1cnc(Cl)c(C=Cc2ccncc2)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2035637,,None,376.25,0,3.32,6j,CN1CCCC(Cc2nc3c(oc4ccc(Br)cc43)c(=O)[nH]2)C1,IC50,'=',534,nM,6.27,,,UO_0000065,16.67,0.37,2.95,10.1,0,CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034948,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL2030376,,None,364.2,0,2,6k,O=c1[nH]c(CN2CC[C@H](O)C2)nc2c1oc1ccc(Br)cc12,IC50,'=',121,nM,6.92,,,UO_0000065,18.99,0.43,4.92,8.4,0,CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034948,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL2030386,,None,364.2,0,2,6l,O=c1[nH]c(CN2CC[C@@H](O)C2)nc2c1oc1ccc(Br)cc12,IC50,'=',68,nM,7.17,,,UO_0000065,19.68,0.44,5.17,8.7,0,CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034948,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL2035639,,None,332.79,0,2.07,7a,CN1CCN(Cc2nc3c(oc4ccc(Cl)cc43)c(=O)[nH]2)CC1,IC50,'=',480,nM,6.32,,,UO_0000065,18.99,0.38,4.25,9.67,0,CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034948,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL412142,LADUVIGLUSIB,-1,465.35,0,4.94,SID103905640,Cc1cnc(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)[nH]1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2017357,,None,386.44,0,4.08,13y,NC(=O)c1ccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3sccc23)cc1,IC50,'=',17,nM,7.77,,,UO_0000065,20.11,0.38,3.69,7.09,0,CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016532,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL119385,NEFLAMAPIMOD,2,436.27,1,5.49,SID103905630,O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL483158,ALISERTIB,3,518.93,2,5.75,Alisertib,COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL607707,PELITINIB,2,467.93,1,5.1,Pelitinib,CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL283120,AXL-1717,2,414.41,0,2.41,AXL-1717,COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL1091644,LINSITINIB,3,421.5,0,4.82,Linsitinib,C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3687535,,None,534.64,1,4.11,BDBM151932,CO[C@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2nc(-c3cc(C(=O)NC(C)C)ccc3F)ccc2N)C[C@@H]1C,IC50,'=',2.56,nM,8.59,,292187,UO_0000065,16.07,0.3,4.48,5.92,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3651909,,None,453.49,0,3.13,BDBM106813,Cc1ccc(F)c(-c2cccc(C(=O)Nc3cnccc3N3C[C@@H](N)[C@H](O)[C@@H](C)C3)n2)c1F,IC50,'=',4,nM,8.4,,225834,UO_0000065,18.52,0.35,5.27,8.05,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1974254,,None,484.59,1,5.99,SID103904317,CCOc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1,Ki,'=',1258.93,nM,5.9,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1969049,,None,346.43,0,4.56,SID103904559,COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(C)c2)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1641799,,None,358.42,0,4.26,18,CC(C)(C)c1cc(C(=O)O)c(NC(=O)Nc2ccc3[nH]ncc3c2)s1,Inhibition,'=',0,%,,,,UO_0000187,,,,,0,CHEMBL1646820,Inhibition of PIM2 at 10 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1641460,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL3394164,,None,377.48,0,4.08,24,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(NC5CCCC5)n4)c3c2)s1,IC50,'=',6,nM,8.22,,,UO_0000065,21.78,0.42,4.14,7.8,1,CHEMBL3395659,Inhibition of full length recombinant PIM2 (unknown origin) using biotinylated-BAD peptide as substrate assessed as phosphorylation at serine 112 after 90 mins by HTRF method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3393014,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL2387475,,None,503.51,1,4.18,10,O=C(Nc1c[nH]c2ncc(-c3c(F)cccc3F)cc12)c1cnn2ccc(OCC3CCNCC3)nc12,Ki,'=',0.65,nM,9.19,,,UO_0000065,18.25,0.34,5.01,8.41,0,CHEMBL2387969,Inhibition of PIM2 (unknown origin) using FAM-pimtide as substrate after 90 mins by spectrophotometry in presence of ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2385019,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL1915639,,None,390.81,1,5.1,15m,Fc1ccc(Cl)cc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12,IC50,'=',10,nM,8,,,UO_0000065,20.47,0.39,2.9,10.08,0,CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914433,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL220241,GSK-269962A,None,570.61,2,3.84,SID103905674,CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1991078,,None,454.49,0,4.14,SID103904505,COc1ccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)cc1OC,Ki,'>',2511.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2000685,,None,708.8,2,1.02,SID103904743,CC(=NNC(=N)N)c1cc(NC(=O)c2cccc(C(=O)Nc3cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c3)c2)cc(C(C)=NNC(=N)N)c1,Ki,'=',63.1,nM,7.2,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2442312,,None,260.3,0,3.13,9b,Nc1ccn2ncc(-c3ccc4ccccc4c3)c2n1,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL2446210,Inhibition of Pim2 (unknown origin) using STK1 as substrate preincubated for 30 mins followed by substrate and ATP addition at > 5000 nM after 60 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2440090,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL1684654,,None,331.42,0,3.79,11o,Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1,Inhibition,'=',105,%,,,,UO_0000187,,,,,0,CHEMBL1686068,Inhibition of Pim-2 at 1 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1681705,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL1975500,,None,460.49,0,3.24,SID103904712,COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCCNC(C)=O)cc2NC3=O)ccc1O,Ki,'=',1000,nM,6,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL394619,,None,374.47,1,5.5,SID103904295,Cc1cccc(NC(=O)Nc2ccc(-c3csc4ccnc(N)c34)cc2)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1984162,,None,527.63,2,5.72,SID103904784,COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(C)cc(C)c5o4)cc3)c3c(N)ncnc32)CC1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2204538,THPP-1,None,464.91,0,3.06,EUB0000751,COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2,% Control,,98,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507293,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 100.0 nM
CHEMBL4078609,,None,381.19,0,3.39,Tab 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4067797,,None,453.11,0,3.36,Tab 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3105022,,None,457.46,0,2.96,5c,C[C@H]1CN(c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@@H]1O,Ki,'=',0.002,nM,,Outside typical range,,UO_0000065,,,,,0,CHEMBL3106178,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3102815,1,Scientific Literature,ACS Med Chem Lett,2013,None,
CHEMBL3103861,,None,389.46,0,2.3,4c,Nc1ccc(-c2cccnc2)nc1C(=O)Nc1cnccc1N1CCC[C@H](N)C1,Ki,'=',12,nM,7.92,,,UO_0000065,20.34,0.37,5.62,6.44,0,CHEMBL3106178,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3102815,1,Scientific Literature,ACS Med Chem Lett,2013,None,
CHEMBL4282264,A-485,None,536.48,1,3.68,EUB0000328,CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O,% Control,,98,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507259,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL4538174,ERKi,None,311.35,0,2.33,EUB0000298,C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1,% Control,,100,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507286,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 100.0 nM
CHEMBL1970340,,None,226.24,0,2.78,SID103905579,Nc1noc2cccc(-c3cccc(O)c3)c12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1971186,,None,378.41,0,3.35,SID103904414,Fc1ccc(-c2nc3occn3c2-c2ccnc(NC3CCNCC3)n2)cc1,Ki,'=',1000,nM,6,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1976872,,None,175.19,0,1.29,SID103905485,CC(=O)Nc1cc2ccccn2n1,Ki,'=',199.53,nM,6.7,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1641992,,None,493.41,0,4.19,11,CN1CCN(CCC(=O)Nc2ccc3c(C#N)cnc(Nc4cccc(Br)c4)c3c2)CC1,Activity,'=',92,%,,,,UO_0000187,,,,,0,CHEMBL1648729,Inhibition of PIM2 assessed as residual activity at 10 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1641579,1,Scientific Literature,Bioorg Med Chem,2011,None,
CHEMBL215993,GW284372X,None,393.45,1,6.21,GW284372X,c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1,Inhibition,'=',0.63,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3427182,,None,274.3,0,1.89,14,O=C(O)[C@@H]1CSC(c2ccc3cc(O)ccc3n2)=N1,Activity,'=',56,%,,,,UO_0000187,,,,,0,CHEMBL3427823,Inhibition of PIM2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3425453,1,Scientific Literature,Eur J Med Chem,2015,None,
CHEMBL258721,,None,473.36,0,4.5,K00600a,CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12,Thermal melting change,'=',-0.1,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL328216,,None,330.19,0,3.3,K00041,Nc1cc2ncnc(Nc3cccc(Br)c3)c2cc1N,Thermal melting change,'=',2.6,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL1725279,SP-600125,None,220.23,0,4.43,SP600125,Oc1c2ccccc2c2c3c(cccc13)N=N2,Residual Activity,'=',21,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1240885,,None,244.23,0,1.82,CGP-57380,Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12,Residual Activity,'=',99,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3948849,,None,420.47,0,4.8,rac-22d,N[C@H]1CCC[C@@H](c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1,IC50,'=',27,nM,7.57,,,UO_0000065,18,0.33,2.77,9.33,0,CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3864151,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL196022,GW642125X,None,241.25,0,2.48,GW642125X,COc1ccc(-c2coc3ncnc(N)c23)cc1,Inhibition,'=',0.43,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL529066,GW574783B,None,599.54,2,6,GW574783B,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl,Inhibition,'=',-0.34,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL2017360,,None,367.86,1,5.21,9j,CNC(=O)c1cccc2c1nc(Nc1ccccc1Cl)c1ccsc12,IC50,'=',28,nM,7.55,,,UO_0000065,20.53,0.41,2.34,13.98,0,CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016532,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL1794067,GSK-978744A,None,487.97,0,3.71,GSK978744A,C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl,Inhibition,'=',-0.13,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3758376,,None,461.59,0,3.8,22c,CN(C)CCNC(=O)c1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3s2)cc1,Inhibition,'=',1,%,,,,UO_0000187,,,,,0,CHEMBL3761595,Inhibition of PIM2 (unknown origin) at 500 nM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3758163,1,Scientific Literature,Eur J Med Chem,2016,None,
CHEMBL273564,GW795493X,None,413.36,1,5.13,GW795493X,Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12,Inhibition,'=',0.72,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3660050,,None,359.43,0,3.47,BDBM104175,c1cc(OC2CCCNCC2)c2nc(-c3nnc4ccccn34)ccc2c1,IC50,'=',1000,nM,6,,222662,UO_0000065,16.69,0.3,2.53,9.33,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3660089,,None,417.49,0,4.29,BDBM104221,FC1CCNCCC1Oc1cccc2ccc(-c3nnc4ccc(C5CC5)cn34)nc12,IC50,'=',661.3,nM,6.18,,222632,UO_0000065,14.8,0.27,1.89,9.6,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3652017,,None,484.52,1,5.44,BDBM106923,COc1cc(F)c(-c2nc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)CC(C)(C)C3)ccc2F)c(F)c1,IC50,'=',4,nM,8.4,,225944,UO_0000065,17.33,0.33,2.96,9.32,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3687419,,None,469.47,0,4.48,BDBM151812,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)/C1=N\O,IC50,'=',6.81,nM,8.17,,292068,UO_0000065,17.4,0.33,3.69,7.2,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL50894,ALSTERPAULLONE,None,293.28,0,3.24,K00062,O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1,Thermal melting change,'=',1.5,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL439259,,None,341.8,0,4.85,K00614a,COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12,Thermal melting change,'=',1,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL35820,,None,388.26,0,4.93,K00042,CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC,Thermal melting change,'=',1.1,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL3427171,,None,294.36,0,2.04,3,COC(=O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1,Activity,'=',66,%,,,,UO_0000187,,,,,0,CHEMBL3427823,Inhibition of PIM2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3425453,1,Scientific Literature,Eur J Med Chem,2015,None,
CHEMBL2442301,,None,371.49,0,4.45,9n,CCN1CCCC1CNc1ccn2ncc(-c3ccc4ccccc4c3)c2n1,IC50,'=',4308,nM,5.37,,,UO_0000065,14.44,0.26,0.92,11.8,0,CHEMBL2446212,Inhibition of Pim2 (unknown origin) using STK1 as substrate preincubated for 30 mins followed by substrate and ATP addition after 60 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2440090,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL3298678,,None,449.91,0,2.66,38,O=C(N[C@H](CO)c1ccc(Cl)c(F)c1)N1CCc2cnc(NC3CCOCC3)nc2C1,Inhibition,'=',0.3,%,,,,UO_0000187,,,,,0,CHEMBL3361558,Inhibition of PIM2 (unknown origin) at 100 nM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3297705,1,Scientific Literature,Bioorg Med Chem Lett,2014,None,
CHEMBL2442295,,None,329.41,0,2.96,9h,c1ccc2cc(-c3cnn4ccc(N5CCNCC5)nc34)ccc2c1,IC50,'=',1462,nM,5.83,,,UO_0000065,17.71,0.32,2.88,12.84,0,CHEMBL2446212,Inhibition of Pim2 (unknown origin) using STK1 as substrate preincubated for 30 mins followed by substrate and ATP addition after 60 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2440090,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL2442292,,None,319.37,0,2.16,11k,NCCNc1ccn2ncc(-c3cccc(-c4ncc[nH]4)c3)c2n1,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL2446210,Inhibition of Pim2 (unknown origin) using STK1 as substrate preincubated for 30 mins followed by substrate and ATP addition at > 5000 nM after 60 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2440090,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL30432,GW282974X,None,395.47,0,4.23,GW282974X,CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1,Inhibition,'=',-0.29,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3651961,,None,457.46,0,3.35,BDBM106931,Nc1cc(F)c(-c2c(F)cccc2F)nc1C(=O)Nc1cnccc1[C@@H]1CC[C@H](O)[C@H](N)C1,IC50,'=',7,nM,8.15,,225952,UO_0000065,17.83,0.34,4.8,6.41,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL261720,,None,425.45,0,1.77,K00546,Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F,Thermal melting change,'=',0.6,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL2387479,,None,408.44,0,2.22,14,O=C(Nc1c[nH]c2ncccc12)c1cnn2ccc(NC[C@@H]3CCNC[C@H]3F)nc12,Ki,'=',2,nM,8.7,,,UO_0000065,21.3,0.4,6.48,7.76,0,CHEMBL2387969,Inhibition of PIM2 (unknown origin) using FAM-pimtide as substrate after 90 mins by spectrophotometry in presence of ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2385019,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL2387466,,None,355.37,0,2.29,1,O=C(Nc1ccc(F)cc1)c1cnn2c(O)cc(C3CCNCC3)nc12,Ki,'=',250,nM,6.6,,,UO_0000065,18.58,0.35,4.31,7.21,0,CHEMBL2387969,Inhibition of PIM2 (unknown origin) using FAM-pimtide as substrate after 90 mins by spectrophotometry in presence of ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2385019,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL210833,,None,360.44,0,3,Flt_3_inhibitor,COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC,Residual Activity,'=',114,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1254209,,None,389.26,0,2.45,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL493326,GSK-317314A,None,427.91,0,4.99,GSK317314A,COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1,Inhibition,'=',-3.96,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3394168,,None,377.47,0,4.65,28,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(OC5CCCC5)n4)c3c2)s1,IC50,'=',6900,nM,5.16,,,UO_0000065,13.67,0.26,0.51,5.75,0,CHEMBL3395662,Inhibition of PIM2 in human U2OS cells assessed as phosphorylation of BAD,B,BAO_0000219,cell-based format,Homo sapiens,None,None,U2OS,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3393014,1,Scientific Literature,Bioorg Med Chem Lett,2015,CHEMBL3307757,
CHEMBL3394173,,None,352.42,0,3.51,33,CC(C)Oc1cnc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)cn1,IC50,,,,,,Not Determined,,,,,,0,CHEMBL3395662,Inhibition of PIM2 in human U2OS cells assessed as phosphorylation of BAD,B,BAO_0000219,cell-based format,Homo sapiens,None,None,U2OS,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3393014,1,Scientific Literature,Bioorg Med Chem Lett,2015,CHEMBL3307757,
CHEMBL3953116,,None,432.49,0,2.77,BDBM225092,CC(C)Nc1nnc(-c2ccc3[nH]cc(-c4nccc(N5CCN(C)C(=O)C5)n4)c3c2)o1,IC50,'=',46.75,nM,7.33,,393085,UO_0000065,16.95,0.31,4.56,6.32,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL271843,GW275944X,None,330.37,0,1.41,GW275944X,Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2,Inhibition,'=',1.85,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1909404,GW581744X,None,406.42,0,2.49,GW581744X,NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1,Inhibition,'=',1.11,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3651947,,None,455.48,0,4.63,BDBM106933,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)c(F)cc2N)C1,IC50,'=',4,nM,8.4,,225954,UO_0000065,18.44,0.35,3.77,7.85,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3652030,,None,457.45,0,4.05,BDBM106938,C[C@@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](O)[C@H]1O,IC50,'=',45,nM,7.35,,225959,UO_0000065,16.06,0.3,3.3,7.71,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3666767,,None,462.56,0,1.97,BDBM141330,COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CCC2,IC50,'=',5913,nM,5.23,,276605,UO_0000065,11.3,0.21,3.26,4.57,0,CHEMBL3707966,Kinase Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates are trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3746984,,None,427.43,0,3.74,15,N[C@H]1CCCN(c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C1,Ki,'<',3,nM,,,,UO_0000065,,,,,0,CHEMBL3750240,Inhibition of PIM2 kinase (unknown origin) using NH2-AGAGRSRHSSYPAGT-OH as substrate by kinase-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3745712,1,Scientific Literature,J Med Chem,2015,None,
CHEMBL215205,,None,218.22,0,1.7,CAN508,Nc1n[nH]c(N)c1/N=N/c1ccc(O)cc1,Activity,'=',69,%,,,,UO_0000187,,,,,0,CHEMBL1825909,Inhibition of PIM2 assessed as residual activity at 10 uM by radioactivity assay in presence of 5 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1821675,1,Scientific Literature,Eur J Med Chem,2011,None,
CHEMBL206544,GW682841X,None,340.43,1,5.32,GW682841X,CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1,Inhibition,'=',-0.34,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL365072,,None,258.29,0,1.65,SB-751148,CCc1nccc2c1nc(-c1nonc1N)n2CC,Inhibition,'=',0.4,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3355543,,None,377.37,0,3.22,8,N[C@H]1CCCN(c2ccn3ncc(-c4cccc(OC(F)(F)F)c4)c3n2)C1,IC50,'=',987,nM,6.01,,,UO_0000065,15.91,0.3,2.79,8.74,0,CHEMBL3375413,Inhibition of Pim2 (unknown origin) using luciferase-luciferin based ATP detection reagent by Kinase-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3351833,1,Scientific Literature,ACS Med Chem Lett,2015,None,
CHEMBL3354522,,None,424.48,1,5.12,5,Fc1cccc(F)c1-c1nc2c(Nc3cnccc3O[C@H]3CCNC3)cccc2s1,IC50,'=',180,nM,6.75,,,UO_0000065,15.89,0.31,1.62,11.42,0,CHEMBL3376647,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352230,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL247228,GW770249X,None,431.35,1,5.27,GW770249X,Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12,Inhibition,'=',1.14,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3634758,,None,374.45,0,2.35,37,Cn1cc(-c2cc3c(-c4cccc(N5CCC[C@H](N)C5)n4)n[nH]c3cn2)cn1,Ki,'=',0.26,nM,9.59,,,UO_0000065,25.6,0.47,7.24,9.44,0,CHEMBL3636741,Inhibition of Pim2 (unknown origin) using 5FAM-ARKRRRHPSGPPTA as substrate after 90 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632547,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL95207,,None,352.42,0,3,SB-220455,CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1,Inhibition,'=',0.18,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL185962,,None,242.24,0,1.4,SB-736302,Nc1nonc1-c1nc2cnccc2n1C1CC1,Inhibition,'=',11.27,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3898134,,None,366.45,0,3.9,BDBM224933,CCCCOc1cnc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)cn1,IC50,'=',1546.83,nM,5.81,,393216,UO_0000065,15.86,0.31,1.91,5.66,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3898842,,None,473.45,0,3.75,BDBM191093,CNC(=O)c1ccc(-c2c(-c3cccc(OC(F)(F)F)c3)cc3n2C(CCO)CNC3=O)cc1,IC50,'=',75,nM,7.12,,341764,UO_0000065,15.05,0.29,3.37,7.7,0,CHEMBL3887520,Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP,,,,,,,,,,,,,,,,,,,,,,
CHEMBL218970,GW445017X,None,272.74,0,3.27,GW445017X,CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1,Inhibition,'=',0.13,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3957954,,None,347.42,0,3.18,BDBM238556,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1(C)CC1,IC50,'=',0.3,nM,9.52,,416678,UO_0000065,27.41,0.5,6.34,11.51,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4111268,,None,422.44,0,2.94,BDBM192585,N[C@H]1C[C@@H](F)CN(c2ccncc2Nc2ncc3ccc(-c4ncccc4F)nn23)C1,IC50,'=',10.9,nM,7.96,,344652,UO_0000065,18.85,0.35,5.02,8.19,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL519881,GW861893X,None,483.53,1,5.66,GW861893X,COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC,Inhibition,'=',1.14,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL71191,,None,266.3,0,3.31,Tyrphostin AG-1296,COc1cc2ncc(-c3ccccc3)nc2cc1OC,Residual Activity,'=',144,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL359482,,None,301.35,0,4.07,GSK_3_inhibitor_XIII,Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1,Residual Activity,'=',88,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3394170,,None,338.4,0,3.12,30,CCOc1cncc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)n1,IC50,'=',28,nM,7.55,,,UO_0000065,22.32,0.43,4.43,7.36,1,CHEMBL3395659,Inhibition of full length recombinant PIM2 (unknown origin) using biotinylated-BAD peptide as substrate assessed as phosphorylation at serine 112 after 90 mins by HTRF method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3393014,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL1945950,,None,366.47,0,3.59,39,CC(C)(O)c1ccc(-c2cnc3[nH]c(=O)n(CC4CCCCC4)c3n2)cc1,Activity,'=',91,%,,,,UO_0000187,,,,,0,CHEMBL1948961,Inhibition of Pim2 assessed as activity remaining at 10 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1944561,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL485598,GSK-317354A,None,494.45,1,5.12,GSK317354A,CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1,Inhibition,'=',0.44,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1794058,GW278681X,None,329.38,0,2.46,GW278681X,CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1,Inhibition,'=',0.67,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL188247,GW832467X,None,504.47,2,5.7,GW832467X,Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1,Inhibition,'=',0.44,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3933275,,None,369.39,0,3.94,BDBM225070,c1cc(-c2nnc(-c3ccc4[nH]cc(-c5cncc(C6CC6)n5)c4c3)o2)[nH]n1,IC50,'=',158.31,nM,6.8,,393063,UO_0000065,18.41,0.33,2.86,6.23,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3975848,,None,319.32,0,2.85,BDBM225069,O=c1[nH]nc(-c2ccc3[nH]cc(-c4cncc(C5CC5)n4)c3c2)o1,IC50,'=',54.54,nM,7.26,,393062,UO_0000065,22.75,0.41,4.41,7.23,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3946988,,None,393.49,0,4.42,BDBM224891,NC1CCN(c2nnc(-c3ccc4[nH]cc(-c5ccccc5F)c4c3)s2)CC1,IC50,'=',1697.16,nM,5.77,,393167,UO_0000065,14.66,0.28,1.35,8.15,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL365286,GW549034X,None,229.24,0,1.69,GW549034X,CCn1c(-c2nonc2N)nc2ccccc21,Inhibition,'=',1.82,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL506414,GW684626B,None,467.98,1,7.53,GW684626B,Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1,Inhibition,'=',1.54,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3394166,,None,337.41,0,3.73,BDBM50061602,CCOc1cccc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)n1,IC50,'=',21.56,nM,7.67,,393187,UO_0000065,22.72,0.44,3.94,8.55,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1945561,,None,326.23,0,3.05,23,Cn1c2c(c3ccc(Cl)c(Cl)c31)C(CN)C(C)(C)NC2=O,Delta Tm,'=',3.2,degrees C,,,,UO_0000027,,,,,0,CHEMBL1947284,Binding affinity to PIM2 assessed as change in thermal denaturation at 10 uM by thermal stability shift assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1944596,1,Scientific Literature,J Med Chem,2012,None,
CHEMBL3981694,,None,415.41,0,4.46,BDBM192567,Nc1cncc(-c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)c1,IC50,'>',1000,nM,,,344559,UO_0000065,,,,,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1794072,,None,490,1,5.74,SB-682330-A,CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl,Inhibition,'=',0.08,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3927004,,None,387.45,0,2.96,BDBM224979,c1cc2[nH]cc(-c3cncc(C4CC4)n3)c2cc1-c1nnc(N2CCNCC2)o1,IC50,'=',21.53,nM,7.67,,393269,UO_0000065,19.79,0.36,4.71,8.01,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3965588,,None,378.41,0,4.51,BDBM225013,CC(C)Nc1nnc(-c2cc3c(-c4nccc(C5CC5)n4)c[nH]c3cc2F)o1,IC50,'=',1.88,nM,8.73,,393302,UO_0000065,23.06,0.43,4.22,9.43,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4100435,,None,377.28,0,3.13,12; Tab 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1909353,GW458344A,None,379.85,0,4.31,GW458344A,Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl,Inhibition,'=',1.49,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL13485,SU-11652,None,414.94,0,3.85,SU11652,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C,Residual Activity,'=',92,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4071926,,None,367.28,0,3.79,Tab 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3934853,,None,577.69,2,3.46,BDBM238804,Cc1nc2cccc(-c3cc4c([nH]3)[C@@H](C)NC4=O)c2nc1N[C@H]1CCC[C@@H](NC(=O)[C@@H](CO)NC(=O)OC(C)(C)C)C1,IC50,'=',10,nM,8,,416913,UO_0000065,13.85,0.26,4.54,4.7,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3909947,,None,389.44,0,3.13,BDBM249063,Cc1cncc(-c2cc3c(cn2)cnn3-c2cccc(C3(F)CCCNC3)n2)n1,Ki,'=',2.37,nM,8.62,,434267,UO_0000065,22.15,0.41,5.5,10.59,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3924903,,None,401.47,0,3.23,BDBM249074,Cc1cncc(-c2cc3c(cn2)cnn3-c2cccc(OC3CCCC(N)C3)n2)n1,Ki,'=',0.986,nM,9.01,,434278,UO_0000065,22.43,0.41,5.78,8.61,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3986516,,None,375.48,0,3.96,BDBM238502,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1CCCCC1,IC50,'=',4.9,nM,8.31,,416239,UO_0000065,22.13,0.41,4.35,10.05,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3685736,,None,448.48,0,3.61,BDBM124899,N[C@@H]1CN(c2ccncc2Nc2cccc3cnc(-c4c(F)cccc4F)nc23)CC[C@H]1O,IC50,'=',230,nM,6.64,,254201,UO_0000065,14.8,0.27,3.03,6.63,0,CHEMBL3705221,ATP Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 ul per well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3685743,,None,450.47,0,4.59,BDBM124906,N[C@H]1CN(c2ccncc2Nc2cccc3cnc(-c4c(F)cccc4F)nc23)CC[C@@H]1F,IC50,'>',25000,nM,,,254208,UO_0000065,,,,,0,CHEMBL3705221,ATP Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 ul per well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3985653,,None,308.37,0,2.91,BDBM224928,Nc1cc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)ccn1,IC50,'=',270.03,nM,6.57,,393209,UO_0000065,21.3,0.41,3.66,6.17,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3925309,,None,365.44,0,2.4,BDBM238518,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NCC(C)(C)O,IC50,'=',8.7,nM,8.06,,416662,UO_0000065,22.06,0.41,5.66,7.83,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL374453,GSK-299115A,None,415.28,0,4.39,GSK299115A,CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1,Inhibition,'=',0.05,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL273564,GW795493X,None,413.36,1,5.13,GW795493X,Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12,Inhibition,'=',0.42,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3946464,,None,417.48,0,1.09,BDBM249051,OCCNc1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CCNCC3)n2)n1,Ki,'=',0.357,nM,9.45,,434255,UO_0000065,22.63,0.42,8.36,8.08,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL522266,,None,416.84,0,3.94,12,CCn1c2cc(Cl)c(F)cc2c(=O)c2c(=O)on(CCOCc3ccccc3)c21,Ki,'>',1424,nM,,,,UO_0000065,,,,,0,CHEMBL994191,Inhibition of Pim2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144228,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,
CHEMBL3930148,,None,417.49,0,3.85,BDBM192629,C[C@H]1C[C@@H](N)CN(c2ccncc2Nc2ncc3ccc(-c4ccccc4F)nn23)C1,IC50,'=',0.1,nM,10,,344645,UO_0000065,23.95,0.44,6.15,11.85,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3951741,,None,413.49,0,1.89,BDBM249053,c1cc(N2CCNCC2)nc(-n2ncc3cnc(-c4cncc(N5CCC5)n4)cc32)c1,Ki,'=',1.83,nM,8.74,,434257,UO_0000065,21.13,0.38,6.85,9.94,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4110951,,None,500.58,1,3.74,BDBM192599,C[C@@H]1C[C@H](N)CN(c2ccncc2Nc2ncc3ccc(-c4cc(C(=O)NC5CC5)ccc4F)nn23)C1,IC50,'=',0.1,nM,10,,344669,UO_0000065,19.98,0.37,6.26,8.81,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1950359,,None,619.75,2,5.86,13,CN(C)c1cccc2c(S(=O)(=O)NCc3cn(CCCCn4c5ccccc5c5ccc6c(C=O)c[nH]c6c54)nn3)cccc12,IC50,,,,,,Not Determined,,,,,,0,CHEMBL1955504,Inhibition of human recombinant PIM2 expressed in Escherichia coli using RSRHSSYPAGT as substrate after 30 mins,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1949527,1,Scientific Literature,Eur J Med Chem,2012,None,
CHEMBL30432,GW282974X,None,395.47,0,4.23,GW282974X,CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1,Inhibition,'=',0.31,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL2325894,,None,338.37,0,0.94,3p,C[C@@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(=O)N1CC(C#N)C1,Inhibition,'=',-11,%,,Outside typical range,,UO_0000187,,,,,0,CHEMBL2329065,Inhibition of PIM2 (unknown origin) at 1 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2321829,1,Scientific Literature,J Med Chem,2013,None,
CHEMBL2325903,,None,286.38,0,3,3e,C[C@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(C)(C)C,Inhibition,'=',-14,%,,Outside typical range,,UO_0000187,,,,,0,CHEMBL2329065,Inhibition of PIM2 (unknown origin) at 1 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2321829,1,Scientific Literature,J Med Chem,2013,None,
CHEMBL1096626,GSK-938890A,None,447.5,0,2.28,GSK938890A,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21,Inhibition,'=',0.23,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3890727,,None,365.41,0,3.32,BDBM238705,Cc1nc2ccc(F)c(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1(C)CC1,IC50,'=',0.162,nM,9.79,,416814,UO_0000065,26.79,0.5,6.47,11.84,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3957722,,None,379.44,0,3.71,BDBM238712,Cc1nc2ccc(F)c(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1(C)CCC1,IC50,'=',0.136,nM,9.87,,416821,UO_0000065,26,0.48,6.16,11.93,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3929011,,None,385.48,0,3.57,BDBM248979,Cc1cncc(-c2cc3c(cn2)cnn3-c2cccc(C3CCCC(N)C3)n2)n1,Ki,'=',2.99,nM,8.52,,434188,UO_0000065,22.11,0.4,4.95,8.94,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3949500,,None,428.45,1,5.37,BDBM192579,Cc1cc(N)cc(-c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)c1,IC50,'=',34.4,nM,7.46,,344641,UO_0000065,17.42,0.32,2.09,9.2,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3691969,,None,532.53,1,4.36,BDBM151991,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1n1cc(C#N)nn1,IC50,'=',13.33,nM,7.88,,292246,UO_0000065,14.79,0.28,3.52,5.82,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL102346,,None,485.54,0,4.79,PDGF_RTK_Inhibitor_III,COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC,Residual Activity,'=',92,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3909217,,None,379.46,0,3.43,BDBM238794,CCn1c(NC(C)(C)C)nc2c(-c3cc4c([nH]3)[C@@H](C)NC4=O)cccc2c1=O,IC50,'=',0.077,nM,10.11,,416903,UO_0000065,26.65,0.49,6.68,11.02,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL101683,,None,337.81,0,4.6,VEGF_Receptor_Tyrosine_Kinase_Inhibitor_II,O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1,Residual Activity,'=',124,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4085846,,None,439.08,0,2.8,Tab 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL576349,IC261,None,311.34,0,3.21,IC261,COc1cc(OC)c(C=C2C(=O)Nc3ccccc32)c(OC)c1,Activity,'=',75,%,,,,UO_0000187,,,,,0,CHEMBL2433266,Inhibition of human PIM2 assessed as residual activity at 25 uM relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2429821,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL218932,GW432441X,None,339.4,0,2.95,GW432441X,CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1,Inhibition,'=',-0.21,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3966323,,None,361.41,0,2.57,BDBM238762,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC(=O)C1CC1,IC50,'=',131,nM,6.88,,416871,UO_0000065,19.04,0.35,4.31,6.9,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4455923,,None,575.63,2,4.23,48c,CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1,Inhibition,'<',50,%,,,,UO_0000187,,,,,0,CHEMBL4405512,Inhibition of wild-type human partial length PIM2 (M1 to E291 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4402587,1,Scientific Literature,J Med Chem,2020,None,
CHEMBL3965029,,None,391.5,0,3.96,BDBM224906,CC1CCN(c2cncc(-c3c[nH]c4ccc(-c5nnc(N)s5)cc34)n2)CC1,IC50,'=',49.39,nM,7.31,,393185,UO_0000065,18.66,0.36,3.35,7.56,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3771285,,None,371.85,0,4.22,12,Cc1c(Cl)cccc1NC(=O)c1sc2nc3c(cc2c1N)C(=O)CC3,Activity,'=',80,%,,,,UO_0000187,,,,,0,CHEMBL3771749,Inhibition of human recombinant PIM2 assessed as residual activity at 10 uM after 1 hr by qPCR analysis relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3769377,1,Scientific Literature,Medchemcomm,2015,None,
CHEMBL3905618,,None,373.42,0,2.94,BDBM224980,c1cc2[nH]cc(-c3cncc(C4CC4)n3)c2cc1-c1nnc(NC2CNC2)o1,IC50,'=',1.051,nM,8.98,,393270,UO_0000065,24.04,0.44,6.04,8.59,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1794057,GW284408X,None,292.3,0,2.26,GW284408X,O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1,Inhibition,'=',0.27,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3634793,,None,388.45,0,3.75,11,N[C@H]1CCCN(c2ccncc2-c2cc3c(-c4ccccc4F)n[nH]c3cn2)C1,Ki,'=',35,nM,7.46,,,UO_0000065,19.19,0.35,3.71,8.91,0,CHEMBL3636741,Inhibition of Pim2 (unknown origin) using 5FAM-ARKRRRHPSGPPTA as substrate after 90 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632547,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL3894496,,None,377.45,0,2.67,BDBM238621,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NCC1(C)COC1,IC50,'=',2.8,nM,8.55,,416728,UO_0000065,22.66,0.42,5.88,9.3,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL24338,,None,314.44,0,3.54,K00208,O=c1sn(Cc2ccccc2)c(=S)n1Cc1ccccc1,Thermal melting change,'=',-0.2,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL3687482,,None,517.56,1,2.83,BDBM151878,COC(=O)N[C@@H]1[C@H](N)CN(c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)sc2N)C[C@@H]1C,IC50,'=',0.83,nM,9.08,,292134,UO_0000065,17.55,0.34,6.25,6.12,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2442298,,None,379.47,1,5.07,9k,c1ccc(NCCNc2ccn3ncc(-c4ccc5ccccc5c4)c3n2)cc1,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL2446210,Inhibition of Pim2 (unknown origin) using STK1 as substrate preincubated for 30 mins followed by substrate and ATP addition at > 5000 nM after 60 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2440090,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL4281048,,None,505.09,1,4.55,40; JSH-150,COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1,Activity,'=',53,%,,,,UO_0000187,,,,,0,CHEMBL4264480,Binding affinity to wild-type human partial length PIM2 (M1 to E291 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4261600,1,Scientific Literature,Eur J Med Chem,2018,None,
CHEMBL3354515,,None,417.44,0,4.29,3c,O=C(Nc1cnccc1OC1CCOCC1)c1csc(-c2c(F)cccc2F)n1,IC50,'=',400,nM,6.4,,,UO_0000065,15.33,0.3,2.11,8.72,0,CHEMBL3376647,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352230,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL191384,,None,372.46,0,3.94,AS-601245,N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1,Residual Activity,'=',3,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3355552,,None,418.46,1,5.16,11a,CC(C)(O)[C@H]1CC[C@H](Nc2ccn3ncc(-c4cccc(C(F)(F)F)c4)c3n2)CC1,IC50,'=',525,nM,6.28,,,UO_0000065,15.01,0.29,1.12,10.06,0,CHEMBL3375413,Inhibition of Pim2 (unknown origin) using luciferase-luciferin based ATP detection reagent by Kinase-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3351833,1,Scientific Literature,ACS Med Chem Lett,2015,None,
CHEMBL3355548,,None,392.38,0,4.13,13,FC(F)(F)Oc1cccc(-c2cnn3ccc(NCC4CCOCC4)nc23)c1,IC50,'=',3730,nM,5.43,,,UO_0000065,13.83,0.26,1.3,8.95,0,CHEMBL3375413,Inhibition of Pim2 (unknown origin) using luciferase-luciferin based ATP detection reagent by Kinase-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3351833,1,Scientific Literature,ACS Med Chem Lett,2015,None,
CHEMBL4456165,,None,405.5,0,3.92,12,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C5(C)CC5)c(NC(C)(C)C)nc34)[nH]c21,IC50,'=',0.16,nM,9.8,,,UO_0000065,24.16,0.45,5.88,10.67,0,CHEMBL4370146,Inhibition of full length recombinant PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues preincubated for 30 mins followed by biotinylated BAD addition and measured after 1 hr by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4368910,1,Scientific Literature,J Med Chem,2019,None,
CHEMBL84558,,None,263.32,0,2.8,16a,CCCOc1ccc(/C=C2\SC(=O)NC2=O)cc1,Inhibition,'=',62,%,,,,UO_0000187,,,,,0,CHEMBL1012712,Inhibition of PIM2 at 5 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139352,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL1909413,,None,349.82,0,4.51,SB-610251-B,Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1,Inhibition,'=',0.33,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3959634,,None,376.42,0,0.73,BDBM249039,Cn1cc(-c2cc3c(cn2)cnn3-c2cccc(N3CC(O)(CN)C3)n2)cn1,Ki,'=',20.4,nM,7.69,,434243,UO_0000065,20.43,0.38,6.96,6.93,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1186409,,None,487.65,1,7.32,AG_G_60025,CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21,Residual Activity,'=',136,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3927342,,None,295.28,0,3,BDBM225047,Nc1nnc(-c2ccc3[nH]cc(-c4ccccc4F)c3n2)o1,IC50,'=',717.26,nM,6.14,,393033,UO_0000065,20.81,0.38,3.14,6.56,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3970213,,None,372.4,0,3.9,BDBM238464,Nc1ccc(-c2ccc3cccc(-c4cc5c([nH]4)CCNC5=O)c3n2)c(F)c1,IC50,'=',46.1,nM,7.34,,416207,UO_0000065,19.7,0.36,3.44,8.75,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3958501,,None,442.34,0,4.35,BDBM225058,Brc1nnc(-c2ccc3[nH]cc(-c4cccc(N5CCOCC5)n4)c3c2)s1,IC50,'>',3000,nM,,,393051,UO_0000065,,,,,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3982237,,None,393.49,0,4.66,BDBM224883,Fc1ccccc1-c1c[nH]c2ccc(-c3nnc(N[C@H]4CCCNC4)s3)cc12,IC50,'=',105.8,nM,6.98,,393162,UO_0000065,17.73,0.34,2.32,10.63,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3970104,,None,343.39,0,4.43,BDBM225075,c1cc2[nH]cc(-c3cncc(C4CC4)n3)c2cc1-c1nnc(C2CC2)o1,IC50,'=',26.01,nM,7.58,,393068,UO_0000065,22.09,0.4,3.15,9.42,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3957441,,None,406.48,0,2,BDBM225053,CN1CCN(c2cncc(-c3c[nH]c4ccc(-c5nnc(N)s5)cc34)n2)CC1=O,IC50,'=',89.2,nM,7.05,,393042,UO_0000065,17.34,0.33,5.05,6.03,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3986124,,None,349.42,0,3.3,BDBM225052,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(NC5CC5)n4)c3c2)s1,IC50,'=',20.07,nM,7.7,,393039,UO_0000065,22.03,0.42,4.4,7.3,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3957476,,None,395.4,0,2.99,BDBM225020,CNC(=O)c1ncc(F)c(-c2c[nH]c3ccc(-c4nnc(NC(C)C)o4)cc23)n1,IC50,'=',301,nM,6.52,,393312,UO_0000065,16.49,0.31,3.53,5.36,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3394069,,None,376.49,0,4.69,BDBM50061611,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(NC5CCCC5)n4)c3c2)s1,IC50,'=',21.11,nM,7.68,,393040,UO_0000065,20.39,0.39,2.99,8.3,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL104264,,None,446.37,0,3.58,H89,O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12,Residual Activity,'=',132,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4062256,,None,424.89,0,3.25,9,COc1ccc2c(c1CN1CCNCC1)O/C(=C\c1c[nH]c3nc(Cl)ccc13)C2=O,Inhibition,'=',41,%,,,,UO_0000187,,,,,0,CHEMBL3997633,Inhibition of full length recombinant human N-terminal GST-tagged PIM2 (1 to 311 residues) expressed in baculovirus infected sf21 cells at 200 nM using S6K2 peptide as substrate by electrophoretic mobility shift assay relative to control,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3994673,1,Scientific Literature,ACS Med Chem Lett,2017,None,
CHEMBL4084953,,None,390.44,0,2.6,11,Cc1ccc2c(/C=C3\Oc4c(ccc(O)c4CN4CCNCC4)C3=O)c[nH]c2n1,IC50,'=',510,nM,6.29,,,UO_0000065,16.12,0.3,3.69,6.95,0,CHEMBL3997632,Inhibition of full length recombinant human N-terminal GST-tagged PIM2 (1 to 311 residues) expressed in baculovirus infected sf21 cells using S6K2 peptide as substrate by electrophoretic mobility shift assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3994673,1,Scientific Literature,ACS Med Chem Lett,2017,None,
CHEMBL4111637,,None,415.5,0,2.21,BDBM248891,CCc1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CCNC[C@@H](O)C3)n2)c1,Ki,'=',4.59,nM,8.34,,434098,UO_0000065,20.07,0.37,6.13,9.06,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL234838,GW572738X,None,300.36,0,3.89,GW572738X,N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2,Inhibition,'=',0.56,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL4526274,,None,450.33,0,4.53,8m,O=C(CCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO,Inhibition,'=',1,%,,,,UO_0000187,,,,,0,CHEMBL4347771,Inhibition of recombinant human PIM2 at 200 nM using CREBtide as substrate measured after 60 mins by LANCE method relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4346670,1,Scientific Literature,J Med Chem,2019,None,
CHEMBL1945339,,None,350.25,0,4.39,7,CCC1(CC)NC(=O)c2c(c3ccc(Cl)c(Cl)c3n2C)C1C#N,Delta Tm,'=',2,degrees C,,,,UO_0000027,,,,,0,CHEMBL1947284,Binding affinity to PIM2 assessed as change in thermal denaturation at 10 uM by thermal stability shift assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1944596,1,Scientific Literature,J Med Chem,2012,None,
CHEMBL4446411,,None,419.49,0,2.69,31,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(CC5(O)CC5)c(NC5(C)CC5)nc34)[nH]c21,IC50,'=',0.18,nM,9.74,,,UO_0000065,23.23,0.43,7.05,8.7,0,CHEMBL4370146,Inhibition of full length recombinant PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues preincubated for 30 mins followed by biotinylated BAD addition and measured after 1 hr by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4368910,1,Scientific Literature,J Med Chem,2019,None,
CHEMBL3961358,,None,389.85,0,3.93,BDBM238731,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1-c1cnccc1Cl,IC50,'=',65.6,nM,7.18,,416840,UO_0000065,18.43,0.35,3.25,8.6,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL288064,,None,395.23,0,4.03,K00026,Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1,Thermal melting change,'=',0.1,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL3892131,,None,379.42,0,2.49,BDBM238433,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC(C)(C)C(=O)O,IC50,'=',191,nM,6.72,,416631,UO_0000065,17.71,0.33,4.23,5.6,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL7939,CGP-53353,None,365.34,0,4.34,CGP-53353,O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21,Residual Activity,'=',31,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3902504,,None,408.48,0,2.72,BDBM238790,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@H]1C[C@@H](NCCF)C1,IC50,'=',1,nM,9,,416899,UO_0000065,22.03,0.41,6.28,9.5,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2376154,,None,488.94,0,2.66,6k,Cn1nc(-c2cnc3[nH]cc(C(=O)N[C@@H](C(=O)N4CC(C#N)C4)C4CC4)c3n2)c2ccc(Cl)cc21,Inhibition,'=',91,%,,,,UO_0000187,,,,,0,CHEMBL2378211,Inhibition of PIM2 (unknown origin) at 10 uM relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2375236,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL296586,KENPAULLONE,None,327.18,0,4.09,Kenpaullone,O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1,Residual Activity,'=',100,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL222102,KU-55933,None,395.51,0,4.76,KU-55933,O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1,Residual Activity,'=',29,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1221601,,None,555.85,2,5.66,CGK733,O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1,Residual Activity,'=',70,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL261454,,None,272.31,0,3.69,LY-364947,c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1,Residual Activity,'=',120,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2048872,,None,379.49,0,3.61,28,N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1,IC50,'=',150,nM,6.82,,,UO_0000065,17.98,0.35,3.21,9.05,0,CHEMBL2049743,Inhibition of human PIM2 using FITC-(AHX)RSRHSSYPAGT-COOH as substrate after 90 mins by mobility shift assay in presence of 5 mM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2046384,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL493937,,None,338.41,0,2.38,1,CN1CCCN(c2cncc(-c3cccc(/C=C/C(=O)O)c3)n2)CC1,IC50,'=',40,nM,7.4,,,UO_0000065,21.86,0.4,5.02,10.64,1,CHEMBL960121,Inhibition of Pim2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153342,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL572783,,None,324.41,0,3.19,15b,CN(C)Cc1nc2c(sc3ccc(-c4ccc[nH]4)cc32)c(=O)[nH]1,Ki,'=',3,nM,8.52,,,UO_0000065,26.27,0.51,5.33,13.16,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL573957,,None,328.44,0,2.8,17a,CN(C)Cc1nc2c(sc3ccc(N4CCCC4)cc32)c(=O)[nH]1,Ki,'=',5,nM,8.3,,,UO_0000065,25.27,0.49,5.5,15.89,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL266487,RO-316233,None,327.34,0,3.22,BIM4,O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12,Residual Activity,'=',8,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL404941,,None,311.34,0,3.21,SU5607,COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1,Residual Activity,'=',111,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL582844,,None,369.88,0,4.52,14d,CN(C)Cc1nc2c(sc3ccc(-c4cccc(Cl)c4)cc32)c(=O)[nH]1,Ki,'=',13,nM,7.89,,,UO_0000065,21.32,0.43,3.37,16.1,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL1909347,,None,546.38,0,3.37,SB-732881-H,CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O,Inhibition,'=',1.73,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL379300,A-443654,None,397.48,0,4.36,A-443654,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12,Activity,'=',59,%,,,,UO_0000187,,,,,0,CHEMBL1051298,Percentage PIM2 activity remaining in the presence of 0.01uM inhibitor,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL576982,QUIZARTINIB,3,560.68,2,5.86,AC220,CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL1909354,GW459057A,None,390.88,0,4.11,GW459057A,Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl,Inhibition,'=',-0.15,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL4471849,,None,457.54,0,3.5,33,CC(c1cn(C)cn1)n1c(NC2(C)CC2)nc2c(-c3cc4c([nH]3)[C@@H](C)NC4=O)cccc2c1=O,IC50,'=',0.11,nM,9.96,,,UO_0000065,21.77,0.4,6.46,9.08,0,CHEMBL4370146,Inhibition of full length recombinant PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues preincubated for 30 mins followed by biotinylated BAD addition and measured after 1 hr by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4368910,1,Scientific Literature,J Med Chem,2019,None,
CHEMBL409450,6BIO,None,356.18,0,3.42,Indirubin_6bromo_oxime,O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O,Residual Activity,'=',106,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL413,SIROLIMUS,4,914.19,3,6.18,Rapamycin,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,Residual Activity,'=',142,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL160937,,None,314.73,0,2.53,SB-390527,O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1,Inhibition,'=',0.28,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL4097778,TP-030n,None,458.54,0,1.13,TP-030n,CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21,IC50,,1000,nM,,,,UO_0000065,,,,,0,CHEMBL4885388,Pim2(PIM2LHY1) Takeda global kinase panel,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507327,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1.0 碌M
CHEMBL3691930,,None,577.63,1,3.67,BDBM151952,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)c(F)cc2N)C[C@@H](N)[C@H]1OCCS(C)(=O)=O,IC50,'=',0.47,nM,9.33,,292207,UO_0000065,16.15,0.32,5.66,6.21,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3652638,,None,447.52,0,2.97,BDBM119398,Cn1ncc(NC(=O)c2nc(-c3c(F)cccc3F)sc2N)c1N1CCC[C@@H](N)CC1,Ki,'=',0.167,nM,9.78,,246165,UO_0000065,21.85,0.43,6.81,8.5,0,CHEMBL3707982,Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL313417,,None,297.36,0,3.86,SKF-86002,Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1,Residual Activity,'=',128,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL508928,,None,438.5,0,4.33,SID103904288,Cc1cccc(NC(=O)Nc2ccc(-c3cnc4c(-c5cnn(C)c5)cnn4c3N)cc2)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL104264,,None,446.37,0,3.58,H89,O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12,Residual Activity,'=',139,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL50894,ALSTERPAULLONE,None,293.28,0,3.24,Alsterpaullone,O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1,Residual Activity,'=',119,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1802727,,None,365.39,0,1.94,Indirubin_E804,O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO,Residual Activity,'=',98,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL35482,,None,267.28,0,3.05,PD-98059,COc1cccc(-c2cc(=O)c3ccccc3o2)c1N,Residual Activity,'=',126,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1964275,,None,467.61,1,6.04,11,Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1,Activity,,,,,,Not Evaluated,,,,,,0,CHEMBL982757,Binding affinity to human PIM2 at 10 uM relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1151712,1,Scientific Literature,J Med Chem,2008,None,
CHEMBL399410,,None,453.57,1,5.72,SB-437013,COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1,Inhibition,'=',-0.02,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3687505,,None,512.58,2,5.79,BDBM151901,CO[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C(C)C)cc3F)n2)C[C@@H]1C,IC50,'=',1.38,nM,8.86,,292157,UO_0000065,17.29,0.33,3.07,9.83,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2087361,ICOTINIB,3,391.43,0,3.16,Icotinib,C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3912577,,None,428.5,0,3.79,BDBM238795,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(-c5cccnc5)c(NC(C)(C)C)nc34)[nH]c21,IC50,'=',2.77,nM,8.56,,416904,UO_0000065,19.97,0.37,4.77,8.17,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3935874,,None,427.48,0,3.8,BDBM192569,N[C@H]1CCCN(c2sncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1,IC50,'=',136,nM,6.87,,344561,UO_0000065,16.06,0.31,3.07,8.14,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3660030,,None,363.4,0,3.02,BDBM104148,F[C@H]1CNCCC1Oc1cccc2ccc(-c3nnc4ccccn34)nc12,IC50,'=',686,nM,6.16,,222565,UO_0000065,16.96,0.31,3.14,9.58,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3660048,,None,377.42,0,3.41,BDBM104169,FC1CCNCCC1Oc1cccc2ccc(-c3nnc4ccccn34)nc12,IC50,'=',290,nM,6.54,,222587,UO_0000065,17.32,0.32,3.13,10.16,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3660060,,None,426.32,0,4.07,BDBM104186,CC(C)(CN)COc1cccc2ccc(-c3nnc4ccc(Br)cn34)nc12,IC50,'=',101,nM,7,,222599,UO_0000065,16.41,0.35,2.93,8.93,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3971342,,None,383.88,0,4.08,BDBM238686,Cc1nc2cccc(-c3[nH]c4c(c3Cl)C(=O)NCC4)c2nc1NC(C)(C)C,IC50,'=',0.454,nM,9.34,,416795,UO_0000065,24.34,0.47,5.26,11.3,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3986680,,None,363.46,0,3.74,BDBM238688,Cc1nc2cccc(-c3[nH]c4c(c3C)C(=O)NCC4)c2nc1NC(C)(C)C,IC50,'=',3.38,nM,8.47,,416797,UO_0000065,23.31,0.43,4.73,10.24,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3979545,,None,363.42,0,2.42,BDBM238444,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1CCOC1,IC50,'=',6.1,nM,8.21,,416642,UO_0000065,22.6,0.42,5.79,8.94,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3922440,,None,395.46,0,2.57,BDBM238806,COC[C@@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C)c(NC(C)(C)C)nc34)[nH]c21,IC50,'=',5,nM,8.3,,416915,UO_0000065,20.99,0.39,5.73,8.22,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1614766,RO-4987655,1,565.29,1,3.16,Ro-4987655,O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL483321,CP-724714,2,469.55,0,4.95,CP-724714,COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3105022,,None,457.46,0,2.96,3,C[C@H]1CN(c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@@H]1O,Ki,'<',3,nM,,,,UO_0000065,,,,,1,CHEMBL3750240,Inhibition of PIM2 kinase (unknown origin) using NH2-AGAGRSRHSSYPAGT-OH as substrate by kinase-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3745712,1,Scientific Literature,J Med Chem,2015,None,
CHEMBL1989474,,None,254.27,0,2.68,SID103905180,Cn1cc(-c2ccncn2)c(-c2ccc(F)cc2)n1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1980540,,None,366.73,0,4.95,SID103904899,O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(Cl)cccc12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3934565,,None,351.41,0,2.93,BDBM238727,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)[nH]c(NC(C)(C)C)nc34)[nH]c21,IC50,'=',0.24,nM,9.62,,416836,UO_0000065,27.37,0.51,6.69,9.37,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2000429,,None,468.51,0,4.35,SID103904769,CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3939400,,None,403.87,0,4.12,BDBM238732,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1-c1ccc(N)cc1Cl,IC50,'=',33.4,nM,7.48,,416841,UO_0000065,18.51,0.35,3.36,7.73,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3652026,,None,456.47,0,4.01,BDBM106934,C[C@@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1O,IC50,'=',16,nM,7.8,,225955,UO_0000065,17.08,0.32,3.79,7.71,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3980052,,None,365.86,0,4.11,BDBM191079,NCCC1CNC(=O)c2cc(-c3cccc(Cl)c3)c(-c3ccccc3)n21,IC50,'=',117,nM,6.93,,341750,UO_0000065,18.95,0.36,2.82,11.54,0,CHEMBL3887520,Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3652647,,None,443.55,0,3.32,BDBM119407,CCn1ncc(NC(=O)c2nc(-c3ccccc3F)sc2N)c1N1CCC[C@@H](N)CC1,Ki,'=',124,nM,6.91,,246174,UO_0000065,15.57,0.3,3.59,6,0,CHEMBL3707982,Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3687478,,None,465.48,0,4.79,BDBM151874,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1C#N,IC50,'=',11.96,nM,7.92,,292130,UO_0000065,17.02,0.32,3.13,7.57,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3639908,,None,578.65,1,2.76,BDBM152004,COC(=O)N[C@@H]1[C@H](N)CN(c2ccncc2NC(=O)c2nc(-c3cc(C(=O)NC(C)C)ccc3F)ccc2N)C[C@@H]1C,IC50,'=',2.18,nM,8.66,,292259,UO_0000065,14.97,0.28,5.9,4.88,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3651958,,None,404.49,0,4.77,BDBM106862,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2cccc(-c3ccccc3F)n2)C1,IC50,'=',7,nM,8.15,,225883,UO_0000065,20.16,0.37,3.38,10.08,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3687448,,None,532.5,2,5.58,BDBM151844,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@@H]1OP(C)(C)=O,IC50,'=',45.51,nM,7.34,,292100,UO_0000065,13.79,0.27,1.76,6.85,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3687455,,None,528.53,1,4.51,BDBM151851,C[C@@H]1C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@H](N)[C@H]1OCCC(=O)O,IC50,'>',25000,nM,,,292107,UO_0000065,,,,,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1927262,,None,296.35,0,3.53,73,Cc1ccc(F)cc1-c1nc2[nH]nc(N)c2c2c1CCCC2,Activity,'=',100,%,,,,UO_0000187,,,,,0,CHEMBL1929879,Inhibition of PIM2 assessed as residual activity at 10 uM using [33P-ATP] by radiometric filter binding assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1926576,1,Scientific Literature,Eur J Med Chem,2012,None,
CHEMBL4574669,,None,395.46,0,1.93,(R,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1721885,SU-014813,2,442.49,0,1.69,SU-14813,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3651899,,None,473.46,0,2.66,BDBM106802,C[C@H]1CN(c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(O)cc3F)n2)C[C@@H](N)[C@@H]1O,IC50,'=',1,nM,9,,225823,UO_0000065,19.01,0.36,6.34,7.22,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3103877,,None,299.34,0,0.12,3b,Nc1nccnc1C(=O)Nc1cnccc1N1CCNCC1,Ki,'>',12500,nM,,,,UO_0000065,,,,,0,CHEMBL3106178,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3102815,1,Scientific Literature,ACS Med Chem Lett,2013,None,
CHEMBL1952329,SGI-1776,1,405.42,0,4.05,SGI-1776,CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1,Ki,'=',610,nM,6.21,,,UO_0000065,15.33,0.29,2.16,11.36,1,CHEMBL3106178,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3102815,1,Scientific Literature,ACS Med Chem Lett,2013,None,
CHEMBL3651947,,None,455.48,0,4.63,BDBM106851,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)c(F)cc2N)C1,IC50,'=',2,nM,8.7,,225872,UO_0000065,19.1,0.36,4.07,8.14,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3892885,,None,416.49,0,2,BDBM248987,Cc1cncc(-c2cc3c(cn2)cnn3-c2ccc(CO)c(N3CCC[C@H](N)C3)n2)n1,Ki,'=',0.394,nM,9.4,,434194,UO_0000065,22.58,0.41,7.4,7.91,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3946306,,None,392.85,0,2.34,BDBM249044,Clc1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CCNCC3)n2)n1,Ki,'=',5.74,nM,8.24,,434248,UO_0000065,20.98,0.4,5.9,9.74,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1981723,,None,397.36,0,4.27,SID103905637,Cn1ccc2c(-c3ccccc3F)nc(N(C(N)=O)c3c(F)cccc3F)nc21,Ki,'=',1258.93,nM,5.9,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3652012,,None,422.46,0,2.07,BDBM106918,C[C@H]1CN(c2ccncc2NC(=O)c2ccc(F)c(-c3cccnc3)n2)C[C@@H](N)[C@@H]1O,IC50,'=',29,nM,7.54,,225939,UO_0000065,17.84,0.33,5.47,6.43,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL233001,GW620972X,None,332.43,0,4.9,JNK_Inhibitor_IX,N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2,Residual Activity,'=',105,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3687425,,None,483.49,0,4.66,BDBM151818,CO/N=C1/[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H]1C,IC50,'=',16.07,nM,7.79,,292074,UO_0000065,16.12,0.3,3.13,7.6,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3634772,,None,400.49,0,2.7,22,c1cc(-c2n[nH]c3cnc(-c4cnn(CC5CC5)c4)cc23)nc(N2CCNCC2)c1,Ki,'=',0.253,nM,9.6,,,UO_0000065,23.96,0.44,6.9,10.96,0,CHEMBL3636741,Inhibition of Pim2 (unknown origin) using 5FAM-ARKRRRHPSGPPTA as substrate after 90 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632547,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL1908394,GSK-461364,1,543.62,2,5.09,GSK-461364A,C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL3355547,,None,406.41,0,4.66,12,CO[C@H]1CC[C@H](Nc2ccn3ncc(-c4cccc(OC(F)(F)F)c4)c3n2)CC1,IC50,'=',3620,nM,5.44,,,UO_0000065,13.39,0.26,0.78,8.97,0,CHEMBL3375413,Inhibition of Pim2 (unknown origin) using luciferase-luciferin based ATP detection reagent by Kinase-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3351833,1,Scientific Literature,ACS Med Chem Lett,2015,None,
CHEMBL3355542,,None,391.4,0,3.98,7,N[C@H]1CC[C@H](Nc2ccn3ncc(-c4cccc(OC(F)(F)F)c4)c3n2)CC1,IC50,'=',100,nM,7,,,UO_0000065,17.88,0.34,3.02,9.04,0,CHEMBL3375413,Inhibition of Pim2 (unknown origin) using luciferase-luciferin based ATP detection reagent by Kinase-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3351833,1,Scientific Literature,ACS Med Chem Lett,2015,None,
CHEMBL3355990,,None,390.9,0,3.29,14b,O=S1(=O)CCC(CNc2ccn3ncc(-c4cccc(Cl)c4)c3n2)CC1,IC50,'=',2070,nM,5.68,,,UO_0000065,14.54,0.3,2.39,7.44,0,CHEMBL3375413,Inhibition of Pim2 (unknown origin) using luciferase-luciferin based ATP detection reagent by Kinase-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3351833,1,Scientific Literature,ACS Med Chem Lett,2015,None,
CHEMBL249697,BMS-345541,None,255.32,0,1.87,BMS-345541,Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL411645,,None,403.18,0,3.26,K00192,O=C1Nc2ccc(I)cc2/C1=C1/Nc2ccccc2/C1=N\O,Thermal melting change,'=',-0.5,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL3355988,,None,356.86,0,4.42,12b,CO[C@H]1CC[C@H](Nc2ccn3ncc(-c4cccc(Cl)c4)c3n2)CC1,IC50,'=',1020,nM,5.99,,,UO_0000065,16.79,0.33,1.57,11.65,0,CHEMBL3375413,Inhibition of Pim2 (unknown origin) using luciferase-luciferin based ATP detection reagent by Kinase-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3351833,1,Scientific Literature,ACS Med Chem Lett,2015,None,
CHEMBL3394165,,None,391.5,0,4.47,25,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(NC5CCCCC5)n4)c3c2)s1,IC50,'=',2600,nM,5.58,,,UO_0000065,14.27,0.27,1.12,5.3,0,CHEMBL3395662,Inhibition of PIM2 in human U2OS cells assessed as phosphorylation of BAD,B,BAO_0000219,cell-based format,Homo sapiens,None,None,U2OS,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3393014,1,Scientific Literature,Bioorg Med Chem Lett,2015,CHEMBL3307757,
CHEMBL102346,,None,485.54,0,4.79,PDGF_RTK_Inhibitor_III,COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC,Residual Activity,'=',149,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL371206,,None,403.51,1,5.51,SID103904294,Cc1cc(C)cc(NC(=O)Nc2ccc(-c3c(C)sc4ncnc(N)c34)cc2)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1977135,,None,288.35,0,3.68,SID103904563,O=C(NCc1ccccc1)c1ccc(-c2ccncc2)cc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3394064,,None,328.35,0,4.21,13,Nc1nnc(-c2ccc3[nH]cc(-c4c(F)cccc4F)c3c2)s1,IC50,,,,,,Not Determined,,,,,,0,CHEMBL3395662,Inhibition of PIM2 in human U2OS cells assessed as phosphorylation of BAD,B,BAO_0000219,cell-based format,Homo sapiens,None,None,U2OS,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3393014,1,Scientific Literature,Bioorg Med Chem Lett,2015,CHEMBL3307757,
CHEMBL3703176,,None,647.87,2,7.08,BDBM149684,CCc1cccc(CC)c1NC(=O)c1c2c(n(C)c1C)-c1nc(Nc3ccc(N4CCC(N5CCCC5)CC4)cc3OC)ncc1CC2,IC50,'>',10000,nM,,,288342,UO_0000065,,,,,0,CHEMBL3707582,Kinase Inhibition Assay: The buffer for PIM-2 assay was composed of HEPES 50 mM,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3394061,,None,343.42,0,4.48,3,Nc1nnc(-c2ccc3[nH]cc(-c4cnc5ccccc5c4)c3c2)s1,IC50,'=',1010,nM,6,,,UO_0000065,17.46,0.33,1.52,7.45,1,CHEMBL3395659,Inhibition of full length recombinant PIM2 (unknown origin) using biotinylated-BAD peptide as substrate assessed as phosphorylation at serine 112 after 90 mins by HTRF method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3393014,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL3394066,,None,362.46,0,3.93,15,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(N5CCCC5)n4)c3c2)s1,IC50,'=',104,nM,6.98,,,UO_0000065,19.27,0.37,3.05,8.34,1,CHEMBL3395659,Inhibition of full length recombinant PIM2 (unknown origin) using biotinylated-BAD peptide as substrate assessed as phosphorylation at serine 112 after 90 mins by HTRF method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3393014,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL3687471,,None,528.54,1,3.66,BDBM151867,COC(=O)N(C)[C@@H]1[C@H](N)CN(c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H]1C,IC50,'=',1.07,nM,8.97,,292123,UO_0000065,16.97,0.32,5.31,7.89,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1909362,GW830900A,None,534.09,0,3.22,GW830900A,CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl,Inhibition,'=',2.68,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1991063,,None,427.34,1,5.19,SID103904480,Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccc(Cl)c(Cl)c4)c3)cc12,Ki,'=',12.59,nM,7.9,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL595373,,None,512.64,2,6.57,25,COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1,Residual activity,'=',113,%,,,,UO_0000187,,,,,0,CHEMBL1050333,Residual activity of PIM2 at 10 uM by microplate scintillation counting,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1152560,1,Scientific Literature,Bioorg Med Chem,2009,None,
CHEMBL2012574,,None,337.35,0,3.96,42,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1914471,,None,364.36,0,4.16,17j,CNC(=O)c1cccc2c1nc(Nc1c(F)cccc1F)c1ccncc12,IC50,'=',2,nM,8.7,,,UO_0000065,23.87,0.44,4.54,13,0,CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914433,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL573339,PI-103,None,348.36,0,2.98,PI_103,Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1,Residual Activity,'=',109,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL47940,,None,370.46,1,5.59,Lck_Inhibitor,Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1,Residual Activity,'=',132,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL35482,,None,267.28,0,3.05,PD-98059,COc1cccc(-c2cc(=O)c3ccccc3o2)c1N,Residual Activity,'=',102,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL256835,,None,368.41,0,3.63,SID103905255,COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL92461,,None,307.38,0,4.13,VEGF_Receptor_2_Kinase_Inhibitor_IV,COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1,Residual Activity,'=',123,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL400402,,None,475.98,1,5.58,TG-100572,Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3931685,,None,350.43,0,3.22,BDBM238797,C[C@H]1NC(=O)c2cc(-c3cccc4c(N)nc(NC(C)(C)C)nc34)[nH]c21,IC50,'=',7.66,nM,8.12,,416906,UO_0000065,23.16,0.43,4.9,7.46,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3301607,FILGOTINIB,4,425.51,0,1.98,Filgotinib,O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL7064,,None,220.23,0,2.77,K00068,O=C1c2ccccc2-c2n[nH]c3cccc1c23,Thermal melting change,'=',3.6,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL3918273,,None,406.49,0,2.41,BDBM238819,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C)c(N[C@H]5CCC[C@@H](N)C5)nc34)[nH]c21,IC50,'=',0.1,nM,10,,416928,UO_0000065,24.6,0.46,7.59,8.49,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2397527,,None,252.28,0,2.79,16b,COc1ccc2[nH]c3c(N)cc4[nH]ncc4c3c2c1,Activity,'=',123,%,,,,UO_0000187,,,,,0,CHEMBL2401343,Inhibition of human PIM2 assessed as residual activity using RSRHSSYPAGT as substrate at 1 uM after 30 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2396576,1,Scientific Literature,Bioorg Med Chem,2013,None,
CHEMBL4092706,,None,389.29,0,4.03,Tab 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4088490,,None,503.05,1,4.13,21,CN(C)Cc1ccc(-c2c(-c3ccc(N4CCNCC4)cc3)n(C)c3nc(C(N)=O)cc(Cl)c23)cc1,IC50,'>',30000,nM,,,,UO_0000065,,,,,0,CHEMBL4047686,Inhibition of PIM2 (unknown origin) assessed as reduction in full length human BAD phosphorylation at Ser112 residues by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4043256,1,Scientific Literature,Bioorg Med Chem Lett,2017,None,
CHEMBL4098659,,None,383.88,0,2.74,24,CN1CCN(c2ccc(-c3cc4c(Cl)cc(C(N)=O)nc4n3C)cc2)CC1,IC50,'>',30000,nM,,,,UO_0000065,,,,,1,CHEMBL4047686,Inhibition of PIM2 (unknown origin) assessed as reduction in full length human BAD phosphorylation at Ser112 residues by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4043256,1,Scientific Literature,Bioorg Med Chem Lett,2017,None,
CHEMBL3660018,,None,403.44,0,2.62,BDBM104136,COC(=O)[C@@H]1C[C@@H](Oc2cccc3ccc(-c4nnc5ccccn45)nc23)CCN1,IC50,'=',189,nM,6.72,,222553,UO_0000065,16.67,0.31,4.1,7.42,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL4075702,,None,359.28,0,3.09,Tab 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3354524,,None,316.33,0,3.85,9a,NC(=O)c1ccc(-c2csc(-c3c(F)cccc3F)n2)cc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3376647,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352230,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL3354526,,None,297.32,0,1.13,9d,NC(=O)c1ccc(-c2c[nH]c3ncnc(NCCO)c23)cc1,IC50,'=',1900,nM,5.72,,,UO_0000065,19.24,0.36,4.59,4.89,0,CHEMBL3376647,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352230,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL3354523,,None,408.48,0,4.71,7b,Fc1cccc(F)c1-c1nc(-c2ccc3nccc(N4CCNCC4)c3c2)cs1,IC50,'=',190,nM,6.72,,,UO_0000065,16.45,0.32,2.01,16.37,0,CHEMBL3376647,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352230,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL1088391,,None,273.69,0,3.97,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL599428,,None,431.5,0,1.79,52,Cn1nc(C(N)=O)c2c1-c1nc(NC3CCN(C(=O)c4ccccc4)CC3)ncc1CC2,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1072222,Inhibition of PIM2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1157561,1,Scientific Literature,J Med Chem,2010,None,
CHEMBL220244,GW427984X,None,296.37,0,3.28,GW427984X,Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1,Inhibition,'=',0.34,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1421,DASATINIB,4,488.02,0,3.31,K00617a,Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1,Thermal melting change,'=',0,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL361708,HYMENIALDISINE,None,324.14,0,0.07,K00010,NC1=NC(=O)/C(=C2\CCNC(=O)c3[nH]c(Br)cc32)N1,Thermal melting change,'=',3.7,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL608533,MIDOSTAURIN,4,570.65,2,5.91,Midostaurin,CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1244923,Binding affinity to PIM2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240346,1,Scientific Literature,Blood,2009,None,
CHEMBL3430783,,None,None,None,None,K00069,,Thermal melting change,'=',1.9,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL2442288,,None,335.44,0,3.5,11n,NCCNc1ccn2ncc(-c3ccc(-c4ccccc4)s3)c2n1,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL2446210,Inhibition of Pim2 (unknown origin) using STK1 as substrate preincubated for 30 mins followed by substrate and ATP addition at > 5000 nM after 60 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2440090,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL410072,GW301784X,None,445.5,0,0.85,GW301784X,CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2,Inhibition,'=',4.28,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3819210,,None,498.59,0,4.62,25,Cc1cc(-c2cnn3c(NCC4CCOCC4)nc(Oc4ccccc4)nc23)ccc1C(=O)NC1CC1,Inhibition,'=',-11,%,,Outside typical range,,UO_0000187,,,,,0,CHEMBL3820354,Inhibition of full length recombinant human N-terminal GST-tagged PIM2 expressed in Escherichia coli at 1 uM by radiometric assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3817791,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL3950192,,None,343.82,0,2.45,21a,N[C@H]1CCCN(c2ccncc2Nc2ncc3ccc(Cl)nn23)C1,IC50,'=',99,nM,7,,,UO_0000065,20.37,0.4,4.55,8.3,0,CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3864151,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL1909384,,None,378.82,0,0.26,SB-772077-B,CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl,Inhibition,'=',9.73,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL507329,GW869810X,None,608.1,2,5.36,GW869810X,O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1,Inhibition,'=',-0.36,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL2397521,,None,252.28,0,2.79,7b,COc1ccc2[nH]c3c(N)cc4cn[nH]c4c3c2c1,Activity,'=',120,%,,,,UO_0000187,,,,,0,CHEMBL2401343,Inhibition of human PIM2 assessed as residual activity using RSRHSSYPAGT as substrate at 1 uM after 30 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2396576,1,Scientific Literature,Bioorg Med Chem,2013,None,
CHEMBL3913112,,None,439.45,0,3.69,22n,N[C@H]1C[C@@H](F)CN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1,IC50,'=',3.2,nM,8.49,,,UO_0000065,19.33,0.36,4.8,10.07,0,CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3864151,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL189231,,None,284.32,0,2.57,SB-734117,Nc1nonc1-c1nc2cnccc2n1C1CCCCC1,Inhibition,'=',37.5,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL28324,,None,721.86,2,5.13,KN_62,CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12,Residual Activity,'=',98,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL517907,GW680191X,None,438.55,0,3.15,GW680191X,C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1,Inhibition,'=',-2.91,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1909401,,None,465.41,0,4.56,SB-285234-W,O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+],Inhibition,'=',-0.61,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL442363,GW809885X,None,373.42,0,3.36,GW809885X,COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1,Inhibition,'=',-0.5,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL305477,GW829874X,None,374.4,0,3.28,GW829874X,COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1,Inhibition,'=',-0.75,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3660046,,None,353.39,0,3.92,BDBM104167,c1cncc(COc2cccc3ccc(-c4nnc5ccccn45)nc23)c1,IC50,'=',7473,nM,5.13,,222581,UO_0000065,14.51,0.26,1.21,7.86,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL1241075,,None,248.28,0,3.92,3j,Cc1ccc2c(c1)[nH]c1c2ccc2c(C=O)c[nH]c21,Activity,'=',39,%,,,,UO_0000187,,,,,0,CHEMBL1248949,Inhibition of human GST fused Pim2 expressed in Escherichia coli assessed as residual activity at 10 uM after 30 mins,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240519,1,Scientific Literature,Bioorg Med Chem,2010,None,
CHEMBL1973145,,None,390.47,0,4.48,SID103904363,Cc1cccc(NC(=O)Nc2ccc(-c3csc4nc(N)nc(N)c34)cc2)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1969372,,None,364.38,0,3.05,SID103904758,COCCNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1969537,,None,320.43,0,2.8,SID103905585,S=c1[nH]nc2c3c4c(sc3n3c(=S)[nH]nc3n12)CCC4,Ki,'=',31.62,nM,7.5,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1996543,,None,361.42,0,4.32,SID103904467,NC(COc1cncc(-c2ccc(F)cc2)c1)Cc1c[nH]c2ccccc12,Ki,'=',1258.93,nM,5.9,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1977681,,None,275.31,0,2.79,SID103904940,CNC(=O)c1cc2c(-c3ccccc3F)n[nH]c2s1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL116070,,None,349.21,0,3.95,SID103905046,NC(=O)c1cc2c(Oc3ccc(Br)cc3)cncc2s1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1990912,,None,265.32,0,2.7,SID103904736,OCCNc1cc2cc(-c3cccnc3)ccc2cn1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1981720,,None,265.28,0,2.67,SID103904889,O=C(Nc1cnccn1)Nc1ccnc2ccccc12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1970522,,None,326.38,0,3.29,SID103905209,COc1cc(C=C2SC(=Nc3ccccc3)NC2=O)ccc1O,Ki,'=',158.49,nM,6.8,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL482967,CYC-116,1,368.47,0,3.07,SID103904403,Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1243094,,None,279.26,0,3.52,3g,O=Cc1c[nH]c2c1ccc1c3cc([N+](=O)[O-])ccc3[nH]c12,Activity,'=',126,%,,,,UO_0000187,,,,,0,CHEMBL1248949,Inhibition of human GST fused Pim2 expressed in Escherichia coli assessed as residual activity at 10 uM after 30 mins,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240519,1,Scientific Literature,Bioorg Med Chem,2010,None,
CHEMBL1985580,,None,394.48,0,4.31,SID103904969,NC(Cc1cccc2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1240920,,None,303.15,0,4.92,3a,O=Cc1c[nH]c2c1ccc1c2[nH]c2cc(Cl)cc(Cl)c21,Activity,'=',54,%,,,,UO_0000187,,,,,0,CHEMBL1248947,Inhibition of human GST fused Pim2 expressed in Escherichia coli assessed as residual activity at 1 uM after 30 mins,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240519,1,Scientific Literature,Bioorg Med Chem,2010,None,
CHEMBL1782511,,None,326.36,0,2.74,19,NCCCCNc1ccnc(-c2ccc3oc(C(=O)O)cc3c2)n1,IC50,'=',1200,nM,5.92,,,UO_0000065,18.14,0.34,3.18,5.18,0,CHEMBL1786238,Inhibition of human Pim2 using 5-FAM-RSRHSSYPAGT-CONH2 as substrate after 90 mins by off-chip mobility shift method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1781944,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL2048869,,None,347.44,0,2.34,25,CCOc1cccc(/C=C2\SC(=O)NC2=O)c1N1CCC[C@@H](N)C1,IC50,'<',4,nM,,,,UO_0000065,,,,,0,CHEMBL2049740,Inhibition of human PIM2 using FITC-(AHX)RSRHSSYPAGT-COOH as substrate after 90 mins by mobility shift assay in presence of 50 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2046384,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL2017352,,None,373.44,0,4.99,13t,COc1ccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3sccc23)cc1,IC50,'=',6,nM,8.22,,,UO_0000065,22.02,0.42,3.23,10.86,0,CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016532,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL2035625,,None,405.64,0,4.76,5h,COc1cccc(-c2nc3c(oc4ccc(Br)cc43)c(=O)[nH]2)c1Cl,IC50,'=',1741,nM,5.76,,,UO_0000065,14.2,0.33,1,8.45,0,CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034948,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL2017351,,None,373.44,0,4.99,13s,COc1cccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3sccc23)c1,IC50,'=',28,nM,7.55,,,UO_0000065,20.23,0.38,2.56,9.97,0,CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016532,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL3125726,,None,420.54,1,5.14,20,COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)(C)C)c4)cnc3[nH]2)cc1,Activity,'=',93,%,,,,UO_0000187,,,,,0,CHEMBL3130705,Inhibition of human PIM-2 assessed as residual activity at 1 uM relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3124838,1,Scientific Literature,Bioorg Med Chem Lett,2014,None,
CHEMBL2204495,,None,399.43,1,5.11,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL383899,ANILINOPYRIMIDINE1,None,413.4,1,5.33,K00603a,O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1,Thermal melting change,'=',6.9,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL1910912,,None,406.47,0,3.77,34,CC(C)[C@H](N)COc1cncc(-c2ccc3[nH]cc(-c4ccc(N)nc4F)c3c2)n1,IC50,'=',72,nM,7.14,,,UO_0000065,17.57,0.33,3.37,6.17,0,CHEMBL1912526,Inhibition of PIM2 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1909629,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL3125727,,None,406.51,0,4.75,19,COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)C)c4)cnc3[nH]2)cc1,Activity,'=',90,%,,,,UO_0000187,,,,,0,CHEMBL3130705,Inhibition of human PIM-2 assessed as residual activity at 1 uM relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3124838,1,Scientific Literature,Bioorg Med Chem Lett,2014,None,
CHEMBL2376144,,None,462.9,0,2.27,6a,C[C@@H](NC(=O)c1c[nH]c2ncc(-c3nn(C)c4cc(Cl)ccc34)nc12)C(=O)N1CC(C#N)C1,Inhibition,'=',-15,%,,Outside typical range,,UO_0000187,,,,,0,CHEMBL2378211,Inhibition of PIM2 (unknown origin) at 10 uM relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2375236,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL1945559,,None,363.25,0,2.96,20,Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C1(CCNCC1)NC2=O,Delta Tm,'=',6.5,degrees C,,,,UO_0000027,,,,,0,CHEMBL1947284,Binding affinity to PIM2 assessed as change in thermal denaturation at 10 uM by thermal stability shift assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1944596,1,Scientific Literature,J Med Chem,2012,None,
CHEMBL2377712,,None,260.25,0,2.49,11,CCOCc1c[nH]c2c([N+](=O)[O-])cc3cn[nH]c3c12,Inhibition,'=',109,%,,,,UO_0000187,,,,,0,CHEMBL2378598,Inhibition of human full length Pim-2 using RSRHSSYPAGT as substrate assessed as residual activity at 1 uM after 30 mins in presence of [gamma-33P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2375344,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL1964444,,None,346.31,0,4.6,SID103904873,Cc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL4174988,,None,494.04,0,4.2,15i,Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1,Activity,'=',77,%,,,,UO_0000187,,,,,0,CHEMBL4157212,Binding affinity to wild-type human partial length PIM2 (M1 to E291 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4152344,1,Scientific Literature,Eur J Med Chem,2018,None,
CHEMBL590109,,None,425.52,0,4.4,31a,NCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1073310,Inhibition of PIM2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153138,1,Scientific Literature,Bioorg Med Chem Lett,2010,None,
CHEMBL1997023,,None,265.29,0,1.39,SID103905667,CN(C)c1cc2sncc2cc1NC(=O)C(=O)O,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL4528675,,None,535.55,1,4.76,8d-1,COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1,Inhibition,'=',0.23,%,,,,UO_0000187,,,,,0,CHEMBL4366540,Inhibition of human PIM2 at 100 nM using RSRHSSYPAGT as substrate by [gamma-33P]-ATP assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4364276,1,Scientific Literature,Eur J Med Chem,2019,None,
CHEMBL3932720,,None,384.47,0,4.85,BDBM224876,CNc1nnc(-c2ccc3[nH]cc(-c4nccc(-c5ccccc5)n4)c3c2)s1,IC50,'=',35.77,nM,7.45,,393154,UO_0000065,19.37,0.36,2.6,9.38,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL587723,AEE-788,2,440.6,0,4.94,AEE-788,CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL379300,A-443654,None,397.48,0,4.36,A-443654,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12,Activity,'=',15,%,,,Antagonist,UO_0000187,,,,,0,CHEMBL1051299,Percentage PIM2 activity remaining in the presence of 0.1uM inhibitor,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL1615025,TAK-733,1,504.23,1,1.07,TAK-733,Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3660048,,None,377.42,0,3.41,BDBM104169,FC1CCNCCC1Oc1cccc2ccc(-c3nnc4ccccn34)nc12,IC50,'=',100,nM,7,,222586,UO_0000065,18.55,0.34,3.59,10.88,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL4278763,,None,469.57,0,4.2,21,NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1,Inhibition,'=',-1,%,,,,UO_0000187,,,,,0,CHEMBL4263905,Inhibition of PIM2 (unknown origin) at 1 uM relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4261595,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL1952142,,None,422.41,0,3.13,2; ETP-47453,COc1cc(NCC2CCNCC2)nc2c1nnn2-c1cccc(OC(F)(F)F)c1,IC50,'=',29,nM,7.54,,,UO_0000065,17.84,0.34,4.41,8.75,0,CHEMBL4340984,Inhibition of His tagged human recombinant PIM2 using PIM tide (ARKRRRHPSGPPTA) as substrate incubated for 1 hr by fluorescence based assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4340512,1,Scientific Literature,Eur J Med Chem,2019,None,
CHEMBL85105,,None,205.24,0,2.01,7,O=C1NC(=O)/C(=C/c2ccccc2)S1,IC50,'=',4700,nM,5.33,,,UO_0000065,25.96,0.52,3.32,11.54,0,CHEMBL2049740,Inhibition of human PIM2 using FITC-(AHX)RSRHSSYPAGT-COOH as substrate after 90 mins by mobility shift assay in presence of 50 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2046384,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL3427177,,None,322.41,0,3.03,9,COc1ccc2nc(C3=N[C@@H](C(=O)O)C(C)(C)S3)sc2c1,Activity,'=',76,%,,,,UO_0000187,,,,,0,CHEMBL3427823,Inhibition of PIM2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3425453,1,Scientific Literature,Eur J Med Chem,2015,None,
CHEMBL3916318,,None,541.69,1,4.2,BDBM182823,CN(C)C1CCN(C[C@@H](NC(=O)C[C@H]2CNC(=O)c3cc(-c4ccc(F)c(F)c4)cn32)C2CCCCC2)CC1,IC50,'=',171,nM,6.77,,330369,UO_0000065,12.49,0.24,2.57,9.72,0,CHEMBL3887311,Kinase Inhibition Assay: Method for PIM2 Kinase Inhibition Assay: Dowex Technique i. Kinase Buffer (KB)The buffer for PIM2 assay was composed of HEPES 50 mM,,,,,,,,,,,,,,,,,,,,,,
CHEMBL397570,,None,300.36,0,3.89,SB-347804,N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2,Inhibition,'=',-0.05,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL517507,GW782912X,None,362.47,0,4.08,GW782912X,Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1,Inhibition,'=',-0.51,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3912741,,None,335.37,0,3.08,BDBM224842,CC(C)Nc1cncc(-c2c[nH]c3ccc(-c4nnc(N)o4)cc23)n1,IC50,'=',4.025,nM,8.39,,393124,UO_0000065,25.03,0.46,5.32,7.08,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1909373,GW701427A,None,497.9,0,4.88,GW701427A,COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl,Inhibition,'=',-4.42,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL103080,,None,370.43,0,2.95,SB-742864,CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1,Inhibition,'=',0.5,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1909349,GSK-1007102B,None,561.52,0,2.28,GSK1007102B,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F,Inhibition,'=',20.65,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1990635,,None,388.43,1,5.76,SID103905478,CC1CCCN1CCc1cc2cc(-c3ccc(OC(F)(F)F)cc3)ccc2[nH]1,Ki,'=',1000,nM,6,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL514499,GW843682X,None,477.46,0,4.8,GW843682X,COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC,Inhibition,'=',-3.6,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL427159,GW827396X,None,430.42,0,4.88,GW827396X,COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1,Inhibition,'=',4.2,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL103098,,None,356.41,0,2.23,SB-738482,NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1,Inhibition,'=',0.28,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL581096,GW440139A,None,363.85,1,5.05,GW440139A,Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl,Inhibition,'=',0.49,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL119385,NEFLAMAPIMOD,2,436.27,1,5.49,VX-745,O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL2218939,,None,361.47,0,3.93,MEK_Inhibitor_I,N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1,Residual Activity,'=',137,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL404939,,None,289.67,0,1.67,MEK_Inhibitor_II,O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21,Residual Activity,'=',99,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL286721,AMINOPURVALANOL,None,403.92,0,3.82,Aminopurvalanol,CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1,Residual Activity,'=',133,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1909407,,None,374.85,0,2.65,SB-220025-R,Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1,Inhibition,'=',1.8,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL479079,GW612286X,None,406.45,0,4.17,GW612286X,COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC,Inhibition,'=',1.57,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL482326,GSK-1030062A,None,505.52,2,5.4,GSK1030062A,COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC,Inhibition,'=',-0.26,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3634760,,None,388.48,0,2.66,39,Cc1ccc(-c2n[nH]c3cnc(-c4cnn(C)c4)cc23)nc1N1CCC[C@H](N)C1,Ki,'=',0.088,nM,10.06,,,UO_0000065,25.88,0.47,7.4,9.9,0,CHEMBL3636741,Inhibition of Pim2 (unknown origin) using 5FAM-ARKRRRHPSGPPTA as substrate after 90 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632547,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL1945340,,None,253.31,0,2.31,8,Cn1c2c(c3ccccc31)C(C#N)C(C)(C)NC2=O,Delta Tm,'=',-0.2,degrees C,,,,UO_0000027,,,,,0,CHEMBL1947284,Binding affinity to PIM2 assessed as change in thermal denaturation at 10 uM by thermal stability shift assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1944596,1,Scientific Literature,J Med Chem,2012,None,
CHEMBL3639863,,None,570.61,1,4.67,BDBM151923,CO[C@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C4(O)CCOCC4)cc3F)n2)C[C@@H]1C,IC50,'=',1.53,nM,8.81,,292178,UO_0000065,15.45,0.29,4.15,7.37,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL105442,CI-1040,2,478.66,1,5.04,PD-184352,O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl,Activity,'=',92,%,,,,UO_0000187,,,,,0,CHEMBL1061149,Percentage PIM2 activity remaining in the presence of 10uM inhibitor,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL1909407,,None,374.85,0,2.65,SB-220025-A,Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1,Inhibition,'=',0.2,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3652630,,None,410.46,0,1.78,BDBM119390,Cn1ncc(NC(=O)c2nc(-c3ccccc3F)cnc2N)c1N1CCC[C@H](N)C1,Ki,'=',2.13,nM,8.67,,246157,UO_0000065,21.13,0.39,6.89,6.78,0,CHEMBL3707982,Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1975900,,None,348.19,0,3.34,SID103905263,O=c1c(NCc2ccc(Cl)c(Cl)c2)c(Nc2ccncc2)c1=O,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1998545,,None,332.4,0,3.08,SID103904581,O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1969561,,None,374.45,0,3.35,SID103904515,CC(C)N(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1972840,,None,400.51,0,4.79,SID103904751,NC(COc1cncc(-c2cc3cnccc3s2)c1)Cc1c[nH]c2ccccc12,Ki,'=',199.53,nM,6.7,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2001485,,None,539.67,2,6.01,SID103904283,Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C(C)C(=O)N(C)C)c5)cnc(N)c34)cc2)cc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3652627,,None,423.5,0,2.77,BDBM119387,Cn1ncc(NC(=O)c2nc(-c3ccccc3F)ccc2N)c1N1CCCC(N)CC1,Ki,'=',1.65,nM,8.78,,246154,UO_0000065,20.74,0.39,6.01,7.63,0,CHEMBL3707982,Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3914356,,None,487.48,0,4.09,BDBM191090,CN(C)C(=O)c1ccc(-c2c(-c3cccc(OC(F)(F)F)c3)cc3n2C(CCO)CNC3=O)cc1,IC50,'=',93,nM,7.03,,341761,UO_0000065,14.42,0.27,2.94,8.39,0,CHEMBL3887520,Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3687520,,None,620.67,2,5.04,BDBM151916,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C4(F)CCOCC4)cc3F)n2)C[C@@H](N)[C@H]1S(C)(=O)=O,IC50,'=',10.38,nM,7.98,,292172,UO_0000065,12.86,0.25,2.94,6.42,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL381604,GW799251X,None,446.87,0,4.36,GW799251X,Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1,Inhibition,'=',0.62,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL103667,DORAMAPIMOD,2,527.67,2,5.99,BIRB-796,Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1,Kd,'>',10000,nM,,,,UO_0000065,,,,,1,CHEMBL1061184,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150977,1,Scientific Literature,Nat Biotechnol,2008,None,
CHEMBL514261,GSK-1819799A,None,519.58,1,4.82,GSK1819799A,COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1,Inhibition,'=',0.53,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3736320,,None,464.45,0,4.66,1,CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21,Inhibition,'=',-1,%,,,,UO_0000187,,,,,0,CHEMBL4230185,Inhibition of PIM2 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4229333,1,Scientific Literature,Eur J Med Chem,2018,None,
CHEMBL4247506,,None,472.47,1,5.62,2a,CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21,Inhibition,'=',0,%,,,,UO_0000187,,,,,0,CHEMBL4230185,Inhibition of PIM2 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4229333,1,Scientific Literature,Eur J Med Chem,2018,None,
CHEMBL278041,SB-202190,None,331.35,0,4.65,SB-202190,Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1061184,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150977,1,Scientific Literature,Nat Biotechnol,2008,None,
CHEMBL2035638,,None,350.17,0,1.61,6m,O=c1[nH]c(CN2CC(O)C2)nc2c1oc1ccc(Br)cc12,IC50,'=',142,nM,6.85,,,UO_0000065,19.56,0.45,5.24,8.31,0,CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034948,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL522892,DOVITINIB,3,392.44,0,2.54,CHIR-258/TKI-258,CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1,Kd,'>',10000,nM,,,,UO_0000065,,,,,1,CHEMBL1061184,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150977,1,Scientific Literature,Nat Biotechnol,2008,None,
CHEMBL191003,JNJ-7706621,None,394.36,0,1.22,JNJ-7706621,Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1061184,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150977,1,Scientific Literature,Nat Biotechnol,2008,None,
CHEMBL418348,,None,493.56,0,4.27,SB-254169,CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1,Inhibition,'=',0.42,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3687418,,None,508.51,1,3.43,BDBM151811,C[C@H]1CN(c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1n1ccnn1,IC50,'=',1.24,nM,8.91,,292067,UO_0000065,17.52,0.33,5.48,7.75,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3691920,,None,528.58,2,5.21,BDBM151942,CCOCc1cc(F)c(-c2nc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@H](OC)[C@@H](C)C3)ccc2F)c(F)c1,IC50,'=',1.47,nM,8.83,,292197,UO_0000065,16.71,0.32,3.62,8.89,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL480371,GW853609X,None,496.31,1,5.55,GW853609X,NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br,Inhibition,'=',-0.35,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL215993,GW284372X,None,393.45,1,6.21,GW284372X,c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1,Inhibition,'=',1.2,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1909365,GW607049C,None,617.56,2,6.69,GW607049C,COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O,Inhibition,'=',-0.3,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL485745,GW434756X,None,289.31,0,4.2,GW434756X,Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1,Inhibition,'=',-0.05,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL572743,,None,307.81,0,2.9,6j,CN(C)CCc1nc2c(sc3ccc(Cl)cc32)c(=O)[nH]1,Ki,'=',399,nM,6.4,,,UO_0000065,20.79,0.44,3.5,13.06,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL575469,,None,341.82,0,4.4,6l,O=c1[nH]c(CNc2ccccc2)nc2c1sc1ccc(Cl)cc12,Ki,'>',1424,nM,,,,UO_0000065,,,,,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL575255,,None,378.5,0,3.93,14n,CN(C)Cc1nc2c(sc3ccc(-c4ccc(N(C)C)cc4)cc32)c(=O)[nH]1,Ki,'=',13,nM,7.89,,,UO_0000065,20.84,0.4,3.96,15.1,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL497606,,None,447.36,1,5.84,5a,O=C1S/C(=C\c2cccc(C(F)(F)F)c2)C(=O)N1Cc1ccc(OC(F)(F)F)cc1,IC50,'>',100000,nM,,,,UO_0000065,,,,,0,CHEMBL957366,Inhibition of human recombinant Pim2 by ATP depletion assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139352,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL512076,GSK-192082A,None,566.06,2,5.63,GSK192082A,CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1,Inhibition,'=',-0.15,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3691963,,None,607.64,1,4.48,BDBM151985,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C4(O)CCOCC4)cc3F)n2)C[C@@H](N)[C@H]1n1ccnn1,IC50,'=',3.19,nM,8.5,,292240,UO_0000065,13.98,0.26,4.02,6.02,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL103667,DORAMAPIMOD,2,527.67,2,5.99,BIRB-796,Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1,Activity,'=',124,%,,,,UO_0000187,,,,,0,CHEMBL1061086,Percentage PIM2 activity remaining in the presence of 1uM inhibitor,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL493937,,None,338.41,0,2.38,1,CN1CCCN(c2cncc(-c3cccc(/C=C/C(=O)O)c3)n2)CC1,IC50,'=',1200,nM,5.92,,,UO_0000065,17.5,0.32,3.54,8.51,0,CHEMBL960094,Inhibition of GST-tagged Pim2 preincubated for 30 mins before addition of ATP measured after 30 mins by scintillation counting-reversal assay in presence of 20 uM [gamma33P]ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153342,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL2088999,,None,265.27,0,3.08,20,Nc1cccc2[nH]c3c(cc(C(=O)O)c4cc[nH]c43)c12,IC50,,,,,,Not Determined,,,,,,0,CHEMBL2090488,Inhibition of human Pim2 using RSRHSSYPAGT as substrate,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2086229,1,Scientific Literature,Eur J Med Chem,2012,None,
CHEMBL493937,,None,338.41,0,2.38,6,CN1CCCN(c2cncc(-c3cccc(/C=C/C(=O)O)c3)n2)CC1,IC50,'=',40,nM,7.4,,,UO_0000065,21.86,0.4,5.02,10.64,0,CHEMBL2184777,Competitive inhibition of PIM2 in presence of ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2176972,1,Scientific Literature,J Med Chem,2012,None,
CHEMBL384073,GSK-180736A,None,365.37,0,2.97,GSK180736A,CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1,Inhibition,'=',-0.13,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL189148,GW829055X,None,398.86,1,5.25,GW829055X,Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1,Inhibition,'=',0.51,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1972158,,None,366.43,0,4.12,SID103904464,Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2005186,BELUMOSUDIL,4,452.52,0,4.82,SID103905007,CC(C)NC(=O)COc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3ccccc3n2)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1241462,,None,228.3,0,1.94,29,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL572513,,None,335.82,0,2.36,6e,O=c1[nH]c(CN2CC[C@H](O)C2)nc2c1sc1ccc(Cl)cc12,Ki,'=',29,nM,7.54,,,UO_0000065,22.45,0.47,5.18,10.89,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL3691934,,None,533.55,2,5.06,BDBM151956,C[C@@H]1C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@H](N)[C@@H]1n1ccccc1=O,IC50,'>',25000,nM,,,292211,UO_0000065,,,,,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3691968,,None,579.62,2,5.32,BDBM151990,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C4(O)CCC4)cc3F)n2)C[C@@H](N)[C@H]1OCCC#N,IC50,'=',2.04,nM,8.69,,292245,UO_0000065,14.99,0.28,3.37,6.48,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3687444,,None,518.56,1,4.07,BDBM151840,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@@H]1S(C)(=O)=O,IC50,'=',47.24,nM,7.33,,292096,UO_0000065,14.13,0.28,3.26,6.37,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL583972,,None,234.26,0,3.61,9,O=Cc1c[nH]c2c1ccc1c3ccccc3[nH]c12,IC50,'=',510,nM,6.29,,,UO_0000065,26.86,0.48,2.68,12.93,1,CHEMBL1051395,Inhibition of Pim-2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154186,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL568477,,None,328.35,1,5.42,32,O=Cc1c[nH]c2c1ccc1c3cc(-c4ccc(F)cc4)ccc3[nH]c12,Activity,'=',72,%,,,,UO_0000187,,,,,0,CHEMBL1051392,Inhibition of Pim-2 assessed as residual enzyme activity at 1 uM relative to untreated control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154186,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL105442,CI-1040,2,478.66,1,5.04,CI-1040,O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL1980704,,None,345.43,0,4.13,SID103905204,Cc1cc2nnc(SCc3cn4ccccc4n3)n2c2ccccc12,Ki,'=',398.11,nM,6.4,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2004447,,None,312.35,0,3.06,SID103905103,CC(C)(C)c1n[nH]c2c1C(c1ccccc1F)C(C#N)=C(N)O2,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3651959,,None,422.48,0,4.91,BDBM106863,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2cccc(-c3c(F)cccc3F)n2)C1,IC50,'=',3,nM,8.52,,225884,UO_0000065,20.17,0.38,3.61,10.54,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL583144,,None,271.13,0,3.44,SID103905309,O=c1[nH]cnc2c1sc1c(Cl)ccc(Cl)c12,Ki,'=',158.49,nM,6.8,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3932201,,None,360.42,0,4.37,BDBM225077,CC(C)Nc1nnc(-c2ccc3[nH]cc(-c4cncc(C5CC5)n4)c3c2)o1,IC50,'=',4.252,nM,8.37,,393070,UO_0000065,23.23,0.42,4,9.05,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1992740,,None,429.48,0,2.65,SID103905384,CCN1CCN(CCCC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1909400,,None,557.55,1,5.48,SB-284847-BT,Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F,Inhibition,'=',0.06,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1909358,GW654652C,None,489,0,3.98,GW654652C,CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl,Inhibition,'=',0.56,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3930916,,None,429.51,0,3.25,BDBM225056,Cc1nnc2n1CCN(c1cccc(-c3c[nH]c4ccc(-c5nnc(N)s5)cc34)n1)C2,IC50,'=',88.68,nM,7.05,,393049,UO_0000065,16.42,0.31,3.8,6.16,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3947143,,None,409.49,0,3.05,BDBM238775,COCCn1c(NC(C)(C)C)nc2c(-c3cc4c([nH]3)[C@@H](C)NC4=O)cccc2c1=O,IC50,'=',0.193,nM,9.71,,416884,UO_0000065,23.72,0.44,6.66,9.61,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4159505,,None,297.36,0,1.95,19,CN(C)CCn1cc(-c2cccc(O)c2)c2c(N)ncnc21,Inhibition,'=',5,%,,,,UO_0000187,,,,,0,CHEMBL4156125,Inhibition of recombinant full length human GST-tagged PIM2 expressed in baculovirus expression system at 500 nM by Z-LYTE assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4152312,1,Scientific Literature,Eur J Med Chem,2018,None,
CHEMBL3687423,,None,513.52,1,4.38,BDBM151816,COC(=O)N[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H]1C,IC50,'=',34.07,nM,7.47,,292072,UO_0000065,14.54,0.28,3.09,6.26,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3949953,,None,393.49,0,3.28,BDBM238586,Cc1nc2cccc(-c3cc4n(c3)C(CCO)CNC4=O)c2nc1NC(C)(C)C,IC50,'=',14.5,nM,7.84,,416701,UO_0000065,19.92,0.37,4.56,8.51,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL405021,,None,277.33,0,3.58,SB-732941,O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1,Inhibition,'=',0.26,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL517907,GW680191X,None,438.55,0,3.15,GW680191X,C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1,Inhibition,'=',-1.09,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3968103,,None,354.37,0,4.26,BDBM238391,O=c1[nH]cnc2[nH]c(-c3cccc4ccc(Oc5ccccc5)nc34)cc12,IC50,'=',80.2,nM,7.1,,416169,UO_0000065,20.02,0.36,2.84,8.48,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3394064,,None,328.35,0,4.21,13,Nc1nnc(-c2ccc3[nH]cc(-c4c(F)cccc4F)c3c2)s1,IC50,'=',348,nM,6.46,,,UO_0000065,19.67,0.38,2.25,9.56,1,CHEMBL3395659,Inhibition of full length recombinant PIM2 (unknown origin) using biotinylated-BAD peptide as substrate assessed as phosphorylation at serine 112 after 90 mins by HTRF method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3393014,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL3394065,,None,308.37,0,2.91,14,Nc1cccc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)n1,IC50,'=',977,nM,6.01,,,UO_0000065,19.49,0.37,3.1,5.64,1,CHEMBL3395659,Inhibition of full length recombinant PIM2 (unknown origin) using biotinylated-BAD peptide as substrate assessed as phosphorylation at serine 112 after 90 mins by HTRF method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3393014,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL4437940,,None,447.52,0,2.97,9,Cn1ncc(NC(=O)c2nc(-c3c(F)cccc3F)sc2N)c1N1CCC[C@H](N)CC1,Ki,'=',0.1,nM,10,,,UO_0000065,22.35,0.44,7.03,8.69,0,CHEMBL4317000,Inhibition of recombinant human PIM2 using FAM-pimtide as substrate after 90 mins by Z-LYTE assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4316591,1,Scientific Literature,J Med Chem,2019,None,
CHEMBL311228,,None,346.82,0,2.63,K00015,CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21,Thermal melting change,'=',0.6,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL258893,CHELERYTHRINE CHLORIDE,None,383.83,0,3.72,K00233,COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC.[Cl-],Thermal melting change,'=',-3.1,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL3355991,,None,326.79,0,3.22,16b,O=C1CCN(c2ccn3ncc(-c4cccc(Cl)c4)c3n2)CC1,IC50,'=',564,nM,6.25,,,UO_0000065,19.12,0.37,3.03,12.37,0,CHEMBL3375413,Inhibition of Pim2 (unknown origin) using luciferase-luciferin based ATP detection reagent by Kinase-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3351833,1,Scientific Literature,ACS Med Chem Lett,2015,None,
CHEMBL157258,,None,383.62,0,3.83,SB-390523,O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1,Inhibition,'=',0.46,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL207410,GW772405X,None,486.93,1,5.35,GW772405X,CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1,Inhibition,'=',0.37,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3933147,,None,418.48,0,3.39,BDBM192619,C[C@H]1CC[C@@H](N)CN1c1ccncc1Nc1ncc2ccc(-c3ncccc3F)nn12,IC50,'=',2.8,nM,8.55,,344693,UO_0000065,20.44,0.38,5.16,8.79,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3890986,,None,458.45,0,2.71,BDBM251452,Nc1ncc(-c2ncccc2C(F)(F)F)nc1C(=O)Nc1ncccc1N1CCC(N)CC1,IC50,'>',10000,nM,,,438371,UO_0000065,,,,,0,CHEMBL3889161,In Vitro Caliper Kinase Assay: For comparison between certain PKC inhibitors of the present application and structurally comparable PIM kinase inhibitors,,,,,,,,,,,,,,,,,,,,,,
CHEMBL573696,,None,371.85,0,4.41,6p,COc1cccc(NCc2nc3c(sc4ccc(Cl)cc43)c(=O)[nH]2)c1,Ki,'>',1424,nM,,,,UO_0000065,,,,,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL573697,,None,373.82,0,3.81,6q,O=c1[nH]c(CNc2cc(O)cc(O)c2)nc2c1sc1ccc(Cl)cc12,Ki,'=',711,nM,6.15,,,UO_0000065,16.45,0.34,2.34,6.26,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL3908049,,None,391.38,0,4.59,BDBM238536,O=C1NCCc2[nH]c(-c3cccc4ccc(Oc5c(F)cccc5F)nc34)cc21,IC50,'=',4.7,nM,8.33,,416259,UO_0000065,21.28,0.39,3.74,12.43,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL478649,,None,348.45,0,3.69,10,Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1,Activity,,,,,,Not Evaluated,,,,,,0,CHEMBL982757,Binding affinity to human PIM2 at 10 uM relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1151712,1,Scientific Literature,J Med Chem,2008,None,
CHEMBL4066592,,None,349.35,0,3.77,38,COC(=O)Nc1noc2cc(-c3c(-c4ccccn4)n[nH]c3C)ccc12,Inhibition,'=',1.7,%,,,,UO_0000187,,,,,0,CHEMBL4057638,Inhibition of PIM2 (unknown origin) at 0.078 uM relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4052759,1,Scientific Literature,Bioorg Med Chem Lett,2017,None,
CHEMBL3676272,,None,447.49,0,3.86,BDBM131742,NC1CC(CF)CN(c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C1,IC50,'=',3,nM,8.52,,263975,UO_0000065,19.05,0.38,4.66,10.13,0,CHEMBL3706072,Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4129118,,None,435.55,0,3.67,27,CN(C)CCNc1cncc(-c2ccc3[nH]cc(-c4ccc(S(C)(=O)=O)cc4)c3c2)n1,IC50,'=',2160,nM,5.67,,,UO_0000065,13.01,0.25,2,6.23,0,CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4118246,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL3691958,,None,529.52,1,2.9,BDBM151980,COC(=O)N[C@@H]1[C@H](N)CN(c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)c(F)cc2N)C[C@@H]1C,IC50,'=',0.65,nM,9.19,,292235,UO_0000065,17.35,0.33,6.29,6.19,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3652003,,None,506.48,2,5.46,BDBM106909,COc1cc(F)c(-c2cccc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)C[C@@H](C(F)(F)F)C3)n2)c(F)c1,IC50,'=',2,nM,8.7,,225930,UO_0000065,17.18,0.33,3.24,9.65,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1910898,,None,371.45,0,2.68,12,Nc1ccc(-c2ccc3c(-c4ccc(N5CCNCC5)cc4)n[nH]c3n2)cn1,IC50,'>',25000,nM,,,,UO_0000065,,,,,0,CHEMBL1912526,Inhibition of PIM2 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1909629,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL1789941,RUXOLITINIB,4,306.37,0,3.47,INCB18424,N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL3326555,,None,264.24,0,3.17,7,O=[N+]([O-])c1cc2[nH]ncc2c2c1ncc1ccccc12,Activity,'=',8.1,%,,,,UO_0000187,,,,,0,CHEMBL3369948,Inhibition of full-length human PIM2 using RSRHSSYPAGT as substrate assessed as residual kinase activity at 10 uM after 30 mins in presence of [gamma-33P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352653,1,Scientific Literature,Bioorg Med Chem,2014,None,
CHEMBL3326556,,None,294.27,0,3.18,8,COc1ccc2c(cnc3c([N+](=O)[O-])cc4[nH]ncc4c32)c1,Activity,'=',55,%,,,,UO_0000187,,,,,0,CHEMBL3369948,Inhibition of full-length human PIM2 using RSRHSSYPAGT as substrate assessed as residual kinase activity at 10 uM after 30 mins in presence of [gamma-33P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352653,1,Scientific Literature,Bioorg Med Chem,2014,None,
CHEMBL3326557,,None,298.69,0,3.83,9,O=[N+]([O-])c1cc2[nH]ncc2c2c1ncc1ccc(Cl)cc12,Activity,'=',47,%,,,,UO_0000187,,,,,0,CHEMBL3369948,Inhibition of full-length human PIM2 using RSRHSSYPAGT as substrate assessed as residual kinase activity at 10 uM after 30 mins in presence of [gamma-33P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352653,1,Scientific Literature,Bioorg Med Chem,2014,None,
CHEMBL437612,,None,228.25,0,2.1,K00011,Cc1cc(C=C2C(=O)C=CC2=O)cc(C)c1O,Thermal melting change,'=',-5.7,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL3660021,,None,359.43,0,3.32,BDBM104139,c1cc(OCC2CCCNC2)c2nc(-c3nnc4ccccn34)ccc2c1,IC50,'=',169,nM,6.77,,222556,UO_0000065,18.84,0.34,3.45,10.53,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL4568120,,None,388.83,0,3.29,G28_14,C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl,Activity,'=',10,%,,,,UO_0000187,,,,,0,CHEMBL4335230,Inhibition of recombinant human Pim2 (2 to end residues) assessed as residual activity at 1 uM using RSRHSSYPAGT as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4334438,1,Scientific Literature,Eur J Med Chem,2019,None,
CHEMBL180022,NERATINIB,4,557.05,2,5.93,Neratinib,CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL402548,DANUSERTIB,2,474.57,0,2.64,Danusertib,CO[C@@H](C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL475251,R-406,2,470.46,0,3.63,R-406,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3942833,,None,354.41,0,4.26,BDBM238377,O=C1NCCc2[nH]c(-c3cccc4ccc(Nc5ccccc5)nc34)cc21,IC50,'=',8,nM,8.1,,416154,UO_0000065,22.85,0.41,3.84,11.6,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3660017,,None,331.38,0,2.69,BDBM104135,c1cc(O[C@H]2CCNC2)c2nc(-c3nnc4ccccn34)ccc2c1,IC50,'=',4910,nM,5.31,,222552,UO_0000065,16.02,0.29,2.62,8.25,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL4074201,,None,418.5,0,3.16,4,CCc1ccc2c(/C=C3\Oc4c(ccc(OC)c4CN4CCNCC4)C3=O)c[nH]c2n1,IC50,'=',290,nM,6.54,,,UO_0000065,15.62,0.29,3.38,8.23,0,CHEMBL3997632,Inhibition of full length recombinant human N-terminal GST-tagged PIM2 (1 to 311 residues) expressed in baculovirus infected sf21 cells using S6K2 peptide as substrate by electrophoretic mobility shift assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3994673,1,Scientific Literature,ACS Med Chem Lett,2017,None,
CHEMBL1782527,,None,383.2,0,1.7,35,O=C(O)c1cc2cc(Br)cc(OCC(=O)N3CCNCC3)c2o1,IC50,'=',1300,nM,5.89,,,UO_0000065,15.36,0.35,4.19,6.4,0,CHEMBL1786238,Inhibition of human Pim2 using 5-FAM-RSRHSSYPAGT-CONH2 as substrate after 90 mins by off-chip mobility shift method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1781944,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL3942347,,None,311.77,0,3.73,BDBM238401,CC1CNC(=O)c2cc(-c3cccc4ccc(Cl)nc34)[nH]c21,IC50,'=',366,nM,6.44,,416178,UO_0000065,20.65,0.4,2.71,11.14,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3961692,,None,387.45,0,1.65,BDBM249016,Nc1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CCCNCC3)n2)n1,Ki,'=',0.664,nM,9.18,,434220,UO_0000065,23.69,0.43,7.53,8.29,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3896124,,None,361.45,0,3.88,BDBM238662,Cc1nc2cccc(-c3cc4c([nH]3)C3(CC3)NC4=O)c2nc1NC(C)(C)C,IC50,'=',0.223,nM,9.65,,416771,UO_0000065,26.7,0.49,5.77,11.67,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3971664,,None,376.3,0,3.2,BDBM224854,Nc1nnc(-c2ccc3[nH]cc(-c4nccc(OCC(F)(F)F)n4)c3c2)o1,IC50,'=',2.378,nM,8.62,,393133,UO_0000065,22.92,0.44,5.42,7.45,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3394074,,None,351.44,0,3.55,23,CC(C)Nc1cncc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)n1,IC50,'=',10,nM,8,,,UO_0000065,22.76,0.44,4.45,7.59,1,CHEMBL3395659,Inhibition of full length recombinant PIM2 (unknown origin) using biotinylated-BAD peptide as substrate assessed as phosphorylation at serine 112 after 90 mins by HTRF method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3393014,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL4588900,BI 1230,None,816.98,3,6.14,BI 1230,COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C,% Control,,100,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507284,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL2036117,,None,405.5,1,5.39,7,CC(C)(C)OC(=O)NCCCCn1c2ccccc2c2ccc3c(C=O)c[nH]c3c21,Activity,'=',54,%,,,,UO_0000187,,,,,0,CHEMBL2040256,Inhibition of Pim-2 using RSRHSSYPAGT as substrate assessed as residual activity at 10 uM after 30 mins,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034961,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL583972,,None,234.26,0,3.61,A,O=Cc1c[nH]c2c1ccc1c3ccccc3[nH]c12,Activity,,,,,,Not Determined,,,,,,0,CHEMBL2040257,Inhibition of Pim-2 using RSRHSSYPAGT as substrate assessed as residual activity at 1 uM after 30 mins,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034961,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL3652024,,None,471.48,0,3.6,BDBM106930,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)c(F)cc2N)C[C@@H](N)[C@@H]1O,IC50,'=',7,nM,8.15,,225951,UO_0000065,17.3,0.33,4.55,6.41,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3913540,,None,418.48,0,3.24,BDBM192593,C[C@@H]1C[C@H](N)CN(c2ccncc2Nc2ncc3ccc(-c4ncccc4F)nn23)C1,IC50,'=',0.4,nM,9.4,,344664,UO_0000065,22.46,0.41,6.16,9.66,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3894390,,None,352.37,0,4.39,BDBM224824,CC(C)Oc1ccc(F)c(-c2c[nH]c3ccc(-c4nnc(N)o4)cc23)c1,IC50,'=',193.39,nM,6.71,,393106,UO_0000065,19.05,0.35,2.32,7.46,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3937011,,None,377.41,0,2.48,BDBM224832,C[C@H]1COCCN1c1ccnc(-c2c[nH]c3ccc(-c4nnc(N)o4)cc23)n1,IC50,'=',1.069,nM,8.97,,393114,UO_0000065,23.77,0.44,6.49,7.54,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3967996,,None,354.37,0,3.92,BDBM224860,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(-c5ccccc5)n4)c3c2)o1,IC50,'=',14.02,nM,7.85,,393138,UO_0000065,22.16,0.4,3.93,7.37,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4448899,BAY-876,None,496.42,0,4.17,EUB0000307,Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1,% Control,,94,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507267,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL4129166,,None,426.44,1,5.25,30,CN(C)CCOc1cncc(-c2ccc3[nH]cc(-c4ccc(C(F)(F)F)cc4)c3c2)n1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4118246,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL3927492,,None,363.45,0,3.59,BDBM225059,c1cc(-c2c[nH]c3ccc(-c4nncs4)cc23)nc(N2CCOCC2)c1,IC50,'=',156.65,nM,6.8,,393052,UO_0000065,18.72,0.36,3.22,10.17,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1909380,GW282449A,None,447.93,0,4.79,GW282449A,COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl,Inhibition,'=',0.05,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3908000,,None,335.37,0,3.08,BDBM224844,CC(C)Nc1ccnc(-c2c[nH]c3ccc(-c4nnc(N)o4)cc23)n1,IC50,'=',2.236,nM,8.65,,393126,UO_0000065,25.79,0.47,5.57,7.3,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3970168,,None,375.44,0,3.49,BDBM224847,C[C@H]1CCCN(c2ccnc(-c3c[nH]c4ccc(-c5nnc(N)o5)cc34)n2)C1,IC50,'=',4.807,nM,8.32,,393128,UO_0000065,22.16,0.41,4.83,7.58,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3892287,,None,358.37,0,2.66,BDBM224866,Cn1cc(-c2cncc(-c3c[nH]c4ccc(-c5nnc(N)o5)cc34)n2)cn1,IC50,'=',34.59,nM,7.46,,393144,UO_0000065,20.82,0.38,4.8,6,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4526274,,None,450.33,0,4.53,8m,O=C(CCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO,Inhibition,'=',-5,%,,,,UO_0000187,,,,,0,CHEMBL4347770,Inhibition of recombinant human PIM2 at 20 nM using CREBtide as substrate measured after 60 mins by LANCE method relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4346670,1,Scientific Literature,J Med Chem,2019,None,
CHEMBL3394065,,None,308.37,0,2.91,BDBM50061607,Nc1cccc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)n1,IC50,'=',977.36,nM,6.01,,393213,UO_0000065,19.49,0.37,3.1,5.64,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL388978,STAUROSPORINE,None,466.54,0,4.35,28,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,IC50,'=',345,nM,6.46,,,UO_0000065,13.85,0.25,2.11,9.3,0,CHEMBL960130,Inhibition of Pim2 in presence of 100 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153342,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL4468395,,None,430.52,0,2.67,30,CN1CCC(Nc2cccc3ccc(-c4nnc5c6c(cnn45)N(C)CCO6)nc23)CC1,IC50,'=',2870,nM,5.54,,,UO_0000065,12.87,0.24,2.87,6.62,0,CHEMBL4340984,Inhibition of His tagged human recombinant PIM2 using PIM tide (ARKRRRHPSGPPTA) as substrate incubated for 1 hr by fluorescence based assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4340512,1,Scientific Literature,Eur J Med Chem,2019,None,
CHEMBL4576509,,None,448.51,0,2.67,32,CN1CCOc2c1cnn1c(-c3ccc4cccc(NCC5(F)CCNCC5)c4n3)nnc21,IC50,'=',5530,nM,5.26,,,UO_0000065,11.72,0.22,2.59,5.68,0,CHEMBL4340984,Inhibition of His tagged human recombinant PIM2 using PIM tide (ARKRRRHPSGPPTA) as substrate incubated for 1 hr by fluorescence based assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4340512,1,Scientific Literature,Eur J Med Chem,2019,None,
CHEMBL4228713,A-1211212,None,896.51,3,9.44,EUB0000263,CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1,% Control,,88,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507310,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL3940091,,None,393.49,0,3.99,BDBM238725,CC(C)n1c(NC(C)(C)C)nc2c(-c3cc4c([nH]3)[C@@H](C)NC4=O)cccc2c1=O,IC50,'=',0.012,nM,10.92,,416834,UO_0000065,27.75,0.51,6.93,11.9,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3910446,,None,477.57,1,1.9,BDBM238810,Cc1nc2cccc(-c3cc4c([nH]3)[C@@H](C)NC4=O)c2nc1N[C@H]1CCC[C@@H](NC(=O)[C@H](N)CO)C1,IC50,'=',0.16,nM,9.8,,416919,UO_0000065,20.51,0.38,7.9,6.2,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3951570,,None,370.37,0,4.05,BDBM224849,Nc1nnc(-c2ccc3[nH]cc(-c4nccc(Oc5ccccc5)n4)c3c2)o1,IC50,'=',6.391,nM,8.19,,393129,UO_0000065,22.12,0.4,4.14,7.08,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3980131,,None,375.44,0,3.64,BDBM225039,CC1CCCCN1c1cncc(-c2c[nH]c3ccc(-c4nnc(N)o4)cc23)n1,IC50,'=',2.063,nM,8.69,,393025,UO_0000065,23.13,0.42,5.05,7.91,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2063926,,None,505.7,1,3.58,17,CSc1ccccc1Nc1nc(N2CCN(C3CCNCC3)CC2)nc2c(NCC3CC3)ncnc12,IC50,'<',10000,nM,,,,UO_0000065,,,,,0,CHEMBL2065157,Inhibition of PIM2 by FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2062359,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL4548361,,None,484.09,1,5.19,6,COc1cc(Br)cc2[nH]c(I)c(-c3cnc(-c4ccc[nH]4)o3)c12,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL4338190,Inhibition of PIM2 (unknown origin) by [33P]-ATP filter binding kinase assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4334516,1,Scientific Literature,J Med Chem,2019,None,
CHEMBL1909380,GW282449A,None,447.93,0,4.79,GW282449A,COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl,Inhibition,'=',2.31,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL447741,,None,347.31,0,3.05,7a,COCCOc1c(/C=C2\SC(=O)NC2=O)cccc1C(F)(F)F,IC50,'=',42000,nM,4.38,,,UO_0000065,12.6,0.26,1.33,6.77,0,CHEMBL957366,Inhibition of human recombinant Pim2 by ATP depletion assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139352,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL2062289,,None,550.52,0,3.36,SB-698596-AC,CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O,Inhibition,'=',1.56,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3687426,,None,483.49,0,4.66,BDBM151819,CO/N=C1\[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H]1C,IC50,'=',4.82,nM,8.32,,292075,UO_0000065,17.2,0.32,3.66,8.11,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL505915,GSK-1751853A,None,601.69,1,3.61,GSK1751853A,COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2,Inhibition,'=',-0.02,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3652636,,None,423.5,0,2.63,BDBM119396,Cn1ncc(NC(=O)c2nc(-c3ccccc3F)ccc2N)c1N1CCC[C@H](CN)C1,Ki,'=',10.2,nM,7.99,,246163,UO_0000065,18.87,0.35,5.36,6.94,0,CHEMBL3707982,Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL202891,GW679410X,None,328.38,0,4.21,GW679410X,COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1,Inhibition,'=',0.36,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1794066,GSK-619487A,None,525.49,0,1.34,GSK619487A,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F,Inhibition,'=',1.16,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3950704,,None,363.42,0,2.7,22,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C)c(NC5(C)CC5)nc34)[nH]c21,IC50,'=',0.4,nM,9.4,,,UO_0000065,25.86,0.48,6.7,10.24,0,CHEMBL4478465,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as reduction in phosphorylation of biotinylated-BAD peptide at Serine 112 residue preincubated for 30 mins followed by substrate addition for 1 hr by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4477213,1,Scientific Literature,J Med Chem,2016,None,
CHEMBL3896195,,None,365.41,0,4.12,3,Cc1nc2ccc(F)c(-c3cc4c(=O)[nH]ccc4[nH]3)c2nc1NC(C)(C)C,IC50,'=',0.1,nM,10,,,UO_0000065,27.37,0.51,5.88,11.57,0,CHEMBL4478465,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as reduction in phosphorylation of biotinylated-BAD peptide at Serine 112 residue preincubated for 30 mins followed by substrate addition for 1 hr by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4477213,1,Scientific Literature,J Med Chem,2016,None,
CHEMBL3427183,,None,274.3,0,1.89,15,O=C(O)[C@H]1CSC(c2ccc3cccc(O)c3n2)=N1,Activity,'=',32,%,,,,UO_0000187,,,,,0,CHEMBL3427823,Inhibition of PIM2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3425453,1,Scientific Literature,Eur J Med Chem,2015,None,
CHEMBL939,GEFITINIB,4,446.91,0,4.28,Gefitinib,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1,Thermal melting change,'=',0.6,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL3703184,,None,355.47,0,2.85,BDBM149692,CSc1ncc2ccc3c(C(N)=O)cn([C@H]4CC[C@@H](N)CC4)c3c2n1,IC50,'=',1,nM,9,,288350,UO_0000065,25.32,0.49,6.15,9.02,0,CHEMBL3707582,Kinase Inhibition Assay: The buffer for PIM-2 assay was composed of HEPES 50 mM,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3651979,,None,406.46,0,3.49,BDBM106883,N[C@@H]1C[C@H](c2ccncc2NC(=O)c2cccc(-c3ccccc3F)n2)CC[C@@H]1O,IC50,'=',48,nM,7.32,,225904,UO_0000065,18.01,0.33,3.83,7.24,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL187081,PYRAZOLOPYRIDAZINE 1,None,318.34,0,2.94,GW810576X,COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1,Inhibition,'=',0.37,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL188257,GW827106X,None,452.47,0,4.38,GW827106X,COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1,Inhibition,'=',1.11,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3393700,,None,378.39,0,3.35,13i,Fc1cccc(F)c1-c1ccc2[nH]nc(-c3cncc(NC4CNC4)n3)c2c1,IC50,'=',55,nM,7.26,,,UO_0000065,19.19,0.35,3.91,9.25,0,CHEMBL3396420,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as phosphorylation of biotinylated-BAD peptide at Serine 112 residue,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3392976,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL583187,,None,393.47,0,3.08,20c,O=c1[nH]c(CN2CC[C@H](O)C2)nc2c1sc1ccc(-c3ccc(O)cc3)cc12,Ki,'=',2,nM,8.7,,,UO_0000065,22.11,0.42,5.62,9.72,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL3897313,,None,338.41,0,4.23,BDBM225005,CC(C)(C)Nc1nnc(-c2ccc3[nH]cc(C4=CCOCC4)c3c2)o1,IC50,'=',737.9,nM,6.13,,393294,UO_0000065,18.12,0.33,1.9,8.07,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3891675,,None,454.53,0,3.4,BDBM238789,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@H]1C[C@@H](N(CCF)CCF)C1,IC50,'=',12,nM,7.92,,416898,UO_0000065,17.43,0.33,4.52,9.22,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3903651,,None,346.27,0,3.28,BDBM224836,Nc1nnc(-c2ccc3[nH]cc(-c4cc(C(F)(F)F)ncn4)c3c2)o1,IC50,'=',838.03,nM,6.08,,393118,UO_0000065,17.55,0.33,2.8,5.71,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4115309,,None,416.49,0,4.17,BDBM224985,CC[C@@H]1COCCN1c1nnc(-c2ccc3[nH]cc(-c4cncc(C5CC5)n4)c3c2)o1,IC50,'=',29.82,nM,7.53,,393275,UO_0000065,18.07,0.33,3.36,8.1,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3927952,,None,400.49,0,2.9,BDBM248964,Cc1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CCCC(N)C3C)n2)n1,Ki,'=',4.83,nM,8.32,,434179,UO_0000065,20.76,0.38,5.42,8.43,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4587256,,None,381.44,0,1.92,23,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C)c(NC(C)(C)CO)nc34)[nH]c21,IC50,'=',0.9,nM,9.05,,,UO_0000065,23.71,0.44,7.13,8.07,0,CHEMBL4478465,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as reduction in phosphorylation of biotinylated-BAD peptide at Serine 112 residue preincubated for 30 mins followed by substrate addition for 1 hr by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4477213,1,Scientific Literature,J Med Chem,2016,None,
CHEMBL4125725,,None,347.4,0,3.8,40,NCCNc1cncc(-c2ccc3[nH]cc(-c4ccccc4F)c3c2)n1,IC50,'=',230,nM,6.64,,,UO_0000065,19.11,0.35,2.84,8.34,0,CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4118246,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL3978285,,None,392.44,0,4.9,BDBM225087,CC(C)(C)Nc1nnc(-c2ccc3[nH]cc(-c4ncc(F)c(C5CC5)n4)c3c2)o1,IC50,'=',8.813,nM,8.05,,393080,UO_0000065,20.53,0.38,3.15,8.71,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3918188,,None,380.43,0,4.59,BDBM225088,CCc1nc(-c2c[nH]c3ccc(-c4nnc(NC(C)(C)C)o4)cc23)ncc1F,IC50,'=',20.95,nM,7.68,,393081,UO_0000065,20.18,0.37,3.09,8.3,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1289494,TIVOZANIB,4,454.87,1,5.64,Tivozanib,COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3393692,,None,406.44,0,3.89,13a,NC1CCN(c2cncc(-c3n[nH]c4ccc(-c5c(F)cccc5F)cc34)n2)CC1,IC50,'=',9,nM,8.05,,,UO_0000065,19.8,0.37,4.16,9.61,0,CHEMBL3396420,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as phosphorylation of biotinylated-BAD peptide at Serine 112 residue,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3392976,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL3976511,,None,388.82,0,4.58,BDBM224862,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(-c5ccccc5Cl)n4)c3c2)o1,IC50,'=',57.26,nM,7.24,,393140,UO_0000065,18.63,0.35,2.66,6.8,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2037201,,None,447.92,0,4.53,14,O=C1Nc2ccc(Cl)cc2/C1=C\c1ccc(-c2cccc(C(=O)N3CCCNCC3)c2)o1,IC50,'=',22,nM,7.66,,,UO_0000065,17.1,0.33,3.13,10.27,0,CHEMBL2038829,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034977,1,Scientific Literature,ACS Med Chem Lett,2012,None,
CHEMBL3899011,,None,362.43,0,2.65,BDBM238465,O=C1NCCc2[nH]c(-c3cccc4ccc(O[C@H]5CCCNC5)nc34)cc21,IC50,'=',62,nM,7.21,,416208,UO_0000065,19.89,0.36,4.56,9.12,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3960832,,None,322.37,0,3.32,BDBM224821,CC(C)Cn1cc(-c2c[nH]c3ccc(-c4nnc(N)o4)cc23)cn1,IC50,'=',77.98,nM,7.11,,393103,UO_0000065,22.05,0.4,3.79,7.21,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3910536,,None,416.49,0,1.61,BDBM249070,OCCCc1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CCNCC3)n2)n1,Ki,'=',0.446,nM,9.35,,434274,UO_0000065,22.45,0.41,7.74,8.92,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3901647,,None,434.57,0,4.7,BDBM225063,CC(C)Oc1cccc(-c2c[nH]c3ccc(-c4nnc(NC5CCCNC5)s4)cc23)n1,IC50,'=',20,nM,7.7,,393056,UO_0000065,17.72,0.34,3,8.77,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3938583,,None,402.51,0,2.89,BDBM248900,CCn1cc(-c2cc3c(cn2)cnn3-c2cccc(N3CCNC(C)(C)C3)n2)cn1,Ki,'=',15.9,nM,7.8,,434107,UO_0000065,19.37,0.36,4.91,10.17,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3911670,,None,307.38,0,3.79,BDBM224953,CNc1nnc(-c2ccc3[nH]cc(-c4cccnc4)c3c2)s1,IC50,'=',1231.23,nM,5.91,,393243,UO_0000065,19.23,0.37,2.12,8.89,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3955578,,None,374.39,1,5.41,BDBM224957,CNc1nnc(-c2ccc3[nH]cc(-c4cccc(C(F)(F)F)c4)c3c2)s1,IC50,'>',3000,nM,,,393247,UO_0000065,,,,,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL322970,,None,359.73,0,2.43,SB-415286,O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(O)c(Cl)c1,Activity,'=',46,%,,,Antagonist,UO_0000187,,,,,0,CHEMBL1061149,Percentage PIM2 activity remaining in the presence of 10uM inhibitor,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL1996234,,None,421.5,0,4.82,SID103905463,CC1(O)CC(c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn23)C1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL4225046,,None,349.35,0,1.15,14b,CC(=O)NCCC(=O)Nc1ccc2cnn(-c3cncc(C#N)n3)c2c1,IC50,'>',30000,nM,,,,UO_0000065,,,,,0,CHEMBL4222673,Inhibition of human PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4219163,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL3970953,,None,373.42,0,1.39,BDBM249082,Cc1cncc(-c2cc3c(cnn3-c3cccc(N4CCNCC4)n3)nn2)n1,Ki,'=',0.71,nM,9.15,,434286,UO_0000065,24.5,0.45,7.76,9.38,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1998585,,None,447.42,1,5.74,SID103904277,Nc1ncnc2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3394066,,None,362.46,0,3.93,BDBM50061627,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(N5CCCC5)n4)c3c2)s1,IC50,'=',104.38,nM,6.98,,393199,UO_0000065,19.26,0.37,3.05,8.34,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2087474,,None,473.56,1,-0.32,14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3957552,,None,387.47,0,4.28,BDBM224961,CNc1nnc(-c2ccc3[nH]cc(-c4cccc(-n5cnc(C)c5)n4)c3c2)s1,IC50,'=',8.279,nM,8.08,,393251,UO_0000065,20.86,0.39,3.8,9.59,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2035604,,None,310.74,0,4.3,4c,Cc1ccc2oc3c(=O)[nH]c(-c4ccccc4Cl)nc3c2c1,IC50,'=',3934,nM,5.41,,,UO_0000065,17.39,0.34,1.11,9.18,0,CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034948,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL2035612,,None,325.76,0,4.03,4k,CNc1ccc2oc3c(=O)[nH]c(-c4ccccc4Cl)nc3c2c1,IC50,'=',5000,nM,5.3,,,UO_0000065,16.27,0.31,1.27,7.47,0,CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034948,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL575739,,None,346.34,1,5.56,33,O=Cc1c[nH]c2c1ccc1c3cc(-c4ccc(F)cc4F)ccc3[nH]c12,Activity,'=',59,%,,,,UO_0000187,,,,,0,CHEMBL1051392,Inhibition of Pim-2 assessed as residual enzyme activity at 1 uM relative to untreated control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154186,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL4061176,,None,410.86,0,2.94,14,O=C1/C(=C/c2c[nH]c3nc(Cl)ccc23)Oc2c1ccc(O)c2CN1CCNCC1,IC50,'=',140,nM,6.85,,,UO_0000065,16.68,0.32,3.91,7.58,0,CHEMBL3997632,Inhibition of full length recombinant human N-terminal GST-tagged PIM2 (1 to 311 residues) expressed in baculovirus infected sf21 cells using S6K2 peptide as substrate by electrophoretic mobility shift assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3994673,1,Scientific Literature,ACS Med Chem Lett,2017,None,
CHEMBL4109970,,None,472.48,0,2.4,BDBM249018,C[C@@]1(O)CNCCN(c2cccc(-n3ncc4cnc(-c5cnn(CC(F)(F)F)c5)cc43)n2)C1,Ki,'=',16.8,nM,7.78,,434222,UO_0000065,16.46,0.31,5.37,8.02,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2035603,,None,375.61,0,4.75,3,O=c1[nH]c(-c2ccccc2Cl)nc2c1oc1ccc(Br)cc12,IC50,'=',781,nM,6.11,,,UO_0000065,16.26,0.38,1.36,10.37,0,CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034948,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL2035597,,None,296.71,0,3.99,4a,O=c1[nH]c(-c2ccccc2Cl)nc2c1oc1ccccc12,IC50,'=',5000,nM,5.3,,,UO_0000065,17.87,0.34,1.31,9,0,CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034948,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL4113806,,None,393.48,0,2.95,BDBM192556,O[C@@H]1CCCN(c2ccncc2Nc2ncc3ccc(-c4nccs4)nn23)C1,IC50,'>',1000,nM,,,344548,UO_0000065,,,,,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1909347,,None,546.38,0,3.37,SB-732881-H,CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O,Inhibition,'=',16.46,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL491473,CEDIRANIB,3,450.51,1,5.22,SID103905340,COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1982563,,None,420.49,0,4.39,SID103904766,COCC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(C)nccn23)n1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3652005,,None,464.51,1,5.69,BDBM106911,N[C@@H]1C[C@H](c2ccncc2NC(=O)c2ccc(F)c(C3CCCCC3)n2)C[C@H](C(F)(F)F)C1,IC50,'=',5,nM,8.3,,225932,UO_0000065,17.87,0.34,2.61,10.26,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL91829,RUBOXISTAURIN,3,468.56,0,3.51,LY-333531,CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1,IC50,'>',20000,nM,,,,UO_0000065,,,,,0,CHEMBL939217,Inhibition of PIM2 expressed in Escherichia coli by thermal shift assay,B,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL1088901,,None,428.33,0,4.42,3f,CN(C)CCCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,Activity,'=',62,%,,,,UO_0000187,,,,,0,CHEMBL1104323,Inhibition of PIM2 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1156950,1,Scientific Literature,J Med Chem,2010,None,
CHEMBL1649759,,None,363.8,0,4.97,10,COC(=O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12,IC50,'>',2500,nM,,,,UO_0000065,,,,,0,CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914433,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL1915448,,None,501.98,1,4.68,15e,Clc1cc(OCCN2CCOCC2)ccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12,IC50,'=',7,nM,8.15,,,UO_0000065,16.25,0.31,3.47,8.07,0,CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914433,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL3991932,PEXMETINIB,1,556.64,2,6.07,Pexmetinib,Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3939836,,None,332.39,0,3.81,BDBM224914,Nc1nnc(-c2ccc3[nH]cc(-c4ccc5cn[nH]c5c4)c3c2)s1,IC50,'=',58.33,nM,7.23,,393194,UO_0000065,21.76,0.41,3.42,7.51,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3900578,,None,420.54,0,4.07,BDBM225064,CC(C)Oc1cccc(-c2c[nH]c3ccc(-c4nnc(N5CC[C@@H](N)C5)s4)cc23)n1,IC50,'=',16.71,nM,7.78,,393057,UO_0000065,18.49,0.35,3.71,8.37,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1956068,GW296115X,None,385.38,0,3.86,GW296115X,COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O,Inhibition,'=',21.38,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL270164,GW607117X,None,394.43,1,5.14,GW607117X,Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1,Inhibition,'=',0.29,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL4060101,,None,385.48,0,3.02,9a,Cn1nc(-c2cccc(N3CCC[C@H](N)C3)n2)c2cc(-c3cccnc3)ncc21,Ki,'=',630,nM,6.2,,,UO_0000065,16.09,0.29,3.18,7.23,0,CHEMBL4052120,Inhibition of PIM2 (unknown origin) using 5FAM-ARKRRRHPSGPPTA as substrate after 90 mins in presence of ATP by caliper microfluidic mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4049450,1,Scientific Literature,J Med Chem,2017,None,
CHEMBL3634757,,None,360.43,0,1.96,36,Cn1cc(-c2cc3c(-c4cccc(N5CC[C@@H](N)C5)n4)n[nH]c3cn2)cn1,Ki,'=',0.43,nM,9.37,,,UO_0000065,25.99,0.47,7.41,9.22,0,CHEMBL3636741,Inhibition of Pim2 (unknown origin) using 5FAM-ARKRRRHPSGPPTA as substrate after 90 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632547,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL1909366,GW659386A,None,539.87,2,6.34,GW659386A,COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl,Inhibition,'=',0.76,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL396107,GW795486X,None,481.36,1,6.15,GW795486X,Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12,Inhibition,'=',0.17,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3940389,,None,400.36,0,4.53,BDBM225084,FC(F)(F)CNc1nnc(-c2ccc3[nH]cc(-c4nccc(C5CC5)n4)c3c2)o1,IC50,'=',0.638,nM,9.2,,393077,UO_0000065,22.97,0.43,4.67,9.94,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4064860,,None,355.37,0,3.97,69,N=C1NC(=O)/C(=C/c2csc(-c3ccc(C(F)(F)F)cc3)n2)S1,Activity,'=',2,%,,,,UO_0000187,,,,,0,CHEMBL4029695,Inhibition of partial length wild type human PIM2 (M1 to E291 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by KINOMEscan assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4028814,1,Scientific Literature,Bioorg Med Chem,2017,None,
CHEMBL3910491,,None,362.39,0,3.7,BDBM224995,CC(=O)c1ccnc(-c2c[nH]c3ccc(-c4nnc(NC(C)C)o4)cc23)n1,IC50,'=',70.78,nM,7.15,,393284,UO_0000065,19.73,0.36,3.45,6.52,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4108073,,None,421.55,1,5.44,BDBM224887,Fc1ccccc1-c1c[nH]c2ccc(-c3nnc(NCC[C@H]4CCCCN4)s3)cc12,IC50,'=',480.06,nM,6.32,,393164,UO_0000065,14.99,0.29,0.88,9.63,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3919337,,None,360.42,0,4.37,BDBM224998,CC(C)Nc1nnc(-c2ccc3[nH]cc(-c4nccc(C5CC5)n4)c3c2)o1,IC50,'=',50.99,nM,7.29,,393288,UO_0000065,20.23,0.37,2.92,7.88,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3966499,,None,375.38,0,4.46,BDBM238583,O=C1NCCc2[nH]c(-c3cccc4ccc(-c5c(F)cccc5F)nc34)cc21,IC50,'=',91.9,nM,7.04,,416284,UO_0000065,18.75,0.34,2.58,12.18,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3909351,,None,394.48,0,2.27,BDBM238817,Cn1c(NC(C)(C)C)nc2c(-c3cc4c([nH]3)[C@@H](CCN)NC4=O)cccc2c1=O,IC50,'=',0.02,nM,10.7,,416926,UO_0000065,27.12,0.5,8.43,9.08,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL576387,,None,325.44,0,3.62,12b,CN(C)Cc1nc2c(sc3ccc(/C=C/C4CC4)cc32)c(=O)[nH]1,Ki,'=',2,nM,8.7,,,UO_0000065,26.73,0.52,5.08,17.76,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL3949102,,None,377.42,0,3.77,BDBM238714,Cc1nc2ccc(F)c(-c3cc4c([nH]3)C3(CC3)NC4=O)c2nc1NC1(C)CC1,IC50,'=',0.0354,nM,10.45,,416823,UO_0000065,27.69,0.51,6.68,12.64,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3895124,,None,395.44,0,3.32,BDBM238826,CCn1c(NC2(C)CC2)nc2c(-c3cc4c([nH]3)[C@@H](C)NC4=O)c(F)ccc2c1=O,IC50,'=',0.0378,nM,10.42,,416935,UO_0000065,26.36,0.49,7.1,11.35,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL572745,,None,293.78,0,2.85,6a,CN(C)Cc1nc2c(sc3ccc(Cl)cc32)c(=O)[nH]1,Ki,'=',63,nM,7.2,,,UO_0000065,24.51,0.52,4.35,14.7,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL3981216,,None,378.44,0,1.9,BDBM238435,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC(C)(C)C(N)=O,IC50,'=',22.7,nM,7.64,,416633,UO_0000065,20.2,0.37,5.74,6.08,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL447602,,None,612.66,3,5.18,62,COc1cc2c(Oc3ccc(-c4cnc(Nc5ccc(F)cc5)n(C)c4=O)nc3)ccnc2cc1OCCCN1CCOCC1,IC50,'>',25000,nM,,,,UO_0000065,,,,,0,CHEMBL970669,Inhibition of PIM2 kinase,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140082,1,Scientific Literature,J Med Chem,2008,None,
CHEMBL35482,,None,267.28,0,3.05,PD-98059,COc1cccc(-c2cc(=O)c3ccccc3o2)c1N,Thermal melting change,'=',0.2,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL3895040,,None,360.42,0,4.37,BDBM225034,CC(C)Nc1nnc(-c2ccc3[nH]cc(-c4ccnc(C5CC5)n4)c3c2)o1,IC50,'=',4.65,nM,8.33,,393321,UO_0000065,23.12,0.42,3.96,9.01,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3891287,,None,349.44,0,3.06,BDBM238441,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N(C)C(C)C,IC50,'=',6.1,nM,8.21,,416639,UO_0000065,23.51,0.43,5.15,11.11,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3919520,,None,388.44,0,1.17,BDBM249042,OCc1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CCNCC3)n2)n1,Ki,'=',2.63,nM,8.58,,434246,UO_0000065,22.09,0.4,7.41,8.18,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3897895,,None,354.41,0,4.19,BDBM238529,O=C1NCCn2cc(-c3cccc4ccc(Nc5ccccc5)nc34)cc21,IC50,'=',17.9,nM,7.75,,416255,UO_0000065,21.86,0.39,3.56,13.14,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3920503,,None,403.45,0,1.61,BDBM248992,Cc1cncc(-c2cc3c(cn2)cnn3-c2cnc(O)c(N3CCC[C@H](N)C3)n2)n1,Ki,'=',7.11,nM,8.15,,434199,UO_0000065,20.2,0.37,6.54,6.18,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3926007,,None,407.43,0,3.29,BDBM249028,Cc1cncc(-c2cc3c(cn2)cnn3-c2cccc(C3CNCCC3(F)F)n2)n1,Ki,'=',0.242,nM,9.62,,434232,UO_0000065,23.6,0.44,6.33,11.81,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3905697,,None,363.42,0,2.15,BDBM238445,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1CC(O)C1,IC50,'=',1.9,nM,8.72,,416643,UO_0000065,24,0.44,6.57,8.47,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3967917,,None,363.47,0,3.68,BDBM238446,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC(C)C(C)C,IC50,'=',1.8,nM,8.74,,416644,UO_0000065,24.06,0.44,5.06,10.57,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3977800,,None,376.46,0,2.1,BDBM238570,CC1(C)CNCCN1c1cnc2cccc(-c3cc4c([nH]3)CCNC4=O)c2n1,IC50,'=',5.3,nM,8.28,,416692,UO_0000065,21.98,0.4,6.18,9.63,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3960320,,None,347.42,0,3.18,BDBM238501,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1CCC1,IC50,'=',2.6,nM,8.59,,416238,UO_0000065,24.71,0.45,5.41,10.38,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3934298,,None,389.42,0,1.12,BDBM249001,Cc1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CC(O)C(O)C3)n2)n1,Ki,'=',21.1,nM,7.68,,434208,UO_0000065,19.71,0.36,6.56,6.79,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3897351,,None,416.49,0,1.81,BDBM249002,Cc1cncc(-c2cc3c(cn2)cnn3-c2cc(N3CCC[C@H](N)C3)c(=O)n(C)c2)n1,Ki,'=',2300,nM,5.64,,434209,UO_0000065,13.54,0.25,3.83,5.23,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3906421,,None,387.45,0,2.54,BDBM249068,Cc1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CCC[C@H](O)C3)n2)n1,Ki,'=',4.17,nM,8.38,,434272,UO_0000065,21.63,0.39,5.84,9.03,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3907732,,None,375.48,0,3.2,BDBM238491,N[C@H]1CCC[C@@H](Nc2ccc3cccc(-c4cc5c([nH]4)CCNC5=O)c3n2)C1,IC50,'=',0.3,nM,9.52,,416230,UO_0000065,25.36,0.46,6.32,9.94,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3986159,,None,373.46,0,3.07,BDBM249004,Cn1cc(-c2cc3c(cn2)cnn3-c2cccc(C3CCCNCC3)n2)cn1,Ki,'=',16.5,nM,7.78,,434211,UO_0000065,20.84,0.38,4.71,10.6,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3981028,,None,488.47,0,2.02,BDBM249006,COc1ccc(-n2ncc3cnc(-c4cnn(CC(F)(F)F)c4)cc32)nc1N1CCNCC(O)C1,Ki,'=',10.1,nM,8,,434213,UO_0000065,16.37,0.31,5.98,7.53,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3903686,,None,390.49,0,3.42,BDBM238796,Cc1nc2cccc(-c3cc4c([nH]3)[C@@H](C)NC4=O)c2nc1N[C@H]1CCC[C@@H](N)C1,IC50,'=',0.0358,nM,10.45,,416905,UO_0000065,26.75,0.49,7.03,9.61,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3939783,,None,381.41,0,2.81,BDBM238691,Cc1nc2ccc(F)c(-c3cc4c([nH]3)[C@@H]([C@H](C)O)NC4=O)c2nc1NC1CC1,IC50,'=',2.3,nM,8.64,,416800,UO_0000065,22.65,0.42,5.83,8.39,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3956440,,None,466.57,0,1.52,BDBM248926,CS(=O)(=O)CCn1cc(-c2cc3c(cn2)cnn3-c2cccc(N3CCCNCC3)n2)cn1,Ki,'=',6.2,nM,8.21,,434133,UO_0000065,17.59,0.34,6.69,7.41,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3651920,,None,457.46,0,2.96,BDBM106824,C[C@H]1CN(c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)ccc2F)C[C@@H](N)[C@@H]1O,IC50,'=',2,nM,8.7,,225845,UO_0000065,19.02,0.36,5.74,8.33,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3651978,,None,426.44,0,4.8,BDBM106882,N[C@H]1CCC[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3ccc(F)cc3F)n2)C1,IC50,'=',80,nM,7.1,,225903,UO_0000065,16.64,0.31,2.3,8.77,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3687465,,None,480.49,0,4.04,BDBM151861,Cc1cc(F)c(-c2nc(C(=O)Nc3cnccc3N3C[C@@H](N)[C@@H](C#N)[C@@H](C)C3)ccc2F)c(F)c1,IC50,'=',11.18,nM,7.95,,292117,UO_0000065,16.55,0.31,3.91,7.37,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3651996,,None,439.47,0,3.21,BDBM106902,Nc1ccc(-c2c(F)cccc2F)nc1C(=O)Nc1cnccc1[C@@H]1CC[C@H](O)[C@H](N)C1,IC50,'=',4,nM,8.4,,225923,UO_0000065,19.11,0.36,5.19,6.6,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3949477,,None,493.51,0,3.76,BDBM191100,CS(=O)(=O)c1ccc(-c2c(-c3cccc(OC(F)(F)F)c3)cc3n2[C@@H](CCN)CNC3=O)cc1,IC50,'=',3,nM,8.52,,341771,UO_0000065,17.27,0.34,4.76,8.24,0,CHEMBL3887520,Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3652643,,None,444.46,0,3.47,BDBM119403,Cn1ncc(NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)c1N1CCC[C@@H](N)CC1,Ki,'=',17.3,nM,7.76,,246170,UO_0000065,17.46,0.33,4.29,8.71,0,CHEMBL3707982,Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3897474,,None,435.48,0,3.73,BDBM238459,CS(=O)(=O)c1ccc(-c2ccc3cccc(-c4cc5c([nH]4)CCNC5=O)c3n2)c(F)c1,IC50,'=',143,nM,6.84,,416203,UO_0000065,15.72,0.3,3.11,7.45,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3660009,,None,330.4,0,2.72,BDBM104127,c1cc(N[C@H]2CCNC2)c2nc(-c3nnc4ccccn34)ccc2c1,IC50,'=',6025,nM,5.22,,222545,UO_0000065,15.8,0.29,2.5,7.77,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3962189,,None,390.4,0,2.33,BDBM224823,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(C(=O)N5CCOCC5)c4)c3c2)o1,IC50,'=',1777.29,nM,5.75,,393105,UO_0000065,14.73,0.27,3.42,4.67,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3897606,,None,381.46,0,3.96,BDBM238711,CCC(C)(C)Nc1nc2c(-c3cc4c([nH]3)CCNC4=O)c(F)ccc2nc1C,IC50,'=',0.275,nM,9.56,,416820,UO_0000065,25.06,0.47,5.6,11.56,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3922211,,None,356.39,0,3.7,BDBM238587,O=C1NCCc2[nH]c(-c3cccc4cnc(Oc5ccccc5)nc34)cc21,IC50,'=',40.2,nM,7.4,,416287,UO_0000065,20.75,0.37,3.7,9.26,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3960298,,None,375.44,0,2.61,BDBM224816,CN1CCN(c2cccc(-c3c[nH]c4ccc(-c5nnc(N)o5)cc34)n2)CC1,IC50,'=',6.871,nM,8.16,,393098,UO_0000065,21.74,0.4,5.55,8.15,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4516471,BI 1675,None,554.64,1,2.95,BI 1675,O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1,% Control,,100,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507284,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL3985049,,None,449.56,0,4.69,BDBM238630,Cc1nc2cccc(-c3cc4c(n3C(=O)OC(C)(C)C)CCNC4=O)c2nc1NC(C)(C)C,IC50,'=',35.8,nM,7.45,,416739,UO_0000065,16.56,0.31,2.76,7.59,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3975293,,None,356.39,0,3.7,BDBM238412,O=C1NCCc2[nH]c(-c3cccc4ccc(Oc5cccnc5)nc34)cc21,IC50,'=',4.6,nM,8.34,,416187,UO_0000065,23.39,0.42,4.64,10.43,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3297762,,None,512.1,1,3.8,15a,CN1CCN(C[C@@H](NC(=O)C[C@H]2CNC(=O)c3cc(-c4cccc(Cl)c4)cn32)C2CCCCC2)CC1,IC50,'=',73,nM,7.14,,,UO_0000065,13.94,0.27,3.34,10.25,0,CHEMBL3300844,Inhibition of human PIM2 using ARK-RERTYSFGHHA as substrate incubated for 60 mins prior to substrate addition by topcount scintillation counting analysis in presence of [P33gamma]-ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3297733,1,Scientific Literature,Bioorg Med Chem,2013,None,
CHEMBL599224,,None,369.43,0,0.5,50,CC(=O)N1CCC(Nc2ncc3c(n2)-c2c(c(C(N)=O)nn2C)CC3)CC1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1072222,Inhibition of PIM2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1157561,1,Scientific Literature,J Med Chem,2010,None,
CHEMBL3916586,,None,368.44,0,4.19,BDBM238720,Cc1cccc(C)c1-c1cnc2cccc(-c3cc4c([nH]3)CCNC4=O)c2n1,IC50,'=',34.9,nM,7.46,,416829,UO_0000065,20.24,0.36,3.27,10.55,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3297766,,None,540.15,1,4.57,BDBM50021624,CN(C)C1CCN(C[C@@H](NC(=O)C[C@H]2CNC(=O)c3cc(-c4cccc(Cl)c4)cn32)C2CCCCC2)CC1,IC50,'=',36,nM,7.44,,330371,UO_0000065,13.78,0.27,2.87,10.69,0,CHEMBL3887311,Kinase Inhibition Assay: Method for PIM2 Kinase Inhibition Assay: Dowex Technique i. Kinase Buffer (KB)The buffer for PIM2 assay was composed of HEPES 50 mM,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3896195,,None,365.41,0,4.12,BDBM238707,Cc1nc2ccc(F)c(-c3cc4c(=O)[nH]ccc4[nH]3)c2nc1NC(C)(C)C,IC50,'=',0.0667,nM,10.18,,416816,UO_0000065,27.85,0.51,6.06,11.77,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL111612,ABT-546,None,532.72,2,5.54,EUB0000348,CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC,% Control,,100,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507258,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL3687474,,None,512.59,1,4.46,BDBM151870,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)sc2N)C[C@@H](N)[C@H]1OCCC#N,IC50,'=',1,nM,9,,292126,UO_0000065,17.56,0.34,4.54,6.43,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2377714,,None,216.2,0,2.26,13,Cc1c[nH]c2c([N+](=O)[O-])cc3cn[nH]c3c12,Inhibition,'=',61,%,,,,UO_0000187,,,,,0,CHEMBL2378599,Inhibition of human full length Pim-2 using RSRHSSYPAGT as substrate assessed as residual activity at 10 uM after 30 mins in presence of [gamma-33P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2375344,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL2377710,,None,202.17,0,1.95,9,O=[N+]([O-])c1cc2cn[nH]c2c2cc[nH]c12,Inhibition,'=',80,%,,,,UO_0000187,,,,,0,CHEMBL2378599,Inhibition of human full length Pim-2 using RSRHSSYPAGT as substrate assessed as residual activity at 10 uM after 30 mins in presence of [gamma-33P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2375344,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL104279,,None,353.4,0,2.32,Syk_Inhibitor,Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21,Residual Activity,'=',97,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4513589,,None,418.5,0,2.65,32,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(CC5(N)CC5)c(NC5(C)CC5)nc34)[nH]c21,IC50,'=',0.16,nM,9.8,,,UO_0000065,23.41,0.43,7.15,8.31,0,CHEMBL4370146,Inhibition of full length recombinant PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues preincubated for 30 mins followed by biotinylated BAD addition and measured after 1 hr by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4368910,1,Scientific Literature,J Med Chem,2019,None,
CHEMBL3966363,,None,362.44,0,2.12,BDBM238754,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@H]1C[C@@H](N)C1,IC50,'=',0.301,nM,9.52,,416863,UO_0000065,26.27,0.48,7.4,8.76,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL435734,ARCTIGENIN,None,372.42,0,2.99,K00231,COc1cc(C[C@H]2C(=O)OC[C@@H]2Cc2ccc(OC)c(OC)c2)ccc1O,Thermal melting change,'=',0,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL3931370,,None,365.51,0,4.48,BDBM238670,Cc1nc2cccc(-c3cc4c([nH]3)[C@@H](C)NC4=S)c2nc1NC(C)(C)C,IC50,'=',2.76,nM,8.56,,416779,UO_0000065,23.42,0.45,4.08,13.04,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3913376,,None,385.43,0,2.96,BDBM238609,Cn1c(Nc2ccccc2)nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2c1=O,IC50,'=',2,nM,8.7,,416716,UO_0000065,22.57,0.41,5.74,9.47,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3980483,,None,361.45,0,3.43,BDBM238611,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@@H](C)C1CC1,IC50,'=',1.4,nM,8.85,,416718,UO_0000065,24.5,0.45,5.42,10.71,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3930939,,None,363.47,0,3.82,BDBM238628,Cc1nc2cccc(-c3cc4c([nH]3)C[C@H](C)NC4=O)c2nc1NC(C)(C)C,IC50,'=',3.96,nM,8.4,,416737,UO_0000065,23.12,0.43,4.58,10.16,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3918647,,None,453.54,0,3.07,BDBM238787,COCCOCCn1c(NC(C)(C)C)nc2c(-c3cc4c([nH]3)[C@@H](C)NC4=O)cccc2c1=O,IC50,'=',0.917,nM,9.04,,416896,UO_0000065,19.93,0.37,5.97,8.2,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1909408,GSK-200398A,None,616.15,1,4.38,GSK200398A,Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1,Inhibition,'=',-0.43,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3923078,,None,318.38,0,3.09,BDBM238470,O=C1NCCc2[nH]c(-c3cccc4ccc(NC5CC5)nc34)cc21,IC50,'=',7,nM,8.15,,416649,UO_0000065,25.61,0.46,5.06,11.68,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL428877,,None,443.53,1,5.43,SB-242719,CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1,Inhibition,'=',0.08,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL476351,GW775608X,None,470.57,0,4.29,GW775608X,Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1,Inhibition,'=',0.17,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1975128,,None,416.23,0,3.06,SID103904465,Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3I)cc12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1968406,,None,415.52,1,5.25,SID103904361,CCc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL519697,,None,415.5,0,4.24,SID103905077,CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2C,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2001998,,None,457.54,0,2.64,SID103904816,CNC(=O)N1CCN(CCCOc2ccc3c(c2)-c2[nH]nc(-c4ccc(C#N)nc4)c2C3)CC1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1973808,,None,271.71,0,3.47,SID103904664,O=C(Nc1ccc2[nH]ncc2c1)c1ccc(Cl)cc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3298824,,None,385.37,0,3.02,13i,O=C(CC1CNC(=O)c2cc(-c3ccc(F)c(F)c3)cn21)NCc1ccco1,IC50,'=',2222,nM,5.65,,,UO_0000065,14.67,0.28,2.63,7.41,0,CHEMBL3300844,Inhibition of human PIM2 using ARK-RERTYSFGHHA as substrate incubated for 60 mins prior to substrate addition by topcount scintillation counting analysis in presence of [P33gamma]-ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3297733,1,Scientific Literature,Bioorg Med Chem,2013,None,
CHEMBL1981410,,None,455.44,1,5.12,SID103904744,CNc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc1)CCN2,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1996587,,None,410.43,0,3.15,SID103905444,CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1989423,,None,156.19,0,1.98,SID103905447,c1ccc2c(c1)Cc1c[nH]nc1-2,Ki,'>',15848.93,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1973893,,None,372.45,0,3.34,SID103905137,CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(C)=O)c3c2)cc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3133821,,None,275.31,0,4.17,4f,Oc1cccc(Nc2ccnc3[nH]c4ccccc4c23)c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL3241181,Inhibition of human PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3232836,1,Scientific Literature,Bioorg Med Chem Lett,2014,None,
CHEMBL3687458,,None,507.52,1,4.49,BDBM151854,C[C@@H]1C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@H](N)[C@@H]1n1cncn1,IC50,'=',426.76,nM,6.37,,292110,UO_0000065,12.55,0.24,1.88,5.71,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4225896,,None,354.37,0,3.31,14a,CC(=O)Nc1cccc(-c2ccc3cnn(-c4cncc(C#N)n4)c3c2)c1,IC50,'>',30000,nM,,,,UO_0000065,,,,,0,CHEMBL4222673,Inhibition of human PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4219163,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL3393702,,None,407.42,0,4.1,13k,Fc1cccc(F)c1-c1ccc2[nH]nc(-c3cncc(OC4CCCNC4)n3)c2c1,IC50,'=',16,nM,7.8,,,UO_0000065,19.13,0.35,3.7,10.3,0,CHEMBL3396420,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as phosphorylation of biotinylated-BAD peptide at Serine 112 residue,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3392976,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL3393719,,None,493.56,0,3.75,18l,CS(=O)(=O)c1ccc(-c2ccc3[nH]nc(-c4cncc(O[C@H]5CNCCC56CC6)n4)c3c2)c(F)c1,IC50,'=',1.5,nM,8.82,,,UO_0000065,17.88,0.34,5.07,8.03,0,CHEMBL3396420,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as phosphorylation of biotinylated-BAD peptide at Serine 112 residue,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3392976,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL3394072,,None,363.45,0,3.33,21,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(N5CCCC5)n4)c3c2)s1,IC50,'=',12100,nM,4.92,,,UO_0000065,13.53,0.26,1.59,5.09,0,CHEMBL3395662,Inhibition of PIM2 in human U2OS cells assessed as phosphorylation of BAD,B,BAO_0000219,cell-based format,Homo sapiens,None,None,U2OS,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3393014,1,Scientific Literature,Bioorg Med Chem Lett,2015,CHEMBL3307757,
CHEMBL3393704,,None,433.46,0,4.49,13m,Fc1cccc(F)c1-c1ccc2[nH]nc(-c3cncc(OC4CNCCC45CC5)n3)c2c1,IC50,'=',3,nM,8.52,,,UO_0000065,19.66,0.36,4.03,11.26,0,CHEMBL3396420,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as phosphorylation of biotinylated-BAD peptide at Serine 112 residue,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3392976,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL3944421,,None,421.48,0,4.02,BDBM238811,C[C@H]1NC(=O)c2cc(-c3c(F)ccc4c(=O)n(C5CC5)c(NC5(C)CCC5)nc34)[nH]c21,IC50,'=',0.1,nM,10,,416920,UO_0000065,23.73,0.44,5.98,10.89,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3904783,,None,397.39,0,3.49,BDBM225040,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(N5CCC(F)(F)CC5)n4)c3c2)o1,IC50,'=',2.256,nM,8.65,,393026,UO_0000065,21.76,0.41,5.16,7.88,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL454241,,None,294.69,0,2.12,18,CCn1c2cc(Cl)c(OC)cc2c(=O)c2c(=O)o[nH]c21,Ki,'>',1424,nM,,,,UO_0000065,,,,,0,CHEMBL994191,Inhibition of Pim2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144228,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,
CHEMBL4227556,,None,373.42,0,4,12a,CC(C)Nc1ccc2cnn(-c3cncc(-c4cccc(C(=O)O)c4)n3)c2c1,IC50,'>',30000,nM,,,,UO_0000065,,,,,0,CHEMBL4222673,Inhibition of human PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4219163,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL3957977,,None,470.5,0,4.3,BDBM191129,NCC[C@H]1CNC(=O)c2cc(-c3cccc(OC(F)(F)F)c3)c(-c3ccc(C4(N)CC4)cc3)n21,IC50,'=',3,nM,8.52,,341800,UO_0000065,18.11,0.34,4.22,8.94,0,CHEMBL3887520,Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3961180,,None,347.42,0,2.82,BDBM238508,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N1CCCC1,IC50,'=',30.1,nM,7.52,,416245,UO_0000065,21.65,0.4,4.7,10.18,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3937248,,None,333.4,0,2.43,BDBM238509,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N1CCC1,IC50,'=',16,nM,7.8,,416246,UO_0000065,23.38,0.43,5.37,10.55,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3904800,,None,361.45,0,3.43,BDBM238612,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@H](C)C1CC1,IC50,'=',2,nM,8.7,,416719,UO_0000065,24.07,0.44,5.27,10.52,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3949175,,None,393.47,0,3.73,BDBM238808,C[C@H]1NC(=O)c2cc(-c3c(F)ccc4c3N=C(NC3(C)CC3)N(C3CC3)C4)[nH]c21,IC50,'=',0.06,nM,10.22,,416917,UO_0000065,25.98,0.48,6.49,14.1,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL189963,PALBOCICLIB,4,447.54,0,2.97,Palbociclib,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3973354,,None,379.42,0,2.19,BDBM238506,COC(=O)[C@H](C)Nc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2nc1C,IC50,'=',154,nM,6.81,,416243,UO_0000065,17.95,0.33,4.62,6.25,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4573369,,None,444.5,0,2.11,28,CN1CCOc2c1cnn1c(-c3ccc4cccc(NC(=O)C5CCNCC5)c4n3)nnc21,IC50,'=',3740,nM,5.43,,,UO_0000065,12.21,0.22,3.32,4.95,0,CHEMBL4340984,Inhibition of His tagged human recombinant PIM2 using PIM tide (ARKRRRHPSGPPTA) as substrate incubated for 1 hr by fluorescence based assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4340512,1,Scientific Literature,Eur J Med Chem,2019,None,
CHEMBL3984961,,None,395.44,0,3.49,BDBM238803,CC(C)Nc1nc2c(-c3cc4c([nH]3)[C@@H](C)NC4=O)c(F)ccc2c(=O)n1C1CC1,IC50,'=',0.2,nM,9.7,,416912,UO_0000065,24.53,0.46,6.21,10.56,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3899451,,None,335.37,0,3.08,BDBM225101,CC(C)Nc1cncc(-c2c[nH]c3ccc(-c4noc(N)n4)cc23)n1,IC50,'=',361.74,nM,6.44,,393093,UO_0000065,19.21,0.35,3.36,5.43,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3930311,,None,439.52,1,6.59,BDBM224889,Fc1ccccc1-c1c[nH]c2ccc(-c3nnc(NCc4ccc5[nH]ccc5c4)s3)cc12,IC50,'=',1478.13,nM,5.83,,393165,UO_0000065,13.27,0.25,-0.76,8.4,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3892732,,None,358.41,0,4.13,BDBM225080,c1cc2[nH]cc(-c3cncc(C4CC4)n3)c2cc1-c1nnc(NC2CC2)o1,IC50,'=',7.641,nM,8.12,,393073,UO_0000065,22.65,0.41,3.99,8.77,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3901121,,None,447.51,1,6.29,BDBM224897,CNc1ccc(CNc2nnc(-c3ccc4[nH]cc(-c5ccc(F)cc5F)c4c3)s2)cc1,IC50,'>',3000,nM,,,393173,UO_0000065,,,,,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3930832,,None,361.41,0,3.25,BDBM224830,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(N5CCCCC5)n4)c3c2)o1,IC50,'=',4.765,nM,8.32,,393112,UO_0000065,23.03,0.42,5.07,7.58,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3664619,,None,389.46,0,2.83,BDBM104239,OC1(COc2cccc3ccc(-c4nnc5ccccn45)nc23)CCCNCC1,IC50,'=',1000,nM,6,,222650,UO_0000065,15.41,0.28,3.17,7.09,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3913009,,None,376.49,0,4.32,BDBM224915,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(N5CCCCC5)n4)c3c2)s1,IC50,'=',68.81,nM,7.16,,393195,UO_0000065,19.02,0.36,2.84,8.56,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4750046,,None,338.81,0,2.61,29,Cc1cn([C@H](C)[C@H]2CCNC[C@@H]2F)c2nc(C(N)=O)cc(Cl)c12,IC50,'=',2,nM,8.7,,,UO_0000065,25.68,0.52,6.09,11.93,0,CHEMBL4704282,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4699590,1,Scientific Literature,Bioorg Med Chem Lett,2020,None,
CHEMBL3664622,,None,361.45,0,3.62,BDBM104246,Cc1ccn2c(-c3ccc4cccc(OCC(C)(C)CN)c4n3)nnc2c1,IC50,'=',156,nM,6.81,,222657,UO_0000065,18.83,0.34,3.19,8.69,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL179583,,None,363.8,0,4.77,Chk2_Inhibitor_II,NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1,Residual Activity,'=',119,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4224693,,None,450.52,0,2.99,12l,CC(C)Nc1ccc2cnn(-c3cncc(-c4ccc(C(=O)NS(C)(=O)=O)cc4)n3)c2c1,IC50,'>',30000,nM,,,,UO_0000065,,,,,0,CHEMBL4222673,Inhibition of human PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4219163,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL4224859,,None,391.41,0,4.14,12f,CC(C)Nc1ccc2cnn(-c3cncc(-c4ccc(C(=O)O)c(F)c4)n3)c2c1,IC50,'=',2800,nM,5.55,,,UO_0000065,14.19,0.26,1.41,5.98,0,CHEMBL4222673,Inhibition of human PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4219163,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL1275913,,None,238.29,0,2.8,(+/-)-17b,CC1Cc2nc3cc4[nH]ncc4cc3nc2C1C,Activity,,,,,,Not Active,,,,,,0,CHEMBL1285678,Inhibition of Pim2 assessed as residual enzyme activity at 10 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1275327,1,Scientific Literature,Eur J Med Chem,2010,None,
CHEMBL4207079,,None,498.44,0,3.7,17,Fc1cc(F)cc(-n2cnc3c(NCc4nc5c(F)c(F)ccc5[nH]4)nc(N4CCOCC4)nc32)c1,Activity,'=',94,%,,,,UO_0000187,,,,,0,CHEMBL4187293,Inhibition of wild-type human partial length PIM2 (M1 to E291 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4184198,1,Scientific Literature,Bioorg Med Chem,2018,None,
CHEMBL2062289,,None,550.52,0,3.36,SB-698596-AC,CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O,Inhibition,'=',0.39,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3652622,,None,447.52,0,3.07,BDBM119382,Cn1ncc(NC(=O)c2nc(-c3c(F)cccc3F)sc2N)c1NCC1CCNCC1,Ki,'=',148,nM,6.83,,246149,UO_0000065,15.26,0.3,3.76,6.22,0,CHEMBL3707982,Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3898788,,None,368.42,0,3.26,BDBM225010,CC(C)Nc1nnc(-c2ccc3[nH]cc(-c4ncc(C(N)=O)s4)c3c2)o1,IC50,'=',315,nM,6.5,,393299,UO_0000065,17.65,0.34,3.24,5.3,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL576982,QUIZARTINIB,3,560.68,2,5.86,AC220,CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3660076,,None,403.46,0,3.9,BDBM104203,FC1CNCCC1Oc1cccc2ccc(-c3nnc4ccc(C5CC5)cn34)nc12,IC50,'=',1163,nM,5.93,,222616,UO_0000065,14.71,0.27,2.03,9.22,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL10,SB-203580,None,377.44,0,4.68,SB-203580,C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,Kd,'>',10000,nM,,,,UO_0000065,,,,,1,CHEMBL1061184,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150977,1,Scientific Literature,Nat Biotechnol,2008,None,
CHEMBL3651950,,None,426.54,0,4.12,BDBM106854,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c([C@H]3CC[C@@H](O)CC3)n2)C1,IC50,'=',26,nM,7.58,,225875,UO_0000065,17.78,0.33,3.47,7.5,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2218938,,None,328.34,0,3.04,ERK_Inhibitor_II_Negative_control,Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12,Residual Activity,'=',123,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL38380,FASUDIL,3,291.38,0,1.22,HA-1077,O=S(=O)(c1cccc2cnccc12)N1CCCNCC1,Residual Activity,'=',118,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3985841,,None,434.57,0,4.7,BDBM225066,CC(C)Oc1cccc(-c2c[nH]c3ccc(-c4nnc(N[C@@H]5CCCNC5)s4)cc23)n1,IC50,'=',12.14,nM,7.92,,393059,UO_0000065,18.22,0.35,3.22,9.02,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3951627,,None,321.38,0,2.65,BDBM238442,CCNc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2nc1C,IC50,'=',1.7,nM,8.77,,416640,UO_0000065,27.29,0.5,6.12,10.6,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3914535,,None,363.47,0,3.68,BDBM238652,CCc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC(C)(C)C,IC50,'=',0.195,nM,9.71,,416761,UO_0000065,26.71,0.49,6.03,11.74,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3651995,,None,481.5,0,3.78,BDBM106901,CC(=O)O[C@H]1CC[C@@H](c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)ccc2N)C[C@H]1N,IC50,'=',7,nM,8.15,,225922,UO_0000065,16.94,0.32,4.37,6.12,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4110013,,None,390.52,0,4.57,BDBM224916,C[C@@H]1CCCN(c2cccc(-c3c[nH]c4ccc(-c5nnc(N)s5)cc34)n2)C1,IC50,'=',158.91,nM,6.8,,393197,UO_0000065,17.41,0.33,2.23,8.12,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3937943,,None,394.39,0,3.16,BDBM192547,Fc1cccc(F)c1-c1ccc2cnc(Nc3cnccc3OC3CNC3)n2n1,IC50,'=',99,nM,7,,344539,UO_0000065,17.76,0.33,3.84,9.17,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3660071,,None,354.37,0,3.71,BDBM104198,Nc1cc(Oc2cccc3ccc(-c4nnc5ccccn45)nc23)ccn1,IC50,'=',8935,nM,5.05,,222611,UO_0000065,14.25,0.26,1.34,5.53,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3939749,,None,418.5,0,2.64,BDBM238593,CC(=O)N1CCC[C@H](Nc2nc3c(-c4cc5c([nH]4)CCNC5=O)cccc3nc2C)C1,IC50,'=',137,nM,6.86,,416704,UO_0000065,16.4,0.3,4.22,6.66,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL574819,,None,335.82,0,2.36,6f,O=c1[nH]c(CN2CC[C@@H](O)C2)nc2c1sc1ccc(Cl)cc12,Ki,'=',84,nM,7.08,,,UO_0000065,21.07,0.44,4.72,10.22,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL524057,GW683768X,None,280.34,0,2.32,GW683768X,CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1,Inhibition,'=',0.29,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3660069,,None,389.46,0,3.09,BDBM104196,COC1(COc2cccc3ccc(-c4nnc5ccccn45)nc23)CCNCC1,IC50,'=',79,nM,7.1,,222609,UO_0000065,18.24,0.33,4.01,9.65,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3660094,,None,405.48,0,4.15,BDBM104227,CCN1CCC(F)(COc2cccc3ccc(-c4nnc5ccccn45)nc23)CC1,IC50,'=',191.2,nM,6.72,,222638,UO_0000065,16.57,0.31,2.57,12.09,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL2029988,CEP-32496,1,517.46,2,5.91,CEP-32496,COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3951387,,None,414.47,0,2.14,BDBM249071,Cc1cncc(-c2cc3c(cn2)cnn3-c2cccc(C(=O)N3CCC[C@H](N)C3)n2)n1,Ki,'=',183,nM,6.74,,434275,UO_0000065,16.26,0.3,4.6,5.82,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4472294,,None,390.45,1,5.13,11g,C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21,Activity,'=',80,%,,,,UO_0000187,,,,,0,CHEMBL4337053,Inhibition of recombinant human Pim2 (2 to end residues) assessed as residual activity at 10 uM using RSRHSSYPAG as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4334471,1,Scientific Literature,Bioorg Med Chem Lett,2019,None,
CHEMBL4584365,,None,416.49,0,2.33,29,CN1CCOc2c1cnn1c(-c3ccc4cccc(NC5CCNCC5)c4n3)nnc21,IC50,'=',690,nM,6.16,,,UO_0000065,14.79,0.27,3.83,6.66,0,CHEMBL4340984,Inhibition of His tagged human recombinant PIM2 using PIM tide (ARKRRRHPSGPPTA) as substrate incubated for 1 hr by fluorescence based assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4340512,1,Scientific Literature,Eur J Med Chem,2019,None,
CHEMBL3652019,,None,456.47,0,4.75,BDBM106925,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)ccc(O)c3F)n2)C1,IC50,'=',1,nM,9,,225946,UO_0000065,19.72,0.37,4.25,8.9,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4521605,,None,416.49,0,2.1,36,CN1CCOc2c1cnn1c(-c3ccc4cccc(N5CCC(N)CC5)c4n3)nnc21,IC50,'=',2140,nM,5.67,,,UO_0000065,13.61,0.25,3.57,5.8,0,CHEMBL4340984,Inhibition of His tagged human recombinant PIM2 using PIM tide (ARKRRRHPSGPPTA) as substrate incubated for 1 hr by fluorescence based assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4340512,1,Scientific Literature,Eur J Med Chem,2019,None,
CHEMBL3941897,,None,378.44,0,4.28,BDBM225104,CC(C)Nc1nc(-c2ccc3[nH]cc(-c4cncc(OC(C)C)n4)c3c2)no1,IC50,'=',504.2,nM,6.3,,393096,UO_0000065,16.64,0.31,2.02,6.19,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3951600,,None,355.38,0,2.27,BDBM225017,CS(=O)(=O)c1ccc(-c2c[nH]c3ccc(-c4nnc(N)o4)cc23)nc1,IC50,'=',555,nM,6.26,,393307,UO_0000065,17.6,0.34,3.99,4.9,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3914520,,None,363.45,0,4.26,BDBM224905,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(OC5CCC5)n4)c3c2)s1,IC50,'=',16.83,nM,7.77,,393184,UO_0000065,21.39,0.41,3.51,8.67,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3983984,,None,376.42,0,3.46,BDBM225019,CNC(=O)c1cncc(-c2c[nH]c3ccc(-c4nnc(NC(C)C)o4)cc23)c1,IC50,'=',843,nM,6.07,,393309,UO_0000065,16.14,0.3,2.61,5.59,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3950988,,None,377.45,0,4.32,BDBM225021,CC(C)Nc1nccc(-c2c[nH]c3ccc(-c4nnc(NC(C)C)o4)cc23)n1,IC50,'=',11.1,nM,7.96,,393310,UO_0000065,21.07,0.39,3.63,7.61,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3918771,,None,381.41,0,2.81,BDBM238690,Cc1nc2ccc(F)c(-c3cc4c([nH]3)[C@H]([C@@H](C)O)NC4=O)c2nc1NC1CC1,IC50,'=',16.4,nM,7.79,,416801,UO_0000065,20.41,0.38,4.98,7.56,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3943705,,None,400.49,0,2.63,BDBM248919,CCc1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CCCNCC3)n2)n1,Ki,'=',0.333,nM,9.48,,434126,UO_0000065,23.66,0.43,6.85,11.2,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3916844,,None,402.46,0,1.38,BDBM248917,Cn1ncc(-c2cc3c(cn2)cnn3-c2cccc(N3CCCNCC3)n2)cc1=O,Ki,'=',4100,nM,5.39,,434124,UO_0000065,13.39,0.25,4.01,5.75,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3942446,,None,406.47,0,2.45,BDBM248922,FCCn1cc(-c2cc3c(cn2)cnn3-c2cccc(N3CCCNCC3)n2)cn1,Ki,'=',1.37,nM,8.86,,434129,UO_0000065,21.81,0.4,6.41,11.56,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL576930,,None,310.36,1,5.28,30,O=Cc1c[nH]c2c1ccc1c3cc(-c4ccccc4)ccc3[nH]c12,Activity,'=',53,%,,,,UO_0000187,,,,,0,CHEMBL1057614,Inhibition of Pim-2 assessed as residual enzyme activity at 10 uM relative to untreated control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154186,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL3685737,,None,447.49,0,4.22,BDBM124900,N[C@H]1C[C@@H](O)CN(c2ccncc2Nc2cccc3ccc(-c4c(F)cccc4F)nc23)C1,IC50,'=',512,nM,6.29,,254202,UO_0000065,14.06,0.26,2.07,7.21,0,CHEMBL3705221,ATP Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 ul per well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL578237,,None,394.35,1,6.18,35,O=Cc1c[nH]c2c1ccc1c3cc(-c4ccc(OC(F)(F)F)cc4)ccc3[nH]c12,Activity,'=',70,%,,,,UO_0000187,,,,,0,CHEMBL1057614,Inhibition of Pim-2 assessed as residual enzyme activity at 10 uM relative to untreated control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154186,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL4455041,,None,462.53,0,2.98,51,Cc1cc(NCC2(F)CCNCC2)c2nc(-c3nnc4c5c(cnn34)N(C)CCO5)ccc2c1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL4340984,Inhibition of His tagged human recombinant PIM2 using PIM tide (ARKRRRHPSGPPTA) as substrate incubated for 1 hr by fluorescence based assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4340512,1,Scientific Literature,Eur J Med Chem,2019,None,
CHEMBL3685742,,None,450.47,0,4.59,BDBM124905,N[C@@H]1CN(c2ccncc2Nc2cccc3cnc(-c4c(F)cccc4F)nc23)CC[C@H]1F,IC50,'=',498,nM,6.3,,254207,UO_0000065,13.99,0.26,1.71,7.88,0,CHEMBL3705221,ATP Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 ul per well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3938446,,None,372.36,0,4.06,BDBM224861,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(-c5ccccc5F)n4)c3c2)o1,IC50,'=',19.6,nM,7.71,,393139,UO_0000065,20.7,0.38,3.65,7.24,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3969370,,None,533.59,2,5.26,1; FMF-01-086-2,C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1,Activity,'=',100,%,,,,UO_0000187,,,,,0,CHEMBL4185991,Binding affinity to wild-type human partial length PIM2 (M1 to E291 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4184148,1,Scientific Literature,Bioorg Med Chem Lett,2017,None,
CHEMBL3984463,,None,487.56,1,5.69,BDBM224893,COCC(=O)Nc1cccc(CNc2nnc(-c3ccc4[nH]cc(-c5ccccc5F)c4c3)s2)c1,IC50,'=',2513.75,nM,5.6,,393169,UO_0000065,11.49,0.22,-0.09,6.09,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2103882,TIVANTINIB,3,369.42,0,3.59,Tivantinib,O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL4555442,,None,399.45,0,3.12,17c,Cn1cc(-c2n[nH]c3ccc(NCc4cc(F)ccc4S(C)(=O)=O)cc23)cn1,Inhibition,'=',-1,%,,,,UO_0000187,,,,,0,CHEMBL4349798,Inhibition of recombinant human full length N-terminal GST/His6-tagged PIM2 (M1 to P311) expressed in baculovirus infected Sf9 insect cells at 20 nM using phosphatidylserine as substrate incubated for 60 mins in presence of [33P]-ATP by scintillation counting method,B,BAO_0000219,cell-based format,Homo sapiens,None,None,Sf9,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4346729,1,Scientific Literature,Bioorg Med Chem Lett,2019,CHEMBL3308860,
CHEMBL1946170,REGORAFENIB,4,482.82,1,5.69,Regorafenib,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL2048869,,None,347.44,0,2.34,25,CCOc1cccc(/C=C2\SC(=O)NC2=O)c1N1CCC[C@@H](N)C1,IC50,'=',160,nM,6.8,,,UO_0000065,19.56,0.39,4.46,8.03,0,CHEMBL2049743,Inhibition of human PIM2 using FITC-(AHX)RSRHSSYPAGT-COOH as substrate after 90 mins by mobility shift assay in presence of 5 mM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2046384,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL573477,,None,357.82,0,4.11,6m,O=c1[nH]c(CNc2ccccc2O)nc2c1sc1ccc(Cl)cc12,Ki,'>',1424,nM,,,,UO_0000065,,,,,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL3940091,,None,393.49,0,3.99,10,CC(C)n1c(NC(C)(C)C)nc2c(-c3cc4c([nH]3)[C@@H](C)NC4=O)cccc2c1=O,IC50,'=',0.13,nM,9.89,,,UO_0000065,25.12,0.47,5.9,10.77,0,CHEMBL4370146,Inhibition of full length recombinant PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues preincubated for 30 mins followed by biotinylated BAD addition and measured after 1 hr by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4368910,1,Scientific Literature,J Med Chem,2019,None,
CHEMBL2377719,,None,350.33,0,3.8,18,CCOC(=O)c1[nH]c2c([N+](=O)[O-])cc3cn[nH]c3c2c1-c1ccccc1,Inhibition,'=',113,%,,,,UO_0000187,,,,,0,CHEMBL2378599,Inhibition of human full length Pim-2 using RSRHSSYPAGT as substrate assessed as residual activity at 10 uM after 30 mins in presence of [gamma-33P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2375344,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL7463,GF-109203,None,412.49,0,3.64,BIM1,CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21,Residual Activity,'=',4,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1275912,,None,238.29,0,2.8,(+/-)-17a,CC1Cc2nc3cc4cn[nH]c4cc3nc2C1C,Activity,,,,,,Not Active,,,,,,0,CHEMBL1285678,Inhibition of Pim2 assessed as residual enzyme activity at 10 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1275327,1,Scientific Literature,Eur J Med Chem,2010,None,
CHEMBL13868,,None,507.57,2,6.66,SB-245392,Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1,Inhibition,'=',-0.33,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1794072,,None,490,1,5.74,SB-682330-A,CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl,Inhibition,'=',-0.09,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3898395,,None,378.44,0,2.93,BDBM238648,CC(C)(C)Nc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2nc1/C=N/O,IC50,'=',1.27,nM,8.9,,416757,UO_0000065,23.51,0.43,5.97,7.72,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4445845,,None,422.53,0,3.14,17,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(CC(C)(C)N)c(NC(C)(C)C)nc34)[nH]c21,IC50,'=',2.2,nM,8.66,,,UO_0000065,20.49,0.38,5.52,7.35,0,CHEMBL4370146,Inhibition of full length recombinant PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues preincubated for 30 mins followed by biotinylated BAD addition and measured after 1 hr by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4368910,1,Scientific Literature,J Med Chem,2019,None,
CHEMBL1163510,,None,447.84,1,5.55,5j,O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1,Inhibition,'<',50,%,,,,UO_0000187,,,,,0,CHEMBL1166808,Inhibition of PIM2 at 1 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1165965,1,Scientific Literature,Bioorg Med Chem,2010,None,
CHEMBL3946212,,None,406.52,0,3.11,BDBM224873,CNc1nnc(-c2ccc3[nH]cc(-c4nccc(N5CCC[C@H](N)C5)n4)c3c2)s1,IC50,'=',1.527,nM,8.82,,393151,UO_0000065,21.69,0.42,5.71,8.12,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1983268,ENTRECTINIB,4,560.65,2,5.03,Entrectinib,CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL603469,LESTAURTINIB,3,439.47,0,3.47,Lestaurtinib,C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL551064,AEW-541,1,425.54,0,4.67,AEW-541,Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL253969,OSI-632,2,532.41,1,3.86,CP-547632,NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3974903,,None,376.46,0,3.23,BDBM238455,O=C1NCCc2[nH]c(-c3cccc4ccc(N[C@H]5CC[C@H](O)CC5)nc34)cc21,IC50,'=',57.2,nM,7.24,,416199,UO_0000065,19.24,0.35,4.01,8.04,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4092508,,None,658.56,2,5.74,2t,COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl,Activity,'=',83,%,,,,UO_0000187,,,,,0,CHEMBL4044133,Inhibition of wild-type human partial length PIM2 (M1 to E291 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4043093,1,Scientific Literature,Eur J Med Chem,2017,None,
CHEMBL361894,GW806290X,None,346.35,0,2.7,GW806290X,c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1,Inhibition,'=',0.25,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL403989,TG100-801,2,580.09,2,7.09,TG-100801,Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3935709,,None,375.48,0,3.68,BDBM238565,CC1(C)CCCCN1c1cnc2cccc(-c3cc4c([nH]3)CCNC4=O)c2n1,IC50,'=',2.3,nM,8.64,,416687,UO_0000065,23.01,0.42,4.96,11.69,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4091687,,None,387.45,0,1.78,12,Cc1cncc(-c2cc3c(cnn3-c3cccc(N4CCCNCC4)n3)nn2)n1,Ki,'=',0.48,nM,9.32,,,UO_0000065,24.05,0.44,7.54,9.55,0,CHEMBL4052120,Inhibition of PIM2 (unknown origin) using 5FAM-ARKRRRHPSGPPTA as substrate after 90 mins in presence of ATP by caliper microfluidic mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4049450,1,Scientific Literature,J Med Chem,2017,None,
CHEMBL1090479,GSK-1070916,1,507.64,2,5.94,GSK-1070916,CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3899404,,None,369.39,0,4,BDBM224852,Nc1nnc(-c2ccc3[nH]cc(-c4nccc(Nc5ccccc5)n4)c3c2)o1,IC50,'=',3.099,nM,8.51,,393131,UO_0000065,23.03,0.42,4.51,7.18,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3951087,,None,382.43,0,4.85,BDBM225002,CC(Nc1nnc(-c2ccc3[nH]cc(-c4cnccn4)c3c2)o1)c1ccccc1,IC50,'=',559.3,nM,6.25,,393291,UO_0000065,16.35,0.29,1.4,6.76,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3922231,,None,337.41,0,2.79,BDBM224904,CN(C)c1cncc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)n1,IC50,'=',28.22,nM,7.55,,393181,UO_0000065,22.37,0.43,4.76,7.81,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL270995,BRIVANIB ALANINATE,3,441.46,0,3.42,Brivanib_alaninate,Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3544932,TAK-901,1,504.66,1,4.62,TAK-901,CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL346551,,None,264.28,0,2.17,SKF-62604,O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1,Inhibition,'=',3.49,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1910893,,None,371.44,0,3.41,1,Oc1ccc(-c2ccc3c(-c4ccc(N5CCNCC5)cc4)n[nH]c3n2)cc1,IC50,'=',39,nM,7.41,,,UO_0000065,19.95,0.36,4,9.61,0,CHEMBL1912526,Inhibition of PIM2 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1909629,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL4128290,,None,387.49,0,4.27,20,COc1cccc(-c2c[nH]c3ccc(-c4cncc(NCCN(C)C)n4)cc23)c1,IC50,'=',560,nM,6.25,,,UO_0000065,16.13,0.29,1.98,9.46,0,CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4118246,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL4130297,,None,433.56,1,5.93,26,CN(C)CCNc1cncc(-c2ccc3[nH]cc(-c4ccc(-c5ccccc5)cc4)c3c2)n1,IC50,'=',5330,nM,5.27,,,UO_0000065,12.16,0.22,-0.66,9.28,0,CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4118246,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL2035598,,None,331.16,0,4.64,4b,O=c1[nH]c(-c2ccccc2Cl)nc2c1oc1ccc(Cl)cc12,IC50,'=',858,nM,6.07,,,UO_0000065,18.32,0.38,1.43,10.3,0,CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034948,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL2035607,,None,321.72,0,3.86,4f,N#Cc1ccc2oc3c(=O)[nH]c(-c4ccccc4Cl)nc3c2c1,IC50,'=',3429,nM,5.46,,,UO_0000065,16.99,0.32,1.6,6.61,0,CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034948,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL2035642,,None,340.38,0,1.62,7d,CC(=O)c1ccc2oc3c(=O)[nH]c(CN4CCN(C)CC4)nc3c2c1,IC50,'=',620,nM,6.21,,,UO_0000065,18.24,0.34,4.59,7.53,0,CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034948,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL4087517,,None,467.14,0,3.74,Tab 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4093592,,None,439.08,0,2.66,Tab 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1910908,,None,389.44,0,2.82,30,Nc1ccc(-c2c[nH]c3ccc(-c4cncc(N5CCNCC5)n4)cc23)c(F)n1,IC50,'=',61,nM,7.21,,,UO_0000065,18.53,0.34,4.39,7.53,0,CHEMBL1912526,Inhibition of PIM2 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1909629,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL1909397,GW279320X,None,364.81,0,2.06,GW279320X,Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1,Inhibition,'=',0.51,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1915638,,None,374.35,0,4.59,15l,Fc1ccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3cnccc23)c(F)c1,IC50,'=',6,nM,8.22,,,UO_0000065,21.96,0.4,3.63,10.36,0,CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914433,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL574169,,None,350.45,0,3.45,14k,CN(C)Cc1nc2c(sc3ccc(-c4ccc(N)cc4)cc32)c(=O)[nH]1,Ki,'=',2,nM,8.7,,,UO_0000065,24.82,0.48,5.25,11.6,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL1794059,GW275616X,None,315.35,0,1.74,GW275616X,NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1,Inhibition,'=',0.69,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1957505,,None,448.53,0,1.79,25e,CN(C)CCCNC(=O)c1cn2cc(-c3cccc4[nH]ncc34)nc(N3CCOCC3)c2n1,Inhibition,'=',50,%,,,,UO_0000187,,,,,0,CHEMBL1959621,Inhibition of PIM2 at 5 to 10 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1955823,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL1915442,,None,356.36,0,4.45,14o,Fc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12,IC50,'=',3,nM,8.52,,,UO_0000065,23.92,0.43,4.07,10.74,0,CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914433,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL1785002,,None,472.52,0,3.89,SB-264865,NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1,Inhibition,'=',0.59,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL510836,,None,346.42,0,4.13,21,COc1cc(O)c2c(c1)/C=C/CC[C@H](C)C(=O)CCC[C@H](C)OC2=O,Tm,'<',2,degrees C,,,,UO_0000027,,,,,0,CHEMBL1004482,Binding affinity to human recombinant PIM2 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1140872,1,Scientific Literature,Bioorg Med Chem,2009,None,
CHEMBL1952141,,None,503.5,0,4.05,SGI-1776,CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1.O=S(=O)(O)O,IC50,'=',363,nM,6.44,,,UO_0000065,15.88,0.3,2.39,11.78,0,CHEMBL1954567,Inhibition of PIM2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1949661,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL1952133,,None,393.37,0,3.43,7m,O[C@H]1CC[C@@H](Nc2ccc3nnn(-c4cccc(OC(F)(F)F)c4)c3n2)CC1,IC50,'=',152,nM,6.82,,,UO_0000065,17.33,0.33,3.39,8.01,0,CHEMBL1954567,Inhibition of PIM2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1949661,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL1952134,,None,351.46,0,2.29,8a,CN(C)c1cccc(-n2nnc3ccc(NCC4CCNCC4)nc32)c1,IC50,'>',1000,nM,,,,UO_0000065,,,,,0,CHEMBL1954567,Inhibition of PIM2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1949661,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL1950228,,None,288.35,0,4.36,4,O=Cc1cn2c3c1ccc1c4ccccc4n(c13)CCCC2,IC50,'=',350,nM,6.46,,,UO_0000065,22.39,0.4,2.1,23.97,0,CHEMBL1955504,Inhibition of human recombinant PIM2 expressed in Escherichia coli using RSRHSSYPAGT as substrate after 30 mins,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1949527,1,Scientific Literature,Eur J Med Chem,2012,None,
CHEMBL458438,GSK-1511931A,None,508.63,2,5.53,GSK1511931A,COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1,Inhibition,'=',0.36,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL408982,,None,249.34,0,3.06,TG003,CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21,Residual Activity,'=',19,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3099673,,None,264.24,0,1.45,14,O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O,Activity,'=',142,%,,,,UO_0000187,,,,,0,CHEMBL3101247,Inhibition of human Pim-2 assessed as residual activity at 1 uM relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3098105,1,Scientific Literature,Bioorg Med Chem,2014,None,
CHEMBL2035621,,None,393.6,0,4.89,5d,O=c1[nH]c(-c2cc(F)ccc2Cl)nc2c1oc1ccc(Br)cc12,IC50,'=',653,nM,6.18,,,UO_0000065,15.71,0.37,1.3,10.5,0,CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034948,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL2035626,,None,404.65,0,4.21,5i,NCc1ccc(-c2nc3c(oc4ccc(Br)cc43)c(=O)[nH]2)c(Cl)c1,IC50,'=',87,nM,7.06,,,UO_0000065,17.45,0.4,2.85,8.32,0,CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034948,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL2035628,,None,487.79,0,4.59,5k,O=c1[nH]c(-c2ccc(CNC3CCNCC3)cc2Cl)nc2c1oc1ccc(Br)cc12,IC50,'=',29,nM,7.54,,,UO_0000065,15.45,0.34,2.95,9.09,0,CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034948,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL3809691,,None,359.43,0,3.52,9c,Cc1nc2cccc3c2nc1N[C@H](C)/C=C\C[C@H]1CNC(=O)c2cc-3[nH]c21,IC50,'=',0.5,nM,9.3,,,UO_0000065,25.88,0.47,5.78,11.25,0,CHEMBL3812018,Inhibition of human full-length Pim2 expressed in Escherichia coli assessed as phosphorylation of biotinylated BAD peptide at Ser 112 preincubated for 30 mins followed by substrate addition measured after 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3808325,1,Scientific Literature,ACS Med Chem Lett,2016,None,
CHEMBL1277370,,None,278.36,0,3.68,14a,CC1(C)[C@@H]2CC[C@@]1(C)c1nc3cc4cn[nH]c4cc3nc12,Activity,'=',82,%,,,,UO_0000187,,,,,0,CHEMBL1285679,Inhibition of Pim2 assessed as residual enzyme activity at 1 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1275327,1,Scientific Literature,Eur J Med Chem,2010,None,
CHEMBL3664630,,None,377.42,0,3.42,BDBM104256,FC1(COc2cccc3ccc(-c4nnc5ccccn45)nc23)CCCNC1,IC50,'=',141.6,nM,6.85,,222667,UO_0000065,18.15,0.33,3.43,10.64,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3945003,,None,320.35,0,4.07,BDBM224977,CC(C)Oc1cccc(-c2c[nH]c3ccc(-c4nnco4)cc23)n1,IC50,'=',85.39,nM,7.07,,393267,UO_0000065,22.07,0.4,3,9.2,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1241855,RIGOSERTIB,3,451.5,0,2.8,Rigosertib,COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL4225206,,None,400.49,0,3.94,12m,CC(=O)NCc1ccc(-c2cncc(-n3ncc4ccc(NC(C)C)cc43)n2)cc1,IC50,'>',30000,nM,,,,UO_0000065,,,,,0,CHEMBL4222673,Inhibition of human PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4219163,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL4227791,,None,358.45,0,3.76,12n,CC(C)Nc1ccc2cnn(-c3cncc(-c4ccc(CN)cc4)n3)c2c1,IC50,'>',30000,nM,,,,UO_0000065,,,,,0,CHEMBL4222673,Inhibition of human PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4219163,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL4776788,,None,321.2,0,3.41,22,Brc1ccccc1CSc1ncnc2[nH]cnc12,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4734081,Inhibition of recombinant human GST-tagged PIM2 expressed in baculovirus expression system using serine/threonine-07 peptide as substrate at 10 uM by Z'-LYTE assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4732086,1,Scientific Literature,Eur J Med Chem,2021,None,Dose = 10.0 microM | TIME = 1.0 hr
CHEMBL4559238,,None,364.45,0,3.32,20,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C)c(CC(C)(C)C)nc34)[nH]c21,IC50,'=',4.9,nM,8.31,,,UO_0000065,22.8,0.42,4.99,10.42,0,CHEMBL4478465,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as reduction in phosphorylation of biotinylated-BAD peptide at Serine 112 residue preincubated for 30 mins followed by substrate addition for 1 hr by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4477213,1,Scientific Literature,J Med Chem,2016,None,
CHEMBL3913446,,None,472.52,0,4.61,BDBM238800,Cc1nc2cccc(-c3cc4c([nH]3)[C@@H](C)NC4=O)c2nc1N[C@H]1CCC[C@@H](NCC(F)(F)F)C1,IC50,'=',0.267,nM,9.57,,416909,UO_0000065,20.26,0.38,4.96,10.11,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4126344,,None,443.45,1,5.42,42,CN(C)CCNc1cncc(-c2ccc3[nH]cc(-c4ccc(C(F)(F)F)c(F)c4)c3c2)n1,IC50,'=',7950,nM,5.1,,,UO_0000065,11.5,0.22,-0.32,8.97,0,CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4118246,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL4589855,,None,379.46,0,2.97,24,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C)c(N(C)C(C)(C)C)nc34)[nH]c21,IC50,'=',1,nM,9,,,UO_0000065,23.72,0.44,6.03,10.84,0,CHEMBL4478465,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as reduction in phosphorylation of biotinylated-BAD peptide at Serine 112 residue preincubated for 30 mins followed by substrate addition for 1 hr by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4477213,1,Scientific Literature,J Med Chem,2016,None,
CHEMBL3103867,,None,406.47,0,3.04,2a,Nc1ccc(-c2ccccc2F)nc1C(=O)Nc1cnccc1N1CCC[C@H](N)C1,Ki,'<',3,nM,,,,UO_0000065,,,,,0,CHEMBL3794688,Inhibition of Pim2 (unknown origin) using BAD peptide preincubated for 15 mins followed by ATP addition measured after 60 to 100 mins by Kinase-Glo reagent based luminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3792348,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL3969001,,None,349.39,0,2.03,BDBM238550,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1COC1,IC50,'=',11.4,nM,7.94,,416273,UO_0000065,22.73,0.42,5.91,8.64,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3792736,,None,458.43,0,3.49,4a,Nc1cc(-c2ccncc2NC(=O)c2nc(-c3nccs3)ccc2N)nc(C(F)(F)F)n1,Ki,'<',3,nM,,,,UO_0000065,,,,,0,CHEMBL3794688,Inhibition of Pim2 (unknown origin) using BAD peptide preincubated for 15 mins followed by ATP addition measured after 60 to 100 mins by Kinase-Glo reagent based luminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3792348,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL1909342,,None,395.44,0,1.77,SB-657836-AAA,N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O,Inhibition,'=',1.1,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL477182,GW769076X,None,454.57,1,5.05,GW769076X,Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1,Inhibition,'=',-1.68,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3298564,,None,445.42,0,4.3,13a,O=C(CC1CNC(=O)c2cc(-c3cccc(C(F)(F)F)c3)cn21)NCc1cccc(F)c1,IC50,'=',3620,nM,5.44,,,UO_0000065,12.22,0.23,1.14,8.62,0,CHEMBL3300844,Inhibition of human PIM2 using ARK-RERTYSFGHHA as substrate incubated for 60 mins prior to substrate addition by topcount scintillation counting analysis in presence of [P33gamma]-ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3297733,1,Scientific Literature,Bioorg Med Chem,2013,None,
CHEMBL3956063,,None,325.8,0,4.12,BDBM238394,CCC1CNC(=O)c2cc(-c3cccc4ccc(Cl)nc34)[nH]c21,IC50,'=',248,nM,6.61,,416174,UO_0000065,20.27,0.39,2.49,11.43,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3298887,,None,401.82,0,3.53,13k,O=C(CC1CNC(=O)c2cc(-c3cc(Cl)ccc3F)cn21)NCc1ccco1,IC50,'=',2406,nM,5.62,,,UO_0000065,13.98,0.27,2.09,7.37,0,CHEMBL3300844,Inhibition of human PIM2 using ARK-RERTYSFGHHA as substrate incubated for 60 mins prior to substrate addition by topcount scintillation counting analysis in presence of [P33gamma]-ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3297733,1,Scientific Literature,Bioorg Med Chem,2013,None,
CHEMBL4228654,,None,373.42,0,4,12b,CC(C)Nc1ccc2cnn(-c3cncc(-c4ccc(C(=O)O)cc4)n3)c2c1,IC50,'=',1400,nM,5.85,,,UO_0000065,15.68,0.29,1.85,6.3,0,CHEMBL4222673,Inhibition of human PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4219163,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL303687,GW829877X,None,358.41,0,3.58,GW829877X,COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1,Inhibition,'=',0.75,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1910907,,None,418.48,0,4.06,29,Nc1ccc(-c2c[nH]c3ccc(-c4cncc(O[C@H]5CC[C@H](N)CC5)n4)cc23)c(F)n1,IC50,'=',83,nM,7.08,,,UO_0000065,16.92,0.31,3.02,6.12,0,CHEMBL1912526,Inhibition of PIM2 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1909629,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL261440,,None,313.31,0,3.86,SB-735465,O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1,Inhibition,'=',-0.55,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3651984,,None,442.44,0,3.77,BDBM106888,N[C@@H]1C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)CC[C@@H]1O,IC50,'=',11,nM,7.96,,225909,UO_0000065,17.99,0.34,4.19,7.87,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2397522,,None,256.7,0,3.43,7c,Nc1cc2cn[nH]c2c2c1[nH]c1ccc(Cl)cc12,Activity,'=',79,%,,,,UO_0000187,,,,,0,CHEMBL2401344,Inhibition of human PIM2 assessed as residual activity using RSRHSSYPAGT as substrate at 10 uM after 30 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2396576,1,Scientific Literature,Bioorg Med Chem,2013,None,
CHEMBL1991188,,None,380.42,0,4.4,SID103905120,COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3F)cc2OC)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3935407,,None,333.4,0,3.39,BDBM238812,C[C@H]1NC(=O)c2cc(-c3cccc4cnc(NC5(C)CC5)nc34)[nH]c21,IC50,'=',1.6,nM,8.8,,416921,UO_0000065,26.38,0.48,5.41,10.64,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4466764,,None,423.3,0,2.13,22a,NC(=O)c1cc(Cl)c2c(Cl)c(C#CC3COCCO3)n([C@H]3CCCNC3)c2n1,IC50,'=',8.8,nM,8.06,,,UO_0000065,19.03,0.39,5.93,8.81,0,CHEMBL4373003,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser-112 residue by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4371067,1,Scientific Literature,Bioorg Med Chem Lett,2019,None,
CHEMBL3950282,,None,417.47,0,3.48,BDBM238708,Cc1nnc(-c2nc3cccc(-c4cc5c([nH]4)CCNC5=O)c3nc2NC(C)(C)C)o1,IC50,'=',74.8,nM,7.13,,416817,UO_0000065,17.07,0.31,3.65,5.86,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3973280,,None,387.37,0,3.64,BDBM238717,Cc1nc2cccc(-c3cc4c([nH]3)C3(CC3)NC4=O)c2nc1NCC(F)(F)F,IC50,'=',1.36,nM,8.87,,416826,UO_0000065,22.89,0.43,5.23,10.72,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3936450,,None,336.36,0,3.04,BDBM225102,CC(C)Oc1cncc(-c2c[nH]c3ccc(-c4noc(N)n4)cc23)n1,IC50,'=',538.27,nM,6.27,,393094,UO_0000065,18.64,0.34,3.23,5.42,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3896782,,None,395.44,0,3.23,BDBM238815,C[C@H]1NC(=O)c2cc(-c3c(F)ccc4c(=O)n(C)c(NC5(C)CCC5)nc34)[nH]c21,IC50,'=',0.2,nM,9.7,,416924,UO_0000065,24.53,0.46,6.47,10.56,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3897388,,None,348.38,0,3.31,BDBM238620,CC#CCC1CNC(=O)c2cc(-c3cccc4nc(C)c(F)nc34)[nH]c21,IC50,'=',706,nM,6.15,,416727,UO_0000065,17.66,0.32,2.84,8.7,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3950989,,None,363.43,0,3.78,BDBM225006,Cc1cc(N)nc(-c2c[nH]c3ccc(-c4nnc(NC(C)(C)C)o4)cc23)n1,IC50,'=',350.99,nM,6.46,,393295,UO_0000065,17.76,0.33,2.67,5.45,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3896741,,None,310.36,0,4.07,BDBM224881,Nc1nnc(-c2ccc3[nH]cc(-c4ccccc4F)c3c2)s1,IC50,'=',59.99,nM,7.22,,393159,UO_0000065,23.27,0.45,3.15,10.68,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3943059,,None,344.37,0,3.48,BDBM238750,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1-c1ccoc1,IC50,'=',61.9,nM,7.21,,416859,UO_0000065,20.93,0.38,3.73,8.6,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4225287,,None,372.43,0,4.61,13,CC(C)Nc1ccc2ccn(-c3cncc(-c4ccc(C(=O)O)cc4)n3)c2c1,IC50,'=',10000,nM,5,,,UO_0000065,13.43,0.24,0.39,6.25,0,CHEMBL4222673,Inhibition of human PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4219163,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL3956884,,None,375.48,0,3.96,BDBM238440,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1(C)CCCC1,IC50,'=',0.6,nM,9.22,,416638,UO_0000065,24.56,0.45,5.26,11.15,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3918907,,None,351.41,0,2.41,BDBM238624,CC(C)(C)Nc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2[nH]c1=O,IC50,'=',0.0378,nM,10.42,,416733,UO_0000065,29.66,0.55,8.01,10.15,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1971029,,None,590.5,1,3.31,SID103904602,CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(N3CCN(C(C)=O)CC3)ccc2OC)ncc1Br,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL4069560,,None,304.42,0,3.3,26,O=C1NC(=S)S/C1=C\c1csc(-c2ccccc2)n1,Delta Tm,'=',12,degrees C,,,,UO_0000027,,,,,0,CHEMBL4029682,Inhibition of recombinant PIM2 (unknown origin) assessed as change in melting temperature at 10 uM by SYPRO orange dye-based differential scanning fluorimetry,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4028814,1,Scientific Literature,Bioorg Med Chem,2017,None,
CHEMBL3978345,,None,389.38,0,3.58,BDBM238601,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@H](C)C(F)(F)F,IC50,'=',4.32,nM,8.37,,416708,UO_0000065,21.48,0.41,4.78,10.11,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3961328,,None,401.39,0,3.73,BDBM238602,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1(C(F)(F)F)CC1,IC50,'=',0.338,nM,9.47,,416709,UO_0000065,23.6,0.45,5.74,11.45,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4583118,,None,422.32,0,1.71,29a,NC(=O)c1cc(Cl)c2c(Cl)c(C#CC3CNCCO3)n([C@H]3CCCNC3)c2n1,IC50,'=',7.6,nM,8.12,,,UO_0000065,19.23,0.4,6.41,8.62,0,CHEMBL4373003,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser-112 residue by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4371067,1,Scientific Literature,Bioorg Med Chem Lett,2019,None,
CHEMBL3394170,,None,338.4,0,3.12,BDBM50061605,CCOc1cncc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)n1,IC50,'=',27.79,nM,7.56,,393043,UO_0000065,22.33,0.43,4.44,7.36,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3902148,,None,383.43,0,3.08,BDBM238724,C[C@H]1NC(=O)c2cc(-c3c(F)ccc4c(=O)n(C)c(NC(C)(C)C)nc34)[nH]c21,IC50,'=',0.012,nM,10.92,,416833,UO_0000065,28.48,0.53,7.84,11.9,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4518492,,None,407.3,0,2.9,20b,NC(=O)c1cc(Cl)c2c(Cl)c(C#CC3CCCO3)n([C@H]3CCCNC3)c2n1,IC50,'=',7.4,nM,8.13,,,UO_0000065,19.96,0.41,5.23,9.9,0,CHEMBL4373003,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser-112 residue by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4371067,1,Scientific Literature,Bioorg Med Chem Lett,2019,None,
CHEMBL3394164,,None,377.48,0,4.08,BDBM50061613,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(NC5CCCC5)n4)c3c2)s1,IC50,'=',5.923,nM,8.23,,393041,UO_0000065,21.8,0.42,4.15,7.81,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3919362,,None,395.46,0,2.49,BDBM238774,COCCn1c(NC(C)(C)C)nc2c(-c3cc4c([nH]3)CNC4=O)cccc2c1=O,IC50,'=',0.218,nM,9.66,,416883,UO_0000065,24.43,0.46,7.17,9.56,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3930502,,None,363.45,0,3.33,BDBM224930,Nc1nnc(-c2ccc3[nH]cc(-c4cnc(N5CCCC5)cn4)c3c2)s1,IC50,'=',689.91,nM,6.16,,393212,UO_0000065,16.95,0.32,2.83,6.38,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3968456,,None,348.41,0,4.19,BDBM225004,Cc1ccnc(-c2c[nH]c3ccc(-c4nnc(NC(C)(C)C)o4)cc23)n1,IC50,'=',34.83,nM,7.46,,393293,UO_0000065,21.41,0.39,3.27,8.06,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4534005,GSM-NC,None,496.49,0,4.53,EUB0000739,COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1,% Control,,100,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507289,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL3652632,,None,395.27,0,0.73,BDBM119392,Cn1ncc(NC(=O)c2nc(Br)cnc2N)c1N1CCC[C@H](N)C1,Ki,'=',154,nM,6.81,,246159,UO_0000065,17.24,0.39,6.08,5.32,0,CHEMBL3707982,Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3298893,,None,407.45,0,2.82,14e,O=C(C[C@H]1CNC(=O)c2cc(-c3cccc(F)c3)cn21)N[C@H](CO)c1ccccc1,IC50,'=',516,nM,6.29,,,UO_0000065,15.43,0.29,3.47,7.54,0,CHEMBL3300844,Inhibition of human PIM2 using ARK-RERTYSFGHHA as substrate incubated for 60 mins prior to substrate addition by topcount scintillation counting analysis in presence of [P33gamma]-ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3297733,1,Scientific Literature,Bioorg Med Chem,2013,None,
CHEMBL3687509,,None,554.61,2,5.56,BDBM151905,CO[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C4CCOCC4)cc3F)n2)C[C@@H]1C,IC50,'=',1.08,nM,8.97,,292161,UO_0000065,16.17,0.31,3.41,9.02,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3900171,,None,390.52,0,4.71,BDBM224900,C[C@H]1CCCCN1c1cccc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)n1,IC50,'=',64.4,nM,7.19,,393190,UO_0000065,18.41,0.35,2.48,8.59,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3947565,,None,343.39,0,4.43,BDBM225074,c1cc(C2CC2)nc(-c2c[nH]c3ccc(-c4nnc(C5CC5)o4)cc23)n1,IC50,'=',4.317,nM,8.37,,393067,UO_0000065,24.36,0.44,3.93,10.39,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3956256,,None,359.39,0,3.73,BDBM225076,CC(C)c1ccnc(-c2c[nH]c3ccc(-c4nnc(NCC#N)o4)cc23)n1,IC50,'=',2.826,nM,8.55,,393069,UO_0000065,23.79,0.43,4.82,7.35,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3954270,,None,335.37,0,3.08,BDBM225098,CC(C)Nc1cncc(-c2c[nH]c3ccc(-c4nc(N)no4)cc23)n1,IC50,'=',58.88,nM,7.23,,393090,UO_0000065,21.56,0.39,4.15,6.1,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3691962,,None,613.64,1,4.38,BDBM151984,COC(=O)N[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C4(O)CCOCC4)cc3F)n2)C[C@@H]1C,IC50,'=',14.94,nM,7.83,,292239,UO_0000065,12.75,0.24,3.45,5.26,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3691967,,None,609.65,2,5.51,BDBM151989,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(OC4CCOCC4)cc3F)n2)C[C@@H](N)[C@H]1OCCC#N,IC50,'=',3.08,nM,8.51,,292244,UO_0000065,13.96,0.26,3,6.43,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1945560,,None,348.23,0,4.53,22,N#CC1c2c([nH]c3c(Cl)c(Cl)ccc23)C(=O)NC12CCCCC2,Delta Tm,'=',1.4,degrees C,,,,UO_0000027,,,,,0,CHEMBL1947284,Binding affinity to PIM2 assessed as change in thermal denaturation at 10 uM by thermal stability shift assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1944596,1,Scientific Literature,J Med Chem,2012,None,
CHEMBL3918311,,None,323.36,0,2.71,BDBM224872,CC(C)Cn1cc(-c2c[nH]c3ccc(-c4nnc(N)o4)nc23)cn1,IC50,'=',289.38,nM,6.54,,393150,UO_0000065,20.22,0.37,3.83,5.87,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3911843,,None,379.47,0,3.89,BDBM224913,Cc1cn(-c2nc(-c3c[nH]c4ccc(-c5nnc(N)s5)cc34)cs2)cn1,IC50,'=',100.42,nM,7,,393193,UO_0000065,18.44,0.37,3.11,7.12,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3901582,,None,373.45,0,3.82,BDBM224903,Cc1cn(-c2cccc(-c3c[nH]c4ccc(-c5nnc(N)s5)cc34)n2)cn1,IC50,'=',2.254,nM,8.65,,393178,UO_0000065,23.15,0.44,4.83,8.8,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3961776,,None,361.33,0,3.15,BDBM238641,Cc1nc2cccc(-c3cc4c([nH]3)CNC4=O)c2nc1NCC(F)(F)F,IC50,'=',1.91,nM,8.72,,416750,UO_0000065,24.13,0.46,5.57,10.54,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3916993,,None,375.35,0,3.19,BDBM238674,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NCC(F)(F)F,IC50,'=',1.32,nM,8.88,,416783,UO_0000065,23.66,0.45,5.69,10.74,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3986733,,None,308.34,0,2.31,BDBM238675,CCOc1cnc2cccc(-c3cc4c([nH]3)CCNC4=O)c2n1,IC50,'=',54.6,nM,7.26,,416784,UO_0000065,23.55,0.43,4.95,9.09,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL365286,GW549034X,None,229.24,0,1.69,GW549034X,CCn1c(-c2nonc2N)nc2ccccc21,Inhibition,'=',-0.12,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL361237,GW785804X,None,322.37,0,4.14,GW785804X,Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1,Inhibition,'=',0.96,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL275724,,None,458.5,0,3.96,SB-242718,NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1,Inhibition,'=',-0.5,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1910894,,None,369.47,0,4.62,4,Oc1ccc(-c2ccc3c(-c4ccc(N5CCNCC5)cc4)c[nH]c3c2)cc1,IC50,'=',42,nM,7.38,,,UO_0000065,19.97,0.36,2.76,14.38,0,CHEMBL1912526,Inhibition of PIM2 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1909629,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL1888586,,None,353.4,0,3.2,SB-223133,Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1,Inhibition,'=',0.53,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3691938,,None,510.57,1,3.99,BDBM151960,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)sc2N)C[C@@H](N)[C@H]1n1ccnn1,IC50,'=',1.04,nM,8.98,,292215,UO_0000065,17.59,0.34,4.99,6.53,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL200528,,None,306.37,0,3.42,1; K00135,CC(=O)c1cccc(-c2cnc3ccc(NCC4CC4)nn23)c1,Delta Tm,'>',4,degrees C,,,,UO_0000027,,,,,0,CHEMBL4728262,Binding affinity to PIM2 (unknown origin) assessed as change in melting temperature at 10 uM incubated for 10 mins using SYPRO orange dye by RT-PCR-based fluorescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4725345,1,Scientific Literature,J Med Chem,2020,None,Dose = 10.0 microM | TIME = 0.1667 hr
CHEMBL261849,GW632580X,None,366.42,0,2.83,GW632580X,COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,Inhibition,'=',3.29,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL4227817,,None,391.41,0,4.14,12c,CC(C)Nc1ccc2cnn(-c3cncc(-c4ccc(C(=O)O)cc4F)n3)c2c1,IC50,'=',8600,nM,5.07,,,UO_0000065,12.94,0.24,0.93,5.45,0,CHEMBL4222673,Inhibition of human PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4219163,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL397434,,None,242.31,0,2.65,7,c1ccc(CSc2ncnc3[nH]cnc23)cc1,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4734081,Inhibition of recombinant human GST-tagged PIM2 expressed in baculovirus expression system using serine/threonine-07 peptide as substrate at 10 uM by Z'-LYTE assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4732086,1,Scientific Literature,Eur J Med Chem,2021,None,Dose = 10.0 microM | TIME = 1.0 hr
CHEMBL4069365,,None,421.38,0,4.14,13,CC1(C)OCC(=O)Nc2cc(Nc3nc(NCC(F)(F)F)c4occc4n3)ccc21,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL4007735,Inhibition of PIM2 (unknown origin) after 60 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4007384,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL2387474,,None,501.54,1,4.74,9,O=C(Nc1c[nH]c2ncc(-c3c(F)cccc3F)cc12)c1cnn2ccc(CCC3CCNCC3)nc12,Ki,'=',0.17,nM,9.77,,,UO_0000065,19.48,0.36,5.03,9.77,0,CHEMBL2387969,Inhibition of PIM2 (unknown origin) using FAM-pimtide as substrate after 90 mins by spectrophotometry in presence of ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2385019,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL479533,HERBIMYCIN,None,574.67,1,2.71,Herbimycin_A,CO[C@H]1[C@@H](OC)C[C@H](C)[C@@H](OC)C2=CC(=O)C=C(NC(=O)/C(C)=C/C=C/[C@H](OC)[C@@H](OC(N)=O)/C(C)=C/[C@@H]1C)C2=O,Residual Activity,'=',129,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2218936,,None,567.11,1,4.31,Met_Kinase_Inhibitor,CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1,Residual Activity,'=',147,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3899208,,None,379.45,0,2.56,BDBM225049,Nc1nnc(-c2ccc3[nH]cc(-c4nccc(N5CCOCC5)n4)c3c2)s1,IC50,'=',8.613,nM,8.06,,393035,UO_0000065,21.25,0.41,5.5,7.62,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL595143,,None,541.68,2,5.72,24,COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1,Residual activity,'=',73,%,,,,UO_0000187,,,,,0,CHEMBL1050333,Residual activity of PIM2 at 10 uM by microplate scintillation counting,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1152560,1,Scientific Literature,Bioorg Med Chem,2009,None,
CHEMBL191003,JNJ-7706621,None,394.36,0,1.22,JNJ-7706621,Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F,Residual Activity,'=',73,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2035614,,None,312.71,0,3.7,4m,O=c1[nH]c(-c2ccccc2Cl)nc2c1oc1cc(O)ccc12,IC50,'=',2377,nM,5.62,,,UO_0000065,17.98,0.35,1.92,7.11,0,CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034948,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL2425145,,None,428.54,1,5.62,16,Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-n3cnc(C)c3)cc2)cc1,Inhibition,'=',7,%,,,,UO_0000187,,,,,0,CHEMBL2429585,Inhibition of PIM-2 (unknown origin) at 1 uM by [33P]-ATP filter-binding assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2424535,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL4522773,BAY-827,None,385.86,0,4.94,BAY-827,CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1,% Control,,100,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507263,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL2387463,,None,484.54,0,4.08,16,O=C(Nc1c[nH]c2ncc(-c3ccccc3F)cc12)c1cnn2ccc(NCC3CCNCC3)nc12,Ki,'=',0.094,nM,10.03,,,UO_0000065,20.69,0.38,5.95,8.95,0,CHEMBL2387969,Inhibition of PIM2 (unknown origin) using FAM-pimtide as substrate after 90 mins by spectrophotometry in presence of ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2385019,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL2387462,,None,408.44,0,2.36,15,O=C(Nc1c[nH]c2ncccc12)c1cnn2ccc(NCC3(F)CCNCC3)nc12,Ki,'=',4.9,nM,8.31,,,UO_0000065,20.35,0.38,5.95,7.42,0,CHEMBL2387969,Inhibition of PIM2 (unknown origin) using FAM-pimtide as substrate after 90 mins by spectrophotometry in presence of ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2385019,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL2387478,,None,408.44,0,2.22,13,O=C(Nc1c[nH]c2ncccc12)c1cnn2ccc(NC[C@H]3CCNC[C@@H]3F)nc12,Ki,'=',5.9,nM,8.23,,,UO_0000065,20.15,0.37,6.01,7.35,0,CHEMBL2387969,Inhibition of PIM2 (unknown origin) using FAM-pimtide as substrate after 90 mins by spectrophotometry in presence of ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2385019,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL2387472,,None,501.54,1,4.82,7,O=C(Nc1c[nH]c2ccc(-c3c(F)cccc3F)cc12)c1cnn2ccc(NCC3CCNCC3)nc12,Ki,'=',1.3,nM,8.89,,,UO_0000065,17.72,0.33,4.07,8.96,0,CHEMBL2387969,Inhibition of PIM2 (unknown origin) using FAM-pimtide as substrate after 90 mins by spectrophotometry in presence of ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2385019,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL2387471,,None,502.53,1,4.21,6,O=C(Nc1c[nH]c2ncc(-c3c(F)cccc3F)cc12)c1cnn2ccc(NCC3CCNCC3)nc12,Ki,'=',0.076,nM,10.12,,,UO_0000065,20.14,0.37,5.91,9.03,0,CHEMBL2387969,Inhibition of PIM2 (unknown origin) using FAM-pimtide as substrate after 90 mins by spectrophotometry in presence of ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2385019,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL2387470,,None,390.45,0,2.27,5,O=C(Nc1c[nH]c2ncccc12)c1cnn2ccc(NCC3CCNCC3)nc12,Ki,'=',7.8,nM,8.11,,,UO_0000065,20.77,0.38,5.84,7.24,0,CHEMBL2387969,Inhibition of PIM2 (unknown origin) using FAM-pimtide as substrate after 90 mins by spectrophotometry in presence of ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2385019,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL2387467,,None,387.37,0,3.29,2,N#Cc1ccc(Cc2cc(O)n3ncc(C(=O)Nc4ccc(F)cc4)c3n2)cc1,Ki,'=',31,nM,7.51,,,UO_0000065,19.38,0.35,4.22,7.27,0,CHEMBL2387969,Inhibition of PIM2 (unknown origin) using FAM-pimtide as substrate after 90 mins by spectrophotometry in presence of ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2385019,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL3639846,,None,433.47,0,4.04,BDBM124908,N[C@H]1CCCN(c2ncncc2Nc2cccc3cnc(-c4c(F)cccc4F)nc23)C1,IC50,'>',25000,nM,,,254210,UO_0000065,,,,,0,CHEMBL3705221,ATP Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 ul per well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3958862,,None,389.46,0,3.5,26,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C5CC5)c(NC5(C)CC5)nc34)[nH]c21,IC50,'=',0.09,nM,10.05,,,UO_0000065,25.79,0.47,6.55,10.94,0,CHEMBL4370146,Inhibition of full length recombinant PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues preincubated for 30 mins followed by biotinylated BAD addition and measured after 1 hr by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4368910,1,Scientific Literature,J Med Chem,2019,None,
CHEMBL1952329,SGI-1776,1,405.42,0,4.05,6; SGI-1776,CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1,IC50,'=',363,nM,6.44,,,UO_0000065,15.88,0.3,2.39,11.78,0,CHEMBL4360607,Inhibition of human Pim-2 expressed in Escherichia coli cells using KKRNRTLTV as substrate after 40 mins by [gamma-33P]-ATP assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4359824,1,Scientific Literature,Eur J Med Chem,2019,None,
CHEMBL4759685,,None,338.81,0,2.61,31,Cc1cn([C@@H](C)[C@H]2CCNC[C@H]2F)c2nc(C(N)=O)cc(Cl)c12,IC50,'=',6,nM,8.22,,,UO_0000065,24.27,0.49,5.61,11.27,0,CHEMBL4704282,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4699590,1,Scientific Literature,Bioorg Med Chem Lett,2020,None,
CHEMBL4436404,,None,403.49,0,3.57,30,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(CC5CC5)c(NC5(C)CC5)nc34)[nH]c21,IC50,'=',0.12,nM,9.92,,,UO_0000065,24.59,0.45,6.35,10.81,0,CHEMBL4370146,Inhibition of full length recombinant PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues preincubated for 30 mins followed by biotinylated BAD addition and measured after 1 hr by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4368910,1,Scientific Literature,J Med Chem,2019,None,
CHEMBL69863,PICEATANNOL,None,244.25,0,2.68,Piceatannol,Oc1cc(O)cc(/C=C/c2ccc(O)c(O)c2)c1,Thermal melting change,'=',2,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL1182777,,None,314.3,0,3.29,STO_609,O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21,Residual Activity,'=',0,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3959910,,None,350.38,0,3.5,BDBM225030,COc1nccc(-c2c[nH]c3ccc(-c4nnc(NC(C)C)o4)cc23)n1,IC50,'=',73.8,nM,7.13,,393317,UO_0000065,20.35,0.37,3.63,7.01,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3981885,,None,391.38,0,4.59,BDBM238384,O=C1NCCc2[nH]c(-c3cccc4ccc(Oc5ccc(F)cc5F)nc34)cc21,IC50,'=',21.1,nM,7.68,,416162,UO_0000065,19.61,0.36,3.09,11.45,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3648724,,None,477.54,0,2.6,20,CO[C@@H]1CCN(c2c(NC(=O)c3nc(-c4c(F)cccc4F)sc3N)cnn2C)CC[C@H]1N,Ki,'=',0.2,nM,9.7,,,UO_0000065,20.31,0.4,7.1,7.8,0,CHEMBL4317000,Inhibition of recombinant human PIM2 using FAM-pimtide as substrate after 90 mins by Z-LYTE assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4316591,1,Scientific Literature,J Med Chem,2019,None,
CHEMBL553,ERLOTINIB,4,393.44,0,3.41,Erlotinib,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,Inhibition,'=',-16,%,,Outside typical range,,UO_0000187,,,,,0,CHEMBL3857070,Inhibition of GST tagged recombinant full length human PIM2 expressed in baculovirus at 500 nM by Z'-LYTE assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3856204,1,Scientific Literature,Eur J Med Chem,2016,None,
CHEMBL3792742,,None,414.44,0,4.07,3a,Cc1cc(-c2ccncc2NC(=O)c2nc(-c3ccccc3F)ccc2N)cc(N)n1,Ki,'=',4,nM,8.4,,,UO_0000065,20.26,0.37,4.33,7.01,0,CHEMBL3794688,Inhibition of Pim2 (unknown origin) using BAD peptide preincubated for 15 mins followed by ATP addition measured after 60 to 100 mins by Kinase-Glo reagent based luminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3792348,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL4438748,,None,457.49,0,4.13,12j,CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL4379285,Inhibition of recombinant human Pim2 (2 to end residues) using RSRHSSYPAGT as substrate incubated for 40 mins in presence of [gamma33P]ATP by radiometric scintillation counting analysis,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4376834,1,Scientific Literature,J Med Chem,2019,None,
CHEMBL4518492,,None,407.3,0,2.9,20a,NC(=O)c1cc(Cl)c2c(Cl)c(C#CC3CCCO3)n([C@H]3CCCNC3)c2n1,IC50,'=',21,nM,7.68,,,UO_0000065,18.85,0.39,4.78,9.34,0,CHEMBL4373003,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser-112 residue by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4371067,1,Scientific Literature,Bioorg Med Chem Lett,2019,None,
CHEMBL4445116,,None,418.33,0,3.66,27,CC(C)(C#N)CC#Cc1c(Cl)c2c(Cl)cc(C(N)=O)nc2n1[C@H]1CCCNC1,IC50,'=',29.4,nM,7.53,,,UO_0000065,18,0.37,3.87,7.79,0,CHEMBL4373003,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser-112 residue by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4371067,1,Scientific Literature,Bioorg Med Chem Lett,2019,None,
CHEMBL4466080,,None,367.24,0,1.71,12,NC(=O)c1cc(Cl)c2c(Cl)c(C#CCO)n([C@H]3CCCNC3)c2n1,IC50,'=',11,nM,7.96,,,UO_0000065,21.67,0.45,6.25,8.54,0,CHEMBL4373003,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser-112 residue by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4371067,1,Scientific Literature,Bioorg Med Chem Lett,2019,None,
CHEMBL4466764,,None,423.3,0,2.13,22b,NC(=O)c1cc(Cl)c2c(Cl)c(C#CC3COCCO3)n([C@H]3CCCNC3)c2n1,IC50,'=',6,nM,8.22,,,UO_0000065,19.42,0.4,6.09,9,0,CHEMBL4373003,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser-112 residue by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4371067,1,Scientific Literature,Bioorg Med Chem Lett,2019,None,
CHEMBL3930282,,None,296.3,0,2.36,BDBM238496,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1F,IC50,'>',1000,nM,,,416233,UO_0000065,,,,,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3913664,,None,393.42,0,4.2,BDBM225023,CNC(=O)c1ccc(F)c(-c2c[nH]c3ccc(-c4nnc(NC(C)C)o4)cc23)c1,IC50,'=',238,nM,6.62,,393313,UO_0000065,16.84,0.31,2.42,6.91,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL454557,,None,289.23,0,2.91,11a,O=C1NC(=O)/C(=C/c2ccc(OC(F)(F)F)cc2)S1,IC50,'=',500,nM,6.3,,,UO_0000065,21.79,0.45,3.39,11.37,0,CHEMBL957366,Inhibition of human recombinant Pim2 by ATP depletion assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139352,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL496995,,None,239.68,0,2.66,21a,O=C1NC(=O)/C(=C/c2ccc(Cl)cc2)S1,IC50,'=',200,nM,6.7,,,UO_0000065,27.95,0.61,4.04,14.51,0,CHEMBL957366,Inhibition of human recombinant Pim2 by ATP depletion assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139352,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL86755,,None,210.24,0,2.51,6,O=C1Nc2ccccc2/C1=C/c1ccc[nH]1,Activity,,,,,,Not Evaluated,,,,,,0,CHEMBL982757,Binding affinity to human PIM2 at 10 uM relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1151712,1,Scientific Literature,J Med Chem,2008,None,
CHEMBL1986603,,None,451.51,0,3.75,SID103905597,Cc1cc(NC(=O)CCNC(=O)Nc2nc(C)c(-c3ccc(-n4cccn4)cc3)s2)no1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL359482,,None,301.35,0,4.07,K00244,Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1,Thermal melting change,'=',0.7,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL3676286,,None,433.46,0,4.26,BDBM131756,Nc1sc(-c2c(F)cccc2F)nc1C(=O)Nc1cnccc1N1CCC(F)CC1,IC50,'=',55,nM,7.26,,263989,UO_0000065,16.75,0.33,3,8.63,0,CHEMBL3706072,Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3676290,,None,414.48,0,4.72,BDBM131760,N[C@H]1CCC[C@@H](c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C1,IC50,'=',29,nM,7.54,,263993,UO_0000065,18.19,0.35,2.82,9.32,0,CHEMBL3706072,Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3676292,,None,445.5,0,2.88,BDBM131762,C[C@H]1CN(c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C[C@@H](N)[C@@H]1O,IC50,'=',3,nM,8.52,,263995,UO_0000065,19.13,0.38,5.64,8.17,0,CHEMBL3706072,Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3651906,,None,452.51,1,5,BDBM106810,CC1(C)C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3ccc(O)cc3F)n2)C1,IC50,'=',12,nM,7.92,,225831,UO_0000065,17.5,0.33,2.92,7.83,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL416056,,None,467.48,0,3.66,K00077,COC(=O)[C@]1(O)C[C@@H]2O[C@@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,Thermal melting change,'=',3.8,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL3958862,,None,389.46,0,3.5,BDBM238805,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C5CC5)c(NC5(C)CC5)nc34)[nH]c21,IC50,'=',0.1,nM,10,,416914,UO_0000065,25.68,0.47,6.5,10.89,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL374060,GW439255X,None,325.41,0,4.53,GW439255X,Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1,Inhibition,'=',0.32,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL261849,GW632580X,None,366.42,0,2.83,K00591a,COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,Thermal melting change,'=',0.2,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL2147845,,None,390.44,0,2.59,14,COc1ccc2c(c1CN1CCNCC1)O/C(=C\c1n[nH]c3ccccc13)C2=O,Inhibition,'=',19,%,,,,UO_0000187,,,,,0,CHEMBL2149334,Inhibition of PIM2 at 300 nM by electrophoretic mobility shift assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2146430,1,Scientific Literature,J Med Chem,2012,None,
CHEMBL1971649,,None,387.42,0,4.97,SID103904350,Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc4nccnc4c3N)cc2)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3676281,,None,443.52,0,4.3,BDBM131751,CC[C@@H]1C[C@H](N)CN(c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C1,IC50,'=',3,nM,8.52,,263984,UO_0000065,19.22,0.38,4.22,10.13,0,CHEMBL3706072,Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1973211,,None,481.63,1,5.95,SID103904281,Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCCC5)cnc(N)c34)cc2)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2048872,,None,379.49,0,3.61,AZD1208,N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1,Ki,'=',0.16,nM,9.8,,,UO_0000065,25.81,0.5,6.19,12.99,1,CHEMBL3106178,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3102815,1,Scientific Literature,ACS Med Chem Lett,2013,None,
CHEMBL458997,,None,468.95,0,3.82,SID103904601,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1725279,SP-600125,None,220.23,0,4.43,SID103905675,Oc1c2ccccc2c2c3c(cccc13)N=N2,Ki,'=',316.23,nM,6.5,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1971947,,None,475.58,1,6.29,SID103904297,Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#Cc5cccnc5)cnc(N)c34)cc2)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1970104,,None,290.37,0,4.4,SID103904906,CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL246970,,None,404.9,0,3.83,SID103905472,NCC1CCC(CNc2nc(NCc3ccccc3Cl)ncc2[N+](=O)[O-])CC1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1972365,,None,210.24,0,1.98,SID103905283,Nc1cc2nc(-c3ccccc3)cn2cn1,Ki,'>',15848.93,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL4587596,,None,367.43,0,3.57,1,Cc1nc2ccc(F)c(-c3cc4c([nH]3)CCNC4=O)c2nc1NC(C)(C)C,IC50,'=',0.3,nM,9.52,,,UO_0000065,25.92,0.48,5.95,11.51,0,CHEMBL4478465,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as reduction in phosphorylation of biotinylated-BAD peptide at Serine 112 residue preincubated for 30 mins followed by substrate addition for 1 hr by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4477213,1,Scientific Literature,J Med Chem,2016,None,
CHEMBL3652641,,None,409.47,0,2.59,BDBM119401,Cn1ncc(NC(=O)c2cncc(-c3ccccc3F)n2)c1N1CCC[C@H](N)CC1,Ki,'=',581,nM,6.24,,246168,UO_0000065,15.23,0.28,3.65,6.12,0,CHEMBL3707982,Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3355987,,None,384.91,0,4.79,11b,CC(C)(O)[C@H]1CC[C@H](Nc2ccn3ncc(-c4cccc(Cl)c4)c3n2)CC1,Inhibition,'>',50,%,,,,UO_0000187,,,,,0,CHEMBL3375430,Inhibition of Pim2 (unknown origin) at 1 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3351833,1,Scientific Literature,ACS Med Chem Lett,2015,None,
CHEMBL2006263,,None,328.4,0,2.63,SID103904950,Cc1nc2ccc(NS(=O)(=O)c3ccc(N)cc3)cc2nc1C,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL210618,,None,356.38,0,2.13,SID103905189,CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1964692,,None,426.4,0,4.88,SID103904366,Cn1nc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)cncc21,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1952144,,None,426.83,0,3.78,9c,FC(F)(F)Oc1cccc(-n2nnc3cc(Cl)c(NCC4CCNCC4)nc32)c1,IC50,'=',1000,nM,6,,,UO_0000065,14.06,0.28,2.22,7.8,0,CHEMBL1954567,Inhibition of PIM2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1949661,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL1982610,,None,371.57,0,2.95,SID103905053,O=c1[nH]cc(I)c2nc(-c3cccc(Cl)c3)cn12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1983963,,None,359.39,0,4.42,SID103904275,Cc1cccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2001920,,None,341.21,0,2.26,SID103905481,O=C1NC(=S)SC1=C1C(=O)Nc2ccc(Br)cc21,Ki,'=',251.19,nM,6.6,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1974288,,None,318.38,0,3.21,SID103904552,O=C(NC(CO)c1ccccc1)c1ccc(-c2ccncc2)cc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2000335,,None,389.48,1,5.2,SID103904296,Cc1ccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)cc1C,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1794069,GSK-571989A,None,525.07,2,5.7,GSK571989A,C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl,Inhibition,'=',0.64,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1965660,,None,348.19,0,3.13,SID103904985,NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1967544,,None,497.62,0,4.67,SID103905145,CN(C)c1cccc2c(S(=O)(=O)N(CCN)c3cncc(-c4ccc5cnccc5c4)c3)cccc12,Ki,'=',1258.93,nM,5.9,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1964804,,None,343.41,0,2.22,SID103904475,CS(=O)(=O)NCCOc1cncc(-c2ccc3cnccc3c2)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1985095,,None,439.5,0,3.92,SID103904962,NC(=O)Cn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1990288,,None,399.43,1,5.36,SID103904425,CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1964644,,None,278.29,0,2.37,SID103905106,O=C(NCc1ccccc1)Nc1ncc([N+](=O)[O-])s1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2004892,,None,302.36,0,2.18,SID103904487,CS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1988163,,None,365.42,0,2.81,SID103905250,NS(=O)(=O)c1cccc(Nc2ncc3ccn(-c4ccccc4)c3n2)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL123,ELLIPTECINE,None,246.31,0,4.49,K00071,Cc1c2ccncc2c(C)c2c1[nH]c1ccccc12,Thermal melting change,'=',7.1,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL1782509,,None,352.39,0,3,17,O=C(O)c1cc2cc(-c3cncc(NCC4CCNCC4)n3)ccc2o1,IC50,'=',160,nM,6.8,,,UO_0000065,19.29,0.36,3.8,6.78,0,CHEMBL1786238,Inhibition of human Pim2 using 5-FAM-RSRHSSYPAGT-CONH2 as substrate after 90 mins by off-chip mobility shift method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1781944,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL3652001,,None,421.45,0,4.15,BDBM106907,Nc1ccc(-c2c(F)cccc2F)nc1C(=O)Nc1cnccc1C1=CC(N)CCC1,IC50,'=',7,nM,8.15,,225928,UO_0000065,19.35,0.36,4,7.63,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1794051,,None,522.96,1,4.81,GW-5074,Oc1c(Br)cc(C=C2c3cc(I)ccc3NC2O)cc1Br,IC50,'=',70,nM,7.16,,Antagonist,UO_0000065,13.68,0.47,2.34,13.63,0,CHEMBL1062793,Inhibition of PIM2 in the presence of 5uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL2442303,,None,310.39,0,2.38,11b,NCCNc1ccn2ncc(-c3ccc4scnc4c3)c2n1,IC50,'=',212,nM,6.67,,,UO_0000065,21.5,0.41,4.29,8.23,0,CHEMBL2446212,Inhibition of Pim2 (unknown origin) using STK1 as substrate preincubated for 30 mins followed by substrate and ATP addition after 60 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2440090,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL3651925,,None,437.49,0,3.9,BDBM106829,Cc1ccc(F)c(-c2cccc(C(=O)Nc3cnccc3[C@@H]3C[C@H](N)C[C@H](N)C3)n2)c1F,IC50,'=',4,nM,8.4,,225850,UO_0000065,19.2,0.36,4.5,7.85,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1952113,,None,392.39,0,3.13,6b,FC(F)(F)Oc1cccc(-n2nnc3ccc(NCC4CCNCC4)nc32)c1,IC50,'=',230,nM,6.64,,,UO_0000065,16.92,0.32,3.51,8.63,0,CHEMBL1954567,Inhibition of PIM2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1949661,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL409892,GW305178X,None,367.39,0,1.65,GW305178X,NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1,Inhibition,'=',9.88,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL215152,AZD-1152-HQPA,None,507.57,1,3.5,AZD-1152 HQPA,CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL3809691,,None,359.43,0,3.52,9c,Cc1nc2cccc3c2nc1N[C@H](C)/C=C\C[C@H]1CNC(=O)c2cc-3[nH]c21,Activity,'<',10,%,,,,UO_0000187,,,,,0,CHEMBL3812032,Inhibition of human PIM2 assessed as remaining enzyme activity at 1 uM by KINOMEscan assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3808325,1,Scientific Literature,ACS Med Chem Lett,2016,None,
CHEMBL38380,FASUDIL,3,291.38,0,1.22,HA-1077,O=S(=O)(c1cccc2cnccc12)N1CCCNCC1,Activity,'=',82,%,,,,UO_0000187,,,,,0,CHEMBL1061149,Percentage PIM2 activity remaining in the presence of 10uM inhibitor,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL578252,,None,340.38,1,5.29,29,COc1cccc(-c2ccc3[nH]c4c(ccc5c(C=O)c[nH]c54)c3c2)c1,Activity,'=',65,%,,,,UO_0000187,,,,,0,CHEMBL1051392,Inhibition of Pim-2 assessed as residual enzyme activity at 1 uM relative to untreated control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154186,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL1782521,,None,353.22,0,3.31,29,O=C(O)c1cc2cc(Br)cc(NCC3CCNCC3)c2o1,Inhibition,'=',26,%,,,,UO_0000187,,,,,0,CHEMBL1786241,Inhibition of human Pim2 using 5-FAM-RSRHSSYPAGT-CONH2 as substrate at 100 uM after 90 mins by off-chip mobility shift method relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1781944,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL3634779,,None,389.44,0,3.15,14,NC1CCN(c2cncc(-c3cc4c(-c5ccccc5F)n[nH]c4cn3)n2)CC1,Ki,'=',3,nM,8.52,,,UO_0000065,21.88,0.4,5.37,8.82,0,CHEMBL3636741,Inhibition of Pim2 (unknown origin) using 5FAM-ARKRRRHPSGPPTA as substrate after 90 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632547,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL1782516,,None,366.42,0,3.52,24,NC[C@H]1CC[C@H](Nc2cncc(-c3ccc4oc(C(=O)O)cc4c3)n2)CC1,IC50,'=',21,nM,7.68,,,UO_0000065,20.95,0.39,4.16,6.72,0,CHEMBL1786238,Inhibition of human Pim2 using 5-FAM-RSRHSSYPAGT-CONH2 as substrate after 90 mins by off-chip mobility shift method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1781944,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL3394166,,None,337.41,0,3.73,26,CCOc1cccc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)n1,IC50,'=',3730,nM,5.43,,,UO_0000065,16.09,0.31,1.7,6.05,0,CHEMBL3395662,Inhibition of PIM2 in human U2OS cells assessed as phosphorylation of BAD,B,BAO_0000219,cell-based format,Homo sapiens,None,None,U2OS,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3393014,1,Scientific Literature,Bioorg Med Chem Lett,2015,CHEMBL3307757,
CHEMBL1945559,,None,363.25,0,2.96,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4225633,,None,363.38,0,1.54,14c,CC(=O)NCCCC(=O)Nc1ccc2cnn(-c3cncc(C#N)n3)c2c1,IC50,'>',30000,nM,,,,UO_0000065,,,,,0,CHEMBL4222673,Inhibition of human PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4219163,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL3325691,,None,234.26,0,2.85,12,Nc1cc2[nH]ncc2c2c1ncc1ccccc12,Activity,'=',43,%,,,,UO_0000187,,,,,0,CHEMBL3369948,Inhibition of full-length human PIM2 using RSRHSSYPAGT as substrate assessed as residual kinase activity at 10 uM after 30 mins in presence of [gamma-33P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352653,1,Scientific Literature,Bioorg Med Chem,2014,None,
CHEMBL1975121,,None,332.4,0,4.25,SID103904565,COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1969735,,None,426.88,0,4.08,SID103904771,CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(Cl)nccn23)n1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1999918,,None,369.19,0,4.1,SID103905043,NC(=O)c1cc2c(-c3ccc(Br)c(F)c3F)cncc2s1,Ki,'=',501.19,nM,6.3,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL493937,,None,338.41,0,2.38,1,CN1CCCN(c2cncc(-c3cccc(/C=C/C(=O)O)c3)n2)CC1,IC50,'>',20000,nM,,,,UO_0000065,,,,,0,CHEMBL960092,Inhibition of GST-tagged Pim2 after 15 mins by scintillation counting-based competition assay in presence of 100 uM [gamma33P]ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153342,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL4281348,,None,434.85,1,6.5,18i,CCNc1cc(-c2ccc(NC(=O)Nc3cccc(Cl)c3)cc2C(F)(F)F)ccn1,Activity,'=',88,%,,,,UO_0000187,,,,,0,CHEMBL4254348,Inhibition of wild-type human partial length PIM2 (M1 to E291 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4251622,1,Scientific Literature,Eur J Med Chem,2018,None,
CHEMBL1782531,,None,353.22,0,3.58,39,N[C@H]1CC[C@H](Nc2cc(Br)cc3cc(C(=O)O)oc23)CC1,IC50,'=',66,nM,7.18,,,UO_0000065,20.33,0.47,3.6,8.11,0,CHEMBL1786238,Inhibition of human Pim2 using 5-FAM-RSRHSSYPAGT-CONH2 as substrate after 90 mins by off-chip mobility shift method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1781944,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL237571,,None,483.59,1,5.69,SB-633825,COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1,Inhibition,'=',0.92,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3687502,,None,470.5,0,4.67,BDBM151898,CO[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H]1C,IC50,'=',4.71,nM,8.33,,292154,UO_0000065,17.7,0.33,3.66,9.24,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3298817,,None,435.45,0,3.39,13b,O=C(CC1CNC(=O)c2cc(-c3cccc(C(F)(F)F)c3)cn21)NCC1CCOCC1,IC50,'=',3130,nM,5.5,,,UO_0000065,12.64,0.24,2.11,7.61,0,CHEMBL3300844,Inhibition of human PIM2 using ARK-RERTYSFGHHA as substrate incubated for 60 mins prior to substrate addition by topcount scintillation counting analysis in presence of [P33gamma]-ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3297733,1,Scientific Literature,Bioorg Med Chem,2013,None,
CHEMBL1987982,,None,358.36,1,5.11,SID103905479,FC(F)(F)Oc1ccc(-c2ccc3[nH]cc(C4=CCNCC4)c3c2)cc1,Ki,'=',794.33,nM,6.1,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3918714,,None,349.44,0,3.95,8,Cc1nc2cccc(-c3cc4c([nH]3)[C@H](C)NC4=O)c2nc1NC(C)(C)C,IC50,'=',1.8,nM,8.74,,,UO_0000065,25.02,0.46,4.79,10.57,0,CHEMBL4478465,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as reduction in phosphorylation of biotinylated-BAD peptide at Serine 112 residue preincubated for 30 mins followed by substrate addition for 1 hr by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4477213,1,Scientific Literature,J Med Chem,2016,None,
CHEMBL493560,,None,326.36,0,1.79,18,CC(=O)NCCNc1cncc(-c2cccc(/C=C/C(=O)O)c2)n1,IC50,'=',1020,nM,5.99,,,UO_0000065,18.36,0.34,4.2,5.75,0,CHEMBL960121,Inhibition of Pim2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153342,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL494354,,None,338.41,0,2.92,23,N[C@H]1CC[C@H](Nc2cncc(-c3cccc(/C=C/C(=O)O)c3)n2)CC1,IC50,'=',12,nM,7.92,,,UO_0000065,23.41,0.43,5,7.83,0,CHEMBL960121,Inhibition of Pim2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1153342,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL479079,GW612286X,None,406.45,0,4.17,GW612286X,COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC,Inhibition,'=',1.46,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3103859,,None,404.47,0,3.03,4a,Nc1ccc(Oc2ccccc2)nc1C(=O)Nc1cnccc1N1CCC[C@H](N)C1,Ki,'=',122,nM,6.91,,,UO_0000065,17.09,0.31,3.88,5.79,0,CHEMBL3106178,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3102815,1,Scientific Literature,ACS Med Chem Lett,2013,None,
CHEMBL177820,TETRABROMOBENZOTRIAZOLE,None,434.71,0,4.01,K00040,Brc1c(Br)c(Br)c2[nH]nnc2c1Br,Thermal melting change,'=',4.2,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL2397526,,None,222.25,0,2.78,16a,Nc1cc2[nH]ncc2c2c1[nH]c1ccccc12,Activity,'=',71,%,,,,UO_0000187,,,,,0,CHEMBL2401344,Inhibition of human PIM2 assessed as residual activity using RSRHSSYPAGT as substrate at 10 uM after 30 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2396576,1,Scientific Literature,Bioorg Med Chem,2013,None,
CHEMBL2397601,,None,222.25,0,2.78,7a,Nc1cc2cn[nH]c2c2c1[nH]c1ccccc12,Activity,'=',78,%,,,,UO_0000187,,,,,0,CHEMBL2401344,Inhibition of human PIM2 assessed as residual activity using RSRHSSYPAGT as substrate at 10 uM after 30 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2396576,1,Scientific Literature,Bioorg Med Chem,2013,None,
CHEMBL3103880,,None,327.39,0,0.88,3e,NCC1CCCN(c2ccncc2NC(=O)c2nccnc2N)C1,Ki,'=',700,nM,6.16,,,UO_0000065,18.8,0.35,5.27,5,0,CHEMBL3106178,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3102815,1,Scientific Literature,ACS Med Chem Lett,2013,None,
CHEMBL1909369,GW693917A,None,556.93,2,7.07,GW693917A,COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl,Inhibition,'=',0.12,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3298892,,None,413.49,0,3.03,14d,O=C(C[C@H]1CNC(=O)c2cc(-c3cccc(F)c3)cn21)N[C@H](CO)C1CCCCC1,IC50,'=',252,nM,6.6,,,UO_0000065,15.96,0.3,3.57,7.92,0,CHEMBL3300844,Inhibition of human PIM2 using ARK-RERTYSFGHHA as substrate incubated for 60 mins prior to substrate addition by topcount scintillation counting analysis in presence of [P33gamma]-ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3297733,1,Scientific Literature,Bioorg Med Chem,2013,None,
CHEMBL3297758,,None,421.47,0,2.69,14f,O=C(C[C@H]1CNC(=O)c2cc(-c3cccc(F)c3)cn21)N[C@H](CO)Cc1ccccc1,IC50,'=',684,nM,6.17,,,UO_0000065,14.63,0.27,3.47,7.4,0,CHEMBL3300844,Inhibition of human PIM2 using ARK-RERTYSFGHHA as substrate incubated for 60 mins prior to substrate addition by topcount scintillation counting analysis in presence of [P33gamma]-ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3297733,1,Scientific Literature,Bioorg Med Chem,2013,None,
CHEMBL3676280,,None,451.45,0,3.91,BDBM131750,N[C@@H]1CN(c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)CC(F)(F)C1,IC50,'=',38,nM,7.42,,263983,UO_0000065,16.44,0.33,3.51,8.82,0,CHEMBL3706072,Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1982476,,None,451.94,1,5.2,SID103904309,CNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)csc12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2007002,,None,359.39,0,4.2,SID103904737,COc1cc(-c2ccc3[nH]nc(C(=O)Nc4ccccc4)c3c2)ccc1O,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL101253,VATALANIB,3,346.82,1,5.01,K00618a,Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1,Thermal melting change,'=',-0.3,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL3687461,,None,453.49,0,3.92,BDBM151857,CO[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccnc(-c3c(F)cccc3F)n2)C[C@@H]1C,IC50,'=',69.11,nM,7.16,,292113,UO_0000065,15.79,0.3,3.24,6.95,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3687512,,None,484.52,0,4.98,BDBM151908,CO[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C)cc3F)n2)C[C@@H]1C,IC50,'=',2.18,nM,8.66,,292164,UO_0000065,17.88,0.34,3.68,9.61,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3393706,,None,433.46,0,4.49,13o,Fc1cccc(F)c1-c1ccc2[nH]nc(-c3cncc(O[C@H]4CNCCC45CC5)n3)c2c1,IC50,'=',1.1,nM,8.96,,,UO_0000065,20.67,0.38,4.47,11.83,0,CHEMBL3396420,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as phosphorylation of biotinylated-BAD peptide at Serine 112 residue,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3392976,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL185710,,None,230.23,0,1.08,SB-738561,CCn1c(-c2nonc2N)nc2ccncc21,Inhibition,'=',0.12,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL2387468,,None,409.41,0,3.03,3,N#Cc1ccc(Cc2cc(O)n3ncc(C(=O)Nc4c[nH]c5ncccc45)c3n2)cc1,Ki,'=',2.8,nM,8.55,,,UO_0000065,20.89,0.38,5.52,6.48,0,CHEMBL2387969,Inhibition of PIM2 (unknown origin) using FAM-pimtide as substrate after 90 mins by spectrophotometry in presence of ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2385019,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL183993,GW811761X,None,400.36,0,4.35,GW811761X,CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1,Inhibition,'=',-0.33,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL13045,CHELERYTHRINE,None,348.38,0,3.72,SID11110929,COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC,Residual Activity,'=',86,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL156987,,None,377.18,0,3.17,SB-409513,O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1,Inhibition,'=',-0.53,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL103115,GW831091X,None,348.36,0,2.31,GW831091X,NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1,Inhibition,'=',-0.39,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL210928,,None,443.91,0,2.32,SID103905197,CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1Cl,Ki,'>',1400,nM,,,,UO_0000065,,,,,0,CHEMBL863188,Inhibition of Pim2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148638,1,Scientific Literature,J Med Chem,2006,None,
CHEMBL175321,,None,263.3,0,3.2,GR-105659X,O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21,Inhibition,'=',1.46,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3939394,,None,385.48,0,2.99,BDBM248910,Cc1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CCCNCC3)n2)c1,Ki,'=',3.37,nM,8.47,,434117,UO_0000065,21.98,0.4,5.48,11.81,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3691948,,None,564.57,1,3.54,BDBM151970,C[C@H]1CN(c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C4COC4)cc3F)n2)C[C@@H](N)[C@H]1n1ccnn1,IC50,'=',270.24,nM,6.57,,292225,UO_0000065,11.63,0.22,3.03,5.29,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3703183,,None,357.48,0,2.31,BDBM149691,CSc1ncc2c(n1)-c1c(c(C(N)=O)cn1[C@H]1CC[C@@H](N)CC1)CC2,IC50,'=',7,nM,8.15,,288349,UO_0000065,22.81,0.45,5.84,8.17,0,CHEMBL3707582,Kinase Inhibition Assay: The buffer for PIM-2 assay was composed of HEPES 50 mM,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1909344,,None,372.86,0,2.3,SB-678557-A,CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl,Inhibition,'=',1.49,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL521806,GSK-237700A,None,457.94,0,5,GSK237700A,COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC,Inhibition,'=',0.91,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1965507,,None,418.48,0,4.48,SID103904355,Cc1cccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1970142,,None,525.64,2,5.67,SID103904293,CNC(=O)C(C)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(C)cc5)cc4)csc23)cn1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1989646,,None,304.36,0,2.76,SID103904483,Cc1c(-c2ccc3[nH]nc(N)c3c2)nnn1Cc1ccccc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL248757,,None,471.93,0,4.27,SID103905151,N#Cc1ncc2nc1OCCCCOc1cc(NCc3cncs3)c(Cl)cc1NC(=O)N2,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2006567,,None,258.31,0,2.22,SID103905192,CC(=O)Nc1cc(N)c(C#N)c(-c2ccsc2)n1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1090360,,None,587.71,2,6.28,SID103904420,O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3942200,,None,382.47,0,4.88,BDBM238472,Cc1cccc(C)c1Nc1ccc2cccc(-c3cc4c([nH]3)CCNC4=O)c2n1,IC50,'=',73.9,nM,7.13,,416210,UO_0000065,18.65,0.34,2.25,10.22,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4115439,,None,418.45,0,4.71,BDBM192608,N[C@H]1C=C(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)CCC1,IC50,'=',6.3,nM,8.2,,344679,UO_0000065,19.6,0.36,3.49,10.11,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1999774,,None,336.78,0,1.37,SID103905288,Cc1c(Cl)c(N2CCC(CN)C2)nc2[nH]cc(C(=O)O)c(=O)c12,Ki,'=',1258.93,nM,5.9,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1991180,,None,388.34,1,-0.06,SID103905665,COCc1nnn(-c2nonc2N)c1C(=O)NN=C(C)c1ccc(O)cc1O,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1997534,,None,405.52,1,5.41,SID103904738,COc1cccc(C(C)NC(=O)c2cc(C)c(-c3ccc4[nH]nc(C)c4c3)s2)c1,Ki,'=',501.19,nM,6.3,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1989708,,None,498.61,1,5.74,SID103904354,Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1,Ki,'>',1000,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1969190,,None,410.38,1,5.01,SID103904443,COc1ccc(-c2ccc(NC(=O)Nc3cc(F)cc(F)c3)cc2)c2c(N)noc12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1976093,,None,419.51,0,3.99,SID103904757,CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1,Ki,'=',1258.93,nM,5.9,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1977346,,None,338.11,0,2.39,SID103905414,O=C1Nc2ccccc2Nc2nnc(I)cc21,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2017339,,None,377.86,1,5.63,13f,Clc1cccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3sccc23)c1,IC50,'=',6,nM,8.22,,,UO_0000065,21.76,0.43,2.59,12.37,0,CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016532,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL3970651,,None,454.37,0,4.77,21e,N[C@H]1CCCN(c2ccncc2Nc2ncc3ccc(-c4ccc(Cl)cc4Cl)nn23)C1,IC50,'=',11,nM,7.96,,,UO_0000065,17.52,0.35,3.19,9.43,0,CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3864151,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL3691935,,None,610.62,1,4.4,BDBM151957,C[C@H]1CN(c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C4(F)CCOCC4)cc3F)n2)C[C@@H](N)[C@H]1n1ccnn1,IC50,'=',2.04,nM,8.69,,292212,UO_0000065,14.23,0.27,4.29,7,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1969102,,None,440.53,1,5.89,SID103904308,Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cn[nH]c5)cnc(N)c34)cc2)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2007044,,None,367.46,0,3.61,SID103904810,CCN(CC)CC#Cc1ccc2c(c1)-c1[nH]nc(-c3ccc(C#N)nc3)c1C2,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1992306,,None,430.39,0,4.9,SID103904741,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccn1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1965910,,None,467.62,1,5.84,SID103904995,Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2C1CCC(N2CCCC2)CC1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL223460,,None,466.91,0,2.96,SID103905152,CS(=O)(=O)Nc1cc2c(cc1Cl)NC(=O)Nc1cnc(C#N)c(n1)OCCCCCO2,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL475251,R-406,2,470.46,0,3.63,SID103904600,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1972576,,None,418.48,0,4.48,SID103904331,Cc1ccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)cc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL4469964,,None,464.52,0,3.98,24,Cn1ncc(NC(=O)c2nc(-c3c(F)cccc3F)sc2N)c1C1CCC(N)C(F)CC1,Ki,'=',0.3,nM,9.52,,,UO_0000065,20.5,0.41,5.54,8.51,0,CHEMBL4317000,Inhibition of recombinant human PIM2 using FAM-pimtide as substrate after 90 mins by Z-LYTE assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4316591,1,Scientific Literature,J Med Chem,2019,None,
CHEMBL1965660,,None,348.19,0,3.13,SID103904984,NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1241473,,None,440.42,0,3,SID103904595,COc1cc(Nc2ncc([N+](=O)[O-])c(Nc3ccccc3C(N)=O)n2)cc(OC)c1OC,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3687484,,None,576.64,1,4.39,BDBM151880,Cc1cc(F)c(-c2nc(C(=O)Nc3cnccc3[C@H]3C[C@@H](C)[C@@H](OCCS(C)(=O)=O)[C@@H](N)C3)ccc2F)c(F)c1,IC50,'=',2483.1,nM,5.61,,292136,UO_0000065,9.72,0.19,1.22,4.51,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL97162,,None,368.41,0,3.63,K00570a,COc1nccc(-c2c(-c3ccc(F)cc3)ncn2[C@H]2CC[C@H](O)CC2)n1,Thermal melting change,'=',0.5,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL4568404,,None,403.49,0,3.67,28,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C5(C)CC5)c(NC5(C)CC5)nc34)[nH]c21,IC50,'=',0.05,nM,10.3,,,UO_0000065,25.53,0.47,6.63,11.22,0,CHEMBL4370146,Inhibition of full length recombinant PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues preincubated for 30 mins followed by biotinylated BAD addition and measured after 1 hr by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4368910,1,Scientific Literature,J Med Chem,2019,None,
CHEMBL259850,,None,308.32,0,2.38,SID103904634,COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1991846,,None,331.42,0,3.6,SID103904967,NC(COc1cncc(C=Cc2ccncc2)c1)Cc1ccccc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1516890,GW441756X,None,275.31,0,3.07,SID103905238,Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1997822,,None,433.56,1,5.41,SID103904321,Cc1cc2cc(-c3csc4c(-c5cccc(S(C)(=O)=O)c5)cnc(N)c34)ccc2[nH]1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1965845,,None,376.46,0,4.13,SID103905119,COc1cccc(C(C)NC(=O)N2CC=C(c3c[nH]c4ncccc34)CC2)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3979678,,None,365.44,0,2.94,8,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C)c(NC(C)(C)C)nc34)[nH]c21,IC50,'=',0.38,nM,9.42,,,UO_0000065,25.78,0.48,6.48,10.26,0,CHEMBL4370146,Inhibition of full length recombinant PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues preincubated for 30 mins followed by biotinylated BAD addition and measured after 1 hr by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4368910,1,Scientific Literature,J Med Chem,2019,None,
CHEMBL4446498,,None,434.33,0,2.34,26,NC(=O)c1cc(Cl)c2c(Cl)c(C#CCN3CCCC3=O)n([C@H]3CCCNC3)c2n1,IC50,'=',6.7,nM,8.17,,,UO_0000065,18.82,0.38,5.83,8.77,0,CHEMBL4373003,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser-112 residue by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4371067,1,Scientific Literature,Bioorg Med Chem Lett,2019,None,
CHEMBL4588948,,None,395.29,0,2.49,16,CC(O)CC#Cc1c(Cl)c2c(Cl)cc(C(N)=O)nc2n1[C@H]1CCCNC1,IC50,'=',6.1,nM,8.21,,,UO_0000065,20.78,0.43,5.72,8.82,0,CHEMBL4373003,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser-112 residue by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4371067,1,Scientific Literature,Bioorg Med Chem Lett,2019,None,
CHEMBL485070,,None,354.43,0,3.48,K00066,CCOc1cc(/C=C(\C#N)C(N)=O)cc(CSc2ccccc2)c1O,Thermal melting change,'=',0.1,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL3966407,,None,347.42,0,3.84,BDBM238453,O=C1NCCc2[nH]c(-c3cccc4ccc(OC5CCCC5)nc34)cc21,IC50,'=',30.5,nM,7.52,,416197,UO_0000065,21.63,0.39,3.68,11.22,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3913508,,None,403.87,0,4.84,BDBM238461,COc1ccc(Cl)cc1-c1ccc2cccc(-c3cc4c([nH]3)CCNC4=O)c2n1,IC50,'=',166,nM,6.78,,416205,UO_0000065,16.79,0.32,1.94,10.12,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3937161,,None,357.36,0,3.41,BDBM238718,Cc1nc2cccc(-c3cc4c([nH]3)[C@@H](C)NC4=O)c2nc1NCC(F)F,IC50,'=',0.246,nM,9.61,,416827,UO_0000065,26.89,0.5,6.2,11.62,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1982866,,None,314.78,0,3.31,SID103905540,COCCn1cc(-c2ccncn2)c(-c2ccc(Cl)cc2)n1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1994938,,None,482.41,0,4.72,SID103904796,Nc1ncc(C=CC(=O)NCCCn2ccnc2)c2scc(-c3ccc(Br)cc3)c12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3895619,,None,370.37,0,4.05,BDBM224833,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(Oc5ccccc5)n4)c3c2)o1,IC50,'=',46.56,nM,7.33,,393115,UO_0000065,19.8,0.36,3.28,6.33,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3981435,,None,383.45,1,5.26,BDBM238395,CCC1CNC(=O)c2cc(-c3cccc4ccc(Oc5ccccc5)nc34)[nH]c21,IC50,'=',53.6,nM,7.27,,416175,UO_0000065,18.96,0.34,2.01,10.85,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3942145,,None,349.39,0,2.28,BDBM238702,Cc1nc2cccc(-c3cc4c([nH]3)[C@@H](CO)NC4=O)c2nc1NC1CC1,IC50,'=',0.177,nM,9.75,,416811,UO_0000065,27.91,0.51,7.47,9.47,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1979252,,None,347.3,0,3.05,SID103905144,O=c1c(NCc2cccc(C(F)(F)F)c2)c(Nc2ccncc2)c1=O,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3687435,,None,497.52,0,4.16,BDBM151830,CC(=O)N[C@@H]1[C@H](C)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H]1N,IC50,'=',2700,nM,5.57,,292086,UO_0000065,11.19,0.21,1.41,5.06,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3651915,,None,436.51,1,5.22,BDBM106819,CCc1ccc(F)c(-c2cccc(C(=O)Nc3cnccc3[C@@H]3CCC[C@H](N)C3)n2)c1F,IC50,'=',54,nM,7.27,,225840,UO_0000065,16.65,0.31,2.05,8.98,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1973395,,None,294.36,0,2.59,SID103904214,OC1CCN(c2ncnc3[nH]cc(-c4ccccc4)c23)CC1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL429298,,None,324.83,0,2.48,K00008,O=S(=O)(c1cccc2c(Cl)cccc12)N1CCCNCC1,Thermal melting change,'=',1.7,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL3687443,,None,486.56,1,5.39,BDBM151839,CS[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H]1C,IC50,'=',0.68,nM,9.17,,292095,UO_0000065,18.84,0.37,3.78,11.33,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3652640,,None,423.5,0,2.77,BDBM119400,Cn1ncc(NC(=O)c2nc(-c3ccccc3F)ccc2N)c1N1CCC[C@H](N)CC1,Ki,'=',3.13,nM,8.5,,246167,UO_0000065,20.08,0.37,5.73,7.39,0,CHEMBL3707982,Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3652013,,None,440.45,0,2.21,BDBM106919,C[C@H]1CN(c2ccncc2NC(=O)c2ccc(F)c(-c3ccncc3F)n2)C[C@@H](N)[C@@H]1O,IC50,'=',4,nM,8.4,,225940,UO_0000065,19.07,0.36,6.19,7.16,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3264258,,None,402.51,0,3.42,7g,CCN(CC)CCNc1cncc(-c2ccc3[nH]cc(-c4ccnc(N)n4)c3c2)n1,IC50,'=',310,nM,6.51,,,UO_0000065,16.17,0.3,3.09,5.99,0,CHEMBL3269287,Inhibition of PIM2 kinase (unknown origin) using 5-FAM-labeled BAD peptide as substrate after 90 mins by fluorescence polarization assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3259764,1,Scientific Literature,Bioorg Med Chem Lett,2014,None,
CHEMBL4535474,BAY-293,None,448.59,1,5.58,EUB0000320,CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1,% Control,,100,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507273,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL2007064,,None,310.35,0,3.14,SID103905113,Cc1[nH]c(C=C2C(=O)Nc3ccccc32)c(C)c1CCC(=O)O,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1976220,,None,439.34,1,5.95,SID103904362,Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Br)c4)cc3)c12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1982383,,None,435.51,0,2.92,SID103904768,CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CCN)nccn23)n1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL228043,,None,360.01,0,3.51,K00067,C/C(O)=C(\C#N)C(=O)Nc1cc(Br)ccc1Br,Thermal melting change,'=',1.9,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL1984586,,None,359.39,0,4.42,SID103904368,Cc1ccccc1NC(=O)Nc1ccc(-c2coc3ncnc(N)c23)cc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1982361,,None,297.29,0,2.17,SID103904729,O=c1c(NCc2ccccc2F)c(Nc2ccncc2)c1=O,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1991725,,None,479.58,0,4.45,SID103904474,CN(C)CC(=O)NC(COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1991285,,None,429.86,0,3.83,SID103905154,Cc1cc(OCC2CCC(C(=O)O)C2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1993661,,None,479.95,0,3.55,SID103904591,CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(OC)c(OC)c(OC)c2)ncc1Cl,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL272453,,None,408.85,1,5.38,SID103904857,COc1ccc(NC(=O)Nc2ccc(-c3cccc4onc(N)c34)cc2)cc1Cl,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1969523,,None,379.46,0,3.71,SID103904937,Cc1cccc(Nc2nccc(Nc3c(NC(C)C(C)(C)C)c(=O)c3=O)n2)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL4443684,,None,464.57,0,2.74,21,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C[C@H]5CN(C)CCO5)c(NC(C)(C)C)nc34)[nH]c21,IC50,'=',1.6,nM,8.8,,,UO_0000065,18.93,0.35,6.06,8.43,0,CHEMBL4370146,Inhibition of full length recombinant PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues preincubated for 30 mins followed by biotinylated BAD addition and measured after 1 hr by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4368910,1,Scientific Literature,J Med Chem,2019,None,
CHEMBL4457389,,None,421.33,0,3.14,24,CC1(CC#Cc2c(Cl)c3c(Cl)cc(C(N)=O)nc3n2[C@H]2CCCNC2)COC1,IC50,'=',15.7,nM,7.8,,,UO_0000065,18.52,0.38,4.66,9.5,0,CHEMBL4373003,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser-112 residue by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4371067,1,Scientific Literature,Bioorg Med Chem Lett,2019,None,
CHEMBL3651957,,None,440.47,1,5.04,BDBM106861,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3cc(F)ccc3F)n2)C1,IC50,'=',6,nM,8.22,,225882,UO_0000065,18.67,0.35,3.18,10.16,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3394165,,None,391.5,0,4.47,BDBM50061608,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(NC5CCCCC5)n4)c3c2)s1,IC50,'=',18.07,nM,7.74,,393231,UO_0000065,19.78,0.38,3.27,7.35,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3652004,,None,509.45,2,5.17,BDBM106910,Nc1cc(F)c(-c2c(F)cccc2F)nc1C(=O)Nc1cnccc1[C@H]1C[C@@H](N)C[C@@H](C(F)(F)F)C1,IC50,'=',1,nM,9,,225931,UO_0000065,17.67,0.34,3.83,8.42,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3687434,,None,513.52,1,4.38,BDBM151829,COC(=O)N[C@@H]1[C@H](C)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H]1N,IC50,'=',1400,nM,5.85,,292085,UO_0000065,11.4,0.22,1.47,4.91,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3687511,,None,528.58,2,5.46,BDBM151907,CO[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(OC(C)C)cc3F)n2)C[C@@H]1C,IC50,'=',3.01,nM,8.52,,292163,UO_0000065,16.12,0.31,3.06,8.58,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3942619,,None,419.49,0,2.31,BDBM251575,COc1ccc(-c2cnc(N)c(C(=O)Nc3cnccc3N3CCC(N)CC3)n2)cc1,IC50,'=',13,nM,7.89,,438369,UO_0000065,18.8,0.35,5.58,5.96,0,CHEMBL3889161,In Vitro Caliper Kinase Assay: For comparison between certain PKC inhibitors of the present application and structurally comparable PIM kinase inhibitors,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3355551,,None,390.41,0,4.52,10a,C[C@]1(O)CC[C@H](Nc2ccn3ncc(-c4cccc(C(F)(F)F)c4)c3n2)CC1,IC50,'=',639,nM,6.19,,,UO_0000065,15.87,0.3,1.67,9.92,0,CHEMBL3375413,Inhibition of Pim2 (unknown origin) using luciferase-luciferin based ATP detection reagent by Kinase-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3351833,1,Scientific Literature,ACS Med Chem Lett,2015,None,
CHEMBL2003456,,None,211.22,0,1.92,SID103904364,O=c1[nH]c2cc(-c3ccccc3)cnc2[nH]1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL402846,,None,390.42,0,4.31,SID103904342,Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1976455,,None,333.27,0,3.69,SID103904884,O=C(Nc1cnccn1)Nc1ccnc2ccc(C(F)(F)F)cc12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1970903,,None,397.48,0,4.36,SID103904484,Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4c[nH]c5ccccc45)c3)cc12,Ki,'=',6.31,nM,8.2,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2002992,,None,286.38,0,2.66,SID103905614,CC(N)C1CCC(C(=O)Nc2ccnc3[nH]ccc23)CC1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL377383,,None,383.86,0,2.05,SID103905002,CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1Cl,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1973142,,None,303.17,0,3.27,SID103905605,CC(=O)Nc1c(C(N)=O)sc2ccc(Cl)c(Cl)c12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1909394,GW621823A,None,659.61,2,7.26,GW621823A,CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl,Inhibition,'=',-0.45,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL4093612,A-1596586,None,539.53,2,5.45,EUB0000544,COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1,% Control,,100,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507262,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL2397599,,None,282.26,0,3.11,6b,COc1ccc2[nH]c3c([N+](=O)[O-])cc4cn[nH]c4c3c2c1,Activity,'=',72,%,,,,UO_0000187,,,,,0,CHEMBL2401344,Inhibition of human PIM2 assessed as residual activity using RSRHSSYPAGT as substrate at 10 uM after 30 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2396576,1,Scientific Literature,Bioorg Med Chem,2013,None,
CHEMBL3651948,,None,438.48,0,3.88,BDBM106852,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2cccc(-c3c(F)cccc3F)n2)C[C@@H](N)[C@@H]1O,IC50,'=',3,nM,8.52,,225873,UO_0000065,19.44,0.36,4.64,8.43,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1979057,,None,340.39,0,4.22,SID103905248,O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3[nH]2)cc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3393722,,None,406.44,0,3.89,3,NC1CCCN(c2cncc(-c3n[nH]c4ccc(-c5c(F)cccc5F)cc34)n2)C1,IC50,'=',70,nM,7.16,,,UO_0000065,17.6,0.33,3.26,8.55,0,CHEMBL3396420,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as phosphorylation of biotinylated-BAD peptide at Serine 112 residue,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3392976,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL4290222,,None,426.57,0,2.51,31,CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C5CCOCC5)c34)CC2)CC1,Inhibition,'=',-5,%,,,,UO_0000187,,,,,0,CHEMBL4266609,Inhibition of human PIM2 expressed in Escherichia coli at 1 uM relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4265877,1,Scientific Literature,Bioorg Med Chem,2018,None,
CHEMBL4225378,,None,367.46,0,2.57,14e,CC(=O)NCCCNc1cncc(-n2ncc3ccc(NC(C)C)cc32)n1,IC50,'>',30000,nM,,,,UO_0000065,,,,,0,CHEMBL4222673,Inhibition of human PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4219163,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL1988838,,None,428.47,0,1.78,SID103904596,Cc1cnc(Nc2cccc(S(N)(=O)=O)c2)nc1Nc1ccc(OCC(N)=O)cc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2048871,,None,361.47,0,2.73,27,CC(C)Oc1cccc(/C=C2\SC(=O)NC2=O)c1N1CCC[C@@H](N)C1,IC50,'<',3,nM,,,,UO_0000065,,,,,0,CHEMBL2049740,Inhibition of human PIM2 using FITC-(AHX)RSRHSSYPAGT-COOH as substrate after 90 mins by mobility shift assay in presence of 50 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2046384,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL1999714,,None,224.26,0,3.3,SID103904727,Cc1ccc2c(c1)NC(=O)c1ccccc1N2,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2178352,,None,468.61,1,5.18,9e,CN1CCN(c2ccc(Nc3ncc4nc(Nc5ccccc5)n(C5CCCC5)c4n3)cc2)CC1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL2188517,Inhibition of human recombinant PIM2 by radiometric kinase assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2177100,1,Scientific Literature,J Med Chem,2012,None,
CHEMBL939,GEFITINIB,4,446.91,0,4.28,SID103905344,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1,Ki,'>',794.33,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL4552354,BI 3017,None,407.43,0,1.3,EUB0001066,Cc1nccc(COC(=O)N2C[C@@H]3[C@@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@@H]3C2)n1,% Control,,0,%,,,Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507275,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL3691966,,None,569.58,1,4.49,BDBM151988,COC(=O)N[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C4COC4)cc3F)n2)C[C@@H]1C,IC50,'=',37.43,nM,7.43,,292243,UO_0000065,13.04,0.25,2.94,5.78,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4763702,,None,469.49,0,3.09,13,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2nc(-c3ncccc3F)ccc2N)C[C@@H](O)[C@@]1(O)CF,Ki,'<',3,nM,,,,UO_0000065,,,,,0,CHEMBL4723884,Inhibition of PIM2 (unknown origin) using Bad peptide NH2-AGAGRSRHSSYPAGT-OH as substrate measured after 10 mins in presence of ATP by luciferase-luciferin based Kinase-Glo luminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4715870,1,Scientific Literature,J Med Chem,2020,None,TIME = 0.1667 hr
CHEMBL3652011,,None,457.45,0,4.05,4,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](O)[C@@H]1O,Ki,'<',3,nM,,,,UO_0000065,,,,,0,CHEMBL4723884,Inhibition of PIM2 (unknown origin) using Bad peptide NH2-AGAGRSRHSSYPAGT-OH as substrate measured after 10 mins in presence of ATP by luciferase-luciferin based Kinase-Glo luminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4715870,1,Scientific Literature,J Med Chem,2020,None,TIME = 0.1667 hr
CHEMBL3651966,,None,440.47,1,5.04,2,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C1,Ki,'<',3,nM,,,,UO_0000065,,,,,0,CHEMBL4723884,Inhibition of PIM2 (unknown origin) using Bad peptide NH2-AGAGRSRHSSYPAGT-OH as substrate measured after 10 mins in presence of ATP by luciferase-luciferin based Kinase-Glo luminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4715870,1,Scientific Literature,J Med Chem,2020,None,TIME = 0.1667 hr
CHEMBL4796070,,None,468.5,0,3.88,10,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)ccc2N)C[C@@H](O)[C@]1(C)O,Ki,'<',3,nM,,,,UO_0000065,,,,,0,CHEMBL4723884,Inhibition of PIM2 (unknown origin) using Bad peptide NH2-AGAGRSRHSSYPAGT-OH as substrate measured after 10 mins in presence of ATP by luciferase-luciferin based Kinase-Glo luminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4715870,1,Scientific Literature,J Med Chem,2020,None,TIME = 0.1667 hr
CHEMBL4791128,,None,454.48,0,3.69,7,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccnc(-c3c(F)cccc3F)n2)C[C@@H](O)[C@]1(C)O,Ki,'=',13,nM,7.89,,,UO_0000065,17.35,0.33,4.2,7.29,0,CHEMBL4723884,Inhibition of PIM2 (unknown origin) using Bad peptide NH2-AGAGRSRHSSYPAGT-OH as substrate measured after 10 mins in presence of ATP by luciferase-luciferin based Kinase-Glo luminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4715870,1,Scientific Literature,J Med Chem,2020,None,TIME = 0.1667 hr
CHEMBL4576489,,None,915.85,None,None,8b,CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,Kd,,,,,,Not Determined,,,,,,0,CHEMBL4322740,Binding affinity to recombinant human full-length N-terminal GST-tagged PIM2 expressed in baculovirus expression system using S6K2 peptide as substrate incubated for 1 hr by TR-FRET assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4321812,1,Scientific Literature,Bioorg Med Chem Lett,2019,None,
CHEMBL4513786,A-545,None,532.72,2,5.54,EUB0000289,CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC,% Control,,96.3,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507258,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL2017345,,None,461.86,1,6.53,13k,FC(F)(F)Oc1ccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3sccc23)c(Cl)c1,IC50,'=',76,nM,7.12,,,UO_0000065,15.41,0.31,0.59,9.4,0,CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016532,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL83980,BOHEMINE,None,340.43,0,2.81,K00054,CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21,Thermal melting change,'=',0.2,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL2005899,,None,315.37,0,2.21,SID103905650,CC(=O)N(c1ccncc1)c1c(NC(C)C(C)(C)C)c(=O)c1=O,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL387971,,None,476.6,0,3.11,SID103904812,COCCOCC#Cc1cc(-c2n[nH]c3c2C(=O)c2cc(CN4CCN(C)CC4)ccc2-3)cs1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1966343,,None,256.31,0,3,SID103904482,CC(C)Cc1cc(-c2ccc3[nH]nc(N)c3c2)on1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL460472,,None,539.59,1,4.71,59e,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL388978,STAUROSPORINE,None,466.54,0,4.35,Staurosporine,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,IC50,'=',4.73,nM,8.32,,,UO_0000065,17.84,0.32,3.98,11.99,0,CHEMBL4720601,Inhibition of human PIM2 using RSRHSSYPAGT as substrate by [gamma-33P]-ATP assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4715818,1,Scientific Literature,Bioorg Med Chem,2018,None,
CHEMBL1910895,,None,355.45,0,3.7,9,c1ccc(-c2ccc3c(-c4ccc(N5CCNCC5)cc4)n[nH]c3n2)cc1,IC50,'=',7200,nM,5.14,,,UO_0000065,14.47,0.26,1.44,9.05,0,CHEMBL1912526,Inhibition of PIM2 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1909629,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL3651993,,None,426.44,0,4.8,16,N[C@H]1CCC[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C1,Ki,'=',5,nM,8.3,,,UO_0000065,19.47,0.37,3.5,10.26,0,CHEMBL3750240,Inhibition of PIM2 kinase (unknown origin) using NH2-AGAGRSRHSSYPAGT-OH as substrate by kinase-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3745712,1,Scientific Literature,J Med Chem,2015,None,
CHEMBL1971245,,None,428.5,0,2.39,SID103904422,CN1CCN(c2cccc(Nc3nccc(-c4c(C(N)=O)nc5ccccn45)n3)c2)CC1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3701197,A-226,None,221.27,0,3.78,EUB0000547,CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1,% Control,,100,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507256,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL3687432,,None,562.61,1,4.08,BDBM151826,COCCS(=O)(=O)[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H]1C,IC50,'=',6.68,nM,8.18,,292082,UO_0000065,14.53,0.29,4.1,6.58,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4520788,BAY-294,None,448.59,1,5.58,EUB0000743,CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1,% Control,,100,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507273,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL4742957,,None,465.53,0,3.53,12,CC[C@]1(O)[C@H](O)C[C@H](c2ccncc2NC(=O)c2nc(-c3ncccc3F)ccc2N)C[C@@H]1C,Ki,'=',11,nM,7.96,,,UO_0000065,17.1,0.32,4.43,5.93,0,CHEMBL4723884,Inhibition of PIM2 (unknown origin) using Bad peptide NH2-AGAGRSRHSSYPAGT-OH as substrate measured after 10 mins in presence of ATP by luciferase-luciferin based Kinase-Glo luminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4715870,1,Scientific Literature,J Med Chem,2020,None,TIME = 0.1667 hr
CHEMBL3691964,,None,527.55,1,4.69,BDBM151986,COC(=O)N[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C)cc3F)n2)C[C@@H]1C,IC50,'=',7.47,nM,8.13,,292241,UO_0000065,15.4,0.29,3.44,6.82,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1994526,,None,247.34,0,2.17,SID103904954,CC(N)C1CCC(C(=O)Nc2ccncc2)CC1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1987009,,None,363.44,0,4.23,SID103904702,COc1cccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3891519,,None,368.44,0,4.57,BDBM238417,Cc1cccc(Nc2ccc3cccc(-c4cc5c([nH]4)CCNC5=O)c3n2)c1,IC50,'=',29.2,nM,7.54,,416192,UO_0000065,20.45,0.37,2.96,10.79,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL553,ERLOTINIB,4,393.44,0,3.41,Erlotinib,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,Inhibition,'=',-16,%,,Outside typical range,,UO_0000187,,,,,0,CHEMBL4718881,Inhibition of recombinant full length GST-tagged human PIM2 expressed in baculovirus expression system at 500 nM using Ser/Thr 07 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4715760,1,Scientific Literature,Eur J Med Chem,2016,None,Dose = 500.0 nM | TIME = 1.0 hr
CHEMBL1966279,,None,477.55,0,2.47,SID103905097,NCCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1999112,,None,409.42,0,1.09,SID103905318,CCOC(=O)C1=c2sc(=Cc3ccco3)c(=O)n2C(N)=C(C#N)C1c1ccco1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL4279192,,None,384.53,0,3,2,CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc([C@H]4CC[C@H](C(N)=O)CC4)c23)CC1,Inhibition,'=',-3,%,,,,UO_0000187,,,,,0,CHEMBL4266609,Inhibition of human PIM2 expressed in Escherichia coli at 1 uM relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4265877,1,Scientific Literature,Bioorg Med Chem,2018,None,
CHEMBL1970709,,None,345.2,0,3.65,SID103904666,O=C(NCc1ccc(Br)cc1)Nc1ccc2[nH]ncc2c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1331734,,None,271.34,0,4.07,Cdk4_Inhibitor_II,COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12,Residual Activity,'=',77,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3685738,,None,461.52,0,4.46,BDBM124901,N[C@H]1C[C@@H](CO)CN(c2ccncc2Nc2cccc3ccc(-c4c(F)cccc4F)nc23)C1,IC50,'=',286,nM,6.54,,254203,UO_0000065,14.18,0.26,2.08,7.5,0,CHEMBL3705221,ATP Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 ul per well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3685739,,None,476.53,0,4.66,BDBM124902,CCO[C@@H]1C[C@H](N)CN(c2ccncc2Nc2cccc3cnc(-c4c(F)cccc4F)nc23)C1,IC50,'=',460,nM,6.34,,254204,UO_0000065,13.3,0.25,1.68,7.11,0,CHEMBL3705221,ATP Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 ul per well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3687529,,None,506.6,1,3.99,BDBM151926,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1S(C)(=O)=O,IC50,'=',146.59,nM,6.83,,292181,UO_0000065,13.49,0.27,2.84,5.94,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2048871,,None,361.47,0,2.73,27,CC(C)Oc1cccc(/C=C2\SC(=O)NC2=O)c1N1CCC[C@@H](N)C1,IC50,'=',50,nM,7.3,,,UO_0000065,20.2,0.4,4.57,8.62,0,CHEMBL2049743,Inhibition of human PIM2 using FITC-(AHX)RSRHSSYPAGT-COOH as substrate after 90 mins by mobility shift assay in presence of 5 mM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2046384,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL3912000,,None,379.46,0,2.93,BDBM238783,Cc1nc2cccc(-c3cc4c(n3C)C(CO)NC4=O)c2nc1NC(C)(C)C,IC50,'=',7.8,nM,8.11,,416892,UO_0000065,21.37,0.4,5.18,8.81,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3941161,,None,350.43,0,2.76,BDBM238784,Cc1nc2cccc(-c3cc4n(n3)CCNC4=O)c2nc1NC(C)(C)C,IC50,'=',593,nM,6.23,,416893,UO_0000065,17.77,0.33,3.47,7.35,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4867844,,None,494.05,0,3.38,C7,Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1,Activity,'>',75,%,,,,UO_0000187,,,,,0,CHEMBL4807956,Inhibition of PIM2 (unknown origin) assessed as residual activity measured at 1 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4806967,38,Patent Bioactivity Data,,,None,Dose = 1.0 microM
CHEMBL3973409,,None,295.28,0,2.31,BDBM238607,Cc1nc2cccc(-c3cc4c(=O)[nH]cnc4[nH]3)c2nc1F,IC50,'=',1690,nM,5.77,,416714,UO_0000065,19.55,0.36,3.46,6.61,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3917533,,None,354.41,0,3.89,BDBM238743,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1-c1ccccc1,IC50,'=',82.1,nM,7.09,,416852,UO_0000065,19.99,0.36,3.2,10.03,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3916569,,None,506.61,1,3.98,BDBM238822,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C)c(N[C@@H]5CCC[C@H](NC(=O)OC(C)(C)C)C5)nc34)[nH]c21,IC50,'=',15,nM,7.82,,416931,UO_0000065,15.44,0.29,3.84,6.01,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3950062,,None,311.35,0,3.47,BDBM224945,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(F)n4)c3c2)s1,IC50,'=',557.99,nM,6.25,,393232,UO_0000065,20.08,0.39,2.78,7.77,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3394071,,None,309.36,0,2.31,BDBM50061620,Nc1cncc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)n1,IC50,'=',192.34,nM,6.72,,393233,UO_0000065,21.71,0.42,4.41,5.63,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3929651,,None,359.43,0,3.1,BDBM238647,C#Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC(C)(C)C,IC50,'=',1.45,nM,8.84,,416756,UO_0000065,24.59,0.45,5.74,10.69,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2017327,,None,343.42,0,4.98,10f,c1ccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3ccsc23)cc1,IC50,'=',14,nM,7.85,,,UO_0000065,22.87,0.43,2.87,11.81,0,CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016532,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL2017330,,None,326.36,0,4.02,20a,c1ccc(Nc2nc3c(-c4nnc[nH]4)cccc3n3cccc23)cc1,IC50,'=',30,nM,7.52,,,UO_0000065,23.05,0.41,3.5,10.61,0,CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016532,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL2035631,,None,362.23,0,3.42,6a,O=c1[nH]c(CN2CCCCC2)nc2c1oc1ccc(Br)cc12,IC50,'=',730,nM,6.14,,,UO_0000065,16.94,0.38,2.72,9.88,0,CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034948,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL3965757,,None,435.48,0,4.13,BDBM192642,C[C@@H]1CC[C@H](N)CN1c1ccncc1Nc1ncc2ccc(-c3c(F)cccc3F)nn12,IC50,'=',0.3,nM,9.52,,344683,UO_0000065,21.87,0.41,5.39,11.29,1,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1643772,CRTH2-negative-control,None,494.57,0,2.45,EUB0000334,CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1,% Control,,100,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507290,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL1800285,MSD-M1PAM,None,388.43,0,2.45,EUB0000252,N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1,% Control,,100,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507295,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL304428,,None,393.4,0,4.61,SB-218078,O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1,Residual Activity,'=',-2,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3913792,,None,379.46,0,2.73,BDBM238610,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1OCCC(C)(C)N,IC50,'=',65.3,nM,7.18,,416717,UO_0000065,18.94,0.35,4.46,6.78,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3962883,,None,388.86,0,4.54,BDBM238746,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1-c1ccccc1Cl,IC50,'=',82,nM,7.09,,416855,UO_0000065,18.22,0.35,2.55,10.03,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3960320,,None,347.42,0,3.18,BDBM238501,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1CCC1,IC50,'=',0.8,nM,9.1,,416652,UO_0000065,26.18,0.48,5.92,11,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3959102,,None,363.47,0,3.82,BDBM238629,Cc1nc2cccc(-c3cc4c([nH]3)C[C@@H](C)NC4=O)c2nc1NC(C)(C)C,IC50,'=',3.37,nM,8.47,,416738,UO_0000065,23.31,0.43,4.65,10.24,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL80713,,None,400.48,0,1.82,Cdk2_Inhibitor_III,COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1,Residual Activity,'=',130,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3651905,,None,424.45,0,4.36,BDBM106809,N[C@H]1CCC[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3ccc(O)cc3F)n2)C1,IC50,'=',8,nM,8.1,,225830,UO_0000065,19.08,0.36,3.74,8.01,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3687497,,None,482.47,0,4.28,BDBM151893,C[C@H]1CN(c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1N=[N+]=[N-],IC50,'=',0.74,nM,9.13,,292149,UO_0000065,18.93,0.36,4.85,6.87,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4752776,,None,358.47,0,4.75,11s; SGC-STK17B-1,O=C(O)CSc1ncnc2cc(-c3cc4ccccc4s3)sc12,Kd,'=',1500,nM,5.82,,,UO_0000065,16.25,0.35,1.07,9.23,0,CHEMBL4723775,Binding affinity to human PIM2 assessed as displacement of immobilized ligand by KINOMEscan scanMAX assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4715866,1,Scientific Literature,J Med Chem,2020,None,
CHEMBL4792066,,None,474.53,0,3.94,8,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)sc2N)C[C@@H](O)[C@]1(C)O,Ki,'<',3,nM,,,,UO_0000065,,,,,0,CHEMBL4723884,Inhibition of PIM2 (unknown origin) using Bad peptide NH2-AGAGRSRHSSYPAGT-OH as substrate measured after 10 mins in presence of ATP by luciferase-luciferin based Kinase-Glo luminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4715870,1,Scientific Literature,J Med Chem,2020,None,TIME = 0.1667 hr
CHEMBL4781892,,None,487.48,0,3.23,14,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)ncc2N)C[C@@H](O)[C@@]1(O)CF,Ki,'<',3,nM,,,,UO_0000065,,,,,0,CHEMBL4723884,Inhibition of PIM2 (unknown origin) using Bad peptide NH2-AGAGRSRHSSYPAGT-OH as substrate measured after 10 mins in presence of ATP by luciferase-luciferin based Kinase-Glo luminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4715870,1,Scientific Literature,J Med Chem,2020,None,TIME = 0.1667 hr
CHEMBL3933868,,None,418.46,0,0.71,BDBM249046,OCC(O)c1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CCNCC3)n2)n1,Ki,'=',4.67,nM,8.33,,434250,UO_0000065,19.91,0.37,7.62,6.66,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3900423,,None,374.41,0,0.98,BDBM249056,O=c1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CCNCC3)n2)[nH]1,Ki,'=',17.5,nM,7.76,,434260,UO_0000065,20.72,0.38,6.78,7.41,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3651931,,None,420.49,0,4.47,BDBM106835,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2cccc(-c3cc(O)ccc3F)n2)C1,IC50,'=',6,nM,8.22,,225856,UO_0000065,19.55,0.36,3.75,8.13,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4630644,BAY-386,None,514.53,1,3.27,EUB0000291,O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1,% Control,,100,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507269,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL1965836,,None,442.44,0,4.78,SID103904463,Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(OC(F)(F)F)c4)c3)cc12,Ki,'=',10,nM,8,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3651999,,None,436.46,0,4.43,BDBM106905,CC1CC(c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)ccc2N)=CC(O)C1,IC50,'=',6,nM,8.22,,225926,UO_0000065,18.84,0.35,3.79,8.13,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4741855,,None,471.48,0,4.44,5,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](O)[C@]1(C)O,Ki,'<',3,nM,,,,UO_0000065,,,,,0,CHEMBL4723884,Inhibition of PIM2 (unknown origin) using Bad peptide NH2-AGAGRSRHSSYPAGT-OH as substrate measured after 10 mins in presence of ATP by luciferase-luciferin based Kinase-Glo luminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4715870,1,Scientific Literature,J Med Chem,2020,None,TIME = 0.1667 hr
CHEMBL3651993,,None,426.44,0,4.8,BDBM106899,N[C@H]1CCC[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C1,IC50,'=',5,nM,8.3,,225920,UO_0000065,19.47,0.37,3.5,10.26,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2403108,CERITINIB,4,558.15,2,6.36,LDK378,Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1,Activity,'=',92,%,,,,UO_0000187,,,,,0,CHEMBL4716275,Inhibition of recombinant full length N-terminal GST-tagged human PIM2 expressed in Escherichia coli assessed as residual activity at 1 uM relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4715694,1,Scientific Literature,Bioorg Med Chem,2016,None,Dose = 1.0 microM
CHEMBL4748740,,None,481.58,1,3.87,1; IACS-9439,COc1cc(OCc2ccnc(Nc3cnn(C)c3)n2)cc2sc(N[C@H]3CCCC[C@@H]3O)nc12,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4729068,Inhibition of wild-type human partial length PIM2 (M1 to E291 residues) expressed in bacterial expression system at 1 uM by Kinomescan method,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4725356,1,Scientific Literature,J Med Chem,2020,None,Dose = 1.0 microM
CHEMBL290904,,None,284.34,0,3.13,K00601a,Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1,Thermal melting change,'=',-0.6,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL3927716,,None,383.43,0,2.54,2,Cc1nc2ccc(F)c(-c3cc4c([nH]3)CCNC4=O)c2nc1NC(C)(C)CO,IC50,'=',0.3,nM,9.52,,,UO_0000065,24.84,0.46,6.98,9.25,0,CHEMBL4478465,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as reduction in phosphorylation of biotinylated-BAD peptide at Serine 112 residue preincubated for 30 mins followed by substrate addition for 1 hr by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4477213,1,Scientific Literature,J Med Chem,2016,None,
CHEMBL3979678,,None,365.44,0,2.94,17,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C)c(NC(C)(C)C)nc34)[nH]c21,IC50,'=',0.2,nM,9.7,,,UO_0000065,26.54,0.49,6.76,10.56,0,CHEMBL4478465,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as reduction in phosphorylation of biotinylated-BAD peptide at Serine 112 residue preincubated for 30 mins followed by substrate addition for 1 hr by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4477213,1,Scientific Literature,J Med Chem,2016,None,
CHEMBL3330401,,None,436.49,0,3.2,63,COC(C(=O)Nc1ccc2[nH]nc(-c3cccc(S(N)(=O)=O)c3)c2c1)c1ccccc1,Inhibition,'=',-4,%,,,,UO_0000187,,,,,0,CHEMBL3369104,Inhibition of human Pim-2 at 1 uM by radiometric Assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352261,1,Scientific Literature,Bioorg Med Chem,2014,None,
CHEMBL3354520,,None,396.44,0,4.16,4b,Fc1cccc(F)c1-c1cccc(CNc2cnccc2OC2CCNCC2)n1,IC50,'=',4200,nM,5.38,,,UO_0000065,13.56,0.25,1.22,9.1,0,CHEMBL3376647,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352230,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL572815,,None,349.46,0,4.17,14g,Cc1ccccc1-c1ccc2sc3c(=O)[nH]c(CN(C)C)nc3c2c1,Ki,'=',32,nM,7.5,,,UO_0000065,21.45,0.41,3.32,15.3,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL4445670,BAY-885,None,515.54,1,3.28,EUB0000250,CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1,% Control,,100,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507268,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL3901766,,None,363.47,0,3.54,BDBM238573,CCN(c1cnc2cccc(-c3cc4c([nH]3)CCNC4=O)c2n1)C(C)(C)C,IC50,'=',0.1,nM,10,,416695,UO_0000065,27.51,0.51,6.46,13.53,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3985398,,None,349.44,0,3.15,BDBM238568,CN(c1cnc2cccc(-c3cc4c([nH]3)CCNC4=O)c2n1)C(C)(C)C,IC50,'=',0.7,nM,9.15,,416690,UO_0000065,26.2,0.48,6,12.39,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3354519,,None,378.45,0,4.03,4a,Fc1ccccc1-c1cccc(CNc2cnccc2OC2CCNCC2)n1,IC50,'=',3600,nM,5.44,,,UO_0000065,14.38,0.27,1.41,9.22,0,CHEMBL3376647,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352230,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL4796578,,None,324.79,0,2.36,26,Cc1cn([C@@H](C)[C@@]2(F)CCNC2)c2nc(C(N)=O)cc(Cl)c12,IC50,'=',160,nM,6.8,,,UO_0000065,20.92,0.42,4.44,9.32,0,CHEMBL4704282,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4699590,1,Scientific Literature,Bioorg Med Chem Lett,2020,None,
CHEMBL244948,DAPHNETIN,None,178.14,0,1.2,K00057,O=c1ccc2ccc(O)c(O)c2o1,Thermal melting change,'=',0.7,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL3691955,,None,607.64,2,5.04,BDBM151977,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(OC4CCOCC4)cc3F)n2)C[C@@H](N)[C@H]1n1ccnn1,IC50,'=',10.18,nM,7.99,,292232,UO_0000065,13.15,0.25,2.95,6.14,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3703178,,None,302.4,0,2.45,BDBM149686,CSc1ncc2c(n1)-c1c(c(C(N)=O)cn1C(C)C)CC2,IC50,'=',24,nM,7.62,,288344,UO_0000065,25.2,0.5,5.17,10.32,0,CHEMBL3707582,Kinase Inhibition Assay: The buffer for PIM-2 assay was composed of HEPES 50 mM,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3687521,,None,573.67,1,4.4,BDBM151917,CC(C)NC(=O)c1ccc(F)c(-c2ccc(N)c(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@@H](OCCC#N)[C@@H](C)C3)n2)c1,IC50,'=',0.74,nM,9.13,,292173,UO_0000065,15.92,0.3,4.73,5.4,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4113485,,None,377.41,0,2.22,BDBM224845,Nc1nnc(-c2ccc3[nH]cc(-c4nccc(N5CCC[C@@H](O)C5)n4)c3c2)o1,IC50,'=',7.727,nM,8.11,,393127,UO_0000065,21.49,0.4,5.89,6.24,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL143054,,None,293.35,0,0,K00080,N=C(N)NCCNS(=O)(=O)c1cccc2cnccc12,Thermal melting change,'=',0.6,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL4247704,,None,410.48,0,4.63,7g,CC(C)CN(C(=O)c1cccnc1)c1c2ccccc2c(=O)n2c1[nH]c1ccccc12,Kd,'>=',5000,nM,,,,UO_0000065,,,,,0,CHEMBL4233029,Binding affinity to human PIM2 (M1 to E291 residues) expressed in bacterial expression system by KINOMEscan assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4229410,1,Scientific Literature,Bioorg Med Chem,2018,None,
CHEMBL3703187,,None,343.46,0,2.39,BDBM149695,CSc1ncc2ccc3c(C(N)=O)cn(CC(C)(C)CN)c3c2n1,IC50,'=',34,nM,7.47,,288353,UO_0000065,21.74,0.42,5.08,7.48,0,CHEMBL3707582,Kinase Inhibition Assay: The buffer for PIM-2 assay was composed of HEPES 50 mM,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3951344,,None,352.37,0,4.39,BDBM224820,CC(C)Oc1cc(F)cc(-c2c[nH]c3ccc(-c4nnc(N)o4)cc23)c1,IC50,'=',184.89,nM,6.73,,393102,UO_0000065,19.11,0.35,2.34,7.48,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3394067,,None,378.46,0,3.17,BDBM50061628,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(N5CCOCC5)n4)c3c2)s1,IC50,'=',729.8,nM,6.14,,393236,UO_0000065,16.22,0.31,2.97,6.6,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3921064,,None,420.47,0,4.35,8a,N[C@H]1CCCN(c2ccccc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1,IC50,'=',6.5,nM,8.19,,,UO_0000065,19.47,0.36,3.84,11.45,0,CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3864151,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL3922724,,None,388.82,0,4.58,BDBM224859,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(-c5ccc(Cl)cc5)n4)c3c2)o1,IC50,'=',25.15,nM,7.6,,393137,UO_0000065,19.54,0.37,3.02,7.13,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3948310,,None,405.5,0,4.13,BDBM238824,CC[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C5CC5)c(NC(C)(C)C)nc34)[nH]c21,IC50,'=',0.7,nM,9.15,,416933,UO_0000065,22.58,0.42,5.02,9.97,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3917311,,None,361.41,0,3.61,BDBM225042,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(NC5CCCC5)n4)c3c2)o1,IC50,'=',1.997,nM,8.7,,393028,UO_0000065,24.07,0.44,5.09,7.34,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3687472,,None,484.52,0,4.98,BDBM151868,CO[C@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C)cc3F)n2)C[C@@H]1C,IC50,'=',2.9,nM,8.54,,292124,UO_0000065,17.62,0.33,3.56,9.47,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3652000,,None,393.54,0,4.34,10,Nc1ccc(C2CCCCC2)nc1C(=O)Nc1cnccc1[C@@H]1CCC[C@H](N)C1,Ki,'=',23,nM,7.64,,,UO_0000065,19.41,0.36,3.3,7.14,0,CHEMBL3750240,Inhibition of PIM2 kinase (unknown origin) using NH2-AGAGRSRHSSYPAGT-OH as substrate by kinase-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3745712,1,Scientific Literature,J Med Chem,2015,None,
CHEMBL3651923,,None,454.5,1,5.35,BDBM106827,Cc1ccc(F)c(-c2nc(C(=O)Nc3cnccc3[C@@H]3C[C@H](C)C[C@H](N)C3)ccc2F)c1F,IC50,'=',3,nM,8.52,,225848,UO_0000065,18.75,0.35,3.17,10.54,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3651968,,None,440.47,1,5.04,BDBM106872,C[C@H]1C[C@@H](N)C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C1,IC50,'=',522,nM,6.28,,225893,UO_0000065,14.26,0.27,1.24,7.77,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3687460,,None,458.53,0,4.59,BDBM151856,CO[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C[C@@H]1C,IC50,'=',17.07,nM,7.77,,292112,UO_0000065,16.94,0.33,3.18,8.62,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3963322,,None,379.45,0,2.56,BDBM224932,Nc1nnc(-c2ccc3[nH]cc(-c4cnc(N5CCOCC5)cn4)c3c2)s1,IC50,'=',2404.78,nM,5.62,,393215,UO_0000065,14.81,0.28,3.06,5.31,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1972142,,None,327.39,0,4.16,SID103904567,O=C(NCc1ccccc1)c1cccc(-c2cnc3[nH]ccc3c2)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL289959,,None,221.26,0,3.37,SID103905123,c1ccc(Nc2ncnc3ccccc23)cc1,Ki,'=',1584.89,nM,5.8,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3105021,,None,472.47,0,2.54,BDBM106803,C[C@H]1CN(c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)c(F)cc2N)C[C@@H](N)[C@@H]1O,IC50,'=',1,nM,9,,225824,UO_0000065,19.05,0.36,6.46,6.9,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4765208,,None,324.79,0,2.36,25,Cc1cn([C@H](C)[C@@]2(F)CCNC2)c2nc(C(N)=O)cc(Cl)c12,IC50,'=',1780,nM,5.75,,,UO_0000065,17.7,0.36,3.39,7.88,0,CHEMBL4704282,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4699590,1,Scientific Literature,Bioorg Med Chem Lett,2020,None,
CHEMBL3905144,,None,349.39,0,2.28,BDBM238701,Cc1nc2cccc(-c3cc4c([nH]3)C(CO)NC4=O)c2nc1NC1CC1,IC50,'=',0.212,nM,9.67,,416810,UO_0000065,27.69,0.51,7.39,9.4,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3954897,,None,335.37,0,3.65,BDBM224871,CC(C)Oc1cccc(-c2c[nH]c3ccc(-c4nnc(N)o4)nc23)c1,IC50,'=',243.69,nM,6.61,,393149,UO_0000065,19.72,0.36,2.96,6.43,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1909349,GSK-1007102B,None,561.52,0,2.28,GSK1007102B,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F,Inhibition,'=',2.45,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1375640,,None,332.82,0,3.72,SID103905409,Cc1nc(COc2ccccc2Cl)sc1-c1ccnc(N)n1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1789961,GW513184X,None,360.38,0,2.98,GW513184X,COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O,Inhibition,'=',-0.02,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL4757567,,None,482.55,0,4.61,OX0999,CN1CCC(CNC2=NC(=O)/C(=C/c3csc(-c4ccc(OC(F)(F)F)cc4)n3)S2)CC1,IC50,'=',86,nM,7.07,,,UO_0000065,14.64,0.3,2.46,10.57,0,CHEMBL4687873,Inhibition of human PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4680285,1,Scientific Literature,Bioorg Med Chem,2020,None,
CHEMBL1562756,,None,279.79,1,5.11,SID103905421,CC1(C)CC2=Nc3cc(Cl)ccc3SC2=C(O)C1,Ki,'=',1258.93,nM,5.9,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3651977,,None,426.44,0,4.8,BDBM106881,N[C@H]1CCC[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3cc(F)ccc3F)n2)C1,IC50,'=',25,nM,7.6,,225902,UO_0000065,17.83,0.33,2.8,9.4,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3902148,,None,383.43,0,3.08,18,C[C@H]1NC(=O)c2cc(-c3c(F)ccc4c(=O)n(C)c(NC(C)(C)C)nc34)[nH]c21,IC50,'=',0.1,nM,10,,,UO_0000065,26.08,0.49,6.92,10.89,0,CHEMBL4478465,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as reduction in phosphorylation of biotinylated-BAD peptide at Serine 112 residue preincubated for 30 mins followed by substrate addition for 1 hr by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4477213,1,Scientific Literature,J Med Chem,2016,None,
CHEMBL2377707,,None,272.31,0,2.37,25,CCCc1c(C(=O)OC)[nH]c2c(N)cc3cn[nH]c3c12,Inhibition,'=',105,%,,,,UO_0000187,,,,,0,CHEMBL2378598,Inhibition of human full length Pim-2 using RSRHSSYPAGT as substrate assessed as residual activity at 1 uM after 30 mins in presence of [gamma-33P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2375344,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL2377711,,None,306.32,0,4.18,10,CCc1[nH]c2c([N+](=O)[O-])cc3cn[nH]c3c2c1-c1ccccc1,Inhibition,'=',77,%,,,,UO_0000187,,,,,0,CHEMBL2378598,Inhibition of human full length Pim-2 using RSRHSSYPAGT as substrate assessed as residual activity at 1 uM after 30 mins in presence of [gamma-33P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2375344,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL2377705,,None,258.28,0,2.11,23,CCOC(=O)c1[nH]c2c(N)cc3cn[nH]c3c2c1C,Inhibition,'=',97,%,,,,UO_0000187,,,,,0,CHEMBL2378599,Inhibition of human full length Pim-2 using RSRHSSYPAGT as substrate assessed as residual activity at 10 uM after 30 mins in presence of [gamma-33P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2375344,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL1230609,FORETINIB,2,632.66,2,5.77,Foretinib,COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL2133806,JNJ-38877605,1,377.36,0,3.21,JNJ-38877605,Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL2079588,TELATINIB,2,409.83,0,3.95,Telatinib,CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL2103839,RIDAFOROLIMUS,3,990.22,3,7.74,Deforolimus,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3660016,,None,331.38,0,2.69,BDBM104134,c1cc(O[C@@H]2CCNC2)c2nc(-c3nnc4ccccn34)ccc2c1,IC50,'=',2470,nM,5.61,,222551,UO_0000065,16.92,0.31,2.92,8.72,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3974432,,None,409.54,0,4.31,BDBM224976,CSc1nnc(-c2ccc3[nH]cc(-c4cccc(N5CCOCC5)n4)c3c2)s1,IC50,'=',2818.32,nM,5.55,,393266,UO_0000065,13.55,0.27,1.24,8.29,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3687493,,None,523.56,2,5.26,BDBM151889,Cc1cc(F)c(-c2nc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@@H](OCCC#N)[C@@H](C)C3)ccc2F)c(F)c1,IC50,'=',0.63,nM,9.2,,292145,UO_0000065,17.57,0.33,3.94,8.08,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3137336,UPROSERTIB,2,429.25,0,3.56,Uprosertib,Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3948887,,None,462.55,0,3.64,BDBM238422,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@H]1CCN(C(=O)OC(C)(C)C)C1,IC50,'=',144,nM,6.84,,416620,UO_0000065,14.79,0.27,3.2,6.1,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2035629,,None,529.82,2,5.57,5l,O=C(CCN1CCCCC1)Nc1ccc(-c2nc3c(oc4ccc(Br)cc43)c(=O)[nH]2)c(Cl)c1,IC50,'=',68,nM,7.17,,,UO_0000065,13.53,0.3,1.6,7.86,0,CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034948,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL1909386,GW566221A,None,565.1,2,5.35,GW566221A,CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl,Inhibition,'=',0.48,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL2035636,,None,403.28,0,2.71,6g,CN1C[C@@H]2CC[C@H]1CN2Cc1nc2c(oc3ccc(Br)cc32)c(=O)[nH]1,IC50,'=',162,nM,6.79,,,UO_0000065,16.84,0.37,4.08,10.39,0,CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034948,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL463931,GSK-2163632A,None,548.67,1,4.19,GSK2163632A,COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C,Inhibition,'=',11.95,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL2035605,,None,326.74,0,4,4d,COc1ccc2oc3c(=O)[nH]c(-c4ccccc4Cl)nc3c2c1,IC50,'=',1451,nM,5.84,,,UO_0000065,17.87,0.35,1.84,8.57,0,CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034948,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL1945338,,None,308.17,0,3.6,6,CC1(C)NC(=O)c2[nH]c3c(Cl)c(Cl)ccc3c2C1C#N,Delta Tm,'=',2.3,degrees C,,,,UO_0000027,,,,,0,CHEMBL1947284,Binding affinity to PIM2 assessed as change in thermal denaturation at 10 uM by thermal stability shift assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1944596,1,Scientific Literature,J Med Chem,2012,None,
CHEMBL3660079,,None,434.48,0,2.61,BDBM104206,NC(=O)CN1CCC(F)(COc2cccc3ccc(-c4nnc5ccccn45)nc23)CC1,IC50,'=',193,nM,6.71,,222619,UO_0000065,15.45,0.29,4.1,6.81,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3660040,,None,389.5,0,4.48,BDBM104158,CCCC(Oc1cccc2ccc(-c3nnc4ccccn34)nc12)[C@H](CC)CN,IC50,'=',1359,nM,5.87,,222575,UO_0000065,15.06,0.28,1.39,7.49,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3660072,,None,355.36,0,3.11,BDBM104199,Nc1nccc(Oc2cccc3ccc(-c4nnc5ccccn45)nc23)n1,IC50,'=',10000,nM,5,,222612,UO_0000065,14.07,0.25,1.89,4.8,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3660074,,None,442.29,0,3.79,BDBM104201,FC1CNCCC1Oc1cccc2ccc(-c3nnc4ccc(Br)cn34)nc12,IC50,'=',1278,nM,5.89,,222614,UO_0000065,13.32,0.29,2.1,9.16,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL4102376,,None,326.83,0,3.3,2,Cn1c(-c2ccc(N3CCNCC3)cc2)cc2c(Cl)ccnc21,IC50,'>',30000,nM,,,,UO_0000065,,,,,0,CHEMBL4047686,Inhibition of PIM2 (unknown origin) assessed as reduction in full length human BAD phosphorylation at Ser112 residues by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4043256,1,Scientific Literature,Bioorg Med Chem Lett,2017,None,
CHEMBL4065485,,None,557.14,2,5.14,14,CN1CCC(NC(=O)c2ccc(-c3c(-c4ccc(N5CCN(C)CC5)cc4)n(C)c4nccc(Cl)c34)cc2)CC1,IC50,'=',872,nM,6.06,,,UO_0000065,10.88,0.21,0.92,10.7,0,CHEMBL4047686,Inhibition of PIM2 (unknown origin) assessed as reduction in full length human BAD phosphorylation at Ser112 residues by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4043256,1,Scientific Literature,Bioorg Med Chem Lett,2017,None,
CHEMBL1975233,,None,317.74,0,2.96,SID103904892,COc1cc(C)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1,Ki,'>',1258.93,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1985406,,None,315.32,0,4.25,SID103905036,CCCC(=O)Nc1n[nH]c2ccc(-c3cccc(F)c3F)cc12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL525385,,None,1571.87,None,None,22,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2037134,,None,345.35,0,4.16,6,CN1C(=O)/C(=C/c2ccc(-c3cccc(C(=O)O)c3)o2)c2ccccc21,IC50,,,,,,Not Determined,,,,,,0,CHEMBL2038829,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034977,1,Scientific Literature,ACS Med Chem Lett,2012,None,
CHEMBL573478,,None,358.81,0,4.08,7,O=c1[nH]c(COc2cccc(O)c2)nc2c1sc1ccc(Cl)cc12,Ki,'=',410,nM,6.39,,,UO_0000065,17.8,0.36,2.31,8.49,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL575470,,None,338.23,0,2.96,8,CN(C)Cc1nc2c(sc3ccc(Br)cc32)c(=O)[nH]1,Ki,'=',16,nM,7.8,,,UO_0000065,23.05,0.56,4.84,15.91,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL4080621,,None,432.96,0,4.46,23,Cn1c(-c2ccc(N3CCNCC3)cc2)c(-c2ccc(CO)cc2)c2c(Cl)ccnc21,IC50,'=',13800,nM,4.86,,,UO_0000065,11.23,0.21,0.4,9.12,0,CHEMBL4047686,Inhibition of PIM2 (unknown origin) assessed as reduction in full length human BAD phosphorylation at Ser112 residues by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4043256,1,Scientific Literature,Bioorg Med Chem Lett,2017,None,
CHEMBL4130071,,None,438.45,1,5.44,32,FC(F)(F)c1ccc(-c2c[nH]c3ccc(-c4cncc(OC5CCNCC5)n4)cc23)cc1,IC50,'=',4350,nM,5.36,,,UO_0000065,12.23,0.23,-0.08,8.53,0,CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4118246,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL3956489,,None,435.48,0,4.13,BDBM192632,C[C@H]1[C@@H](N)CCCN1c1ccncc1Nc1ncc2ccc(-c3c(F)cccc3F)nn12,IC50,'=',231,nM,6.64,,344654,UO_0000065,15.24,0.28,2.51,7.87,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4127463,,None,439.49,1,5.31,35,CN(C)CCN(C)c1cncc(-c2ccc3[nH]cc(-c4ccc(C(F)(F)F)cc4)c3c2)n1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4118246,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL3905239,,None,404.45,0,3,BDBM192545,N[C@H]1CCCN(c2ccncc2Nc2ncc3ccc(-c4cccnc4F)nn23)C1,IC50,'=',12,nM,7.92,,344537,UO_0000065,19.58,0.36,4.92,8.14,1,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2377713,,None,230.18,0,1.76,12,O=Cc1c[nH]c2c([N+](=O)[O-])cc3cn[nH]c3c12,Inhibition,'=',70,%,,,,UO_0000187,,,,,0,CHEMBL2378599,Inhibition of human full length Pim-2 using RSRHSSYPAGT as substrate assessed as residual activity at 10 uM after 30 mins in presence of [gamma-33P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2375344,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL1909361,GW830365A,None,576.12,1,2.99,GW830365A,CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl,Inhibition,'=',0.65,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL66292,PYRAZOLOPYRIMIDINE 2,None,422.47,0,2.67,GW811168X,COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1,Inhibition,'=',-2.5,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL189459,GW833373X,None,396.43,1,5.04,GW833373X,Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1,Inhibition,'=',0.72,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL223257,,None,463.88,0,2.32,SID103905153,N#Cc1ncc2nc1OCCCCCOc1cc(OCC(O)CO)c(Cl)cc1NC(=O)N2,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2377722,,None,276.34,0,3.86,21,CCc1[nH]c2c(N)cc3cn[nH]c3c2c1-c1ccccc1,Inhibition,'=',91,%,,,,UO_0000187,,,,,0,CHEMBL2378598,Inhibition of human full length Pim-2 using RSRHSSYPAGT as substrate assessed as residual activity at 1 uM after 30 mins in presence of [gamma-33P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2375344,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL4128926,,None,583.78,2,5.76,1j,CC(C)(C)NS(=O)(=O)c1ccc(-c2sc(C(=O)N[C@H]3C[C@H](C(=O)O)C3)nc2CC2CCCCC2)c2ccccc12,Inhibition,'=',4,%,,,,UO_0000187,,,,,0,CHEMBL4121556,Inhibition of recombinant full length GST-tagged human PIM2 expressed in baculovirus expression system at 10 uM in presence of ATP relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4118122,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL4128205,,None,393.44,0,4.54,47,CN(C)CCNc1cncc(-c2ccc3[nH]cc(-c4cccc(F)c4F)c3c2)n1,IC50,'=',645,nM,6.19,,,UO_0000065,15.73,0.29,1.65,10.89,0,CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4118246,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL1983923,,None,375.48,0,3.17,SID103905558,Cc1cc(Nc2cc(N3CCN(C)CC3)nc(C=Cc3ccccc3)n2)n[nH]1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1982122,,None,361.47,0,4.89,SID103904560,OCCC(Nc1nc2ccc(-c3ccncc3)cc2s1)c1ccccc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2000801,,None,431.41,1,6.77,SID103904379,O=C(Nc1ccc(-c2cccc3sncc23)cc1)Nc1ccc(F)c(C(F)(F)F)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL467581,GSK-2219385A,None,520.57,1,3.52,GSK2219385A,COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1,Inhibition,'=',-2.78,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL505187,GSK-718429A,None,528.62,2,7.34,GSK718429A,CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1,Inhibition,'=',0.13,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL209534,,None,297.32,0,1.26,SID103904794,CCOc1nc(C(=O)NCc2cccnc2)cc(N)c1C#N,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1086939,,None,345.78,0,3.86,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2006493,,None,282.22,0,3.33,SID103905619,O=C1CCCc2oc3cc(C(F)(F)F)ccc3c(=O)c21,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL413460,,None,1677.98,None,None,26,N=C(N)NCCC[C@@H](NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)NC(=O)CCCCCNCCNS(=O)(=O)c1cccc2cnccc12,Activity,'=',9,%,,,,UO_0000187,,,,,0,CHEMBL856384,Percent residual activity,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2005475,,None,339.46,0,4.6,SID103904997,O=C(NCC1CCCCC1)c1cc2c(-c3ccccc3)n[nH]c2s1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL584563,,None,355.49,0,4.24,15d,Cc1cscc1-c1ccc2sc3c(=O)[nH]c(CN(C)C)nc3c2c1,Ki,'=',7,nM,8.15,,,UO_0000065,22.94,0.46,3.91,16.65,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL576388,,None,408.53,0,3.59,18b,CN(C)Cc1nc2c(sc3ccc(-c4ccc(OCCCN)cc4)cc32)c(=O)[nH]1,Ki,'=',6,nM,8.22,,,UO_0000065,20.13,0.39,4.63,9.76,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL573463,,None,367.47,0,3.13,20e,O=c1[nH]c(CN2CC[C@H](O)C2)nc2c1sc1ccc(/C=C/C3CC3)cc12,Ki,'=',0.9,nM,9.05,,,UO_0000065,24.62,0.48,5.92,13.07,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL575263,,None,341.46,0,3.93,15a,CN(C)Cc1nc2c(sc3ccc(-c4ccsc4)cc32)c(=O)[nH]1,Ki,'=',2,nM,8.7,,,UO_0000065,25.48,0.52,4.77,17.76,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL233001,GW620972X,None,332.43,0,4.9,GW620972X,N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2,Inhibition,'=',-0.34,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1915634,,None,370.39,0,4.76,15h,Cc1cc(F)ccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12,IC50,'=',8,nM,8.1,,,UO_0000065,21.86,0.39,3.34,10.2,0,CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914433,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL427058,GSK-466317A,None,448.83,0,4.75,GSK466317A,CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1,Inhibition,'=',0.31,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1915443,,None,352.4,0,4.62,14p,Cc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12,IC50,'=',6,nM,8.22,,,UO_0000065,23.33,0.42,3.6,10.36,0,CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914433,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL1086669,,None,299.71,0,3.56,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1909360,GW830263A,None,665.22,1,4.56,GW830263A,CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl,Inhibition,'=',-0.35,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1086795,,None,312.76,0,2.86,11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1910905,,None,355.45,0,3.7,27,c1cnc(-c2ccc3[nH]cc(-c4ccc(N5CCNCC5)cc4)c3c2)cn1,IC50,'=',13600,nM,4.87,,,UO_0000065,13.69,0.25,1.17,8.56,0,CHEMBL1912526,Inhibition of PIM2 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1909629,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL585182,,None,351.43,0,3.57,14j,CN(C)Cc1nc2c(sc3ccc(-c4ccc(O)cc4)cc32)c(=O)[nH]1,Ki,'=',3,nM,8.52,,,UO_0000065,24.25,0.47,4.95,12.31,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL1915637,,None,386.39,0,4.46,15k,COc1cccc(F)c1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12,IC50,'=',12,nM,7.92,,,UO_0000065,20.5,0.37,3.46,8.94,0,CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914433,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL1915645,,None,392.85,0,4.55,17c,CNC(=O)c1cccc2c1nc(Nc1cccc(OC)c1Cl)c1ccncc12,IC50,'=',5,nM,8.3,,,UO_0000065,21.13,0.4,3.75,10.9,0,CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914433,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL1915648,,None,404.9,1,5.57,17f,CC(C)CNC(=O)c1cccc2c1nc(Nc1ccccc1Cl)c1ccncc12,IC50,'=',5,nM,8.3,,,UO_0000065,20.5,0.39,2.73,12.41,0,CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914433,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL1910903,,None,354.46,0,4.31,25,c1cc(-c2ccc3[nH]cc(-c4ccc(N5CCNCC5)cc4)c3c2)ccn1,IC50,'>',25000,nM,,,,UO_0000065,,,,,0,CHEMBL1912526,Inhibition of PIM2 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1909629,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL573046,,None,342.47,0,3.19,17b,CN(C)Cc1nc2c(sc3ccc(N4CCCCC4)cc32)c(=O)[nH]1,Ki,'=',120,nM,6.92,,,UO_0000065,20.21,0.39,3.73,13.25,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL2218930,,None,473.55,1,5.48,PDGF_RTK_Inhibitor,COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC,Residual Activity,'=',97,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL83980,BOHEMINE,None,340.43,0,2.81,Bohemine,CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21,Residual Activity,'=',134,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL221271,,None,318.25,0,1.28,ERK_Inhibitor_III,N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1,Residual Activity,'=',116,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2218932,,None,340.59,0,4.85,PKR_Inhibitor_Negative_Control,O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1,Residual Activity,'=',3,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL608533,MIDOSTAURIN,4,570.65,2,5.91,PKC_412,CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,Residual Activity,'=',94,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL77456,TYRPHOSTIN 1,None,184.2,0,2.13,Tyrphostin_A1,COc1ccc(C=C(C#N)C#N)cc1,Residual Activity,'=',125,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL261131,DIACYLGLYCEROL KINASE INHIBITOR II,None,489.59,1,5.94,R-59949,O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1,Residual Activity,'=',75,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL76589,,None,236.23,0,1.56,Tyrphostin AG-112,N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1,Residual Activity,'=',104,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL583972,,None,234.26,0,3.61,A,O=Cc1c[nH]c2c1ccc1c3ccccc3[nH]c12,IC50,'=',510,nM,6.29,,,UO_0000065,26.86,0.48,2.68,12.93,1,CHEMBL2090488,Inhibition of human Pim2 using RSRHSSYPAGT as substrate,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2086229,1,Scientific Literature,Eur J Med Chem,2012,None,
CHEMBL1909364,GW589961A,None,488.33,1,5.83,GW589961A,COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl,Inhibition,'=',-0.32,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3956364,,None,390.45,0,3.8,BDBM225025,CC(C)Nc1nnc(-c2ccc3[nH]cc(-c4cccc(C(=O)N(C)C)n4)c3c2)o1,IC50,'=',541,nM,6.27,,393315,UO_0000065,16.05,0.3,2.47,6.27,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1785004,,None,451.45,1,5.14,SB-253228,Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1,Inhibition,'=',-3.98,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL4476513,,None,464.57,0,2.74,22,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C[C@@H]5CN(C)CCO5)c(NC(C)(C)C)nc34)[nH]c21,IC50,'=',0.41,nM,9.39,,,UO_0000065,20.21,0.38,6.65,9,0,CHEMBL4370146,Inhibition of full length recombinant PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues preincubated for 30 mins followed by biotinylated BAD addition and measured after 1 hr by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4368910,1,Scientific Literature,J Med Chem,2019,None,
CHEMBL4592872,BAY-897,None,457.48,1,6.33,EUB0000340,O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1,% Control,,93,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507317,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL3298819,,None,383.47,0,3.67,13d,O=C(CC1CNC(=O)c2cc(-c3ccccc3F)cn21)NCC1CCCCC1,IC50,'=',3120,nM,5.51,,,UO_0000065,14.36,0.27,1.84,8.72,0,CHEMBL3300844,Inhibition of human PIM2 using ARK-RERTYSFGHHA as substrate incubated for 60 mins prior to substrate addition by topcount scintillation counting analysis in presence of [P33gamma]-ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3297733,1,Scientific Literature,Bioorg Med Chem,2013,None,
CHEMBL3298821,,None,401.46,0,3.8,13f,O=C(CC1CNC(=O)c2cc(-c3ccc(F)c(F)c3)cn21)NCC1CCCCC1,IC50,'=',4470,nM,5.35,,,UO_0000065,13.33,0.25,1.55,8.47,0,CHEMBL3300844,Inhibition of human PIM2 using ARK-RERTYSFGHHA as substrate incubated for 60 mins prior to substrate addition by topcount scintillation counting analysis in presence of [P33gamma]-ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3297733,1,Scientific Literature,Bioorg Med Chem,2013,None,
CHEMBL3298822,,None,401.9,0,2.97,13g,O=C(CC1CNC(=O)c2cc(-c3ccnc(Cl)n3)cn21)NCC1CCCCC1,IC50,'=',1315,nM,5.88,,,UO_0000065,14.63,0.29,2.91,6.61,0,CHEMBL3300844,Inhibition of human PIM2 using ARK-RERTYSFGHHA as substrate incubated for 60 mins prior to substrate addition by topcount scintillation counting analysis in presence of [P33gamma]-ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3297733,1,Scientific Literature,Bioorg Med Chem,2013,None,
CHEMBL3298886,,None,383.83,0,3.39,13j,O=C(CC1CNC(=O)c2cc(-c3cccc(Cl)c3)cn21)NCc1ccco1,IC50,'=',980,nM,6.01,,,UO_0000065,15.65,0.3,2.62,7.88,0,CHEMBL3300844,Inhibition of human PIM2 using ARK-RERTYSFGHHA as substrate incubated for 60 mins prior to substrate addition by topcount scintillation counting analysis in presence of [P33gamma]-ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3297733,1,Scientific Literature,Bioorg Med Chem,2013,None,
CHEMBL3298891,,None,406.46,0,2.79,14c,NC[C@@H](NC(=O)C[C@H]1CNC(=O)c2cc(-c3cccc(F)c3)cn21)c1ccccc1,IC50,'=',184,nM,6.74,,,UO_0000065,16.57,0.31,3.95,7.55,0,CHEMBL3300844,Inhibition of human PIM2 using ARK-RERTYSFGHHA as substrate incubated for 60 mins prior to substrate addition by topcount scintillation counting analysis in presence of [P33gamma]-ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3297733,1,Scientific Literature,Bioorg Med Chem,2013,None,
CHEMBL3651904,,None,424.45,0,4.36,BDBM106808,N[C@H]1CCC[C@@H](c2ccncc2NC(=O)c2cccc(-c3c(F)cc(O)cc3F)n2)C1,IC50,'=',4,nM,8.4,,225829,UO_0000065,19.79,0.37,4.04,8.3,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL212250,GW615311X,None,644.12,2,8,GW615311X,O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1,Inhibition,'=',0.88,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL511765,GSK-2213727A,None,506.54,1,3.5,GSK2213727A,COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1,Inhibition,'=',2.33,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL67241,GW794607X,None,372.44,0,3.48,GW794607X,CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1,Inhibition,'=',1.23,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3297760,,None,446.53,0,3.48,14h,CN1CCN(C(=O)C[C@H]2CNC(=O)c3cc(-c4cccc(F)c4)cn32)[C@@H](c2ccccc2)C1,IC50,'=',956,nM,6.02,,,UO_0000065,13.48,0.25,2.54,10.45,0,CHEMBL3300844,Inhibition of human PIM2 using ARK-RERTYSFGHHA as substrate incubated for 60 mins prior to substrate addition by topcount scintillation counting analysis in presence of [P33gamma]-ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3297733,1,Scientific Literature,Bioorg Med Chem,2013,None,
CHEMBL3393714,,None,401.47,0,2.94,18g,Cn1cncc1-c1ccc2[nH]nc(-c3cncc(O[C@H]4CNCCC45CC5)n3)c2c1,IC50,'=',58,nM,7.24,,,UO_0000065,18.03,0.33,4.3,7.74,0,CHEMBL3396420,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as phosphorylation of biotinylated-BAD peptide at Serine 112 residue,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3392976,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL176857,GW442130X,None,502.16,2,5.48,GW442130X,COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O,Inhibition,'=',0.1,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL573462,,None,334.83,0,2.54,6c,O=c1[nH]c(CN2CCCNC2)nc2c1sc1ccc(Cl)cc12,Ki,'=',138,nM,6.86,,,UO_0000065,20.49,0.43,4.32,11.24,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL1230020,PLX-4720,None,413.83,0,3.88,PLX-4720,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL3639862,,None,548.59,1,3.43,BDBM151821,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1S(=O)(=O)CCO,IC50,'=',3.56,nM,8.45,,292077,UO_0000065,15.4,0.3,5.02,6.25,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1909377,,None,341.8,0,3.29,SB-400868-A,Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1,Inhibition,'=',0.83,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3691916,,None,581.6,1,4.51,BDBM151938,COCCOc1cc(F)c(-c2nc(C(=O)Nc3cnccc3C3C[C@@H](N)[C@@H](n4ccnn4)[C@@H](C)C3)ccc2F)c(F)c1,IC50,'=',1.45,nM,8.84,,292193,UO_0000065,15.2,0.29,4.33,6.8,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL485745,GW434756X,None,289.31,0,4.2,GW434756X,Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1,Inhibition,'=',-0.3,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL188048,,None,216.2,0,0.6,SB-736290,Cn1c(-c2nonc2N)nc2cnccc21,Inhibition,'=',1.87,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL258844,,None,551.65,2,6.32,Akti_1_2,O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1,Residual Activity,'=',85,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL391586,,None,367.2,0,4.05,1,N#Cc1c(-c2ccccc2)cc(-c2cc(Br)ccc2O)[nH]c1=O,IC50,'>',20000,nM,,,,UO_0000065,,,,,0,CHEMBL903377,Inhibition of Pim2 kinase,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139114,1,Scientific Literature,Bioorg Med Chem Lett,2007,None,
CHEMBL2325906,,None,297.36,0,2.5,3h,C[C@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(C)(C)C#N,Inhibition,'=',-20,%,,Outside typical range,,UO_0000187,,,,,0,CHEMBL2329065,Inhibition of PIM2 (unknown origin) at 1 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2321829,1,Scientific Literature,J Med Chem,2013,None,
CHEMBL1421,DASATINIB,4,488.02,0,3.31,Dasatinib,Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL1909415,GW693881A,None,487.39,1,6.8,GW693881A,Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1,Inhibition,'=',-2.72,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1243094,,None,279.26,0,3.52,3g,O=Cc1c[nH]c2c1ccc1c3cc([N+](=O)[O-])ccc3[nH]c12,Activity,'=',82,%,,,,UO_0000187,,,,,0,CHEMBL1248947,Inhibition of human GST fused Pim2 expressed in Escherichia coli assessed as residual activity at 1 uM after 30 mins,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240519,1,Scientific Literature,Bioorg Med Chem,2010,None,
CHEMBL1240962,,None,313.15,0,4.38,3e,O=Cc1c[nH]c2c1ccc1c3ccc(Br)cc3[nH]c12,Activity,'=',39,%,,,,UO_0000187,,,,,0,CHEMBL1248949,Inhibition of human GST fused Pim2 expressed in Escherichia coli assessed as residual activity at 10 uM after 30 mins,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240519,1,Scientific Literature,Bioorg Med Chem,2010,None,
CHEMBL359963,GW805758X,None,330.4,0,4.05,GW805758X,CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1,Inhibition,'=',-0.13,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1287853,FEDRATINIB,4,524.69,1,4.82,TG-101348,Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL529066,GW574783B,None,599.54,2,6,GW574783B,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl,Inhibition,'=',0.98,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL189415,GW819077X,None,432.41,1,5.62,GW819077X,FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1,Inhibition,'=',0.77,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL4472803,,None,421.5,0,3.05,18,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(CC5COC5)c(NC(C)(C)C)nc34)[nH]c21,IC50,'=',0.6,nM,9.22,,,UO_0000065,21.88,0.41,6.17,9.13,0,CHEMBL4370146,Inhibition of full length recombinant PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues preincubated for 30 mins followed by biotinylated BAD addition and measured after 1 hr by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4368910,1,Scientific Literature,J Med Chem,2019,None,
CHEMBL506153,GW876790X,None,330.35,0,0.03,GW876790X,CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21,Inhibition,'=',1.81,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1992922,,None,284.32,0,1.39,SID103904209,OCC(CO)Nc1ncnc2[nH]cc(-c3ccccc3)c12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL367625,,None,385.9,0,3.93,CGP-74514A,CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21,Residual Activity,'=',97,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2333445,,None,339.42,0,3.44,1,CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1,Activity,'=',101,%,,,,UO_0000187,,,,,0,CHEMBL2354076,Inhibition of PIM2 (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2346629,1,Scientific Literature,Eur J Med Chem,2013,None,
CHEMBL2000568,,None,236.27,0,3.43,SID103904786,CC(=O)c1cccc(-c2cnc3[nH]ccc3c2)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1975256,,None,386.42,1,1.79,SID103905141,Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1cccs1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1243128,,None,292.29,0,3.4,3k,COC(=O)c1cccc2c1[nH]c1c2ccc2c(C=O)c[nH]c21,Activity,'=',36,%,,,,UO_0000187,,,,,0,CHEMBL1248947,Inhibition of human GST fused Pim2 expressed in Escherichia coli assessed as residual activity at 1 uM after 30 mins,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240519,1,Scientific Literature,Bioorg Med Chem,2010,None,
CHEMBL1950358,,None,572.59,0,3.73,12,C[N+](C)(CCO)Cc1cn(CCCCn2c3ccccc3c3ccc4c(C=O)c[nH]c4c32)nn1.O=C([O-])C(F)(F)F,Activity,'=',65,%,,,,UO_0000187,,,,,0,CHEMBL1955501,Inhibition of human recombinant PIM2 expressed in Escherichia coli assessed as residual activity using RSRHSSYPAGT as substrate at 10 uM after 30 mins,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1949527,1,Scientific Literature,Eur J Med Chem,2012,None,
CHEMBL1970314,,None,263.3,0,2.58,SID103905443,NC(=O)c1cc(-c2cccc(N)c2)cc2cccnc12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL384407,GW616030X,None,620.11,2,6.38,GW616030X,CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,Inhibition,'=',-4.12,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL306380,,None,281.36,0,3.14,PP1,Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1,Activity,'=',111,%,,,,UO_0000187,,,,,0,CHEMBL1061086,Percentage PIM2 activity remaining in the presence of 1uM inhibitor,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL1794065,GSK-554170A,None,539.52,0,1.58,GSK554170A,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F,Inhibition,'=',3.34,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL259084,MLN-8054,1,476.87,1,5.87,MLN-8054,O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1,Activity,'=',101,%,,,,UO_0000187,,,,,0,CHEMBL922032,Activity of human Pim2 kinase at 1 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1147076,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL478629,DORSOMORPHIN,None,399.5,0,4.32,C,c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1,Residual Activity,'=',127,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL263796,GW445014X,None,307.18,0,3.92,GW445014X,CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1,Inhibition,'=',-3.71,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL14014,,None,433.46,1,5,SB-251505,Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1,Inhibition,'=',-0.55,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1909387,GW567808A,None,633.09,2,6.37,GW567808A,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl,Inhibition,'=',-0.48,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1785003,,None,486.55,0,4.28,SB-264866,NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1,Inhibition,'=',0.12,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3925450,,None,433.52,0,3.97,BDBM225093,CC(C)Nc1nnc(-c2ccc3[nH]cc(-c4nccc(OC5CCCN(C)C5)n4)c3c2)o1,IC50,'=',206.54,nM,6.68,,393086,UO_0000065,15.42,0.29,2.71,6.37,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3947790,,None,351.44,0,4.12,BDBM225094,CC(C)Oc1cccc(-c2c[nH]c3ccc(-c4nc(N)ns4)cc23)n1,IC50,'=',400.04,nM,6.4,,393087,UO_0000065,18.2,0.35,2.28,7.13,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4207014,,None,405.44,0,2.34,19,CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1,Inhibition,'=',-7,%,,,,UO_0000187,,,,,0,CHEMBL4191127,Inhibition of recombinant human PIM2 (2 to end residues) at 1 uM using RSRHSSYPAGT as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4190187,1,Scientific Literature,Bioorg Med Chem Lett,2017,None,
CHEMBL2147845,,None,390.44,0,2.59,1,COc1ccc2c(c1CN1CCNCC1)O/C(=C\c1n[nH]c3ccccc13)C2=O,IC50,'>',1000,nM,,,,UO_0000065,,,,,0,CHEMBL3738379,Inhibition of PIM2 (unknown origin) by electrophoretic mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3734671,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL3427175,,None,308.38,0,2.34,7,COC(=O)[C@H]1CSC(c2nc3ccc(OC)cc3s2)=N1,Activity,'=',89,%,,,,UO_0000187,,,,,0,CHEMBL3427823,Inhibition of PIM2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3425453,1,Scientific Literature,Eur J Med Chem,2015,None,
CHEMBL3651942,,None,438.48,0,4.61,BDBM106846,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3cc(O)ccc3F)n2)C1,IC50,'=',2,nM,8.7,,225867,UO_0000065,19.84,0.37,4.09,8.6,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3792552,,None,418.41,0,3.9,2e,Nc1ccc(-c2c(F)cccc2F)nc1C(=O)Nc1cnccc1-c1cccnc1N,Ki,'=',187,nM,6.73,,,UO_0000065,16.08,0.3,2.83,5.62,0,CHEMBL3794688,Inhibition of Pim2 (unknown origin) using BAD peptide preincubated for 15 mins followed by ATP addition measured after 60 to 100 mins by Kinase-Glo reagent based luminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3792348,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL3794146,,None,448.43,0,3.91,3c,COc1cc(-c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)ccc2N)cc(N)n1,Ki,'=',4,nM,8.4,,,UO_0000065,18.73,0.35,4.49,6.51,0,CHEMBL3794688,Inhibition of Pim2 (unknown origin) using BAD peptide preincubated for 15 mins followed by ATP addition measured after 60 to 100 mins by Kinase-Glo reagent based luminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3792348,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL473629,GSK-204925A,None,423.49,0,3.82,GSK204925A,COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC,Inhibition,'=',-0.04,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL573108,,None,547.46,1,3.04,BX-320,CC(C)(C(N)=O)C(=O)NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1Br,Activity,'=',72,%,,,,UO_0000187,,,,,0,CHEMBL1061149,Percentage PIM2 activity remaining in the presence of 10uM inhibitor,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL249697,BMS-345541,None,255.32,0,1.87,BMS-345541,Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1,Activity,'=',95,%,,,,UO_0000187,,,,,0,CHEMBL1061149,Percentage PIM2 activity remaining in the presence of 10uM inhibitor,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL34241,ROTTLERIN,None,516.55,2,5.4,Rottlerin,CC(=O)c1c(O)c(C)c(O)c(Cc2c(O)c3c(c(C(=O)/C=C/c4ccccc4)c2O)OC(C)(C)C=C3)c1O,Activity,'=',98,%,,,,UO_0000187,,,,,0,CHEMBL1061149,Percentage PIM2 activity remaining in the presence of 10uM inhibitor,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL489157,,None,285.76,0,1.13,CK1-7,NCCNS(=O)(=O)c1ccc(Cl)c2ccncc12,Activity,'=',55,%,,,,UO_0000187,,,,,0,CHEMBL1060257,Percentage PIM2 activity remaining in the presence of 25uM inhibitor,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL264406,,None,317.4,0,3.98,NA-PP1,CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21,Activity,'=',100,%,,,,UO_0000187,,,,,0,CHEMBL1061086,Percentage PIM2 activity remaining in the presence of 1uM inhibitor,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL406845,,None,301.78,0,3.48,PP2,CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21,Activity,'=',100,%,,,,UO_0000187,,,,,0,CHEMBL1061086,Percentage PIM2 activity remaining in the presence of 1uM inhibitor,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL1785004,,None,451.45,1,5.14,SB-253228,Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1,Inhibition,'=',-3.35,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1233654,,None,291.38,0,1.22,H-7,C[C@H]1CNCCN1S(=O)(=O)c1cccc2cnccc12,Activity,'=',87,%,,,,UO_0000187,,,,,0,CHEMBL1061149,Percentage PIM2 activity remaining in the presence of 10uM inhibitor,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL458415,GSK-2186269A,None,483.58,0,3.86,GSK2186269A,COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2,Inhibition,'=',0.38,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1794051,,None,522.96,1,4.81,GW-5074,Oc1c(Br)cc(C=C2c3cc(I)ccc3NC2O)cc1Br,Activity,'=',5,%,,,Antagonist,UO_0000187,,,,,0,CHEMBL1061086,Percentage PIM2 activity remaining in the presence of 1uM inhibitor,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL3685747,,None,446.51,0,4.89,BDBM124911,C[C@@H]1C[C@H](N)CN(c2ccncc2Nc2cccc3cnc(-c4c(F)cccc4F)nc23)C1,IC50,'=',9,nM,8.05,,254213,UO_0000065,18.02,0.33,3.16,10.06,0,CHEMBL3705221,ATP Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 ul per well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3685751,,None,479.61,1,5.49,BDBM124915,N[C@H]1CCCN(c2ccncc2Nc2cccc3cnc(-c4cccc(-c5nccs5)c4)nc23)C1,IC50,'=',2000,nM,5.7,,254217,UO_0000065,11.88,0.22,0.21,6.14,0,CHEMBL3705221,ATP Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 ul per well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4125807,,None,413.53,0,3.95,16,Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1,Inhibition,'=',2,%,,,,UO_0000187,,,,,0,CHEMBL4120539,Inhibition of PIM2 (unknown origin) at 0.19 uM relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4118098,1,Scientific Literature,Bioorg Med Chem Lett,2017,None,
CHEMBL1802728,,None,422.53,0,4.54,NU6140,CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1,Residual Activity,'=',143,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL98350,LY-294002,None,307.35,0,3.3,LY-294002,O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12,Residual Activity,'=',88,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4209540,,None,318.41,0,4.31,4b,Cc1cccc(-c2nc(N)sc2-c2ccc3ncccc3n2)c1,Activity,'=',101,%,,,,UO_0000187,,,,,0,CHEMBL4178125,Inhibition of human PIM2 (2 to 334 residues) assessed as residual activity at 500 nM in presence of 33P-ATP by filter binding assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4177526,1,Scientific Literature,Bioorg Med Chem,2017,None,
CHEMBL3652031,,None,458.46,0,4.99,BDBM106939,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1F,IC50,'=',5,nM,8.3,,225960,UO_0000065,18.11,0.34,3.31,10.26,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL577784,BX-795,None,591.48,1,4.75,BX-795,O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1,Inhibition,'=',1,%,,,,UO_0000187,,,,,0,CHEMBL1252619,Inhibition of PIM2 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1250448,1,Scientific Literature,Nat Chem Biol,2009,None,
CHEMBL3393697,,None,406.44,0,4.13,13f,Fc1cccc(F)c1-c1ccc2[nH]nc(-c3cncc(NC4CCNCC4)n3)c2c1,IC50,'=',6,nM,8.22,,,UO_0000065,20.23,0.37,4.09,10.47,0,CHEMBL3396420,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as phosphorylation of biotinylated-BAD peptide at Serine 112 residue,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3392976,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL1909356,GW569530A,None,650.15,2,6.23,GW569530A,CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl,Inhibition,'=',-0.33,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3759480,,None,420.49,0,3.61,24c,COc1cc(C(N)=O)ccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2s1,Inhibition,'=',11,%,,,,UO_0000187,,,,,0,CHEMBL3761595,Inhibition of PIM2 (unknown origin) at 500 nM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3758163,1,Scientific Literature,Eur J Med Chem,2016,None,
CHEMBL3687428,,None,533.58,1,3.57,BDBM151822,C[C@@H]1C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@H](N)[C@H]1NS(C)(=O)=O,IC50,'=',21700,nM,4.66,,292078,UO_0000065,8.74,0.17,1.09,3.67,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3697701,A-079,None,207.25,0,3.47,EUB0000308,CCC(=N\O)/C(C)=C/c1ccc(F)cc1,% Control,,83,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507256,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL4516611,BTZO-1,None,240.29,0,2.72,EUB0000301,O=c1nc(-c2ccccn2)sc2ccccc12,% Control,,97,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507329,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL535,SUNITINIB,4,398.48,0,3.33,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4530740,BI 1950,None,646.51,2,5.16,EUB0000310,C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1,% Control,,100,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507282,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL4098877,MLi-2,None,379.46,0,3.56,EUB0000715,C[C@@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@H](C)O1,Inhibition,,-1.938,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4882870,PIM2 Kinase screen,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507291,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1.0 碌M
CHEMBL4128901,,None,441.46,1,5.16,22,CN(C)CCNc1cncc(-c2ccc3[nH]cc(-c4cccc(OC(F)(F)F)c4)c3c2)n1,IC50,'=',2780,nM,5.56,,,UO_0000065,12.59,0.24,0.4,8.41,0,CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4118246,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL4456123,BI 639667,1,451.48,0,2.78,EUB0000352,CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1,% Control,,100,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507278,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL1909370,GW694234A,None,532.78,1,5.94,GW694234A,COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl,Inhibition,'=',-0.13,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL82242,QUERCITRIN,None,448.38,2,0.49,2,C[C@@H]1O[C@@H](Oc2c(-c3ccc(O)c(O)c3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@H](O)[C@H]1O,IC50,'=',25000,nM,4.6,,,UO_0000065,10.26,0.2,4.11,2.42,0,CHEMBL931462,Inhibition of Pim2 kinase,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144687,1,Scientific Literature,J Nat Prod,2008,None,
CHEMBL3651960,,None,482.53,0,4.42,BDBM106864,CCCOc1ccc(F)c(-c2nc(C(=O)Nc3cnccc3[C@@H]3CC[C@H](O)[C@H](N)C3)ccc2F)c1,IC50,'=',76,nM,7.12,,225885,UO_0000065,14.75,0.28,2.7,6.45,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1800685,PPTN,None,475.51,1,7.36,EUB0000274,O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1,% Control,,100,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507292,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL3691970,,None,547.59,2,5.36,BDBM151992,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1n1cc(C2CC2)nn1,IC50,'=',4.05,nM,8.39,,292247,UO_0000065,15.33,0.29,3.03,7.52,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2147767,,None,390.44,0,2.59,2,COc1ccc2c(c1CN1CCNCC1)O/C(=C\c1c[nH]c3ncccc13)C2=O,IC50,'=',390,nM,6.41,,,UO_0000065,16.41,0.3,3.82,8.06,0,CHEMBL3997632,Inhibition of full length recombinant human N-terminal GST-tagged PIM2 (1 to 311 residues) expressed in baculovirus infected sf21 cells using S6K2 peptide as substrate by electrophoretic mobility shift assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3994673,1,Scientific Literature,ACS Med Chem Lett,2017,None,
CHEMBL450071,GSK-1392956A,None,592.68,2,3.21,GSK1392956A,COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1,Inhibition,'=',-3.2,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL103098,,None,356.41,0,2.23,SB-738482,NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1,Inhibition,'=',-0.15,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL230592,GSK-635416A,None,453.54,0,3.89,GSK635416A,CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N,Inhibition,'=',-0.39,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3660063,,None,373.46,0,3.71,BDBM104190,CC1(COc2cccc3ccc(-c4nnc5ccccn45)nc23)CCNCC1,IC50,'=',69,nM,7.16,,222603,UO_0000065,19.18,0.35,3.45,11.13,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL218969,GW445015X,None,252.32,0,2.92,GW445015X,CNC(=O)c1cncc(/C=C/c2ccccc2C)c1,Inhibition,'=',0.15,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3687513,,None,484.52,0,4.98,BDBM151909,CO[C@@H]1[C@H](C)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C)cc3F)n2)C[C@@H]1N,IC50,'=',130.33,nM,6.88,,292165,UO_0000065,14.21,0.27,1.9,7.64,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL185939,GW828525X,None,490.45,1,5.39,GW828525X,FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1,Inhibition,'=',5.12,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL4750196,,None,598.99,2,5.57,6g,O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F,Activity,'=',101.18,%,,,,UO_0000187,,,,,0,CHEMBL4720946,Inhibition of human PIM2 assessed as residual activity using RSRHSSYPAGT as substrate at 1 uM by [gamma-33P]-ATP assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4715818,1,Scientific Literature,Bioorg Med Chem,2018,None,Dose = 1.0 microM
CHEMBL1081312,,None,319.37,0,3.07,PP121,Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1,Inhibition,'=',3,%,,,,UO_0000187,,,,,0,CHEMBL1244250,Inhibition of PIM2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240340,1,Scientific Literature,Nat Chem Biol,2008,None,
CHEMBL28,APIGENIN,None,270.24,0,2.58,K00045,O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,Thermal melting change,'=',3.8,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL3660050,,None,359.43,0,3.47,BDBM104175,c1cc(OC2CCCNCC2)c2nc(-c3nnc4ccccn34)ccc2c1,IC50,'=',437.7,nM,6.36,,222661,UO_0000065,17.69,0.32,2.89,9.88,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3664629,,None,361.45,0,3.7,BDBM104255,CC(C)(CCN)COc1cccc2ccc(-c3nnc4ccccn34)nc12,IC50,'=',76.5,nM,7.12,,222666,UO_0000065,19.69,0.36,3.42,9.09,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3799512,TP-004,None,363.34,0,2.92,EUB0000303,Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12,% Control,,89,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507303,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL6291,BISINDOLYLMALEIMIDE IX,None,457.56,0,3.72,Ro-318220,Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21,Activity,'=',30,%,,,Antagonist,UO_0000187,,,,,0,CHEMBL1051299,Percentage PIM2 activity remaining in the presence of 0.1uM inhibitor,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL2348350,,None,438.56,0,2.4,15u,CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1,Activity,'=',85,%,,,,UO_0000187,,,,,0,CHEMBL4806709,Inhibition of human PIM2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4804286,38,Patent Bioactivity Data,,,None,Dose = 2000.0 nM
CHEMBL3979182,,None,367.43,0,4.09,26,Cc1nc2ccc(F)c(-c3cc4c([nH]3)[C@@H](C)NC4=O)c2nc1NC(C)(C)C,IC50,'=',0.1,nM,10,,,UO_0000065,27.22,0.51,5.91,12.09,0,CHEMBL4478465,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as reduction in phosphorylation of biotinylated-BAD peptide at Serine 112 residue preincubated for 30 mins followed by substrate addition for 1 hr by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4477213,1,Scientific Literature,J Med Chem,2016,None,
CHEMBL553,ERLOTINIB,4,393.44,0,3.41,Tarceva,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,Kd,,,,,,Not Active,,,,,,0,CHEMBL859489,Average Binding Constant for PIM2; NA=Not Active at 10 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144455,1,Scientific Literature,Nat Biotechnol,2005,None,
CHEMBL574737,UCN-01,2,482.54,0,3.84,UCN-01,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL4449930,,None,529.54,1,4.17,13,Cn1ncc(NC(=O)c2nc(-c3c(F)cccc3F)sc2N)c1N1CCC[C@H](NCC(F)(F)F)CC1,Ki,'=',9,nM,8.05,,,UO_0000065,15.19,0.31,3.88,7.96,0,CHEMBL4317000,Inhibition of recombinant human PIM2 using FAM-pimtide as substrate after 90 mins by Z-LYTE assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4316591,1,Scientific Literature,J Med Chem,2019,None,
CHEMBL2377721,,None,172.19,0,1.63,20,Nc1cc2cn[nH]c2c2cc[nH]c12,Inhibition,'=',104,%,,,,UO_0000187,,,,,0,CHEMBL2378599,Inhibition of human full length Pim-2 using RSRHSSYPAGT as substrate assessed as residual activity at 10 uM after 30 mins in presence of [gamma-33P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2375344,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL4100408,TP-024n,None,377.39,0,4.22,EUB0000336,Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1,% Control,,64,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507305,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL3936239,,None,483.41,1,5.37,BDBM191125,NCC[C@H]1CNC(=O)c2cc(-c3cccc(OC(F)(F)F)c3)c(-c3cccc(C(F)(F)F)c3)n21,IC50,'=',97,nM,7.01,,341796,UO_0000065,14.51,0.28,1.64,10.12,0,CHEMBL3887520,Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1243129,,None,302.25,0,4.63,3l,O=Cc1c[nH]c2c1ccc1c3cccc(C(F)(F)F)c3[nH]c12,Activity,'=',32,%,,,,UO_0000187,,,,,0,CHEMBL1248949,Inhibition of human GST fused Pim2 expressed in Escherichia coli assessed as residual activity at 10 uM after 30 mins,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240519,1,Scientific Literature,Bioorg Med Chem,2010,None,
CHEMBL1909402,GW568326X,None,373.31,0,4.2,GW568326X,Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1,Inhibition,'=',-0.09,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL189353,GW809897X,None,571.49,2,6.48,GW809897X,CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1,Inhibition,'=',0.03,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1915433,,None,338.37,0,4.31,14f,c1ccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3cnccc23)cc1,IC50,'=',10,nM,8,,,UO_0000065,23.64,0.42,3.69,10.08,0,CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914433,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL1915651,,None,350.33,0,3.9,17i,NC(=O)c1cccc2c1nc(Nc1c(F)cccc1F)c1ccncc12,IC50,'=',4,nM,8.4,,,UO_0000065,23.97,0.44,4.5,10.38,0,CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914433,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL4294318,,None,394.44,0,2.59,45,COc1cc(C)c(C(N)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1,Inhibition,'=',0,%,,,,UO_0000187,,,,,0,CHEMBL4255128,Inhibition of recombinant human full length GST-tagged PIM2 expressed in baculovirus expression system at 1 uM relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4251655,1,Scientific Literature,Eur J Med Chem,2018,None,
CHEMBL3648675,,None,465.51,0,2.92,17,Cn1ncc(NC(=O)c2nc(-c3c(F)cccc3F)sc2N)c1N1CCCC(N)C(F)C1,Ki,'=',0.4,nM,9.4,,,UO_0000065,20.19,0.4,6.48,8.17,0,CHEMBL4317000,Inhibition of recombinant human PIM2 using FAM-pimtide as substrate after 90 mins by Z-LYTE assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4316591,1,Scientific Literature,J Med Chem,2019,None,
CHEMBL3902209,,None,364.41,0,1.5,BDBM238498,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@H](C)C(N)=O,IC50,'=',222,nM,6.65,,416235,UO_0000065,18.26,0.34,5.15,5.29,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL241517,GW856804X,None,433.92,0,4.65,GW856804X,Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12,Inhibition,'=',0.52,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1794065,GSK-554170A,None,539.52,0,1.58,GSK554170A,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F,Inhibition,'=',-3.05,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL205966,GW659893X,None,444.9,1,5.57,GW659893X,Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1,Inhibition,'=',0.51,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3972727,,None,403.9,1,5.65,BDBM225062,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(-c5ccc(Cl)cc5)n4)c3c2)s1,IC50,'=',75.51,nM,7.12,,393055,UO_0000065,17.63,0.35,1.47,8.85,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL516248,GW804482X,None,379.44,0,3.77,GW804482X,COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1,Inhibition,'=',0.51,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL521851,PICTILISIB,2,513.65,1,2.15,GDC-0941,CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL1992323,,None,220.62,0,2.32,SID103904797,O=c1[nH]cnc2c1oc1ccc(Cl)cc12,Ki,'=',1000,nM,6,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3660085,,None,395.41,0,3.55,BDBM104213,Fc1cc(OC2CCNCCC2F)c2nc(-c3nnc4ccccn34)ccc2c1,IC50,'=',958.6,nM,6.02,,222654,UO_0000065,15.22,0.28,2.47,9.35,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3660086,,None,391.45,0,3.72,BDBM104215,Cc1ccn2c(-c3ccc4cccc(OC5CCNCCC5F)c4n3)nnc2c1,IC50,'=',244,nM,6.61,,222626,UO_0000065,16.89,0.31,2.89,10.28,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3664624,,None,403.49,0,3.4,BDBM104248,COC1(COc2cccc3ccc(-c4nnc5cc(C)ccn45)nc23)CCNCC1,IC50,'=',429.1,nM,6.37,,222659,UO_0000065,15.78,0.29,2.97,8.65,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3664621,,None,391.45,0,3.76,BDBM104241,CN1CCC(F)C(Oc2cccc3ccc(-c4nnc5ccccn45)nc23)CC1,IC50,'=',573.8,nM,6.24,,222653,UO_0000065,15.94,0.29,2.48,11.24,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3917077,,None,388.44,0,1.69,BDBM248899,COc1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CCNCC3)n2)n1,Ki,'=',1.87,nM,8.73,,434106,UO_0000065,22.47,0.41,7.04,9.3,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3900881,,None,373.42,0,2.09,BDBM249061,Cc1cncc(-c2cc3c(cn2)cnn3-c2ccc3c(n2)CC(CN)CO3)n1,Ki,'=',19.4,nM,7.71,,434265,UO_0000065,20.65,0.38,5.62,7.37,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2002323,,None,242.26,0,2.43,SID103905202,Cc1ccc(F)c(-c2ccc3nnc(N)n3c2)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3972453,,None,464.53,0,3.26,BDBM249045,c1ccc(COc2cncc(-c3cc4c(cn3)cnn4-c3cccc(N4CCNCC4)n3)n2)cc1,Ki,'=',34.8,nM,7.46,,434249,UO_0000065,16.06,0.29,4.2,7.94,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2002322,,None,390.31,1,5.1,SID103905048,NC(=O)c1cc2c(-c3cc(C(F)(F)F)cc(C(F)(F)F)c3)cncc2s1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2000271,,None,372.47,0,4.13,SID103904470,Cc1n[nH]c2ccc(-c3cncc(OCC(CN)Cc4ccccc4)c3)cc12,Ki,'=',158.49,nM,6.8,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3957997,,None,408.42,0,2.62,BDBM249048,FC(F)c1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CCNCC3)n2)n1,Ki,'=',3.99,nM,8.4,,434252,UO_0000065,20.56,0.38,5.78,9.92,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3960554,,None,386.46,0,2.38,BDBM248907,Cc1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CCCNCC3)n2)n1,Ki,'=',0.44,nM,9.36,,434114,UO_0000065,24.21,0.44,6.98,11.05,1,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1973540,,None,449.52,0,3.9,SID103904953,O=C1Nc2ccc3ncsc3c2C1=CNc1ccc(S(=O)(=O)Nc2ccccn2)cc1,Ki,'=',1000,nM,6,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3687442,,None,502.56,1,4.4,BDBM151838,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@@H]1[S@+](C)[O-],IC50,'=',106.11,nM,6.97,,292094,UO_0000065,13.88,0.27,2.57,6.71,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1975534,,None,363.16,0,-0.7,SID103905378,NCC(O)C(O)Cn1cc(I)c2c(N)ncnc21,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL485556,,None,472.55,0,3.58,SID103905075,CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2CCC(N)=O,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3952159,,None,446.43,0,3.88,BDBM191094,O=C1NCC(CCO)n2c1cc(-c1cccc(OC(F)(F)F)c1)c2-c1ccc(CO)cc1,IC50,'=',90,nM,7.05,,341765,UO_0000065,15.78,0.3,3.17,8.42,0,CHEMBL3887520,Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3899619,,None,370.42,0,3.36,BDBM238544,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1Nc1ccccn1,IC50,'=',17.6,nM,7.75,,416267,UO_0000065,20.93,0.38,4.39,8.11,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3900670,,None,366.49,0,4.11,BDBM238574,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1SC(C)(C)C,IC50,'=',4.3,nM,8.37,,416696,UO_0000065,22.83,0.44,4.26,11.84,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3687440,,None,481.48,1,5.33,BDBM151835,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1N=[N+]=[N-],IC50,'=',9.44,nM,8.03,,292091,UO_0000065,16.67,0.31,2.7,6.19,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1915435,,None,368.4,0,4.32,14h,COc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12,IC50,'=',92,nM,7.04,,,UO_0000065,19.1,0.34,2.72,7.94,0,CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914433,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL598797,CUDC-101,1,434.5,0,4.2,CUDC-101,C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL564829,MILCICLIB,2,460.59,0,2.57,Milciclib,CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL2219422,AFURESERTIB,2,427.33,0,3.89,GSK-2110183,Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3691926,,None,528.58,2,5.46,BDBM151948,CO[C@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(OC(C)C)cc3F)n2)C[C@@H]1C,IC50,'=',0.79,nM,9.1,,292203,UO_0000065,17.22,0.33,3.64,9.16,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1996066,,None,317.38,0,3.6,SID103904819,N#Cc1ccc2nc(N)n(-c3nc(-c4ccccc4)cs3)c2c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL522892,DOVITINIB,3,392.44,0,2.54,CHIR-258/TKI-258,CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL95692,SB-242235,None,353.4,0,3.08,SID103905256,COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1983534,,None,317.42,0,4.97,SID103904564,c1ccc(CNc2nc3ccc(-c4ccncc4)cc3s2)cc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3892162,,None,475.52,1,6.2,BDBM224895,CC(=O)Nc1ccc(CNc2nnc(-c3ccc4[nH]cc(-c5ccc(F)cc5F)c4c3)s2)cc1,IC50,'>',3000,nM,,,393171,UO_0000065,,,,,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3903410,,None,386.44,0,3.48,BDBM224927,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(-n5ccccc5=O)n4)c3c2)s1,IC50,'=',243.75,nM,6.61,,393208,UO_0000065,17.11,0.32,3.13,6.45,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1794056,GW301789X,None,303.32,0,2.67,GW301789X,O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1,Inhibition,'=',0.56,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1909378,,None,420.86,0,3.63,SB-431542-A,Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1,Inhibition,'=',0.03,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL397570,,None,300.36,0,3.89,SB-347804,N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2,Inhibition,'=',-0.39,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL4634634,,None,365.44,0,1.44,29,C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C,IC50,'>',100000,nM,,,,UO_0000065,,,,,0,CHEMBL4603582,Inhibition of recombinant full length GST-tagged human PIM2 expressed in baculovirus expression system using Ser/Thr 07 as substrate after 1 hr in presence of ATP by Z'-LYTE assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4602617,1,Scientific Literature,Bioorg Med Chem Lett,2020,None,
CHEMBL3660022,,None,359.43,0,3.59,BDBM104165,NC1CCC(Oc2cccc3ccc(-c4nnc5ccccn45)nc23)CC1,IC50,'=',22,nM,7.66,,222579,UO_0000065,21.3,0.39,4.07,9.78,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL1984700,,None,454.48,0,4.1,SID103904772,CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL272629,,None,349.35,0,0.78,GSK_3b_Inhibitor_XI,O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1,Residual Activity,'=',49,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3979978,,None,471.48,0,4.95,BDBM191111,CC(=O)c1ccc(-c2c(-c3cccc(OC(F)(F)F)c3)cc3n2[C@@H](CCCN)CNC3=O)cc1,IC50,'=',129,nM,6.89,,341782,UO_0000065,14.61,0.28,1.94,7.98,0,CHEMBL3887520,Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4448754,,None,533.57,1,4.18,25b,COc1cc(C(=O)NC2CCNCC2)ccc1Nc1nc(Nc2ccccc2P(C)(C)=O)c2cc[nH]c2n1,Inhibition,'=',-3,%,,,,UO_0000187,,,,,0,CHEMBL4314021,Inhibition of recombinant full length GST-tagged human PIM2 expressed in baculovirus expression system at 0.5 uM using Ser/Thr 07 as substrate in presence of ATP at Km concentration after 1 hr by Z'-LYTE assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4311976,1,Scientific Literature,Eur J Med Chem,2019,None,
CHEMBL1970913,,None,310.36,0,3.37,SID103905383,CCCC(=O)Nc1nn(C(=O)CC)c2nc3ccccc3cc12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3660042,,None,388.43,0,2.87,BDBM104163,NC(=O)N1CCC(Oc2cccc3ccc(-c4nnc5ccccn45)nc23)CC1,IC50,'=',1277,nM,5.89,,222577,UO_0000065,15.17,0.28,3.02,5.98,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3660043,,None,355.35,0,2.92,BDBM104164,NCC(F)(F)COc1cccc2ccc(-c3nnc4ccccn34)nc12,IC50,'=',182,nM,6.74,,222578,UO_0000065,18.97,0.35,3.82,8.6,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL4515441,,None,597.12,2,6.05,15a,C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl,Activity,'=',95,%,,,,UO_0000187,,,,,0,CHEMBL4358069,Binding affinity to wild-type human partial length PIM2 (M1 to E291 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4354843,1,Scientific Literature,J Med Chem,2020,None,
CHEMBL3676270,,None,429.5,0,3.91,BDBM131740,CC1CC(N)CN(c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C1,IC50,'=',4,nM,8.4,,263973,UO_0000065,19.55,0.38,4.49,9.98,0,CHEMBL3706072,Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1789961,GW513184X,None,360.38,0,2.98,GW513184X,COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O,Inhibition,'=',2.11,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1957500,,None,531.04,1,1.84,22,CS(=O)(=O)N1CCN(Cc2cn3c(Cl)c(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3n2)CC1,Inhibition,'=',50,%,,,,UO_0000187,,,,,0,CHEMBL1959621,Inhibition of PIM2 at 5 to 10 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1955823,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL471789,GSK-1030059A,None,476.48,1,5.9,GSK1030059A,COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC,Inhibition,'=',0.28,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL181361,GW693481X,None,305.37,0,3.4,GW693481X,Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1,Inhibition,'=',-0.67,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1895450,GSK-2220400A,None,529.61,1,3.05,GSK2220400A,CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12,Inhibition,'=',1.04,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL4552180,BAY-588,None,527.52,2,5.59,EUB0000251,Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1,% Control,,100,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507267,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL233002,,None,350.42,1,5.04,SB-814597,N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2,Inhibition,'=',-0.36,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3952715,,None,390.45,0,1.91,BDBM238554,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1CCCNC1=O,IC50,'=',41.8,nM,7.38,,416676,UO_0000065,18.9,0.35,5.47,6.6,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3936529,,None,335.37,0,1.52,BDBM238763,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC(=N)N,IC50,'=',139,nM,6.86,,416872,UO_0000065,20.45,0.37,5.34,5.17,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL404939,,None,289.67,0,1.67,MEK_Inhibitor_II,O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21,Residual Activity,'=',131,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3184679,AZD-4547,2,463.58,0,3.65,AZD-4547,COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL2323775,MK-8033,1,471.54,0,3.16,MK-8033,Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3962808,,None,391.5,0,3.08,BDBM225051,CN1CCN(c2cccc(-c3c[nH]c4ccc(-c5nnc(N)s5)cc34)n2)CC1,IC50,'=',10.9,nM,7.96,,393037,UO_0000065,20.34,0.39,4.88,9.16,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3676266,,None,535.58,1,4.5,BDBM131736,N[C@H]1C[C@H](OC(=O)c2ccccc2)CN(c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C1,IC50,'=',479,nM,6.32,,263969,UO_0000065,11.8,0.23,1.82,5.72,0,CHEMBL3706072,Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1972584,,None,591.72,1,4.47,SID103904788,CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1996817,,None,267.33,0,3.8,SID103904502,CCCCOc1ncnc2[nH]cc(-c3ccccc3)c12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3651970,,None,434.52,0,4.05,BDBM106874,Cc1ccc(F)c(-c2cccc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@@H](O)[C@@H](C)C3)n2)c1,IC50,'=',17,nM,7.77,,225895,UO_0000065,17.88,0.33,3.72,7.68,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL259551,,None,327.35,0,2.92,FR-180204,Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12,Residual Activity,'=',123,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL380071,,None,194.24,0,3.23,Rockout,c1ccc2c(-c3ccncc3)c[nH]c2c1,Residual Activity,'=',124,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3937446,,None,389.84,0,4.96,BDBM238414,O=C1NCCc2[nH]c(-c3cccc4ccc(Oc5cccc(Cl)c5)nc34)cc21,IC50,'=',68,nM,7.17,,416189,UO_0000065,18.39,0.35,2.21,10.7,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3985959,,None,347.42,0,2.9,BDBM238576,CC1(C)CCN1c1cnc2cccc(-c3cc4c([nH]3)CCNC4=O)c2n1,IC50,'=',0.8,nM,9.1,,416698,UO_0000065,26.18,0.48,6.2,12.31,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3965031,,None,354.37,0,3.92,BDBM224867,Nc1nnc(-c2ccc3[nH]cc(-c4nccc(-c5ccccc5)n4)c3c2)o1,IC50,'=',3.866,nM,8.41,,393145,UO_0000065,23.74,0.43,4.49,7.9,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL98350,LY-294002,None,307.35,0,3.3,LY-294002,O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12,Residual Activity,'=',73,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3945846,,None,366.38,0,2.8,BDBM225031,COc1nc(-c2c[nH]c3ccc(-c4nnc(NC(C)C)o4)cc23)cc(=O)[nH]1,IC50,'=',24.4,nM,7.61,,393318,UO_0000065,20.78,0.39,4.81,6.25,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3968565,,None,351.44,0,4.19,BDBM224963,CCOc1cccc(-c2c[nH]c3ccc(-c4nnc(NC)s4)cc23)n1,IC50,'=',63.12,nM,7.2,,393253,UO_0000065,20.49,0.39,3.01,9.51,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3913921,,None,378.39,0,3.42,BDBM225105,CC(=O)Nc1nc(-c2ccc3[nH]cc(-c4cncc(OC(C)C)n4)c3c2)no1,IC50,'>',1000,nM,,,393097,UO_0000065,,,,,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3948403,,None,321.41,0,3.98,BDBM224954,CNc1nnc(-c2ccc3[nH]cc(-c4cccc(N)c4)c3c2)s1,IC50,'=',1491.22,nM,5.83,,393244,UO_0000065,18.13,0.35,1.85,7.32,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4088576,,None,321.33,0,3.56,1; 7745532,O=C(COc1cccc2ccccc12)Nc1cccc(C(=O)O)c1,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4050787,Inhibition of human PIM2 using RSRHSSYPAGT as substrate in presence of [gamma-33P]-ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4049413,1,Scientific Literature,Bioorg Med Chem Lett,2017,None,
CHEMBL409450,6BIO,None,356.18,0,3.42,Indirubin_6bromo_oxime,O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O,Residual Activity,'=',85,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1794061,GW627834A,None,297.74,0,3.96,GW627834A,Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1,Inhibition,'=',0.47,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL387187,,None,413.4,1,5.33,EGFR_Inhibitor,O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1,Residual Activity,'=',108,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL233001,GW620972X,None,332.43,0,4.9,JNK_Inhibitor_IX,N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2,Residual Activity,'=',119,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3972742,,None,421.46,0,3.61,BDBM192587,C[C@H]1CN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)CCN1,IC50,'=',65.9,nM,7.18,,344657,UO_0000065,17.04,0.32,3.57,10.2,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4860369,,None,549.66,1,4.84,28,COc1ncc2cc1NS(=O)(=O)c1cccc(c1)C(=O)NCc1ccc(s1)-c1ncnc3c(C)c-2sc13,IC50,'=',13.3,nM,7.88,,,UO_0000065,14.33,0.29,3.04,6.39,0,CHEMBL4845577,Inhibition of PIM2 (unknown origin) using ARKRRRHPSGPPTA as peptide substrate by ADP Hunter Plus assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4842397,1,Scientific Literature,ACS Med Chem Lett,2021,None,
CHEMBL3797887,(S)-9s,None,300.75,0,2.2,EUB0000341,C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N,% Control,,100,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507301,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL3937209,,None,400.49,0,2.9,BDBM248956,Cc1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CCCCC(N)C3)n2)n1,Ki,'=',1.06,nM,8.97,,434163,UO_0000065,22.41,0.41,6.07,9.1,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL221271,,None,318.25,0,1.28,ERK_Inhibitor_III,N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1,Residual Activity,'=',118,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL129177,HARMALOL,None,200.24,0,2.24,Harmalol,CC1=NCCc2c1[nH]c1cc(O)ccc21,Activity,'=',101,%,,,,UO_0000187,,,,,0,CHEMBL1061086,Percentage PIM2 activity remaining in the presence of 1uM inhibitor,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL2336377,,None,306.37,0,0.9,16e,CC[C@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1,Activity,'=',88,%,,,,UO_0000187,,,,,0,CHEMBL2341633,Inhibition of recombinant PIM2 (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2331324,1,Scientific Literature,Eur J Med Chem,2013,None,
CHEMBL3660034,,None,371.44,0,3.61,BDBM104152,c1cc(OC2CC3CCC(C2)N3)c2nc(-c3nnc4ccccn34)ccc2c1,IC50,'=',585,nM,6.23,,222569,UO_0000065,16.78,0.3,2.62,9.69,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL575110,,None,346.41,0,4.51,6,O=S(=O)(c1ccccc1)n1ccc2ccc3c4ccccc4[nH]c3c21,Activity,'=',62,%,,,,UO_0000187,,,,,0,CHEMBL1057614,Inhibition of Pim-2 assessed as residual enzyme activity at 10 uM relative to untreated control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154186,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL583972,,None,234.26,0,3.61,9,O=Cc1c[nH]c2c1ccc1c3ccccc3[nH]c12,Activity,'=',7,%,,,,UO_0000187,,,,,1,CHEMBL1057614,Inhibition of Pim-2 assessed as residual enzyme activity at 10 uM relative to untreated control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154186,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL1950289,TANZISERTIB,2,448.45,0,3.66,Tanzisertib,O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL258805,SU-9516,1,241.25,0,1.91,K00031,COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2,Thermal melting change,'=',1.7,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL3925503,,None,367.45,0,4.25,BDBM225050,NCCCNc1nnc(-c2ccc3[nH]cc(-c4ccccc4F)c3c2)s1,IC50,'=',154.61,nM,6.81,,393036,UO_0000065,18.54,0.36,2.56,8.55,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL7917,TYRPHOSTIN AG-1478,None,315.76,0,4.04,Tyrphostin AG-1478,COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC,Residual Activity,'=',121,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2377717,,None,302.29,0,2.69,16,CCCc1c(C(=O)OC)[nH]c2c([N+](=O)[O-])cc3cn[nH]c3c12,Inhibition,'=',85,%,,,,UO_0000187,,,,,0,CHEMBL2378599,Inhibition of human full length Pim-2 using RSRHSSYPAGT as substrate assessed as residual activity at 10 uM after 30 mins in presence of [gamma-33P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2375344,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL3660019,,None,359.43,0,3.32,BDBM104137,c1cc(OCC2CCNCC2)c2nc(-c3nnc4ccccn34)ccc2c1,IC50,'=',562,nM,6.25,,222554,UO_0000065,17.39,0.32,2.93,9.71,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL288064,,None,395.23,0,4.03,GSK_3b_Inhibitor_II,Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1,Residual Activity,'=',93,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL80713,,None,400.48,0,1.82,Cdk2_Inhibitor_III,COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1,Residual Activity,'=',134,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL270724,,None,463.75,0,4.83,TBCA,O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br,Residual Activity,'=',28,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL410456,,None,398.42,0,3.68,D4476,NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1,Residual Activity,'=',116,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3652634,,None,350.81,0,0.63,BDBM119394,Cn1ncc(NC(=O)c2nc(Cl)cnc2N)c1N1CCC[C@H](N)C1,Ki,'=',587,nM,6.23,,246161,UO_0000065,17.76,0.35,5.6,4.87,0,CHEMBL3707982,Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3664634,,None,377.42,0,3.42,BDBM41535,FC1(COc2cccc3ccc(-c4nnc5ccccn45)nc23)CCNCC1,IC50,'=',52,nM,7.28,,222602,UO_0000065,19.3,0.36,3.86,11.32,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL573107,,None,391.42,0,3.42,BI-D1870,CC(C)CCN1c2nc(Nc3cc(F)c(O)c(F)c3)ncc2N(C)C(=O)C1C,Activity,'=',100,%,,,,UO_0000187,,,,,0,CHEMBL1051299,Percentage PIM2 activity remaining in the presence of 0.1uM inhibitor,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL1240885,,None,244.23,0,1.82,CGP-57380,Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12,Activity,'=',90,%,,,,UO_0000187,,,,,0,CHEMBL1061086,Percentage PIM2 activity remaining in the presence of 1uM inhibitor,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL3660006,,None,344.42,0,3.11,BDBM104124,c1cc(NC2CCNCC2)c2nc(-c3nnc4ccccn34)ccc2c1,IC50,'=',1107,nM,5.96,,222542,UO_0000065,17.29,0.31,2.85,8.87,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3660020,,None,373.46,0,3.86,BDBM104138,c1cc(OCCC2CCCCN2)c2nc(-c3nnc4ccccn34)ccc2c1,IC50,'=',4219,nM,5.38,,222555,UO_0000065,14.39,0.26,1.51,8.35,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3393696,,None,407.42,0,3.93,13e,OC1CCN(c2cncc(-c3n[nH]c4ccc(-c5c(F)cccc5F)cc34)n2)CC1,IC50,'=',362,nM,6.44,,,UO_0000065,15.81,0.29,2.51,8.27,0,CHEMBL3396420,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as phosphorylation of biotinylated-BAD peptide at Serine 112 residue,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3392976,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL340807,HARMALINE,None,214.27,0,2.54,SID26748426,COc1ccc2c3c([nH]c2c1)C(C)=NCC3,Activity,'=',117,%,,,,UO_0000187,,,,,0,CHEMBL1061086,Percentage PIM2 activity remaining in the presence of 1uM inhibitor,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL3393695,,None,392.41,0,3.37,13d,Fc1cccc(F)c1-c1ccc2[nH]nc(-c3cncc(N4CCNCC4)n3)c2c1,IC50,'=',29,nM,7.54,,,UO_0000065,19.21,0.35,4.17,10.81,0,CHEMBL3396420,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as phosphorylation of biotinylated-BAD peptide at Serine 112 residue,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3392976,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL3417525,BI 665915,None,458.53,0,2.78,EUB0000749,CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1,% Ctrl,,101,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4882099,PIM2 Invitrogen selectivity data (BI),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Method: Inhibition of PIM2 | Target type: Kinase,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507276,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 3.0 碌M
CHEMBL3959708,,None,353.39,0,4.65,BDBM225008,Cc1cncc(-c2c[nH]c3ccc(-c4nnc(-c5ccccc5)o4)cc23)n1,IC50,'>',1000,nM,,,393297,UO_0000065,,,,,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3264002,AVUTOMETINIB,1,471.47,0,2.68,Ro-5126766,CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3972469,,None,390.47,0,3.85,BDBM224922,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(N5CCCCC5=O)n4)c3c2)s1,IC50,'=',222.97,nM,6.65,,393204,UO_0000065,17.04,0.32,2.8,6.6,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL24828,VANDETANIB,4,475.36,0,4.43,Vandetanib,COc1cc2/c(=N/c3ccc(Br)cc3F)nc[nH]c2cc1OCC1CCN(C)CC1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL278041,SB-202190,None,331.35,0,4.65,SB-202190,Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,Activity,'=',107,%,,,,UO_0000187,,,,,0,CHEMBL1061086,Percentage PIM2 activity remaining in the presence of 1uM inhibitor,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL261454,,None,272.31,0,3.69,14,c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1,Activity,,,,,,Not Evaluated,,,,,,0,CHEMBL982757,Binding affinity to human PIM2 at 10 uM relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1151712,1,Scientific Literature,J Med Chem,2008,None,
CHEMBL4108940,,None,377.41,0,2.39,BDBM224840,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(O[C@@H]5CCCNC5)n4)c3c2)o1,IC50,'=',12.91,nM,7.89,,393122,UO_0000065,20.9,0.38,5.5,6.17,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3907899,,None,324.37,0,2.73,BDBM224947,COc1cncc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)n1,IC50,'=',30.18,nM,7.52,,393235,UO_0000065,23.18,0.45,4.79,7.33,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3394074,,None,351.44,0,3.55,BDBM50061609,CC(C)Nc1cncc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)n1,IC50,'=',9.654,nM,8.02,,393229,UO_0000065,22.81,0.44,4.47,7.6,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3893588,,None,318.34,0,3.13,BDBM224835,Nc1nnc(-c2ccc3[nH]cc(-c4nccc(C5CC5)n4)c3c2)o1,IC50,'=',0.984,nM,9.01,,393117,UO_0000065,28.29,0.51,5.88,8.46,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3394068,,None,350.45,0,4.15,BDBM50061610,CC(C)Nc1cccc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)n1,IC50,'=',37.16,nM,7.43,,393226,UO_0000065,21.2,0.41,3.28,8.03,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL91829,RUBOXISTAURIN,3,468.56,0,3.51,K00587a,CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1,Thermal melting change,'=',2.1,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL186526,,None,389.46,0,4.27,K00085,Cc1ccc(NC(=O)c2cccc(N(C)C)c2)cc1NC(=O)c1ccc(O)cc1,Thermal melting change,'=',0,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL3325691,,None,234.26,0,2.85,12,Nc1cc2[nH]ncc2c2c1ncc1ccccc12,Activity,'=',86,%,,,,UO_0000187,,,,,0,CHEMBL3370182,Inhibition of full-length human PIM2 using RSRHSSYPAGT as substrate assessed as residual kinase activity at 1 uM after 30 mins in presence of [gamma-33P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352653,1,Scientific Literature,Bioorg Med Chem,2014,None,
CHEMBL3793440,,None,385.4,0,4.18,2b,Nc1ccc(-c2ccccc2F)nc1C(=O)Nc1cnccc1-c1ccncc1,Ki,'=',317,nM,6.5,,,UO_0000065,16.86,0.31,2.32,6.93,0,CHEMBL3794688,Inhibition of Pim2 (unknown origin) using BAD peptide preincubated for 15 mins followed by ATP addition measured after 60 to 100 mins by Kinase-Glo reagent based luminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3792348,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL3660033,,None,361.45,0,3.57,BDBM104151,CNCC(C)(C)COc1cccc2ccc(-c3nnc4ccccn34)nc12,IC50,'=',143,nM,6.84,,222568,UO_0000065,18.94,0.35,3.27,10.64,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL284861,,None,222.27,0,0.66,GSK_3b_Inhibitor_I,Cn1sc(=O)n(Cc2ccccc2)c1=O,Residual Activity,'=',115,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL553,ERLOTINIB,4,393.44,0,3.41,Erlotinib,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,Inhibition,'=',-16,%,,Outside typical range,,UO_0000187,,,,,0,CHEMBL3761595,Inhibition of PIM2 (unknown origin) at 500 nM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3758163,1,Scientific Literature,Eur J Med Chem,2016,None,
CHEMBL104468,,None,281.31,0,2.78,K00019,O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12,Thermal melting change,'=',1,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL4539943,BAY-694,None,505.57,1,3.6,EUB0000725,O=C(O)[C@@H]1[C@@H](Cn2nnc3ccccc3c2=O)CC[C@H]1C(=O)c1ccc(OCCC2CCOCC2)cc1,% Control,,94,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507264,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL103552,LAVENDUSTIN A,None,381.38,0,3.41,K00052,O=C(O)c1cc(N(Cc2ccccc2O)Cc2cc(O)ccc2O)ccc1O,Thermal melting change,'=',1.1,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL3930142,,None,402.46,0,3.78,BDBM224981,C[C@H]1COCCN1c1nnc(-c2ccc3[nH]cc(-c4cncc(C5CC5)n4)c3c2)o1,IC50,'=',48.95,nM,7.31,,393272,UO_0000065,18.16,0.33,3.53,7.86,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1240885,,None,244.23,0,1.82,CGP-57380,Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12,Residual Activity,'=',133,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3933867,,None,389.85,0,3.93,BDBM238730,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1-c1ccncc1Cl,IC50,'=',239,nM,6.62,,416839,UO_0000065,16.98,0.32,2.69,7.92,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3954143,,None,312.76,0,2.87,BDBM238744,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1Cl,IC50,'=',521,nM,6.28,,416853,UO_0000065,20.09,0.39,3.41,8.89,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3758582,,None,475.62,0,4.83,35b,COc1ccc(C(=O)NCCN(C)C)cc1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2s1,Inhibition,'=',-4,%,,,,UO_0000187,,,,,0,CHEMBL3761595,Inhibition of PIM2 (unknown origin) at 500 nM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3758163,1,Scientific Literature,Eur J Med Chem,2016,None,
CHEMBL3759559,,None,391.5,1,5.03,3b,COc1cc(CO)ccc1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2s1,Inhibition,'=',1,%,,,,UO_0000187,,,,,0,CHEMBL3761595,Inhibition of PIM2 (unknown origin) at 500 nM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3758163,1,Scientific Literature,Eur J Med Chem,2016,None,
CHEMBL210963,,None,434.47,0,1.54,6s,CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1C#N,Ki,'>',1400,nM,,,,UO_0000065,,,,,0,CHEMBL863188,Inhibition of Pim2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148638,1,Scientific Literature,J Med Chem,2006,None,
CHEMBL575264,,None,405.5,1,5.18,19b,O=c1[nH]c(CNc2cccc(O)c2)nc2c1sc1ccc(-c3ccsc3)cc12,Ki,'=',152,nM,6.82,,,UO_0000065,16.81,0.33,1.64,8.74,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL1969126,,None,379.37,0,4.87,SID103905066,CC(C)n1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)cc21,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1980995,,None,466.54,0,4.35,SID103905531,CNC1CC2OC(C)(C1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,Ki,'=',3.162,nM,8.5,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2204495,,None,399.43,1,5.11,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1998112,,None,389.42,0,3.26,SID103905233,COc1ccc(-c2cc3nccn3c(Nc3ccccc3C(N)=O)n2)cc1OC,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL260138,ALSTERPAULLONE 2,None,346.35,0,3.69,Alsterpaullone_2,N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2,Residual Activity,'=',120,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL193093,,None,224.31,0,2.16,SC 514,NC(=O)c1sc(-c2ccsc2)cc1N,Activity,'=',55,%,,,,UO_0000187,,,,,0,CHEMBL1061149,Percentage PIM2 activity remaining in the presence of 10uM inhibitor,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL4513415,,None,431.5,0,3.01,34,CN1CCOc2c1cnn1c(-c3ccc4cccc(NCC5CCOCC5)c4n3)nnc21,IC50,'=',6210,nM,5.21,,,UO_0000065,12.07,0.22,2.2,5.8,0,CHEMBL4340984,Inhibition of His tagged human recombinant PIM2 using PIM tide (ARKRRRHPSGPPTA) as substrate incubated for 1 hr by fluorescence based assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4340512,1,Scientific Literature,Eur J Med Chem,2019,None,
CHEMBL4461970,,None,429.53,0,4.16,38,CN1CCOc2c1cnn1c(-c3ccc4cccc(NCC5CCCCC5)c4n3)nnc21,IC50,'>',1000,nM,,,,UO_0000065,,,,,0,CHEMBL4340984,Inhibition of His tagged human recombinant PIM2 using PIM tide (ARKRRRHPSGPPTA) as substrate incubated for 1 hr by fluorescence based assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4340512,1,Scientific Literature,Eur J Med Chem,2019,None,
CHEMBL509801,,None,296.69,0,2.81,6,CC(C)n1c2cc(Cl)c(F)cc2c(=O)c2c(=O)o[nH]c21,Ki,'=',62.8,nM,7.2,,,UO_0000065,24.27,0.49,4.39,10.59,0,CHEMBL994191,Inhibition of Pim2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144228,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,
CHEMBL577784,BX-795,None,591.48,1,4.75,BX-795,O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1,Activity,'=',108,%,,,,UO_0000187,,,,,0,CHEMBL1051298,Percentage PIM2 activity remaining in the presence of 0.01uM inhibitor,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL608533,MIDOSTAURIN,4,570.65,2,5.91,PKC_412,CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,Residual Activity,'=',80,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL104279,,None,353.4,0,2.32,Syk_Inhibitor,Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21,Residual Activity,'=',109,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1991429,,None,585.69,2,6.57,SID103904411,O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2218935,,None,365.5,1,5.03,Flt_3_Inhibitor_III,c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1,Residual Activity,'=',111,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4278211,,None,416.46,0,1.83,18,COc1ccc(S(N)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1,Inhibition,'=',2,%,,,,UO_0000187,,,,,0,CHEMBL4255128,Inhibition of recombinant human full length GST-tagged PIM2 expressed in baculovirus expression system at 1 uM relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4251655,1,Scientific Literature,Eur J Med Chem,2018,None,
CHEMBL4225330,,None,387.44,0,4.31,12g,Cc1cc(-c2cncc(-n3ncc4ccc(NC(C)C)cc43)n2)ccc1C(=O)O,IC50,'>',30000,nM,,,,UO_0000065,,,,,0,CHEMBL4222673,Inhibition of human PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4219163,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL4287097,,None,415.48,0,2.59,38,COc1ccc(S(C)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1,Inhibition,'=',2,%,,,,UO_0000187,,,,,0,CHEMBL4255128,Inhibition of recombinant human full length GST-tagged PIM2 expressed in baculovirus expression system at 1 uM relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4251655,1,Scientific Literature,Eur J Med Chem,2018,None,
CHEMBL4228394,,None,379.45,0,4.06,5,CC(C)Nc1ccc2cnn(-c3cncc(-c4csc(C(=O)O)c4)n3)c2c1,IC50,'>',30000,nM,,,,UO_0000065,,,,,0,CHEMBL4222673,Inhibition of human PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4219163,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL4878072,,None,449.56,0,4.3,Senexin C/6148/GJ-2331/2335,CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1,Activity,'=',81,%,,,,UO_0000187,,,,,0,CHEMBL4805104,Inhibition of human PIM2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4804282,38,Patent Bioactivity Data,,,None,Dose = 2000.0 nM
CHEMBL21156,,None,309.34,0,3.99,JAK_Inhibitor_I,CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1,Residual Activity,'=',43,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3660065,,None,413.53,0,4.49,BDBM104192,c1cc(OCC2(CC3CC3)CCNCC2)c2nc(-c3nnc4ccccn34)ccc2c1,IC50,'=',95,nM,7.02,,222605,UO_0000065,16.98,0.31,2.53,10.91,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL262615,HIAZOLIDINEDIONE1,None,292.36,0,2.08,K00566a,CCOc1ccc(/C=C2/SC(=O)N(CCN)C2=O)cc1,Thermal melting change,'=',-0.1,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL3966701,,None,569.5,2,5.56,BDBM191075,CN(C)Cc1ccc(-c2c(-c3cccc(OC(F)(F)F)c3)cc3n2C(CCOC(=O)C(F)(F)F)CNC3=O)cc1,IC50,'=',38,nM,7.42,,341746,UO_0000065,13.03,0.25,1.86,10.19,0,CHEMBL3887520,Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP,,,,,,,,,,,,,,,,,,,,,,
CHEMBL50,QUERCETIN,3,302.24,0,1.99,K00029,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,Thermal melting change,'=',8.6,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL261849,GW632580X,None,366.42,0,2.83,GW2580,COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,Residual Activity,'=',96,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL65063,,None,211.23,0,1.4,PP3,Nc1ncnc2c1cnn2-c1ccccc1,Residual Activity,'=',107,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL258721,,None,473.36,0,4.5,RGB-286147,CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12,Residual Activity,'=',131,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL286721,AMINOPURVALANOL,None,403.92,0,3.82,Aminopurvalanol,CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1,Residual Activity,'=',101,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2001224,,None,371.83,0,4.28,SID103905155,Cc1cc(OC2CCCC2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL387187,,None,413.4,1,5.33,EGFR_Inhibitor,O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1,Residual Activity,'=',88,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3651988,,None,437.45,0,3.12,BDBM106893,Nc1ccc(-c2c(F)cccc2F)nc1C(=O)Nc1cnccc1C1=C[C@@H](N)[C@@H](O)CC1,IC50,'=',8,nM,8.1,,225914,UO_0000065,18.51,0.35,4.98,6.37,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL379218,,None,358.45,0,3.88,A-674563,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12,Kd,'=',220,nM,6.66,,,UO_0000065,18.57,0.34,2.78,8.67,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL2218931,,None,376.48,0,1.11,Glycyl_H_1152,Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12,Residual Activity,'=',106,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL35820,,None,388.26,0,4.93,56,CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC,Residual Activity,'=',92,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4066040,A-1596584,None,539.53,2,5.45,EUB0000264,COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1,% Control,,100,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507262,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL64758,,None,404.22,0,4.6,Cdk4_Inhibitor,O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21,Residual Activity,'=',27,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1945953,,None,377.41,0,2,2,O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CC1CCOCC1,Activity,'=',93,%,,,,UO_0000187,,,,,0,CHEMBL1948961,Inhibition of Pim2 assessed as activity remaining at 10 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1944561,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL111364,,None,404.51,1,6.17,ML_3403,CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1,Residual Activity,'=',120,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3651927,,None,452.51,0,4.18,BDBM106831,Cc1ccc(F)c(-c2cccc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@@H](O)[C@@H](C)C3)n2)c1F,IC50,'=',7,nM,8.15,,225852,UO_0000065,18.02,0.34,3.97,8.06,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3651949,,None,412.51,0,3.87,BDBM106853,N[C@H]1CCC[C@@H](c2ccncc2NC(=O)c2ccc(F)c([C@H]3CC[C@@H](O)CC3)n2)C1,IC50,'=',149,nM,6.83,,225874,UO_0000065,16.55,0.31,2.96,6.75,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4126838,,None,440.47,1,5.64,31,CN(C)CCCOc1cncc(-c2ccc3[nH]cc(-c4ccc(C(F)(F)F)cc4)c3c2)n1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4118246,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL3936246,,None,355.4,0,3.65,BDBM238598,O=C1NCCc2[nH]c(-c3cccc4cnc(Nc5ccccc5)nc34)cc21,IC50,'=',13.5,nM,7.87,,416294,UO_0000065,22.14,0.4,4.22,9.52,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL259388,,None,459.59,1,5.34,K00070,Cc1nc2sccn2c(=O)c1CCN1CCC(=C(c2ccccc2)c2ccc(F)cc2)CC1,Thermal melting change,'=',3.3,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL576349,IC261,None,311.34,0,3.21,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL255465,DEBROMOHYMENIALDISINE,None,245.24,0,-0.7,K00230,NC1=N/C(=C2/CCNC(=O)c3[nH]ccc32)C(=O)N1,Thermal melting change,'=',2.5,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL4580220,BAY-3827,None,468.54,1,5.45,EUB0000311,CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12,% Control,,99,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507319,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL188762,,None,371.24,0,4.48,PD-174265,CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,Residual Activity,'=',104,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL302449,GO-6976,None,378.44,0,4.6,Go-6976,Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O,Residual Activity,'=',25,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL380071,,None,194.24,0,3.23,Rockout,c1ccc2c(-c3ccncc3)c[nH]c2c1,Residual Activity,'=',97,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4578164,MRL-CB1-NC,None,550.85,2,5.8,EUB0000316,CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O,% Control,,100,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507287,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL3660075,,None,417.49,0,4.29,BDBM104202,FC1(COc2cccc3ccc(-c4nnc5ccc(C6CC6)cn45)nc23)CCNCC1,IC50,'=',55,nM,7.26,,222615,UO_0000065,17.39,0.32,2.97,11.28,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL372585,,None,438.53,0,3.81,K00206,CN(C)CC1CCn2c(c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc32)C1,Thermal melting change,'=',1.7,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL574236,,None,401.43,0,2.65,54,COc1ccccc1-n1c(-c2ccccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12,Activity,'=',115,%,,,,UO_0000187,,,,,0,CHEMBL1056911,Inhibition of PIM2 assessed as remaining enzyme activity at 3 uM relative to DMSO,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154183,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL3907325,,None,363.47,0,3.82,6,Cc1nc2cccc(-c3cc4c([nH]3)CCCNC4=O)c2nc1NC(C)(C)C,IC50,'=',8.1,nM,8.09,,,UO_0000065,22.26,0.41,4.27,9.78,0,CHEMBL4478465,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as reduction in phosphorylation of biotinylated-BAD peptide at Serine 112 residue preincubated for 30 mins followed by substrate addition for 1 hr by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4477213,1,Scientific Literature,J Med Chem,2016,None,
CHEMBL100473,U-0126,None,380.5,0,3.12,K00211,N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(/N)Sc1ccccc1N,Thermal melting change,'=',0,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL408982,,None,249.34,0,3.06,K00243,CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21,Thermal melting change,'=',3.1,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL278041,SB-202190,None,331.35,0,4.65,K00037,Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,Thermal melting change,'=',0.8,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL4126689,,None,382.47,0,4.14,17,CN(C)CCNc1cncc(-c2ccc3[nH]cc(-c4ccc(C#N)cc4)c3c2)n1,IC50,'=',2540,nM,5.59,,,UO_0000065,14.63,0.26,1.46,6.94,0,CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4118246,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL4129023,,None,375.45,0,4.4,24,CN(C)CCNc1cncc(-c2ccc3[nH]cc(-c4cccc(F)c4)c3c2)n1,IC50,'=',650,nM,6.19,,,UO_0000065,16.48,0.3,1.79,10.89,0,CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4118246,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL2218938,,None,328.34,0,3.04,ERK_Inhibitor_II_Negative_control,Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12,Residual Activity,'=',84,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL439259,,None,341.8,0,4.85,IGF_1R_Inhibitor_II,COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12,Residual Activity,'=',100,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL120077,,None,325.34,0,3.88,JNJ-10198409,COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2,Residual Activity,'=',101,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL191384,,None,372.46,0,3.94,AS-601245,N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1,Residual Activity,'=',33,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL274064,SB-220025,None,338.39,0,2.65,SB-220025,Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1,Residual Activity,'=',89,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1987756,,None,446.37,0,3.58,SID103905082,O=S(=O)(NCCNCC=Cc1ccc(Br)cc1)c1cccc2cnccc12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1982924,,None,343.39,0,4.49,SID103904210,COc1cccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL340921,,None,371.4,0,3.17,SID103905356,Cc1cc(O)ccc1-n1cc(C(N)=O)c(=O)c2ccc(-c3ccncc3)cc21,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1421,DASATINIB,4,488.02,0,3.31,SID103905543,Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3676275,,None,429.5,0,3.91,BDBM131745,CC1CCN(c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)CC1N,IC50,'=',8,nM,8.1,,263978,UO_0000065,18.85,0.37,4.19,9.62,0,CHEMBL3706072,Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL406381,KRN-633,1,416.87,0,4.62,K00589a,CCCNC(=O)Nc1ccc(Oc2ncnc3cc(OC)c(OC)cc23)cc1Cl,Thermal melting change,'=',0.2,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL501822,,None,197.15,0,0.93,K00271,O=C(O)Cc1ccc(O)c([N+](=O)[O-])c1,Thermal melting change,'=',-0.1,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL573923,,None,419.43,0,4.77,14e,CN(C)Cc1nc2c(sc3ccc(-c4cccc(OC(F)(F)F)c4)cc32)c(=O)[nH]1,Ki,'=',44,nM,7.36,,,UO_0000065,17.54,0.35,2.59,12.64,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL496973,,None,308.34,0,2.79,E/Z-31c,COc1ccccc1/C=C1\C(=O)NC(=O)N1Cc1ccccc1,IC50,'>',100000,nM,,,,UO_0000065,,,,,0,CHEMBL957366,Inhibition of human recombinant Pim2 by ATP depletion assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139352,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL3899014,,None,379.46,0,3.17,BDBM238651,C[C@@H](O)c1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC(C)(C)C,IC50,'=',1.95,nM,8.71,,416760,UO_0000065,22.95,0.42,5.54,8.46,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3890422,,None,377.47,0,4.72,BDBM224965,CNc1nnc(-c2ccc3[nH]cc(-c4cccc(OC5CCC5)n4)c3c2)s1,IC50,'=',104.13,nM,6.98,,393255,UO_0000065,18.5,0.35,2.26,9.22,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3937821,,None,324.38,0,4.53,BDBM224968,CNc1nnc(-c2ccc3[nH]cc(-c4ccccc4F)c3c2)s1,IC50,'=',781.82,nM,6.11,,393258,UO_0000065,18.83,0.36,1.58,11.39,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3912113,,None,391.44,0,2.73,BDBM224857,CN1CCCC(Oc2ccnc(-c3c[nH]c4ccc(-c5nnc(N)o5)cc34)n2)C1,IC50,'=',2.853,nM,8.54,,393135,UO_0000065,21.83,0.4,5.81,7.18,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4536012,,None,350.4,0,4.19,20c,CCc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1,Inhibition,'=',-0.24,%,,,,UO_0000187,,,,,0,CHEMBL4395903,Inhibition of human recombinant PIM2 at 1 uM using CREBtide as substrate measured after 60 mins in presence of ATP by LANCE assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4393708,1,Scientific Literature,Eur J Med Chem,2019,None,
CHEMBL3941086,,None,417.9,0,4.24,BDBM238614,Cc1nc2cccc(-c3cc4c([nH]3)C(Cc3ccc(Cl)cc3)CNC4=O)c2nc1N,IC50,'=',19.1,nM,7.72,,416721,UO_0000065,18.47,0.35,3.48,7.98,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL409450,6BIO,None,356.18,0,3.42,K00001,O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O,Thermal melting change,'=',0.4,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL405992,,None,254.24,0,2.18,K00056,Cc1ccc2c(c1)C(=O)c1cc(O)cc(O)c1C2=O,Thermal melting change,'=',3.1,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL573044,,None,363.49,0,4.35,14b,CC(c1ccccc1)c1ccc2sc3c(=O)[nH]c(CN(C)C)nc3c2c1,Ki,'=',109,nM,6.96,,,UO_0000065,19.15,0.37,2.61,14.21,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL259551,,None,327.35,0,2.92,K00594a,Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12,Thermal melting change,'=',0.6,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL384304,RG-547,2,441.46,0,1.41,R547,COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL1952329,SGI-1776,1,405.42,0,4.05,SGI-1776,CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1,IC50,'=',618,nM,6.21,,,UO_0000065,15.32,0.29,2.16,11.35,0,CHEMBL4340984,Inhibition of His tagged human recombinant PIM2 using PIM tide (ARKRRRHPSGPPTA) as substrate incubated for 1 hr by fluorescence based assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4340512,1,Scientific Literature,Eur J Med Chem,2019,None,
CHEMBL574168,,None,283.36,0,2.18,13a,C#Cc1ccc2sc3c(=O)[nH]c(CN(C)C)nc3c2c1,Ki,'=',30,nM,7.52,,,UO_0000065,26.55,0.51,5.34,15.36,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL7463,GF-109203,None,412.49,0,3.64,K00201,CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21,Thermal melting change,'=',5.2,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL3651976,,None,426.44,0,4.8,BDBM106880,N[C@H]1CCC[C@@H](c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)ccc2F)C1,IC50,'=',44,nM,7.36,,225901,UO_0000065,17.25,0.32,2.56,9.09,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2017333,,None,345.34,0,3.55,17,Fc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2n2cncc12,IC50,'=',43,nM,7.37,,,UO_0000065,21.33,0.39,3.82,8.79,0,CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016532,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL3687437,,None,533.58,1,3.57,BDBM151832,C[C@@H]1C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@H](N)[C@@H]1NS(C)(=O)=O,IC50,'=',7100,nM,5.15,,292088,UO_0000065,9.65,0.19,1.58,4.05,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2030389,,None,348.2,0,3.03,6b,O=c1[nH]c(CN2CCCC2)nc2c1oc1ccc(Br)cc12,IC50,'=',194,nM,6.71,,,UO_0000065,19.28,0.44,3.68,10.8,0,CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034948,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL2035633,,None,377.24,0,2.18,6d,CN1CCN(Cc2nc3c(oc4ccc(Br)cc43)c(=O)[nH]2)CC1,IC50,'=',197,nM,6.71,,,UO_0000065,17.78,0.4,4.53,10.26,0,CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034948,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL3967337,,None,462.55,0,3.69,BDBM238753,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@H]1C[C@@H](NC(=O)OC(C)(C)C)C1,IC50,'=',17.2,nM,7.76,,416862,UO_0000065,16.79,0.31,4.07,6.42,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2035620,,None,393.6,0,4.89,5c,O=c1[nH]c(-c2ccc(F)cc2Cl)nc2c1oc1ccc(Br)cc12,IC50,'=',850,nM,6.07,,,UO_0000065,15.42,0.36,1.18,10.31,0,CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034948,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL514499,GW843682X,None,477.46,0,4.8,SID103905429,COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2017336,,None,357.44,0,4.85,13c,c1ccc(CNc2nc3c(-c4nnc[nH]4)cccc3c3sccc23)cc1,IC50,'=',52,nM,7.28,,,UO_0000065,20.38,0.38,2.43,10.96,0,CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016532,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL4077554,,None,1215.15,None,None,ARC-1424-5O,NCCCC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CCCCCCCCOc1nc2cc(C(=O)O)ccc2c2cnccc12)C(=O)O,Activity,'=',80,%,,,,UO_0000187,,,,,0,CHEMBL4050335,Inhibition of human PIM2 assessed as residual activity at 1 uM in presence of [33P]ATP by filter binding assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4049403,1,Scientific Literature,Bioorg Med Chem,2017,None,
CHEMBL3949318,,None,365.41,0,3.84,BDBM238715,Cc1nc2ccc(F)c(-c3cc4c([nH]3)[C@@H](C)NC4=O)c2nc1NC1(C)CC1,IC50,'=',0.0484,nM,10.32,,416824,UO_0000065,28.23,0.52,6.48,12.47,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4126750,,None,397.49,0,3.72,43,CN(C)CCNc1cncc(-c2ccc3[nH]cc(-c4ccc(N)c(C#N)c4)c3c2)n1,IC50,'=',259,nM,6.59,,,UO_0000065,16.57,0.3,2.87,6.18,0,CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4118246,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL559147,Y-27632,None,247.34,0,2.17,K00002,C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1,Thermal melting change,'=',0.6,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL31965,CANERTINIB,3,485.95,0,4.39,CI-1033,C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1,Kd,'>',10000,nM,,,,UO_0000065,,,,,1,CHEMBL1061184,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150977,1,Scientific Literature,Nat Biotechnol,2008,None,
CHEMBL328710,,None,264.33,0,3.25,SU4312,CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1,Residual Activity,'=',92,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3125728,,None,420.54,1,5.14,18,COc1ccc(-c2nc3cc(-c4csc(C(=O)NCCC(C)C)c4)cnc3[nH]2)cc1,Activity,'=',94,%,,,,UO_0000187,,,,,0,CHEMBL3130705,Inhibition of human PIM-2 assessed as residual activity at 1 uM relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3124838,1,Scientific Literature,Bioorg Med Chem Lett,2014,None,
CHEMBL4109141,,None,460.51,0,3.15,25,Cn1ncc(NC(=O)c2nc(-c3c(F)cccc3F)sc2N)c1[C@@]12CC[C@@H](N)[C@@H](CC1)O2,Ki,,,,,,Not Determined,,,,,,0,CHEMBL4317000,Inhibition of recombinant human PIM2 using FAM-pimtide as substrate after 90 mins by Z-LYTE assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4316591,1,Scientific Literature,J Med Chem,2019,None,
CHEMBL3660070,,None,339.36,0,4.13,BDBM104197,c1cc(Oc2ccncc2)c2nc(-c3nnc4ccccn34)ccc2c1,IC50,'=',1994,nM,5.7,,222610,UO_0000065,16.8,0.3,1.57,8.74,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL379093,GW651576X,None,429.88,1,5.99,GW651576X,Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1,Inhibition,'=',0.52,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL2037198,,None,388.4,0,4.47,11,O=C1Nc2ccc(F)cc2/C1=C\c1ccc(-c2cccc(C(=O)NC3CC3)c2)o1,IC50,'=',109,nM,6.96,,,UO_0000065,17.93,0.33,2.49,9.76,0,CHEMBL2038829,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034977,1,Scientific Literature,ACS Med Chem Lett,2012,None,
CHEMBL366266,,None,411.47,0,3.41,PKC_beta_inhibitor,O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1,Residual Activity,'=',54,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL468280,,None,282.66,0,2.25,1,CCn1c2cc(Cl)c(F)cc2c(=O)c2c(=O)o[nH]c21,Ki,'=',174,nM,6.76,,,UO_0000065,23.91,0.49,4.51,9.94,0,CHEMBL994191,Inhibition of Pim2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144228,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,
CHEMBL496783,,None,289.23,0,2.91,13a,O=C1NC(=O)/C(=C/c2cccc(OC(F)(F)F)c2)S1,IC50,'=',900,nM,6.05,,,UO_0000065,20.9,0.43,3.14,10.91,0,CHEMBL957366,Inhibition of human recombinant Pim2 by ATP depletion assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139352,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL3890672,,None,486.54,0,4.81,BDBM191113,CN(C)Cc1ccc(-c2c(-c3cccc(OC(F)(F)F)c3)cc3n2[C@@H](CCCN)CNC3=O)cc1,IC50,'=',66,nM,7.18,,341784,UO_0000065,14.76,0.28,2.37,9.9,0,CHEMBL3887520,Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP,,,,,,,,,,,,,,,,,,,,,,
CHEMBL519881,GW861893X,None,483.53,1,5.66,GW861893X,COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC,Inhibition,'=',0.23,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL266487,RO-316233,None,327.34,0,3.22,BIM4,O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12,Residual Activity,'=',23,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL221959,TOFACITINIB,4,312.38,0,1.54,CP-690550,C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12,Kd,'>',10000,nM,,,,UO_0000065,,,,,1,CHEMBL1061184,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150977,1,Scientific Literature,Nat Biotechnol,2008,None,
CHEMBL1336,SORAFENIB,4,464.83,1,5.55,Sorafenib,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,Kd,'>',10000,nM,,,,UO_0000065,,,,,1,CHEMBL1061184,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150977,1,Scientific Literature,Nat Biotechnol,2008,None,
CHEMBL7939,CGP-53353,None,365.34,0,4.34,CGP-53353,O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21,Residual Activity,'=',91,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL583947,,None,385.88,0,3.83,6t,O=c1[nH]c(CNCCc2cccc(O)c2)nc2c1sc1ccc(Cl)cc12,Ki,'=',40,nM,7.4,,,UO_0000065,19.17,0.39,3.57,9.48,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL2397521,,None,252.28,0,2.79,7b,COc1ccc2[nH]c3c(N)cc4cn[nH]c4c3c2c1,Activity,'=',70,%,,,,UO_0000187,,,,,0,CHEMBL2401344,Inhibition of human PIM2 assessed as residual activity using RSRHSSYPAGT as substrate at 10 uM after 30 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2396576,1,Scientific Literature,Bioorg Med Chem,2013,None,
CHEMBL3691979,,None,609.63,2,5.46,BDBM152001,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C4(F)CCOCC4)cc3F)n2)C[C@@H](N)[C@H]1n1ccnn1,IC50,'=',13.74,nM,7.86,,292256,UO_0000065,12.9,0.24,2.4,6.51,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3962427,,None,292.3,0,1.75,BDBM238605,Cc1nc2cccc(-c3cc4c(=O)[nH]cnc4[nH]3)c2nc1N,IC50,'=',21,nM,7.68,,416712,UO_0000065,26.27,0.48,5.93,6.77,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3903402,,None,347.42,0,3.7,BDBM238671,Cc1nc2cccc(-c3cc4c([nH]3)[C@@H](C)NC4=O)c2nc1NC1(C)CC1,IC50,'=',0.183,nM,9.74,,416780,UO_0000065,28.03,0.51,6.04,11.77,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4584981,NVS-MALT1-C,None,574.03,1,4.72,EUB0000747,CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12,% Control,,95,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507320,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL3922362,,None,335.41,0,3.05,BDBM238533,CC(C)(C)Nc1cnc2cccc(-c3cc4n(c3)CCNC4=O)c2n1,IC50,'=',1.4,nM,8.85,,416672,UO_0000065,26.4,0.48,5.8,12.32,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3393711,,None,416.46,0,3.74,18d,Fc1ccncc1-c1ccc2[nH]nc(-c3cncc(O[C@H]4CNCCC45CC5)n3)c2c1,IC50,'=',5,nM,8.3,,,UO_0000065,19.93,0.37,4.56,9.37,0,CHEMBL3396420,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as phosphorylation of biotinylated-BAD peptide at Serine 112 residue,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3392976,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL3393720,,None,508.58,1,3.72,18m,CS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(-c4cncc(O[C@H]5CNCCC56CC6)n4)c3c2)c(F)c1,IC50,'=',0.6,nM,9.22,,,UO_0000065,18.13,0.35,5.5,7.57,0,CHEMBL3396420,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as phosphorylation of biotinylated-BAD peptide at Serine 112 residue,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3392976,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL3956736,,None,361.45,0,3.29,BDBM238569,CC1(C)CCCN1c1cnc2cccc(-c3cc4c([nH]3)CCNC4=O)c2n1,IC50,'=',0.8,nM,9.1,,416691,UO_0000065,25.17,0.46,5.81,12.31,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3264259,,None,388.48,0,3.03,7h,CN(C)CCCNc1cncc(-c2ccc3[nH]cc(-c4ccnc(N)n4)c3c2)n1,IC50,'=',630,nM,6.2,,,UO_0000065,15.96,0.29,3.17,5.71,0,CHEMBL3269287,Inhibition of PIM2 kinase (unknown origin) using 5-FAM-labeled BAD peptide as substrate after 90 mins by fluorescence polarization assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3259764,1,Scientific Literature,Bioorg Med Chem Lett,2014,None,
CHEMBL56543,,None,294.31,0,2.32,K00064,N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1,Thermal melting change,'=',1.9,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL2218927,,None,280.36,0,3.55,Tyrphostin AGL-2043,Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C,Residual Activity,'=',121,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1782521,,None,353.22,0,3.31,29,O=C(O)c1cc2cc(Br)cc(NCC3CCNCC3)c2o1,IC50,'=',190,nM,6.72,,,UO_0000065,19.03,0.44,3.41,9.02,0,CHEMBL1786238,Inhibition of human Pim2 using 5-FAM-RSRHSSYPAGT-CONH2 as substrate after 90 mins by off-chip mobility shift method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1781944,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL1096634,GSK-943949A,None,447.5,0,2.28,GSK943949A,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21,Inhibition,'=',3.44,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3687515,,None,588.59,1,3.35,BDBM151911,COCCOc1cc(F)c(-c2nc(C(=O)Nc3cnccc3N3C[C@@H](N)[C@@H](NC(=O)OC)[C@@H](C)C3)ccc2F)c(F)c1,IC50,'=',3.74,nM,8.43,,292167,UO_0000065,14.32,0.27,5.08,5.98,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3901445,,None,406.85,0,4.68,BDBM238733,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1-c1c(F)cccc1Cl,IC50,'=',22.6,nM,7.65,,416842,UO_0000065,18.79,0.36,2.97,10.82,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3915882,,None,363.47,0,4.12,BDBM238737,Cc1nc2cccc(-c3cc(C(N)=O)c(C4CC4)[nH]3)c2nc1NC(C)(C)C,IC50,'=',7.79,nM,8.11,,416846,UO_0000065,22.31,0.41,3.99,8.39,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2017337,,None,344.4,0,4.37,13d,c1cncc(Nc2nc3c(-c4nnc[nH]4)cccc3c3sccc23)c1,IC50,'=',22,nM,7.66,,,UO_0000065,22.23,0.42,3.29,9.65,0,CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016532,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL3964527,,None,372.4,0,4.4,BDBM238580,O=C1NCCc2[nH]c(-c3c(F)ccc4ccc(Nc5ccccc5)nc34)cc21,IC50,'=',3.9,nM,8.41,,416281,UO_0000065,22.58,0.41,4.01,12.05,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3355550,,None,376.38,0,4.13,9a,O[C@H]1CC[C@H](Nc2ccn3ncc(-c4cccc(C(F)(F)F)c4)c3n2)CC1,IC50,'=',282,nM,6.55,,,UO_0000065,17.4,0.33,2.42,10.49,0,CHEMBL3375413,Inhibition of Pim2 (unknown origin) using luciferase-luciferin based ATP detection reagent by Kinase-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3351833,1,Scientific Literature,ACS Med Chem Lett,2015,None,
CHEMBL4549667,TP-030-2,None,481.35,0,3.12,EUB0000720,CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21,IC50,,1000,nM,,,,UO_0000065,,,,,0,CHEMBL4885101,Pim2(PIM2LHY1) Takeda global kinase panel,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507326,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1.0 碌M
CHEMBL257167,,None,279.3,0,2.14,3,NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O,Activity,,,,,,Not Evaluated,,,,,,0,CHEMBL982757,Binding affinity to human PIM2 at 10 uM relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1151712,1,Scientific Literature,J Med Chem,2008,None,
CHEMBL3983621,,None,364.41,0,2.66,BDBM238776,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C)c(OC5(C)CC5)nc34)[nH]c21,IC50,'=',1.01,nM,9,,416885,UO_0000065,24.69,0.46,6.34,10.11,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3904349,,None,369.43,0,3.68,BDBM238542,CN(c1ccccc1)c1cnc2cccc(-c3cc4c([nH]3)CCNC4=O)c2n1,IC50,'=',4.4,nM,8.36,,416265,UO_0000065,22.62,0.41,4.68,11.31,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3918021,,None,432.53,0,2.49,BDBM238793,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@H]1C[C@@H](N2CCOCC2)C1,IC50,'=',6,nM,8.22,,416902,UO_0000065,19.01,0.35,5.73,8.64,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3902617,,None,371.42,0,1.59,BDBM238591,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NS(C)(=O)=O,IC50,'=',9.6,nM,8.02,,416702,UO_0000065,21.59,0.42,6.43,6.86,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3889660,,None,396.49,1,5.52,BDBM238487,CCC1CNC(=O)c2cc(-c3cccc4cc(C)c(Nc5ccccc5)nc34)[nH]c21,IC50,'=',1.9,nM,8.72,,416293,UO_0000065,22,0.4,3.2,12.49,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3676285,,None,430.48,0,3.25,BDBM131755,Nc1sc(-c2c(F)cccc2F)nc1C(=O)Nc1cnccc1N1CCC[C@H](N)C1,IC50,'=',2,nM,8.7,,263988,UO_0000065,20.21,0.4,5.45,7.9,0,CHEMBL3706072,Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3676298,,None,415.56,0,2.73,BDBM131768,N[C@@H]1C[C@H](c2ccncc2NC(=O)c2csc(C3CCCCC3)n2)C[C@H](N)[C@H]1O,IC50,'=',250,nM,6.6,,264001,UO_0000065,15.89,0.31,3.87,5.19,0,CHEMBL3706072,Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3676299,,None,444.51,0,3.94,BDBM131769,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1O,IC50,'=',46,nM,7.34,,264002,UO_0000065,16.51,0.32,3.4,7.26,0,CHEMBL3706072,Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3660084,,None,381.39,0,3.16,BDBM104211,Fc1cc(OC2CCNCC2F)c2nc(-c3nnc4ccccn34)ccc2c1,IC50,'=',502,nM,6.3,,222623,UO_0000065,16.52,0.31,3.14,9.79,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3660088,,None,363.4,0,3.02,BDBM104217,FC1CNCCC1Oc1cccc2ccc(-c3nnc4ccccn34)nc12,IC50,'=',1000,nM,6,,222631,UO_0000065,16.51,0.3,2.98,9.33,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3975214,,None,353.39,0,4.21,BDBM238543,O=c1[nH]ccc2[nH]c(-c3cccc4ccc(Nc5ccccc5)nc34)nc12,IC50,'=',71.8,nM,7.14,,416266,UO_0000065,20.22,0.36,2.93,8.26,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3894442,,None,464.57,0,3.93,BDBM238677,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC(C)(C)CNC(=O)OC(C)(C)C,IC50,'=',61.8,nM,7.21,,416786,UO_0000065,15.52,0.29,3.28,5.96,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3959100,,None,404.45,0,3,BDBM192552,N[C@H]1CCCN(c2ncncc2Nc2ncc3ccc(-c4ccccc4F)nn23)C1,IC50,'=',160,nM,6.8,,344544,UO_0000065,16.8,0.31,3.8,6.99,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL218859,GW445012X,None,266.34,0,3.23,GW445012X,CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1,Inhibition,'=',-3.47,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1958401,,None,270.34,0,2.58,SID103904798,O=c1cc(-c2ccncc2)nc(NC2CCCCC2)[nH]1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1972584,,None,591.72,1,4.47,SID103904787,CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2006778,,None,380.45,0,4.23,SID103905094,CNC(=O)C=Cc1cnc(N)c2c(-c3cc(F)c4[nH]c(C)cc4c3)csc12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2006010,,None,401.18,1,5.6,SID103904883,O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(Cl)c(Cl)ccc12,Ki,'=',251.19,nM,6.6,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL101253,VATALANIB,3,346.82,1,5.01,SID103905548,Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2007151,,None,481.64,1,6.15,SID103904994,Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CCC(N2CCCC2)CC1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1981782,,None,335.19,0,4.19,SID103904659,O=C(NCc1ccc(Cl)c(Cl)c1)Nc1ccc2[nH]ncc2c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3687416,,None,525.58,1,4.79,BDBM151809,CC(C)C(=O)N[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H]1C,IC50,'=',49.42,nM,7.31,,292065,UO_0000065,13.9,0.26,2.52,6.64,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3687446,,None,502.56,1,4.4,BDBM151842,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1[S+](C)[O-],IC50,'=',29.43,nM,7.53,,292098,UO_0000065,14.99,0.29,3.13,7.24,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1952329,SGI-1776,1,405.42,0,4.05,SGI-1776,CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1,IC50,'=',362,nM,6.44,,,UO_0000065,15.89,0.3,2.39,11.78,0,CHEMBL4340988,Inhibition of human recombinant PIM2 using KKRNRTLTV as substrate in presence of [gamma-33P]ATP incubated for 40 mins by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4340512,1,Scientific Literature,Eur J Med Chem,2019,None,
CHEMBL574738,AST-487,1,529.57,2,5.11,AST-487,CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL3687477,,None,465.48,0,4.79,BDBM151873,C[C@@H]1C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@H](N)[C@@H]1C#N,IC50,'=',73.6,nM,7.13,,292129,UO_0000065,15.32,0.29,2.34,6.81,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3943813,,None,388.48,0,2.91,BDBM251573,Nc1ncc(-c2ccccc2)nc1C(=O)Nc1ccccc1N1CCC(N)CC1,IC50,'=',770,nM,6.11,,438367,UO_0000065,15.74,0.29,3.2,5.55,0,CHEMBL3889161,In Vitro Caliper Kinase Assay: For comparison between certain PKC inhibitors of the present application and structurally comparable PIM kinase inhibitors,,,,,,,,,,,,,,,,,,,,,,
CHEMBL573339,PI-103,None,348.36,0,2.98,PI-103,Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL3928490,,None,407.43,0,3.35,BDBM192551,N[C@H]1CCN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1,IC50,'>',1000,nM,,,344543,UO_0000065,,,,,1,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3918076,,None,486.56,0,3.49,BDBM192601,N[C@H]1CCCN(c2ccncc2Nc2ncc3ccc(-c4cc(C(=O)NC5CC5)ccc4F)nn23)C1,IC50,'=',0.5,nM,9.3,,344671,UO_0000065,19.12,0.35,5.81,8.2,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3986154,,None,511.58,1,2.22,BDBM192561,C[C@H]1CN(c2ccncc2Nc2ncc3ccc(-c4ccc(S(C)(=O)=O)cc4F)nn23)C[C@@H](N)[C@@H]1O,IC50,'=',0.5,nM,9.3,,344553,UO_0000065,18.18,0.35,7.08,6.7,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3966076,,None,403.41,0,3.97,BDBM238599,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC(C)(C)C(F)(F)F,IC50,'=',2.24,nM,8.65,,416706,UO_0000065,21.44,0.41,4.68,10.46,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3947213,,None,310.33,0,2.92,BDBM238524,Cc1nc2cccc(-c3cc4c([nH]3)C(C)CNC4=O)c2nc1F,IC50,'=',758,nM,6.12,,416668,UO_0000065,19.72,0.36,3.2,8.66,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1090360,,None,587.71,2,6.28,26,O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1,IC50,'>',1000,nM,,,,UO_0000065,,,,,0,CHEMBL1109680,Inhibition of PIM2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1156213,1,Scientific Literature,Bioorg Med Chem Lett,2010,None,
CHEMBL2087492,,None,487.59,1,-0.01,32,Cc1c(CN2CCN(S(C)(=O)=O)CC2)nc2c(N3CCOCC3)nc(-c3cnc(N)nc3)cn12,Inhibition,'<',30,%,,,,UO_0000187,,,,,0,CHEMBL2092435,Inhibition of PIM2 at 5 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2086238,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL2088998,,None,279.3,0,3.17,19,COC(=O)c1cc2c([nH]c3cccc(N)c32)c2[nH]ccc12,Activity,'=',93,%,,,,UO_0000187,,,,,0,CHEMBL2090475,Inhibition of human Pim2 using RSRHSSYPAGT as substrate assessed as residual activity at 1 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2086229,1,Scientific Literature,Eur J Med Chem,2012,None,
CHEMBL3899420,,None,455.56,1,5.15,BDBM238781,Cc1nc2cccc(-c3cc4c([nH]3)[C@H](COCc3ccccc3)NC4=O)c2nc1NC(C)(C)C,IC50,'=',7.94,nM,8.1,,416890,UO_0000065,17.78,0.33,2.95,8.81,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL184847,,None,371.44,0,4.86,SID103904377,Cc1ccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)cc1C,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2206008,,None,370.88,0,4.55,16e,CCN(CC)CCOc1ccc(/C=C2\C(=O)Nc3ccc(Cl)cc32)cc1,Activity,'=',94.7,%,,,,UO_0000187,,,,,0,CHEMBL2212371,Inhibition of human recombinant PIM2 expressed in insect cells using CKRREILSRRPSYRK as substrate assessed as residual activity at 1 uM after 60 mins relative to staurosporine,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2203085,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL1682553,,None,292.35,0,3.09,SID103904510,CC(C)Nc1c(-c2ccc3[nH]ncc3c2)nc2ncccn12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL104468,,None,281.31,0,2.78,NU7026,O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12,Residual Activity,'=',87,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL124660,TANDUTINIB,2,562.72,2,5.03,MLN-518,COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1,Kd,,,,,,Not Active,,,,,,0,CHEMBL859489,Average Binding Constant for PIM2; NA=Not Active at 10 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144455,1,Scientific Literature,Nat Biotechnol,2005,None,
CHEMBL1982466,,None,454.56,1,5.9,SID103904290,Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1966808,,None,323.38,0,2.57,SID103904979,O=c1[nH]c2sc3c(c2c2nc(-c4ccncc4)nn12)CCCC3,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL565612,SOTRASTAURIN,2,438.49,0,2.43,SID103905056,CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1,Ki,'=',1.585,nM,8.8,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1986970,,None,390.45,0,2.59,SID103904516,COCCN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL14762,SELICICLIB,2,354.46,0,3.2,roscovitine,CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1,Kd,,,,,,Not Active,,,,,,0,CHEMBL859489,Average Binding Constant for PIM2; NA=Not Active at 10 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144455,1,Scientific Literature,Nat Biotechnol,2005,None,
CHEMBL4224959,,None,397.45,0,3.48,12j,CC(C)Nc1ccc2cnn(-c3cncc(-c4ccc(-c5nnn[nH]5)cc4)n3)c2c1,IC50,'>',30000,nM,,,,UO_0000065,,,,,0,CHEMBL4222673,Inhibition of human PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4219163,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL2000345,,None,384.23,0,4.41,SID103905618,COc1cc(C=C(C#N)c2nc3cc(C)ccc3[nH]2)c(Br)cc1O,Ki,'=',251.19,nM,6.6,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL4070441,,None,453.11,0,3.49,Tab 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL408019,,None,294.31,0,2.68,13,O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1,Activity,'=',0.4,%,,,,UO_0000187,,,,,0,CHEMBL982757,Binding affinity to human PIM2 at 10 uM relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1151712,1,Scientific Literature,J Med Chem,2008,None,
CHEMBL4095220,,None,453.11,0,3.49,Tab 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3660022,,None,359.43,0,3.59,BDBM104140,NC1CCC(Oc2cccc3ccc(-c4nnc5ccccn45)nc23)CC1,IC50,'=',134,nM,6.87,,222557,UO_0000065,19.12,0.35,3.28,8.77,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3941570,,None,411.49,0,1.45,BDBM238657,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N1CC(S(C)(=O)=O)C1,IC50,'=',272,nM,6.57,,416767,UO_0000065,15.96,0.31,5.12,6.08,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4129779,,None,387.49,0,4.27,19,COc1ccc(-c2c[nH]c3ccc(-c4cncc(NCCN(C)C)n4)cc23)cc1,IC50,'=',870,nM,6.06,,,UO_0000065,15.64,0.29,1.79,9.17,0,CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4118246,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL36450,,None,236.27,0,3.71,SC-68376,Cc1nc(-c2ccccc2)c(-c2ccncc2)o1,Residual Activity,'=',117,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3634792,,None,308.39,0,2.26,10,Cc1n[nH]c2cnc(-c3cnccc3N3CCC[C@H](N)C3)cc12,Ki,'=',8300,nM,5.08,,,UO_0000065,16.48,0.3,2.82,6.07,0,CHEMBL3636741,Inhibition of Pim2 (unknown origin) using 5FAM-ARKRRRHPSGPPTA as substrate after 90 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632547,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL3687445,,None,486.56,1,5.39,BDBM151841,CS[C@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H]1C,IC50,'=',7.94,nM,8.1,,292097,UO_0000065,16.65,0.33,2.71,10.01,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3687523,,None,533.55,2,5.5,BDBM151919,C[C@@H]1C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@H](N)[C@@H]1Oc1ccccn1,IC50,'=',120.03,nM,6.92,,292175,UO_0000065,12.97,0.24,1.42,6.72,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2220486,LUCITANIB,2,443.5,0,4.42,Lucitanib,CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL2218927,,None,280.36,0,3.55,Tyrphostin AGL-2043,Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C,Residual Activity,'=',90,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL155333,,None,501.05,1,4.68,KN_93,COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1,Residual Activity,'=',137,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3942186,,None,435.48,0,3.99,BDBM192574,C[C@@H]1C[C@H](N)CN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1,IC50,'=',0.3,nM,9.52,,344659,UO_0000065,21.87,0.41,5.53,11.29,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4080797,,None,408.51,0,2.82,35,COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1,Activity,'=',100,%,,,,UO_0000187,,,,,0,CHEMBL4055243,Inhibition of wild-type human partial length PIM2 (M1 to E291 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4052645,1,Scientific Literature,Bioorg Med Chem Lett,2017,None,
CHEMBL1986499,,None,384.42,0,4.26,SID103904466,Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccc(F)cc3)cc12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1980142,,None,400.28,1,5.31,SID103904901,O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(C(F)(F)F)cccc12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3809377,,None,361.45,0,3.6,10f,Cc1nc2cccc3c2nc1NC[C@H](C)CC[C@H]1CNC(=O)c2cc-3[nH]c21,IC50,'=',0.4,nM,9.4,,,UO_0000065,26,0.48,5.8,11.36,0,CHEMBL3812018,Inhibition of human full-length Pim2 expressed in Escherichia coli assessed as phosphorylation of biotinylated BAD peptide at Ser 112 preincubated for 30 mins followed by substrate addition measured after 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3808325,1,Scientific Literature,ACS Med Chem Lett,2016,None,
CHEMBL4527131,,None,352.46,0,4.12,15,Cc1nc2cccc(-c3cc4c(s3)C(=O)NC4)c2nc1NC(C)(C)C,IC50,'=',2.5,nM,8.6,,,UO_0000065,24.41,0.47,4.48,12.86,0,CHEMBL4478465,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as reduction in phosphorylation of biotinylated-BAD peptide at Serine 112 residue preincubated for 30 mins followed by substrate addition for 1 hr by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4477213,1,Scientific Literature,J Med Chem,2016,None,
CHEMBL3902228,,None,435.48,0,3.99,BDBM192646,C[C@H]1CCN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C[C@H]1N,IC50,'=',15.7,nM,7.8,,344694,UO_0000065,17.92,0.33,3.81,9.25,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4107702,,None,435.48,0,3.99,BDBM192647,C[C@@H]1CCN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C[C@@H]1N,IC50,'=',1.6,nM,8.8,,344695,UO_0000065,20.2,0.38,4.81,10.43,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3902922,,None,416.39,0,4.17,BDBM192566,O=c1ccc(-c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)c[nH]1,IC50,'=',281,nM,6.55,,344558,UO_0000065,15.73,0.29,2.38,7.45,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2218939,,None,361.47,0,3.93,MEK_Inhibitor_I,N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1,Residual Activity,'=',137,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3957474,,None,481.56,0,3,BDBM192560,CS(=O)(=O)c1ccc(-c2ccc3cnc(Nc4cnccc4N4CCC[C@H](N)C4)n3n2)c(F)c1,IC50,'=',9.1,nM,8.04,,344552,UO_0000065,16.7,0.32,5.04,6.79,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL506711,,None,225.24,0,2.02,25b,O=C1CSC(=O)N1Cc1ccccc1F,IC50,'>',100000,nM,,,,UO_0000065,,,,,0,CHEMBL957366,Inhibition of human recombinant Pim2 by ATP depletion assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139352,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL1999590,,None,344.38,0,3.68,SID103905140,Cc1cc(-c2ccccc2)n(-c2cc(NN=Cc3ccco3)ncn2)n1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL183906,,None,273.24,0,3.03,4a,O=C1NC(=O)/C(=C/c2cccc(C(F)(F)F)c2)S1,IC50,'=',100,nM,7,,,UO_0000065,25.62,0.53,3.97,15.16,0,CHEMBL957366,Inhibition of human recombinant Pim2 by ATP depletion assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139352,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL497607,,None,333.29,0,3.01,6a,COCOc1c(/C=C2\SC(=O)NC2=O)cccc1C(F)(F)F,IC50,'=',1500,nM,5.82,,,UO_0000065,17.47,0.36,2.81,9.01,0,CHEMBL957366,Inhibition of human recombinant Pim2 by ATP depletion assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1139352,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL3970786,,None,535.55,1,3.28,BDBM191133,CS(=O)(=O)c1ccc(-c2c(-c3cccc(OC(F)(F)F)c3)cc3n2[C@@H](CCNC(=N)N)CNC3=O)cc1,IC50,'=',19,nM,7.72,,341804,UO_0000065,14.42,0.29,4.44,5.54,0,CHEMBL3887520,Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3967769,,None,383.85,0,4.25,BDBM191073,NCCC1CNC(=O)c2cc(-c3cc(Cl)ccc3F)c(-c3ccccc3)n21,IC50,'=',32,nM,7.5,,341744,UO_0000065,19.53,0.38,3.24,12.48,0,CHEMBL3887520,Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3943279,,None,429.44,0,3.97,BDBM191084,NCCC1CNC(=O)c2cc(-c3cccc(C(F)(F)F)c3)c(-c3ccc(CO)cc3)n21,IC50,'=',102,nM,6.99,,341755,UO_0000065,16.28,0.31,3.02,8.71,0,CHEMBL3887520,Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3972842,,None,307.36,0,2.26,BDBM238572,CNc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2nc1C,IC50,'=',4.1,nM,8.39,,416694,UO_0000065,27.29,0.5,6.13,10.14,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4070019,,None,453.11,0,3.31,Tab 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL231623,GSK-620503A,None,307.33,0,3.24,GSK620503A,NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N,Inhibition,'=',-1.22,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL206010,GW814408X,None,344.38,0,3.47,GW814408X,COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1,Inhibition,'=',-0.12,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL215814,GW576484X,None,614.62,2,6.5,GW576484X,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1,Inhibition,'=',0.19,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3973086,,None,421.44,0,4.42,BDBM191071,NCCC1CNC(=O)c2cc(-c3cccc(OC(F)(F)F)c3)c(-c3ccsc3)n21,IC50,'=',143,nM,6.84,,341742,UO_0000065,16.24,0.32,2.42,9.88,0,CHEMBL3887520,Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3898611,,None,439.45,0,3.69,BDBM192649,N[C@H]1CN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)CC[C@@H]1F,IC50,'=',1.1,nM,8.96,,344642,UO_0000065,20.39,0.38,5.27,10.62,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3297762,,None,512.1,1,3.8,BDBM50021618,CN1CCN(C[C@@H](NC(=O)C[C@H]2CNC(=O)c3cc(-c4cccc(Cl)c4)cn32)C2CCCCC2)CC1,IC50,'=',37,nM,7.43,,330368,UO_0000065,14.51,0.28,3.63,10.68,0,CHEMBL3887311,Kinase Inhibition Assay: Method for PIM2 Kinase Inhibition Assay: Dowex Technique i. Kinase Buffer (KB)The buffer for PIM2 assay was composed of HEPES 50 mM,,,,,,,,,,,,,,,,,,,,,,
CHEMBL218970,GW445017X,None,272.74,0,3.27,GW445017X,CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1,Inhibition,'=',0.04,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL361894,GW806290X,None,346.35,0,2.7,GW806290X,c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1,Inhibition,'=',4.39,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL605003,,None,371.46,0,2.64,SU-6656,CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2,Activity,'=',95,%,,,,UO_0000187,,,,,0,CHEMBL1061086,Percentage PIM2 activity remaining in the presence of 1uM inhibitor,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1150976,1,Scientific Literature,Biochem J,2007,None,
CHEMBL3908673,,None,399.46,0,3.18,BDBM238660,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC(C)c1cnccn1,IC50,'=',163,nM,6.79,,416769,UO_0000065,16.99,0.31,3.61,6.26,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3940411,,None,335.41,0,3.39,BDBM238672,Cc1nc2cccc(-c3cc4c([nH]3)CNC4=O)c2nc1NC(C)(C)C,IC50,'=',0.882,nM,9.05,,416781,UO_0000065,27,0.49,5.66,10.95,1,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1909400,,None,557.55,1,5.48,SB-284847-BT,Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F,Inhibition,'=',-0.07,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3906206,,None,372.4,0,4.4,BDBM238418,O=C1NCCc2[nH]c(-c3cccc4ccc(Nc5cccc(F)c5)nc34)cc21,IC50,'=',7.7,nM,8.11,,416193,UO_0000065,21.79,0.4,3.71,11.62,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3898550,,None,375.35,0,3.85,BDBM238452,CC(Oc1ccc2cccc(-c3cc4c([nH]3)CCNC4=O)c2n1)C(F)(F)F,IC50,'=',204,nM,6.69,,416196,UO_0000065,17.82,0.34,2.84,9.98,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3900646,,None,435.48,0,4.13,BDBM192640,C[C@H]1CC[C@H](N)CN1c1ccncc1Nc1ncc2ccc(-c3c(F)cccc3F)nn12,IC50,'=',38.7,nM,7.41,,344681,UO_0000065,17.02,0.32,3.28,8.79,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4112982,,None,435.48,0,4.13,BDBM192641,C[C@@H]1CC[C@@H](N)CN1c1ccncc1Nc1ncc2ccc(-c3c(F)cccc3F)nn12,IC50,'=',1,nM,9,,344682,UO_0000065,20.67,0.38,4.87,10.67,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3927283,,None,353.43,0,4.3,BDBM238489,O=C1NCC(Cc2ccccc2)c2[nH]c(-c3cccc4cccnc34)cc21,IC50,'=',206,nM,6.69,,416227,UO_0000065,18.92,0.34,2.39,11.57,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2017344,,None,379.4,1,5.26,13q,Fc1cc(F)cc(Nc2nc3c(-c4nnc[nH]4)cccc3c3sccc23)c1,IC50,'=',24,nM,7.62,,,UO_0000065,20.08,0.39,2.36,11.46,0,CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016532,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL3927458,,None,324.39,0,2.64,BDBM238780,Cc1nc2cccc(-c3cc(C(N)=O)n[nH]3)c2nc1NC(C)(C)C,IC50,'=',8.9,nM,8.05,,416889,UO_0000065,24.82,0.46,5.41,7.35,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2017323,,None,377.86,1,5.63,10b,Clc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2sccc12,IC50,'=',2,nM,8.7,,,UO_0000065,23.02,0.46,3.07,13.08,0,CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016532,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL2017331,,None,360.81,0,4.67,20b,Clc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2n2cccc12,IC50,'=',41,nM,7.39,,,UO_0000065,20.47,0.39,2.72,10.42,0,CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016532,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL446024,GW683003X,None,294.24,0,2.16,GW683003X,FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1,Inhibition,'=',1.1,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL4794578,,None,397.44,0,2.58,7,CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12,Activity,'=',94.72,%,,,,UO_0000187,,,,,0,CHEMBL4721497,Inhibition of wild-type human partial length PIM2 (M1 to E291 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4715821,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,Dose = 1.0 microM
CHEMBL1201182,TEMSIROLIMUS,4,1030.3,None,None,Temsirolimus,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL2377716,,None,244.25,0,2.9,15,CCCc1c[nH]c2c([N+](=O)[O-])cc3cn[nH]c3c12,Inhibition,'=',66,%,,,,UO_0000187,,,,,0,CHEMBL2378598,Inhibition of human full length Pim-2 using RSRHSSYPAGT as substrate assessed as residual activity at 1 uM after 30 mins in presence of [gamma-33P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2375344,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL2377708,,None,248.29,0,3.29,26,Nc1cc2cn[nH]c2c2c(-c3ccccc3)c[nH]c12,Inhibition,'=',92,%,,,,UO_0000187,,,,,0,CHEMBL2378599,Inhibition of human full length Pim-2 using RSRHSSYPAGT as substrate assessed as residual activity at 10 uM after 30 mins in presence of [gamma-33P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2375344,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL2377707,,None,272.31,0,2.37,25,CCCc1c(C(=O)OC)[nH]c2c(N)cc3cn[nH]c3c12,Inhibition,'=',78,%,,,,UO_0000187,,,,,0,CHEMBL2378599,Inhibition of human full length Pim-2 using RSRHSSYPAGT as substrate assessed as residual activity at 10 uM after 30 mins in presence of [gamma-33P]ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2375344,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL3912242,,None,435.48,0,4,BDBM192588,CN[C@H]1CCCN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1,IC50,'=',31,nM,7.51,,344658,UO_0000065,17.24,0.32,3.51,10.67,1,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4115280,,None,434.94,0,3.76,BDBM192605,C[C@@H]1C[C@H](N)CN(c2ccncc2Nc2ncc3ccc(-c4ncccc4Cl)nn23)C1,IC50,'=',0.5,nM,9.3,,344676,UO_0000065,21.38,0.41,5.54,9.56,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1909379,,None,387.87,0,4.84,GR-269666A,Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1,Inhibition,'=',0.02,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3809463,,None,345.41,0,3.13,8a,Cc1nc2cccc3c2nc1NC/C=C/C[C@H]1CNC(=O)c2cc-3[nH]c21,IC50,'=',0.5,nM,9.3,,,UO_0000065,26.93,0.49,6.17,11.25,0,CHEMBL3812018,Inhibition of human full-length Pim2 expressed in Escherichia coli assessed as phosphorylation of biotinylated BAD peptide at Ser 112 preincubated for 30 mins followed by substrate addition measured after 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3808325,1,Scientific Literature,ACS Med Chem Lett,2016,None,
CHEMBL3808887,,None,359.43,0,3.52,8c,Cc1nc2cccc3c2nc1N[C@H](C)/C=C/C[C@H]1CNC(=O)c2cc-3[nH]c21,IC50,'=',0.05,nM,10.3,,,UO_0000065,28.66,0.52,6.78,12.46,0,CHEMBL3812018,Inhibition of human full-length Pim2 expressed in Escherichia coli assessed as phosphorylation of biotinylated BAD peptide at Ser 112 preincubated for 30 mins followed by substrate addition measured after 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3808325,1,Scientific Literature,ACS Med Chem Lett,2016,None,
CHEMBL3809986,,None,359.43,0,3.52,8d,Cc1nc2cccc3c2nc1N[C@@H](C)/C=C/C[C@H]1CNC(=O)c2cc-3[nH]c21,IC50,'=',0.3,nM,9.52,,,UO_0000065,26.49,0.48,6,11.51,0,CHEMBL3812018,Inhibition of human full-length Pim2 expressed in Escherichia coli assessed as phosphorylation of biotinylated BAD peptide at Ser 112 preincubated for 30 mins followed by substrate addition measured after 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3808325,1,Scientific Literature,ACS Med Chem Lett,2016,None,
CHEMBL3810085,,None,369.43,0,3.96,1,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1Nc1ccccc1,IC50,'=',2,nM,8.7,,,UO_0000065,23.55,0.42,4.74,10.52,0,CHEMBL3812018,Inhibition of human full-length Pim2 expressed in Escherichia coli assessed as phosphorylation of biotinylated BAD peptide at Ser 112 preincubated for 30 mins followed by substrate addition measured after 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3808325,1,Scientific Literature,ACS Med Chem Lett,2016,None,
CHEMBL1096626,GSK-938890A,None,447.5,0,2.28,GSK938890A,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21,Inhibition,'=',2.38,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1398474,,None,344.89,1,5.71,Akt_Inhibitor_X,CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21,Residual Activity,'=',125,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL91730,,None,365.8,1,5.1,p38_Inhibitor,Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1,Residual Activity,'=',128,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1782515,,None,338.37,0,2.75,23,O=C(O)c1cc2cc(-c3cncc(NC4CCNCC4)n3)ccc2o1,IC50,'=',150,nM,6.82,,,UO_0000065,20.17,0.37,4.07,6.8,0,CHEMBL1786238,Inhibition of human Pim2 using 5-FAM-RSRHSSYPAGT-CONH2 as substrate after 90 mins by off-chip mobility shift method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1781944,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL3898587,,None,367.45,0,4.67,BDBM238485,CC(c1ccccc1)c1ccc2cccc(-c3cc4c([nH]3)CCNC4=O)c2n1,IC50,'=',122,nM,6.91,,416223,UO_0000065,18.82,0.34,2.24,11.97,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3958307,,None,390.49,0,2.9,BDBM238510,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@@H]1CCC[C@H](N)C1,IC50,'<',0.1,nM,,,416654,UO_0000065,,,,,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3940808,,None,363.47,0,3.68,BDBM238517,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NCC(C)(C)C,IC50,'=',0.6,nM,9.22,,416661,UO_0000065,25.37,0.47,5.54,11.15,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2218936,,None,567.11,1,4.31,Met_Kinase_Inhibitor,CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1,Residual Activity,'=',101,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1915447,,None,456.82,1,5.86,15d,FC(F)(F)Oc1ccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3cnccc23)c(Cl)c1,IC50,'=',113,nM,6.95,,,UO_0000065,15.21,0.3,1.09,7.84,0,CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914433,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL2048867,,None,382.28,0,2.7,23,N[C@@H]1CCCN(c2c(Br)cccc2/C=C2\SC(=O)NC2=O)C1,IC50,'<',3,nM,,,,UO_0000065,,,,,0,CHEMBL2049740,Inhibition of human PIM2 using FITC-(AHX)RSRHSSYPAGT-COOH as substrate after 90 mins by mobility shift assay in presence of 50 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2046384,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL4173266,,None,242.28,0,2.53,2月8日,COc1ccc2c(c1)[nH]c1c(C)nc(CO)cc12,Activity,'=',4.7,%,,,,UO_0000187,,,,,0,CHEMBL4151472,Inhibition of human PIM2 expressed in bacterial expression system assessed as remaining enzyme activity at 10 uM by kinome scan assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4145671,1,Scientific Literature,J Med Chem,2018,None,
CHEMBL505187,GSK-718429A,None,528.62,2,7.34,GSK718429A,CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1,Inhibition,'=',0.19,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1985566,,None,560.65,2,6.2,SID103904722,COc1cc(-c2ccc3c(c2)Nc2ccc(CCOc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1CC#N,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2325901,,None,244.3,0,1.97,3a,CC(C)NC(=O)c1c[nH]c2ncc(C3CC3)nc12,Inhibition,'=',-28,%,,Outside typical range,,UO_0000187,,,,,0,CHEMBL2329527,Inhibition of PIM2 (unknown origin) at 10 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2321829,1,Scientific Literature,J Med Chem,2013,None,
CHEMBL2017340,,None,377.86,1,5.63,13g,Clc1ccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3sccc23)cc1,IC50,'=',86,nM,7.07,,,UO_0000065,18.7,0.37,1.44,10.63,0,CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016532,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL3958307,,None,390.49,0,2.9,BDBM238510,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@@H]1CCC[C@H](N)C1,IC50,'=',3.5,nM,8.46,,416655,UO_0000065,21.65,0.4,5.56,7.78,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3676267,,None,433.46,0,3.61,BDBM131737,N[C@H]1C[C@@H](F)CN(c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C1,IC50,'=',55,nM,7.26,,263970,UO_0000065,16.75,0.33,3.65,8.63,0,CHEMBL3706072,Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1952142,,None,422.41,0,3.13,9a,COc1cc(NCC2CCNCC2)nc2c1nnn2-c1cccc(OC(F)(F)F)c1,IC50,'=',29,nM,7.54,,,UO_0000065,17.84,0.34,4.41,8.75,1,CHEMBL1954567,Inhibition of PIM2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1949661,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL3895531,,None,400.49,0,2.77,BDBM248953,Cc1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CCNC(C)CC3)n2)n1,Ki,'=',2.42,nM,8.62,,434160,UO_0000065,21.51,0.39,5.85,10.18,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3900258,,None,386.46,0,2.74,BDBM248959,Cc1cncc(-c2cc3c(cn2)cnn3-c2cccc(NC3CCNCC3)n2)n1,Ki,'=',1.28,nM,8.89,,434166,UO_0000065,23.01,0.42,6.15,9.52,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3920778,,None,427.52,0,2.78,BDBM249007,Cc1cncc(-c2cc3c(cn2)cnn3-c2cnc(C3CC3)c(N3CCC[C@H](N)C3)n2)n1,Ki,'=',0.257,nM,9.59,,434214,UO_0000065,22.43,0.41,6.81,8.6,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL249282,,None,387.44,0,2.63,SID103904817,N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCN4CCOCC4)cc2-3)cn1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1969264,,None,318.38,0,3.79,SID103905515,CC(C)(C)NC(=O)c1ccc2nc3[nH]c4ccccc4c3nc2c1,Ki,'=',501.19,nM,6.3,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1973711,,None,287.66,0,1.98,SID103905594,N#Cc1c(O)[nH]c(=O)c2c(=N)oc3ccc(Cl)cc3c12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3651962,,None,439.47,0,3.21,BDBM106866,Nc1cc(F)c(-c2ccccc2F)nc1C(=O)Nc1cnccc1[C@@H]1CC[C@H](O)[C@H](N)C1,IC50,'=',4,nM,8.4,,225887,UO_0000065,19.11,0.36,5.19,6.6,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3660051,,None,416.49,0,2.53,BDBM104177,CN(C)C(=O)[C@@H]1CC(Oc2cccc3ccc(-c4nnc5ccccn45)nc23)CCN1,IC50,'=',10000,nM,5,,222590,UO_0000065,12.01,0.22,2.47,5.91,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3660052,,None,432.48,0,2.46,BDBM104178,CON(C)C(=O)[C@@H]1CC(Oc2cccc3ccc(-c4nnc5ccccn45)nc23)CCN1,IC50,'=',10000,nM,5,,222591,UO_0000065,11.56,0.21,2.54,5.33,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL1984191,,None,291.14,0,3.84,SID103905424,Clc1ccc(-c2n[nH]cc2-c2ccncn2)cc1Cl,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3660036,,None,375.48,0,4.09,BDBM104154,CCC(Oc1cccc2ccc(-c3nnc4ccccn34)nc12)[C@H](CC)CN,IC50,'=',413,nM,6.38,,222571,UO_0000065,17,0.31,2.29,8.15,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3964505,,None,365.44,0,4.58,BDBM238483,C=C(c1ccccc1)c1ccc2cccc(-c3cc4c([nH]3)CCNC4=O)c2n1,IC50,'=',8.1,nM,8.09,,416221,UO_0000065,22.14,0.39,3.51,14,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2017338,,None,344.4,0,4.37,13e,c1cc(-c2nnc[nH]2)c2nc(Nc3ccncc3)c3ccsc3c2c1,IC50,'=',68,nM,7.17,,,UO_0000065,20.81,0.39,2.8,9.03,0,CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016532,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL3960453,,None,417.48,0,1.02,BDBM249055,NCCOc1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CCNCC3)n2)n1,Ki,'=',0.806,nM,9.09,,434259,UO_0000065,21.78,0.4,8.07,7.58,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4247298,,None,586.7,2,5.44,15i,Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1,Activity,'=',93,%,,,,UO_0000187,,,,,0,CHEMBL4230891,Binding affinity to wild-type human partial length PIM2 (M1 to E291 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4229344,1,Scientific Literature,Eur J Med Chem,2018,None,
CHEMBL522709,GSK-317315A,None,461.47,1,5.35,GSK317315A,COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1,Inhibition,'=',0.75,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL4167749,,None,385.47,1,5.15,12,CCC(=O)Nc1ccc(-c2c[nH]c3ncnc(N[C@H](C)c4ccccc4)c23)cc1,Inhibition,'=',8,%,,,,UO_0000187,,,,,0,CHEMBL4156125,Inhibition of recombinant full length human GST-tagged PIM2 expressed in baculovirus expression system at 500 nM by Z-LYTE assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4152312,1,Scientific Literature,Eur J Med Chem,2018,None,
CHEMBL3660038,,None,361.45,0,3.7,BDBM104156,CC[C@H](CN)C(C)Oc1cccc2ccc(-c3nnc4ccccn34)nc12,IC50,'=',279,nM,6.55,,222573,UO_0000065,18.13,0.33,2.85,8.37,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3935018,,None,401.48,0,2.21,BDBM248997,Cc1cncc(-c2cc3c(cn2)cnn3-c2cnc(C)c(N3CCC[C@H](N)C3)n2)n1,Ki,'=',0.724,nM,9.14,,434204,UO_0000065,22.77,0.42,6.93,8.2,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL212250,GW615311X,None,644.12,2,8,GW615311X,O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1,Inhibition,'=',2.24,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL572514,,None,369.42,0,3.71,14m,CN(C)Cc1nc2c(sc3ccc(-c4ccc(O)c(F)c4)cc32)c(=O)[nH]1,Ki,'=',5,nM,8.3,,,UO_0000065,22.47,0.44,4.59,11.99,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL511765,GSK-2213727A,None,506.54,1,3.5,GSK2213727A,COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1,Inhibition,'=',0.16,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL408564,,None,347.17,0,3.33,SB-739452,O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1,Inhibition,'=',0.42,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL4783569,,None,360.42,0,3.78,51,COc1ccccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2[nH]1,Inhibition,'=',5,%,,,,UO_0000187,,,,,0,CHEMBL4718881,Inhibition of recombinant full length GST-tagged human PIM2 expressed in baculovirus expression system at 500 nM using Ser/Thr 07 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4715760,1,Scientific Literature,Eur J Med Chem,2016,None,Dose = 500.0 nM | TIME = 1.0 hr
CHEMBL185238,GW786460X,None,287.33,0,3.39,GW786460X,Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1,Inhibition,'=',-0.16,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL231013,GSK-605714A,None,228.25,0,1.86,GSK605714A,COc1ccc(-c2ccncc2)cc1C(N)=O,Inhibition,'=',-0.49,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL10,SB-203580,None,377.44,0,4.68,K00038,C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,Thermal melting change,'=',0,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL2048859,,None,317.41,0,2.15,8,CN(C)C1CCN(c2ccccc2/C=C2\SC(=O)NC2=O)C1,IC50,'=',500,nM,6.3,,,UO_0000065,19.85,0.39,4.15,11.97,0,CHEMBL2049740,Inhibition of human PIM2 using FITC-(AHX)RSRHSSYPAGT-COOH as substrate after 90 mins by mobility shift assay in presence of 50 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2046384,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL2048862,,None,289.36,0,1.55,11,N[C@H]1CCN(c2ccccc2/C=C2\SC(=O)NC2=O)C1,IC50,'=',250,nM,6.6,,,UO_0000065,22.82,0.45,5.05,8.75,0,CHEMBL2049740,Inhibition of human PIM2 using FITC-(AHX)RSRHSSYPAGT-COOH as substrate after 90 mins by mobility shift assay in presence of 50 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2046384,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL2048864,,None,323.81,0,2.07,14,O=C1NC(=O)/C(=C/c2cccc(Cl)c2N2CCNCC2)S1,IC50,'=',82,nM,7.09,,,UO_0000065,21.88,0.46,5.02,11.53,0,CHEMBL2049740,Inhibition of human PIM2 using FITC-(AHX)RSRHSSYPAGT-COOH as substrate after 90 mins by mobility shift assay in presence of 50 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2046384,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL3892409,,None,391.48,0,3.2,BDBM238557,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1(C)CCOCC1,IC50,'=',5.6,nM,8.25,,416679,UO_0000065,21.08,0.39,5.05,8.98,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4110731,,None,374.45,0,2.24,BDBM248905,CCn1cc(-c2cc3c(cn2)cnn3-c2cccc(N3CC[C@@H](N)C3)n2)cn1,Ki,'=',17.3,nM,7.76,,434112,UO_0000065,20.73,0.38,5.52,8.56,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL222419,GSK-237701A,None,457.94,0,5,GSK237701A,COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC,Inhibition,'=',0.26,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL4557026,ERKi-NC,None,312.33,0,1.73,EUB0000700,C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1,% Control,,100,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507286,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL2206014,,None,429.5,1,5.06,15b,O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Br)c(O)c(Br)c1,Activity,'=',29,%,,,,UO_0000187,,,,,0,CHEMBL3382228,Inhibition of human recombinant Pim2 kinase expressed insect cells using CREBtide (CKRREILSRRPSYRK) substrate assessed as remaining enzyme activity at 1 uM after 60 mins relative to control,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3352815,1,Scientific Literature,Bioorg Med Chem Lett,2014,None,
CHEMBL3932537,,None,430.49,0,3.94,7,N[C@H]1CCCN(c2ccnc(NC(=O)c3c[nH]c4ccc(-c5ccccc5F)nc34)c2)C1,IC50,'=',314,nM,6.5,,,UO_0000065,15.11,0.28,2.56,6.51,0,CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3864151,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL3137331,DEFACTINIB,2,510.5,1,2.4,EUB0000138,CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1,Inhibition,,0,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4887140,PIM2 Invitrogen kinase activity assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507299,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1.0 碌M
CHEMBL3951088,,None,411.51,0,3.55,BDBM248881,c1cc(N2CCCNCC2)nc(-n2ncc3cnc(-c4cncc(C5CC5)c4)cc32)c1,Ki,'=',3.87,nM,8.41,,434088,UO_0000065,20.44,0.37,4.86,11.72,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2064515,,None,413.46,1,5.3,14d,N#Cc1ccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCO5)o3)cc2)cc1,Activity,'>',80,%,,,,UO_0000187,,,,,0,CHEMBL2066259,Inhibition of human recombinant Pim2 expressed in insect cells using CREBtide as substrate assessed as residual activity at 1 uM after 60 mins by Cerep assay,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2062370,1,Scientific Literature,J Med Chem,2012,None,
CHEMBL2037206,,None,490,1,5.65,19,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL495902,GW820759X,None,291.35,0,3.43,GW820759X,Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1,Inhibition,'=',0.52,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL605003,,None,371.46,0,2.64,SU6656,CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2,Residual Activity,'=',123,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1915643,,None,348.79,0,4.28,17a,NC(=O)c1cccc2c1nc(Nc1ccccc1Cl)c1ccncc12,IC50,'=',8,nM,8.1,,,UO_0000065,23.21,0.44,3.82,10.01,0,CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914433,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL2425645,,None,309.37,0,2.53,11,O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1,Inhibition,'=',99,%,,,,UO_0000187,,,,,0,CHEMBL2429482,Competitive binding affinity to PIM2 (unknown origin) at 10 uM in presence of ATP relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2424622,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL3103867,,None,406.47,0,3.04,4i,Nc1ccc(-c2ccccc2F)nc1C(=O)Nc1cnccc1N1CCC[C@H](N)C1,Ki,'<',1,nM,,,,UO_0000065,,,,,0,CHEMBL3106180,Inhibition of PIM2 (unknown origin) using NH2-AGAGRSRHSSYPAGT-OH as substrate by Kinase-Glo assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3102815,1,Scientific Literature,ACS Med Chem Lett,2013,None,
CHEMBL595373,,None,512.64,2,6.57,25,COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1,Residual activity,'=',104,%,,,,UO_0000187,,,,,0,CHEMBL1070476,Residual activity of PIM2 at 0.1 uM by microplate scintillation counting,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1152560,1,Scientific Literature,Bioorg Med Chem,2009,None,
CHEMBL477772,PAZOPANIB,4,437.53,0,3.14,Pazopanib,Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL7724,AG1295,None,234.3,0,3.91,K00237,Cc1cc2ncc(-c3ccccc3)nc2cc1C,Thermal melting change,'=',0.4,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL4097308,,None,385.48,0,2.99,13,Cc1cncc(-c2ccc3cnn(-c4cccc(N5CCCNCC5)n4)c3c2)n1,Ki,'=',7.9,nM,8.1,,,UO_0000065,21.02,0.38,5.11,11.29,0,CHEMBL4052120,Inhibition of PIM2 (unknown origin) using 5FAM-ARKRRRHPSGPPTA as substrate after 90 mins in presence of ATP by caliper microfluidic mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4049450,1,Scientific Literature,J Med Chem,2017,None,
CHEMBL4081716,,None,403.52,0,3.32,17,Cc1cncc(-c2cc3c(-c4cccc(N5CCCNCC5)n4)nsc3cn2)n1,Ki,'=',18,nM,7.75,,,UO_0000065,19.19,0.36,4.42,9.71,0,CHEMBL4052120,Inhibition of PIM2 (unknown origin) using 5FAM-ARKRRRHPSGPPTA as substrate after 90 mins in presence of ATP by caliper microfluidic mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4049450,1,Scientific Literature,J Med Chem,2017,None,
CHEMBL1909389,GW574782A,None,633.09,2,6.37,GW574782A,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl,Inhibition,'=',1.13,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL2017253,,None,434.57,0,3.12,3,CSc1ccccc1Nc1nc(N2CC3(CNC3)C2)nc2c(NCC3CC3)ncnc12,Inhibition,'=',25,%,,,,UO_0000187,,,,,0,CHEMBL2065127,Inhibition of PIM2 at 10 uM by FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2062359,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL402108,GW708893X,None,417.9,1,5.6,GW708893X,Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1,Inhibition,'=',-3.59,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL4130104,,None,372.48,0,3.85,15,CN(C)CCNc1cncc(-c2ccc3[nH]cc(-c4ccc(N)cc4)c3c2)n1,IC50,'=',460,nM,6.34,,,UO_0000065,17.01,0.31,2.49,7.65,0,CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4118246,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL270054,GW280670X,None,350.79,0,1.76,GW280670X,NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1,Inhibition,'=',-0.27,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3664614,,None,451.5,0,3.44,BDBM104234,COCCOc1ccc2nnc(-c3ccc4cccc(OCC5(F)CCNCC5)c4n3)n2c1,IC50,'=',1000,nM,6,,222645,UO_0000065,13.29,0.25,2.56,7.25,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3660091,,None,402.43,0,3.96,BDBM104224,[C-]#[N+]c1ccc2nnc(-c3ccc4cccc(OC5CCNCCC5F)c4n3)n2c1,IC50,'=',1000,nM,6,,222635,UO_0000065,14.91,0.27,2.04,8.73,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3664632,,None,411.46,0,4.2,BDBM104258,CC(C)(CNCC(F)F)COc1cccc2ccc(-c3nnc4ccccn34)nc12,IC50,'=',506.2,nM,6.3,,222669,UO_0000065,15.3,0.29,2.1,9.79,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3973604,,None,382.47,1,5.21,BDBM238590,CC[C@H]1CNC(=O)c2cc(-c3cccc4ccc(Nc5ccccc5)nc34)[nH]c21,IC50,'=',2.8,nM,8.55,,416290,UO_0000065,22.36,0.4,3.34,12.25,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3916074,,None,438.49,1,5.17,BDBM225067,COc1ccc(CNc2nnc(-c3ccc4[nH]cc(-c5cncc(C6CC6)n5)c4c3)o2)cc1,IC50,'=',211.59,nM,6.67,,393060,UO_0000065,15.22,0.28,1.5,6.56,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3927624,,None,333.4,0,2.72,BDBM238585,Cc1nc2cccc(-c3cc4n(c3)CCNC4=O)c2nc1NC1CC1,IC50,'=',16.4,nM,7.79,,416286,UO_0000065,23.35,0.43,5.07,10.84,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3937933,,None,378.44,0,4.28,BDBM225091,CC(C)Nc1nnc(-c2ccc3[nH]cc(-c4nccc(OC(C)C)n4)c3c2)o1,IC50,'=',13.46,nM,7.87,,393084,UO_0000065,20.8,0.38,3.59,7.74,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2037203,,None,496.39,1,5.52,16,CN1CCCN(C(=O)c2ccc(Cl)c(-c3ccc(/C=C4/C(=O)Nc5ccc(Cl)cc54)o3)c2)CC1,IC50,'=',217,nM,6.66,,,UO_0000065,13.42,0.27,1.14,10.13,0,CHEMBL2038829,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034977,1,Scientific Literature,ACS Med Chem Lett,2012,None,
CHEMBL3814140,,None,388.48,0,2.95,40,CCc1cc(-c2c[nH]c3ncc(-c4cnn(C5CCNCC5)c4)cc23)nc(N)n1,Activity,'=',-87,%,,,,UO_0000187,,,,,0,CHEMBL3815502,Inhibition of human PIM2 (2 to 334 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3813616,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL3815046,,None,416.53,0,3.73,42,CCCCc1cc(-c2c[nH]c3ncc(-c4cnn(C5CCNCC5)c4)cc23)nc(N)n1,Activity,'=',-98,%,,,,UO_0000187,,,,,0,CHEMBL3815502,Inhibition of human PIM2 (2 to 334 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3813616,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL4782674,,None,488.01,0,4.45,8,COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCNC2,Activity,'=',94,%,,,,UO_0000187,,,,,0,CHEMBL4716275,Inhibition of recombinant full length N-terminal GST-tagged human PIM2 expressed in Escherichia coli assessed as residual activity at 1 uM relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4715694,1,Scientific Literature,Bioorg Med Chem,2016,None,Dose = 1.0 microM
CHEMBL3685746,,None,446.51,0,4.89,BDBM124910,C[C@H]1C[C@@H](N)CN(c2ccncc2Nc2cccc3cnc(-c4c(F)cccc4F)nc23)C1,IC50,'=',852,nM,6.07,,254212,UO_0000065,13.59,0.25,1.18,7.59,0,CHEMBL3705221,ATP Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 ul per well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2006188,,None,404.51,0,4.01,SID103904561,COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2NCCCN)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL497151,,None,437.22,0,4.04,SID103905371,O=c1nc(-c2cc3c(Oc4ccc(I)cc4)cncc3s2)[nH]o1,Ki,'=',630.96,nM,6.2,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2006439,,None,327.82,0,4.42,SID103904197,Clc1cc(-c2c[nH]c3ncccc23)nc(NC2CCCCC2)n1,Ki,'>',1995.26,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3660061,,None,387.49,0,4.19,BDBM104187,CC(C)(CN)COc1cccc2ccc(-c3nnc4ccc(C5CC5)cn34)nc12,IC50,'=',323,nM,6.49,,222600,UO_0000065,16.75,0.31,2.3,8.29,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL1909374,GW709042A,None,585.95,2,7.41,GW709042A,Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F,Inhibition,'=',-0.34,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL4536197,A-486,None,536.48,1,3.68,EUB0000326,CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O,% Control,,89,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507259,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL3907606,,None,414.47,0,2.88,BDBM238722,CC(C)Nc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2c(=O)n1-c1cccnc1,IC50,'=',16.4,nM,7.79,,416831,UO_0000065,18.78,0.34,4.91,7.44,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL523823,,None,280.67,0,1.81,19,CCn1c2cc(Cl)c(O)cc2c(=O)c2c(=O)o[nH]c21,Ki,'=',43.5,nM,7.36,,,UO_0000065,26.23,0.53,5.55,8.34,0,CHEMBL994191,Inhibition of Pim2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144228,1,Scientific Literature,Bioorg Med Chem Lett,2008,None,
CHEMBL4455357,TP-020,None,654.02,2,5.45,EUB0000315,Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1,% Control,,100,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507302,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL1945335,,None,364.23,0,3.38,11,Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C1(CCOCC1)NC2=O,Delta Tm,'=',2.2,degrees C,,,,UO_0000027,,,,,0,CHEMBL1947284,Binding affinity to PIM2 assessed as change in thermal denaturation at 10 uM by thermal stability shift assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1944596,1,Scientific Literature,J Med Chem,2012,None,
CHEMBL3889720,,None,396.45,0,3.59,BDBM238584,Cc1ccc(C(N)=O)cc1-c1ccc2cccc(-c3cc4c([nH]3)CCNC4=O)c2n1,IC50,'=',52.9,nM,7.28,,416285,UO_0000065,18.35,0.33,3.69,7.21,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3963777,,None,377.45,0,2.53,BDBM238566,CC1(C)COCCN1c1cnc2cccc(-c3cc4c([nH]3)CCNC4=O)c2n1,IC50,'=',3.2,nM,8.49,,416688,UO_0000065,22.51,0.41,5.96,10.22,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL208637,,None,220.23,0,0.89,6a,CCOc1nc(NC(C)=O)cc(N)c1C#N,Ki,'>',1400,nM,,,,UO_0000065,,,,,0,CHEMBL863188,Inhibition of Pim2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148638,1,Scientific Literature,J Med Chem,2006,None,
CHEMBL205798,GW703087X,None,486.93,1,5.95,GW703087X,CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1,Inhibition,'=',0.84,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL410072,GW301784X,None,445.5,0,0.85,GW301784X,CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2,Inhibition,'=',0.31,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL237347,GW559768X,None,328.39,0,3.4,GW559768X,Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12,Inhibition,'=',0.8,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1909392,GW580496A,None,643.99,2,6.11,GW580496A,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl,Inhibition,'=',-3.07,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL234838,GW572738X,None,300.36,0,3.89,GW572738X,N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2,Inhibition,'=',0.14,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3651910,,None,444.43,0,4.94,BDBM106814,N[C@H]1CCC[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3cc(F)cc(F)c3F)n2)C1,IC50,'=',40,nM,7.4,,225835,UO_0000065,16.65,0.32,2.46,9.14,0,CHEMBL3707781,ATP Depletion Assay: The activity of PIM1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3687421,,None,527.55,1,4.77,BDBM151814,CCOC(=O)N[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H]1C,IC50,'=',20.5,nM,7.69,,292070,UO_0000065,14.57,0.28,2.92,6.45,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3921045,,None,404.47,0,2.25,BDBM238549,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1CCC(=O)N(C)C1,IC50,'=',177,nM,6.75,,416272,UO_0000065,16.69,0.31,4.5,6.55,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3957810,,None,363.42,0,2.06,BDBM238503,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N1CCOCC1,IC50,'=',99.8,nM,7,,416240,UO_0000065,19.26,0.35,4.94,8.42,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3961876,,None,395.46,0,2.57,BDBM238807,COC[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C)c(NC(C)(C)C)nc34)[nH]c21,IC50,'=',2,nM,8.7,,416916,UO_0000065,22,0.41,6.13,8.61,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL255421,,None,265.29,0,2.03,6,COc1ccc(/C=C2\SC(=O)NC2=O)cc1OC,IC50,'=',2500,nM,5.6,,,UO_0000065,21.12,0.43,3.57,8.67,0,CHEMBL2049740,Inhibition of human PIM2 using FITC-(AHX)RSRHSSYPAGT-COOH as substrate after 90 mins by mobility shift assay in presence of 50 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2046384,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL3687487,,None,562.61,1,4.08,BDBM151883,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1OCCS(C)(=O)=O,IC50,'=',1.44,nM,8.84,,292139,UO_0000065,15.72,0.31,4.76,7.11,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3691937,,None,611.64,2,5.93,BDBM151959,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C4(F)CCOCC4)cc3F)n2)C[C@@H](N)[C@H]1OCCC#N,IC50,'=',0.74,nM,9.13,,292214,UO_0000065,14.93,0.28,3.2,7.41,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3652626,,None,447.52,0,2.97,BDBM119386,Cn1ncc(NC(=O)c2nc(-c3c(F)cccc3F)sc2N)c1N1CCCC(N)CC1,Ki,'=',0.316,nM,9.5,,246153,UO_0000065,21.23,0.42,6.53,8.25,0,CHEMBL3707982,Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3889626,,None,359.43,0,3.28,BDBM238450,Cc1nc2cccc(-c3cc4c([nH]3)C3(CC3)CNC4=O)c2nc1NC1CC1,IC50,'=',3.8,nM,8.42,,416648,UO_0000065,23.43,0.43,5.14,10.18,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3925863,,None,363.45,0,3.55,BDBM224944,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(NCC5CC5)n4)c3c2)s1,IC50,'=',7.705,nM,8.11,,393230,UO_0000065,22.32,0.43,4.56,7.7,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL296468,BMS-387032,1,380.54,0,3.66,BMS-387032/SNS-032,CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1,Kd,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL1908761,Binding constant for PIM2 kinase domain,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1908390,1,Scientific Literature,Nat Biotechnol,2011,None,
CHEMBL4108465,,None,435.48,0,4,BDBM192584,C[C@@H]1CN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)[C@@H](C)CN1,IC50,'=',162,nM,6.79,,344649,UO_0000065,15.59,0.29,2.79,9.65,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3920138,,None,435.48,0,4,BDBM192630,C[C@@H]1CN[C@@H](C)CN1c1ccncc1Nc1ncc2ccc(-c3c(F)cccc3F)nn12,IC50,'=',59,nM,7.23,,344650,UO_0000065,16.6,0.31,3.23,10.27,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3691980,,None,571.66,1,3.93,BDBM152002,CC(C)NC(=O)c1ccc(F)c(-c2ccc(N)c(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@@H](n4ccnn4)[C@@H](C)C3)n2)c1,IC50,'=',2.6,nM,8.59,,292257,UO_0000065,15.02,0.28,4.66,5.15,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3894736,,None,391.44,0,2.87,BDBM224853,COC[C@@H]1CCCN1c1ccnc(-c2c[nH]c3ccc(-c4nnc(N)o4)cc23)n1,IC50,'=',26.78,nM,7.57,,393132,UO_0000065,19.34,0.36,4.7,6.36,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3923772,,None,353.36,0,3.79,BDBM224870,CC(C)Oc1ccc(F)c(-c2c[nH]c3ccc(-c4nnc(N)o4)nc23)c1,IC50,'=',57.03,nM,7.24,,393148,UO_0000065,20.5,0.38,3.45,7.04,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3892308,,None,386.42,0,2.5,BDBM249021,Cc1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CCCNC3=O)n2)n1,Ki,'=',35,nM,7.46,,434225,UO_0000065,19.29,0.35,4.96,7.33,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4587382,,None,395.29,0,2.49,14,CC(C)(O)C#Cc1c(Cl)c2c(Cl)cc(C(N)=O)nc2n1[C@H]1CCCNC1,IC50,'=',9.9,nM,8,,,UO_0000065,20.25,0.42,5.51,8.59,0,CHEMBL4373003,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser-112 residue by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4371067,1,Scientific Literature,Bioorg Med Chem Lett,2019,None,
CHEMBL3691925,,None,620.69,1,4.87,BDBM151947,CC(C)Oc1cc(F)c(-c2nc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@@H](OCCS(C)(=O)=O)[C@@H](C)C3)ccc2F)c(F)c1,IC50,'=',1.17,nM,8.93,,292202,UO_0000065,14.39,0.28,4.06,6.69,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL379300,A-443654,None,397.48,0,4.36,A-443654,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12,Inhibition,'=',95,%,,,,UO_0000187,,,,,0,CHEMBL1252619,Inhibition of PIM2 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1250448,1,Scientific Literature,Nat Chem Biol,2009,None,
CHEMBL2037196,,None,481.96,0,4.4,9,Cl.O=C1Nc2ccc(F)cc2/C1=C\c1ccc(-c2cccc(C(=O)NCCN3CCCC3)c2)o1,IC50,'=',127,nM,6.9,,,UO_0000065,15.48,0.29,2.5,9.25,0,CHEMBL2038829,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034977,1,Scientific Literature,ACS Med Chem Lett,2012,None,
CHEMBL3921312,,None,361.45,0,2.68,BDBM238494,O=C1NCCc2[nH]c(-c3cccc4ccc(N[C@@H]5CCCNC5)nc34)cc21,IC50,'=',141,nM,6.85,,416232,UO_0000065,18.95,0.35,4.17,8.37,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3913060,,None,382.47,0,4.69,BDBM238481,C[C@@H](Nc1ccc2cccc(-c3cc4c([nH]3)CCNC4=O)c2n1)c1ccccc1,IC50,'=',181,nM,6.74,,416219,UO_0000065,17.63,0.32,2.05,9.66,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1968070,,None,289.68,0,1.54,SID103905636,NC(=O)c1cccc2c1Nc1nnc(Cl)cc1C(=O)N2,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1988608,,None,375.39,0,2.47,SID103904658,CC(=O)Nc1cccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1970074,,None,410.4,1,6.2,SID103904358,Cc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1972221,,None,386.48,0,3.73,SID103905136,CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(=O)CC)c3c2)cc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL378627,,None,448.5,0,1.92,SID103905196,COc1cc(S(C)(=O)=O)c(OC)cc1CC(=O)Nc1cc(N)c(C#N)c(OC(C)C)n1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2336379,,None,306.37,0,0.9,16g,CC[C@@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1,Activity,'=',91,%,,,,UO_0000187,,,,,0,CHEMBL2341633,Inhibition of recombinant PIM2 (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2331324,1,Scientific Literature,Eur J Med Chem,2013,None,
CHEMBL3660024,,None,377.45,0,2.8,BDBM104142,CC(C)(CO)COc1cccc2ccc(-c3nnc4cc(CN)ccn34)nc12,IC50,'=',17,nM,7.77,,222559,UO_0000065,20.58,0.38,4.97,7.88,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3971473,,None,361.41,0,3.25,BDBM224838,CC1CCCN1c1ccnc(-c2c[nH]c3ccc(-c4nnc(N)o4)cc23)n1,IC50,'=',1.7,nM,8.77,,393120,UO_0000065,24.26,0.44,5.52,7.99,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1882194,GW780056X,None,373.46,0,3.77,GW780056X,CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1,Inhibition,'=',-3.66,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3687525,,None,521.62,1,3.57,BDBM151921,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)sc2N)C[C@@H](N)[C@H]1S(C)(=O)=O,IC50,'=',2.48,nM,8.61,,292176,UO_0000065,16.5,0.34,5.04,6.1,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3903697,,None,429.44,0,4.74,BDBM191105,NCCC[C@H]1CNC(=O)c2cc(-c3cccc(OC(F)(F)F)c3)c(-c3ccccc3)n21,IC50,'=',156,nM,6.81,,341776,UO_0000065,15.85,0.3,2.07,9.83,0,CHEMBL3887520,Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3691973,,None,514.5,1,4.12,BDBM151995,C[C@@H]1C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@H](N)[C@@H]1OCC(=O)O,IC50,'=',4400,nM,5.36,,292250,UO_0000065,10.41,0.2,1.24,4.2,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL257167,,None,279.3,0,2.14,TPCA_1,NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O,Residual Activity,'=',93,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4630643,BAY-448,None,458.46,0,2.78,EUB0000333,Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1,% Control,,100,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507269,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL473773,,None,376.21,0,3.86,WHI-P154,COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC,Residual Activity,'=',78,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3660025,,None,347.42,0,3.44,BDBM104143,CC(C)COc1cccc2ccc(-c3nnc4cc(CN)ccn34)nc12,IC50,'=',51,nM,7.29,,222560,UO_0000065,20.99,0.38,3.85,9.31,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL3952360,,None,400.45,0,2.04,BDBM248994,Cc1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CCC[C@H](N)C3=O)n2)n1,Ki,'=',4.29,nM,8.37,,434201,UO_0000065,20.9,0.38,6.33,7.23,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3978475,,None,347.42,0,3.11,BDBM238471,Cc1nc2cccc(-c3cc4n(c3)CCNC4=O)c2nc1NC1(C)CC1,IC50,'=',0.961,nM,9.02,,416650,UO_0000065,25.95,0.47,5.91,12.55,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3972017,,None,440.51,0,2.64,BDBM249060,Cc1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CCCC4(CN(C=O)C4)C3)n2)n1,Ki,'=',40.9,nM,7.39,,434264,UO_0000065,16.77,0.31,4.75,7.95,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3963604,,None,424.46,0,4.28,BDBM192603,COC(C)CN(C)c1ccncc1Nc1ncc2ccc(-c3c(F)cccc3F)nn12,IC50,'>',1000,nM,,,344674,UO_0000065,,,,,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3910979,,None,362.44,0,2.12,BDBM238427,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@@H]1CC[C@@H]1N,IC50,'=',2.9,nM,8.54,,416625,UO_0000065,23.56,0.43,6.42,7.85,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL388978,STAUROSPORINE,None,466.54,0,4.35,Staurosporine,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,Residual Activity,'=',8,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3913945,,None,360.43,0,1.61,BDBM249025,Cn1cc(-c2cc3c(cn2)cnn3-c2cccc(N3CC(CN)C3)n2)cn1,Ki,'=',83.2,nM,7.08,,434229,UO_0000065,19.64,0.36,5.47,7.81,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2218940,,None,335.35,0,4.23,SL327,N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F,Residual Activity,'=',133,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3968206,,None,388.48,0,2.5,BDBM248895,CCn1cc(-c2cc3c(cn2)cnn3-c2cccc(N3CCN[C@@H](C)C3)n2)cn1,Ki,'=',7.36,nM,8.13,,434102,UO_0000065,20.94,0.38,5.63,10.61,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3898989,,None,411.47,0,2.38,BDBM248970,Cc1cncc(-c2cc3c(cn2)cnn3-c2ccc(C#N)c(N3CCC[C@H](N)C3)n2)n1,Ki,'=',0.286,nM,9.54,,434177,UO_0000065,23.19,0.42,7.16,7.8,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4106807,,None,375.44,0,2.27,BDBM248897,CCn1cc(-c2cc3c(cn2)cnn3-c2cccc(N3CC[C@@H](O)C3)n2)cn1,Ki,'=',56.7,nM,7.25,,434104,UO_0000065,19.3,0.35,4.98,8.54,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL7463,GF-109203,None,412.49,0,3.64,BIM1,CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21,Residual Activity,'=',15,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3264257,,None,374.45,0,2.64,7f,CN(C)CCNc1cncc(-c2ccc3[nH]cc(-c4ccnc(N)n4)c3c2)n1,IC50,'=',110,nM,6.96,,,UO_0000065,18.58,0.34,4.32,6.41,0,CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4118246,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL3651898,,None,441.45,1,5.08,3,C[C@@H]1C[C@H](O)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C1,Ki,'=',4,nM,8.4,,,UO_0000065,19.02,0.36,3.32,11.18,0,CHEMBL4723884,Inhibition of PIM2 (unknown origin) using Bad peptide NH2-AGAGRSRHSSYPAGT-OH as substrate measured after 10 mins in presence of ATP by luciferase-luciferin based Kinase-Glo luminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4715870,1,Scientific Literature,J Med Chem,2020,None,TIME = 0.1667 hr
CHEMBL518968,GSK-1030061A,None,491.49,1,5.06,GSK1030061A,CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F,Inhibition,'=',0.56,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL205798,GW703087X,None,486.93,1,5.95,GW703087X,CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1,Inhibition,'=',1.31,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL188794,GW829115X,None,496.88,1,6.28,GW829115X,COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1,Inhibition,'=',0.12,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL408732,,None,308.34,0,2.98,SB-711237,COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1,Inhibition,'=',-0.37,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1782526,,None,381.23,0,3.22,34,O=C(CC1CCNCC1)Nc1cc(Br)cc2cc(C(=O)O)oc12,IC50,'=',340,nM,6.47,,,UO_0000065,16.97,0.38,3.25,7.06,0,CHEMBL1786238,Inhibition of human Pim2 using 5-FAM-RSRHSSYPAGT-CONH2 as substrate after 90 mins by off-chip mobility shift method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1781944,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL388978,STAUROSPORINE,None,466.54,0,4.35,Staurosporine,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,IC50,'=',21.7,nM,7.66,,,UO_0000065,16.43,0.3,3.31,11.03,0,CHEMBL4328556,Inhibition of human PIM2 using RSRHSSYPAGT as substrate by [gamma-33P]-ATP assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4325871,1,Scientific Literature,Eur J Med Chem,2019,None,
CHEMBL1802485,,None,234.26,0,2.78,JNK_Inhibitor_Negative_Control,Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2,Residual Activity,'=',44,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL126077,INDIRUBIN-3-MONOXIME,None,277.28,0,4.42,Indirubin_oxime,O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12,Residual Activity,'=',68,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL259850,,None,308.32,0,2.38,AR_A0_14418,COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1,Residual Activity,'=',135,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4546373,,None,401.49,0,2.5,21,C[C@H]1NC(=O)c2cc(-c3cccc4c3N=C(NC(C)(C)C)N(C)S4(=O)=O)[nH]c21,IC50,'=',5.2,nM,8.28,,,UO_0000065,20.63,0.4,5.78,7.77,0,CHEMBL4478465,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as reduction in phosphorylation of biotinylated-BAD peptide at Serine 112 residue preincubated for 30 mins followed by substrate addition for 1 hr by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4477213,1,Scientific Literature,J Med Chem,2016,None,
CHEMBL3989914,GLESATINIB,2,619.72,2,6.22,MGCD-265,COCCNCc1ccc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccc(F)cc5)cc4F)c3s2)nc1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL2218926,,None,305.17,0,3.88,Tyrphostin AG-1024,CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O,Residual Activity,'=',89,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL553,ERLOTINIB,4,393.44,0,3.41,Erlotinib,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL1945337,,None,322.2,0,3.61,5,Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C(C)(C)NC2=O,Delta Tm,'=',3.6,degrees C,,,,UO_0000027,,,,,0,CHEMBL1947284,Binding affinity to PIM2 assessed as change in thermal denaturation at 10 uM by thermal stability shift assay,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1944596,1,Scientific Literature,J Med Chem,2012,None,
CHEMBL572810,,None,340.45,0,2.11,13b,CN(C)CC#Cc1ccc2sc3c(=O)[nH]c(CN(C)C)nc3c2c1,Ki,'=',99,nM,7,,,UO_0000065,20.57,0.4,4.89,13.41,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL1241009,,None,313.15,0,4.38,3f,O=Cc1c[nH]c2c1ccc1c3cccc(Br)c3[nH]c12,Activity,'=',40,%,,,,UO_0000187,,,,,0,CHEMBL1248947,Inhibition of human GST fused Pim2 expressed in Escherichia coli assessed as residual activity at 1 uM after 30 mins,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240519,1,Scientific Literature,Bioorg Med Chem,2010,None,
CHEMBL4282644,,None,380.41,0,2.28,36,COc1ccc(C(N)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1,Inhibition,'=',-1,%,,,,UO_0000187,,,,,0,CHEMBL4255128,Inhibition of recombinant human full length GST-tagged PIM2 expressed in baculovirus expression system at 1 uM relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4251655,1,Scientific Literature,Eur J Med Chem,2018,None,
CHEMBL222102,KU-55933,None,395.51,0,4.76,KU-55933,O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1,Residual Activity,'=',68,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL235658,,None,349.41,1,5.16,MK2a_Inhibitor,O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1,Residual Activity,'=',116,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL188381,GW806742X,None,573.56,2,5.18,GW806742X,CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1,Inhibition,'=',0.55,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL275473,GW572401X,None,401.49,0,4.12,GW572401X,CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1,Inhibition,'=',0.18,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3965741,,None,413.49,0,2.4,BDBM248883,c1cc(N2CCNCC2)nc(-n2ncc3cnc(-c4cncc(C5COC5)c4)cc32)c1,Ki,'=',16.9,nM,7.77,,434090,UO_0000065,18.8,0.34,5.37,9.6,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL596674,,None,331.46,1,5.32,ZM-39923,CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1,Residual Activity,'=',107,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL226838,,None,335.41,0,4.47,SB-505124,Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1,Residual Activity,'=',124,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3924903,,None,401.47,0,3.23,BDBM249074,Cc1cncc(-c2cc3c(cn2)cnn3-c2cccc(OC3CCCC(N)C3)n2)n1,Ki,'=',0.779,nM,9.11,,434284,UO_0000065,22.69,0.41,5.88,8.71,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3952845,,None,413.53,0,3.93,BDBM248877,CC(C)c1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CCC[C@H](N)C3)n2)c1,Ki,'=',1.93,nM,8.71,,434084,UO_0000065,21.07,0.38,4.78,10.16,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3933668,,None,348.41,0,1.6,BDBM238520,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1CNC1,IC50,'=',5.9,nM,8.23,,416664,UO_0000065,23.62,0.43,6.63,8.69,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3923557,,None,379.46,0,3.17,BDBM238650,C[C@H](O)c1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC(C)(C)C,IC50,'=',3,nM,8.52,,416759,UO_0000065,22.46,0.42,5.35,8.28,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3946970,,None,386.46,0,2.24,BDBM248918,CCc1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CCNCC3)n2)n1,Ki,'=',0.678,nM,9.17,,434125,UO_0000065,23.73,0.43,6.93,10.83,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1802728,,None,422.53,0,4.54,NU6140,CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1,Residual Activity,'=',112,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3966069,,None,471.52,1,5.65,BDBM191124,CC(C)(C)c1ccc(-c2c(-c3cccc(OC(F)(F)F)c3)cc3n2[C@@H](CCN)CNC3=O)cc1,IC50,'=',160,nM,6.8,,341795,UO_0000065,14.41,0.27,1.15,9.81,0,CHEMBL3887520,Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4099731,,None,403.47,0,3.12,18,Cc1cncc(-c2cc(F)c3cnn(-c4cccc(N5CCCNCC5)n4)c3c2)n1,Ki,'=',7400,nM,5.13,,,UO_0000065,12.72,0.23,2.01,7.15,0,CHEMBL4052120,Inhibition of PIM2 (unknown origin) using 5FAM-ARKRRRHPSGPPTA as substrate after 90 mins in presence of ATP by caliper microfluidic mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4049450,1,Scientific Literature,J Med Chem,2017,None,
CHEMBL3942758,,None,420.9,0,4.32,BDBM192554,Clc1ccccc1-c1ccc2cnc(Nc3cnccc3O[C@H]3CCCNC3)n2n1,IC50,'=',298,nM,6.53,,344546,UO_0000065,15.5,0.3,2.21,8.54,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3957073,,None,333.4,0,3.14,BDBM238694,Cc1nc2cccc(-c3cc4c([nH]3)CNC4=O)c2nc1NC1(C)CC1,IC50,'=',0.57,nM,9.24,,416803,UO_0000065,27.73,0.5,6.1,11.18,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3948398,,None,363.42,0,2.67,BDBM238696,Cc1nc2cccc(-c3cc4c([nH]3)C(CO)NC4=O)c2nc1NC1(C)CC1,IC50,'=',1.37,nM,8.86,,416805,UO_0000065,24.39,0.45,6.19,8.61,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1909354,GW459057A,None,390.88,0,4.11,GW459057A,Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl,Inhibition,'=',0.01,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL2036116,,None,315.38,0,4.78,3,N#CCCCCn1c2ccccc2c2ccc3c(C=O)c[nH]c3c21,Activity,'=',40,%,,,,UO_0000187,,,,,0,CHEMBL2040256,Inhibition of Pim-2 using RSRHSSYPAGT as substrate assessed as residual activity at 10 uM after 30 mins,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034961,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL4564337,,None,358.2,0,4.59,3,COc1cc2c(-c3cnc(-c4ccc[nH]4)o3)c[nH]c2cc1Br,IC50,'=',11000,nM,4.96,,,UO_0000065,13.84,0.31,0.37,7.42,0,CHEMBL4338190,Inhibition of PIM2 (unknown origin) by [33P]-ATP filter binding kinase assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4334516,1,Scientific Literature,J Med Chem,2019,None,
CHEMBL4564337,,None,358.2,0,4.59,3,COc1cc2c(-c3cnc(-c4ccc[nH]4)o3)c[nH]c2cc1Br,Activity,'=',54,%,,,,UO_0000187,,,,,0,CHEMBL4338225,Binding affinity to wild-type human partial length PIM2 (M1 to E291 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by active-site directed competition binding assay based Kinomescan method relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4334516,1,Scientific Literature,J Med Chem,2019,None,
CHEMBL3962885,,None,365.44,0,2.36,BDBM238765,Cn1c(NC(C)(C)C)nc2c(-c3cc4n(c3)CCNC4=O)cccc2c1=O,IC50,'=',4.05,nM,8.39,,416874,UO_0000065,22.97,0.42,6.03,10.37,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3979182,,None,367.43,0,4.09,BDBM238637,Cc1nc2ccc(F)c(-c3cc4c([nH]3)[C@@H](C)NC4=O)c2nc1NC(C)(C)C,IC50,'=',0.109,nM,9.96,,416746,UO_0000065,27.11,0.5,5.87,12.05,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3964978,,None,391.48,0,2.93,BDBM238559,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1CCCCC1O,IC50,'=',4.5,nM,8.35,,416681,UO_0000065,21.32,0.39,5.42,8.11,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3974455,,None,379.44,0,4.02,BDBM238635,Cc1nc2ccc(F)c(-c3cc4c([nH]3)C3(CC3)NC4=O)c2nc1NC(C)(C)C,IC50,'=',0.52,nM,9.28,,416744,UO_0000065,24.47,0.45,5.26,11.23,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3916951,,None,363.47,0,4.09,BDBM238689,COC1=NCCc2[nH]c(-c3cccc4nc(C)c(NC(C)(C)C)nc34)cc21,IC50,'=',8.9,nM,8.05,,416798,UO_0000065,22.15,0.41,3.96,10.71,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3907991,,None,468.58,0,3.01,BDBM238802,Cc1nc2cccc(-c3cc4c([nH]3)[C@@H](C)NC4=O)c2nc1N[C@H]1CCC[C@@H](NS(C)(=O)=O)C1,IC50,'=',2,nM,8.7,,416911,UO_0000065,18.56,0.36,5.69,6.75,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3896312,,None,400.49,0,2.76,BDBM248925,CCc1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CCC[C@H](N)C3)n2)n1,Ki,'=',0.37,nM,9.43,,434132,UO_0000065,23.55,0.43,6.67,9.56,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3986065,,None,404.47,0,2.3,BDBM238429,CC(=O)N[C@@H]1CC[C@@H]1Nc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2nc1C,IC50,'=',25.7,nM,7.59,,416630,UO_0000065,18.77,0.35,5.29,6.79,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4062258,,None,393.28,0,2.77,Tab 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3915285,,None,386.84,1,5.47,BDBM238478,O=c1[nH]ccc2[nH]c(-c3cccc4ccc(Nc5ccccc5Cl)nc34)cc12,IC50,'=',32.2,nM,7.49,,416215,UO_0000065,19.37,0.37,2.02,10.18,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3897912,,None,417.48,0,1.91,BDBM248991,COc1ncc(-n2ncc3cnc(-c4cncc(C)n4)cc32)nc1N1CCC[C@H](N)C1,Ki,'=',0.979,nM,9.01,,434198,UO_0000065,21.58,0.4,7.1,7.46,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3691944,,None,608.62,1,3.43,BDBM151966,C[C@H]1CN(c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C4(O)CCOCC4)cc3F)n2)C[C@@H](N)[C@H]1n1ccnn1,IC50,'=',1.9,nM,8.72,,292221,UO_0000065,14.33,0.27,5.29,6.04,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3950251,,None,452.47,0,1.65,22r,N[C@@H]1CN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C[C@H](N)[C@H]1O,IC50,'=',0.09,nM,10.05,,,UO_0000065,22.2,0.42,8.4,7.69,0,CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3864151,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL3963283,,None,418.48,0,3.39,30b,C[C@@H]1CC[C@H](N)CN1c1ccncc1Nc1ncc2ccc(-c3ncccc3F)nn12,IC50,'=',1.3,nM,8.89,,,UO_0000065,21.23,0.39,5.5,9.14,0,CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3864151,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL1909391,GW576924A,None,579.1,2,5.92,GW576924A,Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1,Inhibition,'=',-0.49,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL23327,PURVALANOLA,None,388.9,0,4.23,Purvalanol_A,CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1,Residual Activity,'=',116,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3976139,,None,547.02,2,5.38,BDBM191097,CN1CCN(Cc2ccc(-c3c(-c4cccc(OC(F)(F)F)c4)cc4n3C(CCCl)CNC4=O)cc2)CC1,IC50,'=',44,nM,7.36,,341768,UO_0000065,13.45,0.26,1.98,14.79,0,CHEMBL3887520,Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4106584,,None,377.48,0,2.87,BDBM248879,N[C@@H]1CCCN(c2cccc(-n3ncc4cnc(-c5cncs5)cc43)n2)C1,Ki,'=',4.5,nM,8.35,,434086,UO_0000065,22.11,0.42,5.48,9.73,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3792425,,None,487.39,0,4.31,3f,Nc1cc(-c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)ccc2N)nc(C(F)(F)F)n1,Ki,'<',3,nM,,,,UO_0000065,,,,,0,CHEMBL3794688,Inhibition of Pim2 (unknown origin) using BAD peptide preincubated for 15 mins followed by ATP addition measured after 60 to 100 mins by Kinase-Glo reagent based luminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3792348,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL3937096,,None,386.46,0,2.38,BDBM248938,Cc1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CCNC(C)C3)n2)n1,Ki,'=',0.596,nM,9.22,,434169,UO_0000065,23.87,0.43,6.84,10.9,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3965946,,None,435.48,0,3.99,BDBM192575,C[C@H]1C[C@@H](N)CN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1,IC50,'=',0.1,nM,10,,344637,UO_0000065,22.96,0.43,6.01,11.85,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3917176,,None,362.44,0,1.95,BDBM238594,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1CN(C)C1,IC50,'=',1050,nM,5.98,,416705,UO_0000065,16.5,0.3,4.03,6.96,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3974543,,None,349.44,0,3.95,BDBM238664,Cc1nc2cccc(-c3cc4c([nH]3)[C@@H](C)NC4=O)c2nc1NC(C)(C)C,IC50,'=',0.559,nM,9.25,,416773,UO_0000065,26.48,0.49,5.3,11.19,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3896585,,None,389.88,0,4.31,BDBM191072,NCCC1CNC(=O)c2cc(-c3cc(Cl)ccc3F)c(-c3ccsc3)n21,IC50,'=',77,nM,7.11,,341743,UO_0000065,18.25,0.37,2.8,11.85,0,CHEMBL3887520,Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4526341,A-108,None,504.47,2,5.04,EUB0000736,Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1,% Control,,100,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507257,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL3983065,,None,383.46,0,4.07,BDBM238540,CCN(c1ccccc1)c1cnc2cccc(-c3cc4c([nH]3)CCNC4=O)c2n1,IC50,'=',4.3,nM,8.37,,416263,UO_0000065,21.82,0.39,4.3,11.32,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL31965,CANERTINIB,3,485.95,0,4.39,CI-1033,C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1,Kd,,,,,,Not Active,,,,,,0,CHEMBL859489,Average Binding Constant for PIM2; NA=Not Active at 10 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144455,1,Scientific Literature,Nat Biotechnol,2005,None,
CHEMBL4746428,,None,338.81,0,2.61,32,Cc1cn([C@@H](C)[C@@H]2CCNC[C@@H]2F)c2nc(C(N)=O)cc(Cl)c12,IC50,'=',22,nM,7.66,,,UO_0000065,22.6,0.45,5.05,10.5,0,CHEMBL4704282,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4699590,1,Scientific Literature,Bioorg Med Chem Lett,2020,None,
CHEMBL1933538,,None,418.52,0,3.66,11,O=C(c1cc2cc(F)ccc2[nH]1)N1C[C@]2(CCN(C3CCCNC3)C2)c2ccccc21,IC50,'>',30000,nM,,,,UO_0000065,,,,,0,CHEMBL1936080,Inhibition of Pim-2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1933021,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL1794064,GSK-561866B,None,470.41,0,0.12,GSK561866B,CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F,Inhibition,'=',3.26,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL588025,GW770249A,None,467.81,1,5.27,GW770249A,Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12,Inhibition,'=',0.22,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL4781364,,None,324.79,0,2.36,28,Cc1cn([C@H](C)[C@]2(F)CCNC2)c2nc(C(N)=O)cc(Cl)c12,IC50,'=',515,nM,6.29,,,UO_0000065,19.36,0.39,3.93,8.62,0,CHEMBL4704282,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4699590,1,Scientific Literature,Bioorg Med Chem Lett,2020,None,
CHEMBL1909391,GW576924A,None,579.1,2,5.92,GW576924A,Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1,Inhibition,'=',0.23,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL217092,SARACATINIB,3,542.04,1,3.94,Saracatinib,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL4870304,,None,499.53,0,3.51,IV,COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F,Activity,'=',91,%,,,,UO_0000187,,,,,0,CHEMBL4805692,Inhibition of human PIM2 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4804283,38,Patent Bioactivity Data,,,None,Dose = 1000.0 nM
CHEMBL3182444,MK-5108,1,461.95,1,5.71,MK-5108,O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL261692,,None,211.22,0,1.9,K00007,O=C1Nc2ccccc2/C1=C/c1cnc[nH]1,Thermal melting change,'=',1.9,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL3792922,,None,404.46,0,2.78,4b,Cc1cc(-c2ccncc2NC(=O)c2nc(-c3nccs3)ccc2N)nc(N)n1,Ki,'<',3,nM,,,,UO_0000065,,,,,0,CHEMBL3794688,Inhibition of Pim2 (unknown origin) using BAD peptide preincubated for 15 mins followed by ATP addition measured after 60 to 100 mins by Kinase-Glo reagent based luminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3792348,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL3937096,,None,386.46,0,2.38,BDBM248938,Cc1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CCNC(C)C3)n2)n1,Ki,'=',0.54,nM,9.27,,434161,UO_0000065,23.98,0.44,6.89,10.95,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3890745,,None,427.51,0,2.79,BDBM248882,C[C@H]1CN(c2cccc(-n3ncc4cnc(-c5cncc(C6COC6)c5)cc43)n2)CCN1,Ki,'=',10.1,nM,8,,434089,UO_0000065,18.7,0.34,5.21,9.87,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3974543,,None,349.44,0,3.95,9,Cc1nc2cccc(-c3cc4c([nH]3)[C@@H](C)NC4=O)c2nc1NC(C)(C)C,IC50,'=',1,nM,9,,,UO_0000065,25.76,0.47,5.05,10.88,0,CHEMBL4478465,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as reduction in phosphorylation of biotinylated-BAD peptide at Serine 112 residue preincubated for 30 mins followed by substrate addition for 1 hr by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4477213,1,Scientific Literature,J Med Chem,2016,None,
CHEMBL4514782,,None,352.46,0,4.12,14,Cc1nc2cccc(-c3cc4c(s3)CNC4=O)c2nc1NC(C)(C)C,IC50,'=',6.8,nM,8.17,,,UO_0000065,23.17,0.45,4.05,12.21,0,CHEMBL4478465,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as reduction in phosphorylation of biotinylated-BAD peptide at Serine 112 residue preincubated for 30 mins followed by substrate addition for 1 hr by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4477213,1,Scientific Literature,J Med Chem,2016,None,
CHEMBL251549,GW782612X,None,345.37,0,2.94,GW782612X,NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1,Inhibition,'=',0.4,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL521806,GSK-237700A,None,457.94,0,5,GSK237700A,COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC,Inhibition,'=',-0.11,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL4289040,,None,429.5,0,2.89,21,COc1cc(C)c(S(C)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1,Inhibition,'=',5,%,,,,UO_0000187,,,,,0,CHEMBL4255128,Inhibition of recombinant human full length GST-tagged PIM2 expressed in baculovirus expression system at 1 uM relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4251655,1,Scientific Literature,Eur J Med Chem,2018,None,
CHEMBL1725279,SP-600125,None,220.23,0,4.43,SP-600125,Oc1c2ccccc2c2c3c(cccc13)N=N2,Kd,'=',460,nM,6.34,,,UO_0000065,28.78,0.51,1.91,14.1,0,CHEMBL859489,Average Binding Constant for PIM2; NA=Not Active at 10 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144455,1,Scientific Literature,Nat Biotechnol,2005,None,
CHEMBL3758802,,None,387.46,0,4.58,3e,C#Cc1cccc(Nc2ncnc3sc(-c4ccc(CO)cc4OC)cc23)c1,Inhibition,'=',11,%,,,,UO_0000187,,,,,0,CHEMBL3761595,Inhibition of PIM2 (unknown origin) at 500 nM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3758163,1,Scientific Literature,Eur J Med Chem,2016,None,
CHEMBL4086461,,None,353.25,0,3.24,(R)-11,NC(=O)c1cc(Cl)c2c(Cl)c(C3CC3)n([C@@H]3CCCNC3)c2n1,IC50,'=',22,nM,7.66,,,UO_0000065,21.68,0.45,4.42,10.5,0,CHEMBL4047363,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4043238,1,Scientific Literature,Bioorg Med Chem Lett,2017,None,
CHEMBL4224786,,None,335.33,0,0.76,14d,CC(=O)NCC(=O)Nc1ccc2cnn(-c3cncc(C#N)n3)c2c1,IC50,'>',30000,nM,,,,UO_0000065,,,,,0,CHEMBL4222673,Inhibition of human PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4219163,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL3687417,,None,590.64,2,5.16,BDBM151810,C[C@H]1CN(c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1n1cc(-c2ccsc2)nn1,IC50,'=',4.28,nM,8.37,,292066,UO_0000065,14.17,0.27,3.21,7.29,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3427173,,None,294.36,0,2.25,5,COc1ccc2nc(C3=N[C@@H](C(=O)O)CS3)sc2c1,Activity,'=',89,%,,,,UO_0000187,,,,,0,CHEMBL3427823,Inhibition of PIM2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3425453,1,Scientific Literature,Eur J Med Chem,2015,None,
CHEMBL4445670,BAY-885,None,515.54,1,3.28,EUB0000250,CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1,% residual kinase activity,,110,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4881180,Pim-2(h) Eurofins Kinase panel,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507268,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1.0 碌M
CHEMBL3687429,,None,533.58,1,3.57,BDBM151823,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@@H]1NS(C)(=O)=O,IC50,'=',388.52,nM,6.41,,292079,UO_0000065,12.01,0.24,2.84,5.04,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3691985,,None,571.6,1,4.92,BDBM152008,CCOCc1cc(F)c(-c2nc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@@H](NC(=O)OC)[C@@H](C)C3)ccc2F)c(F)c1,IC50,'=',16.14,nM,7.79,,292263,UO_0000065,13.63,0.26,2.87,6.07,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3691922,,None,540.59,2,5.04,BDBM151944,CO[C@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C4(O)CCC4)cc3F)n2)C[C@@H]1C,IC50,'=',1.22,nM,8.91,,292199,UO_0000065,16.49,0.31,3.87,8.08,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4101554,,None,395.29,0,3.17,Tab 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3691942,,None,584.6,1,3.69,BDBM151964,COC(=O)N[C@@H]1[C@H](N)CN(c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C4(O)CCC4)cc3F)n2)C[C@@H]1C,IC50,'=',0.81,nM,9.09,,292219,UO_0000065,15.55,0.3,5.4,6.37,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL303687,GW829877X,None,358.41,0,3.58,GW829877X,COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1,Inhibition,'=',-0.44,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3691931,,None,566.59,1,4.22,BDBM151953,CC(C)Oc1cc(F)c(-c2nc(C(=O)Nc3cnccc3N3C[C@@H](N)[C@@H](n4ccnn4)[C@@H](C)C3)ccc2F)c(F)c1,IC50,'=',1.69,nM,8.77,,292208,UO_0000065,15.48,0.29,4.55,7.07,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3815093,,None,417.49,0,2.36,2,CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1,Inhibition,'=',-1,%,,,,UO_0000187,,,,,0,CHEMBL3815944,Inhibition of human PIM2 at 1 uM using [RSRHSSYPAGT] as substrate,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3813650,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL1641990,,None,450.34,0,4.67,9,CN(C)C/C=C/C(=O)Nc1ccc2c(C#N)cnc(Nc3cccc(Br)c3)c2c1,Activity,'=',89,%,,,,UO_0000187,,,,,0,CHEMBL1648729,Inhibition of PIM2 assessed as residual activity at 10 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1641579,1,Scientific Literature,Bioorg Med Chem,2011,None,
CHEMBL3905194,,None,435.48,0,4.13,22h,C[C@@H]1[C@@H](N)CCCN1c1ccncc1Nc1ncc2ccc(-c3c(F)cccc3F)nn12,IC50,'=',0.29,nM,9.54,,,UO_0000065,21.9,0.41,5.41,11.3,0,CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3864151,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL3963838,,None,365.44,0,2.4,BDBM238555,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC(C)(C)CO,IC50,'=',2.8,nM,8.55,,416278,UO_0000065,23.4,0.43,6.15,8.31,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3103884,,None,296.37,0,2.91,1d,Nc1cccnc1C(=O)Nc1ccccc1N1CCCCC1,Ki,'>',12500,nM,,,,UO_0000065,,,,,0,CHEMBL3106178,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3102815,1,Scientific Literature,ACS Med Chem Lett,2013,None,
CHEMBL2037197,,None,461.95,0,4.92,10,O=C1Nc2c(Cl)cccc2/C1=C\c1ccc(-c2cccc(C(=O)NCCN3CCCC3)c2)o1,IC50,'=',445,nM,6.35,,,UO_0000065,13.75,0.26,1.43,8.52,0,CHEMBL2038829,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034977,1,Scientific Literature,ACS Med Chem Lett,2012,None,
CHEMBL2037133,,None,331.33,0,4.14,5,O=C1Nc2ccccc2/C1=C\c1ccc(-c2cccc(C(=O)O)c2)o1,IC50,,,,,,Not Determined,,,,,,0,CHEMBL2038829,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034977,1,Scientific Literature,ACS Med Chem Lett,2012,None,
CHEMBL83980,BOHEMINE,None,340.43,0,2.81,Bohemine,CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21,Residual Activity,'=',87,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL281948,K-252A,None,467.48,0,3.66,K-252a,COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,Residual Activity,'=',-2,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1882194,GW780056X,None,373.46,0,3.77,GW780056X,CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1,Inhibition,'=',-0.59,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1909343,,None,394.31,0,1.76,SB-675259-M,O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F,Inhibition,'=',4.25,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL379787,,None,395.42,0,2.53,IRAK_1_4_Inhibitor,O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1,Residual Activity,'=',78,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4165749,BI 2545,None,527.43,1,4.24,EUB0000318,O=C(NC[C@@H]1[C@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@@H]12)c1ccc2[nH]nnc2c1,% Control,,100,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507275,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL4540759,BI 0054,None,382.39,0,2.12,EUB0000545,CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1,% Control,,100,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507279,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL3949896,,None,405.5,0,3.89,12,Cc1nc2cccc(-c3cc4c([nH]3)C3(CCOCC3)NC4=O)c2nc1NC(C)(C)C,IC50,'=',117,nM,6.93,,,UO_0000065,17.09,0.32,3.04,7.54,0,CHEMBL4478465,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as reduction in phosphorylation of biotinylated-BAD peptide at Serine 112 residue preincubated for 30 mins followed by substrate addition for 1 hr by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4477213,1,Scientific Literature,J Med Chem,2016,None,
CHEMBL3941443,,None,422.44,0,3.14,8d,N[C@H]1CCCN(c2ncncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1,IC50,'=',110,nM,6.96,,,UO_0000065,16.47,0.31,3.82,7.15,0,CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3864151,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL4541192,,None,378.48,0,3.28,10,Cc1nc2cccc(-c3cc4c([nH]3)[C@@H](CCN)NC4=O)c2nc1NC(C)(C)C,IC50,'=',0.3,nM,9.52,,,UO_0000065,25.16,0.46,6.24,8.76,0,CHEMBL4478465,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as reduction in phosphorylation of biotinylated-BAD peptide at Serine 112 residue preincubated for 30 mins followed by substrate addition for 1 hr by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4477213,1,Scientific Literature,J Med Chem,2016,None,
CHEMBL235641,,None,268.3,0,2.51,PKR_Inhibitor,O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1,Residual Activity,'=',3,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1957499,,None,521.61,1,1.06,21,CS(=O)(=O)N1CCN(Cc2cn3c(C#N)c(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3n2)CC1,Inhibition,'=',50,%,,,,UO_0000187,,,,,0,CHEMBL1959621,Inhibition of PIM2 at 5 to 10 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1955823,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL3949181,,None,347.42,0,3.21,BDBM238505,C=C(C)CNc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2nc1C,IC50,'=',4.7,nM,8.33,,416242,UO_0000065,23.97,0.44,5.12,10.07,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3937682,,None,358.4,0,3.79,BDBM238752,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1-c1ccoc1C,IC50,'=',40.9,nM,7.39,,416861,UO_0000065,20.61,0.37,3.6,8.82,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2087491,,None,552.46,2,0.44,31,CS(=O)(=O)N1CCN(Cc2nc3c(N4CCOCC4)nc(-c4cnc(N)nc4)cn3c2Br)CC1,Inhibition,'<',30,%,,,,UO_0000187,,,,,0,CHEMBL2092435,Inhibition of PIM2 at 5 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2086238,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL2089001,,None,250.26,0,3.5,29,O=C(O)c1cc2c3ccccc3[nH]c2c2[nH]ccc12,Activity,'=',93,%,,,,UO_0000187,,,,,0,CHEMBL2090474,Inhibition of human Pim2 using RSRHSSYPAGT as substrate assessed as residual activity at 10 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2086229,1,Scientific Literature,Eur J Med Chem,2012,None,
CHEMBL3922469,,None,403.47,0,3.6,21b,N[C@H]1CCCN(c2ccncc2Nc2ncc3ccc(-c4ccccc4F)nn23)C1,IC50,'=',1.6,nM,8.8,,,UO_0000065,21.8,0.4,5.2,10.43,0,CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3864151,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL2180408,JNJ-42396302,1,353.43,0,2.13,None,COCCc1ccc(-c2c(C)nc3c(N4CCOCC4)ccnn23)cn1,Inhibition,,-44,%,,Outside typical range,Not Active,UO_0000187,,,,,0,CHEMBL4886317,pim-2 oncogene  Millipore kinase panel,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4800727,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 10.0 碌M
CHEMBL3582461,MSD-CYP11B2-Negative-control,None,303.29,0,4.45,EUB0000733,FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1,% Control,,100,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507294,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL257167,,None,279.3,0,2.14,TPCA_1,NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O,Residual Activity,'=',60,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL75680,ALOISINE A,None,267.33,0,3.67,Aloisine_A,CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12,Residual Activity,'=',120,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4245507,,None,437.57,0,3.06,28,O=C(Cc1cccc(OCCCN2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1,IC50,'>',1000,nM,,,,UO_0000065,,,,,0,CHEMBL4233381,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4229420,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL296586,KENPAULLONE,None,327.18,0,4.09,Kenpaullone,O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1,Residual Activity,'=',79,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL480371,GW853609X,None,496.31,1,5.55,GW853609X,NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br,Inhibition,'=',1.16,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL2088999,,None,265.27,0,3.08,20,Nc1cccc2[nH]c3c(cc(C(=O)O)c4cc[nH]c43)c12,Activity,'=',89,%,,,,UO_0000187,,,,,0,CHEMBL2090474,Inhibition of human Pim2 using RSRHSSYPAGT as substrate assessed as residual activity at 10 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2086229,1,Scientific Literature,Eur J Med Chem,2012,None,
CHEMBL2087493,,None,508.01,2,0.34,38,CS(=O)(=O)N1CCN(Cc2cn3c(Cl)c(-c4cnc(N)nc4)nc(N4CCOCC4)c3n2)CC1,Inhibition,'<',30,%,,,,UO_0000187,,,,,0,CHEMBL2092435,Inhibition of PIM2 at 5 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2086238,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL417804,,None,445.5,0,4.87,SB-251527,COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1,Inhibition,'=',0.39,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1234833,,None,385.47,0,1.59,4k,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2003420,,None,384.48,0,2.34,SID103904793,O=C(NCCCCCCNC(=O)NCc1cccnc1)NCc1cccnc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2048867,,None,382.28,0,2.7,23,N[C@@H]1CCCN(c2c(Br)cccc2/C=C2\SC(=O)NC2=O)C1,Inhibition,'>',50,%,,,,UO_0000187,,,,,0,CHEMBL2049750,Inhibition of human PIM2 at 1 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2046384,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL71191,,None,266.3,0,3.31,Tyrphostin AG-1296,COc1cc2ncc(-c3ccccc3)nc2cc1OC,Residual Activity,'=',127,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2218929,,None,287.32,0,3.57,JAK3_Inhibitor_VI,O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1,Residual Activity,'=',5,%,,,,UO_0000187,,,,,0,CHEMBL2219138,Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4585243,BAY-7598,None,505.57,1,3.6,EUB0000728,O=C(O)[C@H]1[C@H](Cn2nnc3ccccc3c2=O)CC[C@@H]1C(=O)c1ccc(OCCC2CCOCC2)cc1,% Control,,96,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507264,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL4530924,,None,366.43,0,2.34,19,C[C@H]1NC(=O)c2cc(-c3nccc4c(=O)n(C)c(NC(C)(C)C)nc34)[nH]c21,IC50,'=',7.4,nM,8.13,,,UO_0000065,22.19,0.41,5.79,7.77,0,CHEMBL4478465,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as reduction in phosphorylation of biotinylated-BAD peptide at Serine 112 residue preincubated for 30 mins followed by substrate addition for 1 hr by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4477213,1,Scientific Literature,J Med Chem,2016,None,
CHEMBL4572195,,None,391.48,0,3.11,25,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C)c(N5CCCC5(C)C)nc34)[nH]c21,IC50,'=',0.6,nM,9.22,,,UO_0000065,23.56,0.43,6.11,11.11,0,CHEMBL4478465,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as reduction in phosphorylation of biotinylated-BAD peptide at Serine 112 residue preincubated for 30 mins followed by substrate addition for 1 hr by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4477213,1,Scientific Literature,J Med Chem,2016,None,
CHEMBL3901481,,None,385.48,0,2.85,BDBM248873,CCc1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CCNCC3)n2)c1,Ki,'=',3.86,nM,8.41,,434080,UO_0000065,21.83,0.4,5.56,11.72,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3976760,,None,415.5,0,2.21,BDBM248875,CCc1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CCNCC(O)C3)n2)c1,Ki,'=',7.26,nM,8.14,,434082,UO_0000065,19.59,0.36,5.93,8.85,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3936808,,None,427.51,0,2.53,BDBM248884,OC1CNCCN(c2cccc(-n3ncc4cnc(-c5cncc(C6CC6)c5)cc43)n2)C1,Ki,'=',14.9,nM,7.83,,434091,UO_0000065,18.31,0.33,5.3,8.51,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL507936,,None,369.43,0,4.83,SID103904369,Cc1cccc(NC(=O)Nc2ccc(-c3ccc4nccnc4c3N)cc2)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL518953,GSK-1023156A,None,428.31,0,4.53,GSK1023156A,NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br,Inhibition,'=',-0.36,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL326282,,None,392.67,1,5.81,SID103905352,O=C1CC(c2ccc(Cl)cc2Cl)Cc2nc3cc(Cl)ccc3c(O)c21,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1909390,GW576609A,None,691.1,2,6.57,GW576609A,O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1,Inhibition,'=',0.73,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1398474,,None,344.89,1,5.71,Akt_Inhibitor_X,CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21,Residual Activity,'=',97,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL572809,,None,279.75,0,2.51,6i,CNCc1nc2c(sc3ccc(Cl)cc32)c(=O)[nH]1,Ki,'=',153,nM,6.82,,,UO_0000065,24.36,0.52,4.31,11.8,0,CHEMBL1059318,Inhibition of human PIM2 by scintillation counting,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1154637,1,Scientific Literature,J Med Chem,2009,None,
CHEMBL290904,,None,284.34,0,3.13,Cdk4_inhibitor_III,Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1,Residual Activity,'=',99,%,,,,UO_0000187,,,,,0,CHEMBL2219137,Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3932879,,None,383.88,0,4.6,13,Cc1nc2cccc(-c3[nH]c4c(c3Cl)C(=O)N[C@@H]4C)c2nc1NC(C)(C)C,IC50,'=',1,nM,9,,,UO_0000065,23.44,0.46,4.4,10.88,0,CHEMBL4478465,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as reduction in phosphorylation of biotinylated-BAD peptide at Serine 112 residue preincubated for 30 mins followed by substrate addition for 1 hr by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4477213,1,Scientific Literature,J Med Chem,2016,None,
CHEMBL1651534,PF-04457845,2,455.44,1,5.39,EUB0000306,O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1,% Control,,97,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507297,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL3965074,,None,418.48,0,3.39,BDBM192602,C[C@H]1[C@@H](N)CCCN1c1ccncc1Nc1ncc2ccc(-c3ncccc3F)nn12,IC50,'=',30.9,nM,7.51,,344672,UO_0000065,17.95,0.33,4.12,7.72,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3952009,,None,397.88,0,4.56,BDBM191082,Cc1cccc(-c2c(-c3cc(Cl)ccc3F)cc3n2C(CCN)CNC3=O)c1,IC50,'=',114,nM,6.94,,341753,UO_0000065,17.45,0.34,2.38,11.56,0,CHEMBL3887520,Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP,,,,,,,,,,,,,,,,,,,,,,
CHEMBL5091825,,None,485.27,1,1.43,4t,OCCOCc1cn(CCNc2nonc2/C(=N/O)Nc2ccc(F)c(Br)c2)nn1,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL5058325,Inhibition of PIM2 (unknown origin) at 1 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL5055685,1,Scientific Literature,J Med Chem,2021,None,Dose = 1.0 microM
CHEMBL3963636,,None,433.41,0,4.49,BDBM191098,NCC[C@H]1CNC(=O)c2cc(-c3cccc(OC(F)(F)F)c3)c(-c3ccc(F)cc3)n21,IC50,'=',27,nM,7.57,,341769,UO_0000065,17.46,0.33,3.08,10.92,0,CHEMBL3887520,Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4564312,BAY-786,None,672.12,2,5.26,EUB0000335,O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1,% Control,,92,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507266,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL3940085,,None,335.41,0,3.69,BDBM238740,Cc1nc2cccc(-c3cc4n(c3)C(=O)NC4)c2nc1NC(C)(C)C,IC50,'=',189,nM,6.72,,416849,UO_0000065,20.05,0.37,3.03,9.36,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3660007,,None,400.53,0,4.67,BDBM104125,CC1(C)CC(Nc2cccc3ccc(-c4nnc5ccccn45)nc23)CC(C)(C)N1,IC50,'=',10000,nM,5,,222543,UO_0000065,12.48,0.23,0.33,7.45,0,CHEMBL3705115,PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL),,,,,,,,,,,,,,,,,,,,,,
CHEMBL1990583,,None,405.39,0,3.35,SID103904451,Nc1ncnn2ccc(C(=O)Nc3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3634778,,None,309.38,0,1.65,13,Cc1n[nH]c2cnc(-c3cncc(N4CCC(N)CC4)n3)cc12,Ki,'=',170,nM,6.77,,,UO_0000065,21.88,0.4,5.12,7.01,0,CHEMBL3636741,Inhibition of Pim2 (unknown origin) using 5FAM-ARKRRRHPSGPPTA as substrate after 90 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632547,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL4591082,SR-302,None,622.79,1,3.26,EUB0000712,CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1,% Control,,100,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507324,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 100.0 nM
CHEMBL2007296,,None,360.46,1,5.03,SID103904566,CCCOc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1240961,,None,313.15,0,4.38,3d,O=Cc1c[nH]c2c1ccc1c2[nH]c2cccc(Br)c21,IC50,'=',131,nM,6.88,,,UO_0000065,21.98,0.49,2.5,14.15,0,CHEMBL1248424,Inhibition of human GST fused Pim2 expressed in Escherichia coli after 30 mins,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1240519,1,Scientific Literature,Bioorg Med Chem,2010,None,
CHEMBL2004290,,None,528.64,2,5.83,SID103904291,COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)(C)O)c5)cnc(N)c34)cc2)cc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL4229130,,None,325.42,0,2.4,14f,CC(C)Nc1ccc2cnn(-c3cncc(NCCCN)n3)c2c1,IC50,'=',140,nM,6.85,,,UO_0000065,21.06,0.39,4.45,7.32,0,CHEMBL4222673,Inhibition of human PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4219163,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL4061176,,None,410.86,0,2.94,14,O=C1/C(=C/c2c[nH]c3nc(Cl)ccc23)Oc2c1ccc(O)c2CN1CCNCC1,Inhibition,'=',58,%,,,,UO_0000187,,,,,0,CHEMBL3997633,Inhibition of full length recombinant human N-terminal GST-tagged PIM2 (1 to 311 residues) expressed in baculovirus infected sf21 cells at 200 nM using S6K2 peptide as substrate by electrophoretic mobility shift assay relative to control,B,BAO_0000219,cell-based format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3994673,1,Scientific Literature,ACS Med Chem Lett,2017,None,
CHEMBL1991138,,None,453.59,1,5.15,SID103905464,Nc1nccn2c(C3CC(CN4CCCC4)C3)nc(-c3cccc(OCc4ccccc4)c3)c12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1979970,,None,317.3,0,3.04,SID103905386,CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3895998,,None,407.45,0,2.44,BDBM251572,Nc1ncc(-c2ccccc2F)nc1C(=O)Nc1cnccc1N1CCC(N)CC1,IC50,'=',1.4,nM,8.85,,438366,UO_0000065,21.73,0.4,6.41,7.2,0,CHEMBL3889161,In Vitro Caliper Kinase Assay: For comparison between certain PKC inhibitors of the present application and structurally comparable PIM kinase inhibitors,,,,,,,,,,,,,,,,,,,,,,
CHEMBL440411,,None,357.35,0,1.9,K00193,O=C1Nc2ccc(S(=O)(=O)O)cc2/C1=C1/Nc2ccccc2/C1=N\O,Thermal melting change,'=',3.5,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL3933170,,None,360.46,0,4.26,BDBM238456,O=C1NCCc2[nH]c(-c3cccc4ccc(NC5CCCCC5)nc34)cc21,IC50,'=',15,nM,7.82,,416200,UO_0000065,21.71,0.4,3.56,11.21,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL223367,,None,431.88,0,3.51,22,N#Cc1ncc2nc1OCCCCCOc1cc(CCCO)c(Cl)cc1NC(=O)N2,Ki,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL915361,Inhibition of Pim2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1142994,1,Scientific Literature,J Med Chem,2007,None,
CHEMBL3953807,,None,348.41,0,3.38,BDBM238742,Cc1nc2cccc(-c3cc4c(=O)[nH]ncc4[nH]3)c2nc1NC(C)(C)C,IC50,'=',3.71,nM,8.43,,416851,UO_0000065,24.2,0.44,5.05,8.49,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3942200,,None,382.47,0,4.88,BDBM238472,Cc1cccc(C)c1Nc1ccc2cccc(-c3cc4c([nH]3)CCNC4=O)c2n1,IC50,'=',80.9,nM,7.09,,416209,UO_0000065,18.54,0.33,2.21,10.16,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3949873,,None,443.47,1,5.12,BDBM191131,CC(C)[C@H]1CNC(=O)c2cc(-c3cccc(OC(F)(F)F)c3)c(-c3ccc(CN)cc3)n21,IC50,'=',173,nM,6.76,,341802,UO_0000065,15.25,0.29,1.64,9.76,0,CHEMBL3887520,Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3959008,,None,473.5,0,4.98,BDBM191122,COc1c(C)cc(-c2c(-c3cccc(OC(F)(F)F)c3)cc3n2[C@@H](CCN)CNC3=O)cc1C,IC50,'=',32,nM,7.5,,341793,UO_0000065,15.83,0.3,2.51,9.55,0,CHEMBL3887520,Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP,,,,,,,,,,,,,,,,,,,,,,
CHEMBL231209,,None,378.43,1,5.33,SID103904347,Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1968245,,None,404.9,0,4.73,SID103904753,NC(COc1cc(C=Cc2ccncc2)cnc1Cl)Cc1c[nH]c2ccccc12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1990884,,None,390.42,0,4.68,SID103905315,Cc1cc(C)c2oc(Nc3ccc(-c4cccc(C(N)=O)c4N)cc3F)nc2c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2004438,,None,423.4,1,5.54,SID103904371,Nc1c(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccc2nccnc12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2048872,,None,379.49,0,3.61,2; AZD1208,N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1,Ki,'=',0.16,nM,9.8,,,UO_0000065,25.81,0.5,6.19,12.99,0,CHEMBL3750380,Inhibition of PIM2 kinase (unknown origin) using Biotin-AGAGRSRHSSYPAGT-OH as substrate after 2 hrs by alphascreen assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3745712,1,Scientific Literature,J Med Chem,2015,None,
CHEMBL3427174,,None,294.36,0,2.25,6,COc1ccc2nc(C3=N[C@H](C(=O)O)CS3)sc2c1,Activity,'=',76,%,,,,UO_0000187,,,,,0,CHEMBL3427823,Inhibition of PIM2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3425453,1,Scientific Literature,Eur J Med Chem,2015,None,
CHEMBL3951026,,None,458.48,0,4.42,BDBM191110,CN(C)c1ccc(-c2c(-c3cccc(OC(F)(F)F)c3)cc3n2[C@@H](CCN)CNC3=O)cc1,IC50,'=',46,nM,7.34,,341781,UO_0000065,16,0.3,2.92,10.12,0,CHEMBL3887520,Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4248525,,None,490.63,0,3.88,37,CN1CCN(CCCOc2cccc(CC(=O)Nc3nc(-c4c[nH]c5ncccc45)cs3)c2)CC1,Ki,,,,,,Not Determined,,,,,,0,CHEMBL4235411,Inhibition of Pim2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4229506,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL4450356,,None,483.5,0,3.22,15,Cn1ncc(NC(=O)c2nc(-c3c(F)cccc3F)sc2N)c1N1CC[C@@H](N)C(F)(F)CC1,Ki,'=',0.3,nM,9.52,,,UO_0000065,19.7,0.39,6.3,8.27,0,CHEMBL4317000,Inhibition of recombinant human PIM2 using FAM-pimtide as substrate after 90 mins by Z-LYTE assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4316591,1,Scientific Literature,J Med Chem,2019,None,
CHEMBL4521827,,None,415.5,0,3.91,58,CN1CCOc2c1cnn1c(-c3ccc4ccnc(NC5CCCCC5)c4c3)nnc21,IC50,'=',1100,nM,5.96,,,UO_0000065,14.34,0.26,2.05,7.4,0,CHEMBL4340984,Inhibition of His tagged human recombinant PIM2 using PIM tide (ARKRRRHPSGPPTA) as substrate incubated for 1 hr by fluorescence based assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4340512,1,Scientific Literature,Eur J Med Chem,2019,None,
CHEMBL4562507,,None,430.51,0,3.61,60,CN1CCOc2c1cnn1c(-c3ccc4cccc(NCC5CCOCC5)c4c3)nnc21,IC50,'=',9940,nM,5,,,UO_0000065,11.62,0.21,1.39,6.51,0,CHEMBL4340984,Inhibition of His tagged human recombinant PIM2 using PIM tide (ARKRRRHPSGPPTA) as substrate incubated for 1 hr by fluorescence based assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4340512,1,Scientific Literature,Eur J Med Chem,2019,None,
CHEMBL3103867,,None,406.47,0,3.04,7,Nc1ccc(-c2ccccc2F)nc1C(=O)Nc1cnccc1N1CCC[C@H](N)C1,Ki,'=',0.2,nM,9.7,,,UO_0000065,23.86,0.44,6.66,8.8,0,CHEMBL4317000,Inhibition of recombinant human PIM2 using FAM-pimtide as substrate after 90 mins by Z-LYTE assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4316591,1,Scientific Literature,J Med Chem,2019,None,
CHEMBL4539555,BI 9307,None,546.61,1,1.77,EUB0000343,CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1,% Control,,86,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507278,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL2007592,,None,322.39,0,3.18,SID103904978,O=c1[nH]c2sc3c(c2c2nc(-c4ccccc4)nn12)CCCC3,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2001751,,None,476.54,1,5.26,SID103904754,NC(COc1cncc(-c2ccc3c(c2)C(=Cc2ccco2)C(=O)N3)c1)Cc1c[nH]c2ccccc12,Ki,'=',1,nM,9,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3687451,,None,534.56,1,4,BDBM151847,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@@H]1OS(C)(=O)=O,IC50,'=',20.32,nM,7.69,,292103,UO_0000065,14.39,0.28,3.69,6.19,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3896124,,None,361.45,0,3.88,11,Cc1nc2cccc(-c3cc4c([nH]3)C3(CC3)NC4=O)c2nc1NC(C)(C)C,IC50,'=',0.5,nM,9.3,,,UO_0000065,25.73,0.47,5.42,11.25,0,CHEMBL4478465,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as reduction in phosphorylation of biotinylated-BAD peptide at Serine 112 residue preincubated for 30 mins followed by substrate addition for 1 hr by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4477213,1,Scientific Literature,J Med Chem,2016,None,
CHEMBL561132,MK-7246,1,416.47,0,3.04,EUB0000297,CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1,% Control,,100,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507290,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL377408,,None,375.41,0,0.51,SID103905185,CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1C#N,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1975357,,None,365.48,1,5.79,SID103905644,CC(C)(C)OC(=O)n1cc(-c2cncn2C2CCCCC2)c2ccccc21,Ki,'=',630.96,nM,6.2,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1986943,,None,343.82,0,3.39,SID103904193,OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1,Ki,'=',398.11,nM,6.4,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3914616,,None,362.44,0,1.99,BDBM238434,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@@H]1CCNC1,IC50,'=',26.4,nM,7.58,,416632,UO_0000065,20.91,0.38,5.59,8,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3957649,,None,393.43,0,1.92,BDBM251576,Nc1ncc(-c2ccccc2F)nc1C(=O)Nc1cnccc1N1CCNCC1,IC50,'=',78,nM,7.11,,438370,UO_0000065,18.07,0.33,5.19,6.52,0,CHEMBL3889161,In Vitro Caliper Kinase Assay: For comparison between certain PKC inhibitors of the present application and structurally comparable PIM kinase inhibitors,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3676282,,None,483.47,0,4.45,BDBM131752,N[C@@H]1C[C@@H](C(F)(F)F)CN(c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C1,IC50,'=',72,nM,7.14,,263985,UO_0000065,14.77,0.3,2.69,8.49,0,CHEMBL3706072,Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3676284,,None,429.5,0,3.91,BDBM131754,C[C@@H]1C[C@H](N)CN(c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C1,IC50,'=',2,nM,8.7,,263987,UO_0000065,20.25,0.4,4.79,10.34,0,CHEMBL3706072,Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3676288,,None,444.51,0,4.58,BDBM131758,C[C@@H]1C[C@H](O)C[C@H](c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)sc2N)C1,IC50,'=',5,nM,8.3,,263991,UO_0000065,18.67,0.37,3.72,8.21,0,CHEMBL3706072,Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3676289,,None,429.5,0,4.3,BDBM131759,Nc1sc(-c2c(F)cccc2F)nc1C(=O)Nc1cnccc1[C@@H]1CCC[C@H](N)C1,IC50,'=',3,nM,8.52,,263992,UO_0000065,19.84,0.39,4.22,7.97,0,CHEMBL3706072,Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1987793,,None,435.52,1,6.94,SID103905169,Cc1ccccc1-c1c(C(=O)O)n(CCCOc2cccc3ccccc23)c2ccccc12,Ki,'=',1584.89,nM,5.8,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2035606,,None,312.71,0,3.7,4e,O=c1[nH]c(-c2ccccc2Cl)nc2c1oc1ccc(O)cc12,IC50,'=',3755,nM,5.42,,,UO_0000065,17.35,0.34,1.73,6.86,0,CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034948,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL3977535,,None,414.47,0,2.88,BDBM238734,CC(C)Nc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2c(=O)n1-c1ccccn1,IC50,'=',29.4,nM,7.53,,416843,UO_0000065,18.17,0.33,4.65,7.19,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3980532,,None,364.45,0,2.37,BDBM238443,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NCC(C)(C)N,IC50,'=',6.3,nM,8.2,,416641,UO_0000065,22.5,0.41,5.83,7.54,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3577885,PF-05105679,1,428.46,1,5.48,EUB0000304,C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1,% Control,,100,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507296,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL2000114,,None,238.32,0,1.47,SID103904504,CSc1c[nH]c2ncnc(NCCCO)c12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1975647,,None,283.27,0,2.81,SID103904887,O=C(Nc1cnccn1)Nc1ccnc2c(F)cccc12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1983945,,None,383.45,0,3.64,SID103904683,NC(Cc1c[nH]c2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3985018,,None,356.39,0,3.7,BDBM238537,O=C1NCCc2[nH]c(-c3cccc4ncc(Oc5ccccc5)nc34)cc21,IC50,'=',18.4,nM,7.74,,416260,UO_0000065,21.7,0.39,4.04,9.68,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3935691,,None,375.48,0,3.2,BDBM238490,N[C@@H]1CCC[C@@H](Nc2ccc3cccc(-c4cc5c([nH]4)CCNC5=O)c3n2)C1,IC50,'=',4.6,nM,8.34,,416228,UO_0000065,22.2,0.41,5.14,8.7,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4526558,,None,484.49,0,2.95,48,CN1CCOc2c1cnn1c(-c3ccc4c(F)c(F)cc(NCC5(F)CCNCC5)c4n3)nnc21,IC50,'=',3590,nM,5.45,,,UO_0000065,11.24,0.21,2.49,5.89,0,CHEMBL4340984,Inhibition of His tagged human recombinant PIM2 using PIM tide (ARKRRRHPSGPPTA) as substrate incubated for 1 hr by fluorescence based assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4340512,1,Scientific Literature,Eur J Med Chem,2019,None,
CHEMBL3634759,,None,373.46,0,2.95,38,Cn1cc(-c2cc3c(-c4cccc(N5CCC[C@@H](N)C5)c4)n[nH]c3cn2)cn1,Ki,'=',1.25,nM,8.9,,,UO_0000065,23.84,0.43,5.95,10.04,0,CHEMBL3636741,Inhibition of Pim2 (unknown origin) using 5FAM-ARKRRRHPSGPPTA as substrate after 90 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632547,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL3687479,,None,473.55,0,4.17,BDBM151875,CO[C@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)sc2N)C[C@@H]1C,IC50,'=',1.17,nM,8.93,,292131,UO_0000065,18.86,0.37,4.76,7.69,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL607707,PELITINIB,2,467.93,1,5.1,EKB-569,CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C,Kd,,,,,,Not Active,,,,,,0,CHEMBL859489,Average Binding Constant for PIM2; NA=Not Active at 10 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1144455,1,Scientific Literature,Nat Biotechnol,2005,None,
CHEMBL3979444,,None,479.89,1,5.02,BDBM191120,COc1ccc(-c2c(-c3cccc(OC(F)(F)F)c3)cc3n2[C@@H](CCN)CNC3=O)cc1Cl,IC50,'=',21,nM,7.68,,341791,UO_0000065,16,0.32,2.66,9.78,0,CHEMBL3887520,Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3348923,TOVORAFENIB,2,506.3,1,3.98,MLN-2480,C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL1231124,AZD-1480,2,348.77,0,3.01,AZD-1480,Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL218720,GSK-466314A,None,428.41,0,4.41,GSK466314A,CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1,Inhibition,'=',0.55,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3953089,,None,459.42,0,3.49,BDBM191089,NC(=O)c1ccc(-c2c(-c3cccc(OC(F)(F)F)c3)cc3n2C(CCO)CNC3=O)cc1,IC50,'=',58,nM,7.24,,341760,UO_0000065,15.75,0.3,3.75,6.79,0,CHEMBL3887520,Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1738757,REBASTINIB,2,553.6,2,6.05,Rebastinib,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL372764,PERIFOSINE,3,461.67,1,6.99,Perifosine,CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1,Kd,'>',30000,nM,,,Inactive,UO_0000065,,,,,0,CHEMBL3991825,Kinobeads (epsilon),,,,,,,,,,,,,,,,,,,,,,
CHEMBL1971149,,None,438.44,0,3.96,SID103904775,Cc1nccn2c(-c3ccnc(NCC(C)(C)C(=O)O)n3)c(-c3ccc(F)cc3F)nc12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1989856,,None,251.25,0,2.19,SID103905300,Cc1c(C=O)c(O)n2c(nc3ccccc32)c1C#N,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL226403,,None,340.39,0,3.58,SID103905260,O=C1NCCc2[nH]c(-c3ccnc(-c4cnc5ccccc5c4)c3)cc21,Ki,'=',398.11,nM,6.4,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3634756,,None,374.45,0,2.35,35,Cn1cc(-c2cc3c(-c4cccc(N5CCC[C@@H](N)C5)n4)n[nH]c3cn2)cn1,Ki,'=',0.72,nM,9.14,,,UO_0000065,24.42,0.45,6.79,9,0,CHEMBL3636741,Inhibition of Pim2 (unknown origin) using 5FAM-ARKRRRHPSGPPTA as substrate after 90 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632547,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL4580220,BAY-3827,None,468.54,1,5.45,EUB0000311,CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12,% residual kinase activity,,102,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4884431,Pim-2(h) Eurofins kinase panel,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507319,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1.0 碌M
CHEMBL3916044,,None,390.39,1,5.29,BDBM224958,CNc1nnc(-c2ccc3[nH]cc(-c4cccc(OC(F)(F)F)c4)c3c2)s1,IC50,'>',3000,nM,,,393248,UO_0000065,,,,,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL378627,,None,448.5,0,1.92,18b,COc1cc(S(C)(=O)=O)c(OC)cc1CC(=O)Nc1cc(N)c(C#N)c(OC(C)C)n1,Ki,'>',1400,nM,,,,UO_0000065,,,,,0,CHEMBL863188,Inhibition of Pim2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148638,1,Scientific Literature,J Med Chem,2006,None,
CHEMBL4537788,BAY-784,None,672.12,2,5.26,EUB0000347,O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1,% Control,,94,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507266,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL204232,NAPHTHYRIDINONE,None,514.8,2,6.39,EUB0000296,CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12,% Control,,100,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507287,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL4533479,A-1806262,None,558.68,2,5.81,EUB0000339,CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1,% Control,,99,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507261,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL2017353,,None,430.54,0,4.92,13u,CN(C)CCOc1ccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3sccc23)cc1,IC50,'=',34,nM,7.47,,,UO_0000065,17.35,0.33,2.55,9.46,0,CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016532,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL4560589,MLi-2-NC,None,393.49,0,3.58,EUB0000706,C[C@@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@H](C)O1,% Control,,100,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507291,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL3981107,,None,415.42,0,4.35,BDBM191077,NCC[C@H]1CNC(=O)c2cc(-c3cccc(OC(F)(F)F)c3)c(-c3ccccc3)n21,IC50,'=',38,nM,7.42,,341748,UO_0000065,17.86,0.34,3.07,10.71,0,CHEMBL3887520,Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3919725,,None,391.48,0,3.74,BDBM238788,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C5CC5)c(NC(C)(C)C)nc34)[nH]c21,IC50,'=',0.076,nM,10.12,,416897,UO_0000065,25.85,0.48,6.38,11.02,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3617968,BAY-678,None,400.36,0,4.11,EUB0000735,CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1,% Control,,98.2,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507272,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL3930725,,None,472.48,0,2.4,BDBM249017,C[C@]1(O)CNCCN(c2cccc(-n3ncc4cnc(-c5cnn(CC(F)(F)F)c5)cc43)n2)C1,Ki,'=',22.1,nM,7.66,,434221,UO_0000065,16.2,0.31,5.26,7.9,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1682540,,None,235.25,0,2.27,SID103904528,c1cnc2nc(-c3ccc4[nH]ncc4c3)cn2c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2002446,,None,458.63,0,4.23,SID103904811,CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCOCC5CC5)c4)n[nH]c2-3)CC1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2035616,,None,326.74,0,4,4o,COc1cccc2oc3c(=O)[nH]c(-c4ccccc4Cl)nc3c12,IC50,'=',5000,nM,5.3,,,UO_0000065,16.22,0.31,1.3,7.78,0,CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034948,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL1782528,,None,367.2,0,2.38,36,O=C(O)c1cc2cc(Br)cc(C(=O)NC3CCNCC3)c2o1,IC50,'=',7000,nM,5.16,,,UO_0000065,14.04,0.32,2.77,5.63,0,CHEMBL1786238,Inhibition of human Pim2 using 5-FAM-RSRHSSYPAGT-CONH2 as substrate after 90 mins by off-chip mobility shift method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1781944,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL1782533,,None,354.2,0,3.61,41,O=C(O)c1cc2cc(Br)cc(N[C@H]3CC[C@H](O)CC3)c2o1,IC50,'=',6100,nM,5.21,,,UO_0000065,14.72,0.34,1.6,6.31,0,CHEMBL1786238,Inhibition of human Pim2 using 5-FAM-RSRHSSYPAGT-CONH2 as substrate after 90 mins by off-chip mobility shift method,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1781944,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL4758068,,None,469.49,0,3.28,9,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)ncc2N)C[C@@H](O)[C@]1(C)O,Ki,'<',3,nM,,,,UO_0000065,,,,,0,CHEMBL4723884,Inhibition of PIM2 (unknown origin) using Bad peptide NH2-AGAGRSRHSSYPAGT-OH as substrate measured after 10 mins in presence of ATP by luciferase-luciferin based Kinase-Glo luminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4715870,1,Scientific Literature,J Med Chem,2020,None,TIME = 0.1667 hr
CHEMBL210032,,None,252.28,0,2.16,24,CC(=O)Nc1cc(N)c(C#N)c(-c2ccccc2)n1,Ki,'>',1400,nM,,,,UO_0000065,,,,,0,CHEMBL863188,Inhibition of Pim2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1148638,1,Scientific Literature,J Med Chem,2006,None,
CHEMBL3973432,,None,439.45,0,3.69,BDBM192580,N[C@@H]1CN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)CC[C@H]1F,IC50,'=',48.8,nM,7.31,,344643,UO_0000065,16.64,0.31,3.62,8.67,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4537673,BAY-985,None,553.59,1,4.38,EUB0000305,C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1,% Control,,100,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507318,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 100.0 nM
CHEMBL5079648,,None,473.56,0,3.62,51,CCN(CC)c1cnc2ccc(-c3nc(Nc4ccc(N5CCNCC5)cn4)ncc3F)cc2n1,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL5041384,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL5038637,1,Scientific Literature,J Med Chem,2022,None,
CHEMBL3945507,,None,369.43,0,3.59,BDBM238749,Cc1cccnc1-c1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2nc1C,IC50,'=',257,nM,6.59,,416858,UO_0000065,17.84,0.32,3,7.89,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3891786,,None,365.44,0,2.61,BDBM238646,CC(C)(C)Nc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2nc1CO,IC50,'=',2.26,nM,8.65,,416755,UO_0000065,23.66,0.44,6.04,8.4,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4780458,,None,457.42,0,4.04,EUB0000540,O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1,% Control,,100,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507297,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL2402081,,None,432.46,0,3.1,37,CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1,Inhibition,'=',-8,%,,,,UO_0000187,,,,,0,CHEMBL2406522,Inhibition of PIM2 (unknown origin) at 10 uM relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2401733,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL3973242,,None,364.41,0,1.5,BDBM238499,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@@H](C)C(N)=O,IC50,'=',227,nM,6.64,,416236,UO_0000065,18.23,0.34,5.14,5.28,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1979577,,None,455.59,1,5.59,SID103904303,Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CC(C)(C)N)cnc(N)c34)cc2)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1989029,,None,269.3,0,2.42,SID103905114,CC(C)OC1=NNC(=O)C1=Cc1c[nH]c2ccccc12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL4780286,,None,330.39,0,3.77,50,OC[C@@H](Nc1ncnc2[nH]c(-c3ccccc3)cc12)c1ccccc1,Inhibition,'=',9,%,,,,UO_0000187,,,,,0,CHEMBL4718881,Inhibition of recombinant full length GST-tagged human PIM2 expressed in baculovirus expression system at 500 nM using Ser/Thr 07 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4715760,1,Scientific Literature,Eur J Med Chem,2016,None,Dose = 500.0 nM | TIME = 1.0 hr
CHEMBL3286797,PF-04418948,1,409.41,0,3.59,EUB0000351,COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1,% Control,,100,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507298,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL1939880,BI 4395,None,374.4,0,3.2,EUB0000727,Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1,% Control,,81,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507281,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 100.0 nM
CHEMBL3943843,,None,388.82,0,4.58,BDBM224863,Nc1nnc(-c2ccc3[nH]cc(-c4nccc(-c5ccccc5Cl)n4)c3c2)o1,IC50,'=',19.17,nM,7.72,,393141,UO_0000065,19.85,0.38,3.14,7.25,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3890347,,None,362.39,0,2.7,BDBM225044,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(N5CCOCC5)n4)c3c2)o1,IC50,'=',20.77,nM,7.68,,393030,UO_0000065,21.2,0.39,4.98,7.24,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2152944,Skepinone-L,None,425.43,0,3.77,EUB0000717,O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21,% Residual activity with Skepinone-L,,97,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4884052,PIM2 ProQinase selectivity panel,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507316,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1.0 碌M
CHEMBL3944062,,None,372.44,0,1.99,BDBM248892,Cc1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CCNCC3)n2)n1,Ki,'=',0.893,nM,9.05,,434099,UO_0000065,24.3,0.44,7.06,10.69,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1983932,,None,373.21,0,4.04,SID103904891,COc1ccc2c(NC(=O)Nc3cccc(Br)n3)ccnc2c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1972937,,None,310.38,0,3.59,SID103904703,COc1cccc(C=C2SC(=Nc3ccccc3)NC2=O)c1,Ki,'=',1000,nM,6,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1988594,,None,404.46,0,4.17,SID103904352,Nc1ncnc2scc(C(=O)Nc3ccc(NC(=O)Nc4ccccc4)cc3)c12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1976240,,None,347.42,0,3.19,SID103904556,COc1cccc(C(CN)NC(=O)c2ccc(-c3ccncc3)cc2)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL183844,,None,371.44,0,4.86,SID103904360,Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2C)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3892866,,None,404.83,1,5.61,BDBM238386,O=c1[nH]ccc2[nH]c(-c3cccc4ccc(Nc5c(F)cccc5Cl)nc34)cc12,IC50,'=',11,nM,7.96,,416164,UO_0000065,19.66,0.37,2.35,10.82,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3894660,,None,379.46,0,3.09,BDBM238639,Cc1nc2cccc(-c3cc4c([nH]3)CCN(CO)C4=O)c2nc1NC(C)(C)C,IC50,'=',9,nM,8.05,,416748,UO_0000065,21.2,0.39,4.96,8.55,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4113226,,None,419.47,0,2.64,BDBM192617,C[C@@H]1C[C@H](N)CN(c2ccncc2Nc2nnc3ccc(-c4ncccc4F)nn23)C1,IC50,'=',10.6,nM,7.97,,344688,UO_0000065,19.01,0.35,5.33,7.24,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3918209,,None,389.5,0,4.35,BDBM238523,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1(C)CCCCC1,IC50,'=',1.5,nM,8.82,,416667,UO_0000065,22.65,0.42,4.47,10.67,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3927624,,None,333.4,0,2.72,BDBM238585,Cc1nc2cccc(-c3cc4n(c3)CCNC4=O)c2nc1NC1CC1,IC50,'=',6.9,nM,8.16,,416700,UO_0000065,24.48,0.45,5.44,11.36,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3897690,,None,363.47,0,4.12,BDBM238779,Cc1nc2cccc(-c3cc4c([nH]3)C(C)(C)NC4=O)c2nc1NC(C)(C)C,IC50,'=',1.93,nM,8.71,,416888,UO_0000065,23.98,0.44,4.59,10.54,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4108287,,None,436.47,0,3.38,BDBM192611,C[C@@H]1C[C@H](N)CN(c2ccncc2Nc2nnc3ccc(-c4c(F)cccc4F)nn23)C1,IC50,'=',3.9,nM,8.41,,344686,UO_0000065,19.27,0.36,5.03,8.65,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3901441,,None,335.37,0,3.65,BDBM224828,CC(C)Oc1cccc(-c2c[nH]c3ccc(-c4nnc(N)o4)cc23)n1,IC50,'=',5.458,nM,8.26,,393110,UO_0000065,24.64,0.45,4.61,8.03,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3964669,,None,363.38,0,2.09,BDBM224831,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(N5CCOCC5)n4)c3c2)o1,IC50,'=',13.45,nM,7.87,,393113,UO_0000065,21.66,0.4,5.78,6.62,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3918714,,None,349.44,0,3.95,BDBM238665,Cc1nc2cccc(-c3cc4c([nH]3)[C@H](C)NC4=O)c2nc1NC(C)(C)C,IC50,'=',2.02,nM,8.7,,416774,UO_0000065,24.88,0.46,4.74,10.51,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3906819,,None,390.45,0,1.91,BDBM238553,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1CCC(=O)NC1,IC50,'=',26.2,nM,7.58,,416675,UO_0000065,19.42,0.36,5.67,6.78,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3934584,,None,371.4,0,3.29,BDBM238409,Nc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1Oc1ccccc1,IC50,'=',1.8,nM,8.74,,416617,UO_0000065,23.55,0.43,5.45,8.26,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3103882,,None,287.39,0,3.39,1b,O=C(Nc1ccccc1N1CCCCC1)c1cscn1,Ki,'>',12500,nM,,,,UO_0000065,,,,,0,CHEMBL3106178,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3102815,1,Scientific Literature,ACS Med Chem Lett,2013,None,
CHEMBL1981045,,None,611.69,1,4.86,SID103904725,COc1cc(-c2ccc3c(c2)Nc2ccc(CCOc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1OCC(O)CO,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1980163,,None,327.39,0,4.95,SID103904652,c1ccc(COc2ccc(Nc3ncnc4ccccc34)cc2)cc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL4577237,BI 9446,None,602.48,2,5.77,EUB0000549,C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21,% Control,,98,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507282,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL1684525,,None,420.5,0,3.86,9k,Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1,Inhibition,'=',101,%,,,,UO_0000187,,,,,0,CHEMBL1686068,Inhibition of Pim-2 at 1 uM,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1681705,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL1990885,,None,398.48,0,3.33,SID103905670,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc32)c1C,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL234085,,None,312.38,0,1.54,SID103905419,CC1CCN(C(=O)CC#N)CC1N(C)c1ncnc2[nH]ccc12,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL4527736,,None,466.5,0,2.81,50,CN1CCOc2c1cnn1c(-c3ccc4c(F)ccc(NCC5(F)CCNCC5)c4n3)nnc21,IC50,'=',3010,nM,5.52,,,UO_0000065,11.84,0.22,2.71,5.97,0,CHEMBL4340984,Inhibition of His tagged human recombinant PIM2 using PIM tide (ARKRRRHPSGPPTA) as substrate incubated for 1 hr by fluorescence based assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4340512,1,Scientific Literature,Eur J Med Chem,2019,None,
CHEMBL4460019,,None,448.51,0,2.67,57,CN1CCOc2c1cnn1c(-c3ccc4ccnc(NCC5(F)CCNCC5)c4c3)nnc21,IC50,'=',122,nM,6.91,,,UO_0000065,15.41,0.29,4.24,7.47,0,CHEMBL4340984,Inhibition of His tagged human recombinant PIM2 using PIM tide (ARKRRRHPSGPPTA) as substrate incubated for 1 hr by fluorescence based assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4340512,1,Scientific Literature,Eur J Med Chem,2019,None,
CHEMBL3394060,,None,342.43,1,5.09,BDBM50061703,Nc1ncc(-c2ccc3[nH]cc(-c4cnc5ccccc5c4)c3c2)s1,IC50,'=',2708.96,nM,5.57,,393044,UO_0000065,16.26,0.3,0.48,8.24,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3915388,,None,342.37,0,4.67,BDBM225055,CNc1nnc(-c2ccc3[nH]cc(-c4ccc(F)cc4F)c3c2)s1,IC50,'=',1552.41,nM,5.81,,393047,UO_0000065,16.97,0.33,1.14,10.84,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3965588,,None,378.41,0,4.51,BDBM225013,CC(C)Nc1nnc(-c2cc3c(-c4nccc(C5CC5)n4)c[nH]c3cc2F)o1,IC50,'=',8.04,nM,8.1,,393303,UO_0000065,21.39,0.39,3.58,8.75,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4543342,,None,444.54,0,2.92,31,CN1CCC(CNc2cccc3ccc(-c4nnc5c6c(cnn45)N(C)CCO6)nc23)CC1,IC50,'=',4250,nM,5.37,,,UO_0000065,12.08,0.22,2.45,6.42,0,CHEMBL4340984,Inhibition of His tagged human recombinant PIM2 using PIM tide (ARKRRRHPSGPPTA) as substrate incubated for 1 hr by fluorescence based assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4340512,1,Scientific Literature,Eur J Med Chem,2019,None,
CHEMBL4547383,,None,415.5,0,3.91,35,CN1CCOc2c1cnn1c(-c3ccc4cccc(NC5CCCCC5)c4n3)nnc21,IC50,'=',3330,nM,5.48,,,UO_0000065,13.18,0.24,1.57,6.81,0,CHEMBL4340984,Inhibition of His tagged human recombinant PIM2 using PIM tide (ARKRRRHPSGPPTA) as substrate incubated for 1 hr by fluorescence based assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4340512,1,Scientific Literature,Eur J Med Chem,2019,None,
CHEMBL4526234,,None,443.56,0,4.55,37,CN1CCOc2c1cnn1c(-c3ccc4cccc(NC5CCC(C)(C)CC5)c4n3)nnc21,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL4340984,Inhibition of His tagged human recombinant PIM2 using PIM tide (ARKRRRHPSGPPTA) as substrate incubated for 1 hr by fluorescence based assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4340512,1,Scientific Literature,Eur J Med Chem,2019,None,
CHEMBL4748367,,None,448.55,0,3.56,71,CN(C)CCNCc1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3[nH]2)cc1F,Inhibition,'=',-5,%,,,,UO_0000187,,,,,0,CHEMBL4718881,Inhibition of recombinant full length GST-tagged human PIM2 expressed in baculovirus expression system at 500 nM using Ser/Thr 07 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4715760,1,Scientific Literature,Eur J Med Chem,2016,None,Dose = 500.0 nM | TIME = 1.0 hr
CHEMBL3959112,,None,379.45,0,2.56,BDBM224878,Nc1nnc(-c2ccc3[nH]cc(-c4ccnc(N5CCOCC5)n4)c3c2)s1,IC50,'=',19.41,nM,7.71,,393156,UO_0000065,20.32,0.39,5.15,7.29,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3934276,,None,364.45,0,3.43,BDBM238640,Cc1nc2cccc(-c3cc4c([nH]3)CCN/C4=N/O)c2nc1NC(C)(C)C,IC50,'=',12,nM,7.92,,416749,UO_0000065,21.73,0.4,4.49,8.06,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3676283,,None,483.47,0,4.45,BDBM131753,N[C@H]1C[C@@H](C(F)(F)F)CN(c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C1,IC50,'=',3,nM,8.52,,263986,UO_0000065,17.63,0.35,4.07,10.13,0,CHEMBL3706072,Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3676295,,None,430.48,0,3.69,BDBM131765,N[C@@H]1C[C@H](c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)CC[C@H]1O,IC50,'=',95,nM,7.02,,263998,UO_0000065,16.31,0.32,3.33,6.94,0,CHEMBL3706072,Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4077499,,None,372.42,0,4.32,31,O=C1NC(=S)S/C1=C\c1csc(-c2ccccc2C(F)(F)F)n1,Delta Tm,'=',8.2,degrees C,,,,UO_0000027,,,,,0,CHEMBL4029682,Inhibition of recombinant PIM2 (unknown origin) assessed as change in melting temperature at 10 uM by SYPRO orange dye-based differential scanning fluorimetry,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4028814,1,Scientific Literature,Bioorg Med Chem,2017,None,
CHEMBL4069566,,None,320.42,0,3,37,O=C1NC(=S)S/C1=C\c1csc(-c2ccccc2O)n1,Delta Tm,'=',17,degrees C,,,,UO_0000027,,,,,0,CHEMBL4029682,Inhibition of recombinant PIM2 (unknown origin) assessed as change in melting temperature at 10 uM by SYPRO orange dye-based differential scanning fluorimetry,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4028814,1,Scientific Literature,Bioorg Med Chem,2017,None,
CHEMBL4518342,THPP-1-NC,None,493.45,1,5.47,EUB0000744,CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1,% Control,,100,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507293,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 100.0 nM
CHEMBL1834184,BI 99179,None,391.47,0,4.15,EUB0000294,CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1,% Control,,100,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507280,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL3919337,,None,360.42,0,4.37,BDBM224998,CC(C)Nc1nnc(-c2ccc3[nH]cc(-c4nccc(C5CC5)n4)c3c2)o1,IC50,'=',1.394,nM,8.86,,393287,UO_0000065,24.57,0.45,4.49,9.57,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3417525,BI 665915,None,458.53,0,2.78,EUB0000749,CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1,% Control,,100,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507276,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL2348350,,None,438.56,0,2.4,15u,CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1,Activity,'=',89,%,,,,UO_0000187,,,,,0,CHEMBL4806709,Inhibition of human PIM2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4804286,38,Patent Bioactivity Data,,,None,Dose = 2000.0 nM
CHEMBL388978,STAUROSPORINE,None,466.54,0,4.35,Staurosporine,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,Activity,'<',65,%,,,,UO_0000187,,,,,0,CHEMBL4328192,Inhibition of human PIM2 assessed as residual activity at 100 uM using RSRHSSYPAGT as substrate by [gamma-33P]-ATP assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4325871,1,Scientific Literature,Eur J Med Chem,2019,None,
CHEMBL3919725,,None,391.48,0,3.74,11,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C5CC5)c(NC(C)(C)C)nc34)[nH]c21,IC50,'=',0.12,nM,9.92,,,UO_0000065,25.34,0.47,6.18,10.81,0,CHEMBL4370146,Inhibition of full length recombinant PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues preincubated for 30 mins followed by biotinylated BAD addition and measured after 1 hr by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4368910,1,Scientific Literature,J Med Chem,2019,None,
CHEMBL4585920,TP-020n,None,520.95,1,3.61,EUB0001079,Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1,% Control,,85,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507302,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL3236464,,None,397.46,0,2.7,16,CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N,Activity,'=',108,%,,,,UO_0000187,,,,,0,CHEMBL3241827,Inhibition of human Pim-2 assessed as enzyme activity at 1 uM relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3232845,1,Scientific Literature,Bioorg Med Chem Lett,2014,None,
CHEMBL4530401,MRL-SYKi-NC,None,505.56,2,6.37,EUB0000704,Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1,% Control,,87.9,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507285,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 100.0 nM
CHEMBL4522930,BI-605906,None,432.52,0,2.49,None,CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12,% Ctrl,,101,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4887656,PIM2 DUNDEE kinase screen (BI),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Assay technology: Radioactive Assay | Method: PIM2 | Mode of action: inhibitor | Target type: Kinase under EC2.7,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4800722,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 10.0 碌M
CHEMBL4249686,,None,265.36,0,4.15,40,CCCCCc1cc2nn(-c3ccccc3)cc2cn1,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4231774,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4229372,1,Scientific Literature,Eur J Med Chem,2018,None,
CHEMBL4109699,,None,472.48,0,2.32,BDBM249029,Cc1ccc(-n2ncc3cnc(-c4cnn(CC(F)(F)F)c4)cc32)nc1N1CCNC[C@@H](O)C1,Ki,'=',1.54,nM,8.81,,434233,UO_0000065,18.65,0.35,6.49,9.09,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3961823,,None,454.46,0,3.53,BDBM248989,Cc1cncc(-c2cc3c(cn2)cnn3-c2ccc(C(F)(F)F)c(N3CCC[C@H](N)C3)n2)n1,Ki,'=',0.115,nM,9.94,,434196,UO_0000065,21.87,0.41,6.41,10.08,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3929332,,None,421.47,1,-0.31,BDBM249023,Cn1cc(-c2cc3c(cn2)cnn3-c2cn(C)c(=O)c(N3CCNCC(O)C3)n2)cn1,Ki,'=',718,nM,6.14,,434227,UO_0000065,14.58,0.27,6.45,5.17,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3968874,,None,347.38,0,1.4,BDBM249022,Cn1cc(-c2cc3c(cn2)cnn3-c2cccc(N3CC(O)C3)n2)cn1,Ki,'=',45.1,nM,7.35,,434226,UO_0000065,21.15,0.39,5.95,8.65,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1986263,,None,342.42,0,3.45,SID103904649,CCn1c(C)c(-c2ccnc(Nc3cccc(OC)c3)n2)sc1=O,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1992342,,None,330.41,0,2.96,SID103904472,CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1971141,,None,345.4,0,4.4,SID103904383,Cc1cccc(NC(=O)Nc2ccc(-c3cccc(C(N)=O)c3)cc2)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL274064,SB-220025,None,338.39,0,2.65,SID103905253,Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1979883,,None,455.59,1,5.41,SID103904280,Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN(C)C)cnc(N)c34)cc2)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1976134,,None,234.26,0,3.11,SID103905212,c1cc2cc(-c3ccc4cn[nH]c4c3)cnc2[nH]1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL3924352,,None,419.92,0,4.12,21c,N[C@H]1CCCN(c2ccncc2Nc2ncc3ccc(-c4ccccc4Cl)nn23)C1,IC50,'=',3.4,nM,8.47,,,UO_0000065,20.17,0.39,4.35,10.04,0,CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3864151,1,Scientific Literature,Bioorg Med Chem Lett,2016,None,
CHEMBL1909410,GSK-259178A,None,728.7,2,5.27,GSK259178A,O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1,Inhibition,'=',0.44,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3910416,,None,447.43,0,4.8,BDBM191127,Cc1cc(-c2c(-c3cccc(OC(F)(F)F)c3)cc3n2[C@@H](CCN)CNC3=O)ccc1F,IC50,'=',86,nM,7.07,,341798,UO_0000065,15.79,0.3,2.27,10.2,0,CHEMBL3887520,Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3984169,,None,530.55,1,3.68,BDBM191091,CN(C)CCNC(=O)c1ccc(-c2c(-c3cccc(OC(F)(F)F)c3)cc3n2C(CCO)CNC3=O)cc1,IC50,'=',90,nM,7.05,,341762,UO_0000065,13.28,0.25,3.37,7.35,0,CHEMBL3887520,Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3923364,,None,556.59,1,4.21,BDBM191092,CN1CCC(NC(=O)c2ccc(-c3c(-c4cccc(OC(F)(F)F)c4)cc4n3C(CCO)CNC4=O)cc2)CC1,IC50,'=',69,nM,7.16,,341763,UO_0000065,12.87,0.24,2.95,7.47,0,CHEMBL3887520,Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1909376,,None,378.82,0,0.13,SB-759335-B,CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl,Inhibition,'=',-0.88,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1915640,,None,430.44,0,4.48,15n,COCCOc1ccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3cnccc23)c(F)c1,IC50,'=',30,nM,7.52,,,UO_0000065,17.48,0.32,3.04,7.69,0,CHEMBL1919424,Inhibition of PIM2 by millipore assay in the presence of 15 uM [ATP],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1914433,1,Scientific Literature,Bioorg Med Chem Lett,2011,None,
CHEMBL3105022,,None,457.46,0,2.96,1,C[C@H]1CN(c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@@H]1O,Ki,'<',3,nM,,,,UO_0000065,,,,,0,CHEMBL4723884,Inhibition of PIM2 (unknown origin) using Bad peptide NH2-AGAGRSRHSSYPAGT-OH as substrate measured after 10 mins in presence of ATP by luciferase-luciferin based Kinase-Glo luminescence assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4715870,1,Scientific Literature,J Med Chem,2020,None,TIME = 0.1667 hr
CHEMBL3935096,,None,386.46,0,2.51,BDBM248906,Cc1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CCC[C@H](N)C3)n2)n1,Ki,'=',0.499,nM,9.3,,434113,UO_0000065,24.07,0.44,6.79,9.43,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4098659,,None,383.88,0,2.74,1,CN1CCN(c2ccc(-c3cc4c(Cl)cc(C(N)=O)nc4n3C)cc2)CC1,IC50,'>',30000,nM,,,,UO_0000065,,,,,0,CHEMBL4047363,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4043238,1,Scientific Literature,Bioorg Med Chem Lett,2017,None,
CHEMBL3973689,,None,414.42,1,5.06,BDBM192565,Nc1cccc(-c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)c1,IC50,'=',121,nM,6.92,,344557,UO_0000065,16.69,0.3,1.86,8.53,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1909374,GW709042A,None,585.95,2,7.41,GW709042A,Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F,Inhibition,'=',-0.13,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL2031893,,None,528.54,2,5.23,1,COc1cc2nccc(Oc3ccc(NC(=O)c4c(C)n(C)n(-c5ccccc5)c4=O)cc3F)c2cc1OC,IC50,'=',25000,nM,4.6,,,UO_0000065,8.71,0.16,-0.63,4.76,0,CHEMBL2032475,Inhibition of PIM2,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2029218,1,Scientific Literature,J Med Chem,2012,None,
CHEMBL3905644,,None,348.41,0,3.15,BDBM238521,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1OC1CCC1,IC50,'=',12.3,nM,7.91,,416665,UO_0000065,22.7,0.42,4.76,9.9,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3897826,,None,334.42,0,3.73,BDBM238678,CC(C)(C)Nc1ccc2cccc(-c3cc4c([nH]3)CCNC4=O)c2n1,IC50,'=',1.11,nM,8.96,,416787,UO_0000065,26.78,0.49,5.22,12.83,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL509032,TAE-684,None,614.22,2,5.02,TAE684,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,Activity,'=',107,%,,,,UO_0000187,,,,,0,CHEMBL2015709,Inhibition of PIM2 assessed as residual activity at 10 uM relative to control,B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2010643,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL4546802,BAY-4900,None,437.24,1,5.07,EUB0000709,Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21,% Control,,88,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507274,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 100.0 nM
CHEMBL4521594,BAY-1797,None,416.89,0,3.96,EUB0000309,NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1,% Control,,100,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507265,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL1084546,PF-00562271,1,507.5,1,3.14,SID103905684,CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL404367,,None,372.43,0,4.17,SID103904339,Cc1cccc(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1968791,,None,467.62,1,5.61,SID103904993,Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CC(CN2CCCC2)C1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2002682,,None,600.16,2,6.68,SID103905173,Cc1cccc(Cl)c1-c1cccc2c(CCCOc3cccc4ccccc34)c(C(=O)NCCOCCOCCN)[nH]c12,Ki,'=',630.96,nM,6.2,,active,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL2003482,,None,275.74,0,2.73,SID103905510,O=C(Cc1ccc(Cl)cc1)Nc1[nH]nc2c1CCC2,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL1988300,,None,383.48,1,5.17,SID103905092,Nc1ccc(-c2csc3c(C=Cc4nc5ccccc5[nH]4)cnc(N)c23)cc1,Ki,'>',1584.89,nM,,,inactive,UO_0000065,,,,,0,CHEMBL1963820,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM2,F,BAO_0000019,assay format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1201862,7,PubChem BioAssays,,,None,
CHEMBL275666,,None,483.47,1,5.88,SB-253226,Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1,Inhibition,'=',0.36,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL4878958,,None,567.65,1,4.98,31,COc1ncc2cc1NS(=O)(=O)c1ccc(F)c(c1)C(=O)NCc1ccc(s1)-c1ncnc3c(C)c-2sc13,IC50,'=',8.04,nM,8.1,,,UO_0000065,14.26,0.29,3.11,6.57,0,CHEMBL4845577,Inhibition of PIM2 (unknown origin) using ARKRRRHPSGPPTA as peptide substrate by ADP Hunter Plus assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4842397,1,Scientific Literature,ACS Med Chem Lett,2021,None,
CHEMBL3897323,,None,435.48,0,3.99,BDBM192571,C[C@H]1C[C@H](N)CN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1,IC50,'=',0.8,nM,9.1,,344633,UO_0000065,20.89,0.39,5.11,10.78,1,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL517171,GSK-1713088A,None,568.05,2,5.6,GSK1713088A,CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1,Inhibition,'=',0.5,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3984232,,None,331.38,0,2.65,BDBM249065,Cc1cncc(-c2cc3c(cn2)cnn3-c2cccc(N(C)C)n2)n1,Ki,'=',9.69,nM,8.01,,434269,UO_0000065,24.18,0.44,5.36,11.04,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2017359,,None,353.83,0,4.95,9a,NC(=O)c1cccc2c1nc(Nc1ccccc1Cl)c1ccsc12,IC50,'=',12,nM,7.92,,,UO_0000065,22.39,0.45,2.97,11.65,0,CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2016532,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL3919616,,None,409.49,0,2.79,BDBM238813,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(CCCO)c(NC(C)(C)C)nc34)[nH]c21,IC50,'=',0.11,nM,9.96,,416922,UO_0000065,24.32,0.45,7.17,8.89,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3934383,,None,412.46,0,1.03,BDBM249069,OCC#Cc1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CCNCC3)n2)n1,Ki,'=',0.228,nM,9.64,,434273,UO_0000065,23.38,0.42,8.61,9.19,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3974800,,None,387.45,0,2.15,BDBM249057,Cc1cncc(-c2cc3c(cn2)cnn3-c2cccc(C3(O)CCCNC3)n2)n1,Ki,'=',5.56,nM,8.26,,434261,UO_0000065,21.31,0.39,6.1,8.12,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3958785,,None,398.47,0,2.56,BDBM248934,c1cc(N2CCNCC2)nc(-n2ncc3cnc(-c4cncc(C5CC5)n4)cc32)c1,Ki,'=',1.14,nM,8.94,,434141,UO_0000065,22.44,0.41,6.38,10.56,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3634764,,None,378.44,0,0.37,29,O=C1CN(c2cc3c(-c4cccc(N5CCNCC5)n4)n[nH]c3cn2)CCN1,Ki,'=',17,nM,7.77,,,UO_0000065,20.53,0.38,7.4,7.61,0,CHEMBL3636741,Inhibition of Pim2 (unknown origin) using 5FAM-ARKRRRHPSGPPTA as substrate after 90 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632547,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL3918196,,None,379.46,0,2.79,BDBM238619,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC(C)(C)CCO,IC50,'=',1,nM,9,,416726,UO_0000065,23.72,0.44,6.21,8.74,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3925655,,None,547.02,2,5.38,BDBM191130,CN1CCN(Cc2ccc(-c3c(-c4cccc(OC(F)(F)F)c4)cc4n3[C@@H](CCCl)CNC4=O)cc2)CC1,IC50,'=',99,nM,7,,341801,UO_0000065,12.8,0.25,1.62,14.08,0,CHEMBL3887520,Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4128740,,None,382.47,0,4.14,18,CN(C)CCNc1cncc(-c2ccc3[nH]cc(-c4cccc(C#N)c4)c3c2)n1,IC50,'=',770,nM,6.11,,,UO_0000065,15.98,0.29,1.97,7.58,0,CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4118246,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL3955604,,None,401.47,0,2.81,BDBM249064,COC1(c2cccc(-n3ncc4cnc(-c5cncc(C)n5)cc43)n2)CCCNC1,Ki,'=',1.43,nM,8.85,,434268,UO_0000065,22.03,0.4,6.03,9.76,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3937054,,None,355.4,0,3.65,BDBM238411,O=C1NCCc2[nH]c(-c3cccc4ccc(Nc5cccnc5)nc34)cc21,IC50,'=',0.7,nM,9.15,,416186,UO_0000065,25.76,0.46,5.5,11.07,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1091513,MRK-560,None,517.93,1,4.67,EUB0000750,O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F,% Control,,100,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507288,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL3931279,,None,371.45,0,3.05,BDBM248935,Cc1cncc(-c2cc3c(cn2)cnn3-c2cccc(C3CCNCC3)n2)n1,Ki,'=',4.62,nM,8.34,,434142,UO_0000065,22.44,0.41,5.29,10.24,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3932047,,None,471.58,0,2.84,BDBM238821,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(CCCS(C)(=O)=O)c(NC(C)(C)C)nc34)[nH]c21,IC50,'=',0.3,nM,9.52,,416930,UO_0000065,20.19,0.39,6.68,7.56,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3946176,,None,379.46,0,3.33,BDBM238818,CC[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C)c(NC(C)(C)C)nc34)[nH]c21,IC50,'=',0.8,nM,9.1,,416927,UO_0000065,23.97,0.44,5.77,9.91,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3959083,,None,389.46,0,2.18,BDBM248999,Cn1cc(-c2cc3c(cn2)cnn3-c2cccc(C3(O)CCCNCC3)n2)cn1,Ki,'=',63.3,nM,7.2,,434206,UO_0000065,18.48,0.34,5.02,7.68,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3983224,,None,412.5,0,2.77,BDBM249062,Cc1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CCCC4(CNC4)C3)n2)n1,Ki,'=',1.48,nM,8.83,,434266,UO_0000065,21.41,0.39,6.06,10.43,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3959091,,None,401.48,0,1.96,BDBM248977,Cc1nc(-c2cc3c(cn2)cnn3-c2cccc(N3CCCNCC3)n2)cnc1N,Ki,'=',0.748,nM,9.13,,434184,UO_0000065,22.73,0.42,7.17,8.25,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4126252,,None,425.46,1,5.28,13,CN(C)CCNc1cncc(-c2ccc3[nH]cc(-c4ccc(C(F)(F)F)cc4)c3c2)n1,IC50,'=',5800,nM,5.24,,,UO_0000065,12.31,0.23,-0.04,9.21,0,CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4118246,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL3961360,,None,418.46,0,1.05,BDBM249047,OCCOc1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CCNCC3)n2)n1,Ki,'=',2.62,nM,8.58,,434251,UO_0000065,20.51,0.38,7.53,7.52,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3929011,,None,385.48,0,3.57,BDBM248979,Cc1cncc(-c2cc3c(cn2)cnn3-c2cccc(C3CCCC(N)C3)n2)n1,Ki,'=',9.39,nM,8.03,,434186,UO_0000065,20.82,0.38,4.46,8.41,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3394066,,None,362.46,0,3.93,BDBM50061627,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(N5CCCC5)n4)c3c2)s1,IC50,'=',41.98,nM,7.38,,393038,UO_0000065,20.35,0.39,3.45,8.81,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3582478,MSD-CYP11B2,None,311.36,0,3.8,EUB0000313,CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1,% Control,,100,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507294,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL3907493,,None,457.54,0,1.64,BDBM249049,OC[C@@H]1CCCN1c1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CCNCC3)n2)n1,Ki,'=',18,nM,7.75,,434253,UO_0000065,16.93,0.31,6.1,7.16,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3971171,,None,423.52,0,3.07,BDBM238656,COCCOCC(C)(C)Nc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2nc1C,IC50,'=',14.7,nM,7.83,,416765,UO_0000065,18.49,0.35,4.76,7.74,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3963946,,None,388.48,0,2.63,BDBM248902,CCn1cc(-c2cc3c(cn2)cnn3-c2cccc(N3CCC[C@H](N)C3)n2)cn1,Ki,'=',4.56,nM,8.34,,434109,UO_0000065,21.47,0.39,5.71,9.2,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3685734,,None,429.47,1,5.61,BDBM124897,NC1C=C(c2ccncc2Nc2cccc3cnc(-c4c(F)cccc4F)nc23)CCC1,IC50,'=',392,nM,6.41,,254199,UO_0000065,14.92,0.27,0.8,8.35,0,CHEMBL3705221,ATP Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 ul per well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3358954,BI 653048,1,515.53,1,3.8,EUB0000314,CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1,% Control,,100,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507277,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL4082756,TP-024,None,392.36,0,3.73,EUB0000317,Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O,% Control,,83,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507305,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL3941232,,None,471.48,0,4.19,BDBM191132,Cc1cccc(-c2c(-c3cccc(OC(F)(F)F)c3)cc3n2[C@@H](CCNC(=N)N)CNC3=O)c1,IC50,'=',12,nM,7.92,,341803,UO_0000065,16.8,0.32,3.73,7.53,0,CHEMBL3887520,Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3976993,,None,371.47,0,4.67,BDBM238379,O=C1NCCc2[nH]c(-c3cccc4ccc(Sc5ccccc5)nc34)cc21,IC50,'=',11.5,nM,7.94,,416157,UO_0000065,21.37,0.4,3.27,13.74,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3966805,,None,355.4,0,4.31,BDBM238410,O=C1NCCc2[nH]c(-c3cccc4ccc(Oc5ccccc5)nc34)cc21,IC50,'=',13.9,nM,7.86,,416185,UO_0000065,22.11,0.4,3.55,11.73,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3968854,,None,377.45,0,3.09,BDBM238778,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C)c(NC5(C)CCC5)nc34)[nH]c21,IC50,'=',0.13,nM,9.89,,416887,UO_0000065,26.19,0.48,6.8,10.77,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3949162,,None,457.46,0,3.32,BDBM251571,Nc1ncc(-c2ccccc2C(F)(F)F)nc1C(=O)Nc1cnccc1N1CCCC(N)C1,IC50,'=',490,nM,6.31,,438365,UO_0000065,13.79,0.26,2.99,5.13,0,CHEMBL3889161,In Vitro Caliper Kinase Assay: For comparison between certain PKC inhibitors of the present application and structurally comparable PIM kinase inhibitors,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3957078,,None,306.39,0,4.4,BDBM224956,CNc1nnc(-c2ccc3[nH]cc(-c4ccccc4)c3c2)s1,IC50,'=',1948.12,nM,5.71,,393246,UO_0000065,18.64,0.35,1.31,10.65,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3963379,,None,462.55,0,3.64,BDBM238421,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@@H]1CCN(C(=O)OC(C)(C)C)C1,IC50,'=',116,nM,6.94,,416619,UO_0000065,14.99,0.28,3.3,6.18,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3903837,,None,319.37,0,2.75,BDBM238699,Cc1nc2cccc(-c3cc4c([nH]3)CNC4=O)c2nc1NC1CC1,IC50,'=',0.297,nM,9.53,,416808,UO_0000065,29.83,0.54,6.78,11.52,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3908000,,None,335.37,0,3.08,BDBM224844,CC(C)Nc1ccnc(-c2c[nH]c3ccc(-c4nnc(N)o4)cc23)n1,IC50,'=',2.236,nM,8.65,,393029,UO_0000065,25.79,0.47,5.57,7.3,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3956295,,None,507.53,1,4.15,BDBM191112,CS(=O)(=O)c1ccc(-c2c(-c3cccc(OC(F)(F)F)c3)cc3n2[C@@H](CCCN)CNC3=O)cc1,IC50,'=',82,nM,7.09,,341783,UO_0000065,13.96,0.28,2.94,6.85,0,CHEMBL3887520,Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3967392,,None,541.62,1,4.49,BDBM191114,CN1CCN(Cc2ccc(-c3c(-c4cccc(OC(F)(F)F)c4)cc4n3[C@@H](CCCN)CNC4=O)cc2)CC1,IC50,'=',13,nM,7.89,,341785,UO_0000065,14.56,0.28,3.4,10.41,0,CHEMBL3887520,Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3676276,,None,399.56,0,4.01,BDBM131746,CC1CC(N)CN(c2ccncc2NC(=O)c2csc(C3CCCCC3)n2)C1,IC50,'=',18,nM,7.75,,263979,UO_0000065,19.38,0.38,3.73,9.2,0,CHEMBL3706072,Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3898204,,None,445.44,0,4.45,BDBM191107,NCCC[C@H]1CNC(=O)c2cc(-c3cccc(OC(F)(F)F)c3)c(-c3ccc(O)cc3)n21,IC50,'=',48,nM,7.32,,341778,UO_0000065,16.43,0.31,2.87,8.18,0,CHEMBL3887520,Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3634774,,None,337.39,0,0.46,24,NC(=O)Cc1cc2c(-c3cccc(N4CCNCC4)n3)n[nH]c2cn1,Ki,'=',1100,nM,5.96,,,UO_0000065,17.66,0.33,5.5,5.28,0,CHEMBL3636741,Inhibition of Pim2 (unknown origin) using 5FAM-ARKRRRHPSGPPTA as substrate after 90 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632547,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL3918797,,None,468.58,0,1.8,BDBM238759,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@H]1C[C@@H](NCCS(C)(=O)=O)C1,IC50,'=',1.3,nM,8.89,,416868,UO_0000065,18.96,0.37,7.09,6.9,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3634762,,None,350.43,0,2.28,27,c1cc(-c2n[nH]c3cnc(C4CCCO4)cc23)nc(N2CCNCC2)c1,Ki,'=',82,nM,7.09,,,UO_0000065,20.22,0.37,4.81,8.97,0,CHEMBL3636741,Inhibition of Pim2 (unknown origin) using 5FAM-ARKRRRHPSGPPTA as substrate after 90 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632547,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL3960858,,None,372.44,0,2.07,BDBM248944,c1cc(N2CCCNCC2)nc(-n2ncc3cnc(-c4cncnc4)cc32)c1,Ki,'=',196,nM,6.71,,434151,UO_0000065,18.01,0.33,4.64,7.92,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2312303,,None,505.45,1,4.49,31,O=C(NCCCN1CCCC1=O)c1cnc(NCc2cc(Cl)ccc2Cl)nc1NC1CCCC1,IC50,'>',30000,nM,,,,UO_0000065,,,,,0,CHEMBL2319122,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2311468,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL3973012,,None,494.5,0,3,BDBM191119,NCC[C@H]1CNC(=O)c2cc(-c3cccc(OC(F)(F)F)c3)c(-c3ccc(S(N)(=O)=O)cc3)n21,IC50,'=',3,nM,8.52,,341790,UO_0000065,17.24,0.34,5.52,6.58,0,CHEMBL3887520,Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3922035,,None,496.61,0,2.35,BDBM238786,COCCN(CCOC)CCC(C)(C)Nc1nc2c(-c3cc4c([nH]3)CNC4=O)cccc2c(=O)n1C,IC50,'=',36,nM,7.44,,416895,UO_0000065,14.99,0.28,5.09,6.56,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3979464,,None,470.6,0,2.04,BDBM238680,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC(C)(C)CNCCS(C)(=O)=O,IC50,'=',20.4,nM,7.69,,416789,UO_0000065,16.34,0.32,5.65,5.97,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2376152,,None,480.89,0,2.4,6i,C[C@@H](NC(=O)c1c[nH]c2ncc(-c3nn(C)c4cc(Cl)cc(F)c34)nc12)C(=O)N1CC(C#N)C1,Inhibition,'=',-64,%,,Outside typical range,,UO_0000187,,,,,0,CHEMBL2378211,Inhibition of PIM2 (unknown origin) at 10 uM relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2375236,1,Scientific Literature,Bioorg Med Chem Lett,2013,None,
CHEMBL4551344,A-1210227,None,904.37,3,8.88,EUB0000746,O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1,% Control,,73,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507310,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL3925557,,None,362.43,0,3.11,BDBM238458,O=C1NCCc2[nH]c(-c3cccc4ccc(NC5CCOCC5)nc34)cc21,IC50,'=',22.6,nM,7.65,,416202,UO_0000065,21.1,0.39,4.54,9.67,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3949372,,None,388.86,0,4.91,BDBM238413,O=C1NCCc2[nH]c(-c3cccc4ccc(Nc5cccc(Cl)c5)nc34)cc21,IC50,'=',14.3,nM,7.84,,416188,UO_0000065,20.17,0.38,2.93,11.24,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4108864,,None,391.5,0,3.61,BDBM224899,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(N5CCCC[C@@H]5N)n4)c3c2)s1,IC50,'=',3.702,nM,8.43,,393175,UO_0000065,21.54,0.41,4.82,7.68,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL5081774,,None,370.42,0,3.33,None,[2H]C([2H])([2H])C1(C([2H])([2H])[2H])Cn2nc(-c3ccc(F)cn3)c(-c3ccnc4[nH]ncc34)c2CO1,Inhibition,'=',-4,%,,,Not Active,UO_0000187,,,,,0,CHEMBL5059261,Pim-2(h) Kinase panel,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL5058645,54,Donated Chemical Probes - SGC Frankfurt,,2022,None,Compound concentration = 1.0 碌M
CHEMBL4802045,BAY-091,None,440.48,1,5.56,None,CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O,Inhibition,,6.42,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4888002,Pim-2(h) Millipore kinase panel,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4800729,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1.0 碌M
CHEMBL3896735,,None,376.45,0,3.46,BDBM224908,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(N5CCCC5=O)n4)c3c2)s1,IC50,'=',38.33,nM,7.42,,393189,UO_0000065,19.7,0.38,3.96,7.36,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3892029,,None,365.47,0,3.57,BDBM224902,CCN(CC)c1cncc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)n1,IC50,'=',20.03,nM,7.7,,393177,UO_0000065,21.06,0.4,4.13,7.97,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3394168,,None,377.47,0,4.65,BDBM50061612,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(OC5CCCC5)n4)c3c2)s1,IC50,'=',40.79,nM,7.39,,393186,UO_0000065,19.58,0.37,2.74,8.24,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3952561,,None,374.4,0,3.36,BDBM224990,c1cc(C2CC2)nc(-c2c[nH]c3ccc(-c4nnc(NC5COC5)o4)cc23)n1,IC50,'=',3.204,nM,8.49,,393279,UO_0000065,22.69,0.41,5.13,8.35,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3909227,,None,353.4,0,3.26,BDBM238681,CC(C)(C)Nc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2nc1F,IC50,'=',2.78,nM,8.56,,416790,UO_0000065,24.21,0.45,5.3,10.35,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3947213,,None,310.33,0,2.92,BDBM238524,Cc1nc2cccc(-c3cc4c([nH]3)C(C)CNC4=O)c2nc1F,IC50,'=',0.7,nM,9.15,,416671,UO_0000065,29.5,0.54,6.23,12.95,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3970295,,None,457.45,0,4.56,BDBM191099,CC(=O)c1ccc(-c2c(-c3cccc(OC(F)(F)F)c3)cc3n2[C@@H](CCN)CNC3=O)cc1,IC50,'=',17,nM,7.77,,341770,UO_0000065,16.98,0.32,3.21,9,0,CHEMBL3887520,Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP,,,,,,,,,,,,,,,,,,,,,,
CHEMBL2170610,BI 9627,None,356.35,0,2.05,EUB0000295,CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1,% Control,,100,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507279,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL332794,A-192621,None,558.68,2,5.81,EUB0000350,CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1,% Control,,91,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507261,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL1909375,GSK-614526A,None,525.49,0,1.34,GSK614526A,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F,Inhibition,'=',7.09,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL4088216,TP-030-1,None,402.45,0,2.35,EUB0000719,CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21,IC50,,1000,nM,,,,UO_0000065,,,,,0,CHEMBL4884810,Pim2(PIM2LHY1) Takeda global kinase panel,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507327,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1.0 碌M
CHEMBL3930142,,None,402.46,0,3.78,BDBM224981,C[C@H]1COCCN1c1nnc(-c2ccc3[nH]cc(-c4cncc(C5CC5)n4)c3c2)o1,IC50,'=',60.94,nM,7.21,,393273,UO_0000065,17.93,0.33,3.44,7.76,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3916316,,None,377.45,0,2.55,BDBM238516,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1(CO)CCC1,IC50,'=',7.9,nM,8.1,,416253,UO_0000065,21.47,0.4,5.55,7.87,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3910718,,None,376.42,0,3.46,BDBM225018,CNC(=O)c1cccc(-c2c[nH]c3ccc(-c4nnc(NC(C)C)o4)cc23)n1,IC50,'=',760,nM,6.12,,393308,UO_0000065,16.26,0.3,2.66,5.63,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL359999,GW801372X,None,348.37,0,2.95,GW801372X,COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1,Inhibition,'=',6.78,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL1794070,GSK-579289A,None,511.05,2,5.45,GSK579289A,C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl,Inhibition,'=',-4.35,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL507329,GW869810X,None,608.1,2,5.36,GW869810X,O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1,Inhibition,'=',0.28,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL2035619,,None,383.25,1,5.22,5b,CC(C)c1ccccc1-c1nc2c(oc3ccc(Br)cc32)c(=O)[nH]1,IC50,'=',5000,nM,5.3,,,UO_0000065,13.83,0.3,0.08,9,0,CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034948,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL2035608,,None,372.81,1,5.66,4g,O=c1[nH]c(-c2ccccc2Cl)nc2c1oc1ccc(-c3ccccc3)cc12,IC50,'=',5000,nM,5.3,,,UO_0000065,14.22,0.27,-0.36,9,0,CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL2034948,1,Scientific Literature,Bioorg Med Chem Lett,2012,None,
CHEMBL3924862,,None,358.41,0,4.13,BDBM224991,c1cc(C2CC2)nc(-c2c[nH]c3ccc(-c4nnc(NC5CC5)o4)cc23)n1,IC50,'=',1.41,nM,8.85,,393280,UO_0000065,24.69,0.45,4.72,9.57,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL443563,GW627512B,None,326.35,0,4.11,GW627512B,COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC,Inhibition,'=',1.06,%,,,,UO_0000187,,,,,0,CHEMBL1961995,GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3975787,,None,391.45,0,3.15,BDBM249005,Cn1cc(-c2cc3c(cn2)cnn3-c2cccc(C3(F)CCCNCC3)n2)cn1,Ki,'=',8.6,nM,8.07,,434212,UO_0000065,20.6,0.38,4.92,10.98,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3901533,,None,375.44,0,2.27,BDBM248896,CCn1cc(-c2cc3c(cn2)cnn3-c2cccc(N3CC[C@H](O)C3)n2)cn1,Ki,'=',30.7,nM,7.51,,434103,UO_0000065,20.01,0.37,5.24,8.85,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4073332,,None,383.28,0,3.22,Tab 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4090269,,None,397.31,0,3.12,Tab 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3916902,,None,424.46,0,2.74,BDBM248931,FC(F)Cn1cc(-c2cc3c(cn2)cnn3-c2cccc(N3CCCNCC3)n2)cn1,Ki,'=',2.26,nM,8.65,,434138,UO_0000065,20.37,0.38,5.91,11.27,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3900425,,None,445.42,0,3.66,BDBM249075,FC1CCNCC1c1cccc(-n2ncc3cnc(-c4cnn(CC(F)(F)F)c4)cc32)n1,Ki,'=',0.56,nM,9.25,,434279,UO_0000065,20.77,0.39,5.59,12.6,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL1952329,SGI-1776,1,405.42,0,4.05,SGI-1776,CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1,IC50,'=',363,nM,6.44,,,UO_0000065,15.88,0.3,2.39,11.78,1,CHEMBL4331756,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4330088,1,Scientific Literature,Eur J Med Chem,2019,None,
CHEMBL4125914,,None,417.49,0,4.61,46,CC(=O)c1ccc(F)c(-c2c[nH]c3ccc(-c4cncc(NCCN(C)C)n4)cc23)c1,IC50,'=',220,nM,6.66,,,UO_0000065,15.95,0.29,2.05,9.01,0,CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4118246,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL4086532,,None,454.1,0,3.52,Tab 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4102030,,None,455.13,0,3.39,Tab 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4568735,NVS-MALT1,None,574.03,1,4.72,EUB0000239,CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12,% Control,,100,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507320,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL4104355,,None,353.25,0,3.24,(S)-11,NC(=O)c1cc(Cl)c2c(Cl)c(C3CC3)n([C@H]3CCCNC3)c2n1,IC50,'=',6,nM,8.22,,,UO_0000065,23.27,0.49,4.98,11.27,0,CHEMBL4047363,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4043238,1,Scientific Literature,Bioorg Med Chem Lett,2017,None,
CHEMBL3953538,,None,389.47,0,1.89,BDBM248932,CCn1cc(-c2cc3c(cn2)cnn3-c2cncc(N3CCCNCC3)n2)cn1,Ki,'=',26.6,nM,7.58,,434139,UO_0000065,19.45,0.36,5.69,8.46,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4130159,,None,419.46,0,4.1,45,CN(C)CCNc1cncc(-c2ccc3[nH]cc(-c4cc(C(=O)O)ccc4F)c3c2)n1,IC50,'=',1426,nM,5.85,,,UO_0000065,13.94,0.26,1.75,6.21,0,CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4118246,1,Scientific Literature,Bioorg Med Chem Lett,2018,None,
CHEMBL3893598,,None,432.49,0,1.36,BDBM248976,COc1ccc(-n2ncc3cnc(-c4cncc(C)n4)cc32)nc1N1CCNCC(O)C1,Ki,'=',3.67,nM,8.44,,434183,UO_0000065,19.5,0.36,7.08,7.39,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4072887,,None,453.11,0,3.05,Tab 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3634767,,None,374.45,0,2.22,32,Cn1cc(-c2cc3c(-c4cccc(N5CCCNCC5)n4)n[nH]c3cn2)cn1,Ki,'=',0.17,nM,9.77,,,UO_0000065,26.09,0.48,7.55,11.16,0,CHEMBL3636741,Inhibition of Pim2 (unknown origin) using 5FAM-ARKRRRHPSGPPTA as substrate after 90 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632547,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL1794073,GW770220A,None,459.96,0,2.83,GW770220A,Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl,Inhibition,'=',0.22,%,,,,UO_0000187,,,,,0,CHEMBL1961994,GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn],B,BAO_0000357,single protein format,None,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1961873,16,GSK Published Kinase Inhibitor Set,,,None,
CHEMBL3955880,,None,379.46,0,3.31,BDBM238777,Cc1nc2cccc(-c3cc4c([nH]3)C(CCO)NC4=O)c2nc1NC(C)(C)C,IC50,'=',0.47,nM,9.33,,416886,UO_0000065,24.58,0.45,6.02,9.06,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3634770,,None,360.43,0,1.83,20,Cn1cc(-c2cc3c(-c4cccc(N5CCNCC5)n4)n[nH]c3cn2)cn1,Ki,'=',0.58,nM,9.24,,,UO_0000065,25.63,0.47,7.41,10.55,0,CHEMBL3636741,Inhibition of Pim2 (unknown origin) using 5FAM-ARKRRRHPSGPPTA as substrate after 90 mins,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3632547,1,Scientific Literature,Bioorg Med Chem Lett,2015,None,
CHEMBL3906357,,None,361.45,0,3.43,BDBM238626,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NCC1(C)CC1,IC50,'=',0.996,nM,9,,416782,UO_0000065,24.9,0.46,5.57,10.88,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3974822,,None,363.42,0,2.15,BDBM238760,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@H]1C[C@H](O)C1,IC50,'=',1.73,nM,8.76,,416869,UO_0000065,24.11,0.44,6.61,8.51,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3967448,,None,404.5,0,4.31,BDBM224969,CNc1nnc(-c2ccc3[nH]cc(-c4cccc(N5CCCCC5=O)n4)c3c2)s1,IC50,'=',538.32,nM,6.27,,393259,UO_0000065,15.5,0.3,1.96,7.22,0,CHEMBL3888378,Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3687469,,None,527.55,1,4.72,BDBM151865,COC(=O)N(C)[C@@H]1[C@H](C)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H]1N,IC50,'=',866.28,nM,6.06,,292121,UO_0000065,11.49,0.22,1.34,5.49,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3960752,,None,378.47,0,2.4,BDBM192541,c1cc(N2CCNCC2)c(Nc2ncc3ccc(-c4nccs4)nn23)cn1,IC50,'=',154,nM,6.81,,344533,UO_0000065,18,0.34,4.41,8.18,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4522930,BI-605906,None,432.52,0,2.49,None,CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12,% Ctrl,,99,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4887548,PIM2 Invitrogen Lab (UK) kinase screen (BI),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Assay technology: Z麓-LYTE | Mode of action: inhibitor | Target type: Kinase,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4800722,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1.0 碌M
CHEMBL4098877,MLi-2,None,379.46,0,3.56,EUB0000715,C[C@@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@H](C)O1,% Control,,88,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507291,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 100.0 nM
CHEMBL3986236,,None,476.58,0,4.03,BDBM238425,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@@H]1CCCN(C(=O)OC(C)(C)C)C1,IC50,'=',403,nM,6.39,,416623,UO_0000065,13.42,0.25,2.36,5.7,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3937248,,None,333.4,0,2.43,BDBM238509,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N1CCC1,IC50,'=',19.7,nM,7.71,,416653,UO_0000065,23.11,0.42,5.28,10.43,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3943939,,None,353.43,0,4.11,BDBM238396,O=C1NCCc2[nH]c(-c3cccc4ccc(Cc5ccccc5)nc34)cc21,IC50,'=',37,nM,7.43,,416155,UO_0000065,21.03,0.38,3.32,12.86,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4455582,BAY-693,None,529.57,1,3.59,EUB0000708,Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1,% Control,,100,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507268,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL3956734,,None,393.45,0,2.58,BDBM238430,COC(=O)C(C)(C)Nc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2nc1C,IC50,'=',54.3,nM,7.26,,416628,UO_0000065,18.47,0.34,4.69,6.67,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3986065,,None,404.47,0,2.3,BDBM238429,CC(=O)N[C@@H]1CC[C@@H]1Nc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2nc1C,IC50,'=',180,nM,6.75,,416629,UO_0000065,16.68,0.31,4.44,6.03,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3942827,,None,434.48,0,2.21,BDBM192594,C[C@H]1CN(c2ccncc2Nc2ncc3ccc(-c4ncccc4F)nn23)C[C@@H](N)[C@@H]1O,IC50,'=',1.3,nM,8.89,,344665,UO_0000065,20.45,0.38,6.68,7.56,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3978196,,None,373.39,0,3.79,BDBM238581,O=C1NCCc2[nH]c(-c3c(F)ccc4ccc(Nc5cccnc5)nc34)cc21,IC50,'=',0.9,nM,9.05,,416282,UO_0000065,24.23,0.44,5.26,10.94,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3910008,,None,392.49,0,2.92,BDBM192546,N[C@H]1CCCN(c2ccncc2Nc2ncc3ccc(-c4nccs4)nn23)C1,IC50,'=',3,nM,8.52,,344538,UO_0000065,21.71,0.42,5.6,8.76,1,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3931277,,None,376.42,0,1.92,BDBM238531,O=C1NCCn2cc(-c3cccc4ccc(C(=O)N5CCOCC5)nc34)cc21,IC50,'=',667,nM,6.18,,416257,UO_0000065,16.41,0.3,4.26,8.08,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4568183,SR-301,None,673.84,1,3.82,EUB0001060,CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1,% Control,,88,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507324,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 100.0 nM
CHEMBL3958307,,None,390.49,0,2.9,BDBM238510,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@@H]1CCC[C@H](N)C1,IC50,'=',0.2,nM,9.7,,416247,UO_0000065,24.84,0.46,6.8,8.92,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3950192,,None,343.82,0,2.45,BDBM192562,N[C@H]1CCCN(c2ccncc2Nc2ncc3ccc(Cl)nn23)C1,IC50,'=',99,nM,7,,344554,UO_0000065,20.37,0.4,4.55,8.3,1,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3966443,,None,379.46,0,4.6,BDBM238484,O=C1NCCc2[nH]c(-c3cccc4ccc(C5(c6ccccc6)CC5)nc34)cc21,IC50,'=',8.9,nM,8.05,,416222,UO_0000065,21.22,0.38,3.45,13.93,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4115547,,None,435.48,0,4.13,BDBM192633,C[C@@H]1[C@H](N)CCCN1c1ccncc1Nc1ncc2ccc(-c3c(F)cccc3F)nn12,IC50,'=',10.9,nM,7.96,,344655,UO_0000065,18.28,0.34,3.83,9.44,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3906127,,None,442.53,0,2.62,BDBM249019,Cc1cncc(-c2cc3c(cn2)cnn3-c2cc(C3COC3)cc(N3CCC[C@H](N)C3)n2)n1,Ki,'=',24.8,nM,7.61,,434223,UO_0000065,17.19,0.31,4.99,7.05,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4449080,,None,432.5,0,3.39,12,Cn1ncc(NC(=O)c2csc(-c3c(F)cccc3F)n2)c1N1CCC[C@H](N)CC1,Ki,'=',8.1,nM,8.09,,,UO_0000065,18.71,0.37,4.7,9.08,0,CHEMBL4317000,Inhibition of recombinant human PIM2 using FAM-pimtide as substrate after 90 mins by Z-LYTE assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4316591,1,Scientific Literature,J Med Chem,2019,None,
CHEMBL3342332,A-1155463,None,669.8,2,6.33,None,CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1,% Control,,100,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507311,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL3623162,,None,497.52,0,3.61,19,Cn1ncc(NC(=O)c2nc(-c3c(F)cccc3F)sc2N)c1N1CC[C@@](C)(N)CC(F)(F)C1,Ki,,,,,,Not Determined,,,,,,0,CHEMBL4317000,Inhibition of recombinant human PIM2 using FAM-pimtide as substrate after 90 mins by Z-LYTE assay,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4316591,1,Scientific Literature,J Med Chem,2019,None,
CHEMBL3936412,,None,365.44,0,2.92,BDBM238782,Cc1nc2cccc(-c3cc4c([nH]3)C(CO)NC4=O)c2nc1NC(C)(C)C,IC50,'=',2.16,nM,8.67,,416891,UO_0000065,23.71,0.44,5.75,8.42,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3917922,,None,382.47,1,5.21,BDBM238400,CC[C@@H]1CNC(=O)c2cc(-c3cccc4ccc(Nc5ccccc5)nc34)[nH]c21,IC50,'=',29.7,nM,7.53,,416177,UO_0000065,19.68,0.35,2.32,10.78,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3913500,,None,349.44,0,3.36,BDBM238534,Cc1nc2cccc(-c3cc4n(c3)CCNC4=O)c2nc1NC(C)(C)C,IC50,'=',3.5,nM,8.46,,416673,UO_0000065,24.2,0.44,5.1,11.77,0,CHEMBL3888800,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3900795,,None,435.48,0,4.13,BDBM192634,C[C@H]1[C@H](N)CCCN1c1ccncc1Nc1ncc2ccc(-c3c(F)cccc3F)nn12,IC50,'=',5.4,nM,8.27,,344656,UO_0000065,18.99,0.35,4.14,9.8,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3924352,,None,419.92,0,4.12,BDBM192542,N[C@H]1CCCN(c2ccncc2Nc2ncc3ccc(-c4ccccc4Cl)nn23)C1,IC50,'=',3,nM,8.52,,344534,UO_0000065,20.3,0.39,4.4,10.1,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4754930,,None,276.75,0,3.3,15,Clc1cccc(CSc2ncnc3[nH]cnc23)c1,Inhibition,,,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4734081,Inhibition of recombinant human GST-tagged PIM2 expressed in baculovirus expression system using serine/threonine-07 peptide as substrate at 10 uM by Z'-LYTE assay,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4732086,1,Scientific Literature,Eur J Med Chem,2021,None,Dose = 10.0 microM | TIME = 1.0 hr
CHEMBL3799292,(R)-9s,None,300.75,0,2.2,EUB0000300,C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N,% Control,,100,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507301,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL286721,AMINOPURVALANOL,None,403.92,0,3.82,K00613a,CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1,Thermal melting change,'=',-0.1,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL3980526,,None,377.45,0,2.81,BDBM238552,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1CCCOC1,IC50,'=',8.7,nM,8.06,,416275,UO_0000065,21.36,0.39,5.25,8.77,0,CHEMBL3888798,Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF庐 (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3687433,,None,498.51,0,3.1,BDBM151827,CC(=O)N[C@@H]1[C@H](N)CN(c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H]1C,IC50,'=',7.66,nM,8.12,,292083,UO_0000065,16.28,0.31,5.02,7.17,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL4531775,SR-321,None,512.58,2,5.91,EUB0000711,O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1,% Control,,100,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507315,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 100.0 nM
CHEMBL4566600,PPTN-NC,None,489.54,1,7.67,EUB0000337,Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12,% Control,,100,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507292,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL3947309,,None,384.45,0,2.33,BDBM249043,C=Cc1cncc(-c2cc3c(cn2)cnn3-c2cccc(N3CCNCC3)n2)n1,Ki,'=',4.26,nM,8.37,,434247,UO_0000065,21.77,0.39,6.04,9.89,0,CHEMBL3889102,Kinase Binding Assay: PIM-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3911258,,None,421.46,0,3.74,BDBM192596,N[C@@H]1CCCN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1,IC50,'=',35.2,nM,7.45,,344668,UO_0000065,17.68,0.33,3.71,8.83,0,CHEMBL3887609,PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL5084426,,None,534.52,1,4.35,None,COc1cnccc1Nc1nc(-c2nn(Cc3c(F)cc(OCCO)cc3F)c3ccccc23)ncc1OC,Inhibition,'=',100,%,,,Not Active,UO_0000187,,,,,0,CHEMBL5059930,PIM2 DiscoveRx kinase panel,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL5058649,54,Donated Chemical Probes - SGC Frankfurt,,2022,None,Compound concentration = 1.0 碌M
CHEMBL406821,,None,319.43,0,1.92,K00003,Cc1cncc2cccc(S(=O)(=O)N3CCCNC[C@@H]3C)c12,Thermal melting change,'=',0.7,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL258765,FASCAPLYSIN CHLORIDE,None,306.75,0,3.14,K00073,O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21.[Cl-],Thermal melting change,'=',-2.4,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL4777342,,None,418.79,0,3.64,21,Cn1cc(NC(=O)c2cnn3cccnc23)c(-c2cc(Cl)ccc2OC(F)F)n1,Inhibition,'=',2,%,,,,UO_0000187,,,,,0,CHEMBL4666957,Inhibition of recombinant human GST-tagged full length PIM2 expressed in baculovirus expression system using Ser/Thr 07 as substrate at 0.1 uM incubated for 60 mins by Z'-lyte assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4665643,1,Scientific Literature,Bioorg Med Chem Lett,2019,None,Dose = 0.1 microM | TIME = 1.0 hr
CHEMBL4531220,BI 3047,None,515.53,1,3.8,EUB0000586,CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1,% Control,,99,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507277,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL4752776,,None,358.47,0,4.75,11s; SGC-STK17B-1,O=C(O)CSc1ncnc2cc(-c3cc4ccccc4s3)sc12,IC50,'>',10000,nM,,,,UO_0000065,,,,,0,CHEMBL4723785,Inhibition of human PIM2 in presence of ATP at Km level,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4715866,1,Scientific Literature,J Med Chem,2020,None,
CHEMBL3430786,,None,None,None,None,K00565a,,Thermal melting change,'=',-5,degrees C,,,,UO_0000027,,,,,0,CHEMBL3430828,Delta TM value showing the stabilisation of PIM2 produced by compound binding,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc Natl Acad Sci U S A,2007,None,
CHEMBL3687420,,None,522.54,1,3.74,BDBM151813,Cc1cn([C@@H]2[C@H](N)CN(c3ccncc3NC(=O)c3ccc(F)c(-c4c(F)cccc4F)n3)C[C@@H]2C)nn1,IC50,'=',1.39,nM,8.86,,292069,UO_0000065,16.95,0.32,5.12,7.71,0,CHEMBL3707802,AlphaScreen Assay: Pim 1,,,,,,,,,,,,,,,,,,,,,,
CHEMBL3427179,,None,308.38,0,2.73,11,CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@H]1C(=O)O,Activity,'=',64,%,,,,UO_0000187,,,,,0,CHEMBL3427823,Inhibition of PIM2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3425453,1,Scientific Literature,Eur J Med Chem,2015,None,
CHEMBL4518706,PF-00911705,None,508.49,1,2.53,EUB0000702,CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O,% Control,,100,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507299,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL607535,MEISOINDIGO,None,276.3,0,2.53,Meisoindigo,CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21,Activity,'=',100,%,,,,UO_0000187,,,,,0,CHEMBL4806147,Inhibition of DNA-tagged human PIM2 assessed as percent of control at 50000 nM by qPCR analysis relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4804284,38,Patent Bioactivity Data,,,None,Dose = 50000.0 nM
CHEMBL4793380,,None,423.48,0,4.34,17d,CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1,Activity,'=',88,%,,,,UO_0000187,,,,,0,CHEMBL4766887,Inhibition of recombinant human Pim2 (2 to end residues) assessed as residual activity at 10 uM using RSRHSSYPAGT as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4765237,1,Scientific Literature,Eur J Med Chem,2018,None,Dose = 10.0 microM | TIME = 0.6667 hr
CHEMBL4778578,,None,324.79,0,2.36,27,Cc1cn([C@@H](C)[C@]2(F)CCNC2)c2nc(C(N)=O)cc(Cl)c12,IC50,'=',6,nM,8.22,,,UO_0000065,25.31,0.51,5.86,11.27,0,CHEMBL4704282,Inhibition of PIM2 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4699590,1,Scientific Literature,Bioorg Med Chem Lett,2020,None,
CHEMBL4516843,BAY-207,None,477.37,1,5.1,EUB0000548,NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1,% Control,,76,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507265,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL4637601,,None,428.66,1,7.2,12,CN(C)[C@@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)C(c4cccc5cnccc45)=CC[C@@H]32)C1,Inhibition,'>',80,%,,,,UO_0000187,,,,,0,CHEMBL4620284,Inhibition of biotinylated ligand binding to wild-type human partial length PIM2 (M1 to E291 residues) expressed in bacterial expression system at 50 nM measured after 1 hr by kinomescan assay relative to control,B,BAO_0000019,assay format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4619723,1,Scientific Literature,Bioorg Med Chem,2020,None,
CHEMBL4075278,,None,417.85,0,4.43,EUB0000316,O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1,% Control,,84,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507304,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL3337894,T-26c,None,479.51,0,3.34,EUB0000729,COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1,% Control,,100,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507300,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL2204283,MSD-M1PAM-NC,None,441.54,0,2.99,EUB0000344,N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1,% Control,,77,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507295,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL4802042,JNJ-54119936,None,581.12,2,6.17,None,COc1nc2ccc([C@@](O)(c3ccccc3)C3CCN(C(C)=O)CC3)cc2c(Cl)c1Cc1ccc(-n2cccn2)cc1,Inhibition,,1,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4888372,Pim2 Invitrogen kinase panel,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4800728,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 10.0 碌M
CHEMBL4630641,A-769,None,339.47,0,3,EUB0000332,CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1,% Control,,96,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507260,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL4458424,BAY-899,None,459.46,1,5.12,EUB0000240,O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1,% Control,,94,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507317,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL1971943,BAY-549,None,402.79,0,4.71,EUB0000716,Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12,% Control,,100,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507274,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 100.0 nM
CHEMBL3427180,,None,308.38,0,2.73,12,CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@@H]1C(=O)O,Activity,'=',35,%,,,,UO_0000187,,,,,0,CHEMBL3427823,Inhibition of PIM2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL3425453,1,Scientific Literature,Eur J Med Chem,2015,None,
CHEMBL4855726,,None,504.02,2,2.53,B3,Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1,Activity,'>',75,%,,,,UO_0000187,,,,,0,CHEMBL4807956,Inhibition of PIM2 (unknown origin) assessed as residual activity measured at 1 uM,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4806967,38,Patent Bioactivity Data,,,None,Dose = 1.0 microM
CHEMBL4630642,BAY-974,None,422.49,0,4.42,EUB0000707,CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1,% Control,,91,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507319,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
CHEMBL3589752,IPP/CNRS-A017,None,403.4,1,5.45,EUB0000276,Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F,% Control,,99,%,,,Not Active,UO_0000187,,,,,0,CHEMBL4879895,KinomeScan assay: inhibition of PIM2,B,BAO_0000357,single protein format,Homo sapiens,None,None,None,None,Amino acid Start/Stop: M1/E291 | Expression system: bacterial | Kinase construct length: Partial Length | Kinase form: Wild Type,,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,SINGLE PROTEIN,CHEMBL4507312,54,Donated Chemical Probes - SGC Frankfurt,,2021,None,Compound concentration None 1000.0 nM
